Molecule ChEMBL ID,Molecule Name,Molecule Max Phase,Molecular Weight,#RO5 Violations,AlogP,Compound Key,Smiles,Standard Type,Standard Relation,Standard Value,Standard Units,pChEMBL Value,Data Validity Comment,Comment,Uo Units,Ligand Efficiency BEI,Ligand Efficiency LE,Ligand Efficiency LLE,Ligand Efficiency SEI,Potential Duplicate,Assay ChEMBL ID,Assay Description,Assay Type,BAO Format ID,BAO Label,Assay Organism,Assay Tissue ChEMBL ID,Assay Tissue Name,Assay Cell Type,Assay Subcellular Fraction,Assay Parameters,Assay Variant Accession,Assay Variant Mutation,Target ChEMBL ID,Target Name,Target Organism,Target Type,Document ChEMBL ID,Source ID,Source Description,Document Journal,Document Year,Cell ChEMBL ID,Properties,Action Type,Standard Text Value,Value
CHEMBL151713,,None,454.57,1,5.31,26,CC(C)(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL820689,Inhibition of Vascular endothelial growth factor receptor 2 autophosphorylation by VEGF in human umbilical vein endothelial cells (HUVECs) at 50 nM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,CHEMBL3307501,,,,100
CHEMBL359084,,None,410.47,0,4.19,17,CC(=O)c1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',187,nM,6.73,,,UO_0000065,16.39,0.3,2.54,9.43,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,187
CHEMBL149636,,None,442.58,1,5.24,29,CCSCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',21,nM,7.68,,,UO_0000065,17.35,0.33,2.44,14.15,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,21
CHEMBL208229,,None,419.49,1,5.72,45,c1ccc(-c2ccc(Nc3nnc(-c4cccnc4CCc4ccncc4)o3)cc2)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,
CHEMBL208363,,None,411.39,1,5.07,30,FC(F)(F)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1,IC50,'=',720,nM,6.14,,,UO_0000065,14.93,0.28,1.07,8.01,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.72
CHEMBL424321,,None,454.57,1,5.31,25,CCCCOCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL820688,Inhibition of Vascular endothelial growth factor receptor 2 autophosphorylation by VEGF in human umbilical vein endothelial cells (HUVECs) at 200 nM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,CHEMBL3307501,,,,100
CHEMBL412102,,None,475.86,1,5.31,1l,Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc1)CCN2,IC50,'=',6,nM,8.22,,,UO_0000065,17.28,0.34,2.91,7.01,0,CHEMBL928167,Inhibition of KDR in presence of 1 mM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.006
CHEMBL296475,,None,290.33,0,2.89,5j,Cc1cc(C)cc(Nc2nccc(-n3ccnc3C#N)n2)c1,IC50,'=',232,nM,6.63,,,UO_0000065,22.85,0.41,3.74,8.35,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,232
CHEMBL1812379,,None,313.79,0,4.11,5b,Cc1ccc(-c2nc3cc(NC(=O)CCCl)ccc3[nH]2)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1817209,Inhibition of VEGFR-2 at 50 uM after 1 hrs by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1811776,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,
CHEMBL370545,,None,405.48,0,4.9,93,COc1cc(-c2csc3ncnc(N)c23)ccc1NC(=O)Nc1cccc(C)c1,IC50,'=',13,nM,7.89,,,UO_0000065,19.45,0.37,2.99,7.72,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,13
CHEMBL190132,,None,376.51,0,2.93,27,CN1CCN(CCCNc2cc3nc(N)c(-c4ccccc4)cc3cn2)CC1,IC50,'=',2900,nM,5.54,,,UO_0000065,14.71,0.27,2.61,7.88,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,2.9
CHEMBL191389,,None,544.53,2,5.57,34,CN1CCN(CCCNc2cc3nc(NC(=O)NC(C)(C)C)c(-c4c(Cl)cccc4Cl)cc3cn2)CC1,IC50,'=',14,nM,7.85,,,UO_0000065,14.42,0.29,2.28,9.19,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.014
CHEMBL185592,,None,486.64,1,5.34,C2,O=C1Nc2ccccc2S/C1=C\c1c[nH]c2c(C(=O)N3CCC(N4CCCCC4)CC3)cccc12,IC50,'=',170,nM,6.77,,,UO_0000065,13.91,0.26,1.43,9.89,0,CHEMBL832932,Inhibition of Vascular endothelial growth factor receptor 2(KDR) with DTT (dithiothreitol),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138015,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.17
CHEMBL183051,,None,373.48,0,4.93,21,Cc1cccc(N/C(S)=N\c2ccc(-c3cccc4c3CNC4=O)cc2)c1,IC50,'=',10000,nM,5,,,UO_0000065,13.39,0.25,0.07,9.35,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,10
CHEMBL362030,,None,309.32,0,3.25,7,COc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1,IC50,'=',3550,nM,5.45,,,UO_0000065,17.62,0.32,2.2,7.05,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,3.55
CHEMBL181959,,None,337.38,0,4.03,8,COc1ccc(-c2cc3c(NC(=O)C4CCCC4)ncnc3o2)cc1,IC50,'=',1020,nM,5.99,,,UO_0000065,17.76,0.33,1.96,7.76,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,1.02
CHEMBL2017301,,None,338.36,0,2.81,6,C#CCNC(=O)Nc1cccc(COc2ccc(C(=O)OC)cc2)c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2019278,Inhibition of human recombinant VEGFR2 expressed in insect cells using Ulight-CAGAGAIETDKEYYTVKD as substrate at 1 uM after 60 mins by fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016469,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,
CHEMBL3908050,,None,509.85,2,6.07,BDBM235392,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1F,IC50,'=',5.4,nM,8.27,,410027,UO_0000065,16.22,0.32,2.2,7.86,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903645,,None,587.57,2,6.64,BDBM235437,CC1CN(c2cc(NC(=O)Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)cc(C(F)(F)F)c2)CC(C)O1,IC50,'=',6.2,nM,8.21,,410072,UO_0000065,13.97,0.27,1.57,7.83,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986456,,None,485.47,1,5.82,BDBM235461,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1NC(=O)Nc1ccc(F)c(C(C)(F)F)c1,IC50,'=',13.3,nM,7.88,,410096,UO_0000065,16.22,0.31,2.06,7.48,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920945,,None,583.62,2,6.09,BDBM235468,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1NC(=O)Nc1ccc(NC2CCN(C)CC2)c(C(F)(F)F)c1,IC50,'=',13.3,nM,7.88,,410103,UO_0000065,13.5,0.26,1.79,6.54,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923206,,None,489.43,1,5.73,BDBM235482,Cc1cc(NC(=O)Nc2ccc(F)c(C(F)(F)F)c2)cc(Oc2cc(NC(=O)C3CC3)ncn2)c1,IC50,'=',192,nM,6.72,,410117,UO_0000065,13.72,0.26,0.99,6.38,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959805,,None,490.87,1,6.54,BDBM235527,O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',10.2,nM,7.99,,410162,UO_0000065,16.28,0.32,1.45,8.65,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959327,,None,551.5,2,7.09,BDBM235549,O=C(Nc1cc(-c2ccncc2)cc(C(F)(F)F)c1)Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)c(F)c1,IC50,'=',8,nM,8.1,,410184,UO_0000065,14.68,0.28,1.01,7.69,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985563,,None,543.48,2,6.15,BDBM235553,C=CC(=O)Nc1cc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)cc(C(F)(F)F)c1,IC50,'=',11.6,nM,7.94,,410188,UO_0000065,14.6,0.28,1.79,6.53,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983575,,None,559.52,2,5.86,BDBM235579,O=C(Nc1cc(N2CCOCC2)cc(C(F)(F)F)c1)Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)c(F)c1,IC50,'=',10.7,nM,7.97,,410214,UO_0000065,14.25,0.27,2.11,7.6,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974900,,None,404.5,1,5.5,BDBM234599,CCc1cccc(NC(=O)Nc2csc(-c3cc4ccccc4n3C(N)=O)c2)c1,IC50,'=',60,nM,7.22,,409012,UO_0000065,17.85,0.34,1.72,8.1,0,CHEMBL3888558,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL276711,SEMAXANIB,3,238.29,0,3.12,BDBM4810,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,IC50,'=',10600,nM,4.97,,423217,UO_0000065,20.88,0.38,1.85,11.08,1,CHEMBL3887187,Inhibition Assay: Inhibition of various kinase enzyme.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3886207,37,BindingDB Patent Bioactivity Data,,2016,None,,,,10600
CHEMBL3916527,,None,526.62,2,6.56,BDBM250513,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCC(C)(C)N)c4[nH]nc(N)c34)c3ccccc23)c1,IC50,'=',48.3,nM,7.32,,436753,UO_0000065,13.89,0.26,0.76,5.58,0,CHEMBL3889148,Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3928457,,None,367.41,0,4.19,BDBM201229,Nc1n[nH]c2cccc(C#Cc3cccc(NC(=O)Nc4ccccc4)c3)c12,IC50,'=',20,nM,7.7,,357208,UO_0000065,20.95,0.38,3.51,8.03,0,CHEMBL3887846,PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3262864,,None,534.55,1,3.7,11r,COc1cc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)ccc1O,Inhibition,'=',33.2,%,,,,UO_0000187,,,,,0,CHEMBL3271574,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 20 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259649,1,Scientific Literature,Eur J Med Chem,2014,None,,,,33.2
CHEMBL3977676,,None,432.59,1,5.45,BDBM236907,CSc1ncc2c(n1)CCN(c1cc(C)cc(C(=O)Nc3cccc(C(C)C)c3)c1)C2,IC50,'>',1000,nM,,,412726,UO_0000065,,,,,0,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702665,,None,398.39,0,4.31,BDBM139605,O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(N2CCc3ncncc3C2)c1,IC50,'=',19,nM,7.72,,412731,UO_0000065,19.38,0.36,3.41,13.29,1,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985794,,None,445.47,0,4.43,BDBM236909,CSc1ncc2c(n1)CCN(c1cncc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2,IC50,'>',10000,nM,,,412736,UO_0000065,,,,,0,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3644557,,None,472.59,0,4.13,BDBM139625,CC(C)c1cccc(NC(=O)c2cccc(N3CCc4c(cncc4C(=O)NCCCO)C3)c2)c1,IC50,'=',220,nM,6.66,,412751,UO_0000065,14.09,0.26,2.53,7.04,1,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3642830,,None,518.5,2,5.99,BDBM106553,C=CC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1C(F)(F)F,IC50,'=',3000,nM,5.52,,225331,UO_0000065,10.65,0.2,-0.47,5.07,0,CHEMBL3705145,Inhibition Assay (KDR): Compounds may be screened for their ability to inhibit KDR using a standard coupled enzyme assay (Fox et al.,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,13,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,'=',30,nM,7.52,,,UO_0000065,17.19,0.33,4.38,6.32,0,CHEMBL981072,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155848,1,Scientific Literature,J Med Chem,2008,None,,,,30
CHEMBL2023486,,None,432.48,0,4.51,20,CCc1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)ccc34)cc2OC)n[nH]1,IC50,'=',4,nM,8.4,,,UO_0000065,19.42,0.36,3.89,8.54,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.004
CHEMBL2023118,,None,432.48,0,4.44,6,CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)ccc34)cc2OC)cn1,IC50,'=',67,nM,7.17,,,UO_0000065,16.59,0.31,2.73,8.2,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.067
CHEMBL2023484,,None,432.48,0,4.51,18,CCc1c[nH]nc1NC(=O)Cc1ccc(Oc2ccnc3cc(OC)ccc23)cc1OC,IC50,'=',1277,nM,5.89,,,UO_0000065,13.63,0.25,1.38,5.99,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,1.277
CHEMBL2023474,,None,420.44,0,4.57,8,CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(F)ccc34)cc2OC)cn1,IC50,'=',4282,nM,5.37,,,UO_0000065,12.77,0.24,0.8,6.86,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,4.282
CHEMBL196422,,None,496.95,1,6.74,47,CC(C)(C)NC(=O)c1ccc(-c2nnc(Nc3ccc(OC(F)(F)Cl)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL401930,,None,479.97,0,3.86,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2031896,,None,526.57,2,5.79,11c,CCc1cc2c(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OC,Ki,'=',38,nM,7.42,,,UO_0000065,14.09,0.26,1.63,8.49,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,38
CHEMBL2016896,,None,400.44,0,3.61,12,O=C(OCc1ccccc1)N1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',600,nM,6.22,,,UO_0000065,15.54,0.28,2.61,6.83,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.6
CHEMBL2016899,,None,389.39,0,2.65,15,O=C(c1cccnc1)N1CCc2nc(-c3cc4c(F)cccc4[nH]c3=O)[nH]c2C1,IC50,'=',600,nM,6.22,,,UO_0000065,15.98,0.29,3.57,6.57,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.6
CHEMBL2016917,,None,391.48,0,2.29,33,O=C(CN1CCCCC1)N1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',16,nM,7.8,,,UO_0000065,19.91,0.37,5.51,9.16,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.016
CHEMBL2016913,,None,424.48,0,1.19,29,CN1CCN(CC(=O)N2CCc3nc(-c4cc5c(F)cccc5[nH]c4=O)[nH]c3C2)CC1,IC50,'=',1050,nM,5.98,,,UO_0000065,14.09,0.26,4.79,6.77,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,1.05
CHEMBL376245,,None,484.56,0,4.77,34e,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(OCCN4CCCC4=O)c4[nH]nc(N)c34)cc2)c1,IC50,'=',25,nM,7.6,,,UO_0000065,15.69,0.29,2.83,6.06,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,25
CHEMBL374752,,None,375.41,0,4.9,29c,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(F)c4[nH]nc(N)c34)cc2)c1,IC50,'=',5,nM,8.3,,,UO_0000065,22.11,0.4,3.4,8.66,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,5
CHEMBL4868291,,None,407.26,0,4.46,6,COc1cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c(Cl)c(OC)c1Cl,IC50,'>',2000,nM,,,,UO_0000065,,,,,0,CHEMBL4810140,Inhibition of human recombinant N-terminal His6-tagged VEGFR2 expressed in baculovirus infected Sf21insect cells using biotin-labeled EQEDEPEGDYFEWLE peptide as substrate incubated for 20 mins in presence of ATP by plate reader assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808209,1,Scientific Literature,J Med Chem,2021,None,TIME = 0.3333 hr,,,2000
CHEMBL1807479,,None,547.64,1,3.84,8t,O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(OCCN2CCOCC2)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1810161,Inhibition of recombinant GST-tagged VEGFR2 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1806486,1,Scientific Literature,Bioorg Med Chem,2011,CHEMBL3308860,,,,1
CHEMBL271984,,None,374.4,0,4.3,51,COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC,IC50,'=',0.8913,nM,9.05,,,UO_0000065,24.17,0.44,4.75,10.82,1,CHEMBL1244602,Inhibition of human VEGFR2 after 60 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240342,1,Scientific Literature,J Mol Graph Model,2009,None,,,,9.05
CHEMBL4785623,,None,465.56,0,3.38,40,Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(-c3cncc(F)c3)n[nH]c2c1,GI50,'=',1800,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,1.8
CHEMBL4781870,,None,450.57,0,2.58,43,Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(-c3ccn(C)n3)n[nH]c2c1,GI50,'=',351,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.351
CHEMBL539425,,None,350.41,0,3.54,14b,Oc1nc(NCc2ccccc2)nc(Nc2ccc3ncsc3c2)n1,IC50,'=',2000,nM,5.7,,,UO_0000065,16.26,0.31,2.16,5.95,0,CHEMBL831136,In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,None,,,,2
CHEMBL2036871,,None,321.34,0,1.19,7,Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2038040,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL200586,,None,196.23,0,1.72,5,COC(=O)c1cc2c(C)n[nH]c2s1,IC50,'=',23000,nM,4.64,,,UO_0000065,23.64,0.49,2.92,8.44,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,23
CHEMBL199996,,None,315.36,0,2.68,13h,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)Nc3ccccc3)c12,IC50,'=',20000,nM,4.7,,,UO_0000065,14.9,0.29,2.02,4.16,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,20
CHEMBL199737,,None,238.27,0,0.99,13a,CC(=O)Nc1c(C(N)=O)sc2[nH]nc(C)c12,IC50,'=',19000,nM,4.72,,,UO_0000065,19.81,0.4,3.73,4.68,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,19
CHEMBL199755,,None,325.44,0,4.35,9b,O=C(NC1CCCCC1)c1cc2c(-c3ccccc3)[nH]nc2s1,IC50,'=',490,nM,6.31,,,UO_0000065,19.39,0.37,1.96,10.92,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.49
CHEMBL199951,,None,263.37,0,3,8d,Cc1n[nH]c2sc(C(=O)NC3CCCCC3)cc12,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,20
CHEMBL200348,,None,279.37,0,2.4,7b,COC(=O)c1cc2c(CN3CCCCC3)n[nH]c2s1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,100
CHEMBL205823,,None,417.3,1,6.9,13,Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1Cl,IC50,'=',110,nM,6.96,,,UO_0000065,16.68,0.33,0.06,13.73,0,CHEMBL866514,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146055,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.11
CHEMBL203429,,None,418.5,1,5.27,38,O=C(Nc1ccc(Cc2ccccc2)cc1)c1ccccc1Cn1ccc2ncnc-2c1,IC50,'=',2120,nM,5.67,,,UO_0000065,13.56,0.24,0.4,9.49,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,2.12
CHEMBL206403,,None,360.39,0,4.13,31,Cc1ccc(NC(=O)c2ccccc2Cn2ccc3ncnc-3c2)c(F)c1,IC50,'=',210,nM,6.68,,,UO_0000065,18.53,0.34,2.55,11.16,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.21
CHEMBL195054,,None,374.47,0,4.81,64,Cc1cccc(NC(=O)c2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,50000
CHEMBL196934,,None,399.48,0,4.98,68,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)c2cc3ccccc3[nH]2)cc1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,50000
CHEMBL382517,,None,409.9,1,5.55,20,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1,IC50,'=',35,nM,7.46,,,UO_0000065,18.19,0.36,1.91,8.02,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,35
CHEMBL372174,,None,409.9,1,5.55,21,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1,IC50,'=',96,nM,7.02,,,UO_0000065,17.12,0.34,1.47,7.55,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,96
CHEMBL382112,,None,474.59,0,4.91,53,Cc1cccc(NC(=O)Nc2ccc(-c3c(CCC(=O)N(C)C)sc4ncnc(N)c34)cc2)c1,IC50,'=',210,nM,6.68,,,UO_0000065,14.07,0.27,1.77,5.9,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,210
CHEMBL369908,,None,466.57,1,5.88,83,Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4ccncc4)sc4ncnc(N)c34)cc2)c1,IC50,'=',53,nM,7.28,,,UO_0000065,15.59,0.29,1.4,6.88,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,53
CHEMBL196636,,None,446.58,0,5,87,Cc1cccc(NC(=O)Nc2ccc(-c3c(CCN(C)C)sc4ncnc(N)c34)cc2)c1,IC50,'=',230,nM,6.64,,,UO_0000065,14.86,0.28,1.64,6.9,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,230
CHEMBL196615,,None,409.9,1,5.55,92,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2Cl)c1,IC50,'=',83,nM,7.08,,,UO_0000065,17.27,0.35,1.53,7.62,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,83
CHEMBL2113172,,None,419.82,0,2.21,9c,COCCOc1cc2ncnc(NC3=CC(=O)C(OC)=C(Cl)C3=O)c2cc1OC,IC50,'<',1,nM,,,,UO_0000065,,,,,0,CHEMBL862696,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 1 mm ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1
CHEMBL3706824,,None,460.49,0,3.13,12,COCCOc1cc2ncnc(NC3=CC(=O)C(N(C)c4ccccc4)=CC3=O)c2cc1OC,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL3706823,,None,513.91,1,3.92,31,COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=C(Cl)C3=O)c2cc1OC,IC50,'<',1,nM,,,,UO_0000065,,,,,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1
CHEMBL200387,,None,399.4,0,2.03,36,CCOC1=CC(=O)C(Nc2ncnc3cc(OCCOC)c(OC)cc23)=CC1=O,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL200723,,None,438.48,0,2.34,60,COC1=CC(=O)C(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)=CC1=O,IC50,'=',239.3,nM,6.62,,,UO_0000065,15.1,0.28,4.28,6.44,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,239.3
CHEMBL2113184,,None,557.65,1,3.84,62,COc1cc2c(NC3=CC(=O)C(OCCN(C)c4ccccc4)=CC3=O)ncnc2cc1OCC1CCN(C)CC1,IC50,'=',5.8,nM,8.24,,,UO_0000065,14.77,0.27,4.4,7.76,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,5.8
CHEMBL3706843,,None,514.58,1,3.91,63,COc1cc2c(NC3=CC(=O)C(OCc4ccccc4)=CC3=O)ncnc2cc1OCC1CCN(C)CC1,IC50,'=',29.5,nM,7.53,,,UO_0000065,14.63,0.27,3.62,7.32,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,29.5
CHEMBL2113193,,None,502.52,1,3.16,65,COc1cc2c(NC3=CC(=O)C(OC(CF)CF)=CC3=O)ncnc2cc1OCCCN1CCCC1,IC50,'=',6.4,nM,8.19,,,UO_0000065,16.31,0.31,5.03,7.96,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,6.4
CHEMBL2113193,,None,502.52,1,3.16,65,COc1cc2c(NC3=CC(=O)C(OC(CF)CF)=CC3=O)ncnc2cc1OCCCN1CCCC1,IC50,'=',7.4,nM,8.13,,,UO_0000065,16.18,0.31,4.97,7.9,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,7.4
CHEMBL3706816,,None,538.6,1,4.23,70,C#CC(OC1=CC(=O)C(Nc2ncnc3cc(OCCCN4CCCC4)c(OC)cc23)=CC1=O)c1ccccc1,IC50,'=',10.4,nM,7.98,,,UO_0000065,14.82,0.27,3.75,7.76,0,CHEMBL862696,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 1 mm ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,10.4
CHEMBL2113164,,None,488.49,0,3.12,75,COc1cc2c(NC3=CC(=O)C(OCC(F)F)=CC3=O)ncnc2cc1OCCCN1CCCC1,IC50,'=',2.4,nM,8.62,,,UO_0000065,17.65,0.34,5.5,8.38,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,2.4
CHEMBL372657,,None,406.88,0,4.03,58,Clc1cccc(Nc2cncc(-c3cncc(NCCCn4cncn4)c3)n2)c1,IC50,'=',67.61,nM,7.17,,,UO_0000065,17.62,0.34,3.14,7.67,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,7.17
CHEMBL281948,K-252A,None,467.48,0,3.66,1 (K252a),COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',43,nM,7.37,,,UO_0000065,15.76,0.29,3.71,7.78,0,CHEMBL818399,Inhibition of VEGF-receptor 2 (KDR),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135387,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,43
CHEMBL268826,,None,451.56,1,6.56,12d,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccncc5)cnc(N)c34)cc2)c1,IC50,'=',5,nM,8.3,,,UO_0000065,18.38,0.34,1.74,8.93,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,5
CHEMBL181147,,None,354.37,0,2.76,11,COc1ccc(-c2cc3c(NC(=O)N4CCOCC4)ncnc3o2)cc1,IC50,'>',48000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,48
CHEMBL1681945,,None,417.81,0,3.43,4o,CO/N=C/c1c(N)ncnc1Oc1ccc(NC(=O)Nc2cc(C)on2)c(Cl)c1,IC50,'=',2,nM,8.7,,,UO_0000065,20.82,0.41,5.27,5.81,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,2
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,BIRB-796,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,Kd,'=',3900,nM,5.41,,,UO_0000065,10.25,0.19,-0.58,6.71,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,3900
CHEMBL2023224,,None,440.53,1,5.89,14,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cc[nH]n5)cnc(N)c34)cc2)c1,IC50,'=',6,nM,8.22,,,UO_0000065,18.66,0.35,2.33,7.56,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,6
CHEMBL2023227,,None,458.52,1,5.73,20,Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccccc5F)cc4)csc23)cn1,IC50,'=',3,nM,8.52,,,UO_0000065,18.59,0.35,2.79,8.71,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,3
CHEMBL2022854,,None,555.68,2,6.68,32,Nc1ncc(-c2cnn(CCN3CCCCC3)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,IC50,'=',4,nM,8.4,,,UO_0000065,15.11,0.29,1.72,8.31,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,4
CHEMBL2036727,,None,335.8,0,4.43,2c,Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21,IC50,'=',38000,nM,4.42,,,UO_0000065,13.16,0.25,-0.01,7.95,0,CHEMBL2038025,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL463931,GSK-2163632A,None,548.67,1,4.19,GSK2163632A,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C,Inhibition,'=',14.06,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,14.06
CHEMBL150894,CEP-5214,1,440.54,0,4.92,21,CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,Inhibition,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL820694,Inhibition of Vascular endothelial growth factor receptor 2 autophosphorylation by VEGF in human umbilical vein endothelial cells (HUVECs) at 10 nM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,CHEMBL3307501,,,,75
CHEMBL357490,,None,310.36,0,4.14,1,O=C1NCc2c1c1c(c3[nH]c4ccccc4c23)Cc2ccccc2-1,IC50,'=',110,nM,6.96,,,UO_0000065,22.42,0.4,2.82,15.5,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,110
CHEMBL502835,NINTEDANIB,4,539.64,1,3.62,Nintedanib,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,IC50,'=',3.3,nM,8.48,,,UO_0000065,15.72,0.29,4.86,9,0,CHEMBL3993992,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,3.3
CHEMBL2443139,,None,466.54,0,4.19,31,CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1,IC50,'>',10,nM,,,,UO_0000065,,,,,0,CHEMBL2443723,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2439976,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,10
CHEMBL2088108,,None,311.35,0,2.73,21,Cc1cc(Nc2ccnc(NCc3cc(C4CC4)no3)n2)n[nH]1,IC50,'=',794.33,nM,6.1,,,UO_0000065,19.59,0.36,3.37,5.83,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,6.1
CHEMBL5,NALIDIXIC ACID,4,232.24,0,1.42,nalidixic acid,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL991,STAVUDINE,4,224.22,0,-0.71,stavudine,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL22150,CHLORCYCLIZINE,2,300.83,0,3.68,chlorcyclizine,CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL278255,CLINAFLOXACIN,-1,365.79,0,2.36,clinafloxacin,NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3403515,,None,295.34,0,3.54,8,COc1ccc2c(c1)CCN2c1nc(C)nc2oc(C)cc12,IC50,'=',20.9,nM,7.68,,,UO_0000065,26,0.48,4.14,14.94,0,CHEMBL3404062,Inhibition of VEGFR2 in human U251 cells compound pretreated for 60 min before VEGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3400114,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307756,,,,20.9
CHEMBL187130,,None,421.52,0,3.96,C1,O=C1Nc2ccccc2S/C1=C\c1c[nH]c2cc(OCCN3CCOCC3)ccc12,IC50,'=',160,nM,6.8,,,UO_0000065,16.12,0.31,2.84,10.21,0,CHEMBL832932,Inhibition of Vascular endothelial growth factor receptor 2(KDR) with DTT (dithiothreitol),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138015,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.16
CHEMBL44577,,None,483.62,0,4.6,2,CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1,IC50,'=',5320,nM,5.27,,,UO_0000065,10.91,0.2,0.67,6.18,0,CHEMBL818935,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135159,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,5.32
CHEMBL181856,,None,338.37,0,3.53,12,COc1ccc(-c2cc3c(NC(=O)N4CCCC4)ncnc3o2)cc1,IC50,'=',12300,nM,4.91,,,UO_0000065,14.51,0.27,1.38,6.1,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,12.3
CHEMBL78303,,None,326.4,0,4.67,56,Cc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1,IC50,'=',80,nM,7.1,,,UO_0000065,21.74,0.39,2.43,14,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.08
CHEMBL45651,,None,555.69,1,4.46,1a,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)Nc1ccccc1,IC50,'=',263,nM,6.58,,,UO_0000065,11.84,0.22,2.12,5.2,1,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,263
CHEMBL324335,,None,406.51,0,3.84,4a,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cs1,IC50,'=',4,nM,8.4,,,UO_0000065,20.66,0.4,4.56,16.18,0,CHEMBL818936,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135002,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,4
CHEMBL483312,,None,397.4,1,5.09,14,Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,1,CHEMBL1115600,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157122,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,200
CHEMBL1096737,,None,411.28,1,5.39,22,Fc1ccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)cc1Br,IC50,'=',25200,nM,4.6,,,UO_0000065,11.18,0.24,-0.79,8.58,0,CHEMBL1115600,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157122,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,25.2
CHEMBL298566,,None,497.66,0,3.57,4n,CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2,IC50,'=',500,nM,6.3,,,UO_0000065,12.66,0.25,2.73,6.15,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.5
CHEMBL79475,,None,398.51,0,4.34,10,O=c1ccc(-c2ccc3c(c2)ncn3-c2ccccc2)cn1CCN1CCCCC1,IC50,'=',270,nM,6.57,,,UO_0000065,16.48,0.3,2.23,15.25,0,CHEMBL818933,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144948,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,270
CHEMBL47787,,None,570.7,1,4.56,6,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OCc1ccccc1,IC50,'=',34200,nM,4.47,,,UO_0000065,7.83,0.15,-0.09,3.61,0,CHEMBL698970,Inhibition of human VEGF-receptor 2 (kdr) kinase.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135159,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,34.2
CHEMBL179593,,None,445.48,1,5.7,6a,COc1ccc(NC(=O)Nc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)cc1,IC50,'=',1.1,nM,8.96,,,UO_0000065,20.11,0.37,3.26,9.85,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,1.1
CHEMBL178568,,None,460.45,1,5.6,6k,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc([N+](=O)[O-])cc4)cc3)c2cc1OC,IC50,'=',5.6,nM,8.25,,,UO_0000065,17.92,0.33,2.65,6.61,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,5.6
CHEMBL3354189,,None,392.51,0,4.3,8,COC1CCN(c2nccc(Nc3cc4c(ccn4C4CCCC4)cn3)n2)CC1,IC50,'=',2270,nM,5.64,,,UO_0000065,14.38,0.27,1.34,8.29,0,CHEMBL3375807,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351701,1,Scientific Literature,J Med Chem,2014,None,,,,2270
CHEMBL184997,,None,371.44,0,4.57,17,Cc1cccc(NC(=O)N(C)c2ccc(-c3cccc4c3CNC4=O)cc2)c1,IC50,'=',1100,nM,5.96,,,UO_0000065,16.04,0.29,1.39,9.7,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,1.1
CHEMBL361196,,None,280.29,0,2.63,19,O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CC1,IC50,'=',3240,nM,5.49,,,UO_0000065,19.58,0.36,2.86,6.78,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,3.24
CHEMBL183038,,None,307.35,0,4.02,20,O=C(Nc1ncnc2oc(-c3ccccc3)cc12)C1CCCC1,IC50,'>',23000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,23
CHEMBL3919838,,None,508.4,2,6.04,BDBM235604,O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)cc1F)Nc1cc(OC(F)(F)F)ccc1F,IC50,'=',9.4,nM,8.03,,410239,UO_0000065,15.79,0.3,1.99,7.9,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980939,,None,470.45,1,6.12,BDBM235607,CC(F)(F)c1cccc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)c1,IC50,'=',9.9,nM,8,,410242,UO_0000065,17.01,0.32,1.88,8.67,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976600,,None,484.48,1,6.43,BDBM235619,Cc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)cc1NC(=O)Nc1ccc(F)c(C(C)(F)F)c1,IC50,'=',13.4,nM,7.87,,410254,UO_0000065,16.25,0.31,1.44,8.53,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932357,,None,489.43,1,5.61,BDBM235629,Nc1cc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)cc(C(F)(F)F)c1,IC50,'=',9.7,nM,8.01,,410264,UO_0000065,16.37,0.31,2.4,6.77,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983434,,None,421.45,0,2.19,BDBM235819,COc1cc(C2=C(c3cn(CCN)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC,IC50,'=',1885,nM,5.72,,410840,UO_0000065,13.58,0.25,3.53,5.46,0,CHEMBL3888607,Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950267,,None,384.44,0,4.89,BDBM238841,Cc1cccc(NC(=O)Nc2ccc(-c3[nH]c4ccccc4c3C(N)=O)cc2)c1,IC50,'=',13,nM,7.89,,416961,UO_0000065,20.51,0.37,3,7.89,0,CHEMBL3888803,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL595143,,None,541.68,2,5.72,24,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',65,%,,,,UO_0000187,,,,,0,CHEMBL1073160,Residual activity of VEGFR2 at 0.1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,65
CHEMBL1256459,TORIN1,None,607.64,2,6.83,EUB0000092b,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,% of control,'=',65,%,,,% Of Control,UO_0000187,,,,,0,CHEMBL5477110,Selectivity interaction (KinomeScan (DiscoverX)) EUB0000092b KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Protein family: Protein kinase,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5465560,65,EUbOPEN Chemogenomic Library Literature Data,,2024,None,Selectivity number of off-targets = 24.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20064/results,,,65
CHEMBL3971161,,None,491.86,1,5.93,BDBM235402,O=C(Nc1cccc(Oc2cc(NC(=O)C3CC3)ncn2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',9.9,nM,8,,410037,UO_0000065,16.27,0.32,2.07,7.61,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917570,,None,505.43,2,5.61,BDBM235471,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1NC(=O)Nc1ccc(F)c(OC(F)(F)F)c1,IC50,'=',13.3,nM,7.88,,410106,UO_0000065,15.58,0.3,2.27,6.88,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3895044,,None,521.88,2,6.12,BDBM235472,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1NC(=O)Nc1ccc(Cl)c(OC(F)(F)F)c1,IC50,'=',6.8,nM,8.17,,410107,UO_0000065,15.65,0.31,2.05,7.14,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916488,,None,462.9,1,5.09,BDBM235476,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1NC(=O)Nc1ccc(C#N)c(Cl)c1,IC50,'=',8.3,nM,8.08,,410111,UO_0000065,17.46,0.33,2.99,6.26,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL595143,,None,541.68,2,5.72,24,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',40,%,,,,UO_0000187,,,,,0,CHEMBL1043839,Residual activity of VEGFR2 at 1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,40
CHEMBL151713,,None,454.57,1,5.31,26,CC(C)(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',11,nM,7.96,,,UO_0000065,17.51,0.32,2.65,12.54,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,11
CHEMBL151713,,None,454.57,1,5.31,26,CC(C)(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL818937,Inhibition of Vascular endothelial growth factor receptor 2 autophosphorylation by VEGF in human umbilical vein endothelial cells (HUVECs) at 10 nM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,CHEMBL3307501,,,,100
CHEMBL3935348,,None,560.51,2,5.26,BDBM235564,O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)c(F)c1)Nc1cc(C(F)(F)F)cc(N2CCOCC2)n1,IC50,'=',5.4,nM,8.27,,410199,UO_0000065,14.75,0.28,3.01,7.02,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3895175,,None,402.43,1,5.33,BDBM234595,Cc1ccc(F)c(NC(=O)Nc2cccc(-c3cc4ccccc4n3C(N)=O)c2)c1,IC50,'=',334,nM,6.48,,409008,UO_0000065,16.09,0.29,1.15,7.26,0,CHEMBL3888558,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2047251,,None,304.35,0,3.38,BDBM242729,COc1cccc(Nc2nc(N)nc3c2-c2ccccc2C3)c1,IC50,'=',43000,nM,4.37,,423219,UO_0000065,14.35,0.26,0.99,5.98,1,CHEMBL3887187,Inhibition Assay: Inhibition of various kinase enzyme.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3886207,37,BindingDB Patent Bioactivity Data,,2016,None,,,,43000
CHEMBL3909047,,None,549.61,1,2.05,BDBM208454,Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S(C)(=O)CC(=O)N3CC[C@H](O)C3)cnc2N)c1,IC50,'=',3,nM,8.52,,368367,UO_0000065,15.51,0.3,6.47,5.07,0,CHEMBL3888027,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980266,,None,446.53,0,4.3,BDBM208452,Cc1cccc(NC(=O)Nc2cccc(C#Cc3cncc(C(=O)N=S(C)(C)=O)c3)c2)c1,IC50,'=',11,nM,7.96,,368407,UO_0000065,17.82,0.34,3.66,7.92,0,CHEMBL3888028,VEGFR2 Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909047,,None,549.61,1,2.05,BDBM208454,Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S(C)(=O)CC(=O)N3CC[C@H](O)C3)cnc2N)c1,IC50,'=',3,nM,8.52,,368409,UO_0000065,15.51,0.3,6.47,5.07,0,CHEMBL3888028,VEGFR2 Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,B,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,IC50,'=',22,nM,7.66,,,UO_0000065,16.11,0.35,3.23,12.21,1,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.022
CHEMBL2011297,,None,355.38,0,4.19,BDBM50379224,N#Cc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1,IC50,'=',1300,nM,5.89,,421735,UO_0000065,16.56,0.3,1.7,7.31,1,CHEMBL3888877,Kinase Assay: FlashPlates from Perkin Elmer (Boston,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702634,,None,388.48,0,3.39,BDBM139574,CC(C)c1cccc(NC(=O)c2ccnc(N3CCc4nc(N)ncc4C3)c2)c1,IC50,'>',10000,nM,,,412700,UO_0000065,,,,,1,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932797,,None,419.55,0,4.53,BDBM236892,CSc1ncc2c(n1)CCN(c1cccc(C(=O)Nc3cccc(C(C)C)c3)n1)C2,IC50,'>',10000,nM,,,412711,UO_0000065,,,,,0,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,BDBM16673,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',11.1,nM,7.96,,436755,UO_0000065,17.11,0.34,2.4,8.61,0,CHEMBL3889148,Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL598727,,None,336.19,1,5.82,rac-2,CC(Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl,IC50,'=',32000,nM,4.5,,,UO_0000065,13.37,0.28,-1.33,20.32,0,CHEMBL1066394,Inhibition of recombinant KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,32000
CHEMBL1082755,,None,452.56,0,4.96,7m,C=CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',18,nM,7.75,,,UO_0000065,17.11,0.31,2.78,12.68,0,CHEMBL1119625,Inhibition of human recombinant VEGFR2 by time resolved fluorescence measurements,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,18
CHEMBL1085540,,None,470.57,0,4.16,7p,Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(CCCO)c13)CNC2=O,IC50,'=',16,nM,7.8,,,UO_0000065,16.57,0.3,3.64,9.59,0,CHEMBL1119625,Inhibition of human recombinant VEGFR2 by time resolved fluorescence measurements,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,16
CHEMBL1085541,,None,511.67,2,5.12,7q,CCN(CC)CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',16,nM,7.8,,,UO_0000065,15.24,0.28,2.68,12.12,0,CHEMBL1119625,Inhibition of human recombinant VEGFR2 by time resolved fluorescence measurements,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,16
CHEMBL1084062,,None,454.57,1,5.36,7e,CC(C)n1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'<',10,nM,,,,UO_0000065,,,,,0,CHEMBL1119626,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,CHEMBL3307501,,,,10
CHEMBL1083454,,None,480.61,1,5.89,7j,Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(C4CCCC4)c13)CNC2=O,IC50,'<',50,nM,,,,UO_0000065,,,,,0,CHEMBL1119626,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,CHEMBL3307501,,,,50
CHEMBL1085540,,None,470.57,0,4.16,7p,Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(CCCO)c13)CNC2=O,IC50,'<',50,nM,,,,UO_0000065,,,,,0,CHEMBL1119626,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,CHEMBL3307501,,,,50
CHEMBL189322,,None,543.67,2,6.51,42,COc1cc(OC)cc(-c2cc3cnc(NCCCCOc4ccccc4)cc3nc2NC(=O)NC(C)(C)C)c1,IC50,'=',180,nM,6.75,,,UO_0000065,12.41,0.23,0.23,6.33,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.18
CHEMBL1084634,,None,414.47,0,4.67,12,CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12,IC50,'=',48,nM,7.32,,,UO_0000065,17.66,0.32,2.65,7.24,0,CHEMBL1120723,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,0.048
CHEMBL465793,,None,459.51,1,6.15,5,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1,Inhibition,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,58
CHEMBL1084634,,None,414.47,0,4.67,12,CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,5
CHEMBL224497,,None,508.69,2,5.5,65,Cc1ccc(OCC#Cc2cc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)cs2)cc1C,IC50,'=',34,nM,7.47,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,34
CHEMBL390735,,None,494.62,0,4.53,78,CN1CCN(C(=O)c2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',29,nM,7.54,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,29
CHEMBL224027,,None,469.64,1,5.65,79,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(CN4CCSC4)ccc2-3)cs1)COc1ccccc1,IC50,'=',10,nM,8,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,10
CHEMBL223604,,None,442.54,1,5.17,80,COCCOc1ccc2c(c1)Cc1c(-c3csc(C#CCOc4ccccc4)c3)n[nH]c1-2,IC50,'=',92,nM,7.04,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,92
CHEMBL3952249,,None,361.4,0,2.82,BDBM214710,COc1ccc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)cc1,IC50,'=',5,nM,8.3,,377140,UO_0000065,22.97,0.42,5.48,10.35,0,CHEMBL3888173,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL236501,,None,470.69,1,6.27,12,C[C@H]1[C@H](C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)[C@](C)(C(=O)O)[C@@H]5CC[C@]43C)[C@H]12,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3405094,Inhibition of VEGFR-2 (unknown origin) at 50 uM after 1 hr by luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399926,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,0
CHEMBL3401905,,None,493.73,1,7.28,8,CC(=O)O[C@@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(C)C#N,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3405094,Inhibition of VEGFR-2 (unknown origin) at 50 uM after 1 hr by luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399926,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,0
CHEMBL3968883,,None,353.38,0,3.77,BDBM201208,O=C(Nc1ccccc1)Nc1ccc(C#Cc2ccc3nccn3n2)cc1,IC50,'=',267,nM,6.57,,357138,UO_0000065,18.6,0.33,2.8,9.22,0,CHEMBL3887844,PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904823,,None,420.84,0,4.15,BDBM201214,Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4ccc(F)c(Cl)c4)cn3n2)cc1,IC50,'=',1688,nM,5.77,,357144,UO_0000065,13.72,0.26,1.62,5.93,0,CHEMBL3887844,PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903593,,None,352.4,0,3.69,BDBM201220,Cc1cccc(C(=O)Nc2cccc(C#Cc3ccc4nccn4n3)c2)c1,IC50,'=',295,nM,6.53,,357150,UO_0000065,18.53,0.33,2.84,11.01,0,CHEMBL3887844,PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL596292,,None,575.14,2,6.33,19,COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',610,nM,6.21,,,UO_0000065,10.81,0.21,-0.12,8.22,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.61
CHEMBL1173159,,None,400.39,0,4.73,22,O=C(Nc1ccccc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc([N+](=O)[O-])cc1,Inhibition,'=',11.3,%,,,,UO_0000187,,,,,0,CHEMBL1176712,Inhibition of KDR at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,11.3
CHEMBL1173046,,None,454.31,1,6.14,26,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(Cl)c(Cl)c2)cc1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1176712,Inhibition of KDR at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,0
CHEMBL596059,,None,444.52,1,5.68,4,COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OC)cc12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL360878,,None,339.4,0,4.42,4,CCCCCC(=O)Nc1ncnc2oc(-c3ccc(OC)cc3)cc12,IC50,'>',48000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,48
CHEMBL520512,,None,457.58,0,4.22,CER-0264377,Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,0
CHEMBL483710,,None,490.08,1,5.23,CER-0264438,Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,11
CHEMBL422918,,None,469.63,0,4.49,18d,CN(C)CC1CCCN(CCCn2ccc(-c3ccn4c(-c5ccccc5)cnc4c3)cc2=O)C1,IC50,'=',67,nM,7.17,,,UO_0000065,15.28,0.28,2.68,15.67,0,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,67
CHEMBL1082403,,None,563.68,1,3.93,16b,CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCN(S(C)(=O)=O)CC5)c4)cnn3c2N)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1120230,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1158604,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,10000
CHEMBL219722,,None,343.39,0,4.46,1,Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,IC50,'=',64,nM,7.19,,,UO_0000065,20.95,0.38,2.73,7.51,1,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,64
CHEMBL409538,,None,441.44,1,5.44,68,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccon5)cccc4c3)c2cc1OC,IC50,'=',0.2,nM,9.7,,,UO_0000065,21.97,0.4,4.26,10.13,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.2
CHEMBL1171523,,None,506.57,2,5.2,3,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1,Inhibition,'=',0.25,%,,,,UO_0000187,,,,,0,CHEMBL1175117,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177794,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.25
CHEMBL150825,,None,377.8,0,4.2,table5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL599224,,None,369.43,0,0.5,50,CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1072231,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157561,1,Scientific Literature,J Med Chem,2010,None,,,,10
CHEMBL3093588,,None,431.46,0,3.16,3a,Cc1cc(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)cc2)n(C)n1,IC50,'=',12,nM,7.92,,,UO_0000065,18.36,0.34,4.76,6.86,0,CHEMBL3094552,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 5 mins followed by 10 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,12
CHEMBL196609,,None,410.52,1,5.7,44,CNC(=O)c1ccc(-c2nnc(Nc3ccc(C(C)(C)C)cc3)c3ccccc23)cc1,IC50,'=',130,nM,6.89,,,UO_0000065,16.77,0.3,1.19,10.29,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.13
CHEMBL195829,,None,427.84,1,6.22,51,COc1ccc(-c2nnc(Nc3ccc(OC(F)(F)Cl)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL1081831,,None,432.47,0,4.31,36,N[C@H](CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,IC50,'=',300,nM,6.52,,,UO_0000065,15.08,0.3,2.21,8.15,0,CHEMBL1102006,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.3
CHEMBL493670,,None,361.45,0,4.28,15,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(OC(C)C)nncc2c1,IC50,'=',1145,nM,5.94,,,UO_0000065,16.44,0.3,1.66,9.27,0,CHEMBL1024854,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140163,1,Scientific Literature,J Med Chem,2008,None,,,,1145
CHEMBL1909378,,None,420.86,0,3.63,SB-431542-A,Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,Inhibition,'=',2.91,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2.91
CHEMBL1778392,,None,402.45,1,5.24,16,CNC(=O)c1cc(Oc2ccc3oc(Nc4cccc(C(C)C)c4)nc3c2)ccn1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1781720,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1777722,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,
CHEMBL269862,,None,380.35,0,5,43,Nc1noc2cccc(-c3ccc(NC(=O)Nc4cc(F)cc(F)c4)cc3)c12,IC50,'=',81,nM,7.09,,,UO_0000065,18.64,0.35,2.09,7.61,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,81
CHEMBL408292,,None,620.63,2,5.84,6,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc(NCCN2CCOCC2)nc1Oc1ccccc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL948989,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142332,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,25000
CHEMBL1952358,,None,291.73,0,3.03,10b,COc1ccc(C(N)=O)cc1COc1ccc(Cl)cc1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL1955118,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949587,1,Scientific Literature,Bioorg Med Chem,2012,None,,,,50
CHEMBL270793,,None,558.56,1,4.06,8,COc1nc(NCCN2CCOCC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1C,IC50,'=',2030,nM,5.69,,,UO_0000065,10.19,0.19,1.63,4.84,0,CHEMBL948989,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142332,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,2030
CHEMBL407944,,None,496.52,0,4.64,23,CCCNc1nnc(-c2cn3ncnc(Nc4cc(C(=O)NC5CC5)c(F)cc4F)c3c2C(C)C)o1,IC50,'=',17,nM,7.77,,,UO_0000065,15.65,0.29,3.13,6.35,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,17
CHEMBL272802,,None,423.27,1,5.48,31,Nc1noc2cccc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12,IC50,'=',10,nM,8,,,UO_0000065,18.9,0.4,2.52,8.59,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,10
CHEMBL405370,,None,329.36,0,4.33,10,Nc1noc2cccc(-c3ccc(NC(=O)c4ccccc4)cc3)c12,IC50,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,12500
CHEMBL375890,,None,480.64,0,4.89,52,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccc(C#CCOc5ccccc5)s4)n[nH]c2-3)CC1,IC50,'=',316,nM,6.5,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,316
CHEMBL225336,,None,522.68,1,4.63,46,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNC(=O)Nc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',15,nM,7.82,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,15
CHEMBL256824,,None,444.39,1,5.02,12d,Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)cncc21,IC50,'=',3.7,nM,8.43,,,UO_0000065,18.97,0.36,3.41,8.62,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,3.7
CHEMBL403402,,None,430.37,1,5.01,13k,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,IC50,'=',7.9,nM,8.1,,,UO_0000065,18.83,0.36,3.09,7.45,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,7.9
CHEMBL253969,OSI-632,2,532.41,1,3.86,1,NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,IC50,'=',11,nM,7.96,,,UO_0000065,14.95,0.34,4.1,7.26,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,11
CHEMBL257789,,None,399.45,0,3.43,23,CO/N=C(\C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL404718,,None,413.48,0,3.82,24,CCO/N=C(\C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,'=',4,nM,8.4,,,UO_0000065,20.31,0.37,4.58,9.96,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,4
CHEMBL401896,,None,455.56,0,4.88,40,CCO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',4,nM,8.4,,,UO_0000065,18.43,0.34,3.52,11.44,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,4
CHEMBL403823,,None,483.62,1,5.34,38,C/C(=N\OC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',4,nM,8.4,,,UO_0000065,17.36,0.32,3.06,11.44,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,4
CHEMBL486437,,None,494.66,None,None,19,COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC,IC50,'=',3100,nM,5.51,,,UO_0000065,11.14,None,None,None,0,CHEMBL957977,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157465,1,Scientific Literature,J Med Chem,2008,None,,,,3.1
CHEMBL521201,,None,364.4,0,3.23,3,COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc(OC)c1OC,IC50,'=',11000,nM,4.96,,,UO_0000065,13.61,0.25,1.73,6.83,0,CHEMBL957977,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157465,1,Scientific Literature,J Med Chem,2008,None,,,,11
CHEMBL598626,,None,467.53,1,5.38,87,CC(C)(C)c1cc(NC(=O)c2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1,IC50,'=',1370,nM,5.86,,,UO_0000065,12.54,0.23,0.48,5.59,0,CHEMBL1067544,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157573,1,Scientific Literature,J Med Chem,2010,None,,,,1.37
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,1 (ZD-6474),COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,IC50,'=',17,nM,7.77,,,UO_0000065,16.34,0.35,3.34,12.38,0,CHEMBL820672,In vitro inhibition of Vascular endothelial growth factor receptor 2 (VEGFR-2),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135689,1,Scientific Literature,J Med Chem,2002,None,,,,17
CHEMBL254760,,None,517.61,2,5.68,5,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1,IC50,'=',26,nM,7.58,,,UO_0000065,14.65,0.29,1.91,9.36,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.026
CHEMBL535,SUNITINIB,4,398.48,0,3.33,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL404881,,None,491.54,1,5.24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3109348,,None,432.52,0,4.22,19,COCCOc1ccn2c(-c3ccc4cccc(O[C@H]5CC[C@H](N)CC5)c4n3)cnc2c1,IC50,'=',203,nM,6.69,,,UO_0000065,15.47,0.29,2.47,7.98,0,CHEMBL3111862,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108676,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,203
CHEMBL387590,,None,488.98,1,5.64,35,CN1CCN(Cc2cc(Nc3nc4cc(Oc5ccnc6[nH]ccc56)ccc4o3)ccc2Cl)CC1,Ki,'=',2,nM,8.7,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,2
CHEMBL230002,,None,493.95,0,4.98,27,CN1CCC[C@H]1COc1cc(Nc2nc3cc(Oc4ccnc(C(N)=O)c4)ccc3o2)ccc1Cl,Ki,'=',3,nM,8.52,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,3
CHEMBL425825,,None,479.97,0,4.6,33,CNc1cc(Oc2ccc3oc(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)ncn1,IC50,'=',289,nM,6.54,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,289
CHEMBL389963,,None,561.04,2,7.06,29,COc1cc2nccc(Oc3ccc4oc(Nc5ccc(Cl)c(OC[C@@H]6CCCN6C)c5)nc4c3)c2cc1OC,IC50,'=',7,nM,8.15,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,7
CHEMBL231066,,None,404.78,1,6.17,4,FC(F)(F)c1cc(Nc2nc3cc(Oc4ccncc4)ccc3[nH]2)ccc1Cl,IC50,'=',3896,nM,5.41,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,3896
CHEMBL391102,,None,354.84,0,4.04,37,Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(Cl)cc2)c1C,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL397322,,None,326.79,0,3.43,10,O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cccnc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL3104854,,None,196.16,0,0.78,7,Cc1c(O)c(O)c(O)c2c1COC2=O,IC50,'=',5960,nM,5.22,,,UO_0000065,26.64,0.51,4.44,6.01,0,CHEMBL3108315,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J Nat Prod,2014,None,,,,5.96
CHEMBL233827,,None,378.31,0,2.46,51,O=C(Nc1ccc(OC(F)(F)F)cc1)c1nnnn1CCc1ccncc1,IC50,'=',2970,nM,5.53,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,2.97
CHEMBL391104,,None,376.34,0,3.67,43,O=C(Nc1ccc(OC(F)(F)F)cc1)c1nccn1CCc1ccncc1,IC50,'=',1050,nM,5.98,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,1.05
CHEMBL392331,,None,390.37,0,3.98,36,Cc1cc(C(=O)Nc2ccc(OC(F)(F)F)cc2)n(CCc2ccncc2)n1,IC50,'=',1340,nM,5.87,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,1.34
CHEMBL392330,,None,361.23,0,4.08,33,O=C(Nc1ccc(Cl)c(Cl)c1)c1ccnn1CCc1ccncc1,IC50,'=',120,nM,6.92,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.12
CHEMBL234489,,None,373.44,0,3.9,9g,N#Cc1cnc(Nc2ccc(CCO)cc2)nc1-c1nc2ccccc2s1,IC50,'=',340,nM,6.47,,,UO_0000065,17.32,0.33,2.57,6.83,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.34
CHEMBL234065,,None,346.39,0,3.3,9d,COc1ccc(-c2nc(Nc3ccc(CCO)cc3)ncc2C#N)cc1,IC50,'=',150,nM,6.82,,,UO_0000065,19.7,0.36,3.52,7.49,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.15
CHEMBL389102,,None,355.4,0,3.77,9c,N#Cc1cnc(Nc2ccc(CCO)cc2)nc1-c1ccc2[nH]ccc2c1,IC50,'=',90,nM,7.05,,,UO_0000065,19.82,0.36,3.28,7.22,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.09
CHEMBL233669,,None,325.38,0,4.55,2h,Cc1cc2cc(Nc3ncc(C#N)c(-c4ccccc4)n3)ccc2[nH]1,IC50,'=',410,nM,6.39,,,UO_0000065,19.63,0.35,1.84,8.25,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.41
CHEMBL245549,,None,449.44,1,5.86,2,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1,IC50,'=',61,nM,7.21,,,UO_0000065,16.05,0.3,1.35,9.04,0,CHEMBL887077,Inhibition of KDR after 90 mins by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139197,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,61
CHEMBL238531,,None,375.35,0,3.7,41,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'=',1340,nM,5.87,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.34
CHEMBL939,GEFITINIB,4,446.91,0,4.28,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL180022,NERATINIB,4,557.05,2,5.93,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL399076,,None,293.3,0,3.17,2l,O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1,Inhibition,'<=',40,%,,,,UO_0000187,,,,,0,CHEMBL886302,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139946,1,Scientific Literature,Eur J Med Chem,2007,None,,,,40
CHEMBL400897,,None,289.34,0,3.34,2d,Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2,Inhibition,'<=',40,%,,,,UO_0000187,,,,,0,CHEMBL886302,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139946,1,Scientific Literature,Eur J Med Chem,2007,None,,,,40
CHEMBL238525,,None,399.45,0,4.47,22,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Oc2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL241073,,None,399.45,0,4.47,50,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Oc2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL238938,,None,375.35,0,3.7,37,Cn1ncc(NCc2cccnc2)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL247272,,None,399.5,0,3.87,1,c1ccc(-c2oc3ncnc(NCCN4CCNCC4)c3c2-c2ccccc2)cc1,IC50,'=',2600,nM,5.58,,,UO_0000065,13.98,0.25,1.72,8.43,0,CHEMBL903615,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139139,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,2.6
CHEMBL330621,,None,267.36,0,4.26,12,Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1,IC50,'=',19,nM,7.72,,,UO_0000065,28.88,0.56,3.46,20.42,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,19
CHEMBL254760,,None,517.61,2,5.68,10a,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1,IC50,'=',10,nM,8,,,UO_0000065,15.46,0.3,2.32,9.87,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,10
CHEMBL518203,,None,468.51,1,5.49,7h,COc1cc2nccc(Oc3ccc4c(NC(=O)c5cccc(C)c5)nn(C)c4c3)c2cc1OC,IC50,'=',2,nM,8.7,,,UO_0000065,18.57,0.34,3.21,9.94,0,CHEMBL973628,Inhibition of recombinant KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157345,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.002
CHEMBL462175,,None,489.92,1,5.23,7g,COc1cc2nccc(Oc3ccc4c(NC(=O)c5cc(Cl)ccn5)nn(C)c4c3)c2cc1OC,IC50,'=',2,nM,8.7,,,UO_0000065,17.76,0.34,3.47,8.67,0,CHEMBL973628,Inhibition of recombinant KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157345,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.002
CHEMBL462381,,None,440.5,1,5.54,6d,COc1cc2nccc(Oc3ccc4c(NCc5ccccc5)nn(C)c4c3)c2cc1OC,IC50,'=',60,nM,7.22,,,UO_0000065,16.39,0.3,1.68,10.25,0,CHEMBL973628,Inhibition of recombinant KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157345,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.06
CHEMBL1782185,,None,412.24,0,4.13,17,O=C(c1ccc(Br)o1)N1N=C(c2cccnc2)CC1c1ccccc1O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1786951,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781905,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,10
CHEMBL255959,,None,480.59,1,5.24,7c,CCCn1c2ccc(C(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',5,nM,8.3,,,UO_0000065,17.27,0.32,3.06,12.04,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,5
CHEMBL270827,,None,384.48,0,4.19,5d,CC(C)Cn1c2ccccc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',17,nM,7.77,,,UO_0000065,20.21,0.37,3.58,14.98,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,17
CHEMBL377300,BRIVANIB,3,370.38,0,3.52,BMS-540215,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,Kd,'=',5,nM,8.3,,,UO_0000065,22.41,0.42,4.78,9.8,0,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,5
CHEMBL98996,,None,283.36,0,3.96,17,COc1ccnc(Nc2ncc(-c3ccccc3)s2)c1,IC50,'=',11,nM,7.96,,,UO_0000065,28.09,0.54,4,16.92,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,11
CHEMBL392743,,None,391.91,1,5.13,9d,CN(C)CCc1ccc(Nc2ncc(Cl)c(-c3cccc4[nH]ccc34)n2)cc1,IC50,'=',216,nM,6.67,,,UO_0000065,17.01,0.33,1.54,11.73,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.216
CHEMBL304760,,None,313.36,1,5.17,2,c1ccc(Oc2ccc(Nc3ncnc4ccccc34)cc2)cc1,IC50,'=',2720,nM,5.57,,,UO_0000065,17.76,0.32,0.4,11.83,0,CHEMBL817617,Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132739,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,2.72
CHEMBL475510,,None,366.49,0,4.7,11,CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1,IC50,'=',35,nM,7.46,,,UO_0000065,20.34,0.39,2.76,11.14,0,CHEMBL1034022,Inhibition of VEGFR2 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.035
CHEMBL98633,,None,280.35,0,4.06,2,O=C(Nc1ncc(-c2ccccc2)s1)c1ccccc1,IC50,'=',81,nM,7.09,,,UO_0000065,25.3,0.48,3.03,16.89,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,81
CHEMBL376951,,None,376.45,0,4.29,8,Cc1cccc(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1,IC50,'=',13,nM,7.89,,,UO_0000065,20.95,0.4,3.6,7.45,0,CHEMBL864248,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.013
CHEMBL213505,,None,414.35,0,4.53,26,Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,IC50,'=',70,nM,7.16,,,UO_0000065,17.27,0.33,2.62,6.01,0,CHEMBL864248,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.07
CHEMBL469025,,None,425.49,0,4.4,14,COCCn1nc(C(=O)c2ccccc2NCc2ccc3cn[nH]c3c2)c2ccccc21,IC50,'=',560,nM,6.25,,,UO_0000065,14.69,0.27,1.85,7.37,0,CHEMBL976314,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.56
CHEMBL184223,,None,387.44,0,4.56,26,COc1ccc(-c2ccc(NC(=O)Nc3cccc(C)c3)cc2)c2c1C(=O)NC2,IC50,'=',21,nM,7.68,,,UO_0000065,19.82,0.36,3.12,9.66,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,21
CHEMBL359795,,None,356.43,0,4.09,19,Cc1cccc(NC(=O)Cc2ccc(-c3cccc4c3CNC4=O)cc2)c1,IC50,'=',2100,nM,5.68,,,UO_0000065,15.93,0.29,1.59,9.76,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,2.1
CHEMBL1289705,,None,440.6,0,3.98,AEE788,CCN1CCN(Cc2ccc(-c3cc4c([C@](C)(N)c5ccccc5)ncnc4[nH]3)cc2)CC1,IC50,'=',77,nM,7.11,,,UO_0000065,16.15,0.29,3.13,9.6,0,CHEMBL1292980,Inhibition of recombinant VEGFR2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1287660,1,Scientific Literature,Eur J Med Chem,2010,None,,,,77
CHEMBL2088092,,None,406.29,0,3.91,5,Cc1cc(Nc2nc(NCc3cc(C(C)(C)C)no3)ncc2Br)n[nH]1,IC50,'=',3981.07,nM,5.4,,,UO_0000065,13.29,0.29,1.49,5.16,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,5.4
CHEMBL428741,,None,545.57,1,3.77,17,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,Ratio,'=',3.1,,,,,,,,,,0,CHEMBL892962,Ratio of IC50 for VEGFR2 in presence of 1 mM ATP to IC50 for VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,3.1
CHEMBL2088109,,None,314.31,0,0.95,22,Cc1cc(Nc2ccnc(NCc3cc(C(N)=O)no3)n2)n[nH]1,IC50,'=',1258.93,nM,5.9,,,UO_0000065,18.77,0.35,4.95,4,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,5.9
CHEMBL2088111,,None,374.25,0,3.28,24,CCc1cc(Nc2nc(NCc3ccccn3)ncc2Br)n[nH]1,IC50,'=',501.19,nM,6.3,,,UO_0000065,16.83,0.37,3.02,6.89,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,6.3
CHEMBL2088259,,None,431.5,0,3.75,30,COc1cc(CCc2cc(Nc3ccnc(NCc4ccccn4)n3)n[nH]2)cc(OC)c1,IC50,'=',398.11,nM,6.4,,,UO_0000065,14.83,0.27,2.65,5.83,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,6.4
CHEMBL1082946,,None,1069.14,None,None,12,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O,FC,'=',3,,,,,,,,,,0,CHEMBL1118172,Binding affinity to human recombinant VEGFR2 extracellular domain immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155516,1,Scientific Literature,J Med Chem,2010,None,,,,3
CHEMBL2069625,,None,295.34,0,3.72,E,Cc1oc(-c2ccccc2)nc1COc1cccc(CO)c1,IC50,'=',50000,nM,4.3,,,UO_0000065,14.56,0.27,0.58,7.75,0,CHEMBL2072786,Inhibition of human unphosphorylated N-terminal-His6 tagged VEGFR2 catalytic domain using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate after 60 mins by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2069184,1,Scientific Literature,ACS Med Chem Lett,2012,None,,,,50
CHEMBL215000,,None,365.39,0,3.33,4h,COc1cc(OCc2ccncc2)c(C(=O)Nc2ccccn2)cc1OC,Inhibition,'=',24,%,,,,UO_0000187,,,,,0,CHEMBL906911,Inhibition of recombinant KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149489,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,24
CHEMBL216043,,None,372.35,0,4.93,4a,O=C(Nc1ccccc1C(F)(F)F)c1ccccc1OCc1ccncc1,Inhibition,'=',60,%,,,,UO_0000187,,,,,0,CHEMBL906911,Inhibition of recombinant KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149489,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,60
CHEMBL403606,,None,455.56,0,4.71,36,CCCCn1c2ccc(/C(C)=N/OC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL257793,,None,427.51,0,4.07,25,CO/N=C(/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4)C(C)C,IC50,'=',4,nM,8.4,,,UO_0000065,19.64,0.36,4.33,9.96,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,4
CHEMBL404718,,None,413.48,0,3.82,24,CCO/N=C(\C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,'=',2,nM,8.7,,,UO_0000065,21.04,0.38,4.88,10.32,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,2
CHEMBL404322,,None,385.43,0,3.26,27,C/C(=N\O)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',83200,nM,4.08,,,UO_0000065,10.24,0.19,0.75,5.28,0,CHEMBL4819966,Inhibition of recombinant human His-tagged VEGFR2 expressed in Baculovirus expression system using ADP-Glo as substrate measured after 30 mins in presence of ATP by ADP-Glo kinase assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819005,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 0.5 hr,INHIBITOR,,83.2
CHEMBL2086729,,None,406.27,1,5.78,6i,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086733,,None,416.28,1,5.24,6m,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086738,,None,381.39,0,4.17,6r,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086740,,None,395.42,0,4.48,6t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,GW-786034,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,'=',30,nM,7.52,,,UO_0000065,17.19,0.33,4.38,6.32,1,CHEMBL1292980,Inhibition of recombinant VEGFR2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1287660,1,Scientific Literature,Eur J Med Chem,2010,None,,,,30
CHEMBL2086743,,None,382.42,0,4.06,6w,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086744,,None,436.52,1,5,7a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086748,,None,499.6,0,3.41,7f,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086756,,None,481.58,1,5.51,8d,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086760,,None,447.97,0,4.87,8h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2087169,,None,445.54,0,4.66,8k,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL243910,,None,504.4,2,5.73,31,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cn3)cc2[nH]1,IC50,'=',16,nM,7.8,,,UO_0000065,15.46,0.3,2.07,5.98,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,16
CHEMBL244288,,None,502.42,2,5.87,29,COC(=O)Nc1nc2ccc(Oc3ccc(CC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1,IC50,'=',16,nM,7.8,,,UO_0000065,15.52,0.3,1.93,7.4,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,16
CHEMBL244097,,None,461.43,0,4.88,26,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1,IC50,'=',603,nM,6.22,,,UO_0000065,13.48,0.25,1.34,4.02,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,603
CHEMBL244095,,None,517.49,2,6.79,23,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(SC(F)(F)F)c4)cc3)cc2[nH]1,IC50,'=',1.3,nM,8.89,,,UO_0000065,17.17,0.34,2.1,7.57,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,1.3
CHEMBL2113192,,None,479.44,0,2.29,50,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=C(OC)C3=O)c2cc1OC,IC50,'=',5.7,nM,8.24,,,UO_0000065,17.2,0.33,5.95,6.98,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,5.7
CHEMBL2113163,,None,504.54,1,3.64,74,COc1cc2c(NC3=CC(=O)C(OCc4ccco4)=CC3=O)ncnc2cc1OCCCN1CCCC1,IC50,'=',4.2,nM,8.38,,,UO_0000065,16.6,0.31,4.74,7.22,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,4.2
CHEMBL378165,,None,431.89,1,5.03,12,Cn1cnc(NCc2cccc3ncccc23)c1-c1nnc(Nc2ccc(Cl)cc2)o1,IC50,'=',3540,nM,5.45,,,UO_0000065,12.62,0.24,0.42,5.82,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,3.54
CHEMBL118748,,None,445.52,0,4.65,8,O=C(O)C1CCN(CCCOc2ccc3[nH]c(-c4cc5ccccc5nc4O)cc3c2)CC1,IC50,'=',8,nM,8.1,,,UO_0000065,18.17,0.34,3.45,8.21,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,8
CHEMBL365318,,None,443.41,0,3.52,37,CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C)o4)c(C(C)C)c23)c(F)cc1F,IC50,'=',18,nM,7.75,,,UO_0000065,17.47,0.33,4.22,6.48,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,18
CHEMBL427202,,None,370.38,0,3.52,13,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)O)c(C)c34)ccc2[nH]1,IC50,'=',40,nM,7.4,,,UO_0000065,19.97,0.37,3.88,8.74,0,CHEMBL860941,Inhibitory activity against VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146078,1,Scientific Literature,J Med Chem,2006,None,,,,0.04
CHEMBL119276,,None,430.51,0,3.63,7,CC(=O)N1CCN(CCOc2ccc3[nH]c(-c4cc5ccccc5nc4O)cc3c2)CC1,IC50,'=',4,nM,8.4,,,UO_0000065,19.51,0.36,4.77,10.28,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,4
CHEMBL363153,,None,272.74,0,3.78,5,Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1Cl,IC50,'=',1000,nM,6,,,UO_0000065,22,0.43,2.22,13.37,0,CHEMBL876999,In vitro inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141154,1,Scientific Literature,J Med Chem,2005,None,,,,1
CHEMBL365109,,None,415.43,0,3.2,12,CCOC(=O)c1cn2ncnc(Nc3ccc(F)c(C(=O)NOC)c3)c2c1C(C)C,IC50,'=',79,nM,7.1,,,UO_0000065,17.1,0.32,3.9,6.65,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,79
CHEMBL191594,,None,517.54,1,3.81,26,CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OC4CCN(C)CC4)c(C(C)C)c23)c(F)cc1F,IC50,'=',36,nM,7.44,,,UO_0000065,14.38,0.27,3.63,6.1,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,36
CHEMBL328790,,None,306.76,0,4.11,2a,Clc1ccc(-c2cnc3c(-c4ccncc4)cnn3c2)cc1,IC50,'=',113,nM,6.95,,,UO_0000065,22.65,0.43,2.84,16.13,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,113
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Inhibition,'=',94.3,%,,,,UO_0000187,,,,,1,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,94.3
CHEMBL3417525,BI 665915,None,458.53,0,2.78,EUB0000749,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,% Control,'=',87,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507276,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,87
CHEMBL374975,FUSIDIC ACID,4,516.72,2,5.67,fusidic acid,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL186001,,None,268.32,0,3.1,17,Cc1ccc(Nc2ncnn3cc(C)c(C)c23)cc1O,IC50,'=',20,nM,7.7,,,UO_0000065,28.69,0.53,4.6,12.33,0,CHEMBL827963,In vitro inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138664,1,Scientific Literature,J Med Chem,2004,None,,,,0.02
CHEMBL363551,,None,508.67,2,5.38,18,CCN(CC)CCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1,IC50,'=',15,nM,7.82,,,UO_0000065,15.38,0.29,2.44,7.77,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.015
CHEMBL3657550,,None,471.57,0,3.37,BDBM138211,Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(C(=O)C3CC3)cn4C)n2)cc1CN1CC[C@@H](O)C1,IC50,'=',483,nM,6.32,,272111,UO_0000065,13.39,0.25,2.95,6.25,0,CHEMBL3707826,Kinase Inhibition Assay: Compounds of the invention were initially diluted to 10 mM in 100% DMSO (CALBIOCHEM) for storage and made into kinase buffer solution to create a compound concentration ranging from 1 uM and 10 uM. Serial dilutions of compounds of the invention were dispensed into a 96-well plate (GREINER BIOSCIENCES) at 6 uL each. Purified full-length human SYK,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3656038,,None,476.49,0,3.11,BDBM110547,Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc(-c3cc(C(=O)NCC(O)CO)c[nH]3)c2)c1,IC50,'=',26,nM,7.58,,231432,UO_0000065,15.92,0.3,4.48,5.07,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL382716,,None,579.87,2,6.48,15a,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCNC(=O)c1c(F)c(F)c(N=[N+]=[N-])c(F)c1F,IC50,'<',1000,nM,,,,UO_0000065,,,,,0,CHEMBL864485,Inhibitory activity against VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148542,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,1
CHEMBL3648112,,None,444.36,0,3.21,BDBM2492,COc1cc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)ccc1S(C)(=N)=O,IC50,'=',97,nM,7.01,,6381,UO_0000065,15.78,0.37,3.8,5.83,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648102,,None,431.38,0,3.88,BDBM100913,CC(O)C(C)Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br,IC50,'=',150,nM,6.82,,218195,UO_0000065,15.82,0.39,2.94,6.9,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2018764,,None,445.48,1,5.04,62,COc1cccc(NC(=O)Nc2ccc(Nc3ncnc4cc(OC)c(OC)cc34)cc2)c1,IC50,'=',6200,nM,5.21,,,UO_0000065,11.69,0.22,0.17,4.88,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,6.2
CHEMBL3660286,,None,585.64,2,6.38,BDBM110658,COC(=O)CC1CCN(C(=O)c2c[nH]c(-c3cc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)cc4)ccn3)c2)CC1,IC50,'=',116,nM,6.94,,231543,UO_0000065,11.84,0.22,0.56,5.52,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL365286,GW549034X,None,229.24,0,1.69,GW549034X,CCn1c(-c2nonc2N)nc2ccccc21,Inhibition,'=',4.29,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.29
CHEMBL184274,,None,477.52,1,5.2,14c,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(NC(=O)c4cccnc4)c4c3CNC4=O)cc2)c1,IC50,'=',10,nM,8,,,UO_0000065,16.75,0.3,2.8,7.13,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,10
CHEMBL359947,,None,457.53,0,4.05,14d,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(NC(=O)CN(C)C)c4c3CNC4=O)cc2)c1,IC50,'=',350,nM,6.46,,,UO_0000065,14.11,0.26,2.41,6.29,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,350
CHEMBL365448,,None,431.49,0,4.57,27,COCCOc1ccc(-c2ccc(NC(=O)Nc3cccc(C)c3)cc2)c2c1C(=O)NC2,IC50,'=',126,nM,6.9,,,UO_0000065,15.99,0.29,2.33,7.78,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,126
CHEMBL67241,GW794607X,None,372.44,0,3.48,GW794607X,CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',64.93,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,64.93
CHEMBL2010876,,None,545.57,2,5.75,11h,CC(C)Cn1c2ccc(Nc3nccc(C(F)(F)F)n3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2015674,Inhibition of human VEGFR2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL1909404,GW581744X,None,406.42,0,2.49,GW581744X,NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1,Inhibition,'=',6.05,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.05
CHEMBL365411,,None,396.88,0,3.23,42,CN(C)CCNC(=O)c1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,IC50,'=',4265.8,nM,5.37,,,UO_0000065,13.53,0.26,2.14,6.47,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,5.37
CHEMBL190960,,None,369.81,0,3.52,45,COCC(=O)Nc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,pIC50(calc),'=',6.35,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.35
CHEMBL1909374,GW709042A,None,585.95,2,7.41,GW709042A,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,Inhibition,'=',68.13,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,68.13
CHEMBL208437,GW711782X,None,408.47,0,4.48,GW711782X,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1,Inhibition,'=',65.86,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,65.86
CHEMBL3358992,,None,368.39,0,3.14,31,COc1cccc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)c1,IC50,'=',23000,nM,4.64,,,UO_0000065,12.59,0.23,1.5,5.61,0,CHEMBL3376849,Inhibition of human recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL237347,GW559768X,None,328.39,0,3.4,GW559768X,Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12,Inhibition,'=',70.11,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,70.11
CHEMBL1909363,GSK-269962B,None,607.07,2,3.84,GSK269962B,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl,Inhibition,'=',7.83,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.83
CHEMBL306284,,None,347.81,0,4.41,47,Clc1ccc(Nc2nnc(Cc3ccncc3)c3cccnc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,10
CHEMBL3397935,,None,420.48,0,4.93,18d,O=C(Nc1ccc(OCCN2CCCC2)c(F)c1)c1cccc(-c2cccc(O)c2)c1,IC50,'=',4.86,nM,8.31,,,UO_0000065,19.77,0.37,3.38,13.45,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,4.86
CHEMBL3397944,,None,452.94,0,4.68,19f,O=C(Nc1ccc(OCCN2CCOCC2)c(Cl)c1)c1cccc(-c2cccc(O)c2)c1,IC50,'=',77.45,nM,7.11,,,UO_0000065,15.7,0.3,2.43,10.01,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,77.45
CHEMBL1909364,GW589961A,None,488.33,1,5.83,GW589961A,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl,Inhibition,'=',62.5,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,62.5
CHEMBL3397929,,None,416.52,1,5.18,17e,O=C(Nc1ccc(OCCN2CCCCC2)cc1)c1cccc(-c2cccc(O)c2)c1,IC50,'=',214.87,nM,6.67,,,UO_0000065,16.01,0.29,1.49,10.79,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,214.87
CHEMBL3397934,,None,422.5,1,5.17,18c,CCN(CC)CCOc1ccc(NC(=O)c2cccc(-c3cccc(O)c3)c2)cc1F,IC50,'=',8.74,nM,8.06,,,UO_0000065,19.07,0.36,2.89,13.04,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,8.74
CHEMBL396107,GW795486X,None,481.36,1,6.15,GW795486X,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12,Inhibition,'=',68.22,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,68.22
CHEMBL379093,GW651576X,None,429.88,1,5.99,GW651576X,Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1,Inhibition,'=',5.83,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.83
CHEMBL1909362,GW830900A,None,534.09,0,3.22,GW830900A,CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl,Inhibition,'=',18.87,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,18.87
CHEMBL1909352,GW441806A,None,329.79,0,2.75,GW441806A,Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',10.15,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,10.15
CHEMBL267228,,None,371.4,0,4.03,SB-431533,OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,Inhibition,'=',6.53,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.53
CHEMBL1880739,GW305074X,None,520.95,2,5.01,GW305074X,O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1,Inhibition,'=',9.7,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9.7
CHEMBL1794073,GW770220A,None,459.96,0,2.83,GW770220A,Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl,Inhibition,'=',45.4,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,45.4
CHEMBL297012,,None,343.39,0,4.08,2g,COc1ccc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)cc1,IC50,'=',392,nM,6.41,,,UO_0000065,18.66,0.34,2.33,9.88,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,392
CHEMBL1909372,GW700494A,None,622.07,2,6.21,GW700494A,CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl,Inhibition,'=',71.93,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,71.93
CHEMBL101461,,None,355.4,1,5.03,2b,CC(=O)Nc1oc(-c2cncc(-c3ccccc3)c2)nc1-c1ccccc1,IC50,'=',575,nM,6.24,,,UO_0000065,17.56,0.32,1.21,9.17,0,CHEMBL819548,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136194,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,575
CHEMBL205966,GW659893X,None,444.9,1,5.57,GW659893X,Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,Inhibition,'=',5.84,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.84
CHEMBL257113,GW734508X,None,333.39,0,3.85,GW734508X,Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1,Inhibition,'=',6.85,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.85
CHEMBL175321,,None,263.3,0,3.2,GR-105659X,O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21,Inhibition,'=',37.75,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,37.75
CHEMBL3288514,,None,414.42,1,5.5,4m,Nc1n[nH]c2cccc(-c3ccc4c(C(=O)Nc5ccc(F)cc5F)cccc4c3)c12,IC50,'=',2.6,nM,8.59,,,UO_0000065,20.72,0.38,3.09,10.24,0,CHEMBL3295611,Inhibition of VEGFR-2 in HUVEC assessed as inhibition of VEGF (1 to 165)-induced cell proliferation preincubated for 2 hrs followed by VEGF (1 to 165) induction measured after 48 hrs by CCK8 assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286125,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,2.6
CHEMBL3219510,,None,369.19,None,None,9c,COCCOc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OC,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3223748,Inhibition of VEGF-induced KDR phosphorylation in human HUVEC cells at 1 uM by immunoblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,CHEMBL3307501,,,,
CHEMBL3219513,,None,369.19,None,None,12c,COCCOc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OC,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3223748,Inhibition of VEGF-induced KDR phosphorylation in human HUVEC cells at 1 uM by immunoblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,CHEMBL3307501,,,,
CHEMBL153843,,None,371.36,0,4.96,AAL993,O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1,Inhibition,'=',95,%,,,,UO_0000187,,,,,1,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,95
CHEMBL3648096,,None,428.36,0,3.51,BDBM100907,Cc1cc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)ccc1S(C)(=N)=O,IC50,'=',39,nM,7.41,,218191,UO_0000065,17.3,0.4,3.9,6.68,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5089934,,None,358.45,0,2.91,(S)-15,C#Cc1ccc2c(c1)[nH]c1ncnc(N(C)[C@H]3CCCN(CCC#N)C3)c12,Activity,'=',22,%,,,,UO_0000187,,,,,0,CHEMBL5046573,Inhibition of human VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system assessed as residual activity at 500 nM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5046220,1,Scientific Literature,J Med Chem,2022,None,Dose = 500.0 nM,INHIBITOR,,22
CHEMBL148984,,None,402.45,0,4.51,11h,COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)cc1,IC50,'=',1800,nM,5.75,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,1.8
CHEMBL3219506,,None,317.52,None,None,7b,OB(O)c1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3223151,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,1
CHEMBL3219507,,None,329.55,None,None,7c,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B(O)O,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3223151,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,1
CHEMBL3219508,,None,347.54,None,None,7d,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1B(O)O,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3223151,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,1
CHEMBL3219509,,None,325.13,None,None,9a,COc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OC,IC50,'=',390,nM,6.41,,,UO_0000065,19.71,None,None,None,0,CHEMBL3223151,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,0.39
CHEMBL3217774,,None,413.24,None,None,9b,COCCOc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OCCOC,IC50,'=',190,nM,6.72,,,UO_0000065,16.26,None,None,None,0,CHEMBL3223151,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,0.19
CHEMBL3219511,,None,325.13,None,None,12a,COc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OC,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,99
CHEMBL5185599,,None,532.1,2,5.99,m16,CC(C)n1cnc(-c2ccccc2Nc2nc(Nc3ccc(N(C)C4CCN(C)CC4)cc3)ncc2Cl)n1,Inhibition,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL5113349,Inhibition of KDR (unknown origin) at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108089,1,Scientific Literature,RSC Med Chem,2022,None,Dose = 1.0 microM,INHIBITOR,,70
CHEMBL3628628,,None,453.93,0,3.77,5,COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC,Inhibition,'=',7.13,%,,,,UO_0000187,,,,,0,CHEMBL3631268,Inhibition of KDR (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627608,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,7.13
CHEMBL151835,,None,447.33,0,4.75,12,O=C1NCc2c1c1c(c3c2c2cc(Br)ccc2n3CCCO)Cc2ccccc2-1,IC50,'=',104,nM,6.98,,,UO_0000065,15.61,0.33,2.23,12.87,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,104
CHEMBL5081524,,None,300.4,0,3.5,15,COc1ccc2[nH]c3c(c2c1)CN(C(=O)CC(C)C)CCC3,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL5057510,Inhibition of VEGFR2 phosphorylation in VEGF-induced HUVEC cells pretreated measured after overnight incubation by immunoblotting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5055667,1,Scientific Literature,J Med Chem,2021,None,,,,20
CHEMBL5082392,,None,330.35,0,3.47,3k; BSc5364,COC(=O)c1cccc(-c2cnc3[nH]cc(-c4cncnc4)c3c2)c1,Activity,'=',61.3,%,,,,UO_0000187,,,,,0,CHEMBL5054855,Inhibition of human recombinant C-terminal His6 tagged VEGFR2 (789 to 1356 residues) expressed in baculovirus infected insect cells assessed as residual activity at 1 uM pretreated for 20 mins followed by [33P]-ATP addition measured after 120 mins by radiometric hotspot kinase assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5053535,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,Dose = 1.0 microM | TIME = 2.333 hr,,,61.3
CHEMBL5087398,,None,329.36,0,4.08,3n; BSc5367,COC(=O)c1cccc(-c2cnc3[nH]cc(-c4cccnc4)c3c2)c1,Activity,'=',34.3,%,,,,UO_0000187,,,,,0,CHEMBL5054855,Inhibition of human recombinant C-terminal His6 tagged VEGFR2 (789 to 1356 residues) expressed in baculovirus infected insect cells assessed as residual activity at 1 uM pretreated for 20 mins followed by [33P]-ATP addition measured after 120 mins by radiometric hotspot kinase assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5053535,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,Dose = 1.0 microM | TIME = 2.333 hr,INHIBITOR,,34.3
CHEMBL1651522,,None,348.4,0,2.55,2,COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O,IC50,'=',190,nM,6.72,,,UO_0000065,19.29,0.37,4.17,7.22,0,CHEMBL1656382,Inhibition of VEGFR2 by TR-FRET based LanthaScreen assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1649097,1,Scientific Literature,ACS Med Chem Lett,2011,None,,,,190
CHEMBL2012519,,None,364.39,0,1.52,L-783277,COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,IC50,'=',57,nM,7.24,,,UO_0000065,19.88,0.38,5.72,6.39,0,CHEMBL1656542,Inhibition of VEGFR2 autophosphorylation by cell based assay,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1649097,1,Scientific Literature,ACS Med Chem Lett,2011,None,,,,57
CHEMBL1823223,,None,468.6,0,4.55,13f,CC(C)c1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL1828298,Inhibition of KDR activity by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1821705,1,Scientific Literature,J Med Chem,2011,None,,,,5000
CHEMBL1964399,,None,425.49,0,3.42,SID103904938,COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC,Ki,'=',158.49,nM,6.8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.8
CHEMBL225519,,None,213.24,0,1.36,SID103905167,O=C1NCCc2[nH]c(-c3ccncc3)cc21,Ki,'>',3162.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.5
CHEMBL1964413,,None,411.31,0,4.91,SID103904546,FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL398951,,None,415.5,0,3.41,SID103904813,N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6
CHEMBL443296,,None,416.48,0,4.9,9d,CCOc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1,IC50,'=',1000,nM,6,,,UO_0000065,14.41,0.26,1.1,6.56,0,CHEMBL816967,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,1
CHEMBL149243,,None,326.35,0,2.84,11d,COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C,IC50,'=',1200,nM,5.92,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,1.2
CHEMBL362502,,None,495.58,0,3.97,44,COc1cc(OC)cc(-c2cc3cnc(N(CCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1,IC50,'=',1900,nM,5.72,,,UO_0000065,11.54,0.22,1.75,4.54,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,1.9
CHEMBL3128226,,None,498.61,0,4.62,10g,O=S(=O)(Cc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1,IC50,'=',2230,nM,5.65,,,UO_0000065,11.33,0.21,1.03,5.55,0,CHEMBL3130576,Inhibition of recombinant human VEGFR2 incubated for 5 mins with substrate prior to protein addition by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124801,1,Scientific Literature,J Med Chem,2014,None,,,,2.23
CHEMBL3128221,,None,563.48,2,5.24,10b,O=S(=O)(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(Br)cc1,IC50,'=',4890,nM,5.31,,,UO_0000065,9.42,0.2,0.07,5.22,0,CHEMBL3130576,Inhibition of recombinant human VEGFR2 incubated for 5 mins with substrate prior to protein addition by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124801,1,Scientific Literature,J Med Chem,2014,None,,,,4.89
CHEMBL3128239,,None,493.57,1,5.33,9e,COc1ccc(NC(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1,IC50,'=',1090,nM,5.96,,,UO_0000065,12.08,0.22,0.63,5.63,0,CHEMBL3130576,Inhibition of recombinant human VEGFR2 incubated for 5 mins with substrate prior to protein addition by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124801,1,Scientific Literature,J Med Chem,2014,None,,,,1.09
CHEMBL3128234,,None,462.56,0,4.86,8g,O=C(Cc1ccccc1)Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1,IC50,'=',6450,nM,5.19,,,UO_0000065,11.22,0.2,0.33,6.13,0,CHEMBL3130576,Inhibition of recombinant human VEGFR2 incubated for 5 mins with substrate prior to protein addition by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124801,1,Scientific Literature,J Med Chem,2014,None,,,,6.45
CHEMBL2022379,,None,542.67,2,4.37,53,Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1,IC50,'=',108,nM,6.97,,,UO_0000065,12.84,0.24,2.6,5.9,0,CHEMBL2024837,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021851,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,108
CHEMBL205869,,None,357.42,0,4.36,40,Cc1ccccc1Nc1nnc(-c2cccnc2CCc2ccncc2)o1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,
CHEMBL207772,,None,427.39,0,4.95,32,FC(F)(F)Oc1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1,IC50,'=',510,nM,6.29,,,UO_0000065,14.72,0.28,1.34,7.32,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.51
CHEMBL383333,,None,399.5,1,5.35,23,CC(C)(C)c1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1,IC50,'=',520,nM,6.28,,,UO_0000065,15.73,0.29,0.93,8.19,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.52
CHEMBL222076,,None,359.36,0,2.51,29,Cc1cc2c(F)c(Oc3ncnc(N)c3/C=N/OCCCO)ccc2[nH]1,IC50,'=',11,nM,7.96,,,UO_0000065,22.15,0.42,5.45,6.71,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.011
CHEMBL410731,,None,459.41,0,4.8,1j,Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3F)cc1)CCN2,IC50,'=',49,nM,7.31,,,UO_0000065,15.91,0.3,2.51,6.23,0,CHEMBL928167,Inhibition of KDR in presence of 1 mM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.049
CHEMBL220391,,None,414.44,0,2.46,23,Cc1cc2c(F)c(Oc3ncnc(N)c3/C=N/OCCN3CCOCC3)ccc2[nH]1,IC50,'=',39,nM,7.41,,,UO_0000065,17.88,0.34,4.95,6.68,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.039
CHEMBL373826,,None,357.39,0,3.93,15,CCCCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F,IC50,'=',115,nM,6.94,,,UO_0000065,19.42,0.36,3.01,7.05,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.115
CHEMBL407532,,None,273.73,0,2.65,1d,Nc1ncnc2c1N=C(c1cccc(Cl)c1)CCN2,IC50,'=',600,nM,6.22,,,UO_0000065,22.73,0.45,3.57,8.17,0,CHEMBL927115,Inhibition of KDR in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.6
CHEMBL365631,,None,416.92,1,5.38,20,Clc1cccc(Nc2cncc(-c3cncc(NCCCc4ccncc4)c3)n2)c1,pIC50(calc),'=',6.86,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.86
CHEMBL177298,,None,393.48,0,4.37,5,CC(C)(Nc1nc(NO)nc(Nc2ccc3ncsc3c2)n1)c1ccccc1,IC50,'=',40,nM,7.4,,,UO_0000065,18.8,0.36,3.03,6.86,0,CHEMBL831136,In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,None,,,,0.04
CHEMBL539425,,None,350.41,0,3.54,14b,Oc1nc(NCc2ccccc2)nc(Nc2ccc3ncsc3c2)n1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL835238,Inhibition of KDR-induced MAP kinase autophosphorylation assay in HUVEC cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,CHEMBL3307501,,,,30
CHEMBL176078,,None,378.46,0,3.96,14c,CCN(Cc1ccccc1)c1nc(O)nc(Nc2ccc3ncsc3c2)n1,IC50,'=',600,nM,6.22,,,UO_0000065,,,,,0,CHEMBL835238,Inhibition of KDR-induced MAP kinase autophosphorylation assay in HUVEC cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,CHEMBL3307501,,,,0.6
CHEMBL44622,,None,280.34,0,2.6,5i,Cc1cc(C)cc(Nc2nccc(-n3ccnc3N)n2)c1,IC50,'=',4220,nM,5.38,,,UO_0000065,19.17,0.35,2.77,6.58,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,4220
CHEMBL180978,,None,424.51,0,2.25,33,Cc1ccc(Nc2ncnn3cc(C(=O)NCCCN4CCOCC4)c(C)c23)cc1O,IC50,'=',52,nM,7.28,,,UO_0000065,17.16,0.32,5.03,7,0,CHEMBL830878,Inhibitory concentration against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142012,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,52
CHEMBL259013,,None,441.42,0,4.66,1h,Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3ccc(C(F)(F)F)cc3)cc1)CCN2,IC50,'=',110,nM,6.96,,,UO_0000065,15.76,0.3,2.3,5.93,0,CHEMBL928167,Inhibition of KDR in presence of 1 mM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.11
CHEMBL406375,,None,234.26,0,3.98,K00035,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1688354,,None,400.44,0,3.99,25,c1cncc(CNc2ccccc2-c2nnc(Nc3ccc4c(c3)OCCO4)[nH]2)c1,IC50,'=',2800,nM,5.55,,,UO_0000065,13.87,0.25,1.56,5.73,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,2.8
CHEMBL1688356,,None,439.48,0,4.47,27,c1ccc(-c2nnc(Nc3ccc4c(c3)OCCO4)[nH]2)c(NCc2ccc3[nH]ncc3c2)c1,IC50,'=',7300,nM,5.14,,,UO_0000065,11.69,0.21,0.67,4.56,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,7.3
CHEMBL2387002,,None,448.91,1,5.12,15,CC(C)n1cc(C(=O)c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)c2c(N)ncnc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL2389574,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384974,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,10000
CHEMBL2031907,,None,550.62,1,4.77,27,COc1ccc2c(Oc3ccc(NC(=O)c4c(CN5CCCC5)n(C)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',2020,nM,5.7,,,UO_0000065,10.34,0.19,0.92,5.5,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,2020
CHEMBL2031904,,None,613.65,2,5.94,26a,COc1ccc2c(Oc3ccc(NC(=O)c4c(CNC(=O)OC(C)(C)C)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',1240,nM,5.91,,,UO_0000065,9.63,0.18,-0.03,4.7,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,1240
CHEMBL2031902,,None,482.5,0,3.88,22c,COc1ccc2c(Oc3cnc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',1630,nM,5.79,,,UO_0000065,12,0.22,1.91,5.11,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,1630
CHEMBL68082,,None,399.5,1,5.05,9,NCc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1,IC50,'=',677,nM,6.17,,,UO_0000065,15.44,0.28,1.12,6.71,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.677
CHEMBL176553,GW631581B,None,296.33,0,4.1,18,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1,IC50,'=',170,nM,6.77,,,UO_0000065,22.84,0.42,2.67,11.98,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.17
CHEMBL193342,,None,440.84,1,5.31,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL197158,,None,419.28,0,4.9,25,NC(=O)c1ccc(-c2nnc(Nc3ccc(Br)cc3)c3ccccc23)cc1,IC50,'=',100,nM,7,,,UO_0000065,16.7,0.35,2.1,8.65,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.1
CHEMBL195917,,None,370.41,0,4.15,27,COc1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1,IC50,'=',2000,nM,5.7,,,UO_0000065,15.39,0.28,1.55,6.32,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,2
CHEMBL194747,,None,354.41,0,4.45,28,Cc1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1,IC50,'=',1800,nM,5.75,,,UO_0000065,16.21,0.29,1.29,7.1,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,1.8
CHEMBL206536,,None,404.52,1,6.89,56,CC(C)(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1,IC50,'=',75,nM,7.12,,,UO_0000065,17.61,0.31,0.23,14.05,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.075
CHEMBL382818,,None,448.86,1,6.76,58,FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1,IC50,'=',79,nM,7.1,,,UO_0000065,15.82,0.3,0.34,11.85,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.079
CHEMBL202950,,None,404.52,1,6.89,68,CC(C)(C)c1ccc(Nc2nnc(-c3cccc4ncccc34)c3ccccc23)cc1,IC50,'=',2000,nM,5.7,,,UO_0000065,14.09,0.25,-1.19,11.24,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,2
CHEMBL202904,,None,381.83,0,3.87,7,Cn1cnc(NCc2ccccn2)c1-c1nnc(Nc2ccc(Cl)cc2)o1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL378592,,None,407.43,0,3.24,24,COc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1OC,IC50,'=',93,nM,7.03,,,UO_0000065,17.26,0.32,3.79,6.27,0,CHEMBL862191,Inhibition of VEGFR2 in 293 adenovirus transfected kidney cells by cell-based ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.093
CHEMBL1688250,,None,415.48,0,1.76,5,CS(=O)(=O)c1ccc(-c2nnc(-c3cccnc3NCC3COCCO3)[nH]2)cc1,IC50,'=',4500,nM,5.35,,,UO_0000065,12.87,0.25,3.59,4.49,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,4.5
CHEMBL382359,,None,388.39,0,3.61,9,c1cncc(CNc2ncccc2-c2nnc(Nc3ccc4c(c3)OCO4)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,10
CHEMBL196940,,None,382.47,1,5.05,28,Cc1ccc(Nc2nnc(-c3ccc(C(=O)N(C)C)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL193395,,None,490.92,1,5.16,35,Cc1ccc(-c2nnc(Nc3ccc(OC(F)(F)Cl)cc3)c3ccccc23)cc1S(N)(=O)=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL2113172,,None,419.82,0,2.21,9c,COCCOc1cc2ncnc(NC3=CC(=O)C(OC)=C(Cl)C3=O)c2cc1OC,IC50,'=',1,nM,9,,,UO_0000065,21.44,0.42,6.79,8.27,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1
CHEMBL3706825,,None,385.38,0,1.64,16,COCCOc1cc2ncnc(NC3=CC(=O)C(OC)=CC3=O)c2cc1OC,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL2113170,,None,529.6,1,2.81,23,COCCOc1cc2ncnc(NC3=CC(=O)C(N4CCN(Cc5ccccc5)CC4)=CC3=O)c2cc1OC,IC50,'=',84.8,nM,7.07,,,UO_0000065,13.35,0.25,4.26,6.66,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,84.8
CHEMBL200818,,None,467.53,0,1.63,24,CCN1CCN(C2=CC(=O)C(Nc3ncnc4cc(OCCOC)c(OC)cc34)=CC2=O)CC1,IC50,'=',133,nM,6.88,,,UO_0000065,14.71,0.28,5.25,6.48,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,133
CHEMBL200818,,None,467.53,0,1.63,24,CCN1CCN(C2=CC(=O)C(Nc3ncnc4cc(OCCOC)c(OC)cc34)=CC2=O)CC1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL2113176,,None,462.46,0,2.61,27,COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccnc4)=CC3=O)c2cc1OC,IC50,'=',110.5,nM,6.96,,,UO_0000065,15.04,0.28,4.35,5.71,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,110.5
CHEMBL2113171,,None,483.86,0,2.89,30,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=C(Cl)C3=O)c2cc1OC,IC50,'=',792,nM,6.1,,,UO_0000065,12.61,0.25,3.21,5.6,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,792
CHEMBL3706835,,None,435.38,0,2.28,39,COCCOc1cc2ncnc(NC3=CC(=O)C(OCC(F)F)=CC3=O)c2cc1OC,IC50,'=',870,nM,6.06,,,UO_0000065,13.92,0.27,3.78,5.57,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,870
CHEMBL3706839,,None,454.44,0,1.84,42,COCCOc1cc2ncnc(NC3=CC(=O)C(N4CC(C)OC4=O)=CC3=O)c2cc1OC,IC50,'=',59.7,nM,7.22,,,UO_0000065,15.9,0.3,5.38,5.59,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,59.7
CHEMBL1683350,,None,399.49,1,5.69,7d,CC(C)(C)c1ccc(NC(=O)c2c[nH]c3cccc(OCc4ccncc4)c23)cc1,Inhibition,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL1687576,Inhibition of KDR assessed as phosphorylation level of substrate at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681739,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,6
CHEMBL3706834,,None,415.4,0,1.62,49,COCCOc1cc2ncnc(NC3=CC(=O)C(OC)=C(OC)C3=O)c2cc1OC,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL2113192,,None,479.44,0,2.29,50,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=C(OC)C3=O)c2cc1OC,IC50,'=',41,nM,7.39,,,UO_0000065,15.41,0.3,5.1,6.26,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,41
CHEMBL3706826,,None,502.52,1,3.01,61,COc1cc2c(NC3=CC(=O)C(OC(CF)CF)=CC3=O)ncnc2cc1OCC1CCN(C)CC1,IC50,'=',11.2,nM,7.95,,,UO_0000065,15.82,0.3,4.94,7.73,0,CHEMBL862696,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 1 mm ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,11.2
CHEMBL3706843,,None,514.58,1,3.91,63,COc1cc2c(NC3=CC(=O)C(OCc4ccccc4)=CC3=O)ncnc2cc1OCC1CCN(C)CC1,IC50,'=',13.6,nM,7.87,,,UO_0000065,15.29,0.28,3.96,7.65,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,13.6
CHEMBL3706842,,None,538.6,1,3.9,66,COc1cc2c(NC3=CC(=O)C(OCC#Cc4ccccc4)=CC3=O)ncnc2cc1OCCCN1CCCC1,IC50,'=',1.8,nM,8.74,,,UO_0000065,16.24,0.3,4.84,8.5,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1.8
CHEMBL2387003,,None,575.74,1,4.22,2b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5076728,,None,451.51,0,4.01,15d,O=C(CCCCCCn1cc(Nc2ncc3ccn(Cc4ccccc4F)c3n2)cn1)NO,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL5038996,Inhibition of human recombinant VEGFR2 assessed as reduction in substrate phosphorylation at 50 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5038570,1,Scientific Literature,J Med Chem,2022,None,Dose = 50.0 nM | TIME = 1.0 hr,,,0
CHEMBL473250,,None,541.06,2,5.53,7f,Cc1cccc(Cl)c1Nc1nc2ccccc2n1-c1cc(Nc2ccc(CCN3CCOCC3)cn2)ncn1,IC50,'=',1012,nM,6,,,UO_0000065,11.08,0.21,0.46,6.44,0,CHEMBL994995,Inhibition of TEL fused KDR-mediated proliferation of TEL-KDR transformed mouse BA/F3 cells after 48 hrs by bright-glo luciferase assay,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144231,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307634,,,,1.012
CHEMBL447107,,None,571.09,2,4.48,7g,Cc1nc(Nc2cc(-n3c(Nc4c(C)cccc4Cl)nc4ccccc43)ncn2)cc(N2CCN(CCO)CC2)n1,IC50,'=',356,nM,6.45,,,UO_0000065,11.29,0.21,1.97,5.37,0,CHEMBL994995,Inhibition of TEL fused KDR-mediated proliferation of TEL-KDR transformed mouse BA/F3 cells after 48 hrs by bright-glo luciferase assay,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144231,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307634,,,,0.356
CHEMBL2376144,,None,462.9,0,2.27,6a,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-18,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2378439,Inhibition of KDR (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375236,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,-18
CHEMBL1990212,,None,381.82,0,4.21,SID103904923,COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1979252,,None,347.3,0,3.05,SID103905144,O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1970203,,None,432.51,0,4.79,SID103904353,Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL1984191,,None,291.14,0,3.84,SID103905424,Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL226471,,None,307.33,0,3.17,SID103904965,O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21,Ki,'=',7943.28,nM,5.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1965589,,None,408.41,0,3.38,SID103904761,Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1976376,,None,402.45,0,3.93,SID103904992,Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.4
CHEMBL1973795,,None,209.25,0,2.6,SID103904585,O=C1NCc2ccc(-c3ccccc3)cc21,Ki,'>',100000,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4
CHEMBL1984760,,None,391.4,0,4.34,SID103904640,CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.3
CHEMBL1996066,,None,317.38,0,3.6,SID103904819,N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1,Ki,'=',12.59,nM,7.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.9
CHEMBL460466,,None,526.57,2,6.1,2,CCCn1c(C)c(C(=O)Nc2ccc(Oc3ccnc4cc(OC)ccc34)c(F)c2)c(=O)n1-c1ccccc1,IC50,'=',143,nM,6.84,,,UO_0000065,13,0.24,0.74,7.83,0,CHEMBL989220,Inhibition VEGFR2-mediated survival of HUVEC,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157538,1,Scientific Literature,J Med Chem,2008,CHEMBL3307501,,,,143
CHEMBL3099673,,None,264.24,0,1.45,14,O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL3102550,Inhibition of VEGF-R2 (unknown origin) assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098105,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,93
CHEMBL455655,,None,542.6,2,6.59,21,CCn1ccnc1-c1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2s1,IC50,'=',26,nM,7.58,,,UO_0000065,13.98,0.27,1,8.19,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.026
CHEMBL462231,,None,541.61,2,6.01,14,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C)CCN(c6ccccc6)C5=O)cc4F)c3s2)c1,IC50,'=',230,nM,6.64,,,UO_0000065,12.26,0.23,0.63,7.43,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.23
CHEMBL455183,,None,467.53,0,4.55,4h,O=C(/C=C/c1cccc(/C=C2\Oc3ccccc3NC2=O)c1)Nc1ccc(N2CCOCC2)cc1,IC50,'>',400000,ug.mL-1,,Outside typical range,,UO_0000274,,,,,0,CHEMBL1001090,Inhibition of KDR expressed in baculovirus system by ELISA,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140887,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.4
CHEMBL455410,,None,432.48,1,5.93,31,NC(=O)c1ccc(-c2nnc(Nc3ccc(Oc4ccccc4)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL24137,,None,446.91,0,4.28,7,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCOCC1,IC50,'=',9,nM,8.05,,,UO_0000065,18,0.35,3.77,11.7,1,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.009
CHEMBL24979,,None,489.39,1,5.39,27,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCC1CCN(C)CC1,IC50,'=',6,nM,8.22,,,UO_0000065,16.8,0.36,2.83,13.82,0,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.006
CHEMBL96149,,None,302.34,0,3.47,3e,COc1ccc(-c2cnn3cc(-c4ccncc4)cnc23)cc1,Inhibition,'=',71,%,,,,UO_0000187,,,,,0,CHEMBL819552,Inhibition of Vascular endothelial growth factor receptor 2 at 2500 nM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,71
CHEMBL2418750,,None,354.42,0,3.88,1,Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5)c4)c3c2)cn1,Inhibition,'=',28,%,,,,UO_0000187,,,,,0,CHEMBL2423637,Inhibition of KDR (unknown origin) at 100 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2417505,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,28
CHEMBL3099455,,None,592.69,2,5.63,T14,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCCN4CCOCC4)cc3C)cc(OC)c2OC)ccc1/C(C)=N/O,Inhibition,'=',54.7,%,,,,UO_0000187,,,,,0,CHEMBL3222611,Inhibition of VEGFR-2 (unknown origin) at 3.2 nM after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,54.7
CHEMBL3220325,,None,564.68,2,6.25,T9,CCN(CC)CCOc1ccc(C)c(NC(=O)Nc2cc(OC)c(OC)c(-c3ccc(/C(C)=N/O)c(OC)c3)c2)c1,IC50,'=',3.9,nM,8.41,,,UO_0000065,14.89,0.28,2.16,7.38,0,CHEMBL3222612,Inhibition of VEGFR-2 (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,3.9
CHEMBL3220324,,None,536.63,2,5.47,T8,COc1cc(-c2cc(NC(=O)Nc3cc(OCCN(C)C)ccc3C)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3222612,Inhibition of VEGFR-2 (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,
CHEMBL2409790,,None,447.52,0,4.73,33,Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)c2)n(C)n1,IC50,'=',3.6,nM,8.44,,,UO_0000065,18.87,0.36,3.71,8.6,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,3.6
CHEMBL522855,,None,417.51,0,3.7,31,COc1cc2nccc(CN3CCc4c(cccc4C(=O)NC4CC4)C3)c2cc1OC,IC50,'=',92,nM,7.04,,,UO_0000065,16.85,0.31,3.34,11.05,0,CHEMBL1009458,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155071,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,92
CHEMBL5173016,,None,592.69,1,4.96,3e,CC1(C)c2cc(OCCN3CCOCC3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCC4(CO)CC4)ccn3)ccc21,IC50,'=',960,nM,6.02,,,UO_0000065,10.15,0.19,1.06,6.38,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,INHIBITOR,,960
CHEMBL5203355,,None,569.68,2,5.31,9,Cc1c(C(=O)NC(C)(C)C)ccnc1C#Cc1ccc2c3c(oc2c1)C(C)(C)c1cc(NS(C)(=O)=O)ccc1C3=O,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,,,1000
CHEMBL75034,,None,376.85,1,5.02,62,COc1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)ccc1Cl,IC50,'=',140,nM,6.85,,,UO_0000065,18.19,0.35,1.83,11.44,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.14
CHEMBL169643,,None,468.94,0,4.88,11,COc1cc2c(Nc3c(Cl)ccc4ccoc34)ncnc2cc1OCCCN1CCOCC1,IC50,'=',1380,nM,5.86,,,UO_0000065,12.5,0.24,0.98,7.16,0,CHEMBL820673,In vitro inhibitory concentration against VEGF receptor 2.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148412,1,Scientific Literature,J Med Chem,2004,None,,,,1.38
CHEMBL347537,,None,430.51,1,6.16,7,O=C(Nc1cccc(-c2cncc3ccccc23)c1)c1ccccc1NCc1ccncc1,IC50,'=',1.16,nM,8.94,,,UO_0000065,20.76,0.37,2.78,13.35,0,CHEMBL817493,Inhibition of VEGFR induced autophosphorylation of human Vascular endothelial growth factor receptor 2 (VEGFR2) transfected in CHO cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135689,1,Scientific Literature,J Med Chem,2002,CHEMBL3308072,,,,1.16
CHEMBL182560,,None,343.41,0,3.59,5,COc1ccc(-c2cc3c(NC(=O)CCSC)ncnc3o2)cc1,IC50,'>',47000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,47
CHEMBL360340,,None,351.41,0,4.42,10,COc1ccc(-c2cc3c(NC(=O)C4CCCCC4)ncnc3o2)cc1,IC50,'>',48000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,48
CHEMBL185331,,None,371.44,0,4.86,10c,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1,IC50,'=',770,nM,6.11,,,UO_0000065,16.46,0.3,1.25,8.7,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,770
CHEMBL185614,,None,391.86,1,5.2,10g,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(Cl)c2)c1,IC50,'=',71,nM,7.15,,,UO_0000065,18.24,0.35,1.95,10.18,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,71
CHEMBL327518,,None,276.36,0,4.96,3a,c1ccc2c(-c3cncc(-c4ccsc4)c3)c[nH]c2c1,IC50,'=',126,nM,6.9,,,UO_0000065,24.97,0.47,1.94,24.06,0,CHEMBL819548,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136194,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,126
CHEMBL189125,,None,370.84,0,3.31,79,Nc1ncc(NCCCO)cc1-c1cncc(Nc2cccc(Cl)c2)n1,IC50,'=',1360,nM,5.87,,,UO_0000065,15.82,0.31,2.56,5.38,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,1.36
CHEMBL189325,,None,599.73,2,6.58,39,COc1cc(OC)cc(-c2cc3cnc(N(CCCCOCc4ccccc4)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1,IC50,'=',670,nM,6.17,,,UO_0000065,10.29,0.19,-0.41,5.37,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.67
CHEMBL184021,,None,414.47,0,4.51,14a,CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(C)c3)cc2)c2c1C(=O)NC2,IC50,'=',64,nM,7.19,,,UO_0000065,17.36,0.32,2.68,7.24,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,64
CHEMBL2408616,,None,482.52,1,5.36,13f,Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(C(F)F)c(-c3cccc4nnsc34)oc12,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL2410657,Inhibition of KDR autophosphorylation overexpressed in VEGF-stimulated human HEK293 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407065,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3307715,,,,20
CHEMBL434311,,None,460.94,0,4.67,23,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCCN1CCOCC1,IC50,'=',40,nM,7.4,,,UO_0000065,16.05,0.32,2.73,10.76,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.04
CHEMBL360450,,None,436.56,0,3.66,26,CCCc1c(C(=O)NCCCN2CCCC2)cn2ncnc(Nc3ccc(C)c(O)c3)c12,IC50,'=',90,nM,7.05,,,UO_0000065,16.14,0.3,3.39,7.43,0,CHEMBL830878,Inhibitory concentration against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142012,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,90
CHEMBL431342,,None,467.62,1,6.44,10 (cis),Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N2CCCCC2)CC1,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL811945,Inhibition of Vascular endothelial growth factor receptor 2(Not tested),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135158,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,
CHEMBL389524,,None,388.5,1,5.81,23,Cc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ccnc(N)c34)cc2)c1,IC50,'=',27,nM,7.57,,,UO_0000065,19.48,0.37,1.76,9.46,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,27
CHEMBL369751,,None,358.42,0,3.89,21,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1,IC50,'=',50,nM,7.3,,,UO_0000065,20.37,0.4,3.41,8.97,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.05
CHEMBL361642,,None,383.43,0,3.76,26,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C#N)c3)o2)c1,IC50,'=',141,nM,6.85,,,UO_0000065,17.87,0.35,3.09,6.51,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.141
CHEMBL178156,,None,445.48,1,5.7,6e,COc1cccc(NC(=O)Nc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)c1,IC50,'<',1,nM,,,,UO_0000065,,,,,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,1
CHEMBL179227,,None,433.44,1,5.83,6l,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccccc4F)cc3)c2cc1OC,IC50,'=',0.5,nM,9.3,,,UO_0000065,21.46,0.4,3.47,11.38,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,0.5
CHEMBL360349,,None,485.87,1,6.62,6ae,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)cc3Cl)c2cc1OC,IC50,'=',2.6,nM,8.59,,,UO_0000065,17.67,0.34,1.97,10.51,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,2.6
CHEMBL424321,,None,454.57,1,5.31,25,CCCCOCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,Inhibition,'=',,%,,,,UO_0000187,,,,,0,CHEMBL818938,Inhibition of Vascular endothelial growth factor receptor 2 autophosphorylation by VEGF in human umbilical vein endothelial cells (HUVECs) at 10 nM (No decrease),B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,CHEMBL3307501,,,,
CHEMBL81026,,None,300.36,0,4.7,2,COc1ccc(-c2ccc3c(c2)ncn3-c2ccccc2)cc1,IC50,'=',113,nM,6.95,,,UO_0000065,23.13,0.41,2.25,25.68,1,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,113
CHEMBL1289977,,None,288.35,0,4.64,11b,c1ccc(CCNc2ccnc3oc4ccccc4c23)cc1,Ki,'=',2010,nM,5.7,,,UO_0000065,19.76,0.35,1.06,14.97,0,CHEMBL1292127,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1287713,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,2.01
CHEMBL82069,,None,398.51,0,4.95,5,c1ccc(-n2cnc3cc(-c4ccc(OCCN5CCCCC5)nc4)ccc32)cc1,IC50,'=',23,nM,7.64,,,UO_0000065,19.17,0.35,2.69,17.69,0,CHEMBL818933,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144948,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,23
CHEMBL435702,,None,412.54,0,4.71,18a,O=c1cc(-c2ccn3c(-c4ccccc4)cnc3c2)ccn1CCCN1CCCCC1,IC50,'=',28,nM,7.55,,,UO_0000065,18.31,0.33,2.84,17.75,0,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,28
CHEMBL354070,,None,277.35,0,4.12,10f,c1ccc(-c2ccn3c(-c4cncs4)cnc3c2)cc1,IC50,'=',99,nM,7,,,UO_0000065,25.25,0.48,2.88,23.2,0,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,99
CHEMBL4779280,,None,383.5,0,4.77,EUB0000632a,CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1,% of inhibition,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL5212957,Selectivity interaction (HotSpot assay platform (Reaction Biology)) EUB0000632a KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Protein family: Protein Kinase,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5212743,65,EUbOPEN Chemogenomic Library Literature Data,,2023,None,Selectivity Comments: Cell Titer-Glo Luminescent  Cell Viability Assay (Promega,,,
CHEMBL461831,,None,516.5,2,5.83,50,COc1cc2nccc(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)c2cc1OC,Ki,'=',382,nM,6.42,,,UO_0000065,12.43,0.23,0.59,7.33,0,CHEMBL971817,Inhibition of phosphorylated KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,,,,382
CHEMBL2063318,,None,496.57,0,4.69,7b,CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Oc5ccccc5)cc4)n[nH]3)cc2)CC1,IC50,'=',180,nM,6.75,,,UO_0000065,13.58,0.25,2.05,6.57,0,CHEMBL2066305,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2062390,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,180
CHEMBL3261966,,None,456.54,0,4.93,7e,O=c1c2cc(O)ccc2cc(-c2ccc(O)cc2)n1-c1ccc(OCCCN2CCCC2)cc1,Inhibition,'=',48.33,%,,,,UO_0000187,,,,,0,CHEMBL3268857,Inhibition of VEGFR-2 (unknown origin) at 0.1 mg/ml after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259730,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,48.33
CHEMBL3261967,,None,470.57,1,5.32,7f,O=c1c2cc(O)ccc2cc(-c2ccc(O)cc2)n1-c1ccc(OCCCN2CCCCC2)cc1,Inhibition,'=',100.26,%,,,,UO_0000187,,,,,0,CHEMBL3268857,Inhibition of VEGFR-2 (unknown origin) at 0.1 mg/ml after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259730,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,100.26
CHEMBL2063878,,None,506.39,1,3.8,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3782019,,None,388.43,0,4.46,20l,COc1ccc(-c2cnc3cncc(Nc4cc(OC)ccc4OC)c3n2)cc1,IC50,'=',1600,nM,5.8,,,UO_0000065,14.92,0.27,1.34,7.39,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,1.6
CHEMBL231511,,None,450.57,1,7.16,10,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccccc5)cnc(N)c34)cc2)c1,IC50,'=',33,nM,7.48,,,UO_0000065,16.6,0.31,0.32,9.35,1,CHEMBL2024778,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,CHEMBL3307716,,,,33
CHEMBL41632,TIRATRICOL,3,621.93,1,4.63,tiratricol,O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1,AC50,'>',10000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291913,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,10
CHEMBL1675,VITAMIN A PALMITATE,4,524.87,2,11.54,vitamin A palmitate,CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL683,CLOFIBRIC ACID,2,214.65,0,2.58,clofibric acid,CC(C)(Oc1ccc(Cl)cc1)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1160714,PRENALTEROL,2,225.29,0,1.13,prenalterol,CC(C)NC[C@H](O)COc1ccc(O)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1351,CARBOPLATIN,4,371.25,None,None,carboplatin,,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2029678,,None,462.54,0,3.53,23,COCCOc1cnc2ccc([C@H](C)n3nnc4ccn(-c5cc(C)ns5)c(=O)c43)cc2c1,Activity,'=',34,%,,,,UO_0000187,,,,,0,CHEMBL2034589,Inhibition of VEGFR2 assessed as remaining activity at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029295,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,34
CHEMBL194014,PROPYLPARABEN,-1,180.2,0,1.96,propylparaben,CCCOC(=O)c1ccc(O)cc1,AC50,'=',24263.9,nM,4.62,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,24.2639
CHEMBL2023228,,None,474.98,1,6.24,22,Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(Cl)c5)cc4)csc23)cn1,IC50,'=',7,nM,8.15,,,UO_0000065,17.17,0.34,1.91,8.33,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,7
CHEMBL354541,LOMITAPIDE,4,693.73,2,8.38,lomitapide,O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL95,TACRINE,4,198.27,0,2.7,Tacrine,Nc1c2c(nc3ccccc13)CCCC2,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3957061,,None,453.55,1,5.5,Page 91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL356626,,None,440.54,0,4.92,20,CCCOCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL820688,Inhibition of Vascular endothelial growth factor receptor 2 autophosphorylation by VEGF in human umbilical vein endothelial cells (HUVECs) at 200 nM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,CHEMBL3307501,,,,100
CHEMBL402673,,None,576.73,1,3.62,8,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NS(=O)(=O)c1ccccc1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL698970,Inhibition of human VEGF-receptor 2 (kdr) kinase.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135159,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,50
CHEMBL359316,,None,440.54,1,5.09,32 (+/-),CCOC(C)c1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',83,nM,7.08,,,UO_0000065,16.07,0.29,1.99,11.15,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,83
CHEMBL2047250,,None,342.32,0,4.39,10,Nc1nc2c(c(Nc3ccc(C(F)(F)F)cc3)n1)-c1ccccc1C2,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL2050144,Inhibition of VEGFR2 in human U251 cells pretreated for 60 mins measured after 1 hr by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046359,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,200
CHEMBL2047241,,None,292.32,0,3.51,5,Nc1nc2c(c(Nc3ccc(F)cc3)n1)-c1ccccc1C2,IC50,'=',89300,nM,4.05,,,UO_0000065,13.85,0.25,0.54,6.34,0,CHEMBL2050144,Inhibition of VEGFR2 in human U251 cells pretreated for 60 mins measured after 1 hr by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046359,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,89.3
CHEMBL296430,,None,449.36,1,6.11,2l,FC(F)(F)c1cc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)cc(C(F)(F)F)c1,IC50,'=',77,nM,7.11,,,UO_0000065,15.83,0.3,1,12.79,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,77
CHEMBL2036728,,None,386.46,0,3.61,2d,Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2038040,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2071200,,None,393.37,0,2.06,16,Cn1cc(Nc2ncc(C(F)(F)F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1,IC50,'=',35,nM,7.46,,,UO_0000065,18.95,0.36,5.4,6.73,0,CHEMBL2073500,Inhibition of human KDR autophosphorylation expressed in mouse NIH/3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2069252,1,Scientific Literature,Bioorg Med Chem Lett,2012,CHEMBL3307716,,,,35
CHEMBL2071217,,None,435.92,0,3.21,(+)-33,NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cnn(Cc4ccccc4)c3)ncc2Cl)[C@H]2C=C[C@@H]1C2,IC50,'=',42,nM,7.38,,,UO_0000065,16.92,0.32,4.17,6.66,0,CHEMBL2073500,Inhibition of human KDR autophosphorylation expressed in mouse NIH/3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2069252,1,Scientific Literature,Bioorg Med Chem Lett,2012,CHEMBL3307716,,,,42
CHEMBL2071272,,None,402.85,0,0.64,(+)-36,NC(=O)Cn1cc(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1,IC50,'=',167,nM,6.78,,,UO_0000065,16.82,0.33,6.14,4.41,0,CHEMBL2073500,Inhibition of human KDR autophosphorylation expressed in mouse NIH/3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2069252,1,Scientific Literature,Bioorg Med Chem Lett,2012,CHEMBL3307716,,,,167
CHEMBL1173590,,None,496.48,1,6,30,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(-c3cccc([N+](=O)[O-])c3)o2)cc1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1176712,Inhibition of KDR at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,0
CHEMBL2016905,,None,485.56,0,4.24,21,O=C(c1ccc(CN2CCCCC2)cc1)N1CCc2nc(-c3cc4cc(F)ccc4[nH]c3=O)[nH]c2C1,IC50,'=',4.9,nM,8.31,,,UO_0000065,17.11,0.32,4.07,9.77,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.0049
CHEMBL2016925,,None,385.43,0,2.44,41,O=C(Cc1ccncc1)N1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',6.7,nM,8.17,,,UO_0000065,21.21,0.38,5.73,8.63,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.0067
CHEMBL1173150,,None,460.49,0,4.4,49,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CC(=O)O)c2C)cc1,IC50,'=',4.7,nM,8.33,,,UO_0000065,18.08,0.33,3.93,6.28,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,4.7
CHEMBL1173541,,None,474.52,0,4.79,50,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1,IC50,'=',10,nM,8,,,UO_0000065,16.86,0.31,3.21,6.04,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,10
CHEMBL2010878,,None,462.56,1,5.26,11j,CC(C)n1c2ccc(Nc3ccncc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',256,nM,6.59,,,UO_0000065,14.25,0.26,1.33,8.59,0,CHEMBL2015672,Inhibition of human recombinant VEGF-R2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,256
CHEMBL2010875,,None,507.6,1,4.74,11g,COc1ccnc(Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)n1,IC50,'=',32,nM,7.5,,,UO_0000065,14.77,0.27,2.75,7.58,0,CHEMBL2015672,Inhibition of human recombinant VEGF-R2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,32
CHEMBL2010869,,None,491.6,1,5.04,11d,CCCn1c2ccc(Nc3ncc(CC)cn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',9,nM,8.05,,,UO_0000065,16.37,0.3,3.01,8.97,0,CHEMBL2015672,Inhibition of human recombinant VEGF-R2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,9
CHEMBL2010878,,None,462.56,1,5.26,11j,CC(C)n1c2ccc(Nc3ccncc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2015674,Inhibition of human VEGFR2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL2010876,,None,545.57,2,5.75,11h,CC(C)Cn1c2ccc(Nc3nccc(C(F)(F)F)n3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',271,nM,6.57,,,UO_0000065,12.04,0.22,0.82,7.32,0,CHEMBL2015672,Inhibition of human recombinant VEGF-R2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,271
CHEMBL1164526,,None,479.54,0,3.66,7a,CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1,Activity,'=',65,%,,,,UO_0000187,,,,,0,CHEMBL1167145,Inhibition of VEGFR2 assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165969,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,65
CHEMBL3908737,,None,500.93,2,6.94,BDBM235589,Cc1cc(Oc2ccnc(NC(=O)C3CC3)c2)ccc1NC(=O)Nc1ccc(Cl)c(C(C)(F)F)c1,IC50,'=',14,nM,7.85,,410224,UO_0000065,15.68,0.31,0.91,8.5,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916041,,None,489.43,1,5.65,BDBM235592,CC(F)(F)c1ccc(F)c(NC(=O)Nc2cnc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c1,IC50,'=',12.7,nM,7.9,,410227,UO_0000065,16.13,0.31,2.25,7.5,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913137,,None,488.44,1,6.26,BDBM235608,CC(F)(F)c1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)c1,IC50,'=',9.1,nM,8.04,,410243,UO_0000065,16.46,0.31,1.78,8.71,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976542,,None,488.44,1,6.33,BDBM235615,Cc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)cc1NC(=O)Nc1cc(C(F)(F)F)ccc1F,IC50,'=',10.7,nM,7.97,,410250,UO_0000065,16.32,0.31,1.64,8.63,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3928570,,None,311.77,0,3.73,BDBM236223,O=C1Nc2ccccc2C2=NCC(c3ccc(Cl)cc3)CN12,IC50,'>',10000,nM,,,411566,UO_0000065,,,,,0,CHEMBL3888632,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931320,,None,292.34,0,2.66,BDBM236226,Nc1ccc(C2CN=C3c4ccccc4NC(=O)N3C2)cc1,IC50,'>',10000,nM,,,411569,UO_0000065,,,,,0,CHEMBL3888632,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935954,,None,364.41,0,2.91,BDBM236240,CNc1ccc(C2CN=C3c4ccc(C(=O)OC)cc4NC(=O)N3C2)cc1,IC50,'>',10000,nM,,,411583,UO_0000065,,,,,0,CHEMBL3888632,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2403367,,None,337.38,0,2.42,3,COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(C)=O)C3)C(=O)N2,IC50,'=',210,nM,6.68,,,UO_0000065,19.79,0.36,4.26,8.97,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.21
CHEMBL2047248,,None,353.22,0,4.14,BDBM242724,Nc1nc2c(c(Nc3cccc(Br)c3)n1)-c1ccccc1C2,IC50,'>',200000,nM,,Outside typical range,423213,UO_0000065,,,,,1,CHEMBL3887187,Inhibition Assay: Inhibition of various kinase enzyme.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3886207,37,BindingDB Patent Bioactivity Data,,2016,None,,,,200000
CHEMBL3941533,,None,402.43,1,5.03,BDBM238843,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3[nH]c4ccccc4c3C(N)=O)cc2)c1,IC50,'=',17,nM,7.77,,416963,UO_0000065,19.31,0.35,2.74,7.77,0,CHEMBL3888803,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377454,,None,604.68,1,5.64,2f.tartaric,O=C(O)C(O)C(O)C(=O)O.O=c1[nH]c(CN2CCCCC2)nc2cc(-c3cn(Cc4ccccc4)c4ccccc34)sc12,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL2379178,Inhibition of VEGFR2 phosphorylation in growth factor-stimulated HUVEC at 3 uM after 24 hrs,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,CHEMBL3307501,,,,
CHEMBL2377505,,None,296.4,0,4.25,5,COc1ccc(-c2ncnc3sc4c(c23)CCCC4)cc1,Inhibition,'=',47.4,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,47.4
CHEMBL359592,,None,289.3,0,1.88,A1,O=C1NN=C(c2cnccn2)/C1=C/c1cc2ccccc2[nH]1,IC50,'=',40010,nM,4.4,,,UO_0000065,15.2,0.27,2.52,5.3,0,CHEMBL832932,Inhibition of Vascular endothelial growth factor receptor 2(KDR) with DTT (dithiothreitol),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138015,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,40.01
CHEMBL521145,,None,384.49,0,3.16,CER-0264280,Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,0
CHEMBL1076721,,None,295.3,0,1.39,39,COc1ccc(C2=NNC(=O)/C2=N\Nc2cccnc2)cc1,Ki,'=',3400,nM,5.47,,,UO_0000065,18.52,0.34,4.08,6.22,0,CHEMBL1102109,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154953,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,3400
CHEMBL501471,,None,452.56,1,5.27,CER-0263822,Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,11
CHEMBL2022373,,None,563.64,2,5,46,Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1,IC50,'=',481,nM,6.32,,,UO_0000065,11.21,0.22,1.32,6,0,CHEMBL2024837,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021851,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,481
CHEMBL2022711,,None,560.66,2,4.51,56,Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1,IC50,'=',253,nM,6.6,,,UO_0000065,11.77,0.23,2.09,5.58,0,CHEMBL2024837,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021851,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,253
CHEMBL501463,,None,585.48,1,4.34,CER-0262939,Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1,Inhibition,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,17
CHEMBL3969861,,None,475.4,1,5.42,BDBM235509,O=C(Nc1cccc(Oc2cc(NC(=O)C3CC3)ncn2)c1)Nc1ccc(F)c(C(F)(F)F)c1,IC50,'=',14.9,nM,7.83,,410144,UO_0000065,16.46,0.31,2.41,7.44,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3921563,,None,470.45,1,6.12,BDBM235570,CC(F)(F)c1cccc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c1,IC50,'=',9.8,nM,8.01,,410205,UO_0000065,17.02,0.32,1.89,8.67,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3911854,,None,400.44,0,4.89,BDBM234586,COc1cccc(NC(=O)Nc2ccc(-c3cc4ccccc4n3C(N)=O)cc2)c1,IC50,'=',45,nM,7.35,,409025,UO_0000065,18.35,0.33,2.46,7.47,0,CHEMBL3888559,FLIPR (Fluorometric Imaging Plate Reader) Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (EIx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3939918,,None,370.41,0,4.88,BDBM234588,NC(=O)n1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)cc2ccccc21,IC50,'=',150,nM,6.82,,409027,UO_0000065,18.42,0.33,1.94,7.65,0,CHEMBL3888559,FLIPR (Fluorometric Imaging Plate Reader) Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (EIx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976501,,None,367.3,0,3.99,BDBM223059,NC(=O)/C=C\c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1,IC50,'=',2790,nM,5.55,,389862,UO_0000065,15.12,0.29,1.56,6.6,0,CHEMBL3888326,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932854,,None,367.3,0,3.99,BDBM223057,NC(=O)/C=C/c1cccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c1,IC50,'>',10000,nM,,,389863,UO_0000065,,,,,0,CHEMBL3888326,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976755,,None,308.77,0,4.03,BDBM242733,Nc1nc(Nc2ccc(Cl)cc2)c2c(n1)-c1ccccc1C2,IC50,'=',132900,nM,,Outside typical range,423243,UO_0000065,,,,,0,CHEMBL3887187,Inhibition Assay: Inhibition of various kinase enzyme.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3886207,37,BindingDB Patent Bioactivity Data,,2016,None,,,,132900
CHEMBL3933295,,None,562.65,1,3.91,BDBM208472,COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cccc(OC)c3)c2)c1,IC50,'=',5,nM,8.3,,368385,UO_0000065,14.75,0.28,4.39,5.53,0,CHEMBL3888027,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957336,,None,592.67,1,3.91,BDBM208473,COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(OC)c(OC)c3)c2)c1,IC50,'=',15,nM,7.82,,368386,UO_0000065,13.2,0.25,3.91,4.91,0,CHEMBL3888027,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957336,,None,592.67,1,3.91,BDBM208473,COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(OC)c(OC)c3)c2)c1,IC50,'=',4,nM,8.4,,368418,UO_0000065,14.17,0.27,4.49,5.27,0,CHEMBL3888028,VEGFR2 Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL597695,,None,377.38,0,2.76,[11C]8,COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1O[11CH3],Stability,'=',68,% ID/g,,,,,,,,,0,CHEMBL1071381,Binding affinity to VEGFR2 in human HEK293 cells expressing KDR assessed as specific binding at 20 uM by direct radioligand binding assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1158526,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3307715,,,,68
CHEMBL2011305,,None,383.35,1,5.76,BDBM50379217,Fc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nc2-c2ccncc2)cc1,IC50,'=',27000,nM,4.57,,421743,UO_0000065,11.92,0.22,-1.19,14.88,1,CHEMBL3888877,Kinase Assay: FlashPlates from Perkin Elmer (Boston,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,5,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',38,nM,7.42,,,UO_0000065,18.62,0.35,4.09,9.61,0,CHEMBL1110564,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155389,1,Scientific Literature,J Med Chem,2010,None,,,,38
CHEMBL1909364,GW589961A,None,488.33,1,5.83,GW589961A,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl,Inhibition,'=',32.37,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,32.37
CHEMBL171736,,None,416.53,0,3.8,18c,COCCN(C)CCCn1ccc(-c2ccn3c(-c4ccccc4)cnc3c2)cc1=O,IC50,'=',96,nM,7.02,,,UO_0000065,16.85,0.31,3.22,13.56,0,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,96
CHEMBL594810,,None,324.38,0,3.42,3,COc1ccccc1C(=Cc1coc2nc(=N)[nH]c(N)c12)C(C)C,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1038900,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152608,1,Scientific Literature,Bioorg Med Chem,2009,CHEMBL3307756,,,,500
CHEMBL352992,,None,443.94,0,3.63,7,COc1ccc(Cl)c(Nc2ncnc3cc(OCN4CCN(C)CC4)c(OC)cc23)c1,IC50,'=',670,nM,6.17,,,UO_0000065,13.91,0.27,2.54,8.58,0,CHEMBL820673,In vitro inhibitory concentration against VEGF receptor 2.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148412,1,Scientific Literature,J Med Chem,2004,None,,,,0.67
CHEMBL2010874,,None,505.63,2,5.34,11f,Cc1cc(C)nc(Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)n1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2015674,Inhibition of human VEGFR2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL2010871,,None,463.55,0,4.48,11a,CCCn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'<',10,nM,,,,UO_0000065,,,,,0,CHEMBL2015674,Inhibition of human VEGFR2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,10
CHEMBL2010873,,None,505.63,2,5.29,11e,CCc1cnc(Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)nc1,IC50,'<',10,nM,,,,UO_0000065,,,,,0,CHEMBL2015674,Inhibition of human VEGFR2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,10
CHEMBL173453,,None,359.43,0,2.75,1q,Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CNCCO)cc1,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL700242,Tested in vitro for inhibition of KDR-receptor tyrosine kinase; Not determined,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,
CHEMBL607535,MEISOINDIGO,None,276.3,0,2.53,2,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1066110,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152632,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0
CHEMBL2012881,,None,280.29,0,1.66,16e,O=c1[nH]nc2cc(CO)c3ccc(-c4ccc[nH]4)cc3n12,IC50,'=',319,nM,6.5,,,UO_0000065,23.18,0.42,4.84,7.54,0,CHEMBL2013786,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010637,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,319
CHEMBL473556,,None,414.49,1,5.67,1,COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC,IC50,'=',6300,nM,5.2,,,UO_0000065,12.55,0.24,-0.47,7.52,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,6.3
CHEMBL594228,,None,558.68,2,5.81,10,COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',62,nM,7.21,,,UO_0000065,12.9,0.25,1.4,9.53,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.062
CHEMBL593908,,None,608.69,2,6.69,20,COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL173550,,None,410.52,0,4.33,12a,CC(=O)N1CCN(Cc2ccc(-c3ccn4c(-c5ccccc5)cnc4c3)cc2)CC1,IC50,'=',77,nM,7.11,,,UO_0000065,17.33,0.31,2.78,17.41,0,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,77
CHEMBL366452,,None,446.58,0,3.75,12d,CS(=O)(=O)N1CCN(Cc2ccc(-c3ccn4c(-c5ccccc5)cnc4c3)cc2)CC1,IC50,'=',110,nM,6.96,,,UO_0000065,,,,,0,CHEMBL845293,Intrinsic potency against VEGF stimulated KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,110
CHEMBL194042,,None,455.85,1,5.99,52,COC(=O)c1ccc(-c2nnc(Nc3ccc(OC(F)(F)Cl)cc3)c3ccccc23)cc1,IC50,'=',630,nM,6.2,,,UO_0000065,13.6,0.26,0.21,8.45,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.63
CHEMBL427550,,None,440.84,1,5.31,53,NC(=O)c1cccc(-c2nnc(Nc3ccc(OC(F)(F)Cl)cc3)c3ccccc23)c1,IC50,'=',4100,nM,5.39,,,UO_0000065,12.22,0.24,0.08,5.98,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,4.1
CHEMBL420087,,None,211.68,0,2.94,20,Clc1cnc(Nc2ccccn2)s1,IC50,'=',194,nM,6.71,,,UO_0000065,31.71,0.71,3.77,17.75,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,194
CHEMBL69638,,None,370.46,1,5.59,10,Nc1ncnc2c1c(-c1cccc(Oc3ccccc3)c1)cn2C1CCCC1,IC50,'=',7100,nM,5.15,,,UO_0000065,13.9,0.25,-0.44,7.81,0,CHEMBL817617,Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132739,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,7.1
CHEMBL364411,,None,303.32,0,1.89,A2,Cn1cc(/C=C2\C(=O)NN=C2c2cnccn2)c2ccccc21,IC50,'=',100,nM,7,,,UO_0000065,23.08,0.42,5.11,9.7,0,CHEMBL832088,Inhibition of Vascular endothelial growth factor receptor 2(KDR) without DTT (dithiothreitol),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138015,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.1
CHEMBL329713,,None,267.36,0,4.26,10,Cc1cccnc1Nc1ncc(-c2ccccc2)s1,IC50,'=',13,nM,7.89,,,UO_0000065,29.5,0.57,3.63,20.86,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,13
CHEMBL468183,,None,391.47,1,5.87,23,Cc1ccc2[nH]cc(C(=O)c3ccccc3NCc3ccc4ncccc4c3)c2c1,IC50,'=',160,nM,6.8,,,UO_0000065,17.36,0.31,0.93,11.76,0,CHEMBL976315,Inhibition of KDR autophosphorylation by cell based assay,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.16
CHEMBL86531,,None,415.47,0,2.05,9c,NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)CCCC3)C(=O)N2,IC50,'=',600,nM,6.22,,,UO_0000065,14.98,0.29,4.17,4.37,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,0.6
CHEMBL1909412,,None,413.31,0,4.62,SB-476429-A,Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1,Inhibition,'=',69.21,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,69.21
CHEMBL1909412,,None,413.31,0,4.62,SB-476429-A,Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1,Inhibition,'=',74.84,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,74.84
CHEMBL170137,,None,425.54,0,4.13,12b,CNC(=O)N1CCN(Cc2ccc(-c3ccn4c(-c5ccccc5)cnc4c3)cc2)CC1,IC50,'=',52,nM,7.28,,,UO_0000065,17.12,0.31,3.15,13.77,0,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,52
CHEMBL170137,,None,425.54,0,4.13,12b,CNC(=O)N1CCN(Cc2ccc(-c3ccn4c(-c5ccccc5)cnc4c3)cc2)CC1,IC50,'=',410,nM,6.39,,,UO_0000065,,,,,0,CHEMBL845293,Intrinsic potency against VEGF stimulated KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,410
CHEMBL482326,GSK-1030062A,None,505.52,2,5.4,GSK1030062A,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC,Inhibition,'=',27.49,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,27.49
CHEMBL58483,,None,324.34,0,1.76,15k,O=C1Nc2cccc(CCO)c2/C1=C/c1[nH]cc2c1CCOC2=O,IC50,'=',1200,nM,5.92,,,UO_0000065,18.25,0.34,4.16,6.48,0,CHEMBL676766,Inhibitory activity was tested against FLK kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136528,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,1.2
CHEMBL505915,GSK-1751853A,None,601.69,1,3.61,GSK1751853A,COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2,Inhibition,'=',0.99,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,0.99
CHEMBL185238,GW786460X,None,287.33,0,3.39,GW786460X,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,Inhibition,'=',83.22,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,83.22
CHEMBL1950886,,None,427.51,1,5.22,14,CNC(=O)c1cc(Oc2ccc3nc(Nc4cccc(C(C)(C)C)c4)ncc3c2)ccn1,IC50,'<',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1953554,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949510,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,1
CHEMBL296468,BMS-387032,1,380.54,0,3.66,BMS-387032/SNS-032,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,10
CHEMBL558752,RAF-265,2,518.42,2,6.93,CHIR-265/RAF-265,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,Kd,'=',1300,nM,5.89,,,UO_0000065,11.35,0.22,-1.04,7.3,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,1300
CHEMBL124660,TANDUTINIB,2,562.72,2,5.03,MLN-518,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,10
CHEMBL10,SB-203580,None,377.44,0,4.68,SB-203580,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,10
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,ZD-6474,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,Kd,'=',820,nM,6.09,,,UO_0000065,12.8,0.28,1.66,9.7,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,820
CHEMBL1254190,,None,461.83,1,6.08,1b,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,IC50,'=',3.7,nM,8.43,,,UO_0000065,18.26,0.36,2.35,10.4,0,CHEMBL1250684,Inhibition of His-tagged human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250549,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3308860,,,,3.7
CHEMBL194321,,None,409.9,1,5.55,17,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2Cl)cc1,IC50,'=',338.84,nM,6.47,,,UO_0000065,15.78,0.32,0.92,6.96,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,6.47
CHEMBL98653,,None,253.33,0,3.95,7,c1ccc(-c2cnc(Nc3cccnc3)s2)cc1,IC50,'=',240,nM,6.62,,,UO_0000065,26.13,0.5,2.67,17.51,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,240
CHEMBL2016900,,None,389.39,0,2.65,16,O=C(c1cccnc1)N1CCc2nc(-c3cc4cc(F)ccc4[nH]c3=O)[nH]c2C1,IC50,'=',1,nM,9,,,UO_0000065,23.11,0.42,6.35,9.5,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.001
CHEMBL2016922,,None,377.45,0,1.9,38,O=C(CN1CCCC1)N1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',400,nM,6.4,,,UO_0000065,16.95,0.31,4.5,7.52,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.4
CHEMBL2016929,,None,415.45,0,3.52,45,COc1ccc(NC(=O)N2CCc3nc(-c4cc5ccccc5[nH]c4=O)[nH]c3C2)cc1,IC50,'=',46,nM,7.34,,,UO_0000065,17.66,0.32,3.82,7.12,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.046
CHEMBL51709,,None,351.4,0,3.52,4,CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2)C3=O)CC1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL819555,Inhibition of Vascular endothelial growth factor receptor 2 (VEGF-KDR) at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135924,1,Scientific Literature,J Med Chem,2002,None,,,,2
CHEMBL426229,,None,305.77,0,4.74,1b,Clc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL700242,Tested in vitro for inhibition of KDR-receptor tyrosine kinase; Not determined,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,
CHEMBL296185,,None,484.62,0,2.56,3f,CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCOCC1)CCCC3)C(=O)N2,IC50,'=',2300,nM,5.64,,,UO_0000065,11.63,0.23,3.08,5.45,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,2.3
CHEMBL1242852,,None,392.46,0,4.39,PP86,CC(C)n1nc(-c2ccc3c(ccn3C(=O)OC(C)(C)C)c2)c2c(N)ncnc21,IC50,'=',153,nM,6.82,,,UO_0000065,17.37,0.32,2.43,6.76,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.153
CHEMBL1084452,,None,556.67,2,7,2,CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1,IC50,'=',2059,nM,5.69,,,UO_0000065,10.21,0.18,-1.31,5.47,0,CHEMBL1120723,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,2.059
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1097088,,None,332.38,0,4.48,20b,Nc1cc(F)ccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1108247,Inhibition of VGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157789,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,
CHEMBL1080580,,None,471.54,1,5.03,18b,Cc1ccc(NC(=O)c2ccc(/C=C/C(=O)NO)cc2)cc1Nc1nc(-c2cccnc2)cs1,IC50,'=',11000,nM,4.96,,,UO_0000065,10.52,0.2,-0.07,4.27,0,CHEMBL1022425,Inhibition of VEGFR2 by liquid scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153406,1,Scientific Literature,J Med Chem,2009,None,,,,11
CHEMBL2011302,,None,383.62,0,4.17,10,Nc1c(C(=O)O)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl,IC50,'=',43000,nM,4.37,,,UO_0000065,11.38,0.25,0.2,4.64,0,CHEMBL2015056,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL215984,,None,397.86,0,4.77,6e,COc1cc(OCc2ccncc2)c(C(=N)Nc2ccc(Cl)cc2)cc1OC,Activity,,,,,,Not Active,,,,,,0,CHEMBL906911,Inhibition of recombinant KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149489,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL436958,,None,431.41,1,5.13,6d,COc1cc(OCc2ccncc2)c(C(=N)Nc2ccccc2C(F)(F)F)cc1OC,Activity,,,,,,Not Active,,,,,,0,CHEMBL906911,Inhibition of recombinant KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149489,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL13485,SU-11652,None,414.94,0,3.85,SU11652,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,IC50,'=',3000,nM,5.52,,,UO_0000065,13.31,0.26,1.67,7.15,0,CHEMBL996038,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156432,1,Scientific Literature,J Biol Chem,2007,None,,,,3
CHEMBL195640,,None,374.4,0,4.11,7g,COc1ccc(-c2oc3ncnc(N)c3c2-c2cccc(NC(C)=O)c2)cc1,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL828425,Inhibitory concentration against human vascular endothelial growth factor receptor 2; Not determined,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143549,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,
CHEMBL101253,VATALANIB,3,346.82,1,5.01,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL180022,NERATINIB,4,557.05,2,5.93,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL393418,,None,365.39,0,2.09,36,Cn1cnc(NCc2ccncc2)c1C(=O)NCc1ccc2c(c1)OCO2,IC50,'=',1120,nM,5.95,,,UO_0000065,16.29,0.3,3.86,6.59,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.12
CHEMBL241669,,None,391.35,0,3.58,16,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cccc(OC(F)(F)F)c1,IC50,'=',1110,nM,5.96,,,UO_0000065,15.22,0.29,2.37,7.35,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.11
CHEMBL394204,,None,389.38,0,4.01,33,Cc1ccc(NC(=O)c2c(NCc3ccncc3)ncn2C)cc1C(F)(F)F,IC50,'=',89,nM,7.05,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.089
CHEMBL241669,,None,391.35,0,3.58,16,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cccc(OC(F)(F)F)c1,IC50,'=',350,nM,6.46,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.35
CHEMBL245377,,None,523.66,1,4.33,20e,CN1CCN(CC(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2csc(C#CCOc3ccccc3)c2)CC1,IC50,'=',10,nM,8,,,UO_0000065,15.28,0.29,3.67,10.89,0,CHEMBL906389,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139908,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.01
CHEMBL248978,,None,388.35,0,4.24,20,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cccnc1NCc1ccncc1,Ki,'=',23,nM,7.64,,,UO_0000065,19.67,0.37,3.4,10.03,0,CHEMBL925259,Inhibition of phosphorylated-Kdr after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140496,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.023
CHEMBL385178,,None,396.45,1,5.13,19,O=C(Nc1ccc(Oc2ccccc2)cc1)c1cccnc1NCc1ccncc1,Ki,'=',10,nM,8,,,UO_0000065,20.18,0.36,2.87,10.51,0,CHEMBL925259,Inhibition of phosphorylated-Kdr after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140496,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.01
CHEMBL241075,,None,397.48,0,4.27,51,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Cc2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL602703,,None,555.56,2,7,7,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(CC(=O)Nc5ccccc5)C(F)(F)F)cc4F)c3s2)c1,IC50,'=',10,nM,8,,,UO_0000065,14.4,0.28,1,9.87,0,CHEMBL1067992,Inhibition of recombinant GST-fused VEGFR2 expressed in baculovirus infected Sf9 cells by DELFIA,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156855,1,Scientific Literature,Bioorg Med Chem Lett,2010,CHEMBL3308860,,,,0.01
CHEMBL428225,,None,317.35,0,3.53,2a,COc1ccc2nc(-c3n[nH]cc3/C=C/c3cccnc3)[nH]c2c1,IC50,'=',970,nM,6.01,,,UO_0000065,18.95,0.34,2.48,7.57,0,CHEMBL922908,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140656,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.97
CHEMBL425620,,None,417.82,0,4.82,2q,COc1cc2c(cc1OC)Oc1ncnc(Oc3ccc(F)c(Cl)c3)c1N(C)C2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL386052,,None,416.84,1,5.06,2m,COc1cc2c(cc1OC)Oc1nc(C)nc(Nc3cccc(Cl)c3F)c1NC2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL215071,,None,374.4,0,3.94,2b,C#Cc1cccc(Nc2ncnc3c2NCc2cc(OC)c(OC)cc2O3)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL376089,,None,415.86,0,4.57,4b,COc1cc2c(cc1OC)Nc1ncnc(NCc3ccc(F)c(Cl)c3)c1NC2,IC50,'=',2000,nM,5.7,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,2
CHEMBL216039,,None,393.45,0,3.78,4c,COc1cccc(CNc2ncnc3c2NCc2cc(OC)c(OC)cc2N3)c1,IC50,'=',2000,nM,5.7,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,2
CHEMBL3775569,,None,311.34,0,3.4,13,COc1cc2ncnc(Nc3cccc(O)c3C)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,10000
CHEMBL3775934,,None,315.3,0,3.24,23,COc1cc2ncnc(Nc3cc(O)cc(F)c3)c2cc1OC,IC50,'=',66,nM,7.18,,,UO_0000065,22.77,0.43,3.94,9.39,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,66
CHEMBL383541,,None,370.46,0,4.08,1b,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,IC50,'>',50000,nM,,,,UO_0000065,,,,,1,CHEMBL864427,Inhibition of KDR at 1.0 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,50000
CHEMBL83656,,None,301.35,0,4.07,2f,COc1ccc(-c2cnc3c(-c4ccccc4)cnn3c2)cc1,IC50,'=',71,nM,7.15,,,UO_0000065,23.72,0.42,3.08,18.13,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,71
CHEMBL381948,GW680975X,None,316.34,0,4.34,GW680975X,Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',22.17,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,22.17
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Inhibition,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL3778335,Inhibition of human recombinant VEGFR-2 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774355,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,82
CHEMBL3775968,,None,327.77,0,3,7c,Cc1nc2ccccc2n(CC(=O)Nc2ccc(Cl)cc2)c1=O,Inhibition,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL3778335,Inhibition of human recombinant VEGFR-2 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774355,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,19
CHEMBL514162,GW852849X,None,443.91,0,4.44,GW852849X,COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',12.24,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,12.24
CHEMBL4078060,,None,569.64,2,5.49,4d,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)nc2n1C1CCCC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4056586,Inhibition of human VEGFR2 by enzymatic radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052710,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,10
CHEMBL2088099,,None,343.39,0,2.43,12,COCCCc1cc(Nc2ccnc(NCc3cc(C)no3)n2)n[nH]1,IC50,'=',2511.89,nM,5.6,,,UO_0000065,16.31,0.31,3.17,4.92,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,5.6
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',22.6,nM,7.65,,,UO_0000065,19.19,0.36,4.32,9.9,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,22.6
CHEMBL1173149,,None,374.4,0,4.16,37,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1,IC50,'=',30.6,nM,7.51,,,UO_0000065,20.07,0.37,3.35,7.89,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,30.6
CHEMBL1172814,,None,404.43,0,4.17,38,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1OC,IC50,'=',27,nM,7.57,,,UO_0000065,18.71,0.34,3.4,7.24,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,27
CHEMBL1172421,,None,450.88,1,5.12,47,Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)Nc4ccc(Cl)cc4)ccc32)c(C)c1C(=O)O,IC50,'=',7.9,nM,8.1,,,UO_0000065,17.97,0.35,2.98,6.57,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,7.9
CHEMBL1173244,,None,418.41,0,3.86,53,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc(C(=O)O)[nH]2)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,1
CHEMBL1172410,,None,500.54,2,5.59,54,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]ccc2-c2ccc(C(=O)O)s2)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1176708,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,
CHEMBL521,IBUPROFEN,4,206.28,0,3.07,ibuprofen,CC(C)Cc1ccc(C(C)C(=O)O)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL644,TRIMIPRAMINE,4,294.44,0,4.12,trimipramine,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL243917,,None,549.48,2,7.41,47,O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,IC50,'=',42,nM,7.38,,,UO_0000065,13.42,0.25,-0.03,6.82,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,42
CHEMBL387817,,None,445.38,1,5.74,45,Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1,IC50,'=',15,nM,7.82,,,UO_0000065,17.57,0.33,2.08,7.45,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,15
CHEMBL275168,,None,449.92,1,5.52,SB-278539,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2
CHEMBL179453,GW622055X,None,392.86,0,4.54,GW622055X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1,Inhibition,'=',8.35,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.35
CHEMBL392513,,None,376.34,0,4.26,62,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1,IC50,'=',560,nM,6.25,,,UO_0000065,16.61,0.32,1.99,7.81,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.56
CHEMBL240209,,None,443.35,0,4.72,57,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(C(F)(F)F)c1,IC50,'=',920,nM,6.04,,,UO_0000065,13.62,0.27,1.32,8.4,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.92
CHEMBL471789,GSK-1030059A,None,476.48,1,5.9,GSK1030059A,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC,Inhibition,'=',7.57,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.57
CHEMBL392513,,None,376.34,0,4.26,62,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1,IC50,'=',180,nM,6.75,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.18
CHEMBL241492,,None,376.34,0,4.26,61,Cc1noc(NCc2ccncc2)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'=',2270,nM,5.64,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,2.27
CHEMBL241265,,None,409.8,0,4.35,54,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(Cl)c1,IC50,'=',79,nM,7.1,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.079
CHEMBL238525,,None,399.45,0,4.47,22,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Oc2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL238523,,None,383.46,0,4.35,21,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(-c2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL296586,KENPAULLONE,None,327.18,0,4.09,SID103905487,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL458865,GSK-1220512A,None,518.6,1,4.22,GSK1220512A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1,Inhibition,'=',15.33,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,15.33
CHEMBL240642,,None,341.8,0,3.33,45,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL238938,,None,375.35,0,3.7,37,Cn1ncc(NCc2cccnc2)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL428028,,None,384.44,0,4.91,69,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(-c2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL240405,,None,398.47,0,4.83,71,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cc2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL1825138,,None,450.35,1,5.04,SID103905247,CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,Ki,'=',6309.57,nM,5.2,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.2
CHEMBL95207,,None,352.42,0,3,SB-220455,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1,Inhibition,'=',3.28,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,3.28
CHEMBL275200,,None,471.58,1,6.16,SB-278538,CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',6.6,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.6
CHEMBL2018755,,None,368.39,0,3.88,51,COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,IC50,'=',850,nM,6.07,,,UO_0000065,16.48,0.31,2.19,6.42,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.85
CHEMBL2018777,,None,530.07,2,6.49,76,CCCCOc1cc2c(Nc3ccc(NC(=O)OCC)c(Cl)c3)ncnc2cc1OCCN(CC)CC,IC50,'=',4800,nM,5.32,,,UO_0000065,10.03,0.2,-1.17,5.44,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,4.8
CHEMBL2018878,,None,495.62,1,5.76,77,CCCCOc1cc2c(Nc3ccc(NC(=O)OC)c(C)c3)ncnc2cc1OCCN(CC)CC,IC50,'=',9400,nM,5.03,,,UO_0000065,10.14,0.19,-0.73,5.14,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,9.4
CHEMBL2018879,,None,509.65,2,6.15,78,CCCCOc1cc2c(Nc3ccc(NC(=O)OCC)c(C)c3)ncnc2cc1OCCN(CC)CC,IC50,'=',5700,nM,5.24,,,UO_0000065,10.29,0.19,-0.91,5.36,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,5.7
CHEMBL179603,,None,446.46,1,5.09,87,COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)cc1,IC50,'=',70,nM,7.16,,,UO_0000065,16.03,0.3,2.06,6.89,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.07
CHEMBL2018881,,None,446.46,1,5.09,97,COc1cccc(NC(=O)Nc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1,IC50,'=',40,nM,7.4,,,UO_0000065,16.57,0.31,2.31,7.13,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.04
CHEMBL2018886,,None,480.52,1,6.54,102,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc5ccccc5c4)c(C)c3)c2cc1OC,IC50,'=',2,nM,8.7,,,UO_0000065,18.1,0.33,2.16,9.2,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.002
CHEMBL188426,GW807982X,None,430.39,0,4.36,GW807982X,CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',19.14,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,19.14
CHEMBL1909376,,None,378.82,0,0.13,SB-759335-B,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl,Inhibition,'=',9.13,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9.13
CHEMBL1909373,GW701427A,None,497.9,0,4.88,GW701427A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl,Inhibition,'=',4.18,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.18
CHEMBL506414,GW684626B,None,467.98,1,7.53,GW684626B,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1,Inhibition,'=',4.41,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.41
CHEMBL103104,GW831090X,None,330.37,0,2.17,GW831090X,NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1,Inhibition,'=',9.9,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9.9
CHEMBL240643,,None,349.44,0,3.8,48,CC(C)c1ccc(NC(=O)c2c(NCc3ccncc3)cnn2C)cc1,IC50,'=',440,nM,6.36,,,UO_0000065,18.19,0.33,2.56,8.85,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.44
CHEMBL238530,,None,443.35,0,4.72,31,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(C(F)(F)F)c1,IC50,'=',690,nM,6.16,,,UO_0000065,13.9,0.27,1.44,8.58,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.69
CHEMBL438142,,None,342.79,0,3.9,65,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL400898,,None,289.34,0,3.34,2f,Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1,Inhibition,'<=',40,%,,,,UO_0000187,,,,,0,CHEMBL886302,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139946,1,Scientific Literature,Eur J Med Chem,2007,None,,,,40
CHEMBL1956892,,None,454.33,0,4.59,13a,COc1ccc(OC)c(Cn2ccc3c(Nc4cccc(Br)c4)nc(N)nc32)c1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1959284,Inhibition of VEGF-induced VEGFR2 autophosphorylation in human U251 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955729,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,200
CHEMBL1956889,,None,408.3,0,4.88,10a,Cc1ccccc1Cn1ccc2c(Nc3cccc(Br)c3)nc(N)nc21,IC50,'=',113400,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1959284,Inhibition of VEGF-induced VEGFR2 autophosphorylation in human U251 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955729,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,113.4
CHEMBL270544,GW396574X,None,370.43,0,2.53,GW396574X,CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',8.9,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.9
CHEMBL529066,GW574783B,None,599.54,2,6,GW574783B,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl,Inhibition,'=',6.23,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.23
CHEMBL1794064,GSK-561866B,None,470.41,0,0.12,GSK561866B,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,Inhibition,'=',5.24,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.24
CHEMBL442363,GW809885X,None,373.42,0,3.36,GW809885X,COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1,Inhibition,'=',4.01,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.01
CHEMBL362188,,None,449.89,1,6.34,6n,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c2cc1OC,IC50,'=',1.6,nM,8.8,,,UO_0000065,19.55,0.38,2.46,10.76,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,1.6
CHEMBL359617,,None,484.34,1,7,6z,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(Cl)c4)cc3)c2cc1OC,IC50,'=',3.7,nM,8.43,,,UO_0000065,17.41,0.35,1.43,10.32,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,3.7
CHEMBL2089212,,None,412.82,0,4.12,2,Nc1n[nH]c2nc(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncc12,Inhibition,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2091532,Inhibition of KDR at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086267,1,Scientific Literature,Eur J Med Chem,2012,None,,,,96
CHEMBL369760,,None,429.48,1,6,6g,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(C)c4)cc3)c2cc1OC,IC50,'=',0.2,nM,9.7,,,UO_0000065,22.58,0.41,3.7,11.87,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,0.2
CHEMBL179719,,None,451.43,1,5.97,6t,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)c(F)c4)cc3)c2cc1OC,IC50,'=',1.1,nM,8.96,,,UO_0000065,19.84,0.37,2.99,10.96,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,1.1
CHEMBL1909344,,None,372.86,0,2.3,SB-678557-A,CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl,Inhibition,'=',10.62,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,10.62
CHEMBL179816,,None,451.43,1,5.97,6u,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(F)cc(F)c4)cc3)c2cc1OC,IC50,'=',1.8,nM,8.74,,,UO_0000065,19.37,0.36,2.77,10.7,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,1.8
CHEMBL440202,,None,484.34,1,7,6aa,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(Cl)cc(Cl)c4)cc3)c2cc1OC,IC50,'=',8.9,nM,8.05,,,UO_0000065,16.62,0.33,1.05,9.85,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,8.9
CHEMBL1682540,,None,235.25,0,2.27,8a,c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1,Ki,'>',8880,nM,,,,UO_0000065,,,,,0,CHEMBL1685433,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681650,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,8.88
CHEMBL365663,GW780159X,None,338.82,0,4.66,GW780159X,Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',67.44,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,67.44
CHEMBL514261,GSK-1819799A,None,519.58,1,4.82,GSK1819799A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1,Inhibition,'=',4.67,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.67
CHEMBL1909406,,None,333.82,0,3.86,SKF-86002-A2,Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,Inhibition,'=',8.03,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.03
CHEMBL1909360,GW830263A,None,665.22,1,4.56,GW830263A,CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl,Inhibition,'=',21.38,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,21.38
CHEMBL365297,GW827099X,None,440.44,0,4.51,GW827099X,Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',30.59,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,30.59
CHEMBL385426,GW450241X,None,294.4,0,3.74,GW450241X,CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1,Inhibition,'=',8.91,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.91
CHEMBL3905825,,None,489.43,1,5.65,BDBM235494,CC(F)(F)c1ccc(F)c(NC(=O)Nc2ccc(Oc3cc(NC(=O)C4CC4)ncn3)c(F)c2)c1,IC50,'=',10.2,nM,7.99,,410129,UO_0000065,16.33,0.31,2.34,7.59,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL365663,GW780159X,None,338.82,0,4.66,GW780159X,Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',33.12,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,33.12
CHEMBL3974963,,None,536.61,1,3.8,BDBM208465,COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3occc3C)c2)c1,IC50,'=',7,nM,8.15,,368378,UO_0000065,15.2,0.29,4.35,5.3,0,CHEMBL3888027,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2070198,,None,477.36,1,5.91,19,Brc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCCCO5)cc23)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL2071761,Inhibition of VEGFR2 using ATP incubated for 30 mins prior to ATP addition measured after 60 mins by fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2069295,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,10
CHEMBL352222,,None,394.17,0,3.09,SB-358518,O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1,Inhibition,'=',8.59,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.59
CHEMBL103098,,None,356.41,0,2.23,SB-738482,NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,Inhibition,'=',8.35,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.35
CHEMBL101804,,None,268.28,0,2.57,SB-743899,O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1,Inhibition,'=',7.28,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.28
CHEMBL185710,,None,230.23,0,1.08,SB-738561,CCn1c(-c2nonc2N)nc2ccncc21,Inhibition,'=',2.46,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2.46
CHEMBL2011294,,None,360.39,0,4.33,BDBM50379226,COc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1,IC50,'=',1900,nM,5.72,,421732,UO_0000065,15.88,0.29,1.39,8.67,1,CHEMBL3888877,Kinase Assay: FlashPlates from Perkin Elmer (Boston,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909342,,None,395.44,0,1.77,SB-657836-AAA,N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O,Inhibition,'=',4.13,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.13
CHEMBL3702627,,None,346.39,0,2.27,BDBM139567,Nc1ncc2c(n1)CCN(c1cccc(C(=O)Nc3ccccc3)n1)C2,IC50,'>',10000,nM,,,412693,UO_0000065,,,,,1,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702639,,None,400.36,0,3.25,BDBM139579,Nc1ncc2c(n1)CN(c1ccnc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2,IC50,'>',10000,nM,,,412705,UO_0000065,,,,,1,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2023802,,None,491.55,0,4.61,33,CCOc1cc2nccc(Oc3cnc(CC(=O)Nc4n[nH]c(CC)c4C)c(OC)c3)c2cc1OC,IC50,'=',4819,nM,5.32,,,UO_0000065,10.82,0.2,0.71,4.41,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,4.819
CHEMBL3916154,,None,420.47,0,3.44,BDBM214706,COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2ccccc2)C3)cc(OC)c1OC,IC50,'=',4760,nM,5.32,,377136,UO_0000065,12.66,0.23,1.88,6.2,0,CHEMBL3888173,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2023220,,None,457.56,1,5.26,7,CNC(=O)/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12,IC50,'=',22,nM,7.66,,,UO_0000065,16.74,0.32,2.4,7.02,0,CHEMBL2024778,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,CHEMBL3307716,,,,22
CHEMBL3644555,,None,455.44,0,4.7,BDBM139623,COC(=O)c1cncc2c1CCN(c1cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2,IC50,'=',8,nM,8.1,,412749,UO_0000065,17.78,0.34,3.4,11.32,1,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3644559,,None,525.7,2,5.24,BDBM139627,CC(C)c1cccc(NC(=O)c2cccc(N3CCc4c(cncc4C(=O)NCCCN4CCCC4)C3)c2)c1,IC50,'=',230,nM,6.64,,412753,UO_0000065,12.63,0.23,1.4,8.56,1,CHEMBL3888724,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4876578,,None,404.35,0,4.94,17,COc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1,IC50,'=',400,nM,6.4,,,UO_0000065,15.82,0.3,1.46,7.49,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,400
CHEMBL4867760,,None,548.57,2,7.27,29,O=C(Nc1ccc(Oc2cc(Nc3cccc(CN4CCCC4)c3)ncn2)cc1)Nc1cccc(C(F)(F)F)c1,IC50,'=',3.2,nM,8.49,,,UO_0000065,15.49,0.29,1.22,9.29,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,3.2
CHEMBL365072,,None,258.29,0,1.65,SB-751148,CCc1nccc2c1nc(-c1nonc1N)n2CC,Inhibition,'=',5.64,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.64
CHEMBL1940181,,None,468.6,0,4.52,18c,Cc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,IC50,'=',186,nM,6.73,,,UO_0000065,14.36,0.26,2.21,9.3,0,CHEMBL1942686,Inhibition of KDR using Bio-Gastrintide as substrate by TR-FRET assay in presence of 50 uM of ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938232,1,Scientific Literature,Bioorg Med Chem,2012,None,,,,186
CHEMBL2385596,,None,420.52,0,4.36,13r,CN1CCN(c2ccc(-c3cnc4c(-c5ccnc6ccccc56)cnn4c3)cc2)CC1,IC50,'=',1520,nM,5.82,,,UO_0000065,13.84,0.25,1.46,11.74,0,CHEMBL2390517,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384981,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,1520
CHEMBL4847826,,None,447.42,0,4.72,24,C[C@@H](O)CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1,IC50,'=',200,nM,6.7,,,UO_0000065,14.97,0.29,1.98,6.18,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,200
CHEMBL2377495,,None,218.69,0,1.86,14,CSc1nc2nnnc(Cl)c2s1,Inhibition,'=',93.5,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,93.5
CHEMBL2016901,,None,371.4,0,2.51,17,O=C(c1ccncc1)N1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',200,nM,6.7,,,UO_0000065,18.04,0.33,4.19,7.07,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.2
CHEMBL2016902,,None,389.39,0,2.65,18,O=C(c1ccncc1)N1CCc2nc(-c3cc4c(F)cccc4[nH]c3=O)[nH]c2C1,IC50,'=',800,nM,6.1,,,UO_0000065,15.66,0.29,3.45,6.44,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.8
CHEMBL2016909,,None,411.44,0,1.27,25,O=C(CN1CCOCC1)N1CCc2nc(-c3cc4cc(F)ccc4[nH]c3=O)[nH]c2C1,IC50,'=',4.3,nM,8.37,,,UO_0000065,20.33,0.38,7.1,8.87,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.0043
CHEMBL2016912,,None,406.49,0,1.05,28,CN1CCN(CC(=O)N2CCc3nc(-c4cc5ccccc5[nH]c4=O)[nH]c3C2)CC1,IC50,'=',300,nM,6.52,,,UO_0000065,16.05,0.3,5.47,7.38,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.3
CHEMBL98350,LY-294002,-1,307.35,0,3.3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1916891,,None,432.5,0,4.15,36,Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12,Inhibition,'=',7,%,,,,UO_0000187,,,,,0,CHEMBL1919278,Inhibition of KDR relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914368,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,7
CHEMBL86755,,None,210.24,0,2.51,16,O=C1Nc2ccccc2/C1=C/c1ccc[nH]1,IC50,'=',140,nM,6.85,,,UO_0000065,32.6,0.59,4.34,15.27,0,CHEMBL876999,In vitro inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141154,1,Scientific Literature,J Med Chem,2005,None,,,,1.40E-07
CHEMBL1909383,GW784307A,None,494.99,0,2.56,GW784307A,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl,Inhibition,'=',43.63,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,43.63
CHEMBL396472,,None,479.46,0,3.35,34,COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=CC3=O)c2cc1OC,IC50,'=',46.1,nM,7.34,,,UO_0000065,15.3,0.29,3.99,6.74,0,CHEMBL892958,Inhibition of human VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,46.1
CHEMBL1230790,,None,269.31,0,2.36,S1,CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21,Inhibition,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL1244192,Inhibition of VEGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,96
CHEMBL1081312,,None,319.37,0,3.07,PP121,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,IC50,'=',12,nM,7.92,,,UO_0000065,24.8,0.45,4.85,8.06,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.012
CHEMBL1909394,GW621823A,None,659.61,2,7.26,GW621823A,CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl,Inhibition,'=',8.91,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.91
CHEMBL1242200,,None,362.23,0,3.43,PP85,COc1cc(Br)cc(-c2nn(C(C)C)c3ncnc(N)c23)c1,IC50,'=',1020,nM,5.99,,,UO_0000065,16.54,0.37,2.56,7.6,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,1.02
CHEMBL1241767,,None,489.54,0,4.15,PIK-294,Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,50
CHEMBL1241356,,None,226.24,0,1.18,PP211,Nc1ccc(-c2n[nH]c3ncnc(N)c23)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,
CHEMBL450071,GSK-1392956A,None,592.68,2,3.21,GSK1392956A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1,Inhibition,'=',5.49,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.49
CHEMBL1241491,,None,319.37,0,3.94,PP97,Nc1ncnc2c1c(-c1ccc3occc3c1)nn2C1CCCC1,IC50,'=',1220,nM,5.91,,,UO_0000065,18.52,0.34,1.97,7.15,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,1.22
CHEMBL1242758,,None,318.38,0,3.67,PP92,Nc1ncnc2c1c(-c1cccc3[nH]ccc13)nn2C1CCCC1,IC50,'=',4130,nM,5.38,,,UO_0000065,16.91,0.31,1.71,6.3,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,4.13
CHEMBL185939,GW828525X,None,490.45,1,5.39,GW828525X,FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',-0.31,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,-0.31
CHEMBL1241946,,None,295.35,0,2.86,PP55,CC(=O)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1,IC50,'=',100000,nM,4,,,UO_0000065,13.54,0.25,1.14,4.61,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,100
CHEMBL196022,GW642125X,None,241.25,0,2.48,GW642125X,COc1ccc(-c2coc3ncnc(N)c23)cc1,Inhibition,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9
CHEMBL2062289,,None,550.52,0,3.36,SB-698596-AC,CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,Inhibition,'=',0.77,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,0.77
CHEMBL189353,GW809897X,None,571.49,2,6.48,25,CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,IC50,'=',65,nM,7.19,,,UO_0000065,12.58,0.26,0.71,6.18,0,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140275,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,65
CHEMBL1170854,,None,401.42,0,4.54,23,COc1cc(/C=C2\C(=O)Nc3cc(NC(=O)Nc4ccccc4)ccc32)ccc1O,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1176712,Inhibition of KDR at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,0
CHEMBL1082829,,None,468.6,1,5.58,7f,CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',10,nM,8,,,UO_0000065,17.07,0.31,2.42,13.1,0,CHEMBL1119626,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,CHEMBL3307501,,,,10
CHEMBL503055,,None,1244.59,None,None,GU40D,C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)C(=O)CN(CC(C)C)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(CCc1c[nH]c2ccccc12)C(=O)CN(CCCCN)C(=O)CNCCCCN,Activity,,,,,,Active,,,,,,0,CHEMBL956465,Displacement of GU40C-FITC form human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL474346,,None,394.91,1,6.37,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL446087,,None,387.53,0,4.18,CER-0264218,Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,3
CHEMBL465465,,None,590.36,1,4.84,6a,CS(=O)(=O)c1ccc(CNCc2cc(C(=O)O)c(Nc3ccc(I)cc3F)c(F)c2F)cc1,IC50,'=',18000,nM,4.75,,,UO_0000065,8.04,0.2,-0.1,4.97,0,CHEMBL963872,Binding affinity to VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139272,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,18
CHEMBL523559,,None,468.56,1,5.42,6b,Cc1nnc(-c2ccc(-c3cc(C(=O)Nc4cccc(N5CCOCC5)c4)ccc3C)c(C)c2)o1,IC50,'=',6000,nM,5.22,,,UO_0000065,11.14,0.2,-0.2,6.49,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,6
CHEMBL485286,,None,481.6,1,5.52,19c,Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2c(C3CCNCC3)noc2c1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL522579,,None,347.42,0,4.22,6a,Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL521734,,None,374.44,0,3.07,10a,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(=O)n(CC3CC3)nnc2c1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL521479,,None,402.5,0,3.29,CER-0264064,CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,2
CHEMBL519310,,None,400.44,0,1.2,CER-0263083,COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,5
CHEMBL1909353,GW458344A,None,379.85,0,4.31,GW458344A,Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',-2.08,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,-2.08
CHEMBL519976,,None,268.28,0,1.72,7,COc1ncnc2c1ncn2CC(=O)c1ccccc1,IC50,'=',25000,nM,4.6,,,UO_0000065,17.15,0.31,2.88,6.58,0,CHEMBL949886,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137681,1,Scientific Literature,Eur J Med Chem,2009,None,,,,25
CHEMBL485444,,None,253.26,0,1.29,4,Nc1ncnc2ncn(CC(=O)c3ccccc3)c12,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL949886,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137681,1,Scientific Literature,Eur J Med Chem,2009,None,,,,
CHEMBL2023230,,None,470.56,1,5.6,24,COc1ccccc1NC(=O)Nc1ccc(-c2csc3c(-c4cnn(C)c4)cnc(N)c23)cc1,IC50,'=',6,nM,8.22,,,UO_0000065,17.47,0.33,2.62,7.68,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,6
CHEMBL153843,,None,371.36,0,4.96,C,O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1,IC50,'=',90,nM,7.05,,,UO_0000065,18.97,0.36,2.09,13.04,1,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,0.09
CHEMBL516810,,None,439.54,0,2.29,4k,CN1C(=O)/C(=C/c2ccc(/C=C/C(=O)N3CCN(CCO)CC3)s2)Oc2ccccc21,IC50,'>',400000,ug.mL-1,,Outside typical range,,UO_0000274,,,,,0,CHEMBL1001090,Inhibition of KDR expressed in baculovirus system by ELISA,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140887,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.4
CHEMBL461775,,None,380.47,0,3.78,4j,CN1C(=O)/C(=C/c2ccc(/C=C/C(=O)N3CCCC3)s2)Oc2ccccc21,IC50,'>',400000,ug.mL-1,,Outside typical range,,UO_0000274,,,,,0,CHEMBL1001090,Inhibition of KDR expressed in baculovirus system by ELISA,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140887,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.4
CHEMBL461776,,None,417.49,0,3.87,4l,CN1C(=O)/C(=C/c2ccc(/C=C/C(=O)NCc3cccnc3)s2)Oc2ccccc21,Inhibition,'=',76.7,%,,,,UO_0000187,,,,,0,CHEMBL1001089,Inhibition of KDR expressed in baculovirus system at 4 ug/ml by ELISA,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140887,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,76.7
CHEMBL465015,,None,525.61,1,3.59,56,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN2CCN(C)CC2)cc1)c1ccccc1,IC50,'=',83,nM,7.08,,,UO_0000065,13.47,0.25,3.49,6.87,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,83
CHEMBL519213,,None,370.41,0,4.41,61,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1,IC50,'=',8000,nM,5.1,,,UO_0000065,13.76,0.25,0.69,7.56,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,8000
CHEMBL485643,,None,391.47,0,2.98,62,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,10000
CHEMBL484521,,None,460.38,0,3.59,CER-0263706,COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,0
CHEMBL484706,,None,367.45,0,2.03,CER-0263779,O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,4
CHEMBL482715,,None,415.39,1,5.23,19,Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL957463,Inhibition of VEGFR2 expressed in human tumor cells,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150356,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,200
CHEMBL483108,,None,426.29,0,4.97,13,Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1,IC50,'=',198300,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL957463,Inhibition of VEGFR2 expressed in human tumor cells,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150356,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,198.3
CHEMBL502015,,None,444.34,1,5.79,Ref 21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL474538,,None,444.34,1,5.79,Ref 21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL197357,,None,446.51,1,5.72,30,NC(=O)c1ccc(-c2nnc(Nc3ccc(OCc4ccccc4)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL203346,,None,390.49,1,6.71,59,CC(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1,IC50,'=',17,nM,7.77,,,UO_0000065,19.9,0.35,1.06,15.32,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.017
CHEMBL203438,,None,433.52,1,5.43,60,c1cc(-c2nnc(Nc3ccc(N4CCOCC4)cc3)c3ccccc23)c2ccncc2c1,IC50,'=',390,nM,6.41,,,UO_0000065,14.78,0.27,0.98,10.15,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.39
CHEMBL3960801,,None,447.56,1,7.14,20(b),O=C(Nc1cccc(Sc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)c1ccccc1,Ki,'=',1.6,nM,8.8,,,UO_0000065,19.65,0.36,1.66,15.22,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,1.6
CHEMBL233001,GW620972X,None,332.43,0,4.9,GW620972X,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,Inhibition,'=',6.33,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.33
CHEMBL496129,,None,497.67,1,5.37,4d,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc(-c2csc(N)n2)cc1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL176078,,None,378.46,0,3.96,14c,CCN(Cc1ccccc1)c1nc(O)nc(Nc2ccc3ncsc3c2)n1,IC50,'=',49,nM,7.31,,,UO_0000065,19.31,0.37,3.35,8.4,0,CHEMBL831136,In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,None,,,,0.049
CHEMBL521887,,None,450.59,1,5.21,14d,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2ccncc2c1,IC50,'=',800,nM,6.1,,,UO_0000065,13.53,0.24,0.89,12.58,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.8
CHEMBL525443,,None,481.6,1,5.78,34,CCOC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1,IC50,'=',109,nM,6.96,,,UO_0000065,14.46,0.26,1.18,9.85,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,109
CHEMBL501751,,None,454.53,1,5.51,35,O=C1Nc2cc([N+](=O)[O-])ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1,IC50,'=',7,nM,8.15,,,UO_0000065,17.94,0.33,2.64,9.32,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,7
CHEMBL496862,,None,494.64,1,5.7,43,CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1,IC50,'=',1447,nM,5.84,,,UO_0000065,11.81,0.22,0.14,9.03,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,1447
CHEMBL1203982,,None,503.05,0,4.96,44,CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1.Cl,IC50,'=',2099,nM,5.68,,,UO_0000065,12.17,0.22,0.72,7.73,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,2099
CHEMBL3959522,,None,437.52,1,6.84,30(a),O=C(Nc1cccc(Oc2ccc3c(/C=C/c4cccs4)n[nH]c3c2)c1)c1ccccc1,Ki,'=',1.7,nM,8.77,,,UO_0000065,20.04,0.37,1.93,13.09,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,1.7
CHEMBL458023,,None,473.54,1,6.45,15,CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL1029839,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154530,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,5000
CHEMBL84558,,None,263.32,0,2.8,16a,CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1,Inhibition,'=',-4,%,,,,UO_0000187,,,,,0,CHEMBL1012698,Inhibition of KDR at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,,,,-4
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',18.9,nM,,Potential transcription error,,UO_0000065,,,,,1,CHEMBL3998243,Inhibition of VEGFR-2 in human U251 cells assessed as reduction in VEGF induced phosphorylation preincubated for 60 mins followed by VEGF addition measured after 10 mins by ELISA method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3997769,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,18.9
CHEMBL485320,,None,408.3,0,4.83,8,Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL957463,Inhibition of VEGFR2 expressed in human tumor cells,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150356,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,50
CHEMBL499067,,None,368.44,0,4.55,20,Nc1nc(Nc2ccc3[nH]ccc3c2)c2cc(CCc3ccccc3)[nH]c2n1,IC50,'=',24900,nM,4.6,,,UO_0000065,12.5,0.22,0.05,4.83,0,CHEMBL957463,Inhibition of VEGFR2 expressed in human tumor cells,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150356,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,24.9
CHEMBL504416,,None,381.84,0,4.86,14,Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccc3)[nH]c2n1,IC50,'=',132100,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL957463,Inhibition of VEGFR2 expressed in human tumor cells,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150356,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,132.1
CHEMBL484109,,None,458.36,1,5.98,12,Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccc4ccccc4c3)[nH]c2n1,IC50,'=',16800,nM,4.78,,,UO_0000065,10.42,0.22,-1.21,6,0,CHEMBL957463,Inhibition of VEGFR2 expressed in human tumor cells,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150356,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,16.8
CHEMBL461605,,None,378.44,0,4.49,16,c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1,IC50,'=',1190,nM,5.92,,,UO_0000065,15.65,0.28,1.43,8.65,0,CHEMBL960813,Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISA,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,1.19
CHEMBL523320,,None,409.42,1,5.27,21,Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F,IC50,'=',180,nM,6.75,,,UO_0000065,16.47,0.31,1.47,12.12,0,CHEMBL960813,Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISA,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.18
CHEMBL454403,,None,409.42,1,5.27,22,Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F,IC50,'=',2020,nM,5.7,,,UO_0000065,13.91,0.26,0.42,10.24,0,CHEMBL960813,Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISA,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,2.02
CHEMBL464619,,None,350.81,0,3.92,28,Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL474208,,None,512.62,2,6.1,17a,Nc1ccccc1NC(=O)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)s1,IC50,'=',12000,nM,4.92,,,UO_0000065,9.6,0.19,-1.18,4.03,0,CHEMBL1022425,Inhibition of VEGFR2 by liquid scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153406,1,Scientific Literature,J Med Chem,2009,None,,,,12
CHEMBL502835,NINTEDANIB,4,539.64,1,3.62,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1979970,,None,317.3,0,3.04,SID103905386,CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1983980,,None,542.64,2,5.43,SID103905560,O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL1993661,,None,479.95,0,3.55,SID103904591,CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl,Ki,'=',15.85,nM,7.8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.8
CHEMBL1988038,,None,368.39,0,3.83,SID103904701,O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1ccccc1F,Ki,'=',794.33,nM,6.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.1
CHEMBL1968565,,None,263.3,0,2.47,SID103905629,Cc1ccc(-c2c(C#N)c(N)nc3cc(C)nn23)cc1,Ki,'=',3981.07,nM,5.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.4
CHEMBL1562756,,None,279.79,1,5.11,SID103905421,CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1993413,,None,348.79,0,4.53,SID103904263,O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1986263,,None,342.42,0,3.45,SID103904649,CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6
CHEMBL1977681,,None,275.31,0,2.79,SID103904940,CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.4
CHEMBL1977874,,None,289.3,0,-0.41,SID103905659,CCn1c(=O)c2cc(C(N)=O)c(N)nc2n(C2CC2)c1=O,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1968791,,None,467.62,1,5.61,SID103904993,Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1,Ki,'=',316.23,nM,6.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.5
CHEMBL1972125,,None,462.55,0,4.99,SID103904473,Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1972158,,None,366.43,0,4.12,SID103904464,Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1975534,,None,363.16,0,-0.7,SID103905378,NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL492265,,None,393.49,1,5.47,19,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3C)nncc2c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1024854,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140163,1,Scientific Literature,J Med Chem,2008,None,,,,10000
CHEMBL4174041,,None,491.66,1,5.13,12,CCc1ccc2nc(C(c3ccc(OC)c(OC)c3)n3cc(CCN4CCCCC4)nn3)sc2c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4135683,Inhibition of VEGFR2 in HUVEC assessed as decrease in VEGF-induced SRC phosphorylation pretreated for 30 mins followed by VEGF stimulation for 20 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130527,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,
CHEMBL1997623,,None,411.39,1,5.47,SID103904367,Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12,Ki,'=',7.943,nM,8.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.1
CHEMBL1968130,,None,169.58,0,0.36,SID103905652,Nc1nnc2cncc(Cl)n12,Ki,'=',31622.78,nM,4.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.5
CHEMBL4169257,,None,481.56,0,4.35,A3,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)nc(CN(C)C)n2C)c1ccccc1,IC50,'=',384.7,nM,6.42,,,UO_0000065,13.32,0.24,2.06,7.25,0,CHEMBL4132764,Inhibition of N-terminal biotinylated DYKDDDDK tagged human VEGFR2 (790 to 1356 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130391,1,Scientific Literature,Eur J Med Chem,2017,None,,,,384.7
CHEMBL4177112,,None,536.64,1,4.04,A4,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)nc(CN1CCN(C)CC1)n2C)c1ccccc1,IC50,'=',257.2,nM,6.59,,,UO_0000065,12.28,0.22,2.55,7.18,0,CHEMBL4132764,Inhibition of N-terminal biotinylated DYKDDDDK tagged human VEGFR2 (790 to 1356 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130391,1,Scientific Literature,Eur J Med Chem,2017,None,,,,257.2
CHEMBL4591810,,None,594.71,2,5.81,15,CN1CCN(Cc2ccc(C(=O)NCCCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1,GI50,'=',1,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.001
CHEMBL453737,,None,629.66,2,5.92,51,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,Ki,'=',139,nM,6.86,,,UO_0000065,10.89,0.2,0.94,6.86,0,CHEMBL971817,Inhibition of phosphorylated KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,,,,139
CHEMBL459729,,None,512.03,1,4.73,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2018774,,None,467.57,0,4.98,73,CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OCCN(CC)CC)cc23)cc1C,IC50,'=',7250,nM,5.14,,,UO_0000065,10.99,0.21,0.16,5.25,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,7.25
CHEMBL1277162,,None,416.44,1,5.08,86,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)c2cc1OC,IC50,'=',60,nM,7.22,,,UO_0000065,17.34,0.32,2.14,7.63,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.06
CHEMBL2377478,,None,379.71,None,None,32,Clc1ccc(-c2cc3nnnc(N4CCOCC4)c3[se]2)cc1,Inhibition,'=',31,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,31
CHEMBL2377485,,None,355.3,None,None,25,c1ccc2c(c1)CCc1c-2[se]c2c(N3CCCC3)nnnc12,Inhibition,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,17
CHEMBL4167570,,None,462.51,0,4.32,18b,C#Cc1cccc(NC(=O)C2(C(=O)Nc3ccc(-c4ccc5c(=O)nc[nH]c5c4)cc3)CCC2)c1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL4159645,,None,540.93,2,6.01,18c,O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)CCC1,IC50,'=',297.02,nM,6.53,,,UO_0000065,12.07,0.23,0.52,6.28,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,297.02
CHEMBL535,SUNITINIB,4,398.48,0,3.33,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL383267,,None,375.86,1,5.01,42,CN(C(=O)c1ccccc1Cn1ccc2cnccc21)c1ccc(Cl)cc1,Activity,,,,,,Not Determined,,,,,,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL194747,,None,354.41,0,4.45,12,Cc1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1,IC50,'=',1800,nM,5.75,,,UO_0000065,16.21,0.29,1.29,7.1,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,1.8
CHEMBL193533,,None,361.83,1,5.7,42,COc1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL2113169,,None,413.43,0,2.42,29,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(C)C)=CC3=O)c2cc1OC,IC50,'=',481,nM,6.32,,,UO_0000065,15.28,0.29,3.9,5.8,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,481
CHEMBL2113171,,None,483.86,0,2.89,30,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=C(Cl)C3=O)c2cc1OC,IC50,'=',0.4,nM,9.4,,,UO_0000065,19.42,0.39,6.51,8.63,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,0.4
CHEMBL200387,,None,399.4,0,2.03,36,CCOC1=CC(=O)C(Nc2ncnc3cc(OCCOC)c(OC)cc23)=CC1=O,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL204726,,None,337.77,0,2.54,16b,Cn1cc(/C=C2\C(=O)NN=C2c2cnccn2)c2cc(Cl)ccc21,IC50,'=',10,nM,8,,,UO_0000065,23.68,0.46,5.46,11.08,0,CHEMBL866859,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146951,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL404,TAZOBACTAM,4,300.3,0,-1.52,tazobactam,C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1794069,GSK-571989A,None,525.07,2,5.7,GSK571989A,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',36.4,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,36.4
CHEMBL61,PODOFILOX,4,414.41,0,2.41,SID86163,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3958054,,None,490.61,1,5.31,18a,COc1ccc(Cn2nc(-c3ccccc3)c3cc(Nc4ccccc4)nc(N4CCNCC4)c32)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3857162,Inhibition of VEGF-165-induced VEGFR2 autophosphorylation in serum-starved HUVEC assessed as decrease in AKT phosphorylation at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856209,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL4066145,,None,323.4,0,3.85,47,Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC(C)(C)C)cc3)c12,IC50,'=',11382,nM,4.94,,,UO_0000065,15.29,0.28,1.09,5.98,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,11382
CHEMBL4083910,,None,442.52,0,4.72,34,Cc1ccc(N2CCOCC2)c(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1,IC50,'=',26163,nM,4.58,,,UO_0000065,10.36,0.19,-0.14,4.81,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,26163
CHEMBL462359,,None,456.5,1,5.68,5b,COc1cccc(Nc2nn(C)c3cc(Oc4ccnc5cc(OC)c(OC)cc45)ccc23)c1,IC50,'=',230,nM,6.64,,,UO_0000065,14.54,0.27,0.96,8.33,0,CHEMBL973628,Inhibition of recombinant KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157345,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.23
CHEMBL385563,,None,512.99,1,4.79,16,Clc1ccc2c(c1Nc1ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,10
CHEMBL426161,AZM-475271,2,442.95,0,4.76,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL384260,,None,408.46,0,3.58,12,COc1cc(OC2CCN(C)CC2)c2c(Nc3cccc4c3OCO4)ncnc2c1,IC50,'=',2500,nM,5.6,,,UO_0000065,13.72,0.26,2.02,7.18,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,2.5
CHEMBL3809066,,None,546.55,2,6.45,7z,CC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,Inhibition,'=',24,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,24
CHEMBL523308,,None,212.25,0,2.27,5,CN1Cc2cccc(-c3ccc[nH]3)c2C1=O,Inhibition,'<',10,%,,,,UO_0000187,,,,,0,CHEMBL981690,Inhibition of VEGFR2 at 100 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144154,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL521469,,None,452.56,1,5.01,CER-0263965,Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1,Inhibition,'=',31,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,31
CHEMBL3915043,,None,441.53,1,7.05,22(b),C=C(c1cccc(NC(=O)c2ccccc2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1,Ki,'=',0.63,nM,9.2,,,UO_0000065,20.84,0.37,2.15,15.92,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.63
CHEMBL3986713,,None,486.53,1,5.78,43,O=CNc1ccccc1/C=C/c1n[nH]c2cc(C(=O)c3cccc(NC(=O)c4ccccc4)c3)ccc12,Ki,'=',2.6,nM,8.59,,,UO_0000065,17.65,0.32,2.81,8.26,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,2.6
CHEMBL3954818,,None,453.51,1,5.03,32(b),CCn1nc(C)cc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4c[nH]cn4)n[nH]c3c2)c1,Ki,'=',0.08,nM,10.1,,,UO_0000065,22.26,0.41,5.07,8.9,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.08
CHEMBL445196,HAEMATOXYLOL,None,320.3,1,0.91,1,Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@@H]2O)cc1O,Inhibition,'=',89.9,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,89.9
CHEMBL477197,HEMATOXYLIN,None,302.28,0,1.32,26,Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2,Inhibition,'=',99.5,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,99.5
CHEMBL476986,SAPPANCHALCONE,None,286.28,0,2.71,20,COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)c(O)c1,Inhibition,'=',83.5,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,83.5
CHEMBL476776,,None,298.29,0,2.77,18,COc1ccc(/C=C2\COc3cc(O)cc(O)c3C2=O)cc1,Inhibition,'=',1.2,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,1.2
CHEMBL477768,HEMATOXYLONE,None,318.28,0,1.06,7,O=C1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1,Inhibition,'=',84.8,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,84.8
CHEMBL4086831,,None,576.66,2,5.22,4r,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(C#N)cc5)CC4)cc3)nc2n1C1CCCC1,Inhibition,'=',21,%,,,,UO_0000187,,,,,0,CHEMBL4056530,Inhibition of human VEGFR2 at 1 uM by enzymatic radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052710,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,21
CHEMBL2105717,CABOZANTINIB,4,501.51,2,5.54,Cabozantinib,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,IC50,'=',0.48,nM,9.32,,,UO_0000065,18.58,0.34,3.78,9.43,0,CHEMBL4147639,Inhibition of KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1230609,FORETINIB,2,632.66,2,5.77,1,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,'=',0.8,nM,9.1,,,UO_0000065,14.38,0.27,3.33,8.18,1,CHEMBL3293757,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286137,1,Scientific Literature,Eur J Med Chem,2014,None,,,,0.8
CHEMBL488811,,None,470.53,0,4.74,25,COc1cc(C2=C(c3cn(COc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC,IC50,'=',1500,nM,5.82,,,UO_0000065,12.38,0.23,1.08,8.21,0,CHEMBL957977,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157465,1,Scientific Literature,J Med Chem,2008,None,,,,1.5
CHEMBL4069965,,None,384.24,0,3.77,6d,Nc1nc(NCc2ccccc2)c2c(n1)[nH]c1cc(Br)c(O)cc12,Ki,,,,,,Not Active,,,,,,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4090945,,None,339.79,0,3.66,6e,Nc1nc(NCc2ccccc2)c2c(n1)[nH]c1cc(Cl)c(O)cc12,Ki,,,,,,Not Active,,,,,,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4072687,,None,349.39,0,3.33,6i,COc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1,Ki,,,,,,Not Determined,,,,,,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL493046,,None,487.99,1,5.72,24,COc1cc2nccc(CN3CCc4c(cccc4C(=O)Nc4ccc(Cl)cc4)C3)c2cc1OC,IC50,'=',165,nM,6.78,,,UO_0000065,13.9,0.26,1.06,10.65,0,CHEMBL1009458,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155071,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,165
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',41.3,%,,,,UO_0000187,,,,,0,CHEMBL4055526,Inhibition of VEGFR2 in human MDA-MB-231 cells assessed as downregulation of phosphorylated FAK levels at 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,41.3
CHEMBL327721,,None,416.59,1,5.07,3f,CN1CCN(CCCn2cc(-c3cncc(-c4ccsc4)c3)c3ccccc32)CC1,IC50,'=',16,nM,7.8,,,UO_0000065,18.71,0.35,2.73,32.08,0,CHEMBL819548,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136194,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,16
CHEMBL4092026,,None,483.53,1,5.55,22,COc1cc2ncnc(Oc3ccc(NC(=O)NC4(C#N)CCCC4)c4ccccc34)c2cc1OC,IC50,'=',8.7,nM,8.06,,,UO_0000065,16.67,0.31,2.51,6.81,0,CHEMBL4033253,Inhibition of VEGFR2 (unknown origin) using biotin substrate incubated for 1 hr by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028913,1,Scientific Literature,J Med Chem,2018,None,,,,8.7
CHEMBL4067065,,None,487.54,1,5.39,10,COc1cc2ncnc(Oc3ccc(NS(=O)(=O)c4ccccc4)c4ccccc34)c2cc1OC,Inhibition,'=',44.31,%,,,,UO_0000187,,,,,0,CHEMBL4033252,Inhibition of VEGFR2 (unknown origin) at 10 uM using biotin substrate incubated for 1 hr by HTRF method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028913,1,Scientific Literature,J Med Chem,2018,None,,,,44.31
CHEMBL384909,,None,433.51,0,4.96,10,O=C(NCc1ccccc1)c1ccc(F)c(NCc2cnc(Nc3ccccn3)s2)c1,IC50,'=',17,nM,7.77,,,UO_0000065,17.92,0.34,2.81,9.84,0,CHEMBL866816,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138058,1,Scientific Literature,J Med Chem,2006,None,,,,17
CHEMBL208911,,None,411.51,0,4.71,9,O=C(NC1CCCC1)c1ccc(F)c(NCc2cnc(Nc3ccccn3)s2)c1,IC50,'=',110,nM,6.96,,,UO_0000065,16.91,0.33,2.25,8.82,0,CHEMBL866816,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138058,1,Scientific Literature,J Med Chem,2006,None,,,,110
CHEMBL3671565,,None,600.45,1,3.65,BDBM133777,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)N1CCN(C(C)=O)CC1,IC50,'=',782,nM,6.11,,266635,UO_0000065,10.17,0.21,2.46,4.74,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671569,,None,539.37,1,4.54,BDBM133781,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)c1ccc[nH]1,IC50,'=',997,nM,6,,266639,UO_0000065,11.13,0.23,1.46,4.96,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4174711,,None,559.47,2,6.27,CPMA9,Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)cc2n1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4135859,Inhibition of VEGFR-2 (unknown origin) after 60 mins by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130538,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL196486,,None,334.38,0,2.23,20,NC(=O)c1ccc(-c2nnc(N3CCOCC3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL196490,,None,332.41,0,3.39,21,NC(=O)c1ccc(-c2nnc(N3CCCCC3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL196838,,None,441.43,1,5.45,23,NC(=O)c1ccc(-c2nnc(Sc3ccc(OC(F)(F)F)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL522892,DOVITINIB,3,392.44,0,2.54,17,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,IC50,'=',13,nM,7.89,,,UO_0000065,20.09,0.37,5.35,8.39,0,CHEMBL3998343,Inhibition of recombinant VEGFR2 (unknown origin) expressed in baculovirus infected insect cells using biotinylated peptide substrate GGGGQDGKDYIVLPI in presence of ATP incubated for 1 to 4 hrs by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3997770,1,Scientific Literature,Eur J Med Chem,2017,None,,,,13
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4055549,Inhibition of VEGFR2 in human BT474 cells assessed as reduction in PI3K phosphorylation at 20 to 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,
CHEMBL1835952,,None,705.65,3,5.58,1e,CC[C@H](C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1837487,Inhibition of VEGFR2 glycosylation in human HUVEC cells at 2 uM after 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1833959,1,Scientific Literature,J Med Chem,2011,CHEMBL3307501,,,,
CHEMBL1834584,,None,719.67,3,5.8,7g,CCCCCn1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1837487,Inhibition of VEGFR2 glycosylation in human HUVEC cells at 2 uM after 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1833959,1,Scientific Literature,J Med Chem,2011,CHEMBL3307501,,,,
CHEMBL1834591,,None,809.8,3,7.41,7n,O=c1n(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)cnn1CCCCCCc1ccccc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1837487,Inhibition of VEGFR2 glycosylation in human HUVEC cells at 2 uM after 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1833959,1,Scientific Literature,J Med Chem,2011,CHEMBL3307501,,,,
CHEMBL4457815,,None,459.46,0,3.43,6r,COc1cccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(OC)cc43)cc2)c1,IC50,'=',270,nM,6.57,,,UO_0000065,14.3,0.26,3.14,5.05,0,CHEMBL4330587,Inhibition of VEGFR-2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate after 5 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330065,1,Scientific Literature,Eur J Med Chem,2019,None,,,,0.27
CHEMBL333640,,None,484.63,1,5.65,4f,COCCN(CCOc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1)Cc1ccccc1,IC50,'=',19,nM,7.72,,,UO_0000065,15.93,0.3,2.07,14.88,0,CHEMBL818936,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135002,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,19
CHEMBL2086759,,None,431.52,0,4.36,8g,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2088097,,None,319.76,0,2.81,10,Cc1cc(CNc2ncc(Cl)c(Nc3cc(C)[nH]n3)n2)on1,IC50,'=',501.19,nM,6.3,,,UO_0000065,19.7,0.39,3.49,6.03,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,6.3
CHEMBL2088098,,None,285.31,0,2.16,11,Cc1cc(CNc2nccc(Nc3cc(C)[nH]n3)n2)on1,IC50,'=',1000,nM,6,,,UO_0000065,21.03,0.39,3.84,5.74,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,6
CHEMBL2088104,,None,375.23,0,2.72,17,Cc1cnc(CNc2ncc(Br)c(Nc3cc(C)[nH]n3)n2)cn1,IC50,'=',1000,nM,6,,,UO_0000065,15.99,0.36,3.28,5.75,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,6
CHEMBL3526621,,None,386.38,0,2.7,M7,Cc1c(OC[C@@H](C)O)cn2ncnc(Oc3ccc4[nH]c(CO)cc4c3F)c12,IC50,'=',78,nM,7.11,,,UO_0000065,18.4,0.35,4.41,6.78,0,CHEMBL3538196,Inhibition of human recombinant VEGFR-2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,DOSED_COMPOUND_NAME: [14C]brivanib alaninate,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3526109,1,Scientific Literature,Drug Metab Dispos,2011,None,,,,78
CHEMBL2088107,,None,447.3,0,2.85,20,Cc1cc(Nc2nc(NCc3cc(C(=O)N4CCCC4)no3)ncc2Br)n[nH]1,IC50,'=',15848.93,nM,4.8,,,UO_0000065,10.73,0.23,1.95,3.84,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,4.8
CHEMBL3526543,,None,400.37,0,2.91,M26,Cc1c(OC[C@@H](C)O)cn2ncnc(Oc3ccc4[nH]c(C(=O)O)cc4c3F)c12,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL3538196,Inhibition of human recombinant VEGFR-2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,DOSED_COMPOUND_NAME: [14C]brivanib alaninate,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3526109,1,Scientific Literature,Drug Metab Dispos,2011,None,,,,30000
CHEMBL3656124,,None,501.56,2,6.44,BDBM110635,CCN(CC)C(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)ccn2)c1,IC50,'=',20,nM,7.7,,231520,UO_0000065,15.35,0.28,1.26,7.75,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4439227,,None,426.47,0,4.6,g24; XCF-37b,COc1ccc(NC(=O)c2cccc(/C=C3\CC(=O)N(c4ccc(C)cc4)C3=O)c2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4399339,Inhibition of VEGFR2 in VEGF-stimulated HUVEC assessed as downregulation of ERK1/2 phosphorylation at Thr202/Tyr204 residues at 1 to 10 uM pre-incubated for 2 hrs followed by VEGF stimulation and measured after 15 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4396917,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307501,,,,
CHEMBL181567,,None,298.3,0,2.27,14,COC(=O)c1cn2ncnc(Nc3cccc(O)c3)c2c1C,IC50,'=',61,nM,7.21,,,UO_0000065,24.19,0.45,4.94,8.13,0,CHEMBL830878,Inhibitory concentration against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142012,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,61
CHEMBL4520932,,None,564.63,2,6.02,Roxyl-ZV-14J,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5ccc6nnn(C(C)C)c6c5)n4)cc3)CC2)cc1,Inhibition,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,78
CHEMBL3746776,,None,443.51,0,4.11,33n,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C)CC4)[nH]n3)c2)CN1,IC50,'=',0.9,nM,9.05,,,UO_0000065,20.4,0.37,4.94,8.24,0,CHEMBL3749262,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse BaF3 cells using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL187684,,None,430.94,1,5.77,55,Clc1cccc(Nc2cncc(-c3cncc(NCCCCc4ccncc4)c3)n2)c1,IC50,'=',266,nM,6.58,,,UO_0000065,15.26,0.29,0.81,8.69,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,0.266
CHEMBL187684,,None,430.94,1,5.77,55,Clc1cccc(Nc2cncc(-c3cncc(NCCCCc4ccncc4)c3)n2)c1,pIC50(calc),'=',6.77,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.77
CHEMBL525070,,None,475.58,0,3.23,CER-0262928,Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,10
CHEMBL535,SUNITINIB,4,398.48,0,3.33,2,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Activity,'=',79,%,,,,UO_0000187,,,,,0,CHEMBL4384923,Inhibition of VEGF165-induced VEGFR2 phosphorylation in HMEC1 cells assessed as phosphorylated VEGFR2 level at 10 uM preincubated for 24 hrs followed by VEGF stimulation for 30 mins by Western blot assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,None,,,,79
CHEMBL2023119,,None,432.48,0,4.44,7,CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4ccc(OC)cc34)cc2OC)cn1,IC50,'=',2073,nM,5.68,,,UO_0000065,13.14,0.24,1.24,6.5,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,2.073
CHEMBL2023116,,None,463.49,0,3.85,4,CCn1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(OC)c2)cn1,IC50,'=',4773,nM,5.32,,,UO_0000065,11.48,0.21,1.47,4.85,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,4.773
CHEMBL4436123,,None,469.44,0,4.83,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4474583,,None,467.45,0,4.57,16,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccc(OC(F)(F)F)cc5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4443568,,None,401.45,0,3.81,17,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccc(F)cc5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4470561,,None,452.44,0,4.09,37,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5cc(C(F)(F)F)ccn5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4516589,,None,415.47,0,4.12,54,Cc1ccc(F)c(CC(=O)Nc2ccc(-n3c4c(c5ncnc(N)c53)CCC4)cc2)c1,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL3612229,,None,402.5,1,5.96,4c,N#Cc1ccc(NC(=O)Nc2cccc(Sc3ccnc4ccsc34)c2)cc1,IC50,'=',206,nM,6.69,,,UO_0000065,16.61,0.33,0.73,8.59,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,206
CHEMBL4469851,,None,425.49,0,3.46,172,Nc1ncnc2c3c(n(-c4ccc(CC(=O)N5CCOc6ccccc65)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,Vandetanib,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,IC50,'=',0.04,nM,,Potential transcription error,,UO_0000065,,,,,1,CHEMBL5151911,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5150004,1,Scientific Literature,J Med Chem,2021,None,,INHIBITOR,,0.04
CHEMBL1946170,REGORAFENIB,4,482.82,1,5.69,Regorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,IC50,'=',4.2,nM,8.38,,,UO_0000065,17.35,0.35,2.69,9.07,0,CHEMBL4433475,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4433204,1,Scientific Literature,Eur J Med Chem,2019,None,,,,4.2
CHEMBL2031911,,None,554.58,2,5.77,42a,COc1ccc2c(Oc3ccc(NC(=O)c4c(C5CCCO5)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',708,nM,6.15,,,UO_0000065,11.09,0.2,0.38,6.37,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,708
CHEMBL2086737,,None,381.39,0,4.17,6q,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086751,,None,493.61,1,5.38,7i,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2086755,,None,493.61,1,5.38,8c,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL183742,,None,335.32,0,3.74,14,COc1ccc(-c2cc3c(NC(=O)c4ccco4)ncnc3o2)cc1,IC50,'>',48000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,48
CHEMBL383077,,None,432.48,0,3.57,15,Cc1cc2c(F)c(Oc3ncnn4cc(OCCCS(C)(=O)=O)c(C)c34)ccc2[nH]1,IC50,'=',70,nM,7.16,,,UO_0000065,16.54,0.33,3.58,7.26,0,CHEMBL860941,Inhibitory activity against VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146078,1,Scientific Literature,J Med Chem,2006,None,,,,0.07
CHEMBL4453304,,None,398.41,0,2.54,17,COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,GI50,'=',290,nM,,,,UO_0000065,,,,,0,CHEMBL4337762,Inhibition of TEL-fused VEGFR2 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,None,,,,0.29
CHEMBL1980297,ILORASERTIB,2,488.55,1,5.18,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2023481,,None,421.43,0,4.96,15,COc1cc(Oc2ccnc3ccc(F)cc23)ccc1CC(=O)Nc1noc(C)c1C,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,10
CHEMBL2023487,,None,463.49,0,3.67,21,COc1cc(Oc2ncnc3cc(OC)c(OC)cc23)ccc1CC(=O)Nc1cn(C)nc1C,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,10
CHEMBL3706831,,None,410.43,0,1.7,21,COCCOc1cc2ncnc(NC3=CC(=O)C(N4CC4C)=CC3=O)c2cc1OC,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL2113175,,None,449.41,0,2.32,26,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=CC3=O)c2cc1OC,IC50,'=',212,nM,6.67,,,UO_0000065,14.85,0.28,4.35,6.13,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,212
CHEMBL2113176,,None,462.46,0,2.61,27,COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccnc4)=CC3=O)c2cc1OC,IC50,'=',193,nM,6.71,,,UO_0000065,14.52,0.27,4.1,5.51,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,193
CHEMBL2113169,,None,413.43,0,2.42,29,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(C)C)=CC3=O)c2cc1OC,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL383435,,None,333.35,0,1.89,16g,COc1cccc2c1c(/C=C1\C(=O)NN=C1c1cnccn1)cn2C,IC50,'=',26,nM,7.58,,,UO_0000065,22.75,0.41,5.7,9.32,0,CHEMBL866859,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146951,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,26
CHEMBL380915,,None,382.22,0,2.65,16f,Cn1cc(/C=C2\C(=O)NN=C2c2cnccn2)c2c(Br)cccc21,IC50,'=',6,nM,8.22,,,UO_0000065,21.51,0.47,5.57,11.39,0,CHEMBL866859,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146951,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,6
CHEMBL94191,,None,281.31,0,3.39,35,COc1cc2ncnc(Nc3ccccc3)c2cc1OC,IC50,'=',7000,nM,5.16,,,UO_0000065,18.32,0.34,1.76,9.16,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,7
CHEMBL1277620,,None,378.2,0,4.29,38,COc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1OC,IC50,'=',1650,nM,5.78,,,UO_0000065,15.29,0.34,1.49,10.28,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,1.65
CHEMBL3702566,,None,417.47,0,4.84,BDBM139539,Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,IC50,'>',10000,nM,,,273861,UO_0000065,,,,,0,CHEMBL3707510,Kinase Inhibition Assay: The compound of Example 39,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2036868,,None,331.38,0,3.78,2f,COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1,IC50,'=',44000,nM,4.36,,,UO_0000065,13.15,0.24,0.58,6.72,0,CHEMBL2038025,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2334807,,None,427.87,0,4.51,12b,O=C(Nc1ccc(OC2=NS(=O)(=O)c3ccccc32)cc1)Nc1ccccc1Cl,Inhibition,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL2338949,Inhibition of VEGFR-2 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331514,1,Scientific Literature,Eur J Med Chem,2013,None,,,,27
CHEMBL2334806,,None,393.42,0,3.86,12a,O=C(Nc1ccccc1)Nc1ccc(OC2=NS(=O)(=O)c3ccccc32)cc1,Inhibition,'=',35,%,,,,UO_0000187,,,,,0,CHEMBL2338949,Inhibition of VEGFR-2 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331514,1,Scientific Literature,Eur J Med Chem,2013,None,,,,35
CHEMBL3656107,,None,593.64,2,5.45,BDBM110618,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CCC(S(=O)(=O)O)CC5)c[nH]4)c3)cc2)c1,IC50,'=',27,nM,7.57,,231503,UO_0000065,12.75,0.25,2.12,4.92,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648104,,None,445.41,0,4.27,BDBM100915,CC(Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)C(C)(C)O,IC50,'=',110,nM,6.96,,218197,UO_0000065,15.62,0.38,2.69,7.03,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL295679,,None,314.35,0,3.47,4b,c1ccc(-c2nccn2-c2ccnc(Nc3cccnc3)n2)cc1,IC50,'=',340,nM,6.47,,,UO_0000065,20.58,0.37,3,9.44,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,340
CHEMBL190783,,None,495.63,0,4.38,104,CCNC(=O)Nc1nc2nc(NCCCCN(CC)CC)ncc2cc1-c1cc(OC)cc(OC)c1,IC50,'=',190,nM,6.72,,,UO_0000065,13.56,0.25,2.34,5.92,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.19
CHEMBL439182,,None,426.9,0,4.48,26,CN1CCC(COc2cccc3ncnc(Nc4c(Cl)ccc5c4OCO5)c23)CC1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,
CHEMBL3656057,,None,387.41,1,5.57,BDBM110568,Cc1ccc(F)c(C(=O)Nc2ccc(Oc3ccnc(-c4ccc[nH]4)c3)cc2)c1,IC50,'=',10028,nM,5,,231453,UO_0000065,12.9,0.24,-0.57,7.46,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4860202,,None,462.56,0,4.5,Ik,CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccccc4)c3)nc3sccn23)n1,Inhibition,'=',24.78,%,,,,UO_0000187,,,,,0,CHEMBL4832285,Inhibition of KDR (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4831500,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 10.0 microM | TIME = 0.6667 hr,,,24.78
CHEMBL3746293,,None,529.6,1,4.74,23,Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1,Inhibition,'=',-2.4,%,,,,UO_0000187,,,,,0,CHEMBL3751269,Inhibition of KDR (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745631,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,-2.4
CHEMBL3403513,,None,295.34,0,3.54,6,Cc1nc(N(C)c2ccc3c(c2)CCO3)c2cc(C)oc2n1,Ratio IC50,'=',3,,,,,,,,,,0,CHEMBL3404075,Ratio of sunitinib IC50 to compound IC50 for VEGFR2 in human U251 cells compound pretreated for 60 min before VEGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3400114,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307756,,,,3
CHEMBL427233,,None,408.51,1,5.39,28,CNc1ncc2cc(-c3cc(C(=O)Nc4cccc5c4CCC5)ccc3C)ccc2n1,IC50,'=',48,nM,7.32,,,UO_0000065,17.92,0.32,1.93,10.94,0,CHEMBL853495,Inhibition of KDR by HTRF kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149344,1,Scientific Literature,J Med Chem,2006,None,,,,48
CHEMBL4521594,BAY-1797,None,416.89,0,3.96,EUB0000309,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,% Control,'=',77,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507265,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,77
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3614226,Inhibition of VEGFR2 phosphorylation in HUVEC at 2.5 to 5 uM by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307501,,,,
CHEMBL2079588,TELATINIB,2,409.83,0,3.95,2,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,IC50,'=',6,nM,8.22,,,UO_0000065,20.06,0.39,4.27,8.05,1,CHEMBL4839222,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4837240,1,Scientific Literature,J Med Chem,2021,None,,INHIBITOR,,6
CHEMBL4874448,,None,616.11,2,6.14,38k,CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4839141,Inhibition of human KDR/VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4837240,1,Scientific Literature,J Med Chem,2021,None,,,,10000
CHEMBL4860634,,None,468.54,0,4.57,19b,Cc1ccccc1NC(=O)c1ccc(NC(=O)CSc2nc3ccccc3n3cnnc23)cc1,IC50,'=',18.4,nM,7.74,,,UO_0000065,16.51,0.31,3.17,7.64,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,18.4
CHEMBL3125885,,None,555.51,2,7.11,5B,N#Cc1c(Oc2ccc(F)c(NC(=O)Nc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12,IC50,'=',730,nM,6.14,,,UO_0000065,11.05,0.21,-0.97,5.28,0,CHEMBL3129557,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate pretreated for 5 mins before substrate addition measured after overnight incubation,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124815,1,Scientific Literature,J Med Chem,2013,None,,,,730
CHEMBL489326,EXELIXIS,None,519.5,2,5.68,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915340,,None,450.44,0,4.86,22,CC(=O)Nc1cc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)ccn1,Inhibition,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1920421,Inhibition of KDR using Tyr 01 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914443,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,101
CHEMBL3648107,,None,458.38,0,2.95,BDBM2449,C[C@@H](Nc1nc(Nc2ccc(S(=N)(=O)CCO)cc2)ncc1Br)C(C)(C)O,IC50,'=',69,nM,7.16,,6364,UO_0000065,15.62,0.36,4.21,5.46,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4534045,,None,445.68,1,6.3,5s,O=C(Nc1ccc2oc(-c3ccccc3Cl)nc2c1)c1ccc(Br)c(F)c1,Inhibition,'=',59.5,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4553890,,None,462.13,1,6.82,5u,O=C(Nc1ccc2oc(-c3ccccc3Cl)nc2c1)c1ccc(Cl)c(Br)c1,Inhibition,'=',80.9,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4534603,,None,452.89,1,5.36,5w,COc1cc(CC(=O)Nc2ccc3oc(-c4ccccc4Cl)nc3c2)cc(OC)c1OC,Inhibition,'=',75.8,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3087615,,None,358.83,0,4.09,6z,COc1cc2c(Nc3ccc(C)cc3)nnnc2cc1OCCCCl,Inhibition,'=',14.2,%,,,,UO_0000187,,,,,0,CHEMBL3090413,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1254437,,None,453.93,1,5.09,11h,Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ncnc3ccn(C)c23)cc1Cl,IC50,'=',19,nM,7.72,,,UO_0000065,17.01,0.33,2.63,7.81,0,CHEMBL1250684,Inhibition of His-tagged human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250549,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3308860,,,,19
CHEMBL1254515,,None,491.86,1,6.09,11i,COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4ccn(C)c34)cc2Cl)cc1C(F)(F)F,IC50,'=',9.4,nM,8.03,,,UO_0000065,16.32,0.32,1.94,8.89,0,CHEMBL1250684,Inhibition of His-tagged human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250549,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3308860,,,,9.4
CHEMBL3348846,FEXAGRATINIB,2,463.58,0,3.65,AZD4547,COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1,IC50,'=',29.5,nM,7.53,,,UO_0000065,16.24,0.3,3.88,8.23,0,CHEMBL3804518,Inhibition of recombinant VEGFR2 (unknown origin) using (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL382517,,None,409.9,1,5.55,18,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1,IC50,'=',34.67,nM,7.46,,,UO_0000065,18.2,0.36,1.91,8.03,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,7.46
CHEMBL372744,,None,407.47,1,5.34,28,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1,IC50,'=',33.88,nM,7.47,,,UO_0000065,18.33,0.35,2.13,8.04,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,7.47
CHEMBL372755,,None,465.58,1,6.48,39,Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4ccccc4)sc4ncnc(N)c34)cc2)c1,IC50,'=',281.84,nM,6.55,,,UO_0000065,14.07,0.26,0.07,7.05,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,6.55
CHEMBL3818531,,None,361.37,0,4.06,6j,Cc1ccc([N+](=O)[O-])cc1Nc1nccc(Nc2ccc3[nH]ncc3c2)n1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3820579,Inhibition of VEGFR-2 (unknown origin) after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,
CHEMBL3818327,,None,362.35,0,3.48,8a,COc1ccc(Nc2nccc(-n3ncc4cc([N+](=O)[O-])ccc43)n2)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3820579,Inhibition of VEGFR-2 (unknown origin) after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,
CHEMBL3819253,,None,336.79,0,4.49,6c,Clc1ccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)cc1,IC50,'=',168,nM,6.78,,,UO_0000065,20.12,0.39,2.28,8.63,0,CHEMBL3820579,Inhibition of VEGFR-2 (unknown origin) after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,168
CHEMBL3818637,,None,316.37,0,4.15,6a,Cc1ccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)cc1,Inhibition,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL3820578,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,76
CHEMBL560373,,None,234.26,0,-0.48,10,NCC1CN(c2ncnc3[nH]cnc23)CCO1,Inhibition,'=',82.5,%,,,,UO_0000187,,,,,0,CHEMBL3136112,Inhibition of human KDR cytoplasmic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3132769,1,Scientific Literature,Medchemcomm,2014,None,,,,82.5
CHEMBL3125727,,None,406.51,0,4.75,19,COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1,Activity,'=',14,%,,,,UO_0000187,,,,,0,CHEMBL3132498,Inhibition of human KDR assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124838,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,14
CHEMBL565782,,None,529.6,2,6.1,22,CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)CC(=O)N(C)c5ccccc5)cc4F)c3s2)c1,IC50,'=',6,nM,8.22,,,UO_0000065,15.52,0.3,2.12,9.2,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,6
CHEMBL3799169,,None,513.94,2,5.27,13g,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2F)ccn1,Inhibition,'=',26.9,%,,,,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,26.9
CHEMBL3799650,,None,620.01,2,6.31,13u,O=C(Nc1ccc(Oc2ccnc(-c3nncn3CCCN3CCOCC3)c2)c(F)c1)Nc1ccc(Cl)c(C(F)(F)F)c1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0
CHEMBL5208454,,None,444.72,1,5.18,C6,O=C(CCCl)Nc1ccc2ncnc(Nc3ccc4[nH]cc(Br)c4c3)c2c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL5161062,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5154786,1,Scientific Literature,Eur J Med Chem,2022,None,,,,10000
CHEMBL5403747,,None,588.06,2,7.34,I27,COc1cc2c(Oc3ccc(NC(=O)Nc4ccc5occc5c4)c(Cl)c3)ncnc2cc1OCCCN1CCCC1,IC50,'=',0.34,nM,9.47,,,UO_0000065,16.1,0.31,2.13,8.53,0,CHEMBL5328005,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5325476,1,Scientific Literature,Bioorg Med Chem,2023,None,,INHIBITOR,,0.34
CHEMBL5426431,,None,638.12,2,8.49,I29,COc1cc2c(Oc3ccc(NC(=O)Nc4cccc5c4oc4ccccc45)c(Cl)c3)ncnc2cc1OCCCN1CCCC1,IC50,'=',1.13,nM,8.95,,,UO_0000065,14.02,0.27,0.46,8.06,0,CHEMBL5328005,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5325476,1,Scientific Literature,Bioorg Med Chem,2023,None,,INHIBITOR,,1.13
CHEMBL5411585,,None,616.04,2,7.61,I10,COc1cc2c(Oc3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)c(Cl)c3)ncnc2cc1OCCCN1CCCC1,Inhibition,'=',100.19,%,,,,UO_0000187,,,,,0,CHEMBL5328009,Inhibition of KDR (unknown origin) at 0.1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5325476,1,Scientific Literature,Bioorg Med Chem,2023,None,DOSE = 0.1 microM,INHIBITOR,,100.19
CHEMBL1289601,LENVATINIB,4,426.86,0,4.07,8,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,IC50,'=',4,nM,8.4,,,UO_0000065,19.67,0.38,4.33,7.27,1,CHEMBL4839222,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4837240,1,Scientific Literature,J Med Chem,2021,None,,INHIBITOR,,4
CHEMBL4093612,A-1596586,None,539.53,2,5.45,EUB0000544,COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,% Control,'=',80,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507262,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,80
CHEMBL5199374,,None,446.56,0,3.51,56q; CPL30411,COc1cc(CCc2cc(-c3nc4ccc(N5CCN(C)CC5)cc4[nH]3)n[nH]2)cc(OC)c1,IC50,'=',66.26,nM,7.18,,,UO_0000065,16.08,0.3,3.67,8.72,0,CHEMBL5096260,Inhibition of recombinant N-terminal GST-tagged human KDR (790 to 1356 residues) expressed in baculovirus expression system using IGF-1Rtide peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hrs in the presence of ATP by ADP-Glo reagent based luminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5096142,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 1.167 hr,INHIBITOR,,66.26
CHEMBL1290030,,None,441.52,1,5.06,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',90,nM,7.05,,,UO_0000065,15.16,0.3,1.5,7.63,1,CHEMBL1292980,Inhibition of recombinant VEGFR2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1287660,1,Scientific Literature,Eur J Med Chem,2010,None,,,,90
CHEMBL5186340,,None,562.67,2,5.6,1,CC1(C)c2cc(OCCN3CCOCC3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCC4CC4)ccn3)ccc21,IC50,'=',757,nM,6.12,,,UO_0000065,10.88,0.2,0.52,8.27,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,INHIBITOR,,757
CHEMBL5191460,,None,576.69,2,5.99,3c,CC1(C)c2cc(OCCN3CCOCC3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCCC4CC4)ccn3)ccc21,IC50,'=',490,nM,6.31,,,UO_0000065,10.94,0.2,0.32,8.52,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,INHIBITOR,,490
CHEMBL5199099,,None,575.67,1,4.7,4d,CC1(C)c2cc(OCCN3CCNC(=O)C3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCC4CC4)ccn3)ccc21,IC50,'=',413,nM,6.38,,,UO_0000065,11.09,0.2,1.68,6.8,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,INHIBITOR,,413
CHEMBL5178903,,None,623.65,2,6.02,10c,CC(C)(C)NC(=O)c1cc(C#Cc2ccc3c4c(oc3c2)C(C)(C)c2cc(NS(C)(=O)=O)ccc2C4=O)nc(C(F)(F)F)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,,,1000
CHEMBL223360,LINIFANIB,3,375.41,0,4.9,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5183149,,None,575.67,1,4.7,3g,CC1(C)c2cc(OCCN3CCOCC3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(C(=O)NC4CC4)ccn3)ccc21,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,,,1000
CHEMBL604483,,None,559.67,2,5.86,23,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL1073368,Residual activity of VEGFR2 at 10 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,5
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,BIRB-796,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,Kd,'=',3900,nM,5.41,,,UO_0000065,10.25,0.19,-0.58,6.71,1,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,3900
CHEMBL3114028,,None,360.42,0,3.88,7k,COc1cccc(Nc2nccc(N(C)c3ccc4cn(C)nc4c3)n2)c1,IC50,'=',108,nM,6.97,,,UO_0000065,19.33,0.35,3.09,10.23,0,CHEMBL3116994,Inhibition of VEGFR-2 tyrosine kinase (unknown origin) after 30 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3112549,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,108
CHEMBL492251,,None,370.41,0,4.86,4p,COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1034899,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140097,1,Scientific Literature,J Med Chem,2008,None,,,,10
CHEMBL939,GEFITINIB,4,446.91,0,4.28,ZD1839,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1340723,,None,304.77,0,4.44,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1835953,,None,705.65,3,5.58,1f,CC[C@@H](C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1837487,Inhibition of VEGFR2 glycosylation in human HUVEC cells at 2 uM after 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1833959,1,Scientific Literature,J Med Chem,2011,CHEMBL3307501,,,,
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,Pazopanib,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,'=',34,nM,7.47,,,UO_0000065,17.07,0.33,4.33,6.27,0,CHEMBL4195389,Inhibition of VEGFR-2 (unknown origin) after 40 mins by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,0.034
CHEMBL27759,ENTINOSTAT,3,376.42,0,3.34,MS-275,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,Inhibition,,,%,,,Not Determined,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,
CHEMBL227727,,None,239.28,0,1.52,3,NCCc1ccc(-c2ncnc3[nH]cnc23)cc1,Inhibition,'=',72.5,%,,,,UO_0000187,,,,,0,CHEMBL3136644,Inhibition of human KDR cytoplasmic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3132769,1,Scientific Literature,Medchemcomm,2014,None,,,,72.5
CHEMBL460702,BMS-777607,2,512.9,2,5.19,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL610512,,None,295.26,0,0.17,27a,O=C1Cc2cc3c(=O)[nH]c(=O)[nH]c3nc2-c2ncccc2N1,IC50,'=',66000,nM,4.18,,,UO_0000065,14.16,0.26,4.01,3.47,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,66
CHEMBL597586,,None,381.23,0,4.14,28h,O=C1Cc2cnc(Nc3ccc(Br)cc3)nc2-c2ccccc2N1,IC50,'=',290,nM,6.54,,,UO_0000065,17.15,0.37,2.4,9.77,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,0.29
CHEMBL606410,,None,346.39,0,3.78,28i,CCOc1ccc(Nc2ncc3c(n2)-c2ccccc2NC(=O)C3)cc1,IC50,'=',130,nM,6.89,,,UO_0000065,19.88,0.36,3.11,9.04,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,0.13
CHEMBL3297898,,None,283.33,0,3.62,11,COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1,IC50,'=',19.1,nM,7.72,,,UO_0000065,27.24,0.5,4.1,15.02,0,CHEMBL3299341,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297731,1,Scientific Literature,Bioorg Med Chem,2014,CHEMBL3307756,,,,19.1
CHEMBL1094718,,None,578.55,2,7.09,4,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1103916,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157925,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,10
CHEMBL1971943,BAY-549,None,402.79,0,4.71,EUB0000716,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,% Control,'=',81,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507274,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 100.0 nM,,,81
CHEMBL1017,TELMISARTAN,4,514.63,2,7.26,telmisartan,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,AC50,'>',10000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,10
CHEMBL771,CYCLOSERINE,4,102.09,0,-1.62,cycloserine,N[C@@H]1CONC1=O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL403183,,None,207.25,0,1.81,BAY-117082,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,Residual Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1095131,,None,402.26,1,5.32,10,Nc1nc(Nc2cccc(F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,IC50,'=',300,nM,6.52,,,UO_0000065,16.22,0.33,1.2,8.19,0,CHEMBL1112816,Inhibition of VEGFR2 phosphorylation in human U251 cells after 10 mins by FLISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157126,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3307756,,,,0.3
CHEMBL596087,,None,554.72,2,5.98,11,COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(C)c3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',350,nM,6.46,,,UO_0000065,11.64,0.22,0.48,8.54,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.35
CHEMBL604712,,None,376.41,0,3.56,1,CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1064456,Inhibition of VEGFR2 by scintillation proximity assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157586,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,10
CHEMBL593909,,None,593.13,2,6.47,21,COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',2250,nM,5.65,,,UO_0000065,9.52,0.19,-0.82,7.47,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,2.25
CHEMBL2430249,,None,436.53,0,3.88,40,Cc1[nH]c2c(c1C(=O)NCCCN1CCCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21,IC50,'=',3.8,nM,8.42,,,UO_0000065,19.29,0.36,4.54,10.9,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,3.8
CHEMBL1278146,FAMITINIB,3,410.49,0,3.3,9,CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O,IC50,'=',5,nM,8.3,,,UO_0000065,20.22,0.38,5,12.13,0,CHEMBL1285788,Inhibition of human VEGFR2 after 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275399,1,Scientific Literature,J Med Chem,2010,None,,,,0.005
CHEMBL1276891,,None,424.48,0,2.29,14,Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(CCN1CCOCC1)CC2,IC50,'=',25,nM,7.6,,,UO_0000065,17.91,0.33,5.31,9.79,0,CHEMBL1285788,Inhibition of human VEGFR2 after 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275399,1,Scientific Literature,J Med Chem,2010,None,,,,0.025
CHEMBL1276980,,None,454.5,0,1.65,15,Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(C[C@H](O)CN1CCOCC1)CC2,IC50,'=',19,nM,7.72,,,UO_0000065,16.99,0.32,6.07,7.89,0,CHEMBL1285790,Inhibition of VEGFR2-induced cell proliferation in HUVEC after 72 hrs by sulforhodamine B method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275399,1,Scientific Literature,J Med Chem,2010,None,,,,0.019
CHEMBL1277071,,None,438.5,0,2.68,24,Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(CCN1CCOCC1)CCC2,IC50,'=',36,nM,7.44,,,UO_0000065,16.98,0.32,4.76,9.58,0,CHEMBL1285790,Inhibition of VEGFR2-induced cell proliferation in HUVEC after 72 hrs by sulforhodamine B method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275399,1,Scientific Literature,J Med Chem,2010,None,,,,0.036
CHEMBL276711,SEMAXANIB,3,238.29,0,3.12,Semaxanib,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,IC50,'=',12900,nM,4.89,,,UO_0000065,20.52,0.37,1.77,10.89,1,CHEMBL4340079,Inhibition of recombinant human KDR incubated for 1 hr using Tyr1 substrate by fluorimetry based Z'-LYTE-Tyr1 Peptide assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4339217,1,Scientific Literature,ACS Med Chem Lett,2019,None,,,,12.9
CHEMBL4780196,,None,755.76,2,5.73,10n,COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OCCO.Cc1ccc(S(=O)(=O)O)cc1,IC50,'=',12.3,nM,7.91,,,UO_0000065,13.56,0.25,2.18,6.02,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,12.3
CHEMBL4788196,,None,567.55,2,6.67,22b,COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]c(C)c(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OC,IC50,'=',454.9,nM,6.34,,,UO_0000065,11.17,0.21,-0.33,5.7,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,454.9
CHEMBL1230020,PLX-4720,None,413.83,0,3.88,PLX-4720,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,Kd,'=',2100,nM,5.68,,,UO_0000065,13.72,0.29,1.8,6.18,0,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,2100
CHEMBL3765306,,None,575.02,2,5.07,T-1840383,CC1=[N+](c2ccccc2)C(=O)C(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c(F)c2)C=C1.Cl,IC50,'=',2.2,nM,8.66,,,UO_0000065,16.08,0.3,3.59,8.26,0,CHEMBL3767461,Inhibition of VEGFR-2 (unknown origin) by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3763130,1,Scientific Literature,Eur J Med Chem,2016,None,,,,2.2
CHEMBL1957675,,None,397.53,0,4.53,20,CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1,Inhibition,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL1961072,Inhibition of recombinant KDR at 10 uM after 90 mins fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955782,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,94
CHEMBL1915331,,None,407.42,1,5.09,11,Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1,Inhibition,'<',40,%,,,,UO_0000187,,,,,0,CHEMBL1920328,Inhibition of KDR using Tyr 01 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914443,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,40
CHEMBL3759848,,None,532.04,2,6.15,15m,COc1cc2c(Nc3ccc(NC(=O)c4cccc(Cl)c4)cc3)ncnc2cc1OCCN1CCCCC1,IC50,'=',1990,nM,5.7,,,UO_0000065,10.72,0.2,-0.45,6.43,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,1.99
CHEMBL3758585,,None,540.67,1,4.96,15e,COc1cc2c(Nc3ccc(NC(=O)c4ccc(C)cc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',870,nM,6.06,,,UO_0000065,11.21,0.21,1.1,6.6,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.87
CHEMBL1229517,VEMURAFENIB,4,489.93,1,5.54,1,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,IC50,'=',360,nM,6.44,,,UO_0000065,13.15,0.27,0.9,7.01,0,CHEMBL3578340,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576847,1,Scientific Literature,J Med Chem,2015,None,,,,0.36
CHEMBL4099589,,None,335.37,0,3.02,6h,COc1ccc(CNc2nc(N)nc3[nH]c4ccc(O)cc4c23)cc1,Ki,,,,,,Not Determined,,,,,,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1668416,,None,366.84,0,4.1,5,COc1cc(O)c2c(c1)/C=C\CCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O,IC50,'=',82000,nM,4.09,,,UO_0000065,11.14,0.22,-0.01,5.61,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,82
CHEMBL1651523,,None,332.4,0,3.58,11,COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O,IC50,'=',540,nM,6.27,,,UO_0000065,18.86,0.36,2.69,8.61,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,0.54
CHEMBL1972584,,None,591.72,1,4.47,SID103904787,CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1,Ki,'=',3981.07,nM,5.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.4
CHEMBL3360678,,None,465.42,0,3.68,4b,O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3374155,Inhibition of KDR (unknown origin) at 1 uM by ELISA method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352075,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,0
CHEMBL2348996,,None,431.46,0,3.16,19,Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c2)n(C)n1,IC50,'=',0.19,nM,9.72,,,UO_0000065,22.53,0.41,6.56,8.42,0,CHEMBL2353609,Inhibition of VEGFR2 (unknown origin) using biotinylated poly(Glu:Tyr) as substrate after 60 mins by AlphaScreen assay in presence of 1000 uM of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2346507,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,0.19
CHEMBL3361128,,None,254.24,0,2.71,S6,O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21,IC50,'=',5960,nM,5.22,,,UO_0000065,20.55,0.38,2.51,7.83,0,CHEMBL3372230,Inhibition of recombinant KDR (unknown origin) after 60 mins by z'-lyte kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351909,1,Scientific Literature,Eur J Med Chem,2015,None,,,,5.96
CHEMBL3409415,,None,378.42,0,4.1,A2,Nc1nccc(Oc2ccc(NC(=O)Nc3nc4ccccc4s3)cc2)n1,IC50,'=',120,nM,6.92,,,UO_0000065,18.29,0.35,2.82,6.02,0,CHEMBL3411015,Inhibition of VEGFR2 (unknown origin) by [33P]radiolabeled method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3407453,1,Scientific Literature,Eur J Med Chem,2015,None,,,,120
CHEMBL201906,,None,351.48,0,4.7,15,CC(C)c1ccc(NC(=O)c2scnc2CCc2ccncc2)cc1,IC50,'=',120,nM,6.92,,,UO_0000065,19.69,0.38,2.22,12.61,0,CHEMBL861911,Inhibitory activity against VEGFR2 transiently transfected in 293 adenovirus transfected kidney cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148628,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.12
CHEMBL201712,,None,415.56,1,6.03,13,CC(C)(C)c1ccc(NC(=O)c2scnc2CCc2ccc3ccccc3n2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL861911,Inhibitory activity against VEGFR2 transiently transfected in 293 adenovirus transfected kidney cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148628,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL383030,,None,457.48,0,4.48,9,COC(=O)c1c(OCCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,IC50,'=',15500,nM,4.81,,,UO_0000065,10.51,0.19,0.33,5.59,0,CHEMBL862243,Inhibitory activity against VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149378,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,15.5
CHEMBL2206014,,None,429.5,1,5.06,15b,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1,Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL3381544,Inhibition of human recombinant KDR kinase expressed Sf9 cells using Ulight-CAGAGAIETDKEYYTVKD substrate assessed as remaining enzyme activity at 1 uM after 60 mins relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352815,1,Scientific Literature,Bioorg Med Chem Lett,2014,CHEMBL3308860,,,,97
CHEMBL3219505,,None,399.66,None,None,6b,CC1(C)OB(c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)OC1(C)C,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,
CHEMBL1933582,,None,501.51,1,3.16,25,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1936631,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933058,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,10
CHEMBL1923983,,None,379.42,0,1.82,4m,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3287596,,None,531.52,2,5.66,10j,COc1ccc(Nc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)n2)cc1,IC50,'=',4394,nM,5.36,,,UO_0000065,10.08,0.19,-0.3,4.68,0,CHEMBL3291812,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3287599,,None,497.5,0,4.35,10m,CCOCCNc1nccc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)n1,IC50,'=',2468.5,nM,5.61,,,UO_0000065,11.27,0.21,1.26,4.9,0,CHEMBL3291812,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3288505,,None,392.46,1,5.53,4d,Cc1ccc(NC(=O)c2cccc3cc(-c4cccc5[nH]nc(N)c45)ccc23)cc1,IC50,'=',1.9,nM,8.72,,,UO_0000065,22.22,0.4,3.19,10.41,0,CHEMBL3295610,Inhibition of VEGFR-2 (unknown origin) expressed in baculovirus expression system using poly (4 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3288509,,None,410.45,1,5.67,4h,Cc1ccc(NC(=O)c2cccc3cc(-c4cccc5[nH]nc(N)c45)ccc23)c(F)c1,IC50,'=',3.3,nM,8.48,,,UO_0000065,20.66,0.37,2.81,10.12,0,CHEMBL3295611,Inhibition of VEGFR-2 in HUVEC assessed as inhibition of VEGF (1 to 165)-induced cell proliferation preincubated for 2 hrs followed by VEGF (1 to 165) induction measured after 48 hrs by CCK8 assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286125,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,3.3
CHEMBL3288508,,None,410.45,1,5.67,4g,Cc1ccc(F)c(NC(=O)c2cccc3cc(-c4cccc5[nH]nc(N)c45)ccc23)c1,IC50,'=',3.8,nM,8.42,,,UO_0000065,20.51,0.37,2.75,10.05,0,CHEMBL3295610,Inhibition of VEGFR-2 (unknown origin) expressed in baculovirus expression system using poly (4 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3287222,,None,394.91,0,4.63,3,COc1ccc(N(C)c2nc(C)nc3c(Cc4ccccc4)c[nH]c23)cc1.Cl,IC50,'=',21.3,nM,7.67,,,UO_0000065,21.4,0.39,3.04,14.2,0,CHEMBL3295463,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286190,1,Scientific Literature,ACS Med Chem Lett,2014,CHEMBL3307756,,,,21.3
CHEMBL3287219,,None,410.91,0,4.62,6,COc1ccc(Nc2nc(C)nc3c(Cc4ccccc4)c[nH]c23)c(OC)c1.Cl,IC50,'=',30.1,nM,7.52,,,UO_0000065,20.09,0.37,2.9,10.44,0,CHEMBL3295463,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286190,1,Scientific Literature,ACS Med Chem Lett,2014,CHEMBL3307756,,,,30.1
CHEMBL3217783,,None,306.33,0,3.26,20,COc1cc2ncnc(Nc3ccc(C#N)cc3)c2cc1OC,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,
CHEMBL2333989,,None,296.33,0,2.97,23,COc1cc2ncnc(Nc3ccc(N)cc3)c2cc1OC,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,4
CHEMBL1934322,,None,517.58,2,5.55,1c,CN1CCC(COc2ccc3c(Nc4ccc(CC(=O)Nc5ccc(F)c(F)c5)cc4)ncnc3c2)CC1,IC50,'=',73,nM,7.14,,,UO_0000065,13.79,0.26,1.59,8.99,0,CHEMBL1937306,Inhibition of human GST-tagged VEGFR2 intracellular domain using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate after 30 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933000,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,73
CHEMBL218969,GW445015X,None,252.32,0,2.92,GW445015X,CNC(=O)c1cncc(/C=C/c2ccccc2C)c1,Inhibition,'=',4.29,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.29
CHEMBL1242756,,None,276.3,0,2.16,PP111,Cn1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21,IC50,'=',12000,nM,4.92,,,UO_0000065,17.81,0.32,2.76,5.96,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,12
CHEMBL150187,,None,477.27,0,4.09,35,COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCCn1ccnn1,IC50,'=',40,nM,7.4,,,UO_0000065,15.5,0.34,3.31,8.51,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.04
CHEMBL1230609,FORETINIB,2,632.66,2,5.77,Foretinib,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,'=',4.86,nM,8.31,,,UO_0000065,13.14,0.25,2.54,7.47,0,CHEMBL3385131,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352497,1,Scientific Literature,Eur J Med Chem,2014,None,,,,4.86
CHEMBL26050,,None,416.88,0,4.65,32,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC1CCN(C)CC1,IC50,'=',1500,nM,5.82,,,UO_0000065,13.97,0.27,1.17,9.79,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,1.5
CHEMBL1165499,,None,436.51,0,3.61,5d,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1168306,Inhibition of VEGFR2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,50
CHEMBL1242295,,None,318.38,0,3.67,PP94,Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCCC1,IC50,'=',9,nM,8.05,,,UO_0000065,25.27,0.46,4.38,9.42,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.009
CHEMBL1794066,GSK-619487A,None,525.49,0,1.34,GSK619487A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,Inhibition,'=',76.06,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,76.06
CHEMBL1242572,,None,319.37,0,3.07,PP115,Nc1ncnc2c1c(-c1ccc3cn[nH]c3c1)nn2C1CCCC1,IC50,'=',330,nM,6.48,,,UO_0000065,20.29,0.37,3.41,6.59,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.33
CHEMBL127907,,None,297.31,0,3.1,24,COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC,Inhibition,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,88
CHEMBL3944307,,None,369.42,1,5.48,4(b); 12(b),CC(=O)Nc1cccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1,Ki,'=',0.48,nM,9.32,,,UO_0000065,25.23,0.45,3.84,13.91,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.48
CHEMBL92516,,None,278.34,0,3.52,3f,c1cc(-c2cnc3c(-c4ccsc4)cnn3c2)ccn1,IC50,'=',24,nM,7.62,,,UO_0000065,27.38,0.52,4.1,17.69,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,24
CHEMBL554,LAPATINIB,4,581.07,2,6.14,Lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3386315,Inhibition of KDR phosphorylation (unknown origin) expressed in human HUVEC at 0.001 to 10 uM incubated for 2 hrs by Western blot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352165,1,Scientific Literature,Eur J Med Chem,2014,CHEMBL3307501,,,,
CHEMBL3890452,,None,426.48,1,5.32,41(y),CC(C)OC(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1,Inhibition,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,98
CHEMBL3928496,,None,368.44,0,4.56,40(c),Cc1cc(C)c(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)cc1N,Inhibition,'=',24,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,24
CHEMBL3896427,,None,481.54,1,5.61,48(b),Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c(F)cc2C)n(C)n1,Inhibition,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,97
CHEMBL3986713,,None,486.53,1,5.78,43,O=CNc1ccccc1/C=C/c1n[nH]c2cc(C(=O)c3cccc(NC(=O)c4ccccc4)c3)ccc12,Inhibition,'=',56,%,,,,UO_0000187,,,,,0,CHEMBL3881025,Inhibition of human 50 residues truncated cytoplasmic domain of phosphorylated VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,56
CHEMBL3891979,,None,408.46,0,4.87,41(c),C/C=C/C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1,Inhibition,'=',83,%,,,,UO_0000187,,,,,0,CHEMBL3881025,Inhibition of human 50 residues truncated cytoplasmic domain of phosphorylated VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,83
CHEMBL3896103,,None,465.58,1,6.52,12(d),Cc1cnc(C(=O)Nc2cccc(N(C)c3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)c2)s1,Ki,'=',0.39,nM,9.41,,,UO_0000065,20.21,0.38,2.89,12.73,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.39
CHEMBL2031893,,None,528.54,2,5.23,5,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,IC50,'=',7.8,nM,8.11,,,UO_0000065,15.34,0.28,2.88,8.39,1,CHEMBL2395928,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2390843,1,Scientific Literature,Eur J Med Chem,2013,None,,,,7.8
CHEMBL276711,SEMAXANIB,3,238.29,0,3.12,Semaxanib,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,IC50,'=',12.9,nM,,Potential transcription error,,UO_0000065,,,,,1,CHEMBL3404062,Inhibition of VEGFR2 in human U251 cells compound pretreated for 60 min before VEGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3400114,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307756,,,,12.9
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',18.9,nM,,Potential transcription error,,UO_0000065,,,,,1,CHEMBL3404062,Inhibition of VEGFR2 in human U251 cells compound pretreated for 60 min before VEGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3400114,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307756,,,,18.9
CHEMBL3545414,RIVOCERANIB MESYLATE,3,493.59,0,4.68,II,CS(=O)(=O)O.N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,IC50,'=',1,nM,9,,,UO_0000065,22.64,0.41,4.32,9.92,0,CHEMBL3783049,Inhibition of VEGF2 receptor (unknown origin) by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779889,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,1
CHEMBL4062187,,None,441.54,0,4.33,33,Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccccc4N4CCN(C)CC4)cc3)c12,IC50,'=',4164,nM,5.38,,,UO_0000065,12.19,0.22,1.05,6.03,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,4164
CHEMBL4103605,,None,357.42,0,4.89,13,Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1,IC50,'=',1225,nM,5.91,,,UO_0000065,16.54,0.3,1.02,7.15,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,1225
CHEMBL496172,,None,291.31,0,2.79,8d,Cn1c(-c2c(O)c3ccccc3[nH]c2=O)nc2ccccc21,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,25
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',3.12,nM,8.51,,,UO_0000065,18.3,0.36,2.96,9.21,1,CHEMBL5380324,Inhibition of VEGFR-2 (unknown origin) incubated for 45 mins by Kinase-Glo Max assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5376014,1,Scientific Literature,RSC Med Chem,2024,None,TIME = 0.75 hr,INHIBITOR,,3.12
CHEMBL523133,,None,395.39,0,4.96,8,FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL265431,,None,420.5,0,4.55,16,CSc1nnc(-c2cn3ncnc(Nc4cnc5[nH]c(C)cc5c4)c3c2C(C)C)o1,IC50,'=',150,nM,6.82,,,UO_0000065,16.23,0.31,2.27,6.21,0,CHEMBL929417,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145598,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.15
CHEMBL327029,,None,272.31,0,3.74,1,O=c1ccc2ccccc2cc1-c1nc2ccccc2[nH]1,IC50,'=',355,nM,6.45,,,UO_0000065,23.69,0.42,2.71,14.1,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,355
CHEMBL4067760,,None,545.61,2,5.3,3b,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2c1ccn2C,IC50,'=',63.5,nM,7.2,,,UO_0000065,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4082034,,None,596.58,2,6.67,2e,CN1CCN(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)c(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL513838,,None,317.35,0,3.13,5,O=C(c1ccccc1NCc1cn[nH]c1)c1n[nH]c2ccccc12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL976314,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL504547,,None,486.26,0,3.66,89d,O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccoc2)c(O)c1,IC50,'=',10000,nM,5,,,UO_0000065,10.28,0.24,1.34,5.46,0,CHEMBL1016206,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153424,1,Scientific Literature,J Med Chem,2009,None,,,,10
CHEMBL250471,,None,417.69,0,4.76,6,O=C(Nc1ccc(Cl)cc1)c1cc(Br)cnc1NCc1ccncc1,Ki,'=',490,nM,6.31,,,UO_0000065,15.11,0.34,1.55,9.43,0,CHEMBL925259,Inhibition of phosphorylated-Kdr after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140496,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.49
CHEMBL400140,,None,360.46,0,4.68,17,CCCCc1ccc(NC(=O)c2cccnc2NCc2ccncc2)cc1,Ki,'=',19,nM,7.72,,,UO_0000065,21.42,0.39,3.04,11.54,0,CHEMBL925259,Inhibition of phosphorylated-Kdr after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140496,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.019
CHEMBL3810358,,None,622.65,2,5.32,24y,COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1,Inhibition,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,93
CHEMBL275724,,None,458.5,0,3.96,SB-242718,NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',9.7,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9.7
CHEMBL3808744,,None,507.39,2,5.21,6k,COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4ccccc4Br)ccc3C)cnc2[nH]1,Inhibition,'=',41,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,41
CHEMBL3809756,,None,496.49,1,5.47,6l,COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4cccc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,Inhibition,'=',29,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,29
CHEMBL3809745,,None,483.45,0,4.94,6p,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccnc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,Inhibition,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,13
CHEMBL3901622,,None,401.51,1,5.04,6l,C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1,Inhibition,'=',37,%,,,,UO_0000187,,,,,0,CHEMBL3857057,Inhibition of His tagged recombinant human KDR (789 to 1356 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856204,1,Scientific Literature,Eur J Med Chem,2016,None,,,,37
CHEMBL1909363,GSK-269962B,None,607.07,2,3.84,GSK269962B,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl,Inhibition,'=',5.67,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.67
CHEMBL218969,GW445015X,None,252.32,0,2.92,GW445015X,CNC(=O)c1cncc(/C=C/c2ccccc2C)c1,Inhibition,'=',7.71,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.71
CHEMBL1789961,GW513184X,None,360.38,0,2.98,GW513184X,COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O,Inhibition,'=',12.44,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,12.44
CHEMBL1909393,GW583373A,None,595.55,2,6.43,GW583373A,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4
CHEMBL1909411,,None,393.87,0,4.96,GI261520A,COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,3
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',18.9,nM,,Potential transcription error,,UO_0000065,,,,,1,CHEMBL3299341,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297731,1,Scientific Literature,Bioorg Med Chem,2014,CHEMBL3307756,,,,18.9
CHEMBL513897,GSK-994854A,None,481.6,1,5.35,GSK994854A,CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1,Inhibition,'=',17.71,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,17.71
CHEMBL4077123,,None,647.78,2,6.25,9; CHMFL-BTK-01,C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL4025433,Inhibition of wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4024706,1,Scientific Literature,Eur J Med Chem,2017,None,,,,97
CHEMBL380889,,None,460.94,0,3.02,31,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CN(C)C)C(N)=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL379601,,None,403.85,0,3.09,19,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)CC(N)=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL206783,,None,443.91,0,4.01,14,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC[C@@H]1C(N)=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL380454,,None,429.88,0,3.48,11,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CC[C@H](C(N)=O)C1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL207584,,None,429.88,0,3.62,6,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@H]1C(N)=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL516248,GW804482X,None,379.44,0,3.77,GW804482X,COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1,Inhibition,'=',3.07,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,3.07
CHEMBL3099476,,None,577.68,2,5.64,C7,COc1cc(-c2cc(NC(=O)Nc3cc(OCCCN4CCOCC4)ccc3C)cc(OC)c2OC)ccc1C(C)=O,IC50,'=',33.3,nM,7.48,,,UO_0000065,12.94,0.24,1.84,6.95,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,33.3
CHEMBL3099470,,None,521.61,2,5.47,C1,COc1cc(-c2cc(NC(=O)Nc3cc(OCCN(C)C)ccc3C)cc(OC)c2OC)ccc1C(C)=O,IC50,'=',71.4,nM,7.15,,,UO_0000065,13.7,0.26,1.68,7.27,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,71.4
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',1.06,nM,8.97,,,UO_0000065,19.31,0.38,3.42,9.72,1,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,1.06
CHEMBL3099466,,None,561.68,2,6.4,B4,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCN4CCCCC4)cc3C)cc(OC)c2OC)ccc1C(C)=O,IC50,'=',5.26,nM,8.28,,,UO_0000065,14.74,0.28,1.88,8.42,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,5.26
CHEMBL157138,LISURIDE,4,338.46,0,2.84,lisuride,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL370143,PAROMOMYCIN,4,615.63,3,-8.86,paromomycin,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL409450,6BIO,None,356.18,0,3.42,Indirubin_6bromo_oxime,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,Residual Activity,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL332794,A-192621,None,558.68,2,5.81,EUB0000350,CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,% Control,'=',77,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507261,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,77
CHEMBL566003,,None,529.55,2,5.16,8,Cn1cnc(C(=O)c2cc3nccc(Oc4ccc(NC(=O)CC(=O)Nc5ccccc5)cc4F)c3s2)c1,IC50,'=',30,nM,7.52,,,UO_0000065,14.21,0.27,2.36,6.53,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,30
CHEMBL566844,,None,545.6,2,6.09,16,CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)CC(=O)Nc5ccccc5OC)cc4F)c3s2)c1,IC50,'=',6,nM,8.22,,,UO_0000065,15.07,0.29,2.13,7.66,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,6
CHEMBL584701,,None,531.57,2,5.78,18,CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)CC(=O)Nc5ccccc5O)cc4F)c3s2)c1,IC50,'=',7,nM,8.15,,,UO_0000065,15.34,0.29,2.37,6.89,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,7
CHEMBL565807,,None,541.61,2,6.47,21,CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1,IC50,'=',8,nM,8.1,,,UO_0000065,14.95,0.28,1.63,8.25,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,8
CHEMBL1290072,,None,304.35,0,4.6,11d,COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1,Ki,'>',1000000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1292127,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1287713,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,1000
CHEMBL251803,,None,426.43,0,4.65,8c,COc1ccc(-c2[nH]nc3c2C(=O)c2c(NC(=O)Nc4ccc(O)cc4)cccc2-3)cc1,Inhibition,'=',44,%,,,,UO_0000187,,,,,0,CHEMBL928531,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140772,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,44
CHEMBL214258,,None,448.4,1,5.14,12,Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL864249,Inhibition of KDR by cellular assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL378687,,None,432.34,0,4.67,27,Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,IC50,'=',385,nM,6.42,,,UO_0000065,,,,,0,CHEMBL864249,Inhibition of KDR by cellular assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.385
CHEMBL376951,,None,376.45,0,4.29,8,Cc1cccc(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1,IC50,'=',1,nM,9,,,UO_0000065,,,,,0,CHEMBL864249,Inhibition of KDR by cellular assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.001
CHEMBL3545365,ALTIRATINIB,2,510.47,1,5,25; DCC2701,O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1,IC50,'=',9.2,nM,8.04,,,UO_0000065,15.74,0.3,3.04,7.34,1,CHEMBL4330205,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330054,1,Scientific Literature,J Med Chem,2019,None,,,,0.0092
CHEMBL1614725,TAK-285,1,547.97,2,5.92,34e,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3889841,,None,488.55,1,6.48,16(a),CN(c1cccc(NC(=O)c2ccccc2)c1)c1ccc2c(/C=C/c3ccc4c(c3)OCO4)n[nH]c2c1,Ki,'=',0.08,nM,10.1,,,UO_0000065,20.67,0.37,3.62,12.7,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.08
CHEMBL3954085,,None,457.49,1,5.59,42(b),O=C(Nc1cccc(C(=O)c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c1)c1ccccc1,Ki,'=',0.35,nM,9.46,,,UO_0000065,20.67,0.37,3.87,9.13,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.35
CHEMBL3891135,,None,448.49,0,4.64,41(g),Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)n[nH]1,Ki,'=',0.1,nM,10,,,UO_0000065,22.3,0.4,5.36,8.59,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.1
CHEMBL3972427,,None,454.48,1,5.57,33(f),O=C(NCC(F)(F)F)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,Ki,'=',8,nM,8.1,,,UO_0000065,17.82,0.35,2.53,11.46,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,8
CHEMBL3949546,,None,450.5,1,5.21,31(b),Cc1cc(C(=O)Nc2cccc(Oc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)nn1C,Ki,'<',0.1,nM,,,,UO_0000065,,,,,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.1
CHEMBL3904168,,None,488.55,1,5.3,41(t),C=CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1,Ki,'=',0.06,nM,10.22,,,UO_0000065,20.92,0.38,4.92,9.68,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.06
CHEMBL3981871,,None,433.47,0,4.73,45(b),O=C(Nc1cccc(C(=O)c2ccc3c(/C=N/n4cccc4)n[nH]c3c2)c1)c1ccccc1,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,99
CHEMBL3942640,,None,478.94,1,6.27,19(o),O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)c1ccnc(Cl)c1,Inhibition,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,89
CHEMBL3903680,,None,429.55,0,4.23,35(gg),CNCCNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,Inhibition,'=',23,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,23
CHEMBL3986951,,None,426.55,1,5.56,35(c),O=C(NC1CCC1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,Inhibition,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,76
CHEMBL3911428,,None,474.52,1,5.62,41(bb),COc1cccc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)c1,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,99
CHEMBL3914097,,None,455.57,1,5.99,35(y),O=C(Nc1nccs1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,99
CHEMBL1914676,,None,353.43,0,1.81,13,Cc1[nH]c(/C=C2\C(=O)Nc3ccncc32)c(C)c1C(=O)NCCN(C)C,IC50,'=',60,nM,7.22,,,UO_0000065,20.43,0.38,5.41,8.01,0,CHEMBL1920170,Inhibition of human VEGFR2 preincubated for 10 mins before ATP addition measured after 45 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914337,1,Scientific Literature,Eur J Med Chem,2011,None,,,,0.06
CHEMBL515982,CALICOFEROL C,None,412.66,1,7.07,19,C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@]12C)C(C)C,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL1926234,Inhibition of recombinant human VEGF-R2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL383616,,None,450.85,1,7.26,62,FC(F)(F)c1cc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)ccc1Cl,IC50,'=',120,nM,6.92,,,UO_0000065,15.35,0.3,-0.34,13.65,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.12
CHEMBL384558,,None,402.81,0,4.75,2h,COc1cc2c(cc1OC)Oc1ncnc(Nc3ccc(F)cc3Cl)c1NC2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL214868,,None,402.81,0,4.75,2f,COc1cc2c(cc1OC)Oc1ncnc(Nc3cccc(Cl)c3F)c1NC2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',11.7,nM,7.93,,,UO_0000065,17,0.31,3.58,11.42,0,CHEMBL4328464,Inhibition of human KDR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4325871,1,Scientific Literature,Eur J Med Chem,2019,None,,,,1.17
CHEMBL3098312,,None,422.89,0,3.29,8b,COc1cc2nc(Cl)nc(Nc3ccc(S(=O)(=O)N(C)C)cc3)c2cc1OC,IC50,'=',43300,nM,4.36,,,UO_0000065,10.32,0.21,1.07,4.66,0,CHEMBL3101601,Inhibition of VEGFR2 (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098085,1,Scientific Literature,Eur J Med Chem,2014,None,,,,43.3
CHEMBL3098318,,None,378.8,0,2.4,8h,NS(=O)(=O)c1ccc(Nc2nc(Cl)nc3cc4c(cc23)OCO4)cc1,IC50,'=',26900,nM,4.57,,,UO_0000065,12.07,0.25,2.17,3.93,0,CHEMBL3101601,Inhibition of VEGFR2 (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098085,1,Scientific Literature,Eur J Med Chem,2014,None,,,,26.9
CHEMBL525527,,None,477.96,0,4.3,7,COc1cc2nc(Cl)nc(Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)c2cc1OC,IC50,'=',7790,nM,5.11,,,UO_0000065,10.69,0.23,0.81,4.43,0,CHEMBL3101601,Inhibition of VEGFR2 (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098085,1,Scientific Literature,Eur J Med Chem,2014,None,,,,7.79
CHEMBL3098326,,None,372.81,0,4,8p,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL360401,,None,351.41,0,3.09,15,COc1cccc(Nc2cncc(-c3cncc(NCCCO)c3)n2)c1,IC50,'=',741.31,nM,6.13,,,UO_0000065,17.44,0.32,3.04,6.65,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.13
CHEMBL368252,,None,415.45,1,5.69,6c,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)c2cc1OC,IC50,'=',0.2,nM,9.7,,,UO_0000065,23.35,0.43,4.01,11.87,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,0.2
CHEMBL178455,,None,469.42,1,6.11,6ab,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC,IC50,'=',0.9,nM,9.05,,,UO_0000065,19.27,0.36,2.94,11.07,0,CHEMBL829563,Inhibition of vascular endothelial growth factor receptor 2 in cell-intact assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,0.9
CHEMBL371329,,None,389.48,1,5.2,13,Cc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1,IC50,'=',6,nM,8.22,,,UO_0000065,21.11,0.4,3.02,8.85,1,CHEMBL1249718,Inhibition of Kdr kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240311,1,Scientific Literature,Nat Chem Biol,2006,None,,,,0.006
CHEMBL1082940,,None,954,3,-2.53,5,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O,FC,'=',3,,,,,,,,,,0,CHEMBL1118048,Inhibition of VEGFR2 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155516,1,Scientific Literature,J Med Chem,2010,CHEMBL3307501,,,,3
CHEMBL4083567,,None,353.81,0,3.97,6p,Cc1cc2[nH]c3nc(N)nc(NCc4cccc(Cl)c4)c3c2cc1O,Ki,,,,,,Not Determined,,,,,,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3109276,,None,512.59,2,6.01,33SYM,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cc(-c4cccnc4)cc(-c4cccnc4)c3)o2)c1,Inhibition,,,%,,,Dose-dependent effect,UO_0000187,,,,,0,CHEMBL3111580,Inhibition of GST-tagged recombinant human VEGFR2 expressed in Sf9 cells by radiometric assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108731,1,Scientific Literature,Eur J Med Chem,2014,CHEMBL3308860,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',90,nM,7.05,,,UO_0000065,15.16,0.3,1.5,7.63,1,CHEMBL4033254,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028913,1,Scientific Literature,J Med Chem,2018,None,,,,90
CHEMBL456463,,None,460.5,1,6.41,8,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1,IC50,'=',30,nM,7.52,,,UO_0000065,16.34,0.29,1.11,7.68,1,CHEMBL1120723,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,0.03
CHEMBL1084302,,None,538.7,2,5.19,3g,CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)N(C)C6CCCCC6)cc5)cnc34)c2)CC1,IC50,'=',6000,nM,5.22,,,UO_0000065,9.69,0.18,0.03,5.49,0,CHEMBL1120230,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1158604,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,6000
CHEMBL457099,,None,462.51,1,6.17,7,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,4
CHEMBL1085511,,None,499.62,0,4.6,4c,CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1,IC50,'=',4233,nM,5.37,,,UO_0000065,10.75,0.2,0.77,5.32,0,CHEMBL1120230,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1158604,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,4233
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,SID103904444,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',90,nM,7.05,,,UO_0000065,15.16,0.3,1.5,7.63,1,CHEMBL3757594,Inhibition of VGFR-2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.09
CHEMBL182283,GW819230X,None,293.33,0,3.55,GW819230X,Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1,Inhibition,'=',13.43,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,13.43
CHEMBL182283,GW819230X,None,293.33,0,3.55,GW819230X,Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1,Inhibition,'=',6.12,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.12
CHEMBL1909361,GW830365A,None,576.12,1,2.99,GW830365A,CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl,Inhibition,'=',7.07,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.07
CHEMBL218088,GW435821X,None,268.32,0,2.67,GW435821X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1,Inhibition,'=',6.58,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.58
CHEMBL1909354,GW459057A,None,390.88,0,4.11,GW459057A,Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',3.45,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,3.45
CHEMBL2409784,,None,462.54,0,4.5,29a,Cc1nc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2C)c(C)s1,IC50,'=',1.5,nM,8.82,,,UO_0000065,19.08,0.37,4.32,7.98,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.5
CHEMBL4125807,,None,413.53,0,3.95,16,Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1,Inhibition,'=',51,%,,,,UO_0000187,,,,,0,CHEMBL4120547,Inhibition of KDR (unknown origin) at 0.19 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118098,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,51
CHEMBL2409779,,None,430.47,0,3.77,17a,Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c2)n(C)n1,IC50,'=',1.1,nM,8.96,,,UO_0000065,20.81,0.38,5.19,8.74,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.1
CHEMBL4175857,,None,586.37,2,5.9,CPMA2,Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Br)cc5OC(F)(F)F)CC4)cc3)cc2n1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4135859,Inhibition of VEGFR-2 (unknown origin) after 60 mins by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130538,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL4163581,,None,390.83,0,4.89,QZAU5,O=C(Nc1cccc(Cl)c1)Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1,IC50,'=',34.68,nM,7.46,,,UO_0000065,19.09,0.36,2.57,8.59,0,CHEMBL4135859,Inhibition of VEGFR-2 (unknown origin) after 60 mins by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130538,1,Scientific Literature,Eur J Med Chem,2017,None,,,,34.68
CHEMBL391103,,None,425.41,1,5.43,40,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cc2ccccc2n1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL233825,,None,394.78,0,4.45,45,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nccn1CCc1ccncc1,IC50,'=',1310,nM,5.88,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.31
CHEMBL389343,,None,316.36,0,3.29,2f,N#Cc1cnc(Nc2ccc(CCO)cc2)nc1-c1ccccc1,IC50,'=',200,nM,6.7,,,UO_0000065,21.18,0.38,3.41,8.19,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.2
CHEMBL233455,,None,369.47,0,4.4,2c,N#Cc1cnc(Nc2ccc(CCN3CCCC3)cc2)nc1-c1ccccc1,IC50,'=',110,nM,6.96,,,UO_0000065,18.83,0.34,2.56,10.73,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.11
CHEMBL401041,,None,363.47,0,3.98,47,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)(C)C)cc1,IC50,'=',180,nM,6.75,,,UO_0000065,18.56,0.34,2.76,9.39,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.18
CHEMBL429455,,None,392.34,0,4.14,63,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(OC(F)(F)F)cc1,IC50,'=',910,nM,6.04,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.91
CHEMBL238521,,None,341.8,0,3.33,17,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1,IC50,'=',1650,nM,5.78,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.65
CHEMBL438142,,None,342.79,0,3.9,65,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL393409,,None,397.48,0,4.27,23,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cc2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Nexavar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Nexavar,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL245746,,None,454.53,1,5.45,10,CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)ccc2C)n1,IC50,'=',117,nM,6.93,,,UO_0000065,15.25,0.28,1.48,6.8,0,CHEMBL887077,Inhibition of KDR after 90 mins by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139197,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,117
CHEMBL248758,,None,344.2,0,4.34,2h,O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1,Inhibition,'<=',40,%,,,,UO_0000187,,,,,0,CHEMBL886302,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139946,1,Scientific Literature,Eur J Med Chem,2007,None,,,,40
CHEMBL4089245,,None,456.45,0,4.53,1,C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4018333,Inhibition of human VEGFR2 using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4017480,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,10
CHEMBL460990,,None,426.52,0,4.58,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL392987,,None,391.35,0,3.58,15,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(OC(F)(F)F)cc1,IC50,'=',110,nM,6.96,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.11
CHEMBL241073,,None,399.45,0,4.47,50,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Oc2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL4161551,,None,519.56,1,4.19,9e,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cccn1)CC2)c1ccccc1,IC50,'=',300,nM,6.52,,,UO_0000065,12.55,0.23,2.33,6.18,0,CHEMBL4136262,Inhibition of recombinant VEGFR2 (unknown origin) by off-chip mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130560,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,300
CHEMBL2348989,,None,525.49,2,5.16,4,O=C(Nc1cccc(Oc2ccc3nc(NC(=O)C4CCOCC4)cn3n2)c1)c1cccc(C(F)(F)F)c1,IC50,'=',10,nM,8,,,UO_0000065,15.22,0.29,2.84,7.49,0,CHEMBL2353610,Inhibition of VEGFR2 (unknown origin) using biotinylated poly(Glu:Tyr) as substrate after 5 mins by AlphaScreen assay in presence of 1000 uM of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2346507,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,10
CHEMBL185569,,None,357.41,0,4.55,SID103904337,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1,Ki,'=',19.95,nM,7.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.7
CHEMBL1971029,,None,590.5,1,3.31,SID103904602,CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br,Ki,'=',158.49,nM,6.8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.8
CHEMBL1977652,,None,302.36,0,2.66,SID103905014,CCS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2,Ki,'=',3162.28,nM,5.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.5
CHEMBL1230609,FORETINIB,2,632.66,2,5.77,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3656089,,None,531.54,2,5.56,BDBM110600,Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCCC(=O)O)c[nH]4)c3)cc2F)c1,IC50,'=',16,nM,7.8,,231485,UO_0000065,14.67,0.27,2.24,5.36,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3696093,,None,353.41,0,3.14,BDBM144608,NC(=O)c1c(-c2cccc(NC(=O)Nc3ccccc3)c2)nsc1N,IC50,'>',10000,nM,,,280968,UO_0000065,,,,,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1996576,,None,443.47,0,4.27,SID103905480,O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL379975,,None,362.77,0,4.23,SID103905557,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL1988153,,None,377.35,1,5.47,SID103905370,Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1,Ki,'=',7943.28,nM,5.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1969664,AZD-1080,1,334.38,0,2.64,SID103905163,N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL52387,(RS)-ROSCOVITINE,None,354.46,0,3.2,SID103905125,CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL41783,,None,360.37,0,2.58,SID103905385,CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1975787,,None,290.29,0,3.34,SID103905044,NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1,Ki,'=',794.33,nM,6.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.1
CHEMBL1090356,,None,587.71,2,6.28,SID103904417,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,Ki,'=',50.12,nM,7.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.3
CHEMBL1993722,,None,405.39,0,4.29,SID103904859,Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6
CHEMBL1984236,,None,363.28,0,4.71,SID103905379,CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1967720,,None,529.6,2,5.41,SID103904341,CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,Ki,'=',5.012,nM,8.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.3
CHEMBL1969755,,None,350.39,0,3.22,SID103904580,O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1991188,,None,380.42,0,4.4,SID103905120,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1997872,,None,307.35,0,2.7,SID103905009,O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1,Ki,'=',794.33,nM,6.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.1
CHEMBL3646211,,None,530.61,1,4.41,BDBM121390,COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](O)CO)c5)cnc(N)c34)cc2)cc1,IC50,'=',1.83,nM,8.74,,249752,UO_0000065,16.47,0.31,4.33,5.92,0,CHEMBL3705427,Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL482488,,None,446.54,0,3.56,CER-0263252,O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1,Inhibition,'=',35,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,35
CHEMBL485524,,None,419.49,0,2.01,CER-0262864,Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1,Inhibition,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,13
CHEMBL519146,,None,374.49,0,4.29,CER-0262531,Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,0
CHEMBL234451,,None,387.94,0,4.72,9b,Cc1nc(C)c(-c2nc(Nc3ccc(CCN(C)C)cc3)ncc2Cl)s1,IC50,'=',797,nM,6.1,,,UO_0000065,15.72,0.32,1.38,11.31,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.797
CHEMBL3261965,,None,471.56,0,3.7,7d,CN1CCN(CCOc2ccc(-n3c(-c4ccc(O)cc4)cc4ccc(O)cc4c3=O)cc2)CC1,Inhibition,'=',103.34,%,,,,UO_0000187,,,,,0,CHEMBL3268857,Inhibition of VEGFR-2 (unknown origin) at 0.1 mg/ml after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259730,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,103.34
CHEMBL2031893,,None,528.54,2,5.23,26,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,Ki,'=',7.8,nM,8.11,,,UO_0000065,15.34,0.28,2.88,8.39,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,7.8
CHEMBL508307,,None,602.07,2,5.24,9,CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1,Inhibition,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL970598,Inhibition of VEGFR2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138512,1,Scientific Literature,J Med Chem,2009,None,,,,76
CHEMBL230107,,None,560.05,2,6.33,30,COc1cc2nccc(Oc3ccc4oc(Nc5ccc(Cl)c(CN6CCN(C)CC6)c5)nc4c3)c2cc1OC,IC50,'=',101,nM,7,,,UO_0000065,,,,,0,CHEMBL895906,Inhibition of FGF-induced HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,101
CHEMBL439068,,None,376.4,0,4.3,14e,Cc1cc(NC(=O)Nc2ccc(-c3nccc4[nH]nc(N)c34)cc2)ccc1F,IC50,'=',20,nM,7.7,,,UO_0000065,20.45,0.38,3.4,7.08,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL403439,,None,430.37,1,5.01,13m,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12,IC50,'=',2,nM,8.7,,,UO_0000065,20.21,0.38,3.69,8,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,2
CHEMBL3828122,,None,536.47,2,6.13,21b,CC(Oc1ccc2[nH]nc(-c3nc4cc(N5C[C@@H](C)N[C@@H](C)C5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl,IC50,'=',9,nM,8.05,,,UO_0000065,,,,,0,CHEMBL3830047,Inhibition of recombinant human VEGFR2 using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3828439,,None,538.44,2,5.47,19e,CC(Oc1ccc2[nH]nc(-c3nc4cc(N(C)C(=O)CN(C)C)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl,IC50,'=',2.5,nM,8.6,,,UO_0000065,,,,,0,CHEMBL3830047,Inhibition of recombinant human VEGFR2 using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL477778,SAPPANONE B,None,302.28,0,1.35,11,O=C1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)c(O)c1,Inhibition,'=',54.2,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,54.2
CHEMBL521779,,None,298.34,0,3.18,3,CC(C)(C)OC(=O)n1cccc1-c1cccc2c1C(=O)NC2,Inhibition,'=',46,%,,,,UO_0000187,,,,,0,CHEMBL981690,Inhibition of VEGFR2 at 100 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144154,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,46
CHEMBL482621,,None,248.28,0,3.08,12i,O=C1NCc2cccc(-c3cc4ccccc4[nH]3)c21,IC50,'=',144,nM,6.84,,,UO_0000065,27.56,0.49,3.76,15.24,0,CHEMBL981687,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144154,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.144
CHEMBL493671,,None,415.42,0,4.83,16,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(O[C@@H](C)C(F)(F)F)nncc2c1,IC50,'=',2680,nM,5.57,,,UO_0000065,13.41,0.25,0.74,8.69,0,CHEMBL1024854,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140163,1,Scientific Literature,J Med Chem,2008,None,,,,2680
CHEMBL514986,,None,378.38,0,4.42,4,O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,10
CHEMBL509737,,None,389.28,0,4.17,16,O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,10
CHEMBL4792399,,None,1066.43,None,None,PROTAC-3,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCCCCCC(=O)n2nc(N)c3c(-c4cccc(NC(=O)Nc5cccc(C(C)C)c5)c4)cccc32)C(C)(C)C)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4773366,Inhibition of recombinant human N-terminal GST-tagged VEGFR2 (789 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL243410,,None,515.52,1,2.74,16,CCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,Ratio,'=',2.8,,,,,,,,,,0,CHEMBL892962,Ratio of IC50 for VEGFR2 in presence of 1 mM ATP to IC50 for VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,2.8
CHEMBL4793408,,None,574.76,1,4.34,6m,CN1CCN(CCCN2CCc3c(sc4ncnc(Nc5ccc(N(C)C)c(NC(=O)c6ccco6)c5)c34)C2)CC1,Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,88
CHEMBL4797743,,None,519.68,1,4.66,6o,CN(C)CCCN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5ccco5)c4)c23)C1,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,80
CHEMBL4776586,,None,539.62,1,4.94,7c,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cccnc2)C4)cc1NC(=O)c1ccco1,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,93
CHEMBL4798071,,None,555.69,2,5.41,7h,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cccnc2)C4)cc1NC(=O)c1cccs1,Activity,'=',69,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,69
CHEMBL4782332,,None,555.69,2,5.41,7i,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccncc2)C4)cc1NC(=O)c1cccs1,Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,82
CHEMBL4783676,,None,580.68,2,6.02,11,CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccncc5)n[nH]c4c3)cc2C(F)(F)F)CC1,GI50,'=',2,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.002
CHEMBL4780926,,None,643.74,2,7.69,18,CN1CCN(Cc2ccc(NC(=O)Nc3cccc(Sc4ccc5c(/C=C/c6ccccn6)n[nH]c5c4)c3)cc2C(F)(F)F)CC1,GI50,'=',15,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.015
CHEMBL403823,,None,483.62,1,5.34,38,C/C(=N\OC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',31,nM,7.51,,,UO_0000065,15.53,0.28,2.17,10.22,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,31
CHEMBL459044,,None,538.65,2,5.69,1a,CCOc1ccccc1Oc1nc(Nc2ccc(N3CCNCC3)cc2)ncc1C(=O)Nc1c(C)cccc1C,Ki,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1018103,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152191,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,25
CHEMBL452287,,None,437.3,0,4.69,6,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(Br)cnn4c3N)cc2)c1,IC50,'=',72,nM,7.14,,,UO_0000065,16.33,0.35,2.45,7.34,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,72
CHEMBL452783,,None,398.47,0,4.81,31,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(C5CC5)cnn4c3N)cc2)c1,IC50,'=',33,nM,7.48,,,UO_0000065,18.78,0.34,2.67,7.69,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,33
CHEMBL389333,,None,585.56,2,5.34,52,CN1CCN(CC(=O)Nc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1,IC50,'=',1.5,nM,8.82,,,UO_0000065,15.07,0.29,3.48,7.7,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,1.5
CHEMBL397756,,None,484.43,1,5.73,28,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Cc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,
CHEMBL4095072,,None,429.53,0,3.57,1,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,Inhibition,'=',35.7,%,,,,UO_0000187,,,,,1,CHEMBL4120320,Inhibition of KDR (unknown origin) at 0.45 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118098,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,35.7
CHEMBL452288,,None,440.53,1,5.66,29,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cccs5)cnn4c3N)cc2)c1,IC50,'=',49,nM,7.31,,,UO_0000065,16.59,0.31,1.65,7.51,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,49
CHEMBL470076,,None,437.3,0,4.69,6b,Cc1ccc(NC(=O)Nc2ccc(-c3cnc4c(Br)cnn4c3N)cc2)cc1,IC50,'=',810,nM,6.09,,,UO_0000065,13.93,0.3,1.4,6.26,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,810
CHEMBL469455,,None,509.47,2,5.79,34d,Cn1cc(-c2ccn3c(N)c(-c4ccc(NC(=O)Nc5ccc(F)c(C(F)(F)F)c5)cc4)cnc23)cn1,IC50,'=',6,nM,8.22,,,UO_0000065,16.14,0.3,2.43,8.04,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,6
CHEMBL171736,,None,416.53,0,3.8,18c,COCCN(C)CCCn1ccc(-c2ccn3c(-c4ccccc4)cnc3c2)cc1=O,IC50,'=',,nM,,,,UO_0000065,,,,,0,CHEMBL816966,Inhibition of VEGF-stimulated phosphorylation of VEGF-receptor 2 (KDR) expressed in human embryonic kidney cells (not determined),B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,
CHEMBL150085,,None,426.52,0,4.7,35,COC(C)c1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL818939,Inhibition of Vascular endothelial growth factor receptor 2 autophosphorylation by VEGF in human umbilical vein endothelial cells (HUVECs) at 100 nM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,CHEMBL3307501,,,,100
CHEMBL194872,,None,511.41,1,4.32,46,CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(CC(F)(F)F)o4)c(C(C)C)c23)c(F)cc1F,IC50,'=',29,nM,7.54,,,UO_0000065,14.74,0.29,3.22,6.31,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,29
CHEMBL193136,,None,442.43,0,3.26,52,CONC(=O)c1cc(Nc2ncnn3cc(-c4n[nH]c(C)n4)c(C(C)C)c23)c(F)cc1F,IC50,'=',71,nM,7.15,,,UO_0000065,16.16,0.31,3.89,5.85,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,71
CHEMBL191705,GW621431X,None,400.46,0,4.09,36,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1,IC50,'=',91,nM,7.04,,,UO_0000065,17.58,0.34,2.95,7.15,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.091
CHEMBL260015,,None,441.54,0,3.82,15d,c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL935762,Inhibition of KDR at 20 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144852,1,Scientific Literature,J Med Chem,2008,None,,,,50
CHEMBL215726,,None,584.72,2,7.59,32,Cc1cccc(C)c1OC(=O)N(c1cccc(-c2ccccc2)c1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1,IC50,'=',1900,nM,5.72,,,UO_0000065,9.78,0.18,-1.87,7.75,0,CHEMBL870980,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145338,1,Scientific Literature,J Med Chem,2006,None,,,,1.9
CHEMBL212721,,None,557.65,2,6.13,36,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCN(C)C)cc3)n2)c(OC)c1,IC50,'=',220,nM,6.66,,,UO_0000065,11.94,0.22,0.53,6.77,0,CHEMBL870980,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145338,1,Scientific Literature,J Med Chem,2006,None,,,,0.22
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,SID144206064,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,IC50,'=',62,nM,7.21,,,UO_0000065,15.16,0.33,2.78,11.49,0,CHEMBL3636774,Inhibition VEGFR2 (unknown origin) for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632579,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,62
CHEMBL184750,,None,254.29,0,2.8,15,Cc1cc2c(Nc3ccc(C)c(O)c3)ncnn2c1,IC50,'=',400,nM,6.4,,,UO_0000065,25.16,0.46,3.6,10.24,0,CHEMBL827963,In vitro inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138664,1,Scientific Literature,J Med Chem,2004,None,,,,0.4
CHEMBL520515,,None,253.26,0,1.29,3,Nc1ncnc2c1ncn2CC(=O)c1ccccc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL949887,Inhibition of VEGFR2 up to 100 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137681,1,Scientific Literature,Eur J Med Chem,2009,None,,,,
CHEMBL461139,,None,413.48,0,3.32,16,O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12,IC50,'=',100,nM,7,,,UO_0000065,16.93,0.31,3.68,8.06,0,CHEMBL955794,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152141,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.1
CHEMBL185637,,None,262.68,0,3.27,9,Fc1ccc(Nc2ncnn3cccc23)cc1Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL827963,In vitro inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138664,1,Scientific Literature,J Med Chem,2004,None,,,,10
CHEMBL187396,,None,536.68,1,4.76,19,COc1cc(OC)cc(-c2cc3cnc(NCCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1,IC50,'=',6,nM,8.22,,,UO_0000065,15.32,0.29,3.46,7.48,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.006
CHEMBL365937,,None,356.82,0,3.12,8,OCCCNc1cncc(-c2ncnc(Nc3cccc(Cl)c3)n2)c1,IC50,'=',2010,nM,5.7,,,UO_0000065,15.97,0.31,2.58,5.94,0,CHEMBL828555,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145155,1,Scientific Literature,J Med Chem,2005,None,,,,2.01
CHEMBL190805,,None,371.83,0,2.71,33,Nc1nc(Nc2cccc(Cl)c2)nc(-c2ccnc(NCCCO)c2)n1,IC50,'=',1067,nM,5.97,,,UO_0000065,16.06,0.31,3.26,4.9,0,CHEMBL828555,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145155,1,Scientific Literature,J Med Chem,2005,None,,,,1.067
CHEMBL3897723,,None,414.9,1,5.82,10f,COc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccc(Cl)cc2)cc1,IC50,'=',0.41,nM,9.39,,,UO_0000065,22.63,0.43,3.57,15.8,0,CHEMBL3870505,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983586,,None,382.44,1,5.61,10e,Cc1ccc(C(/C=C/c2ccc(F)cc2)=N\Nc2nncc3ccccc23)cc1,IC50,'=',0.7,nM,9.15,,,UO_0000065,23.94,0.43,3.54,18.25,0,CHEMBL3870505,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL265284,,None,523.57,2,5.7,38,CCCn1c2ccc(NC(=O)Oc3ccc(F)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL856506,Activity at VEGFR2 by autophosphorylation assay relative to control,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,76
CHEMBL219253,,None,539.04,2,6.24,31,CCCn1c2ccc(NC(=O)Nc3ccccc3Cl)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL856506,Activity at VEGFR2 by autophosphorylation assay relative to control,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,76
CHEMBL219293,,None,518.62,2,5.62,24,CCCn1c2ccc(NC(=O)N(C)c3ccccc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL856506,Activity at VEGFR2 by autophosphorylation assay relative to control,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,76
CHEMBL2178368,,None,400.49,0,3.59,BDBM173451,CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)[nH]c4n3)cc2)CC1,IC50,'>',1000,nM,,,318793,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL467132,,None,1236.62,None,None,GU40C,CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)Cc1ccc2c(c1)OCO2)C(C)c1ccccc1)C(=O)CNCCCCN,Kd,'=',1000,nM,6,,,UO_0000065,4.85,None,None,None,0,CHEMBL956461,Binding affinity to human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,1
CHEMBL218557,,None,535.6,2,5.57,37,CCCn1c2ccc(NC(=O)Oc3ccc(OC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',12,nM,7.92,,,UO_0000065,14.79,0.27,2.35,7.97,0,CHEMBL814076,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,12
CHEMBL218252,,None,536.61,2,6.04,21,CCCn1c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',29,nM,7.54,,,UO_0000065,14.05,0.26,1.5,8.11,0,CHEMBL814076,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,29
CHEMBL3348846,FEXAGRATINIB,2,463.58,0,3.65,5,COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1,IC50,'=',27,nM,7.57,,,UO_0000065,,,,,0,CHEMBL3830047,Inhibition of recombinant human VEGFR2 using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928692,,None,367.41,0,1.68,12,COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3134912,Inhibition of human KDR cytoplasmic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3132769,1,Scientific Literature,Medchemcomm,2014,None,,,,0
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',320,nM,6.5,,,UO_0000065,13.97,0.28,0.94,7.03,0,CHEMBL4272805,Inhibition of human VEGFR-2 incubated for 2.5 hrs by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4270553,1,Scientific Literature,Eur J Med Chem,2018,None,,,,0.32
CHEMBL385956,,None,449.44,1,5.86,2,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1,IC50,'=',4.2,nM,8.38,,,UO_0000065,18.64,0.35,2.52,10.5,0,CHEMBL1047420,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155237,1,Scientific Literature,J Med Chem,2009,None,,,,4.2
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,Vandetanib,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,IC50,'=',94,nM,7.03,,,UO_0000065,14.78,0.32,2.6,11.2,0,CHEMBL5386908,Inhibition of recombinant VEGFR2 (unknown origin) by kinase glo detection reagent based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5385860,1,Scientific Literature,Eur J Med Chem,2023,None,,INHIBITOR,,94
CHEMBL521851,PICTILISIB,2,513.65,1,2.15,GDC-0941,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL5240749,Inhibition of KDR (unknown origin) at 1 uM by kinase-glo luminescent assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5236659,1,Scientific Literature,Bioorg Med Chem,2023,None,DOSE = 1.0 microM,,,
CHEMBL3623375,,None,509.64,1,4.67,19,CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12,IC50,'=',2458,nM,5.61,,,UO_0000065,11.01,0.21,0.94,4.8,0,CHEMBL3625819,Inhibition of human recombinant KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3621115,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,2.458
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,10
CHEMBL260861,,None,502.58,1,3.48,6l,COc1cc(Nc2nn3c(N[C@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL921779,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143964,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,10
CHEMBL430090,,None,442.4,1,5.75,50,COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12,IC50,'=',11,nM,7.96,,,UO_0000065,17.99,0.34,2.21,7.77,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,11
CHEMBL3612325,,None,445.49,1,7.11,5d,O=C(Nc1ccc(Sc2ccnc3ccsc23)cc1)Nc1cccc(C(F)(F)F)c1,IC50,'=',988,nM,6,,,UO_0000065,13.48,0.27,-1.1,11.12,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,988
CHEMBL270556,,None,375.38,0,3.69,25,COc1cc2ncnc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC,IC50,'=',1.3,nM,8.89,,,UO_0000065,23.67,0.43,5.2,9.2,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,1.3
CHEMBL255404,,None,412.49,0,4.32,6f,CC(=O)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',75,nM,7.12,,,UO_0000065,17.27,0.31,2.8,10.34,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,75
CHEMBL271301,,None,384.44,0,3.28,6b,CC(=O)c1ccc2c(c1)c1c3c(c4c(c1n2C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',10,nM,8,,,UO_0000065,20.81,0.38,4.72,11.61,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL271201,,None,459.55,0,3.49,14,CC(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2)c1,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,5000
CHEMBL260963,,None,532.61,1,4.09,40,COc1cccc(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)c1,IC50,'=',8300,nM,5.08,,,UO_0000065,9.54,0.17,0.99,5.47,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,8.3
CHEMBL410295,,None,530.64,1,4.69,25,Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12,IC50,'=',5100,nM,5.29,,,UO_0000065,9.97,0.18,0.6,6.33,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,5.1
CHEMBL410130,,None,358.4,1,5.03,27,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)c1,IC50,'=',5,nM,8.3,,,UO_0000065,23.16,0.42,3.27,8.91,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,5
CHEMBL260093,,None,373.42,0,3.64,1f,Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3ccccc3)cc1)CCN2,IC50,'=',951,nM,6.02,,,UO_0000065,16.13,0.29,2.38,5.13,0,CHEMBL928167,Inhibition of KDR in presence of 1 mM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.951
CHEMBL1241945,,None,287.3,0,2.5,PP59,CC(C)n1nc(-c2ccc(O)c(F)c2)c2c(N)ncnc21,IC50,'=',1530,nM,5.82,,,UO_0000065,20.24,0.38,3.32,6.47,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,1.53
CHEMBL4533479,A-1806262,None,558.68,2,5.81,EUB0000339,CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,% Control,'=',72,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507261,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,72
CHEMBL1241950,,None,334.39,0,2.49,PP142,CC(C)n1nc(-c2ccc3nc(NN)ccc3c2)c2c(N)ncnc21,IC50,'=',50000,nM,4.3,,,UO_0000065,12.86,0.23,1.81,3.57,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,50
CHEMBL1242385,,None,332.41,0,3.68,PP136,Cn1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21,IC50,'=',172,nM,6.76,,,UO_0000065,20.35,0.37,3.08,9.07,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.172
CHEMBL1241677,,None,330.78,0,1.97,PP409,Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCNC1,IC50,'=',174,nM,6.76,,,UO_0000065,20.43,0.4,4.79,6.63,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.174
CHEMBL1242473,,None,315.38,0,3.64,PP165,Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CC1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,
CHEMBL1242288,,None,326.36,0,1.32,PP407,COc1ccc(-c2nn([C@@H]3CCNC3)c3ncnc(N)c23)cc1O,IC50,'=',872,nM,6.06,,,UO_0000065,18.57,0.34,4.74,5.45,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.872
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,IC50,'=',0.033,nM,10.48,,,UO_0000065,23.53,0.45,4.92,12.93,0,CHEMBL1821204,Inhibition of human N-terminal His-tagged non-phosphorylated VEGFR2 preincubated for 120 mins in presence of ATP by AlphaScreen analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,0.033
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,T1/2,'=',2.167,hr,,,,UO_0000032,,,,,0,CHEMBL1821214,Inhibition of human N-terminal His-tagged non-phosphorylated VEGFR2 assessed as dissociation half life after 60 mins by ligand displacement based enzyme-inhibitor dilution assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,130
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,T1/2,'<',0.08333,hr,,,,UO_0000032,,,,,0,CHEMBL1821215,Inhibition of human N-terminal His-tagged phosphorylated VEGFR2 assessed as dissociation half life after 60 mins by activity based 100 fold dilution assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,5
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,Ki,'=',23,nM,7.64,,,UO_0000065,17.15,0.33,2.08,9.42,0,CHEMBL1821205,Inhibition of human N-terminal His-tagged phosphorylated VEGFR2 in presence of ATP measured without preincubation by AlphaScreen analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,23
CHEMBL1241679,,None,278.32,0,2.53,PP39,CC(C)n1nc(-c2cccc(C#N)c2)c2c(N)ncnc21,IC50,'=',43000,nM,4.37,,,UO_0000065,15.69,0.28,1.84,4.67,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,43
CHEMBL483781,,None,476.58,0,2.87,63,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCC(NC(=O)CN(C)C)CC1)c1ccccc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,10000
CHEMBL3753256,,None,490.35,1,6.51,3e,O=C(Nc1ccc(Nc2ncnc3c2cnn3-c2ccc(Cl)cc2)cc1)Nc1ccccc1Cl,Activity,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL3757171,Inhibition of human VEGFR2 at 10 uM after 20 to 40 mins by liquid scintillation counting analysis in presence of [28P]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751764,1,Scientific Literature,Medchemcomm,2015,None,,,,1
CHEMBL3752890,,None,456.89,1,5.91,4b,O=C(Nc1ccccc1)Nc1ccc(Oc2ncnc3c2cnn3-c2ccc(Cl)cc2)cc1,Activity,'=',-3,%,,,,UO_0000187,,,,,0,CHEMBL3757171,Inhibition of human VEGFR2 at 10 uM after 20 to 40 mins by liquid scintillation counting analysis in presence of [28P]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751764,1,Scientific Literature,Medchemcomm,2015,None,,,,-3
CHEMBL1241674,,None,308.35,0,2.84,PP242,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,Inhibition,'=',59,%,,,,UO_0000187,,,,,0,CHEMBL1244192,Inhibition of VEGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,59
CHEMBL3753656,,None,437.55,0,4.37,16b,Cc1ccc(NC(=O)CN2CCN(c3nnc(-c4ccccc4)c4ccccc34)CC2)cc1,IC50,'=',4270,nM,5.37,,,UO_0000065,12.27,0.22,1,8.75,0,CHEMBL3756334,Inhibition of VGFR-2 (unknown origin) using poly-GluTyr (4:1) as substrate after 5 mins by Alpha Screen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,4.27
CHEMBL443338,,None,264.28,0,2.78,12h,O=C1NCc2cccc(-c3cc4cc(O)ccc4[nH]3)c21,IC50,'=',119,nM,6.92,,,UO_0000065,26.2,0.47,4.14,10.63,0,CHEMBL981687,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144154,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.119
CHEMBL487431,,None,366.47,0,3.53,2,Cc1ccc(C(=O)NCCC2CCCC2)cc1C(=O)Nc1ccc(N)nc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL955808,Inhibition of KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150317,1,Scientific Literature,J Med Chem,2008,None,,,,25
CHEMBL449663,,None,322.36,0,2.84,12c,O=C1NCc2cccc(-c3cc4cc(OCCCO)ccc4[nH]3)c21,IC50,'=',30,nM,7.52,,,UO_0000065,23.34,0.43,4.68,10.12,0,CHEMBL981687,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144154,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.03
CHEMBL245376,,None,362.36,0,3.49,3d,CCNCc1cncc(/C=C/c2c[nH]nc2-c2nc(C(F)(F)F)c[nH]2)c1,IC50,'=',10000,nM,5,,,UO_0000065,13.8,0.26,1.51,6.08,0,CHEMBL922908,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140656,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL2023226,,None,440.53,1,5.59,19,Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccccc5)cc4)csc23)cn1,IC50,'=',3,nM,8.52,,,UO_0000065,19.35,0.36,2.93,8.71,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,3
CHEMBL2023229,,None,474.98,1,6.24,23,Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(Cl)cc5)cc4)csc23)cn1,IC50,'=',8,nM,8.1,,,UO_0000065,17.05,0.34,1.86,8.27,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,8
CHEMBL1980297,ILORASERTIB,2,488.55,1,5.18,SID103904272,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,IC50,'=',2,nM,8.7,,,UO_0000065,17.81,0.34,3.52,7.37,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,2
CHEMBL399438,,None,460.58,1,5.57,35,N#Cc1cnc2cc(-c3ccc(CN4CCOCC4)cc3)ccc2c1N[C@@H]1C[C@H]1c1ccccc1,Ki,'=',170,nM,6.77,,,UO_0000065,14.7,0.26,1.2,11.06,0,CHEMBL923926,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140464,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.17
CHEMBL248220,,None,421.5,1,5.66,23,COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCc1ccccc1,Ki,'=',2600,nM,5.58,,,UO_0000065,13.25,0.24,-0.07,8.31,0,CHEMBL923926,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140464,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,2.6
CHEMBL415049,BARASERTIB,3,587.55,1,3.62,SID103905346,CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O,Ki,'=',316.23,nM,6.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.5
CHEMBL270085,,None,516.61,1,4.39,38,Cc1ccc(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)cc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,25
CHEMBL403522,,None,560.66,1,4.7,26,COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)ccc1N1CCN(C)CC1,IC50,'=',3600,nM,5.44,,,UO_0000065,9.71,0.18,0.74,5.86,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,3.6
CHEMBL272250,,None,427.46,0,4.18,29,COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1C(N)=O,IC50,'=',0.37,nM,9.43,,,UO_0000065,22.06,0.4,5.25,9.11,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,0.37
CHEMBL272251,,None,402.45,0,4.57,27,COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)ccc34)ccc12,IC50,'=',28,nM,7.55,,,UO_0000065,18.77,0.34,2.98,10.84,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,28
CHEMBL1995832,,None,440.45,0,3.57,SID103904767,COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1992937,,None,269.26,0,2.92,SID103905536,Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.6
CHEMBL1971245,,None,428.5,0,2.39,SID103904422,CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL1999910,,None,384.84,0,4.35,SID103905022,O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Cl)c1,Ki,'=',3162.28,nM,5.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.5
CHEMBL1992371,,None,280.29,0,2.98,SID103904871,O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1996048,,None,308.39,0,2.61,SID103904983,Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1,Ki,'>',1258.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL2004025,,None,425.46,0,2.48,SID103905521,COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL1966816,,None,350.28,0,4.43,SID103904882,O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1988370,,None,453.59,1,5.31,SID103904996,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1,Ki,'=',3162.28,nM,5.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.5
CHEMBL595497,,None,324.38,0,3.57,2,CCCC(=Cc1coc2nc(=N)[nH]c(N)c12)c1ccccc1OC,IC50,'=',17800,nM,4.75,,,UO_0000065,14.64,0.27,1.18,4.71,0,CHEMBL1038900,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152608,1,Scientific Literature,Bioorg Med Chem,2009,CHEMBL3307756,,,,17.8
CHEMBL46403,STEARIC ACID,-1,284.48,1,6.33,stearic acid,CCCCCCCCCCCCCCCCCC(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL577784,BX-795,None,591.48,1,4.75,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,Inhibition,'=',79,%,,,,UO_0000187,,,,,0,CHEMBL1252463,Inhibition of KDR at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250448,1,Scientific Literature,Nat Chem Biol,2009,None,,,,79
CHEMBL1096769,,None,314.39,0,4.34,16e,Nc1ccc(Nc2ccc3c(c2)Cc2ccccc2CC3=O)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1108247,Inhibition of VGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157789,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,
CHEMBL1098157,,None,516.48,2,5.63,11,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(C)c5C(F)(F)F)cc4F)c3s2)c1,IC50,'=',700,nM,6.16,,,UO_0000065,11.92,0.23,0.52,7.09,0,CHEMBL1103916,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157925,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.7
CHEMBL3656071,,None,614.68,2,5.72,BDBM110582,COC(=O)C1CCCN1CCCNC(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)ccn2)c1,IC50,'=',32,nM,7.5,,231467,UO_0000065,12.19,0.23,1.77,5.44,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Activity,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL4347530,Inhibition of VEGFR2 in human A549 cells assessed as phosphorylated Erk1/2 level at 10 uM incubated for 24 hrs by Western blot analysis relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,A549,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4346668,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307651,,,,50
CHEMBL1084453,,None,558.69,2,7.1,4,CN(C)CC(C)(C)CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1,Inhibition,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,91
CHEMBL1084451,,None,570.7,2,7.25,1,CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1,IC50,'=',1754,nM,5.76,,,UO_0000065,10.09,0.18,-1.49,5.54,0,CHEMBL1120723,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,1.754
CHEMBL1761929,,None,354.37,0,3.57,42,COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',5800,nM,5.24,,,UO_0000065,14.78,0.28,1.67,5.54,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,5.8
CHEMBL2018760,,None,402.84,0,4.61,56,CCOC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1Cl,IC50,'=',5550,nM,5.26,,,UO_0000065,13.05,0.26,0.65,5.56,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,5.55
CHEMBL2018773,,None,463.35,1,5,72,CCN(CC)CCOc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC,IC50,'=',7450,nM,5.13,,,UO_0000065,11.07,0.24,0.13,8.62,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,7.45
CHEMBL1761930,,None,355.35,0,3.62,82,COC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',700,nM,6.16,,,UO_0000065,17.32,0.32,2.53,6.7,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.7
CHEMBL205089,,None,422.49,0,4.89,85,COc1cc2ncnc(Oc3ccc(NC(=O)NC4CCCCC4)cc3)c2cc1OC,IC50,'=',1000,nM,6,,,UO_0000065,14.2,0.26,1.11,6.34,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,1
CHEMBL3681278,,None,455.52,0,3.18,14,Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1,IC50,'=',120,nM,6.92,,,UO_0000065,15.19,0.28,3.74,5.87,0,CHEMBL3861874,Inhibition of human KDR by time-resolved fluorescence or time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3860107,1,Scientific Literature,J Med Chem,2016,None,,,,120
CHEMBL2018749,,None,396.45,0,4.74,45,CCCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',6800,nM,5.17,,,UO_0000065,13.03,0.24,0.43,5.46,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,6.8
CHEMBL2018768,,None,473.96,0,4.93,67,CCN(CC)CCOc1cc2ncnc(Nc3ccc(NC(=O)OC)c(Cl)c3)c2cc1OC,IC50,'=',5200,nM,5.28,,,UO_0000065,11.15,0.22,0.35,5.4,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,5.2
CHEMBL3891894,,None,455.52,0,3.18,13,Cc1nc2ccc(-n3ncc(C(=O)c4cc5cc(CN6CCOCC6)ccc5[nH]4)c3N)cc2[nH]1,IC50,'=',210,nM,6.68,,,UO_0000065,14.66,0.27,3.5,5.67,0,CHEMBL3861874,Inhibition of human KDR by time-resolved fluorescence or time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3860107,1,Scientific Literature,J Med Chem,2016,None,,,,210
CHEMBL535,SUNITINIB,4,398.48,0,3.33,2,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4384890,Binding affinity to recombinant human VEGFR2 assessed as free VEGFR2 level at 30 uM after 30 mins by ELISA relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,None,,,,80
CHEMBL4544826,,None,488.94,1,5.59,50,COc1cc2ncnc(-n3ncc4cc(NC(=O)Nc5ccc(C)c(Cl)c5)ccc43)c2cc1OC,Inhibition,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4342892,Inhibition of VEGFR2 in human HUVEC assessed as reduction in cell proliferation at 10 uM incubated for 72 hrs by alamarBlue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4342409,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307501,,,,80
CHEMBL4208845,,None,581.6,1,4.8,12k,COCCNC(=O)c1sc2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c2c1C,IC50,'=',83,nM,7.08,,,UO_0000065,12.17,0.24,2.28,5.38,0,CHEMBL4182024,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL483532,DESMETHYLALTENUSIN,None,276.24,0,2.18,7,Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O,IC50,'=',3.8,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL962872,Inhibition of recombinant VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157406,1,Scientific Literature,J Nat Prod,2008,None,,,,3.8
CHEMBL3808450,,None,419.45,0,3.06,13,CC(C)(C)c1cc(NC(=O)c2cnc3cc(Oc4ncnc5c4CNC5)ccn23)no1,IC50,'=',78,nM,7.11,,,UO_0000065,16.95,0.31,4.05,5.95,0,CHEMBL3812628,Inhibition of Tel fused KDR (unknown origin) expressed in BaF3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808377,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,0.078
CHEMBL3808854,,None,340.39,0,3.59,15,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(N)n[nH]3)cc2)no1,IC50,'=',1520,nM,5.82,,,UO_0000065,17.09,0.32,2.23,4.77,0,CHEMBL3812632,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse Baf3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,1.52
CHEMBL4096145,,None,377.49,0,3.42,2,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4055206,Inhibition of wild-type human partial length KDR (R787 to P1253 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052645,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,100
CHEMBL3798031,,None,557.55,2,6.28,13j,CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1,Inhibition,'=',11.5,%,,,,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,11.5
CHEMBL295973,,None,327.39,0,4.38,2c,Cc1ccc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)cc1,IC50,'=',279,nM,6.55,,,UO_0000065,20.02,0.36,2.17,11.78,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,279
CHEMBL1173655,AFATINIB,4,485.95,0,4.39,BIBW-2992,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,10000
CHEMBL520718,,None,394.52,0,4.31,19,Cc1ccc(C(=O)NCCCC2CCCCC2)cc1C(=O)Nc1ccc(N)nc1,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL946389,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1158158,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,5
CHEMBL3752265,,None,390.85,0,3.81,3a,Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL3756760,Inhibition of human KDR using srctide as substrate at 10 uM after 1 hr in presence of 30 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751797,1,Scientific Literature,Medchemcomm,2015,None,,,,0.1
CHEMBL3758922,,None,400.41,0,3.58,6ab,COc1cc2ncnc(Nc3ccccc3F)c2cc1OCCCCC(=O)NO,IC50,'=',840,nM,6.08,,,UO_0000065,15.17,0.29,2.5,5.75,0,CHEMBL3762407,Inhibition of VEGFR2 (unknown origin) preincubated for 5 mins followed by addition of ATP/gastrin precursor(Tyr87) biotinylated peptide cocktail incubated for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758114,1,Scientific Literature,Eur J Med Chem,2016,None,,,,840
CHEMBL172973,,None,316.36,0,3.68,1e,COc1cccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL700241,Tested in vitro for inhibition of KDR-receptor tyrosine kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1
CHEMBL480356,,None,444.49,0,3.9,NP-506,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)NNc4ccccc4)cc32)c(C)c1CCC(=O)O,IC50,'=',70,nM,7.16,,,UO_0000065,16.1,0.3,3.25,5.8,0,CHEMBL1028054,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143293,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.07
CHEMBL3758802,,None,387.46,0,4.58,3e,C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1,Inhibition,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL3761581,Inhibition of KDR (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,,,,8
CHEMBL3752404,,None,358.32,0,4.81,6d,O=C(Nc1ccncc1)Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1,IC50,'=',93.02,nM,7.03,,,UO_0000065,19.62,0.37,2.22,10.51,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,93.02
CHEMBL1278148,,None,334.73,0,4.23,79,COc1cc2ncnc(Oc3ccc(F)c(Cl)c3)c2cc1OC,IC50,'=',9800,nM,5.01,,,UO_0000065,14.96,0.3,0.78,9.37,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,9.8
CHEMBL494072,,None,431.54,0,3.24,1,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1,IC50,'=',10.5,nM,7.98,,,UO_0000065,18.49,0.34,4.74,10.05,0,CHEMBL1024854,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140163,1,Scientific Literature,J Med Chem,2008,None,,,,10.5
CHEMBL494270,,None,431.54,0,3.24,7,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(NCCN3CCOCC3)nncc2c1,IC50,'=',5145,nM,5.29,,,UO_0000065,12.26,0.23,2.05,6.66,0,CHEMBL1024854,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140163,1,Scientific Literature,J Med Chem,2008,None,,,,5145
CHEMBL4087788,,None,570.63,1,4.88,11,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cn3)nc2n1C1CCCC1,Inhibition,'=',-3,%,,,,UO_0000187,,,,,0,CHEMBL4056530,Inhibition of human VEGFR2 at 1 uM by enzymatic radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052710,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,-3
CHEMBL4463898,,None,614.43,1,4.71,LYL-10,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)Cn2cncc2[N+](=O)[O-])CC1,IC50,'=',27.13,nM,7.57,,,UO_0000065,12.31,0.26,2.86,5.5,0,CHEMBL4362207,Inhibition of N-terminal GST-tagged human VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4359867,1,Scientific Literature,Eur J Med Chem,2019,None,,,,27.13
CHEMBL4083641,,None,495.64,0,4.16,20,Cc1nc(-n2nc(Nc3ccc(N4CCN(C5CC6CCC5C6)CC4)cc3)nc2N)c2ccccc2n1,EC50,'=',104,nM,6.98,,,UO_0000065,14.09,0.26,2.82,6.91,0,CHEMBL4057777,Inhibition of VEGF stimulated VEGFR2 phosphorylation at Y165 residues in HUVEC preincubated for 1 hr followed by VEGF addition measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052763,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.104
CHEMBL487254,,None,519.63,2,5.47,10e,N=C(Nc1ccccc1)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21,IC50,'=',4300,nM,5.37,,,UO_0000065,10.33,0.19,-0.1,6.59,0,CHEMBL962248,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151764,1,Scientific Literature,J Med Chem,2008,None,,,,4.3
CHEMBL3931177,,None,461.53,0,4.19,BDBM181020,Cc1nc(NC(=O)N2CCN(C3CCCC3)C2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1,IC50,'>',3300,nM,,,327888,UO_0000065,,,,,0,CHEMBL3887278,In Vitro Receptor Tyrosine Kinase Assay: These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic activity. A 1.3-kb cDNA corresponding to the intracellular domain of c-Met or c-Met IC (Genbank accession number NP000236-1 amino acid 1078 to 1337) is cloned into the BamHI/XhoI sites of the pBlueBacHis2A vector (Invitrogen) for the production of a histidine-tagged version of that enzyme. This construct is used to generate recombinant baculovirus using the Bac-N-BlueÂ¿ system according to the manufacturer's instructions (Invitrogen). The c-Met IC protein is expressed in Hi-5 cells (Trichoplusia Ni) upon infection with recombinant baculovirus construct. Briefly,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4239930,,None,283.36,0,2.8,10; CD03535,Nc1ccccc1SCc1nc2ccccc2c(=O)[nH]1,IC50,'=',67000,nM,4.17,,,UO_0000065,14.73,0.29,1.37,5.82,0,CHEMBL4231194,Inhibition of recombinant human VEGFR2 using peptide as substrate by fluorimetric analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229349,1,Scientific Literature,Eur J Med Chem,2018,None,,,,67
CHEMBL45388,,None,382.25,1,5.38,2j,Clc1cc(Cl)cc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)c1,IC50,'=',26,nM,7.58,,,UO_0000065,19.84,0.4,2.21,13.63,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,26
CHEMBL5171966,,None,590.6,2,5.75,3d,CC1(C)c2cc(OCCN3CCOCC3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCC(F)(F)F)ccn3)ccc21,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,,,1000
CHEMBL2220486,LUCITANIB,2,443.5,0,4.42,18; E3810,CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,IC50,'=',25,nM,7.6,,,UO_0000065,17.14,0.31,3.18,7.94,1,CHEMBL5241427,Inhibition of VEGFR2 (unknown origin) in the presence of ATP at Km concentration,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5241062,1,Scientific Literature,Eur J Med Chem,2021,None,,INHIBITOR,,25
CHEMBL5272452,,None,624.75,2,2.55,12j,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccn[nH]5)cc4)nc(N4CCOCC4)n3)s2)CC1,Inhibition,'=',1.77,%,,,,UO_0000187,,,,,0,CHEMBL5240749,Inhibition of KDR (unknown origin) at 1 uM by kinase-glo luminescent assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5236659,1,Scientific Literature,Bioorg Med Chem,2023,None,DOSE = 1.0 microM,,,1.77
CHEMBL4066684,,None,473.44,0,4.74,34,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,'=',671.8,nM,6.17,,,UO_0000065,13.04,0.24,1.43,6.06,0,CHEMBL4034168,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4174988,,None,494.04,0,4.2,15i,Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1,Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL4157323,Binding affinity to wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152344,1,Scientific Literature,Eur J Med Chem,2018,None,,,,85
CHEMBL5173244,,None,380.41,0,3.04,12,CCC(=O)NC(=O)Nc1ccc(Oc2ccnc(-c3cnn(C)c3)c2)c(C)n1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106444,Inhibition of VEGFR2 (unknown origin) measured by spectrophotometric analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104171,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL5186614,,None,436.47,0,3.05,15,Cc1nc(NC(=O)NC(=O)C2CCOCC2)ccc1Oc1ccnc(-c2cnn(C)c2)c1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106444,Inhibition of VEGFR2 (unknown origin) measured by spectrophotometric analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104171,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL4068896,,None,509.39,2,6.8,BLU9931,C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,Inhibition,'=',23,%,,,,UO_0000187,,,,,0,CHEMBL4018326,Inhibition of human VEGFR2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4017480,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,23
CHEMBL172292,,None,271.32,0,4.06,10b,c1ccc(-c2ccn3c(-c4cccnc4)cnc3c2)cc1,IC50,'=',930,nM,6.03,,,UO_0000065,22.23,0.39,1.97,19.98,0,CHEMBL818934,Inhibition of VEGF stimulated phosphorylation of KDR on tyrosine residues in human kidney cells expressing vascular endothelial growth factor receptor 2,B,BAO_0000219,cell-based format,None,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,930
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',74.75,%,,,,UO_0000187,,,,,0,CHEMBL4055532,Inhibition of VEGFR2 in human BT474 cells assessed as downregulation of phosphorylated FAK levels at 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,74.75
CHEMBL5081704,,None,258.32,0,2.47,12a,COc1ccc2[nH]c3c(c2c1)CN(C(C)=O)CCC3,IC50,'=',6000,nM,5.22,,,UO_0000065,20.21,0.38,2.75,11.52,0,CHEMBL5057510,Inhibition of VEGFR2 phosphorylation in VEGF-induced HUVEC cells pretreated measured after overnight incubation by immunoblotting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5055667,1,Scientific Literature,J Med Chem,2021,None,,INHIBITOR,,6
CHEMBL2397148,,None,438.4,0,4.8,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1908395,,None,497.04,0,3.76,JNJ-28312141,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,Kd,'=',460,nM,6.34,,,UO_0000065,13.76,0.25,2.58,6.03,0,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,460
CHEMBL426887,,None,335.41,0,3.88,17d,Nc1n[nH]c2cccc(-c3ccc(NC(=O)NC4CCCC4)cc3)c12,IC50,'=',153,nM,6.82,,,UO_0000065,20.32,0.37,2.94,7.11,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,153
CHEMBL224889,,None,448.55,1,5.38,83,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4cccn4)ccc2-3)cs1)COc1ccccc1,IC50,'=',49,nM,7.31,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,49
CHEMBL224917,,None,449.54,0,4.78,84,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4ccnn4)ccc2-3)cs1)COc1ccccc1,IC50,'=',148,nM,6.83,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,148
CHEMBL186290,,None,508.58,1,3.59,9,Cc1cc2c3c(c1)c(C1=C(c4cnc5ccccn45)C(=O)NC1=O)cn3CCN(C(=O)N1CCCCC1)C2,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL828051,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J Med Chem,2004,None,,,,20
CHEMBL478629,DORSOMORPHIN,None,399.5,0,4.32,C,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,IC50,'=',220,nM,6.66,,,UO_0000065,16.66,0.3,2.34,11.98,0,CHEMBL3748100,Inhibition of human KDR in presence of (33P)gamma ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745593,1,Scientific Literature,J Med Chem,2015,None,,,,0.22
CHEMBL5076189,,None,407.49,0,3.98,51f,CCc1cc(O)c(F)cc1-c1cc(N[C@H]2C[C@H]3CC[C@@H](C2)N3)c2nc(N)ncc2c1,IC50,'=',125.89,nM,6.9,,,UO_0000065,16.93,0.31,2.92,7.18,0,CHEMBL5047431,Inhibition of human GST/6His-tagged VEGFR2 using Biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate incubated for 90 mins in presence of ATP by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5046242,1,Scientific Literature,J Med Chem,2022,None,TIME = 1.5 hr,INHIBITOR,,6.9
CHEMBL231650,,None,363.78,0,3.9,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1236107,SGX-523,1,359.42,0,3.22,SGX-523,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,10000
CHEMBL1230609,FORETINIB,2,632.66,2,5.77,EXEL-2880/GSK-1363089,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,'=',0.9,nM,9.05,,,UO_0000065,14.3,0.27,3.28,8.13,1,CHEMBL3816041,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5207113,,None,333.82,0,3.86,3a,Cn1c2ccccc2c2ccn3c[n+](-c4ccccc4)cc3c21.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL5176548,,None,495.91,1,6.53,3n,Fc1ccc(Cn2c3ccccc3c3ccn4c[n+](-c5ccc(C(F)(F)F)cc5)cc4c32)cc1.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',90,nM,7.05,,,UO_0000065,15.16,0.3,1.5,7.63,1,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,INHIBITOR,,0.09
CHEMBL394826,,None,461.83,1,5.53,3,CNC(=O)c1cc(Oc2ccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)[nH]c3c2)ccn1,Ki,'=',9,nM,8.05,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,9
CHEMBL230223,,None,525.97,2,5.38,36,CNC(=O)c1cc(Oc2cc(F)c3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1,Ki,'=',3,nM,8.52,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,3
CHEMBL231370,,None,533.55,2,7.14,12,CN1CCC[C@@H]1COc1cc(Nc2nc3cc(Oc4ccnc5ccccc45)ccc3[nH]2)ccc1C(F)(F)F,Ki,'=',1,nM,9,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,1
CHEMBL231270,,None,540.55,2,5.35,11,CNC(=O)c1cc(Oc2ccc3[nH]c(Nc4cc(OCCN5CCCC5)cc(C(F)(F)F)c4)nc3c2)ccn1,Ki,'=',287,nM,6.54,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,287
CHEMBL231269,,None,540.55,2,5.35,9,CNC(=O)c1cc(Oc2ccc3[nH]c(Nc4ccc(C(F)(F)F)c(OC[C@H]5CCCN5C)c4)nc3c2)ccn1,Ki,'=',2,nM,8.7,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,2
CHEMBL231467,,None,478.99,0,4.33,17,CNc1nccc(Oc2ccc3[nH]c(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)n1,IC50,'=',1028,nM,5.99,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,1028
CHEMBL231109,,None,388.5,1,5.75,7e,CCc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1,IC50,'=',25,nM,7.6,,,UO_0000065,19.57,0.37,1.85,9.5,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,25
CHEMBL2448065,,None,467.37,0,4.9,15,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl,IC50,'=',15,nM,7.82,,,UO_0000065,18.16,0.36,2.92,13.15,0,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.015
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',18900,nM,4.72,,,UO_0000065,11.85,0.22,1.39,6.12,1,CHEMBL2344597,Inhibition of VEGFR2 in human U251 cells assessed as inhibition of VEGF-induced tyrosine phosphorylation incubated for 60 mins prior to VEGF-activation measured 10 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331095,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,18.9
CHEMBL2337374,,None,309.76,0,4.09,3,Nc1nc(Nc2ccccc2)c2c(n1)[nH]c1cccc(Cl)c12,IC50,'=',123800,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL2344597,Inhibition of VEGFR2 in human U251 cells assessed as inhibition of VEGF-induced tyrosine phosphorylation incubated for 60 mins prior to VEGF-activation measured 10 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331095,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,123.8
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',3.2,nM,8.49,,,UO_0000065,18.28,0.36,2.94,9.2,1,CHEMBL5114110,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113380,1,Scientific Literature,Eur J Med Chem,2022,None,,INHIBITOR,,3.2
CHEMBL3963327,,None,594.03,2,7.13,Table 6-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920254,,None,450.5,0,4.96,Table 12-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3936547,,None,472.59,0,4.95,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956995,,None,516.65,2,5.22,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940740,,None,400.41,0,2.28,Table 2-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947208,,None,504.52,1,3.59,Table 2-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956652,,None,442.49,0,3.45,Table 2-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL300138,ENZASTAURIN,3,515.62,1,4.93,LY-317615,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,10000
CHEMBL347999,,None,368.44,0,3.99,5,O=C1NCc2c1c1c(c3c2c2ccccc2n3CCCO)Cc2ccccc2-1,IC50,'=',48,nM,7.32,,,UO_0000065,19.86,0.36,3.33,13.49,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,48
CHEMBL1087218,,None,401.43,0,4.26,17,c1ccc(-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c(NCc2ccncc2)c1,IC50,'=',210,nM,6.68,,,UO_0000065,16.63,0.3,2.42,7.08,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,0.21
CHEMBL1688354,,None,400.44,0,3.99,25,c1cncc(CNc2ccccc2-c2nnc(Nc3ccc4c(c3)OCCO4)[nH]2)c1,IC50,'=',3200,nM,5.5,,,UO_0000065,13.72,0.25,1.5,5.67,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,3.2
CHEMBL1688357,,None,450.5,1,5.15,28,c1ccc(-c2nnc(Nc3ccc4c(c3)OCCO4)[nH]2)c(NCc2ccc3ncccc3c2)c1,IC50,'=',150,nM,6.82,,,UO_0000065,15.15,0.27,1.67,7.04,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,0.15
CHEMBL1688247,,None,385.35,0,3.89,2,FC(F)(F)c1cccc(-c2nnc(-c3cccnc3NCc3cn[nH]c3)[nH]2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL150405,,None,456.61,1,5.63,30,CC(C)SCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',57,nM,7.24,,,UO_0000065,15.87,0.3,1.61,13.35,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,57
CHEMBL151219,,None,354.41,0,3.6,6,O=C1NCc2c1c1c(c3c2c2ccccc2n3CCO)Cc2ccccc2-1,IC50,'=',107,nM,6.97,,,UO_0000065,19.67,0.35,3.37,12.85,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,107
CHEMBL314627,,None,593.74,1,4.56,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL281872,ZD-4190,1,459.28,0,3.95,1,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1,IC50,'=',30,nM,7.52,,,UO_0000065,16.38,0.35,3.57,8.65,1,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.03
CHEMBL308672,,None,511.99,1,4.21,26t,CCN(CC)CCNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(Cl)cc4F)c32)[nH]1,IC50,'=',40,nM,7.4,,,UO_0000065,14.45,0.28,3.19,6.43,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,0.04
CHEMBL3582441,,None,501.57,1,3.48,16,O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1,IC50,'=',1000,nM,6,,,UO_0000065,11.96,0.22,2.52,6.66,0,CHEMBL3583132,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3580662,1,Scientific Literature,ACS Med Chem Lett,2015,CHEMBL3307634,,,,1
CHEMBL1807788,,None,534.65,1,3.46,12g,Cc1nc(NCCN2CCOCC2)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1,IC50,'>',1000000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1810161,Inhibition of recombinant GST-tagged VEGFR2 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1806486,1,Scientific Literature,Bioorg Med Chem,2011,CHEMBL3308860,,,,1000
CHEMBL313821,,None,442.52,1,5.08,9h,COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c2c(c1CCC(=O)O)CCCC2,IC50,'=',60,nM,7.22,,,UO_0000065,16.32,0.3,2.14,7.9,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,0.06
CHEMBL1778403,,None,432.55,1,5.88,3,CNC(=O)c1cc(Oc2ccc3sc(Nc4cccc(C(C)(C)C)c4)nc3c2)ccn1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1781720,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1777722,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,
CHEMBL323838,,None,408.48,0,2.81,16,NC1CCN(S(=O)(=O)c2ccc3[nH]c(-c4cc5ccccc5nc4O)cc3c2)C1,IC50,'=',16,nM,7.8,,,UO_0000065,19.09,0.37,4.99,6.94,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,16
CHEMBL1088752,LOSMAPIMOD,3,383.47,0,3.86,2,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1785294,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781916,1,Scientific Literature,J Med Chem,2009,None,,,,
CHEMBL3639469,,None,442.38,0,3.9,BDBM2578,Cc1cc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)ccc1S(C)(=N)=O,IC50,'=',45,nM,7.35,,9113,UO_0000065,16.61,0.39,3.45,6.62,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3612230,,None,395.48,1,6.23,4d,O=C(Nc1ccc(F)cc1)Nc1cccc(Sc2ccnc3ccsc23)c1,IC50,'=',10,nM,8,,,UO_0000065,20.23,0.4,1.77,14.81,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,10
CHEMBL3612324,,None,402.5,1,5.96,5c,N#Cc1ccc(NC(=O)Nc2ccc(Sc3ccnc4ccsc34)cc2)cc1,IC50,'=',8360,nM,5.08,,,UO_0000065,12.62,0.25,-0.88,6.53,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,8360
CHEMBL427202,,None,370.38,0,3.52,(S)-brivanib,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)O)c(C)c34)ccc2[nH]1,IC50,'=',20,nM,7.7,,,UO_0000065,20.79,0.39,4.18,9.09,0,CHEMBL3536555,Inhibition of recombinant VEGFR-2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3525936,1,Scientific Literature,Drug Metab Dispos,2012,None,,,,20
CHEMBL46642,,None,305.39,0,3.9,5f,Cc1cc(C)cc(Nc2nccc(-n3ccnc3C3CC3)n2)c1,IC50,'=',1870,nM,5.73,,,UO_0000065,18.76,0.34,1.83,10.3,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,1870
CHEMBL1668413,,None,368.86,0,4.02,2,COc1cc(O)c2c(c1)CCCCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O,IC50,'=',93000,nM,4.03,,,UO_0000065,10.93,0.22,0.01,5.54,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,93
CHEMBL1668417,,None,411.29,0,4.26,6,COc1cc(O)c2c(c1)/C=C\CCCC(=O)C[C@H](Br)C[C@H](C)OC2=O,IC50,'=',24000,nM,4.62,,,UO_0000065,11.23,0.25,0.36,6.34,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,24
CHEMBL199657,,None,334.79,0,2.94,13f,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cccc(Cl)c3)c12,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,100
CHEMBL4778826,,None,383.83,0,4.14,4d,COc1ccc(/C=C/C(=O)c2nnn(-c3ccc(Cl)cc3)c2C)cc1OC,IC50,'=',388,nM,6.41,,,UO_0000065,16.7,0.32,2.27,9.68,0,CHEMBL4684708,Inhibition of VEGFR2 in human RPMI-8226 cells incubated for 2 hrs by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,RPMI-8226,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4680183,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 2.0 hr,INHIBITOR,,388
CHEMBL24026,,None,433.49,0,4.42,12,COc1cc2c(Nc3ccc(C#N)cc3F)ncnc2cc1OC/C=C/CN1CCCC1,IC50,'=',230,nM,6.64,,,UO_0000065,15.31,0.28,2.22,7.97,0,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.23
CHEMBL419082,,None,386.46,0,4.56,7,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1O,IC50,'=',1000,nM,6,,,UO_0000065,15.53,0.28,1.44,6.96,0,CHEMBL817617,Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132739,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1
CHEMBL1940718,,None,313.81,1,5.15,1,Cc1ccc2nc(Cl)c(/C=C/C(=O)c3ccsc3)cc2c1,IC50,'=',287.28,nM,6.54,,,UO_0000065,20.85,0.43,1.39,21.83,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,287.28
CHEMBL1940848,,None,392.7,1,5.92,10,Cc1ccc2nc(Cl)c(/C=C/C(=O)c3ccc(Br)s3)cc2c1,IC50,'=',112.52,nM,6.95,,,UO_0000065,17.69,0.43,1.03,23.19,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,112.52
CHEMBL1940849,,None,439.7,1,5.76,11,Cc1ccc2nc(Cl)c(/C=C/C(=O)c3ccc(I)s3)cc2c1,IC50,'=',154.27,nM,6.81,,,UO_0000065,15.49,0.42,1.05,22.74,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,154.27
CHEMBL1940851,,None,327.84,1,5.46,13,Cc1ccc2cc(/C=C/C(=O)c3sccc3C)c(Cl)nc2c1,IC50,'=',157.21,nM,6.8,,,UO_0000065,20.75,0.42,1.34,22.71,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,157.21
CHEMBL1940852,,None,327.84,1,5.46,14,Cc1csc(C(=O)/C=C/c2cc3ccc(C)cc3nc2Cl)c1,IC50,'=',139.36,nM,6.86,,,UO_0000065,20.91,0.43,1.4,22.88,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,139.36
CHEMBL1940860,,None,439.7,1,5.76,22,Cc1ccc2cc(/C=C/C(=O)c3ccc(I)s3)c(Cl)nc2c1,IC50,'=',148.31,nM,6.83,,,UO_0000065,15.53,0.42,1.07,22.79,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,148.31
CHEMBL4753486,,None,535.63,2,5.18,29,Cc1ccc(-n2c(SCC(=O)Nc3ccc(C(=O)NNc4ccccc4)cc3)nc3ccccc3c2=O)cc1,IC50,'=',0.648,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL4677737,Inhibition of human VEGFR2 incubated for 2.5 hrs by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673301,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 2.5 hr,INHIBITOR,,0.648
CHEMBL4794044,,None,516.65,1,3.98,18,C/C(=N\NC(N)=S)c1ccc(NC(=O)CSc2nc3ccccc3c(=O)n2-c2ccc(C)cc2)cc1,IC50,'=',0.517,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL4677737,Inhibition of human VEGFR2 incubated for 2.5 hrs by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673301,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 2.5 hr,INHIBITOR,,0.517
CHEMBL468963,GW779439X,None,454.46,0,3.7,GW779439X,CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1,Inhibition,'=',13.07,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,13.07
CHEMBL3706840,,None,551.42,1,3.91,38,COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4c(F)c(F)c(F)c(F)c4F)=CC3=O)c2cc1OC,IC50,'=',18.6,nM,7.73,,,UO_0000065,14.02,0.27,3.82,7.1,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,18.6
CHEMBL3706837,,None,485.5,0,3.06,40,COCCOc1cc2ncnc(NC3=CC(=O)C(OCC#Cc4ccccc4)=CC3=O)c2cc1OC,IC50,'=',8.1,nM,8.09,,,UO_0000065,16.67,0.31,5.03,7.43,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,8.1
CHEMBL199455,,None,438.48,0,2.48,64,COC1=CC(=O)C(Nc2ncnc3cc(OCCCN4CCCC4)c(OC)cc23)=CC1=O,IC50,'=',3,nM,8.52,,,UO_0000065,19.44,0.36,6.04,8.28,0,CHEMBL862697,Inhibitory activity against VEGF stimulated autophosphorylation of VEGFR2 expressed in KDR15 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,KDR15,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,3
CHEMBL2113199,,None,515.57,1,3.45,67,COc1cc2c(NC3=CC(=O)C(OCc4ccccn4)=CC3=O)ncnc2cc1OCCCN1CCCC1,IC50,'=',9.6,nM,8.02,,,UO_0000065,15.55,0.29,4.57,6.93,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,9.6
CHEMBL1934303,,None,417.47,0,3.49,10c,CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1,Inhibition,'=',25.6,%,,,,UO_0000187,,,,,0,CHEMBL1937674,Inhibition of KDR at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933031,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,25.6
CHEMBL301143,,None,456.57,0,2.13,3c,CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2,IC50,'=',60,nM,7.22,,,UO_0000065,15.82,0.31,5.09,6.98,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.06
CHEMBL194176,,None,435.51,0,4.95,39,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1,IC50,'=',22,nM,7.66,,,UO_0000065,17.58,0.34,2.71,8.12,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.022
CHEMBL365815,,None,438.51,0,4.29,42,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4cncn4C)c3)o2)c1,IC50,'=',25,nM,7.6,,,UO_0000065,17.34,0.33,3.31,7.66,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.025
CHEMBL175409,,None,417.47,0,2.33,1s,COc1cccc(-c2cn(-c3ccc(CC(=O)NCCO)cc3)c3ncnc(N)c23)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL700241,Tested in vitro for inhibition of KDR-receptor tyrosine kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1
CHEMBL205884,,None,447.83,0,4.39,15,Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)Cl)cc2)o1,IC50,'=',130,nM,6.89,,,UO_0000065,15.38,0.3,2.5,6.69,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.13
CHEMBL203119,,None,389.46,0,4.34,14,CC(C)c1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1,IC50,'=',440,nM,6.36,,,UO_0000065,16.32,0.3,2.02,6.78,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.44
CHEMBL379908,,None,379.4,0,3.67,26,Cc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c(F)c1,IC50,'=',260,nM,6.58,,,UO_0000065,17.36,0.32,2.92,7.03,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.26
CHEMBL205127,,None,449.82,0,4.89,25,Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(C(F)(F)F)c2)o1,IC50,'=',43,nM,7.37,,,UO_0000065,16.38,0.32,2.48,7.86,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.043
CHEMBL203796,,None,377.41,0,3.23,20,COc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1,IC50,'=',64,nM,7.19,,,UO_0000065,19.06,0.35,3.96,6.99,0,CHEMBL862191,Inhibition of VEGFR2 in 293 adenovirus transfected kidney cells by cell-based ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.064
CHEMBL206538,,None,431.38,0,4.12,18,Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2cccc(OC(F)(F)F)c2)o1,IC50,'=',130,nM,6.89,,,UO_0000065,15.96,0.3,2.77,6.69,0,CHEMBL862191,Inhibition of VEGFR2 in 293 adenovirus transfected kidney cells by cell-based ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.13
CHEMBL380131,,None,415.38,0,4.24,17,Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(F)(F)F)cc2)o1,IC50,'=',82,nM,7.09,,,UO_0000065,17.06,0.32,2.85,7.56,0,CHEMBL862191,Inhibition of VEGFR2 in 293 adenovirus transfected kidney cells by cell-based ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.082
CHEMBL379239,,None,361.41,0,3.53,22,Cc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL862191,Inhibition of VEGFR2 in 293 adenovirus transfected kidney cells by cell-based ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1821202,Competitive inhibition of human N-terminal His-tagged non-phosphorylated VEGFR2 in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,IC50,'=',14,nM,7.85,,,UO_0000065,17.63,0.34,2.29,9.69,0,CHEMBL1821206,Inhibition of human N-terminal His-tagged phosphorylated VEGFR2 preincubated for 120 mins in presence of ATP by AlphaScreen analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,14
CHEMBL1945171,,None,452.03,1,5.64,11b,Cc1ccc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2,IC50,'=',10,nM,8,,,UO_0000065,17.7,0.35,2.36,15.07,0,CHEMBL1948345,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944579,1,Scientific Literature,J Med Chem,2012,None,,,,10
CHEMBL196499,,None,393.45,1,5.03,18,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,IC50,'=',52,nM,7.28,,,UO_0000065,18.51,0.36,2.25,7.84,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,52
CHEMBL194321,,None,409.9,1,5.55,19,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2Cl)cc1,IC50,'=',340,nM,6.47,,,UO_0000065,15.78,0.32,0.92,6.96,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,340
CHEMBL371890,,None,417.54,1,6.02,80,Cc1cccc(NC(=O)Nc2ccc(-c3c(C(C)C)sc4ncnc(N)c34)cc2)c1,IC50,'=',130,nM,6.89,,,UO_0000065,16.49,0.31,0.87,7.41,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,130
CHEMBL371332,,None,409.9,1,5.55,89,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)c(Cl)c2)c1,IC50,'=',100,nM,7,,,UO_0000065,17.08,0.34,1.45,7.53,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,100
CHEMBL371510,,None,393.45,1,5.03,91,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2F)c1,IC50,'=',2,nM,8.7,,,UO_0000065,,,,,0,CHEMBL884695,Cellular inhibition of VEGF induced human KDR phosphorylation in 3T3 murine fibroblasts,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,None,,,,2
CHEMBL204629,,None,379.42,0,3.8,17,Cn1cc(/C=C2\C(=O)N(c3ccccc3)N=C2c2cnccn2)c2ccccc21,Inhibition,'=',23,%,,,,UO_0000187,,,,,0,CHEMBL866861,Inhibition of VEGFR2 at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146951,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,23
CHEMBL205901,,None,461.45,1,6.23,8,FC(F)(F)c1cccc(Nc2nnc(-c3cc4ccccc4nc3CCc3ccncc3)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,10
CHEMBL381182,,None,411.39,1,5.07,27,FC(F)(F)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1,IC50,'=',76,nM,7.12,,,UO_0000065,17.31,0.32,2.05,9.28,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.076
CHEMBL4794578,,None,397.44,0,2.58,7,CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12,Activity,'=',97.74,%,,,,UO_0000187,,,,,0,CHEMBL4721425,Inhibition of wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715821,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,Dose = 1.0 microM,,,97.74
CHEMBL1934324,,None,446.56,0,4.38,1e,CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)NC5CC5)cc4)ncnc3c2)CC1,IC50,'=',98,nM,7.01,,,UO_0000065,15.7,0.29,2.63,7.67,0,CHEMBL1937306,Inhibition of human GST-tagged VEGFR2 intracellular domain using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate after 30 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933000,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,98
CHEMBL1934327,,None,500.58,2,5.88,1h,CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1,IC50,'=',5.5,nM,8.26,,,UO_0000065,16.5,0.3,2.38,9.04,0,CHEMBL1937306,Inhibition of human GST-tagged VEGFR2 intracellular domain using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate after 30 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933000,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,5.5
CHEMBL1929554,,None,417.88,1,5.82,10,Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3cccc4ccccc34)[nH]c2n1,Ratio IC50,'=',39,,,,,,,,,,0,CHEMBL1932345,Ratio of Sunitinib IC50 to compound IC50 for VEGFR2 tyrosine kinase activity in VEGF-stimulated human U251 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1926631,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,39
CHEMBL1940999,,None,445.33,None,None,6a,O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1944082,Inhibition of VEGFR2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938284,1,Scientific Literature,Eur J Med Chem,2012,None,,,,0
CHEMBL65848,,None,470.53,0,3.31,28a,Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(c3)CCC4)c21,IC50,'=',3460,nM,5.46,,,UO_0000065,11.61,0.21,2.15,4.87,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,3.46
CHEMBL474543,,None,387.9,1,6.91,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL459478,,None,555.64,2,6.66,12,CC(C)n1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5CCN(c6ccccc6)C5=O)cc4F)c3s2)c1,IC50,'=',16,nM,7.8,,,UO_0000065,14.03,0.27,1.14,8.73,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.016
CHEMBL453613,,None,542.6,2,6.59,16,CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccccc6)C5=O)cc4F)c3s2)c1,IC50,'=',12,nM,7.92,,,UO_0000065,14.6,0.28,1.33,8.55,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.012
CHEMBL502621,,None,588.67,2,5.48,27,CN(C)[C@H]1CCN(C(=O)c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccccc6)C5=O)cc4F)c3s2)C1,IC50,'=',23,nM,7.64,,,UO_0000065,12.98,0.25,2.16,7.77,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.023
CHEMBL325003,,None,372.43,0,3.18,13,O=C(NC1CCNC1)c1ccc2[nH]c(-c3cc4ccccc4nc3O)cc2c1,IC50,'=',6,nM,8.22,,,UO_0000065,22.08,0.4,5.04,9.13,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,6
CHEMBL4797203,,None,478.95,1,5.67,7d,CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1,Inhibition,'<',60,%,,,,UO_0000187,,,,,0,CHEMBL4717520,Inhibition of N-terminal His6-tagged recombinant human KDR (790 to end residues) expressed in baculovirus infected Sf21 cells at 10 uM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715724,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,Dose = 10.0 microM,,,60
CHEMBL510320,,None,1266.6,None,None,GU40B,CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CNCCCCN,Activity,,,,,,Active,,,,,,0,CHEMBL956461,Binding affinity to human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL75196,,None,381.27,1,5.67,61,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1Cl,IC50,'=',30,nM,7.52,,,UO_0000065,19.73,0.4,1.85,14.84,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.03
CHEMBL525767,SCOPARASIN B,None,543.61,1,2.05,Scoparasin B,COc1ccc(C[C@@H]2NC(=O)[C@@]34OC(=O)O/C=C/[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]3[C@H](O)[C@](C)(O)[C@@H](C)[C@@H]24)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL5229902,Inhibition of VEGF-A-mediated VEGFR2 signaling pathway in human HMEC-1 cells assessed as reduction in mTOR phosphorylation at Ser2448 residue at 5 to 15 nM incubated for 36 hrs by western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HMEC-1,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5226385,1,Scientific Literature,J Nat Prod,2023,None,DOSE_Lower = 5.0 nM | DOSE_Upper = 15.0 nM | TIME = 36.0 hr,INHIBITOR,,
CHEMBL440727,,None,329.33,0,3.54,10,COc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC,IC50,'=',3,nM,8.52,,,UO_0000065,25.88,0.48,4.98,11.14,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.003
CHEMBL276711,SEMAXANIB,3,238.29,0,3.12,SU-5416,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,IC50,'=',200,nM,6.7,,,UO_0000065,28.11,0.51,3.58,14.92,0,CHEMBL817791,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.2
CHEMBL78303,,None,326.4,0,4.67,56,Cc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1,ED50,'=',8,nM,8.1,,,UO_0000065,,,,,0,CHEMBL818396,Inhibition of VEGF-stimulated autophosphorylation of VEGF-receptor 2 (KDR) expressed in CHO cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,CHEMBL3308072,,,,8
CHEMBL4756664,,None,398.53,0,3.8,32,Cc1cc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)cnc1C,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL4679714,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673392,1,Scientific Literature,ACS Med Chem Lett,2021,None,,,,4
CHEMBL3747669,,None,446.51,0,4.62,33r,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C(C)(C)C)on3)c2)CN1,IC50,'=',30,nM,7.52,,,UO_0000065,16.85,0.31,2.9,7.02,0,CHEMBL3749261,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745705,1,Scientific Literature,J Med Chem,2015,None,,,,30
CHEMBL3747226,,None,453.42,0,4.97,33a,O=C(Nc1cccc(C(F)(F)F)c1)n1ccc2cc(Oc3ncnc4c3CCNC4)ccc21,IC50,'=',22,nM,7.66,,,UO_0000065,16.89,0.32,2.69,9.45,0,CHEMBL3749261,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745705,1,Scientific Literature,J Med Chem,2015,None,,,,22
CHEMBL498105,,None,427.5,0,4.47,55,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1,IC50,'=',64,nM,7.19,,,UO_0000065,16.83,0.31,2.72,10.18,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,64
CHEMBL497114,,None,319.39,0,3.61,1,Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1,IC50,'=',7000,nM,5.16,,,UO_0000065,16.14,0.31,1.54,7.46,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,7
CHEMBL500152,,None,294.32,0,1.71,31,Cn1cnc(-c2ccccc2)c1C(=O)Nc1ccnc(N)n1,IC50,'=',98000,nM,4.01,,,UO_0000065,13.62,0.25,2.3,4.06,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,98
CHEMBL455182,,None,409.44,0,1.8,4g,O=C1Nc2ccccc2O/C1=C\c1ccc(/C=C/C(=O)N2CCN(CCO)CC2)o1,Inhibition,'=',76.7,%,,,,UO_0000187,,,,,0,CHEMBL1001089,Inhibition of KDR expressed in baculovirus system at 4 ug/ml by ELISA,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140887,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,76.7
CHEMBL462132,,None,439.85,1,5.63,22,Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1,Activity,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL980066,Inhibition of KDR assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139407,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL484707,,None,445.61,1,6.05,CER-0263959,Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,5
CHEMBL4069483,,None,461.53,1,2.31,12,COc1cc2ncnc(-n3nc(Nc4ccc(N5CCN(C)CC5)cc4)nc3N)c2cc1OC,EC50,'=',3,nM,8.52,,,UO_0000065,18.47,0.34,6.21,7.13,0,CHEMBL4057777,Inhibition of VEGF stimulated VEGFR2 phosphorylation at Y165 residues in HUVEC preincubated for 1 hr followed by VEGF addition measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052763,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.003
CHEMBL502543,,None,319.39,0,3.61,17,Nc1cc(/C=C/c2c(-c3ccccc3)nc3sccn23)ncn1,IC50,'=',35000,nM,4.46,,,UO_0000065,13.95,0.26,0.85,6.45,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,35
CHEMBL497290,,None,333.42,0,4.06,9,CNc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1,IC50,'=',17000,nM,4.77,,,UO_0000065,14.3,0.27,0.71,8.65,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,17
CHEMBL499891,,None,353.43,0,4.14,29,Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2Cc2ccccc2)n1,IC50,'=',7000,nM,5.16,,,UO_0000065,14.59,0.26,1.01,7.4,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,7
CHEMBL526880,,None,291.36,0,2.73,35,Cn1cnc(-c2ccccc2)c1C1CC1c1ccnc(N)n1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,100
CHEMBL450886,,None,280.34,0,2.07,33,Cn1cnc(-c2ccccc2)c1CNc1ccnc(N)n1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,100
CHEMBL48614,,None,385.85,0,4.18,5,CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2Cl)C3=O)CC1,Inhibition,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL819554,Inhibition of Vascular endothelial growth factor receptor 2 (VEGF-KDR) at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135924,1,Scientific Literature,J Med Chem,2002,None,,,,17
CHEMBL3928239,,None,452.52,0,4.78,568,COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',3019.95,nM,5.52,,,UO_0000065,12.2,0.22,0.74,7.06,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.52
CHEMBL3895378,,None,418.5,0,3.53,609,COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',6025.6,nM,5.22,,,UO_0000065,12.47,0.23,1.69,5.72,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.22
CHEMBL3890852,,None,500.53,1,4.73,703,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1,IC50,'=',7585.78,nM,5.12,,,UO_0000065,10.23,0.19,0.39,6.62,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.12
CHEMBL3962492,,None,391.43,0,2.87,706,COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',2570.4,nM,5.59,,,UO_0000065,14.28,0.26,2.72,5.79,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.59
CHEMBL3891525,,None,407.45,0,4.16,735,COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3935838,,None,449.51,0,2.71,736,COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1,IC50,'=',3981.07,nM,5.4,,,UO_0000065,12.01,0.22,2.69,5.11,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.4
CHEMBL3978349,,None,463.54,0,3.1,746,COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1,IC50,'=',6025.6,nM,5.22,,,UO_0000065,11.26,0.21,2.12,4.94,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.22
CHEMBL3927794,,None,433.51,0,3.79,622,COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1,IC50,'=',7943.28,nM,5.1,,,UO_0000065,11.76,0.22,1.31,5.96,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.1
CHEMBL3953833,,None,507.55,1,4.04,688,COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3948306,,None,490.57,0,4.94,753,COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3941227,,None,484.56,0,2.91,758,COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',7413.1,nM,5.13,,,UO_0000065,10.59,0.19,2.22,5.26,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.13
CHEMBL3904745,,None,544.66,1,4.46,343,CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3919270,,None,485.98,1,6.04,359,COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3898120,,None,458.57,0,4.41,207,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1,IC50,'=',66.07,nM,7.18,,,UO_0000065,15.66,0.29,2.77,7.86,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.18
CHEMBL3976280,,None,498.63,1,5.06,73,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1,IC50,'=',48.98,nM,7.31,,,UO_0000065,14.66,0.27,2.25,9.45,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.31
CHEMBL3918751,,None,435.48,0,2.63,233,COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'=',53.7,nM,7.27,,,UO_0000065,16.69,0.31,4.64,6.87,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.27
CHEMBL3950262,,None,401.47,0,4.37,121,C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',234.42,nM,6.63,,,UO_0000065,16.51,0.3,2.26,10.15,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.63
CHEMBL3912630,,None,457.58,1,5.71,203,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3986163,,None,459.55,0,4.71,206,COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3954368,,None,479.56,0,3.87,214,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3947826,,None,415.5,0,4.6,221,COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3948623,,None,500.6,1,4.54,226,CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3976280,,None,498.63,1,5.06,73,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1,IC50,'=',5888.44,nM,5.23,,,UO_0000065,10.49,0.19,0.17,6.76,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.23
CHEMBL3985853,,None,550.11,1,3.96,239,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl,IC50,'=',5623.41,nM,5.25,,,UO_0000065,10.22,0.19,1.29,6.52,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.25
CHEMBL3964675,,None,542.68,1,4.91,55,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1,IC50,'=',5754.4,nM,5.24,,,UO_0000065,9.66,0.18,0.33,5.9,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.24
CHEMBL3937533,,None,594.16,1,3.67,243,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl,IC50,'=',9549.93,nM,5.02,,,UO_0000065,9,0.17,1.35,5.46,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.02
CHEMBL3908529,,None,476.54,0,2.64,249,CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1,IC50,'=',2290.87,nM,5.64,,,UO_0000065,11.84,0.22,3,4.92,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.64
CHEMBL3962805,,None,544.66,1,4.56,250,COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3985750,,None,502.58,1,3.17,253,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3943387,,None,435.48,0,2.54,75,COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',3162.28,nM,5.5,,,UO_0000065,12.63,0.23,2.96,5.2,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.5
CHEMBL3951156,,None,433.51,0,3.96,78,COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',5754.4,nM,5.24,,,UO_0000065,12.09,0.22,1.28,6.13,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.24
CHEMBL3972173,,None,551.67,1,3.45,267,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3920908,,None,404.47,0,3.39,279,CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3948270,,None,432.48,0,4.04,81,COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',5754.4,nM,5.24,,,UO_0000065,12.12,0.22,1.2,5.35,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.24
CHEMBL3923296,,None,472.59,0,4.72,286,COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1380.38,nM,5.86,,,UO_0000065,12.4,0.23,1.14,7.58,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.86
CHEMBL3908877,,None,426.91,0,3.13,294,COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl,IC50,'>=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3986607,,None,428.5,0,3.94,311,CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'=',4168.69,nM,5.38,,,UO_0000065,12.56,0.23,1.44,5.6,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.38
CHEMBL3983996,,None,510.04,0,3.22,321,COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1548.82,nM,5.81,,,UO_0000065,12.27,0.23,2.59,6.14,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.81
CHEMBL370193,,None,419.28,0,4.9,35,NC(=O)c1ccc(-c2nnc(Nc3cccc(Br)c3)c3ccccc23)cc1,IC50,'=',1200,nM,5.92,,,UO_0000065,14.12,0.3,1.02,7.32,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,1.2
CHEMBL196994,,None,396.49,1,5.44,54,CC(C)(C)c1ccc(Nc2nnc(-c3cccc(C(N)=O)c3)c3ccccc23)cc1,IC50,'=',400,nM,6.4,,,UO_0000065,16.14,0.29,0.96,7.91,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.4
CHEMBL3912310,,None,473.58,0,3.53,485,CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1230.27,nM,5.91,,,UO_0000065,12.48,0.23,2.38,6.08,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.91
CHEMBL3914955,,None,516.65,1,4.68,486,COc1cc(OC)cc(N(CCCN2C[C@@H](C)O[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',6760.83,nM,5.17,,,UO_0000065,10.01,0.19,0.49,6.65,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.17
CHEMBL3968124,,None,448.53,0,2.77,502,CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',1096.48,nM,5.96,,,UO_0000065,13.29,0.25,3.19,6.11,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.96
CHEMBL3889890,,None,462.51,0,3.66,506,COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O,IC50,'=',4265.8,nM,5.37,,,UO_0000065,11.61,0.22,1.71,5.01,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.37
CHEMBL3946674,,None,515.03,0,4.52,518,COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',831.76,nM,6.08,,,UO_0000065,12.7,0.24,1.56,7.86,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.08
CHEMBL3931790,,None,515.62,1,3.38,519,COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1819.7,nM,5.74,,,UO_0000065,11.13,0.21,2.36,5.14,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.74
CHEMBL3934487,,None,486.58,0,3.52,102,COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1174.9,nM,5.93,,,UO_0000065,12.19,0.22,2.41,7.63,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.93
CHEMBL3891966,,None,516.52,1,3.7,142,COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',3311.31,nM,5.48,,,UO_0000065,10.61,0.2,1.78,5.62,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.48
CHEMBL3955745,,None,395.46,0,3.27,556,[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',6918.31,nM,5.16,,,UO_0000065,13.15,0.24,1.89,6.29,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.16
CHEMBL3900858,,None,602.48,3,5.71,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952693,,None,529.43,2,6.2,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944502,,None,508.37,2,6.63,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952805,,None,544.51,2,7.27,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949560,,None,535.47,2,5.32,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1946170,REGORAFENIB,4,482.82,1,5.69,Regorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,IC50,'=',4.2,nM,8.38,,,UO_0000065,17.35,0.35,2.69,9.07,1,CHEMBL5151923,Inhibition of VEGFR2 (unknown origin) by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5150004,1,Scientific Literature,J Med Chem,2021,None,,INHIBITOR,,4.2
CHEMBL69068,,None,373.46,0,4.81,17,CC(C)(C)n1cc(-c2ccc(Oc3ccc(N)cc3)cc2)c2c(N)ncnc21,IC50,'=',900,nM,6.05,,,UO_0000065,16.19,0.29,1.24,6.57,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.9
CHEMBL493315,,None,477.57,1,5.09,19b,Cc1ccc(NC(=O)c2ccc(/C=C/C(=O)NO)s2)cc1Nc1ncc(-c2cccnc2)s1,IC50,'=',6700,nM,5.17,,,UO_0000065,10.83,0.21,0.08,4.45,0,CHEMBL1022425,Inhibition of VEGFR2 by liquid scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153406,1,Scientific Literature,J Med Chem,2009,None,,,,6.7
CHEMBL474046,,None,521.61,2,5.74,16b,Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)nc2)cc1Nc1ncc(-c2cccnc2)s1,IC50,'=',9000,nM,5.05,,,UO_0000065,9.67,0.18,-0.69,3.74,0,CHEMBL1022425,Inhibition of VEGFR2 by liquid scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153406,1,Scientific Literature,J Med Chem,2009,None,,,,9
CHEMBL318835,,None,361.51,1,5.38,CC19,CN(C)CCCn1cc(-c2cncc(-c3ccsc3)c2)c2ccccc21,IC50,'=',64,nM,7.19,,,UO_0000065,19.9,0.38,1.81,34.16,1,CHEMBL5138021,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5136983,1,Scientific Literature,Bioorg Med Chem,2022,None,,INHIBITOR,,64
CHEMBL495545,,None,386.46,0,2.68,10,CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2)CC1,IC50,'=',400,nM,6.4,,,UO_0000065,16.56,0.3,3.72,8.59,0,CHEMBL1002019,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143431,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.4
CHEMBL525767,SCOPARASIN B,None,543.61,1,2.05,Scoparasin B,COc1ccc(C[C@@H]2NC(=O)[C@@]34OC(=O)O/C=C/[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]3[C@H](O)[C@](C)(O)[C@@H](C)[C@@H]24)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL5229901,Inhibition of VEGF-A-mediated VEGFR2 signaling pathway in human HUVEC cells assessed as reduction in FAK phosphorylation at Tyr397 residue at 5 to 15 nM incubated for 36 hrs by western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5226385,1,Scientific Literature,J Nat Prod,2023,None,DOSE_Lower = 5.0 nM | DOSE_Upper = 15.0 nM | TIME = 36.0 hr,INHIBITOR,,
CHEMBL146694,,None,416.48,0,4.82,16h,COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C,IC50,'=',4370,nM,5.36,,,UO_0000065,12.87,0.24,0.54,5.86,0,CHEMBL816967,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,4.37
CHEMBL4785698,,None,611.61,2,6.48,22e,COCCn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ncnc5cc(OC)c(OC)cc45)c(F)c3)nccc21,IC50,'>',3000,nM,,,,UO_0000065,,,,,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,,,3000
CHEMBL4784540,,None,486.99,1,7.15,12aa,O=C(Nc1ccccc1)Nc1nc(Nc2ccc(Cl)cc2)cc(Sc2c[nH]c3ccccc23)n1,IC50,'=',1810,nM,5.74,,,UO_0000065,11.79,0.23,-1.41,6.06,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,1.81
CHEMBL4792614,,None,464.98,1,6.01,12k,O=C(Nc1ccc(Cl)cc1)Nc1nc(Sc2c[nH]c3ccccc23)cc(N2CCCC2)n1,IC50,'=',330,nM,6.48,,,UO_0000065,13.94,0.28,0.47,7.54,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,0.33
CHEMBL56569,,None,428.51,0,1.71,3d,CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2,IC50,'=',500,nM,6.3,,,UO_0000065,14.7,0.29,4.59,4.7,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.5
CHEMBL3656112,,None,497.56,1,5.03,BDBM110623,Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CC[C@@H](O)C5)c[nH]4)c3)cc2)c1,IC50,'=',14,nM,7.85,,231508,UO_0000065,15.78,0.29,2.82,6.57,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4749856,,None,534.64,2,5.35,27,Cc1ccc(-n2c(SCC(=O)Nc3ccc(C(=O)NCc4ccccc4)cc3)nc3ccccc3c2=O)cc1,IC50,'=',0.751,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL4677737,Inhibition of human VEGFR2 incubated for 2.5 hrs by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673301,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 2.5 hr,INHIBITOR,,0.751
CHEMBL258424,,None,296.71,0,2.25,6,OCc1cc(O)c(Cc2cc(O)ccc2O)c(Cl)c1O,Inhibition,'=',31.8,%,,,,UO_0000187,,,,,0,CHEMBL931469,Inhibition of KDR kinase at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144688,1,Scientific Literature,J Nat Prod,2008,None,,,,31.8
CHEMBL66102,,None,400.48,1,5.6,20,COc1ccccc1Oc1ccc(-c2cn(C3CCCC3)c3ncnc(N)c23)cc1,IC50,'=',500,nM,6.3,,,UO_0000065,15.73,0.29,0.7,8.38,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.5
CHEMBL3782044,,None,510,2,7.27,7d,COc1ccc(Cc2nnc(Nc3ccc(NC(=O)Nc4ccccc4Cl)cc3)c3ccccc23)cc1,IC50,'=',141,nM,6.85,,,UO_0000065,13.43,0.25,-0.42,7.77,0,CHEMBL3784202,Inhibition of recombinant human VEGFR-2 expressed in Spodoptera frugiperda cells after 5 mins by using biotinylated poly-GluTyr (4:1) as substrate by Alpha Screen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779892,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.141
CHEMBL3780261,,None,371.44,0,4.98,4i,COc1ccc(Cc2nnc(Nc3ccc(OC)cc3)c3ccccc23)cc1,IC50,'=',3450,nM,5.46,,,UO_0000065,14.71,0.27,0.48,9.71,0,CHEMBL3784202,Inhibition of recombinant human VEGFR-2 expressed in Spodoptera frugiperda cells after 5 mins by using biotinylated poly-GluTyr (4:1) as substrate by Alpha Screen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779892,1,Scientific Literature,Eur J Med Chem,2016,None,,,,3.45
CHEMBL66716,,None,449.35,1,6.35,3,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(Br)n2C1CCCC1,IC50,'=',1600,nM,5.8,,,UO_0000065,12.9,0.27,-0.55,8.79,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1.6
CHEMBL3660275,,None,428.45,1,5.52,BDBM110647,Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)O)c[nH]4)c3)cc2)c1,IC50,'=',15,nM,7.82,,231532,UO_0000065,18.26,0.33,2.3,6.73,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3782023,,None,411.51,1,5.43,9g,COc1cccc(Nc2cncc3nc(-c4ccc(N5CCCCC5)cc4)cnc23)c1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,100
CHEMBL522732,,None,410.43,0,2.68,19x,CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(F)c(F)cc5[nH]c4=O)nc3c2)CC1,IC50,'=',190,nM,6.72,,,UO_0000065,16.38,0.31,4.04,7.15,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,0.19
CHEMBL496762,,None,403.49,0,2.45,19m,CNc1cccc2[nH]c(=O)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(N)c12,IC50,'=',53,nM,7.28,,,UO_0000065,18.03,0.33,4.83,6.86,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,0.053
CHEMBL449593,,None,403.49,0,2.45,19v,CNc1ccc2c(N)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(=O)[nH]c2c1,IC50,'=',1000,nM,6,,,UO_0000065,14.87,0.27,3.55,5.66,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,1
CHEMBL118440,,None,261.28,0,3.07,12,O=c1[nH]c2ccccc2cc1-c1nc2ccccc2[nH]1,IC50,'=',1700,nM,5.77,,,UO_0000065,22.08,0.39,2.7,9.38,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,1.7
CHEMBL453354,,None,406.49,1,5.14,6c,CCCCNc1nn(C)c2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12,IC50,'=',800,nM,6.1,,,UO_0000065,15,0.28,0.96,8.66,0,CHEMBL973628,Inhibition of recombinant KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157345,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.8
CHEMBL3921441,,None,425.52,0,3.57,711,[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3927158,,None,476.54,0,4.63,714,COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3922100,,None,470.53,0,2.52,627,COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3980069,,None,515.66,1,4.57,651,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1,IC50,'=',1778.28,nM,5.75,,,UO_0000065,11.15,0.21,1.18,6.43,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.75
CHEMBL3974273,,None,491.56,0,4.21,689,COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3974131,,None,500.56,2,5.11,911,COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3917295,,None,566.69,1,2.44,564,COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',58.88,nM,7.23,,,UO_0000065,12.76,0.25,4.79,5.14,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.23
CHEMBL3932363,,None,539.08,1,4.29,110,CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl,IC50,'=',40.74,nM,7.39,,,UO_0000065,14.7,0.27,3.1,8.54,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.39
CHEMBL3934260,,None,497.04,0,4.57,570,COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',33.88,nM,7.47,,,UO_0000065,16.22,0.3,2.9,9.66,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.47
CHEMBL3895378,,None,418.5,0,3.53,609,COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',123.03,nM,6.91,,,UO_0000065,16.51,0.3,3.38,7.57,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.91
CHEMBL3942606,,None,460.58,0,4.57,698,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1,IC50,'=',79.43,nM,7.1,,,UO_0000065,15.42,0.29,2.53,9.18,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.1
CHEMBL3937972,,None,514.51,1,4.25,648,COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',53.7,nM,7.27,,,UO_0000065,14.13,0.27,3.02,7.7,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.27
CHEMBL3927158,,None,476.54,0,4.63,714,COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',870.96,nM,6.06,,,UO_0000065,12.72,0.23,1.43,7.75,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.06
CHEMBL3953833,,None,507.55,1,4.04,688,COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',602.56,nM,6.22,,,UO_0000065,12.25,0.22,2.18,6.2,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.22
CHEMBL3906938,,None,491.56,0,4.21,765,COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',38.9,nM,7.41,,,UO_0000065,15.07,0.27,3.2,7.11,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.41
CHEMBL3964762,,None,526.99,1,4.26,767,COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',199.53,nM,6.7,,,UO_0000065,12.71,0.24,2.44,5.72,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.7
CHEMBL3937212,,None,503.65,1,4.25,773,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1,IC50,'=',125.89,nM,6.9,,,UO_0000065,13.7,0.25,2.65,8.56,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.9
CHEMBL3964589,,None,515.49,1,4.68,779,COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1000,nM,6,,,UO_0000065,11.64,0.22,1.32,6.55,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3904470,,None,492.58,1,5.6,637,COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3909752,,None,505.58,2,5.27,640,COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',245.47,nM,6.61,,,UO_0000065,13.07,0.24,1.34,7.95,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.61
CHEMBL3950262,,None,401.47,0,4.37,121,C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',2818.38,nM,5.55,,,UO_0000065,13.82,0.25,1.18,8.5,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.55
CHEMBL3973645,,None,477.98,1,6.09,323,COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3969381,,None,534.06,0,4.42,390,COc1cc(OC)cc(N(CCCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',2398.83,nM,5.62,,,UO_0000065,11.29,0.21,1.2,6.09,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.62
CHEMBL3942594,,None,449.51,0,3.19,397,COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',5495.41,nM,5.26,,,UO_0000065,11.7,0.22,2.07,5.55,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.26
CHEMBL3900574,,None,473.46,0,4.11,481,COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',5370.32,nM,5.27,,,UO_0000065,11.13,0.21,1.16,6.16,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.27
CHEMBL3964762,,None,526.99,1,4.26,767,COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3656094,,None,515.55,2,5.17,BDBM110605,Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CC[C@@H](O)C5)c[nH]4)c3)cc2F)c1,IC50,'=',11,nM,7.96,,231490,UO_0000065,15.44,0.29,2.79,6.66,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3678952,,None,472.6,0,4.65,BDBM173443,COc1cccc(Nc2nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n2C(C)C)c1,IC50,'>',1000,nM,,,318786,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3678951,,None,510.57,2,5.67,BDBM173442,CC(C)n1c(Nc2cccc(C(F)(F)F)c2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,IC50,'>',1000,nM,,,318785,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3936672,,None,502.62,1,4.03,108,COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',30.2,nM,7.52,,,UO_0000065,14.96,0.28,3.49,8.47,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,7.52
CHEMBL3982570,,None,509.05,0,4.67,361,COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3985678,,None,447.54,0,4.2,389,COc1cc(OC)cc(N(CC(O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL2086397,,None,438.49,0,3.85,7b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2087167,,None,445.54,0,4.66,8i,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976275,,None,542.55,1,4.92,826,COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F,IC50,'=',22.91,nM,7.64,,,UO_0000065,14.08,0.26,2.72,8.74,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.64
CHEMBL3892005,,None,526.56,2,3.62,830,COc1cc(OC)cc(N(CC(=O)Nc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',707.95,nM,6.15,,,UO_0000065,11.68,0.22,2.53,4.75,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.15
CHEMBL3906253,,None,535.56,2,3.81,831,COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1,IC50,'=',380.19,nM,6.42,,,UO_0000065,11.99,0.22,2.61,5.47,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.42
CHEMBL2333365,,None,455.51,0,3.22,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966660,,None,479.54,0,3.97,899,COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3979662,,None,426.91,0,3.13,438,COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3944739,,None,432.31,0,3.81,453,COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL1080639,,None,544.41,2,5.82,59,COc1ccc(Br)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1,IC50,'=',10,nM,8,,,UO_0000065,14.69,0.3,2.18,7.59,0,CHEMBL1109443,Inhibition of VEGFR2 after 1 hr,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153704,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL3964556,,None,478.33,0,4.25,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3968322,,None,433.32,1,5.72,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3928696,,None,390.27,1,5.48,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3893890,,None,509.37,1,4.31,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914441,,None,553.82,1,4.42,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1077739,,None,444.88,0,3.71,32,O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL1111202,Inhibition of KDR at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154316,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,4
CHEMBL3971864,,None,476.39,1,5.79,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904608,,None,442.54,1,5.45,35(s),CON(C(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)C1CC1,Inhibition,'=',60,%,,,,UO_0000187,,,,,0,CHEMBL3881021,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,60
CHEMBL3928932,,None,354.41,1,5.04,24(e),CCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1,Inhibition,'=',52,%,,,,UO_0000187,,,,,0,CHEMBL3881111,Inhibition of human 50 residues truncated cytoplasmic domain of phosphorylated VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,52
CHEMBL67560,,None,414.51,1,5.64,7,CC(O)c1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1,IC50,'=',1860,nM,5.73,,,UO_0000065,13.82,0.25,0.09,6.65,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1.86
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,IC50,'=',124700,nM,,Outside typical range,,UO_0000065,,,,,1,CHEMBL2343567,Inhibition of VEGF-induced VEGFR2 phosphorylation in human U251 cells overexpressing Flk-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331499,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,124.7
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',18900,nM,4.72,,,UO_0000065,11.85,0.22,1.39,6.12,1,CHEMBL2343567,Inhibition of VEGF-induced VEGFR2 phosphorylation in human U251 cells overexpressing Flk-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331499,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,18.9
CHEMBL461114,,None,445.91,1,5.29,8b,Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)Nc1ccccc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL972550,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156722,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,100
CHEMBL3973321,,None,486.58,0,4.2,132,COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',3981.07,nM,5.4,,,UO_0000065,11.1,0.2,1.2,6.31,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.4
CHEMBL202748,,None,203.23,0,1.55,3a,N#Cc1cnc(Nc2ccncn2)s1,IC50,'=',990,nM,6,,,UO_0000065,29.54,0.59,4.45,8.06,0,CHEMBL860566,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138163,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,990
CHEMBL3935825,,None,595.02,1,4.01,95,COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1071.52,nM,5.97,,,UO_0000065,10.69,0.2,1.96,5.21,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.97
CHEMBL3961923,,None,567.69,1,4.92,463,COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1,IC50,'=',912.01,nM,6.04,,,UO_0000065,10.64,0.2,1.12,5.95,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.04
CHEMBL3965640,,None,442.52,0,3.95,498,CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',2238.72,nM,5.65,,,UO_0000065,12.77,0.23,1.7,6.63,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.65
CHEMBL3969665,,None,483.58,0,4.78,527,COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1148.15,nM,5.94,,,UO_0000065,12.28,0.23,1.16,7.15,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.94
CHEMBL3983529,,None,517.63,1,2.8,528,COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',645.65,nM,6.19,,,UO_0000065,11.96,0.22,3.39,6.73,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.19
CHEMBL3969112,,None,558.73,2,5.71,603,COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1,IC50,'=',1819.7,nM,5.74,,,UO_0000065,10.27,0.19,0.03,6.47,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.74
CHEMBL3910444,,None,529.65,1,3.77,541,COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',416.87,nM,6.38,,,UO_0000065,12.05,0.22,2.61,5.72,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.38
CHEMBL3972617,,None,541.66,1,3.74,544,COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4265.8,nM,5.37,,,UO_0000065,9.91,0.18,1.63,6.04,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.37
CHEMBL3953117,,None,469.55,0,4.43,557,COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3930158,,None,474.52,0,3.64,561,COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',6606.93,nM,5.18,,,UO_0000065,10.92,0.2,1.54,5.46,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.18
CHEMBL3927451,,None,500.65,2,5.45,562,COc1cc(OC)cc(N(CCCN2[C@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1258.93,nM,5.9,,,UO_0000065,11.78,0.22,0.45,8.61,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.9
CHEMBL3913757,,None,444.5,0,3.55,259,COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'=',3548.13,nM,5.45,,,UO_0000065,12.26,0.23,1.9,4.99,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.45
CHEMBL3985222,,None,495.03,0,4.28,264,COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',758.58,nM,6.12,,,UO_0000065,13.35,0.25,1.84,8.93,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.12
CHEMBL3893008,,None,449.51,0,3.02,28,COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'=',2630.27,nM,5.58,,,UO_0000065,12.41,0.23,2.56,5.28,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.58
CHEMBL3907488,,None,431.5,0,3.95,16,COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3937633,,None,418.5,0,3.53,93,COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',3388.44,nM,5.47,,,UO_0000065,13.07,0.24,1.94,5.99,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.47
CHEMBL3937092,,None,490.44,1,5.09,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3895424,,None,557.23,2,5.36,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1914911,,None,306.34,0,4.36,36,CCc1cccc2c(/C=C3\C(=O)Nc4ccc(F)cc43)c[nH]c12,IC50,'=',6580,nM,5.18,,,UO_0000065,16.92,0.31,0.82,11.54,0,CHEMBL1920170,Inhibition of human VEGFR2 preincubated for 10 mins before ATP addition measured after 45 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914337,1,Scientific Literature,Eur J Med Chem,2011,None,,,,6.58
CHEMBL456936,CALICOFEROL E,None,398.63,1,7.11,17,Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,'=',6010,nM,5.22,,,UO_0000065,13.1,0.25,-1.89,14,0,CHEMBL1926234,Inhibition of recombinant human VEGF-R2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL203000,,None,218.25,0,1.13,3b,N#Cc1cnc(Nc2ccnc(N)n2)s1,IC50,'=',557,nM,6.25,,,UO_0000065,28.66,0.57,5.12,6.22,0,CHEMBL860566,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138163,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,557
CHEMBL380944,,None,287.35,0,0.96,3f,N#Cc1cnc(Nc2cc(N3CCNCC3)ncn2)s1,IC50,'=',34,nM,7.47,,,UO_0000065,,,,,0,CHEMBL860567,Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assay,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138163,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,34
CHEMBL1201270,METHENAMINE,4,140.19,0,-1.02,methenamine,C1N2CN3CN1CN(C2)C3,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL4216473,,None,479.52,0,3.89,44; AZD3229,COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1,GI50,'=',1378,nM,,,,UO_0000065,,,,,0,CHEMBL4201681,Inhibition of KDR (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4196201,1,Scientific Literature,J Med Chem,2018,None,,,,1.378
CHEMBL1910892,,None,370.46,0,4.01,3,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)c[nH]c3n2)cc1,IC50,'=',4760,nM,5.32,,,UO_0000065,14.37,0.26,1.31,8.29,0,CHEMBL1912531,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,4.76
CHEMBL3422070,,None,509.65,2,6.01,21,CN1CCC(Oc2ccc(-c3n[nH]c4ccc(NC(=O)C(c5ccccn5)C5CCCC5)cc34)cc2)CC1,IC50,'=',1500,nM,5.82,,,UO_0000065,11.43,0.21,-0.19,7,0,CHEMBL3423901,Inhibition of recombinant KDR (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3421533,1,Scientific Literature,J Med Chem,2015,None,,,,1.5
CHEMBL598797,CUDC-101,1,434.5,0,4.2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL611649,,None,239.25,0,3.32,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL333297,,None,387.48,0,4.95,9,Oc1nc2ccccc2cc1-c1cc2cc(OCCN3CCCCC3)ccc2[nH]1,IC50,'=',4,nM,8.4,,,UO_0000065,21.67,0.4,3.45,13.68,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,4
CHEMBL1076468,,None,602.66,2,6.89,13e,CCN(CC)CCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1,IC50,'=',1726,nM,5.76,,,UO_0000065,9.56,0.18,-1.13,5.76,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,1726
CHEMBL1076471,,None,630.67,2,6.32,13h,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCC2COCCN2)ncn1,IC50,'=',318,nM,6.5,,,UO_0000065,10.3,0.19,0.18,5.51,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,318
CHEMBL1076199,,None,630.72,2,7.67,22f,CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1,IC50,'=',243,nM,6.61,,,UO_0000065,10.49,0.2,-1.06,6.61,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,243
CHEMBL4847003,,None,499.51,0,4.17,19e,O=C(CSc1nc2ccccc2n2cnnc12)Nc1ccc(C(=O)Nc2ccc([N+](=O)[O-])cc2)cc1,IC50,'=',27.9,nM,7.55,,,UO_0000065,15.12,0.29,3.38,5.23,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,27.9
CHEMBL4845883,,None,431.37,0,4.89,27,CC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1,IC50,'=',1.3,nM,8.89,,,UO_0000065,20.6,0.39,4,8.44,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,1.3
CHEMBL4857556,,None,439.34,1,5.25,40,CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c(F)c2F)ncn1,IC50,'=',2.5,nM,8.6,,,UO_0000065,19.58,0.38,3.35,9.76,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,2.5
CHEMBL417006,,None,596.78,2,5.02,12,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)C(C)(C)Cc1ccccc1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL698970,Inhibition of human VEGF-receptor 2 (kdr) kinase.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135159,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,50
CHEMBL183993,GW811761X,None,400.36,0,4.35,GW811761X,CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',4.26,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.26
CHEMBL1909356,GW569530A,None,650.15,2,6.23,GW569530A,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl,Inhibition,'=',2.88,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2.88
CHEMBL199561,,None,421.42,1,6.85,4,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)CCCCBr)cc1OC2(C)C,Ki,'=',0.4,nM,9.4,,,UO_0000065,22.3,0.49,2.55,31.9,0,CHEMBL1686402,Inhibition of human recombinant His-tagged VEGFR2 assessed as infrared absorption,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681679,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.0004
CHEMBL1181730,,None,277.37,0,2.3,9b,CCCCCCC(C(C)O)n1cc2c(N)ncnc2n1,Ki,'=',53,nM,7.28,,,UO_0000065,26.23,0.5,4.98,8.1,0,CHEMBL1686402,Inhibition of human recombinant His-tagged VEGFR2 assessed as infrared absorption,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681679,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,53
CHEMBL4110384,,None,501.56,1,4.08,BDBM202478,C[C@@H](C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C)CC3)c2)ncc1C(F)(F)F,IC50,'=',518,nM,6.29,,358624,UO_0000065,12.53,0.24,2.21,6.16,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL363042,,None,275.4,0,3.55,8e,CCCCCCCCCCn1cc2c(N)ncnc2n1,Ki,'=',0.13,nM,9.89,,,UO_0000065,35.9,0.68,6.34,14.2,0,CHEMBL1686402,Inhibition of human recombinant His-tagged VEGFR2 assessed as infrared absorption,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681679,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.13
CHEMBL3903725,,None,450.38,0,3.29,BDBM236557,Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1,IC50,'>',10000,nM,,,412029,UO_0000065,,,,,0,CHEMBL3888672,Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4791334,,None,940.18,4,8.88,PROTAC-1,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCC(=O)n2nc(N)c3c(-c4cccc(NC(=O)Nc5cccc(C(C)C)c5)c4)cccc32)C(C)(C)C)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4773366,Inhibition of recombinant human N-terminal GST-tagged VEGFR2 (789 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3589744,,None,435.47,0,3.05,9h,NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(/N=C3\C(=O)Nc4ccccc43)cc2)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,
CHEMBL3321893,,None,351.41,1,5.23,7b,Cc1ccccc1-c1nc2ccc(Nc3ncnc4ccccc34)cc2[nH]1,IC50,'=',9350,nM,5.03,,,UO_0000065,14.31,0.25,-0.2,7.56,0,CHEMBL3368964,Inhibition of human recombinant VEGFR2 pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352651,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,9.35
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4055534,Inhibition of VEGFR2 in human MDA-MB-231 cells assessed as reduction in Akt phosphorylation at 20 to 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',96.1,%,,,,UO_0000187,,,,,0,CHEMBL4055525,Inhibition of VEGFR2 in human MDA-MB-231 cells assessed as downregulation of phosphorylated paxillin levels at 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,96.1
CHEMBL1681931,,None,350.77,0,2.24,4a,CNC(=O)Nc1ccc(Oc2ncnc(N)c2/C=N/OC)cc1Cl,IC50,'=',25,nM,7.6,,,UO_0000065,21.67,0.43,5.36,6.14,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,25
CHEMBL1688350,,None,391.39,0,2.98,21,c1cnc(NCc2cnc[nH]2)c(-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c1,IC50,'=',830,nM,6.08,,,UO_0000065,15.54,0.29,3.1,4.94,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,0.83
CHEMBL3793297,,None,403.23,0,3.06,5,COc1cc2ncn(CC(=O)c3ccc(Br)cc3)c(=O)c2cc1OC,Inhibition,'=',53,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3793972,,None,358.78,0,2.55,12,O=c1c2cc3c(cc2ncn1CC(O)c1cccc(Cl)c1)OCCO3,Inhibition,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1683334,,None,356.43,0,4.74,5f,Cc1cccc(NC(=O)c2c[nH]c3cccc(NCc4ccncc4)c23)c1,Inhibition,'=',18,%,,,,UO_0000187,,,,,0,CHEMBL1687576,Inhibition of KDR assessed as phosphorylation level of substrate at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681739,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,18
CHEMBL1688247,,None,385.35,0,3.89,2,FC(F)(F)c1cccc(-c2nnc(-c3cccnc3NCc3cn[nH]c3)[nH]2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,10
CHEMBL3739936,,None,542.59,2,6.1,8d,CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5F)cccc4c3)n2)c1,IC50,'=',2,nM,8.7,,,UO_0000065,16.03,0.3,2.6,7.89,0,CHEMBL3745584,Inhibition of human recombinant VEGFR-2 expressed in baculovirus using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3729305,,None,392.39,0,2.76,P-0063,O=C(c1c(F)ccc(NS(=O)(=O)C2CCC2)c1F)c1c[nH]c2ncncc12,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
CHEMBL3729931,,None,432.38,0,3.41,P-0042,O=C(c1cccc(NS(=O)(=O)c2ccc(F)cc2F)c1F)c1c[nH]c2ncncc12,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
CHEMBL176470,,None,359.43,0,2.75,1o,Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CNCCO,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL700242,Tested in vitro for inhibition of KDR-receptor tyrosine kinase; Not determined,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,
CHEMBL4549013,,None,649.62,2,7.78,Roxyl-ZV-5H,Cc1nc2c(F)cc(-c3nc(Nc4ccc(NC(=O)C5(C(=O)Nc6ccc(C(F)(F)F)cc6)CC5)cc4)ncc3F)cc2n1C(C)C,Inhibition,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,80
CHEMBL4465180,,None,674.55,2,7.2,Roxyl-ZV-6F,Cc1nc2c(F)cc(-c3nc(Nc4ccc(CNC(=O)C5(C(=O)Nc6ccc(Br)cc6)CC5)cc4)ncc3F)cc2n1C(C)C,Inhibition,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,90
CHEMBL4445335,,None,595.65,2,7.07,Roxyl-ZV-5J,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4407846,Inhibition of VEGFR2 in HUVEC cells assessed as reduction in STAT3 phosphorylation at 20 to 40 nM incubated for 48 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307501,,,,
CHEMBL429057,,None,316.36,0,3.16,1k,Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CO,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL700242,Tested in vitro for inhibition of KDR-receptor tyrosine kinase; Not determined,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,
CHEMBL4548772,,None,403.42,0,3.35,80,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccccc5)c(F)c4)c12)COC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4569311,,None,556.64,2,-1.07,61,CC1(C)O[C@@H]2[C@H](O1)[C@@H](CNS(=O)(=O)c1ccc(CN)cc1)O[C@@H]2CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL4430712,Inhibition of biotinylated VEGF-A165 binding to recombinant KDR (unknown origin) at 100 uM measured after 2 hrs by competition binding assay relative to VEGF-A165,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4428108,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,0
CHEMBL4540695,,None,527.6,2,-0.52,56,CC1(C)O[C@@H]2[C@H](O1)[C@@H](CNS(=O)(=O)c1ccccc1)O[C@@H]2CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL4430713,Inhibition of biotinylated VEGF-A165 binding to recombinant KDR (unknown origin) measured after 2 hrs by competition binding assay relative to VEGF-A165,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4428108,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,500
CHEMBL4569311,,None,556.64,2,-1.07,61,CC1(C)O[C@@H]2[C@H](O1)[C@@H](CNS(=O)(=O)c1ccc(CN)cc1)O[C@@H]2CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL4430713,Inhibition of biotinylated VEGF-A165 binding to recombinant KDR (unknown origin) measured after 2 hrs by competition binding assay relative to VEGF-A165,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4428108,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,500
CHEMBL4459013,,None,415.47,0,4.12,92,Cc1ccc(CC(=O)Nc2ccc(-n3c4c(c5ncnc(N)c53)CCC4)cc2)c(F)c1,IC50,'=',10,nM,8,,,UO_0000065,19.26,0.35,3.88,9.32,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,10
CHEMBL4463533,,None,453.43,0,3.48,170,Nc1ncnc2c3c(n(-c4ccc(CC(=O)Nc5ccc(C(F)(F)F)nn5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL1762530,,None,490.61,0,3.46,12,Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1,IC50,'=',818,nM,6.09,,,UO_0000065,12.41,0.23,2.63,7.06,0,CHEMBL1764818,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759854,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.818
CHEMBL3114026,,None,348.39,0,4.01,7i,CN(c1ccc2cn(C)nc2c1)c1ccnc(Nc2cccc(F)c2)n1,IC50,'=',93,nM,7.03,,,UO_0000065,20.18,0.37,3.02,11.94,0,CHEMBL3116994,Inhibition of VEGFR-2 tyrosine kinase (unknown origin) after 30 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3112549,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,93
CHEMBL4795322,,None,517.01,2,6.89,10b,COc1ccc(/N=N/c2sc(N/N=C3\C(=O)N(Cc4ccccc4)c4ccc(Cl)cc43)nc2C)cc1,IC50,'=',175,nM,6.76,,,UO_0000065,13.07,0.26,-0.13,7.38,0,CHEMBL4711015,Inhibition of VEGFR2 (unknown origin) by Kinase-Glo max reagent-based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4706585,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,0.175
CHEMBL302279,,None,400.48,1,5.08,6,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(CO)n2C1CCCC1,IC50,'=',1080,nM,5.97,,,UO_0000065,14.9,0.27,0.89,6.92,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1.08
CHEMBL3690561,,None,497.48,0,3.95,BDBM128623,CC(=O)N1CC(n2cc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)C1,IC50,'>',300,nM,,,259865,UO_0000065,,,,,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690567,,None,487.51,0,4.91,BDBM128629,CNc1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc(SC)n1,IC50,'=',22,nM,7.66,,259872,UO_0000065,15.71,0.31,2.75,7.96,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690568,,None,481.5,1,6.27,BDBM128630,Cc1nc2cc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)ccc2s1,IC50,'=',110,nM,6.96,,259873,UO_0000065,14.45,0.28,0.69,9.76,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690578,,None,388.43,0,3.61,BDBM128641,CCNC(=O)Nc1cccc(-c2cnc3cc(-c4ncc(OC)cn4)ccn23)c1,IC50,'=',140,nM,6.85,,259889,UO_0000065,17.65,0.32,3.24,7.34,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694720,,None,457.42,0,3.22,BDBM128738,Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1CO,IC50,'=',400,nM,6.4,,259897,UO_0000065,13.99,0.26,3.18,4.9,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694646,,None,473.48,0,4.78,BDBM128659,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(NC5CC5)s4)ccn23)c1,IC50,'=',14,nM,7.85,,259903,UO_0000065,16.59,0.33,3.07,8.16,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694682,,None,470.41,0,3.93,BDBM128696,COC(=O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1,IC50,'=',260,nM,6.58,,259904,UO_0000065,14,0.26,2.66,5.96,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690590,,None,469.47,0,4.85,BDBM128653,CC(C)c1cnc(N)nc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1,IC50,'=',14,nM,7.85,,259907,UO_0000065,16.73,0.32,3,7.12,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694645,,None,529.55,2,5.55,BDBM128658,Cc1cn2nc(-c3ccn4c(-c5cc(NC(=O)NCC(F)(F)F)cc(OC(C)C)c5)cnc4c3)sc2n1,IC50,'=',12,nM,7.92,,259914,UO_0000065,14.96,0.29,2.37,8.09,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694684,,None,454.41,0,4.34,BDBM128698,CC(=O)c1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1,IC50,'=',150,nM,6.82,,259920,UO_0000065,15.02,0.28,2.48,6.74,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676342,,None,494.77,0,4.97,BDBM133804,C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3Cl)ncnc2cc1OCCNC(C)=O,IC50,'=',789,nM,6.1,,266662,UO_0000065,12.33,0.26,1.13,5.8,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676350,,None,532.99,1,4.64,BDBM133812,C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccnc4)c(Cl)c3)ncnc2cc1OCCNC(C)=O,IC50,'=',853,nM,6.07,,266670,UO_0000065,11.39,0.22,1.43,4.77,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671535,,None,504.32,1,4.13,BDBM133747,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)OC,IC50,'=',84,nM,7.08,,266605,UO_0000065,14.03,0.3,2.95,6.18,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671574,,None,585.43,1,3.91,BDBM133787,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C1CCCN1C(C)=O,IC50,'=',654,nM,6.18,,266645,UO_0000065,10.56,0.22,2.27,4.93,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671479,,None,554.42,2,5.2,BDBM133689,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)C=C)CC1,IC50,'=',203,nM,6.69,,266547,UO_0000065,12.07,0.25,1.49,6.94,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1230609,FORETINIB,2,632.66,2,5.77,Foretinib,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,'=',1.5,nM,8.82,,,UO_0000065,13.95,0.26,3.05,7.93,0,CHEMBL4342018,Inhibition of KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3747351,,None,421.28,0,4.02,25,Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL3750778,Inhibition of VEGFR2 (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745672,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,1
CHEMBL1682345,,None,275.31,0,2.87,4b,c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1,Ki,'>',8880,nM,,,,UO_0000065,,,,,0,CHEMBL1685405,Inhibition of KDR after 1 hr,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681644,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,8.88
CHEMBL1682353,,None,289.34,0,3.18,4k,Cc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1,Ki,'>',915,nM,,,,UO_0000065,,,,,0,CHEMBL1685405,Inhibition of KDR after 1 hr,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681644,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.915
CHEMBL3309965,,None,512.9,1,4.48,3o,COc1cc(=O)n(-c2ccc(Oc3ccnc(N)c3Cl)c(F)c2)cc1C(=O)NCc1ccc(F)cc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL3372650,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351718,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,25
CHEMBL1688344,,None,424.37,0,4.2,8,FC1(F)Oc2ccc(Nc3nnc(-c4cccnc4NCc4ccncc4)o3)cc2O1,IC50,'=',3160,nM,5.5,,,UO_0000065,12.96,0.24,1.3,5.13,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,3.16
CHEMBL203062,,None,402.41,0,3.65,15,c1cncc(CNc2ncccc2-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,10
CHEMBL1688348,,None,416.44,0,3.7,19,c1cncc(CCNc2ncccc2-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,10
CHEMBL1688248,,None,397.36,0,4.82,3,FC(F)(F)c1cccc(-c2nnc(-c3cccnc3NCc3ccncc3)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL1688344,,None,424.37,0,4.2,8,FC1(F)Oc2ccc(Nc3nnc(-c4cccnc4NCc4ccncc4)o3)cc2O1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL1683349,,None,383.45,0,4.88,7c,O=C(Nc1ccc2c(c1)CCC2)c1c[nH]c2cccc(OCc3ccncc3)c12,Inhibition,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL1687576,Inhibition of KDR assessed as phosphorylation level of substrate at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681739,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,19
CHEMBL4091628,,None,598.07,1,4.99,4,CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1,IC50,'=',48.7,nM,7.31,,,UO_0000065,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1277620,,None,378.2,0,4.29,3c,COc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1OC,IC50,'=',1650,nM,5.78,,,UO_0000065,15.29,0.34,1.49,10.28,1,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,1.65
CHEMBL1761936,,None,396.45,0,4.36,12,CCCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',400,nM,6.4,,,UO_0000065,16.14,0.3,2.04,6.76,0,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.4
CHEMBL1761944,,None,467.89,1,5.83,23,COc1cc2ncnc(Nc3ccc(NC(=O)Nc4ccc(F)c(Cl)c4)cc3)c2cc1OC,IC50,'=',4300,nM,5.37,,,UO_0000065,11.47,0.22,-0.46,5.51,0,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,4.3
CHEMBL494821,,None,348.45,0,3.93,10,Cc1ccn(CCC2CCCC2)c(=O)c1-c1ccc2nc(N)ncc2c1,IC50,'=',1400,nM,5.85,,,UO_0000065,16.8,0.31,1.92,7.93,0,CHEMBL955808,Inhibition of KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150317,1,Scientific Literature,J Med Chem,2008,None,,,,1.4
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',4.8,nM,8.32,,,UO_0000065,,,,,0,CHEMBL4021257,Inhibition of VEGFR-2 (unknown origin) by HTRF method,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4020722,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,4.8
CHEMBL3393804,,None,466.33,1,5.59,CLW15,Cc1cc(C(=O)Nc2ccc(Cl)c(C(=O)Nc3ccc(-c4ncc[nH]4)nc3)c2)ccc1Cl,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3396150,Inhibition of human recombinant VEGFR2 incubated for 1 hr using [gamma-32P]ATP by top count assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392978,1,Scientific Literature,Eur J Med Chem,2015,None,,,,
CHEMBL231526,,None,446.5,0,4.83,NP603,COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1,IC50,'=',930,nM,6.03,,,UO_0000065,13.51,0.25,1.2,5.99,0,CHEMBL1028054,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143293,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.93
CHEMBL1688249,,None,372.39,0,3.27,4,c1cnc(NCc2ccncc2)c(-c2nnc(-c3ccc4c(c3)OCO4)[nH]2)c1,IC50,'=',2300,nM,5.64,,,UO_0000065,15.14,0.28,2.37,5.76,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,2.3
CHEMBL4574669,,None,395.46,0,1.93,(R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL469883,,None,399.37,0,4.91,7,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cccnc1,IC50,'=',294,nM,6.53,,,UO_0000065,16.35,0.31,1.62,9.19,0,CHEMBL946389,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1158158,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.294
CHEMBL4754481,,None,471.59,1,5.97,12d,CCC/C=C/C(=O)Nc1cccc(Oc2nc(Nc3cccc(C#N)c3)nc3c2CSCC3)c1,Inhibition,,,%,,,Not Determined,UO_0000187,,,,,0,CHEMBL4730211,Inhibition of KDR (unknown origin) at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4725402,1,Scientific Literature,Bioorg Med Chem,2020,None,Dose = 1.0 microM,,,
CHEMBL4780534,,None,434.52,0,4.93,13a,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)cc3)nc3c2CSCC3)c1,Inhibition,'=',3.9,%,,,,UO_0000187,,,,,0,CHEMBL4730211,Inhibition of KDR (unknown origin) at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4725402,1,Scientific Literature,Bioorg Med Chem,2020,None,Dose = 1.0 microM,INHIBITOR,,3.9
CHEMBL4095441,,None,1078.22,None,None,2,CCN(CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C)CCOCCOCCOCc1cn(CCCCN2C[C@@H]3C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N3)nn1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4001116,Inhibition of VEGF-A-induced VEGFR2 phosphorylation in human EPC at 1 uM pretreated for 1 hr followed by VEGF-induction measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4000184,1,Scientific Literature,J Med Chem,2017,None,,,,
CHEMBL4093704,,None,497.56,1,-4.27,8,N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2C[C@@H](CN2CCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4001117,Inhibition of VEGF-A-induced VEGFR2 phosphorylation in human EPC at 1 uM coadministered with sunitinib pretreated for 1 hr followed by VEGF-induction measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4000184,1,Scientific Literature,J Med Chem,2017,None,,,,
CHEMBL4103890,,None,344.38,0,3.97,62,Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccnc4)cc3)c12,IC50,'=',3109,nM,5.51,,,UO_0000065,15.99,0.29,1.54,5.76,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,3109
CHEMBL4085974,,None,335.41,0,4,50,Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CCCC4)cc3)c12,IC50,'=',6229,nM,5.21,,,UO_0000065,15.52,0.28,1.21,6.29,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,6229
CHEMBL4092638,,None,414.51,1,5.42,37,CCN(CC)c1ccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)cc1,IC50,'=',5352,nM,5.27,,,UO_0000065,12.72,0.23,-0.15,6.13,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,5352
CHEMBL4092491,,None,503.53,2,5.88,6i,CC(C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,100
CHEMBL4066232,,None,421.5,0,4.45,6s,Cc1cccc(C)c1Nc1ncnc2ccc(NC(=O)CNC(=O)OC(C)(C)C)cc12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL4781587,,None,450.59,0,4.46,5h,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCNC4)cc1NC(=O)c1cccs1,Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,95
CHEMBL4785969,,None,539.62,1,4.94,7d,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccncc2)C4)cc1NC(=O)c1ccco1,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,92
CHEMBL4063380,,None,337.43,0,4.25,44,CCCCCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,50000
CHEMBL517647,,None,536.25,1,1.97,6b,NC(=O)C[C@H](N)C(=O)NCc1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL963872,Binding affinity to VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139272,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,30
CHEMBL3676346,,None,603.47,1,4.91,BDBM133808,C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCCNC(=O)CCN1CCCCC1,IC50,'=',140,nM,6.85,,266666,UO_0000065,11.36,0.24,1.94,6.32,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676347,,None,577.43,1,4.38,BDBM133809,C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCCNC(=O)CCCN(C)C,IC50,'=',958,nM,6.02,,266667,UO_0000065,10.42,0.22,1.64,5.55,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676352,,None,490.35,0,4.33,BDBM133814,C=CC(=O)Nc1cc2c(Nc3cc(OC)c(Cl)cc3Cl)ncnc2cc1OCCNC(C)=O,IC50,'=',10000,nM,5,,266672,UO_0000065,10.2,0.21,0.67,4.37,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890328,,None,435.96,0,4.2,BDBM202418,CC(N)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cc1,IC50,'=',209,nM,6.68,,358617,UO_0000065,15.32,0.29,2.48,6.25,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981577,,None,398.9,0,3.16,BDBM202440,Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C(C)(C)C(N)=O)n2)cn1,IC50,'=',370,nM,6.43,,358621,UO_0000065,16.12,0.31,3.27,6.52,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4797840,,None,551.57,1,4.8,1h,CNC(=O)c1cc(-n2ccc3cc(NC(=O)Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc32)ccn1,IC50,'=',173,nM,6.76,,,UO_0000065,12.26,0.23,1.96,7.15,0,CHEMBL4735616,Inhibition of KDR (unknown origin) in presence of [gamma33]-ATP by liquid scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732124,1,Scientific Literature,Eur J Med Chem,2021,None,,INHIBITOR,,173
CHEMBL3605107,,None,455.54,0,4.95,14g,CNC(=O)Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1,IC50,'=',284,nM,6.55,,,UO_0000065,14.37,0.27,1.6,6.89,0,CHEMBL3607491,Inhibition of KDR (unknown origin) using poly (Glu-Tyr,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944193,,None,418.46,1,6.27,24(g),Oc1ccc(-c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c(Oc2ccccc2)c1,Ki,'=',194,nM,6.71,,,UO_0000065,16.04,0.29,0.44,7.73,0,CHEMBL3881024,Inhibition of human 50 residues truncated cytoplasmic domain of phosphorylated VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.194
CHEMBL505253,,None,380.4,0,2.55,4,COc1cc(C2=C(c3c[nH]c4ccccc34)C(O)NC2=O)cc(OC)c1OC,IC50,'=',5900,nM,5.23,,,UO_0000065,13.75,0.26,2.68,5.63,0,CHEMBL957977,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157465,1,Scientific Literature,J Med Chem,2008,None,,,,5.9
CHEMBL3949392,,None,602.79,2,5.4,18c,COc1ccc(Cn2nc(-c3ccccc3)c3cc(Nc4ccc(N5CCN(C)CC5)cc4)nc(N4CCN(C)CC4)c32)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3857157,Inhibition of VEGF-165-induced VEGFR2 autophosphorylation at Tyr1175 in serum-starved HUVEC at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856209,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL3590222,,None,461.53,1,0.86,4,CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1,IC50,'=',9000,nM,5.05,,,UO_0000065,10.93,0.2,4.19,3.69,0,CHEMBL3591470,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588784,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,9
CHEMBL259381,,None,288.74,0,2.23,2b,Nc1nc(N)c2c(n1)NCCC(c1cccc(Cl)c1)=N2,IC50,'=',21000,nM,4.68,,,UO_0000065,16.2,0.32,2.45,4.58,0,CHEMBL927115,Inhibition of KDR in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,21
CHEMBL3586061,,None,551.36,2,7.04,W4,CC(C)(C)C(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cc(Br)ccc3OC(F)(F)F)cc2)cn1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,1000
CHEMBL514929,,None,390.49,1,5.72,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL461110,,None,429.51,1,5.28,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL491686,,None,399.48,1,5.27,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL473351,,None,430.49,1,5.37,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL448993,,None,566.61,2,7.57,26,CC(=O)c1cccc(-c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccccc6)C5=O)cc4F)c3s2)c1,IC50,'=',880,nM,6.06,,,UO_0000065,10.69,0.2,-1.51,6.59,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.88
CHEMBL449757,,None,625.73,2,7.05,19,O=C(Nc1ccc(Oc2ccnc3cc(-c4cn(CCCN5CCCC5)cn4)sc23)c(F)c1)N1CCN(c2ccccc2)C1=O,IC50,'=',8,nM,8.1,,,UO_0000065,12.94,0.25,1.05,8.45,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.008
CHEMBL3648127,,None,431.38,0,3.88,BDBM2674,CCC(CO)Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br,IC50,'=',170,nM,6.77,,11464,UO_0000065,15.69,0.39,2.89,6.84,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL510676,,None,528.57,2,6.1,20,Cn1ccnc1-c1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2s1,IC50,'=',31,nM,7.51,,,UO_0000065,14.21,0.27,1.41,8.11,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.031
CHEMBL3740781,,None,524.6,2,5.96,8t,CS(=O)(=O)Cc1cccc(Nc2cc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)ncn2)c1,IC50,'=',6.2,nM,8.21,,,UO_0000065,15.65,0.29,2.25,7.44,0,CHEMBL3745584,Inhibition of human recombinant VEGFR-2 expressed in baculovirus using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL500436,,None,453.54,1,5.3,40,O=C1Nc2cc(C(=O)O)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,1000
CHEMBL3593292,,None,545.67,2,5.3,7j,CCN1CCN(c2cc(Nc3ncc(-c4ccc(NC(=O)Nc5cc(C6CC6)on5)cc4)s3)nc(C)n2)CC1,IC50,'=',15,nM,7.82,,,UO_0000065,14.34,0.27,2.52,6.29,0,CHEMBL3595190,Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3593229,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,0.015
CHEMBL3628791,,None,279.73,0,4.23,7,Fc1ccc(Nc2ncnc3sccc23)cc1Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,10000
CHEMBL491872,,None,396.28,1,5.25,20,Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl,IC50,'=',630,nM,6.2,,,UO_0000065,15.65,0.31,0.95,11.15,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.63
CHEMBL460959,,None,438.41,1,5.29,25,FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL516635,,None,411.9,1,5.75,26,Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1,IC50,'=',190,nM,6.72,,,UO_0000065,16.32,0.31,0.97,12.08,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.19
CHEMBL3125884,,None,537.52,2,6.97,6A,N#Cc1c(Oc2cccc(NC(=O)Nc3ccc(C(F)(F)F)cc3)c2)ccc2nc(NC(=O)C3CC3)sc12,IC50,'=',330,nM,6.48,,,UO_0000065,12.06,0.23,-0.49,5.58,0,CHEMBL3129557,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate pretreated for 5 mins before substrate addition measured after overnight incubation,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124815,1,Scientific Literature,J Med Chem,2013,None,,,,330
CHEMBL522629,,None,361.84,0,4.59,3,Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1,IC50,'=',87,nM,7.06,,,UO_0000065,19.51,0.37,2.47,12.69,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.087
CHEMBL523301,,None,361.84,0,4.59,5,Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL498214,,None,402.46,0,2.04,19h,CN1CCN(C(=O)c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1,IC50,'=',26,nM,7.58,,,UO_0000065,18.85,0.35,5.55,6.83,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,0.026
CHEMBL521552,,None,290.33,0,3.11,16a,CNc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12,IC50,'=',220,nM,6.66,,,UO_0000065,22.93,0.41,3.55,9.05,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,0.22
CHEMBL4870768,,None,453.42,1,6.13,42,CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)ncn1,IC50,'=',13,nM,7.89,,,UO_0000065,17.39,0.33,1.76,8.94,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,13
CHEMBL4865373,,None,439.34,1,5.25,48,CNc1cc(Oc2c(F)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ncn1,IC50,'=',50,nM,7.3,,,UO_0000065,16.62,0.32,2.05,8.28,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,50
CHEMBL501256,,None,254.25,0,0.69,6,Nc1ncnc2c1ncn2CC(=O)c1cccnc1,IC50,'=',58000,nM,4.24,,,UO_0000065,16.66,0.3,3.55,4.25,0,CHEMBL949886,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137681,1,Scientific Literature,Eur J Med Chem,2009,None,,,,58
CHEMBL2180561,,None,484.4,0,4.01,III-2,COc1ccc(CNC(=O)c2nc(Br)c3cccnc3c2N[C@H]2CC[C@H](N)CC2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL2185474,Inhibition of KDR at 10 uM in presence of ATP at Km level by kinase profiler method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2176962,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL3656031,,None,464.43,0,4.83,BDBM110539,Cc1ccc(F)c(NC(=O)c2ccc(F)c(Oc3ccnc(-c4cc(C(=O)NO)c[nH]4)c3)c2)c1,IC50,'=',34,nM,7.47,,231425,UO_0000065,16.08,0.3,2.64,6.42,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL513422,,None,374.47,0,4.1,24,Cc1cccc(NC(=S)Nc2ccc(-c3cnc4ccnn4c3N)cc2)c1,IC50,'=',10000,nM,5,,,UO_0000065,13.35,0.25,0.9,6.23,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,10000
CHEMBL3660303,,None,402.43,1,5.96,BDBM110676,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4ccc[nH]4)c3)cc2)c1,IC50,'=',26,nM,7.58,,231561,UO_0000065,18.85,0.35,1.63,9.6,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3646210,,None,498.61,1,5.74,BDBM121388,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](C)O)c5)cnc(N)c34)cc2)c1,IC50,'=',1.6,nM,8.8,,249750,UO_0000065,17.64,0.33,3.06,7.45,0,CHEMBL3705427,Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3739750,,None,445.52,1,6.28,7a,CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,IC50,'=',4490,nM,5.35,,,UO_0000065,12,0.21,-0.93,7.89,0,CHEMBL3744324,Inhibition of VEGFR-2 (unknown origin) by microfluidic assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3739348,1,Scientific Literature,Medchemcomm,2015,None,,,,4.49
CHEMBL3741526,,None,509.99,2,6.9,7f,CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,IC50,'=',2870,nM,5.54,,,UO_0000065,10.87,0.2,-1.36,7.2,0,CHEMBL3744324,Inhibition of VEGFR-2 (unknown origin) by microfluidic assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3739348,1,Scientific Literature,Medchemcomm,2015,None,,,,2.87
CHEMBL368786,,None,361.86,0,3.79,59,OCCCNc1ncc(-c2cncc(Nc3cccc(Cl)c3)n2)s1,IC50,'=',708,nM,6.15,,,UO_0000065,17,0.35,2.36,7.41,0,CHEMBL829594,Inhibition of human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142725,1,Scientific Literature,J Med Chem,2005,None,,,,0.708
CHEMBL3678949,,None,495.01,1,5.44,BDBM173439,CC(C)n1c(Nc2ccc(F)c(Cl)c2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,IC50,'>',1000,nM,,,318783,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3674152,,None,515.62,1,3.8,BDBM173433,COc1cc(C(=O)NN2CCN(C)CC2)ccc1Nc1ncc2nc(Nc3ccccc3)n(C(C)C)c2n1,IC50,'>',1000,nM,,,318778,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL554,LAPATINIB,4,581.07,2,6.14,Lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,10000
CHEMBL306295,,None,328.38,0,4.06,60,Oc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1,IC50,'=',670,nM,6.17,,,UO_0000065,18.8,0.34,2.11,8.7,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.67
CHEMBL1078665,,None,477.35,0,4.89,19,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1100372,Inhibition of KDR at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154277,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,50
CHEMBL105436,,None,417.51,0,3.14,1t,COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL700241,Tested in vitro for inhibition of KDR-receptor tyrosine kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1
CHEMBL4468880,,None,527.53,2,6.39,9e,CC(C)C(=O)Nc1cc(Oc2ccc(Nc3nccc4[nH]cc(-c5ccc(F)cc5)c(=O)c34)cc2F)ccn1,IC50,'=',230.1,nM,6.64,,,UO_0000065,12.58,0.23,0.25,6.09,0,CHEMBL4376512,Inhibition of purified recombinant VEGFR2 kinase domain (unknown origin) using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4373740,1,Scientific Literature,Eur J Med Chem,2020,None,,,,230.1
CHEMBL3913774,,None,587.57,2,6.5,BDBM235578,CN1CCC(Oc2ccc(NC(=O)Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)cc2C(F)(F)F)CC1,IC50,'=',17.2,nM,7.76,,410213,UO_0000065,13.21,0.25,1.26,7.41,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910653,,None,473.43,1,5.98,BDBM235594,O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(Nc2ccnc(NC(=O)C3CC3)c2)cc1F,IC50,'=',9.3,nM,8.03,,410229,UO_0000065,16.96,0.32,2.05,8.44,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3901963,,None,571.58,2,6.83,BDBM235426,CN1CCC(c2ccc(NC(=O)Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)cc2C(F)(F)F)CC1,IC50,'=',15.6,nM,7.81,,410061,UO_0000065,13.66,0.26,0.98,8.17,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909183,,None,573.5,2,6.37,BDBM235431,CC1CN(c2cc(NC(=O)Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)cc(C(F)(F)F)c2)C(=O)O1,IC50,'=',4.2,nM,8.38,,410066,UO_0000065,14.61,0.28,2.01,6.87,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2011299,,None,382.64,0,3.58,BDBM50379222,NC(=O)c1c(-c2ccncc2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1N,IC50,'=',31000,nM,4.51,,421737,UO_0000065,11.78,0.26,0.93,4.52,1,CHEMBL3888877,Kinase Assay: FlashPlates from Perkin Elmer (Boston,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913166,,None,489.43,1,5.73,BDBM235460,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1NC(=O)Nc1ccc(F)c(C(F)(F)F)c1,IC50,'=',11,nM,7.96,,410095,UO_0000065,16.26,0.31,2.23,7.56,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3889544,,None,505.43,2,5.61,BDBM235470,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)ccc1NC(=O)Nc1cc(OC(F)(F)F)ccc1F,IC50,'=',8.1,nM,8.09,,410105,UO_0000065,16.01,0.31,2.48,7.07,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914330,,None,519.91,2,6.47,BDBM235481,Cc1cc(Oc2cc(NC(=O)C3CC3)ncn2)c(F)cc1NC(=O)Nc1ccc(Cl)c(C(C)(F)F)c1,IC50,'=',12.8,nM,7.89,,410116,UO_0000065,15.18,0.3,1.42,7.5,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919864,,None,489.43,1,5.73,BDBM235483,Cc1cc(NC(=O)Nc2cc(F)cc(C(F)(F)F)c2)cc(Oc2cc(NC(=O)C3CC3)ncn2)c1,IC50,'=',200,nM,6.7,,410118,UO_0000065,13.69,0.26,0.97,6.37,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3928634,,None,471.44,1,5.59,BDBM235484,Cc1cc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc(Oc2cc(NC(=O)C3CC3)ncn2)c1,IC50,'=',200,nM,6.7,,410119,UO_0000065,14.21,0.27,1.11,6.37,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5414550,,None,526.04,2,5.62,I2,COc1cc2c(Oc3ccc(NC(=O)NC4CCC4)c(Cl)c3)ncnc2cc1OCCCN1CCCC1,IC50,'=',2.74,nM,8.56,,,UO_0000065,16.28,0.32,2.94,8.75,0,CHEMBL5328005,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5325476,1,Scientific Literature,Bioorg Med Chem,2023,None,,INHIBITOR,,2.74
CHEMBL4871761,,None,468.54,0,4.57,19c,Cc1cccc(NC(=O)c2ccc(NC(=O)CSc3nc4ccccc4n4cnnc34)cc2)c1,IC50,'=',10.7,nM,7.97,,,UO_0000065,17.01,0.32,3.4,7.87,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,10.7
CHEMBL4866887,,None,438.45,0,2.94,22a,O=C(Cn1c(=O)c2nncn2c2ccccc21)Nc1ccc(C(=O)Nc2ccccc2)cc1,IC50,'=',63.4,nM,7.2,,,UO_0000065,16.42,0.3,4.26,6.52,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,63.4
CHEMBL3972455,,None,592.39,2,7,BDBM201215,O=C(Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4ccc(F)c(Cl)c4)cn3n2)cc1)Nc1ccc(F)c(Cl)c1,IC50,'=',2934,nM,5.53,,357145,UO_0000065,9.34,0.18,-1.47,4.92,0,CHEMBL3887844,PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5404512,,None,607.12,1,4.08,6f,O=C(CSc1nc2ccccc2c(=O)n1-c1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1)NCCc1ccccc1,IC50,'=',146,nM,6.84,,,UO_0000065,11.26,0.23,2.76,5.03,0,CHEMBL5386908,Inhibition of recombinant VEGFR2 (unknown origin) by kinase glo detection reagent based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5385860,1,Scientific Literature,Eur J Med Chem,2023,None,,INHIBITOR,,146
CHEMBL4078084,,None,347.38,0,3.85,52,Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCc4ccco4)cc3)c12,IC50,'=',3503,nM,5.46,,,UO_0000065,15.7,0.29,1.61,5.69,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,3503
CHEMBL4096138,,None,349.44,0,4.39,51,Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CCCCC4)cc3)c12,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,50000
CHEMBL3963696,,None,635.06,2,5.57,BDBM208471,COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)c1,IC50,'=',6,nM,8.22,,368416,UO_0000065,12.95,0.26,2.65,5.84,0,CHEMBL3888028,VEGFR2 Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL598435,,None,327.35,0,2.95,20b,O=C1Cc2cnc3cc(-c4ccccc4)nn3c2-c2ncccc2N1,IC50,'=',16000,nM,4.8,,,UO_0000065,14.65,0.26,1.85,6.64,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,16
CHEMBL5440517,,None,571.63,2,2.44,TN-2,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL5379612,Inhibition of VEGF-induced VEGFR2 signal pathway in HUVECs assessed as reduction in p-VEGFR2 level at 12.5 uM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5375999,1,Scientific Literature,J Med Chem,2023,None,DOSE = 12.5 microM,INHIBITOR,,50
CHEMBL608738,,None,433.31,1,5.92,5,CC(Oc1ccc2ncc(/C=C/C(=O)N(C)C)cc2c1)c1c(Cl)ccc(F)c1Cl,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL1066394,Inhibition of recombinant KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,50000
CHEMBL5424475,,None,546.6,1,4.41,4a,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)Nc5nc6c(C(N)=O)cccc6[nH]5)cc4)n3)cc2nn1C,IC50,'=',260,nM,6.58,,,UO_0000065,12.05,0.22,2.18,4.12,0,CHEMBL5324545,Inhibition of VEGFR2 (unknown origin) by Z'-Lyte kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5321287,1,Scientific Literature,J Med Chem,2023,None,,INHIBITOR,,260
CHEMBL5424406,,None,517.6,2,5.13,9b,Cc1cnc(Nc2ccc(-c3nc4c(C(N)=O)cccc4[nH]3)cc2)nc1N(C)c1ccc2c(C)n(C)nc2c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL5324545,Inhibition of VEGFR2 (unknown origin) by Z'-Lyte kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5321287,1,Scientific Literature,J Med Chem,2023,None,,,,10000
CHEMBL5422955,,None,462.89,1,6.46,16b,CN(c1ccc(Cl)cc1)c1ccnc(Nc2ccc(-c3nc4cc(F)c(F)cc4[nH]3)cc2)n1,IC50,'=',427,nM,6.37,,,UO_0000065,13.76,0.26,-0.09,9.13,0,CHEMBL5324545,Inhibition of VEGFR2 (unknown origin) by Z'-Lyte kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5321287,1,Scientific Literature,J Med Chem,2023,None,,INHIBITOR,,427
CHEMBL5433132,,None,474.57,1,6.03,21b,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1-c1nc2ccccc2[nH]1,IC50,'=',171,nM,6.77,,,UO_0000065,14.26,0.26,0.74,7.73,0,CHEMBL5324545,Inhibition of VEGFR2 (unknown origin) by Z'-Lyte kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5321287,1,Scientific Literature,J Med Chem,2023,None,,INHIBITOR,,171
CHEMBL231511,,None,450.57,1,7.16,10,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccccc5)cnc(N)c34)cc2)c1,IC50,'=',13,nM,7.89,,,UO_0000065,17.5,0.33,0.73,9.85,1,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,13
CHEMBL3986748,,None,588.76,2,5.06,18b,COc1ccc(Cn2nc(-c3ccccc3)c3cc(Nc4ccc(N5CCN(C)CC5)cc4)nc(N4CCNCC4)c32)cc1,Inhibition,,,%,,,,UO_0000187,,,,,0,CHEMBL3857164,Inhibition of VEGF-165-induced VEGFR2 autophosphorylation in serum-starved HUVEC assessed as decrease in p38 MAPK phosphorylation at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856209,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL3958054,,None,490.61,1,5.31,18a,COc1ccc(Cn2nc(-c3ccccc3)c3cc(Nc4ccccc4)nc(N4CCNCC4)c32)cc1,Inhibition,,,%,,,,UO_0000187,,,,,0,CHEMBL3857160,Inhibition of VEGF-165-induced VEGFR2 autophosphorylation at Tyr996 in serum-starved HUVEC at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856209,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL4089245,,None,456.45,0,4.53,1,C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1,Inhibition,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL4018326,Inhibition of human VEGFR2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4017480,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,19
CHEMBL4099062,,None,630.55,2,6.11,4h,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(Br)cc5)CC4)cc3)nc2n1C1CCCC1,Inhibition,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL4056530,Inhibition of human VEGFR2 at 1 uM by enzymatic radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052710,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,26
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',70.9,%,,,,UO_0000187,,,,,0,CHEMBL4055528,Inhibition of VEGFR2 in human BT474 cells assessed as downregulation of phosphorylated paxillin levels at 20 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,70.9
CHEMBL4206212,,None,488.47,0,4.33,CSR35,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)O)c(F)c3)c(F)c2)ccn1,Inhibition,'=',35.8,%,,,,UO_0000187,,,,,0,CHEMBL4188395,Inhibition of N-terminal GST tagged recombinant human KDR (789 to end residues) expressed in baculovirus infected Sf9 cells at 20 uM using poly-E4Y1 substrate incubated for 2 hrs by ADP-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4184261,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,,,,35.8
CHEMBL2152970,,None,464.51,0,4.75,29f,O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2155702,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2150974,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL3823809,,None,339.38,0,2.65,8,CS(=O)(=O)c1ccc2nccc(Nc3ccc4[nH]nnc4c3)c2c1,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL3825642,Inhibition of VEGFR2(unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3822396,1,Scientific Literature,J Med Chem,2016,None,,,,5000
CHEMBL3823527,,None,280.33,0,4,19,COc1ccc2nccc(Nc3cc(O)ccc3C)c2c1,IC50,'=',3000,nM,5.52,,,UO_0000065,19.7,0.36,1.52,10.16,0,CHEMBL3825642,Inhibition of VEGFR2(unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3822396,1,Scientific Literature,J Med Chem,2016,None,,,,3000
CHEMBL3696098,,None,535.6,2,5.63,BDBM144613,COc1ccc(CNc2nsc(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2C(N)=O)c(OC)c1,IC50,'=',98,nM,7.01,,280973,UO_0000065,13.09,0.25,1.38,5.49,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660294,,None,446.44,1,5.66,BDBM110666,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)O)c[nH]4)c3)cc2)c1,IC50,'=',31,nM,7.51,,231551,UO_0000065,16.82,0.31,1.85,6.45,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5267844,,None,625.71,2,3.96,82,Cc1c(C(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCCN4CCN(C)CC4)c3)c(F)c2)c(=O)n(-c2ccccc2)n1C,IC50,'=',190,nM,6.72,,,UO_0000065,10.74,0.2,2.76,5.83,0,CHEMBL5263723,Inhibition of VEGFR-2 (unknown origin) kinase activity using poly(Glu-Tyr) at 4:1 ratio as substrate in presence of ATP incubated for 60 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5260829,1,Scientific Literature,Eur J Med Chem,2018,None,TIME = 1.0 hr,INHIBITOR,,0.19
CHEMBL3794032,,None,370.41,0,3.88,7,O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCCO3,Inhibition,'=',45,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915330,,None,408.4,1,5.22,10,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(O)cc1,Inhibition,'<',40,%,,,,UO_0000187,,,,,0,CHEMBL1920421,Inhibition of KDR using Tyr 01 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914443,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,40
CHEMBL4163161,,None,399.46,0,4.58,10b,CCn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(C)cc3)n4C)ncnc21,Inhibition,'=',85.5,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,85.5
CHEMBL2016918,,None,409.47,0,2.43,34,O=C(CN1CCCCC1)N1CCc2nc(-c3cc4c(F)cccc4[nH]c3=O)[nH]c2C1,IC50,'=',740,nM,6.13,,,UO_0000065,14.97,0.28,3.7,7.21,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.74
CHEMBL2016920,,None,425.92,0,2.94,36,O=C(CN1CCCCC1)N1CCc2nc(-c3cc4cc(Cl)ccc4[nH]c3=O)[nH]c2C1,IC50,'=',22,nM,7.66,,,UO_0000065,17.98,0.35,4.72,9,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.022
CHEMBL2016927,,None,419.87,0,3.09,43,O=C(Cc1ccncc1)N1CCc2nc(-c3cc4cc(Cl)ccc4[nH]c3=O)[nH]c2C1,IC50,'=',0.5,nM,9.3,,,UO_0000065,22.15,0.42,6.21,9.82,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.0005
CHEMBL3758229,,None,402.84,0,3.7,6da,COc1cc2ncnc(Nc3ccc(Cl)cc3)c2cc1OCCCC(=O)NO,IC50,'=',182,nM,6.74,,,UO_0000065,16.73,0.33,3.04,6.38,0,CHEMBL3762407,Inhibition of VEGFR2 (unknown origin) preincubated for 5 mins followed by addition of ATP/gastrin precursor(Tyr87) biotinylated peptide cocktail incubated for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758114,1,Scientific Literature,Eur J Med Chem,2016,None,,,,182
CHEMBL3323601,,None,354.39,1,5.66,7j,Fc1ccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)cc1,IC50,'=',1360,nM,5.87,,,UO_0000065,16.55,0.3,0.21,10.94,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,1.36
CHEMBL1915333,,None,407.42,1,5.09,13,Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1,Inhibition,'<',40,%,,,,UO_0000187,,,,,0,CHEMBL1920328,Inhibition of KDR using Tyr 01 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914443,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,40
CHEMBL3394108,,None,482.54,0,4.58,6o,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL3395940,Inhibition of KDR (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393036,1,Scientific Literature,J Med Chem,2015,None,,,,50
CHEMBL4090562,,None,516.05,1,4.5,21,Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccc(Cl)cc12,EC50,'=',196,nM,6.71,,,UO_0000065,13,0.25,2.21,6.64,0,CHEMBL4057777,Inhibition of VEGF stimulated VEGFR2 phosphorylation at Y165 residues in HUVEC preincubated for 1 hr followed by VEGF addition measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052763,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.196
CHEMBL4067869,,None,519.65,1,4.36,26,Cc1csc2c(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)c(F)c4)nc3N)ncnc12,EC50,'=',90,nM,7.05,,,UO_0000065,13.56,0.26,2.69,6.97,0,CHEMBL4057777,Inhibition of VEGF stimulated VEGFR2 phosphorylation at Y165 residues in HUVEC preincubated for 1 hr followed by VEGF addition measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052763,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.09
CHEMBL3696092,,None,406.39,0,3.76,BDBM144607,NC(=O)c1c(-c2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)nsc1N,IC50,'=',1640,nM,5.79,,280967,UO_0000065,14.24,0.28,2.03,5.21,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3746776,,None,443.51,0,4.11,3,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C)CC4)[nH]n3)c2)CN1,IC50,'=',0.9,nM,9.05,,,UO_0000065,20.4,0.37,4.94,8.24,1,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,0.9
CHEMBL3261228,,None,250.28,0,2.09,1,CCOC(=O)c1sc(-c2ccncc2)nc1O,Inhibition,'=',74,%,,,,UO_0000187,,,,,0,CHEMBL3266946,Inhibition of VEGFR2 (unknown origin) at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259739,1,Scientific Literature,Eur J Med Chem,2014,None,,,,74
CHEMBL3741413,,None,559.05,2,6.62,8h,CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)n2)c1,IC50,'=',26.1,nM,7.58,,,UO_0000065,13.56,0.27,0.96,6.88,0,CHEMBL3745584,Inhibition of human recombinant VEGFR-2 expressed in baculovirus using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3740574,,None,489.54,1,5.78,3j,CNC(=O)c1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1,IC50,'=',1.8,nM,8.74,,,UO_0000065,17.86,0.32,2.96,8.31,0,CHEMBL3745584,Inhibition of human recombinant VEGFR-2 expressed in baculovirus using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3741621,,None,525.59,2,5.33,3i,CNS(=O)(=O)c1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1,IC50,'=',4.1,nM,8.39,,,UO_0000065,15.96,0.3,3.06,6.86,0,CHEMBL3745584,Inhibition of human recombinant VEGFR-2 expressed in baculovirus using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3656106,,None,517.52,1,4.86,BDBM110617,COC(=O)CNC(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)ccn2)c1,IC50,'=',30,nM,7.52,,231502,UO_0000065,14.54,0.27,2.66,5.6,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5432289,,None,452.47,0,3.36,13a,NS(=O)(=O)c1ccc(NC(=O)Nc2nc(-c3ccccc3)n(-c3ccc(F)cc3)n2)cc1,IC50,'=',26.3,nM,7.58,,,UO_0000065,16.75,0.32,4.22,5.74,0,CHEMBL5352293,Inhibition of VEGFR-2 (unknown origin) incubated for 45 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5346980,1,Scientific Literature,J Med Chem,2023,None,TIME = 0.75 hr,INHIBITOR,,26.3
CHEMBL4213590,,None,444.44,0,1.03,2,CCCc1cc(O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc2c1C(=O)c1c(O)cc(O)cc1C2=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4201777,Inhibition of VEGFR2 phosphorylation in VEGF-stimulated HUVEC at 10 to 50 uM after 6 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4196206,1,Scientific Literature,J Nat Prod,2018,None,,,,
CHEMBL4877180,,None,454.52,0,4.26,19a,O=C(CSc1nc2ccccc2n2cnnc12)Nc1ccc(C(=O)Nc2ccccc2)cc1,IC50,'=',3.4,nM,8.47,,,UO_0000065,18.63,0.35,4.21,8.36,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,3.4
CHEMBL4868604,,None,468.54,0,3.94,19i,O=C(CSc1nc2ccccc2n2cnnc12)Nc1ccc(C(=O)NCc2ccccc2)cc1,IC50,'=',21.7,nM,7.66,,,UO_0000065,16.36,0.31,3.72,7.57,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,21.7
CHEMBL1681941,,None,413.83,0,3.52,4k,CO/N=C/c1c(N)ncnc1Oc1ccc(NC(=O)Nc2cccnc2)c(Cl)c1,IC50,'=',10,nM,8,,,UO_0000065,19.33,0.38,4.48,5.85,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,10
CHEMBL3753623,,None,404.35,0,4.69,6h,COc1ccc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3ccncc3)c2)cn1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,500
CHEMBL1681934,,None,378.82,0,3.01,4d,CO/N=C/c1c(N)ncnc1Oc1ccc(NC(=O)NC(C)C)c(Cl)c1,IC50,'=',73,nM,7.14,,,UO_0000065,18.84,0.37,4.13,5.77,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,73
CHEMBL147112,,None,402.45,0,4.51,11g,COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C,IC50,'=',40,nM,7.4,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,0.04
CHEMBL3656095,,None,529.57,2,5.56,BDBM110606,Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CCCC(O)C5)c[nH]4)c3)cc2F)c1,IC50,'=',12,nM,7.92,,231491,UO_0000065,14.96,0.28,2.36,6.62,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3699444,,None,535.6,1,3.15,BDBM147463,COc1cc(C2=C(c3cn(CCOC(=O)C(N)CC(C)C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC,IC50,'=',251,nM,6.6,,284787,UO_0000065,12.32,0.23,3.45,5.03,0,CHEMBL3706274,Kinase Assay: The effect of test compounds on the activity of the protein kinases GSK-3β,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3740930,,None,522.61,2,7.33,7g,Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL3744322,Inhibition of VEGFR-2 (unknown origin) at 30 uM by microfluidic assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3739348,1,Scientific Literature,Medchemcomm,2015,None,,,,100
CHEMBL3740713,,None,536.64,2,7.63,7h,Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL3744322,Inhibition of VEGFR-2 (unknown origin) at 30 uM by microfluidic assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3739348,1,Scientific Literature,Medchemcomm,2015,None,,,,100
CHEMBL3740930,,None,522.61,2,7.33,7g,Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1,IC50,'=',3450,nM,5.46,,,UO_0000065,10.45,0.19,-1.87,6.85,0,CHEMBL3744324,Inhibition of VEGFR-2 (unknown origin) by microfluidic assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3739348,1,Scientific Literature,Medchemcomm,2015,None,,,,3.45
CHEMBL3753142,,None,364.35,0,4.87,7b,O=C(Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1)Nc1nccs1,IC50,'=',57.36,nM,7.24,,,UO_0000065,19.87,0.4,2.37,10.82,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,57.36
CHEMBL3758725,,None,475.34,0,4.59,6ec,COc1cc2ncnc(Nc3ccccc3Br)c2cc1OCCCCCC(=O)NO,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3762407,Inhibition of VEGFR2 (unknown origin) preincubated for 5 mins followed by addition of ATP/gastrin precursor(Tyr87) biotinylated peptide cocktail incubated for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758114,1,Scientific Literature,Eur J Med Chem,2016,None,,,,10000
CHEMBL3759313,,None,428.46,0,4.36,6ad,COc1cc2ncnc(Nc3ccccc3F)c2cc1OCCCCCCC(=O)NO,IC50,'=',754,nM,6.12,,,UO_0000065,14.29,0.27,1.76,5.8,0,CHEMBL3762407,Inhibition of VEGFR2 (unknown origin) preincubated for 5 mins followed by addition of ATP/gastrin precursor(Tyr87) biotinylated peptide cocktail incubated for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758114,1,Scientific Literature,Eur J Med Chem,2016,None,,,,754
CHEMBL3323612,,None,405.29,1,6.83,7s,Clc1ccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)cc1Cl,IC50,'=',30,nM,7.52,,,UO_0000065,18.56,0.37,0.69,14.04,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,0.03
CHEMBL4100979,,None,447.45,0,4.45,10g,Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)c(F)c5)CC4)cc3)c12,IC50,'=',1.4,nM,8.85,,,UO_0000065,19.79,0.37,4.4,7.84,0,CHEMBL3993539,Inhibition of VEGFR2 (unknown origin) after 60 mins by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992524,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1.4
CHEMBL3323613,,None,405.29,1,6.83,7t,Clc1cc(Cl)cc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)c1,IC50,'=',80,nM,7.1,,,UO_0000065,17.51,0.35,0.27,13.24,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,0.08
CHEMBL3397928,,None,402.49,0,4.79,17d,O=C(Nc1ccc(OCCN2CCCC2)cc1)c1cccc(-c2cccc(O)c2)c1,IC50,'=',31.98,nM,7.5,,,UO_0000065,18.62,0.34,2.71,12.13,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,31.98
CHEMBL4863009,,None,511.9,2,5.88,W1,O=C(Cn1cc(-c2ccc3c(Nc4cccnc4)n[nH]c3c2)cn1)Nc1ccc(Cl)c(C(F)(F)F)c1,INH,'=',53.8,uM,,,,UO_0000064,,,,,0,CHEMBL4820637,Inhibition of VEGFR2 (unknown origin) at 1 uM incubated for 10 mins followed by kinase substrate addition and measured after 30 mins by caliper mobility shift assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 1.0 microM | TIME = 0.6667 hr,INHIBITOR,,53.8
CHEMBL4860732,,None,486.43,0,4.57,W12,O=C(Cn1cc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cn1)Nc1cccc(C(F)(F)F)c1F,IC50,'=',12,nM,7.92,,,UO_0000065,16.28,0.31,3.35,7.57,0,CHEMBL4820638,Inhibition of VEGFR2 (unknown origin) incubated for 10 mins followed by kinase substrate addition and measured after 30 mins by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 0.6667 hr,INHIBITOR,,12
CHEMBL3957803,,None,312.37,1,5.11,28(b),Oc1ccc(-c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)cc1,Inhibition,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL3881021,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,96
CHEMBL3953845,,None,336.4,1,5.28,52(b),C(=C/c1n[nH]c2cc(-c3ccnc4[nH]ccc34)ccc12)\c1ccccc1,Inhibition,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL3881021,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,94
CHEMBL3936535,,None,337.39,0,4.67,29(q),C(=C/c1n[nH]c2cc(-c3ccncc3)ccc12)\c1nc2ccccc2[nH]1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL3881021,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,11
CHEMBL3648111,,None,444.36,0,3.21,BDBM2491,COc1cc(Nc2ncc(Br)c(N[C@H](C)[C@@H](C)O)n2)ccc1S(C)(=N)=O,IC50,'=',31,nM,7.51,,6378,UO_0000065,16.9,0.39,4.3,6.25,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3586073,,None,509.28,2,5.41,W16,CNC(=O)c1ccc(-c2ccc(NC(=O)Nc3cc(Br)ccc3OC(F)(F)F)cc2)cn1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,
CHEMBL4797847,,None,556.68,1,4.8,7k,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cnccn2)C4)cc1NC(=O)c1cccs1,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,80
CHEMBL4853979,,None,404.37,0,2.84,18,CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3c(c21)CC(=O)N3,IC50,'=',288,nM,6.54,,,UO_0000065,,,,,0,CHEMBL4810176,Inhibition of VEGFR2 (unknown origin) incubated for 90 mins in presence of ATP by HTRF assay,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808209,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,288
CHEMBL4856613,,None,338.37,0,3.16,3,COc1cc(OC)cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1,IC50,'=',452,nM,6.34,,,UO_0000065,,,,,0,CHEMBL4810140,Inhibition of human recombinant N-terminal His6-tagged VEGFR2 expressed in baculovirus infected Sf21insect cells using biotin-labeled EQEDEPEGDYFEWLE peptide as substrate incubated for 20 mins in presence of ATP by plate reader assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808209,1,Scientific Literature,J Med Chem,2021,None,TIME = 0.3333 hr,INHIBITOR,,452
CHEMBL4863146,,None,407.26,0,4.46,5,COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1Cl,IC50,'=',162,nM,6.79,,,UO_0000065,,,,,0,CHEMBL4810140,Inhibition of human recombinant N-terminal His6-tagged VEGFR2 expressed in baculovirus infected Sf21insect cells using biotin-labeled EQEDEPEGDYFEWLE peptide as substrate incubated for 20 mins in presence of ATP by plate reader assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808209,1,Scientific Literature,J Med Chem,2021,None,TIME = 0.3333 hr,INHIBITOR,,162
CHEMBL534948,,None,478.04,1,5.48,14c-HCl,Cc1cccc(C)c1Nc1ncc(-c2ccc(OCC3CCCN(C)C3)cc2)n2cncc12.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL919738,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144561,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,10
CHEMBL3656100,,None,559.6,2,6.03,BDBM110611,CCOC(=O)CCCNC(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)ccn2)c1,IC50,'=',38,nM,7.42,,231496,UO_0000065,13.26,0.25,1.39,5.52,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2023482,,None,433.46,0,4.78,16,CCc1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)ccc34)cc2OC)no1,IC50,'=',20,nM,7.7,,,UO_0000065,17.76,0.33,2.92,8.04,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.02
CHEMBL1967116,,None,454.56,1,5.9,16,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1,IC50,'=',14,nM,7.85,,,UO_0000065,17.28,0.33,1.95,8.03,0,CHEMBL2024778,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,CHEMBL3307716,,,,14
CHEMBL4087886,,None,546.67,2,6.43,8e,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCC(C)CC2)cc1)c1ccccc1,Inhibition,'=',77.1,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,77.1
CHEMBL4095586,,None,550.68,2,5.75,8g,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCSCC2)cc1)c1ccccc1,Inhibition,'=',76.9,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,76.9
CHEMBL333021,L-21649,1,404.54,0,4.99,56,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1,IC50,'=',18,nM,7.75,,,UO_0000065,19.14,0.36,2.75,18.15,0,CHEMBL3995189,Inhibition of recombinant human GST-fused KDR kinase expressed in insect Sf21 cells using poly-Glu/Tyr (4:1) peptide as substrate by ECMA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994587,1,Scientific Literature,Eur J Med Chem,2017,None,,,,18
CHEMBL411050,,None,526.6,1,4.08,15,Cc1ccc(NC(=O)c2cnoc2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,IC50,'=',3784,nM,5.42,,,UO_0000065,10.3,0.19,1.34,4.22,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,3784
CHEMBL408070,,None,589.62,2,5.8,10b,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,IC50,'=',5,nM,8.3,,,UO_0000065,14.08,0.26,2.5,8.1,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,5
CHEMBL3323595,,None,350.43,1,5.83,7d,Cc1ccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)cc1,IC50,'=',4650,nM,5.33,,,UO_0000065,15.22,0.27,-0.5,9.95,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,4.65
CHEMBL3577119,,None,410.5,0,4.74,8,CNc1ncc2cc(-c3ccc(F)c(NC(=O)NCCC(C)(C)C)c3)c(C)nc2n1,IC50,'=',750,nM,6.12,,,UO_0000065,14.92,0.28,1.38,6.67,0,CHEMBL3578340,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576847,1,Scientific Literature,J Med Chem,2015,None,,,,0.75
CHEMBL402182,,None,480.59,1,5.41,7d,CC(C)n1c2ccc(C(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',15,nM,7.82,,,UO_0000065,16.28,0.31,2.41,11.35,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,15
CHEMBL401900,,None,426.52,0,4.4,6g,CC(=O)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',21,nM,7.68,,,UO_0000065,18,0.33,3.28,11.14,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,21
CHEMBL271563,,None,518.49,2,7.47,58,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5cccc(C(F)(F)F)c5)cccc4c3)c2cc1OC,IC50,'=',0.5,nM,9.3,,,UO_0000065,17.94,0.33,1.83,13.35,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.5
CHEMBL257292,,None,358.41,0,4.16,13b,Cc1ccccc1NC(=O)Nc1ccc(-c2ccnc3[nH]nc(N)c23)cc1,IC50,'=',35,nM,7.46,,,UO_0000065,20.8,0.38,3.3,6.86,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,35
CHEMBL269871,,None,402.45,0,4.95,15,CCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12,IC50,'=',1.3,nM,8.89,,,UO_0000065,22.08,0.4,3.94,12.75,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,1.3
CHEMBL255746,,None,378.82,0,4.5,13e,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',1.5,nM,8.82,,,UO_0000065,23.29,0.45,4.32,8.12,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,1.5
CHEMBL2429872,,None,541.72,1,3.62,29,CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(S(=O)(=O)N(CC)CC)cc21,IC50,'=',330.3,nM,6.48,,,UO_0000065,11.96,0.23,2.86,5.65,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,330.3
CHEMBL255406,,None,426.52,0,4.54,6e,CCCCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',26,nM,7.58,,,UO_0000065,17.78,0.32,3.05,11.01,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,26
CHEMBL406909,,None,398.47,0,3.76,6c,CCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',13,nM,7.89,,,UO_0000065,19.79,0.36,4.13,11.44,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,13
CHEMBL409912,,None,428.37,1,5.62,25,Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccccc4OC(F)(F)F)cc3)c12,IC50,'=',806,nM,6.09,,,UO_0000065,14.23,0.27,0.47,5.95,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,806
CHEMBL273048,,None,460.39,1,6.07,55,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OC(F)(F)F)c4onc(N)c34)cc2)c1,IC50,'=',179,nM,6.75,,,UO_0000065,14.66,0.28,0.68,6.59,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,179
CHEMBL410504,,None,362.36,0,4.86,24,Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12,IC50,'=',497,nM,6.3,,,UO_0000065,17.4,0.32,1.44,6.77,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,497
CHEMBL4204192,,None,453.42,0,4.93,5,CC(=O)Nc1cn2cc(-c3cc(NC(=O)c4cc(C(F)(F)F)ccn4)ccc3C)ccc2n1,IC50,'=',2000,nM,5.7,,,UO_0000065,,,,,0,CHEMBL4181660,Inhibition of VEGFR2 (unknown origin),A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177673,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,2
CHEMBL270058,,None,471.51,1,5.78,11,COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C)c2cc1OC,IC50,'=',1,nM,9,,,UO_0000065,19.09,0.35,3.22,10.96,0,CHEMBL950174,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144028,1,Scientific Literature,J Med Chem,2008,None,,,,1
CHEMBL270692,,None,497.56,1,5.34,2,COc1cc(Nc2ncnc(-n3c(Nc4c(C)cccc4C)nc4ccccc43)n2)cc(OC)c1OC,IC50,'=',4,nM,8.4,,,UO_0000065,16.88,0.31,3.06,7.76,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,0.004
CHEMBL4212439,,None,473.56,1,-0.32,1,CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,Inhibition,'<',25,%,,,,UO_0000187,,,,,0,CHEMBL4179661,Inhibition of recombinant human N-terminal GST-tagged VEGFR2 (D807 to V1356 residues) expressed in Sf9 insect cells at 1 uM using Poly(Glu:Tyr)4:1 as substrate by filter binding method relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177600,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,25
CHEMBL4217392,,None,474.55,1,-0.92,2,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,Inhibition,'<',25,%,,,,UO_0000187,,,,,0,CHEMBL4179661,Inhibition of recombinant human N-terminal GST-tagged VEGFR2 (D807 to V1356 residues) expressed in Sf9 insect cells at 1 uM using Poly(Glu:Tyr)4:1 as substrate by filter binding method relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177600,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,25
CHEMBL234009,,None,352.39,0,2.79,34,COc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1OC,IC50,'=',440,nM,6.36,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.44
CHEMBL233822,,None,394.78,0,4.45,31,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccnn1CCc1ccncc1,IC50,'=',750,nM,6.12,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.75
CHEMBL391069,,None,343.39,0,3.32,28,O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1,IC50,'=',180,nM,6.75,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.18
CHEMBL3747182,,None,453.42,1,5.49,33h,C[C@@H]1NCc2ncnc(Oc3ccc4c(ccn4C(=O)Nc4cccc(C(F)(F)F)c4)c3)c21,IC50,'=',118,nM,6.93,,,UO_0000065,15.28,0.29,1.44,8.55,0,CHEMBL3749262,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse BaF3 cells using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3746595,,None,428.37,0,4.81,5a,O=C(Nc1cccc(C(F)(F)F)c1)n1ccc2cc(Oc3cc(CO)ncn3)ccc21,IC50,'=',4,nM,8.4,,,UO_0000065,19.6,0.37,3.59,9.41,0,CHEMBL3749262,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse BaF3 cells using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3745924,,None,481.48,1,5.7,33f,CCN1CCc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cccc(C(F)(F)F)c3)c2)C1,IC50,'=',10,nM,8,,,UO_0000065,16.62,0.31,2.3,11.07,0,CHEMBL3749261,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745705,1,Scientific Literature,J Med Chem,2015,None,,,,10
CHEMBL3660279,,None,500.41,2,6.37,BDBM110651,O=C(Nc1ccc(Oc2ccnc(-c3cc(C(=O)O)c[nH]3)c2)cc1)Nc1ccc(F)c(C(F)(F)F)c1,IC50,'=',54,nM,7.27,,231536,UO_0000065,14.52,0.28,0.9,6.25,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4217462,,None,440.55,1,5.82,6,CC(=O)Nc1cn2cc(-c3cc(NC(=O)c4cccc(C(C)(C)C)c4)ccc3C)ccc2n1,IC50,'=',44,nM,7.36,,,UO_0000065,,,,,0,CHEMBL4181660,Inhibition of VEGFR2 (unknown origin),A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177673,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.044
CHEMBL3092308,,None,514.99,1,4.55,8f,O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3095062,Inhibition of KDR (unknown origin) expressed in baculovirus expression system using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3323593,,None,350.43,1,5.83,7b,Cc1ccccc1-c1nc2ccc(Nc3ccnc4ccccc34)cc2[nH]1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,10
CHEMBL3323599,,None,354.39,1,5.66,7h,Fc1ccccc1-c1nc2ccc(Nc3ccnc4ccccc34)cc2[nH]1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,10
CHEMBL4163188,,None,385.43,0,3.65,9v,Cn1ncc2c(Oc3ccc4c(c3)nc(NCc3ccccc3)n4C)ncnc21,Inhibition,'=',9.12,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,9.12
CHEMBL4171139,,None,501.9,2,6.5,11c,CC(C)n1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(Cl)c(C(F)(F)F)c3)n4C)ncnc21,Inhibition,'=',6.1,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,6.1
CHEMBL4173458,,None,427.51,1,5.08,9j,Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(C(C)(C)C)cc3)n4C)ncnc21,IC50,'=',140,nM,6.85,,,UO_0000065,16.03,0.29,1.77,8.29,0,CHEMBL4155774,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,140
CHEMBL367442,,None,316.36,0,3.16,1m,Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CO)cc1,IC50,'=',600,nM,6.22,,,UO_0000065,19.67,0.35,3.06,8.08,0,CHEMBL700241,Tested in vitro for inhibition of KDR-receptor tyrosine kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.6
CHEMBL4788768,,None,414.47,0,4.95,14c,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccc(C)cc4)cc3)c2cc1OC,IC50,'=',3400,nM,5.47,,,UO_0000065,13.19,0.24,0.52,6.41,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,3.4
CHEMBL2386796,,None,570.7,2,5.31,9p,Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1,Inhibition,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2389824,Inhibition of KDR (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384934,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,97
CHEMBL250610,,None,369.41,0,1.96,14q,COc1ccc(OC)c2c1c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,IC50,'=',10,nM,8,,,UO_0000065,21.66,0.42,6.04,8.83,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL402048,,None,341.37,0,2.39,8g,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(F)c12,IC50,'=',137,nM,6.86,,,UO_0000065,20.11,0.39,4.47,9.51,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,137
CHEMBL402049,,None,357.83,0,2.91,8h,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(Cl)c12,Inhibition,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,26
CHEMBL249994,,None,327.34,0,2.09,14h,Cn1cc(/C=C2\C(=O)NN=C2c2cnns2)c2c(F)cccc21,Inhibition,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,76
CHEMBL400061,,None,432.3,0,3.03,8m,COc1ccc2c(c(/C=C3\C(=O)NN=C3c3snnc3C)cn2C)c1Br,Inhibition,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,76
CHEMBL444138,,None,371.24,0,4.74,3,Cc1ccc(Nc2ccnc(Nc3cccc(Br)c3)n2)cc1O,IC50,'=',6.3,nM,8.2,,,UO_0000065,22.09,0.49,3.46,11.7,0,CHEMBL981071,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155848,1,Scientific Literature,J Med Chem,2008,None,,,,6.3
CHEMBL467549,,None,328.38,0,3.8,4,O=C(c1ccccc1NCc1ccncc1)c1n[nH]c2ccccc12,IC50,'=',1600,nM,5.8,,,UO_0000065,17.65,0.32,2,8.2,0,CHEMBL976314,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,1.6
CHEMBL468829,,None,384.41,1,5.03,39,O=C(c1ccccc1NCc1ccc2cn[nH]c2c1)c1c[nH]c2cc(F)ccc12,IC50,'=',250,nM,6.6,,,UO_0000065,17.17,0.31,1.57,8.97,0,CHEMBL976315,Inhibition of KDR autophosphorylation by cell based assay,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.25
CHEMBL377734,,None,401.44,0,4.06,14,O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F,IC50,'=',23,nM,7.64,,,UO_0000065,19.03,0.37,3.58,9.68,0,CHEMBL866816,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138058,1,Scientific Literature,J Med Chem,2006,None,,,,23
CHEMBL3401989,,None,437.45,0,4.37,16,Cc1nnc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL2407519,,None,410.56,0,3.58,6d,CCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL2411325,Inhibition of KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL270545,,None,423.47,0,4.36,72,COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)NC(C)C)c2cc1OC,IC50,'=',39.81,nM,7.4,,,UO_0000065,17.47,0.33,3.04,9.01,0,CHEMBL1244602,Inhibition of human VEGFR2 after 60 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240342,1,Scientific Literature,J Mol Graph Model,2009,None,,,,7.4
CHEMBL409933,,None,485.54,1,5.71,76,COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)N[C@H](C)c3ccccc3)c2cc1OC,IC50,'=',39.81,nM,7.4,,,UO_0000065,15.24,0.28,1.69,9.01,0,CHEMBL1244602,Inhibition of human VEGFR2 after 60 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240342,1,Scientific Literature,J Mol Graph Model,2009,None,,,,7.4
CHEMBL272691,,None,457.51,1,5.91,29,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5nccs5)cccc4c3)c2cc1OC,IC50,'=',0.302,nM,9.52,,,UO_0000065,20.81,0.39,3.61,11.53,1,CHEMBL1244602,Inhibition of human VEGFR2 after 60 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240342,1,Scientific Literature,J Mol Graph Model,2009,None,,,,9.52
CHEMBL374206,,None,243.29,0,1.92,7a,Nc1ccc(-c2nsc3ncnc(N)c23)cc1,IC50,'=',46000,nM,4.34,,,UO_0000065,17.83,0.35,2.42,4.78,0,CHEMBL864248,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,46
CHEMBL211379,,None,331.34,0,3.12,22,Nc1ncnc2onc(-c3ccc(NC(=O)c4ccccc4)cc3)c12,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL864248,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,50
CHEMBL1242380,,None,343.39,0,1.72,PP495,COc1ccc(-c2nn(C[C@H](C)CO)c3ncnc(N)c23)cc1OC,IC50,'=',100000,nM,4,,,UO_0000065,11.65,0.22,2.28,3.69,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,100
CHEMBL3218350,,None,558.92,2,7.71,10f,CC1(C)C(=O)Nc2cc3nccc(Oc4ccc(NC(=O)Nc5ccc(F)c(C(F)(F)F)c5)cc4Cl)c3cc21,Inhibition,'=',34.1,%,,,,UO_0000187,,,,,0,CHEMBL3226033,Inhibition of VEGFR2 (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217507,1,Scientific Literature,Medchemcomm,2013,None,,,,34.1
CHEMBL1242569,,None,325.37,0,2.67,PP361,C=CCn1nc(-c2ccc(OCC)c(OC)c2)c2c(N)ncnc21,IC50,'=',100000,nM,4,,,UO_0000065,12.29,0.23,1.33,4.54,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,100
CHEMBL3746897,,None,467.45,1,5.36,33d,C[C@@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cccc(C(F)(F)F)c3)c2)CN1,IC50,'=',23,nM,7.64,,,UO_0000065,16.34,0.31,2.28,9.42,0,CHEMBL3749261,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745705,1,Scientific Literature,J Med Chem,2015,None,,,,23
CHEMBL3746357,,None,453.42,0,4.97,33b,O=C(Nc1cccc(C(F)(F)F)c1)n1ccc2cc(Oc3ncnc4c3CNCC4)ccc21,IC50,'=',18,nM,7.75,,,UO_0000065,17.08,0.32,2.77,9.55,0,CHEMBL3749261,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745705,1,Scientific Literature,J Med Chem,2015,None,,,,18
CHEMBL3220326,,None,550.66,2,5.86,T10,COc1cc(-c2cc(NC(=O)Nc3cc(OCCCN(C)C)ccc3C)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,'=',9.87,nM,8.01,,,UO_0000065,14.54,0.27,2.15,7.03,0,CHEMBL3222612,Inhibition of VEGFR-2 (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,9.87
CHEMBL3220320,,None,562.67,2,6.09,T4,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCN4CCCCC4)cc3)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,'=',7.01,nM,8.15,,,UO_0000065,14.49,0.27,2.06,7.16,0,CHEMBL3222612,Inhibition of VEGFR-2 (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,7.01
CHEMBL3696081,,None,457.49,0,4.57,BDBM144596,CCOC(=O)Nc1snc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c1C(N)=O,IC50,'=',50,nM,7.3,,280956,UO_0000065,15.96,0.31,2.73,5.39,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3656048,,None,419.46,1,5.19,BDBM110558,Cc1ccsc1C(=O)Nc1cccc(Oc2ccnc(-c3cc(C(=O)O)c[nH]3)c2)c1,IC50,'=',120,nM,6.92,,231443,UO_0000065,16.5,0.32,1.73,6.63,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1240554,,None,353.43,0,3.6,PP359,CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC,IC50,'=',2070,nM,5.68,,,UO_0000065,16.08,0.3,2.08,6.45,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,2.07
CHEMBL196610,,None,398.42,0,3.93,29,COC(=O)c1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1,IC50,'=',2700,nM,5.57,,,UO_0000065,13.98,0.25,1.64,5.19,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,2.7
CHEMBL407008,,None,374.83,0,4.79,36,NC(=O)c1ccc(-c2nnc(Nc3cccc(Cl)c3)c3ccccc23)cc1,IC50,'=',1700,nM,5.77,,,UO_0000065,15.39,0.29,0.98,7.13,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,1.7
CHEMBL205823,,None,417.3,1,6.9,61,Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1Cl,IC50,'=',110,nM,6.96,,,UO_0000065,16.68,0.33,0.06,13.73,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.11
CHEMBL3589740,,None,374.38,0,4.54,9d,O=C(Nc1ccc(F)cc1)Nc1ccc(/N=C2\C(=O)Nc3ccccc32)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,
CHEMBL53463,DOXORUBICIN,4,543.53,3,0,Doxorubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,
CHEMBL213173,,None,403.8,0,4.8,2o,COc1cc2c(cc1OC)Oc1ncnc(Oc3cccc(Cl)c3F)c1NC2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL1084061,,None,454.57,1,5.19,7d,CCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',8,nM,8.1,,,UO_0000065,17.81,0.33,2.91,13.26,0,CHEMBL1119625,Inhibition of human recombinant VEGFR2 by time resolved fluorescence measurements,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,8
CHEMBL1084338,,None,482.63,1,5.82,7h,CC(C)CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',77,nM,7.11,,,UO_0000065,14.74,0.27,1.29,11.65,0,CHEMBL1119625,Inhibition of human recombinant VEGFR2 by time resolved fluorescence measurements,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,77
CHEMBL1085292,,None,508.67,2,6.36,7l,Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(CC4CCCCC4)c13)CNC2=O,IC50,'=',149,nM,6.83,,,UO_0000065,13.42,0.25,0.47,11.18,0,CHEMBL1119625,Inhibition of human recombinant VEGFR2 by time resolved fluorescence measurements,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,149
CHEMBL1082756,,None,484.6,0,4.82,7n,CCOCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',22,nM,7.66,,,UO_0000065,15.8,0.29,2.84,10.89,0,CHEMBL1119625,Inhibition of human recombinant VEGFR2 by time resolved fluorescence measurements,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,22
CHEMBL1084061,,None,454.57,1,5.19,7d,CCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'<',10,nM,,,,UO_0000065,,,,,0,CHEMBL1119626,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155474,1,Scientific Literature,Bioorg Med Chem Lett,2010,CHEMBL3307501,,,,10
CHEMBL3774720,,None,365.31,0,4.12,17,COc1cc2ncnc(Nc3cccc(O)c3C(F)(F)F)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,10000
CHEMBL554,LAPATINIB,4,581.07,2,6.14,Lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Activity,'=',45,%,,,,UO_0000187,,,,,0,CHEMBL4724264,Effect on human recombinant N-terminal GST-tagged KDR (789 to end) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715878,1,Scientific Literature,J Med Chem,2020,None,Dose = 10.0 microM | TIME = 0.5 hr,ACTIVATOR,,45
CHEMBL4786776,,None,344.42,0,4.16,76,OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL4718867,Inhibition of recombinant human His-tagged KDR (789 to 1356 residues) expressed in baculovirus expression system at 500 nM using Tyr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715760,1,Scientific Literature,Eur J Med Chem,2016,None,Dose = 500.0 nM | TIME = 1.0 hr,,,0
CHEMBL488646,,None,450.54,0,4.48,24,COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC,IC50,'=',4400,nM,5.36,,,UO_0000065,11.89,0.22,0.88,7.55,0,CHEMBL957977,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157465,1,Scientific Literature,J Med Chem,2008,None,,,,4.4
CHEMBL178981,,None,484.34,1,7,6v,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4Cl)cc3)c2cc1OC,IC50,'=',27,nM,7.57,,,UO_0000065,15.63,0.31,0.57,9.26,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,27
CHEMBL279351,,None,485.87,1,6.62,6ac,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(Cl)c3)c2cc1OC,IC50,'=',0.4,nM,9.4,,,UO_0000065,19.34,0.38,2.78,11.5,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,0.4
CHEMBL4799283,,None,463.57,0,2.22,42,Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(-c3cnc(N)nc3)n[nH]c2c1,GI50,'=',5630,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,5.63
CHEMBL223622,,None,301.28,0,2.45,12,CO/N=C/c1c(N)ncnc1Oc1cc2cc[nH]c2cc1F,IC50,'=',121,nM,6.92,,,UO_0000065,22.96,0.43,4.47,7.03,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.121
CHEMBL223535,,None,358.38,0,2.35,20,CNCCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F,IC50,'=',93,nM,7.03,,,UO_0000065,19.62,0.37,4.68,6.37,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.093
CHEMBL221224,,None,341.35,0,3.32,16,C=CCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F,IC50,'=',52,nM,7.28,,,UO_0000065,21.34,0.4,3.96,7.4,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.052
CHEMBL426929,,None,343.36,0,3.54,14,CCCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F,IC50,'=',43,nM,7.37,,,UO_0000065,21.45,0.4,3.83,7.49,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.043
CHEMBL4787082,,None,652.66,2,6.07,10i,COc1cc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)ncnc2cc1OCCN1CCOCC1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,,,
CHEMBL3671475,,None,542.41,2,5.04,BDBM133685,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(C)=O)CC1,IC50,'=',131,nM,6.88,,266543,UO_0000065,12.69,0.27,1.84,7.14,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671477,,None,620.5,1,4.06,BDBM133687,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)CS(C)(=O)=O)CC1,IC50,'=',108,nM,6.97,,266545,UO_0000065,11.23,0.24,2.91,5.33,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671484,,None,585.48,1,4.58,BDBM133694,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)CN(C)C)CC1,IC50,'=',55,nM,7.26,,266552,UO_0000065,12.4,0.26,2.68,7.28,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671499,,None,500.33,1,4.08,BDBM133710,C=CC(=O)NCCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1NC(=O)C=C,IC50,'=',250,nM,6.6,,266568,UO_0000065,13.2,0.28,2.52,6.27,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671506,,None,524.37,1,3.33,BDBM133717,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNS(C)(=O)=O,IC50,'=',369,nM,6.43,,266575,UO_0000065,12.27,0.27,3.1,5.26,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671508,,None,519.4,1,3.87,BDBM133719,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=S)NC,IC50,'=',457,nM,6.34,,266577,UO_0000065,12.21,0.27,2.47,6.33,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671515,,None,502.34,1,4.26,BDBM133726,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCN(C)C(C)=O,IC50,'=',687,nM,6.16,,266584,UO_0000065,12.27,0.26,1.9,6.39,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671518,,None,504.32,1,2.89,BDBM133729,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CO,IC50,'=',325,nM,6.49,,266587,UO_0000065,12.87,0.28,3.6,5.17,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL306707,,None,324.82,0,4.48,54,Cc1c(Cc2ccncc2)nnc(Nc2ccc(Cl)cc2)c1C,IC50,'=',870,nM,6.06,,,UO_0000065,18.66,0.36,1.58,11.95,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.87
CHEMBL231127,,None,452.54,1,5.95,12e,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cncnc5)cnc(N)c34)cc2)c1,IC50,'=',8,nM,8.1,,,UO_0000065,17.89,0.34,2.15,7.65,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,8
CHEMBL231308,,None,388.5,1,5.81,7i,Cc1ccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)cc1C,IC50,'=',41,nM,7.39,,,UO_0000065,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,41
CHEMBL396494,,None,385.45,1,5.06,7h,N#Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1,IC50,'=',198,nM,6.7,,,UO_0000065,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,198
CHEMBL222225,,None,300.39,0,1.56,16,N#Cc1cnc(Nc2cc(CN3CCNCC3)ccn2)s1,IC50,'=',24,nM,7.62,,,UO_0000065,,,,,0,CHEMBL913857,Inhibition of VEGF-induced DNA synthesis in HEK293 cells expressing human KDR by endothelial cell mitogenesis assay,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,24
CHEMBL392934,,None,360.34,0,3.79,18,O=C(Nc1ccc(C(F)(F)F)cc1)c1ccnn1CCc1ccncc1,IC50,'=',69,nM,7.16,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.069
CHEMBL429478,,None,399.46,0,3.68,15g,CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(OC)ccc5[nH]4)c3c2)c1,IC50,'>',100,nM,,,,UO_0000065,,,,,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.1
CHEMBL400906,,None,439.4,0,4.18,15f,CNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(OC(F)(F)F)ccc5[nH]4)c3c2)c1,IC50,'>',100,nM,,,,UO_0000065,,,,,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.1
CHEMBL248712,,None,405.41,0,3.95,15d,CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(F)c(F)cc5[nH]4)c3c2)c1,IC50,'=',100,nM,7,,,UO_0000065,17.27,0.32,3.05,7.36,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.1
CHEMBL249502,,None,447.5,0,4.85,10c,CC(C)NC(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12,IC50,'=',380,nM,6.42,,,UO_0000065,14.35,0.26,1.57,5.72,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.38
CHEMBL4060383,,None,357.44,0,4.58,3,Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccc4ccccc4c3)c12,IC50,'=',160300,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL4007192,Inhibition of VEGF-induced VEGFR2 phosphorylation in human U251 cells preincubated for 60 mins followed by VEGF induction measured after 10 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4004880,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,160.3
CHEMBL3822972,,None,336.38,0,3.5,Compound 1,COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4004207,Inhibition of recombinant human N-terminal GST-tagged KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4002626,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,50
CHEMBL200657,,None,251.35,0,2.8,8c,CCCCN(C)C(=O)c1cc2c(C)n[nH]c2s1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,20
CHEMBL238522,,None,349.44,0,3.8,20,CC(C)c1ccc(NC(=O)c2c(NCc3ccncc3)ncn2C)cc1,IC50,'=',75,nM,7.12,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.075
CHEMBL240644,,None,383.46,0,4.35,49,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(-c2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL238521,,None,341.8,0,3.33,17,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL4792355,,None,540.61,1,4.33,7f,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cnccn2)C4)cc1NC(=O)c1ccco1,Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,90
CHEMBL258844,,None,551.65,2,6.32,Akti_1_2,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,Residual Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL387313,,None,283.29,0,2.31,7,CO/N=C/c1c(N)ncnc1Oc1ccc2[nH]ccc2c1,IC50,'=',276,nM,6.56,,,UO_0000065,23.15,0.43,4.25,6.67,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.276
CHEMBL225261,,None,509.64,1,4.34,75,NC(=O)N1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',20,nM,7.7,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,20
CHEMBL159776,PRAMIRACETAM,2,269.39,0,0.84,pramiracetam,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1908331,ROMURTIDE,2,887.13,3,1.71,romurtide,CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL720,BENZYL ALCOHOL,4,108.14,0,1.18,benzyl alcohol,OCc1ccccc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3914503,,None,356.38,0,4.49,24(d),COc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1,Ki,'=',125,nM,6.9,,,UO_0000065,19.37,0.35,2.41,7.95,0,CHEMBL3881024,Inhibition of human 50 residues truncated cytoplasmic domain of phosphorylated VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.125
CHEMBL3676338,,None,486.94,0,3.35,BDBM133799,C=CC(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCNC(=O)CN(C)C,IC50,'=',945,nM,6.03,,266657,UO_0000065,12.37,0.24,2.67,5.55,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4283690,,None,399.49,1,5.5,8u,O=C(NC1CCCCC1)c1cc(Oc2ccc(/C=C/c3ccncc3)cc2)ccn1,IC50,'=',1220,nM,5.91,,,UO_0000065,14.8,0.27,0.41,9.22,0,CHEMBL4259013,Inhibition of recombinant human N-terminal GST-tagged VEGFR2 (789 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL248890,,None,392.42,0,4.21,9a,OCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,100
CHEMBL3890872,,None,None,None,None,BDBM196653,,Kd,'=',510000,nM,,Outside typical range,349613,UO_0000065,,,,,0,CHEMBL3887714,VEGF-R2 Binding Assay: A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine triphosphosphate (ATP) site directed ligand using a DNA-tagged vascular endothelial growth receptor 2 (VEGFR2) as the target. The ability of the test compound to compete with the immobilized ligand was measured using quantitative polymerase chain reaction (qPCR) of the DNA tag (Fabian,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3829144,Inhibition of VEGFR2 phosphorylation in human MCF7 cells assessed as reduction in expression of phosphorylated Raf1 at 1 uM incubated for 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,MCF7,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3826943,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3308403,,,,
CHEMBL269936,,None,476.43,0,4.53,12,CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3F)ccc2C)c(NC)n1,IC50,'=',6679,nM,5.17,,,UO_0000065,10.86,0.21,0.65,4.79,0,CHEMBL948989,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142332,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,6679
CHEMBL270368,,None,552.59,1,4.2,36,CC(C)c1c(-c2nnc(OCC3CCNCC3)o2)cn2ncnc(Nc3cc(C(=O)NC4CC4)c(F)cc3F)c12,IC50,'=',26,nM,7.58,,,UO_0000065,13.73,0.26,3.39,5.77,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,26
CHEMBL429845,,None,537.58,1,3.57,33,CC(C)c1c(-c2nnc(N3CCN(C)CC3)o2)cn2ncnc(Nc3cc(C(=O)NC4CC4)c(F)cc3F)c12,IC50,'=',21,nM,7.68,,,UO_0000065,14.28,0.27,4.11,6.58,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,21
CHEMBL233958,,None,567.72,2,5.77,28,COc1cc(-c2csc3c(/C=C/CN4CCC(O)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL897114,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148846,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,50
CHEMBL4169073,,None,385.43,0,4.09,9g,Cc1ccc(Nc2nc3cc(Oc4ncnc5c4cnn5C)ccc3n2C)cc1,IC50,'=',17.1,nM,7.77,,,UO_0000065,20.15,0.37,3.68,9.39,0,CHEMBL4155774,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,17.1
CHEMBL255974,,None,482.5,0,3.54,13,CNCc1nnc(-c2cn3ncnc(Nc4cc(C(=O)NC5CC5)c(F)cc4F)c3c2C(C)C)o1,IC50,'=',150,nM,6.82,,,UO_0000065,14.14,0.27,3.28,5.58,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,150
CHEMBL258046,,None,538.56,1,3.95,37,CC(C)c1c(-c2nnc(OC3CCNCC3)o2)cn2ncnc(Nc3cc(C(=O)NC4CC4)c(F)cc3F)c12,IC50,'=',11,nM,7.96,,,UO_0000065,14.78,0.28,4.01,6.05,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,11
CHEMBL402319,,None,511.54,1,3.58,28,CC(C)c1c(-c2nnc(NCCCN)o2)cn2ncnc(Nc3cc(C(=O)NC4CC4)c(F)cc3F)c12,IC50,'=',17,nM,7.77,,,UO_0000065,15.19,0.29,4.19,5.24,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,17
CHEMBL256825,,None,378.82,0,4.5,14a,Nc1n[nH]c2ccnc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',12,nM,7.92,,,UO_0000065,20.91,0.4,3.42,7.29,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,12
CHEMBL439068,,None,376.4,0,4.3,14e,Cc1cc(NC(=O)Nc2ccc(-c3nccc4[nH]nc(N)c34)cc2)ccc1F,IC50,'=',34,nM,7.47,,,UO_0000065,19.84,0.36,3.17,6.87,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,34
CHEMBL404571,,None,412.38,0,4.87,14b,Nc1n[nH]c2ccnc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,IC50,'=',99,nM,7,,,UO_0000065,16.99,0.32,2.13,6.44,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,99
CHEMBL257479,,None,358.41,0,4.16,13c,Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)c1,IC50,'=',1,nM,9,,,UO_0000065,25.11,0.46,4.84,8.28,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,1
CHEMBL4525625,,None,431.47,0,3.82,20,COc1ccc(CC(=O)Nc2ccc(-n3c4c(c5ncnc(N)c53)CCC4)cc2)cc1F,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4582455,,None,401.45,0,3.81,71,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccccc5)cc4F)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4444042,,None,438.49,0,3.71,78,Cn1ccc2cc(CC(=O)Nc3ccc(-n4c5c(c6ncnc(N)c64)COC5)cc3)ccc21,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4441235,,None,499.45,0,4.12,83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4173279,,None,386.46,0,2.28,15,NNC(=O)CSc1nnc(Cn2c(-c3ccco3)nc3ccccc32)s1,IC50,'=',1410,nM,5.85,,,UO_0000065,15.14,0.31,3.57,5.23,0,CHEMBL4139350,Inhibition of human VEGFR2 using TMB substrate by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138096,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1.41
CHEMBL250414,,None,268.27,0,2.76,15,O=C1/C(=C/c2ccc(O)cc2)COc2cc(O)ccc21,Inhibition,'=',59.2,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,59.2
CHEMBL477781,EPIHEMATOXIN,None,332.31,0,0.58,9,CO[C@H]1C23C=CC(=O)C(O)=C2OC[C@]1(O)Cc1cc(O)c(O)cc13,Inhibition,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,25
CHEMBL4246128,,None,426.95,1,5.27,I-5,CCN(CC)CCOc1ccc(Nc2cc(Cl)nc(-c3ccc(OC)cc3)n2)cc1,Inhibition,'=',89.7,%,,,,UO_0000187,,,,,0,CHEMBL4231546,Inhibition of VEGFR2 (unknown origin) at 10 uM using TK substrate after 1 hr by HTRF assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229364,1,Scientific Literature,Eur J Med Chem,2018,None,,,,89.7
CHEMBL4237347,,None,424.93,1,5.02,I-6,COc1ccc(-c2nc(Cl)cc(Nc3ccc(OCCN4CCCC4)cc3)n2)cc1,Inhibition,'=',51.88,%,,,,UO_0000187,,,,,0,CHEMBL4231546,Inhibition of VEGFR2 (unknown origin) at 10 uM using TK substrate after 1 hr by HTRF assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229364,1,Scientific Literature,Eur J Med Chem,2018,None,,,,51.88
CHEMBL4245527,,None,411.89,0,4.05,I-1,COc1ccc(-c2nc(Cl)cc(Nc3ccc(NC(=O)CN(C)C)cc3)n2)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4231547,Inhibition of VEGFR2 (unknown origin) using TK substrate after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229364,1,Scientific Literature,Eur J Med Chem,2018,None,,,,1
CHEMBL4245266,,None,439.95,0,4.83,I-2,CCN(CC)CC(=O)Nc1ccc(Nc2cc(Cl)nc(-c3ccc(OC)cc3)n2)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4231547,Inhibition of VEGFR2 (unknown origin) using TK substrate after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229364,1,Scientific Literature,Eur J Med Chem,2018,None,,,,1
CHEMBL4242028,,None,437.93,0,4.58,I-3,COc1ccc(-c2nc(Cl)cc(Nc3ccc(NC(=O)CN4CCCC4)cc3)n2)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4231547,Inhibition of VEGFR2 (unknown origin) using TK substrate after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229364,1,Scientific Literature,Eur J Med Chem,2018,None,,,,1
CHEMBL4241067,,None,425.92,1,5.07,I-9,COc1ccc(-c2nc(Cl)cc(Oc3ccc(OCCN4CCCC4)cc3)n2)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4231547,Inhibition of VEGFR2 (unknown origin) using TK substrate after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229364,1,Scientific Literature,Eur J Med Chem,2018,None,,,,1
CHEMBL477768,HEMATOXYLONE,None,318.28,0,1.06,7,O=C1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1,IC50,'=',6100,nM,5.21,,,UO_0000065,16.38,0.31,4.15,4.09,0,CHEMBL986503,Inhibition of KDR by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,6.1
CHEMBL515880,,None,378.38,0,4.42,3,O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1,IC50,'=',54,nM,7.27,,,UO_0000065,19.21,0.38,2.85,10.86,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,0.054
CHEMBL475704,,None,378.38,0,4.42,6,O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1,IC50,'=',1530,nM,5.82,,,UO_0000065,15.37,0.31,1.4,8.69,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,1.53
CHEMBL512863,,None,392.41,0,4.73,23,Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F,IC50,'=',710,nM,6.15,,,UO_0000065,15.67,0.31,1.42,9.19,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,0.71
CHEMBL512380,,None,379.24,0,3.76,31,O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,10
CHEMBL118386,,None,406.51,0,3.84,4c,c1cc(OCCN2CCOCC2)cc(-c2cnc3c(-c4ccsc4)cnn3c2)c1,IC50,'=',14,nM,7.85,,,UO_0000065,19.32,0.37,4.01,15.14,0,CHEMBL818936,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135002,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,14
CHEMBL4455512,,None,315.31,0,2.99,G3_9,N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1,Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL4335134,Inhibition of human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334438,1,Scientific Literature,Eur J Med Chem,2019,None,,,,94
CHEMBL219727,,None,436.31,1,5.53,29d,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(Br)c4[nH]nc(N)c34)cc2)c1,IC50,'=',10,nM,8,,,UO_0000065,18.34,0.39,2.47,8.35,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,10
CHEMBL222918,,None,399.5,1,5.26,45,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3c(N(C)C)nn4C)cc2)c1,IC50,'=',3200,nM,5.5,,,UO_0000065,13.75,0.25,0.23,8.84,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,3200
CHEMBL77555,,None,414.82,1,6.03,64,FC(F)(F)c1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)ccc1Cl,ED50,'=',27,nM,7.57,,,UO_0000065,,,,,0,CHEMBL818396,Inhibition of VEGF-stimulated autophosphorylation of VEGF-receptor 2 (KDR) expressed in CHO cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,CHEMBL3308072,,,,27
CHEMBL1254522,,None,468.36,0,4.66,11,COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3n2C)c1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1252157,Inhibition of VEGFR2 expressed in human A431 cells,B,BAO_0000219,cell-based format,None,None,None,A-431,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250424,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3307523,,,,200
CHEMBL220890,,None,345.33,0,2.12,28,Cc1cc2c(F)c(Oc3ncnc(N)c3/C=N/OCCO)ccc2[nH]1,IC50,'=',44,nM,7.36,,,UO_0000065,21.3,0.4,5.24,6.2,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.044
CHEMBL220444,,None,386.43,0,3.08,24,Cc1cc2c(F)c(Oc3ncnc(N)c3/C=N/OCCCN(C)C)ccc2[nH]1,IC50,'=',101,nM,7,,,UO_0000065,18.1,0.34,3.92,6.88,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.101
CHEMBL223892,,None,329.34,0,3.15,13,CCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F,IC50,'=',42,nM,7.38,,,UO_0000065,22.4,0.42,4.23,7.5,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.042
CHEMBL428741,,None,545.57,1,3.77,17,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,IC50,'=',347.6,nM,6.46,,,UO_0000065,11.84,0.22,2.69,5.26,0,CHEMBL892960,Inhibition of human VEGFR2 in presence of 1 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,347.6
CHEMBL428039,,None,451.48,0,2.06,15,CCOc1cc2ncnc(NC3=CC(=O)C(OC)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,Ratio,'=',3.7,,,,,,,,,,0,CHEMBL892962,Ratio of IC50 for VEGFR2 in presence of 1 mM ATP to IC50 for VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,3.7
CHEMBL433936,,None,392.81,0,4.51,16,COCCOc1cc2nccc(Nc3cc(O)c(Cl)cc3F)c2cc1OC,IC50,'<',2,nM,,,,UO_0000065,,,,,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.002
CHEMBL150826,,None,393.8,0,3.91,18,COCCOc1cc2nncc(Nc3cc(O)c(Cl)cc3F)c2cc1OC,IC50,'=',4,nM,8.4,,,UO_0000065,21.33,0.42,4.49,9.8,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.004
CHEMBL258436,,None,483.62,1,5.51,42,C/C(=N\OCC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',2,nM,8.7,,,UO_0000065,17.99,0.33,3.19,11.85,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,2
CHEMBL4534119,,None,501.51,2,7.01,11k,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1,Inhibition,'=',90.1,%,,,,UO_0000187,,,,,0,CHEMBL4412421,Inhibition of VEGFR2 (unknown origin) at 10 nM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4411287,1,Scientific Literature,Eur J Med Chem,2019,None,,,,90.1
CHEMBL3633695,,None,435.51,0,3.88,T6,CCS(=O)(=O)c1ccc(OC)c(Nc2cn(-c3cccc(-c4cccnc4)c3)nn2)c1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3636166,Inhibition of GST-tagged human recombinant VEGFR2 kinase expressed in Sf9 insect cells by radiometric protein kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632540,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,1
CHEMBL194176,,None,435.51,0,4.95,AAZ,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1,IC50,'=',22,nM,7.66,,,UO_0000065,17.58,0.34,2.71,8.12,1,CHEMBL3636166,Inhibition of GST-tagged human recombinant VEGFR2 kinase expressed in Sf9 insect cells by radiometric protein kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632540,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,22
CHEMBL3633763,,None,447.29,0,3.81,6f,COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCCC(=O)NO,IC50,'=',434,nM,6.36,,,UO_0000065,14.22,0.31,2.55,6.03,0,CHEMBL3636774,Inhibition VEGFR2 (unknown origin) for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632579,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,434
CHEMBL1086860,,None,465.52,0,4.3,7i,Cc1ccc(NC(=O)c2cc(C3CC3)n[nH]2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1,IC50,'=',48,nM,7.32,,,UO_0000065,15.72,0.29,3.02,5.25,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,48
CHEMBL1087649,,None,469.94,1,5.36,15g,Cc1ccc(C(=O)Nc2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1,IC50,'=',260,nM,6.58,,,UO_0000065,14.01,0.26,1.23,5.95,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,260
CHEMBL1076196,,None,575.72,2,5.09,22c,Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCN4CCN(C)CC4)ncn3)c2)c1,IC50,'=',2094,nM,5.68,,,UO_0000065,9.86,0.18,0.59,5.5,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,2094
CHEMBL372474,GW678313X,None,452.51,1,5.69,44,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1,IC50,'=',89,nM,7.05,,,UO_0000065,15.58,0.3,1.36,8.66,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.089
CHEMBL371374,,None,328.39,0,3.88,13,CCS(=O)(=O)c1cccc(Nc2ncc(-c3ccccc3)o2)c1,IC50,'=',720,nM,6.14,,,UO_0000065,18.71,0.36,2.26,8.51,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.72
CHEMBL194176,,None,435.51,0,4.95,39,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1,Selectivity,'=',0.022,uM,,,,UO_0000064,,,,,0,CHEMBL830769,Selectivity for human Vascular endothelial growth factor receptor 2 by homologous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.022
CHEMBL4085962,,None,344.38,0,3.97,61,Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccccn4)cc3)c12,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,50000
CHEMBL3808619,,None,382.42,0,3.96,23,CC(=O)Nc1cc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)cc2)[nH]n1,IC50,'=',24,nM,7.62,,,UO_0000065,19.93,0.37,3.66,6.1,0,CHEMBL3812632,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse Baf3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,0.024
CHEMBL4073474,,None,561.65,2,5.41,3e,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc(N2CCCC2)c1,IC50,'=',108.1,nM,6.97,,,UO_0000065,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5206706,,None,528.62,2,7.7,6,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccc4cccnc4c3)cc2)n(-c2ccc3ncccc3c2)n1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL5104835,Inhibition of KDR (unknown origin) by Nano-syn mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104101,1,Scientific Literature,RSC Med Chem,2022,None,,INHIBITOR,,
CHEMBL4087241,,None,501.99,2,6.04,6d,CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL4077859,,None,436.42,0,1.83,(-)-11,C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL4018326,Inhibition of human VEGFR2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4017480,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,11
CHEMBL597211,,None,363.51,0,3.8,10,CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL1074376,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157584,1,Scientific Literature,J Med Chem,2010,None,,,,10
CHEMBL3656104,,None,543.56,2,5.51,BDBM110615,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CCC(C(=O)O)C5)c[nH]4)c3)cc2)c1,IC50,'=',22,nM,7.66,,231500,UO_0000065,14.09,0.26,2.15,5.6,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4104302,,None,458.85,0,4.75,13d,Nc1nccc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)c1Cl,IC50,'=',55,nM,7.26,,,UO_0000065,,,,,0,CHEMBL4021257,Inhibition of VEGFR-2 (unknown origin) by HTRF method,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4020722,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,55
CHEMBL3771118,,None,283.28,0,0.62,4a; PF-06761281,COc1ncc(C)cc1CC[C@@](O)(CC(=O)O)C(=O)O,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3773659,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3769388,1,Scientific Literature,J Med Chem,2016,None,,,,
CHEMBL3676358,,None,508.34,1,4.09,BDBM133820,C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCCNC(=O)COC,IC50,'=',823,nM,6.08,,266678,UO_0000065,11.97,0.24,1.99,5.32,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4086340,,None,563.67,2,5.65,3d,CCN(CC)c1cncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c1,IC50,'=',104.5,nM,6.98,,,UO_0000065,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL248393,,None,471.61,0,4.1,30,COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1,Ki,'=',300,nM,6.52,,,UO_0000065,13.83,0.25,2.42,8.86,0,CHEMBL923926,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140464,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.3
CHEMBL4550702,,None,406.39,0,3.15,9,Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1,IC50,'=',15,nM,7.82,,,UO_0000065,19.25,0.38,4.67,10.15,0,CHEMBL4479737,Inhibition of recombinant human His-tagged cytoplasmic KDR expressed in baculovirus expression system by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477252,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,15
CHEMBL2325903,,None,286.38,0,3,3e,C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C,Inhibition,'=',56,%,,,,UO_0000187,,,,,0,CHEMBL2329185,Inhibition of KDR (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,,,,56
CHEMBL3215582,,None,588.33,1,6.41,1,Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl,IC50,'=',1000,nM,6,,,UO_0000065,12.53,0.23,-0.41,5.75,0,CHEMBL1047420,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155237,1,Scientific Literature,J Med Chem,2009,None,,,,1000
CHEMBL1084452,,None,556.67,2,7,2,CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1,Inhibition,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,67
CHEMBL456463,,None,460.5,1,6.41,8,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,3
CHEMBL361366,,None,349.43,0,4.75,3,CCN(CC)c1ccc(NC(=O)c2c(-c3ccccc3)noc2C)cc1,Inhibition,'=',64,%,,,,UO_0000187,,,,,0,CHEMBL4031012,Inhibition of human VEGFR2 at 30 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028856,1,Scientific Literature,J Med Chem,2017,None,,,,64
CHEMBL4096175,,None,340.19,0,2.01,63,O=C1NC(=S)N2C(=O)C3Nc4cc(Cl)cc(Cl)c4C3C=C12,Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL4029693,Inhibition of partial length wild type human KDR (R787 to P1253 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,99
CHEMBL5191535,,None,375.9,0,4.98,3c,CC(C)Cn1c2ccccc2c2ccn3c[n+](-c4ccccc4)cc3c21.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',82.08,%,,,,UO_0000187,,,,,0,CHEMBL4055531,Inhibition of VEGFR2 in human BT474 cells assessed as downregulation of phosphorylated paxillin levels at 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,82.08
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',58.7,%,,,,UO_0000187,,,,,0,CHEMBL4055522,Inhibition of VEGFR2 in human MDA-MB-231 cells assessed as downregulation of phosphorylated paxillin levels at 20 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,58.7
CHEMBL4083278,,None,568.94,2,7.91,6,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC,Inhibition,'=',99.71,%,,,,UO_0000187,,,,,0,CHEMBL4033252,Inhibition of VEGFR2 (unknown origin) at 10 uM using biotin substrate incubated for 1 hr by HTRF method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028913,1,Scientific Literature,J Med Chem,2018,None,,,,99.71
CHEMBL4077930,,None,534.49,2,7.26,7,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c4ccccc34)c2cc1OC,IC50,'=',28.79,nM,7.54,,,UO_0000065,14.11,0.26,0.28,7.97,0,CHEMBL4033253,Inhibition of VEGFR2 (unknown origin) using biotin substrate incubated for 1 hr by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028913,1,Scientific Literature,J Med Chem,2018,None,,,,28.79
CHEMBL4064860,,None,355.37,0,3.97,69,N=C1NC(=O)/C(=C/c2csc(-c3ccc(C(F)(F)F)cc3)n2)S1,Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL4029693,Inhibition of partial length wild type human KDR (R787 to P1253 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,88
CHEMBL3621296,,None,368.39,0,2.51,8,O=C(CCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2)NO,IC50,'=',290,nM,6.54,,,UO_0000065,17.75,0.33,4.03,5.3,0,CHEMBL3626703,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3621077,1,Scientific Literature,Medchemcomm,2014,None,,,,290
CHEMBL150825,,None,377.8,0,4.2,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL236206,,None,376.34,0,3.67,21,O=C(Nc1cccc(OC(F)(F)F)c1)c1ccnn1CCc1ccncc1,IC50,'=',280,nM,6.55,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.28
CHEMBL392935,,None,320.4,0,3.34,19,CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,IC50,'=',86,nM,7.07,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.086
CHEMBL392934,,None,360.34,0,3.79,18,O=C(Nc1ccc(C(F)(F)F)cc1)c1ccnn1CCc1ccncc1,IC50,'=',48,nM,7.32,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.048
CHEMBL61998,,None,316.33,0,3.75,47,COc1cc(C(=O)/C=C/c2ccc(F)cc2)cc(OC)c1OC,Inhibition,'=',-3.5,%,,,,UO_0000187,,,,,0,CHEMBL3615423,Inhibition of human KDR using and Ulight-CAGAGAIETDKEYYTVKD as substrate at 0.1 umol/L after 1 hr by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3611997,1,Scientific Literature,Eur J Med Chem,2015,None,,,,-3.5
CHEMBL4850964,,None,381.41,0,4.99,35,CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)F)c3)cc2)ncn1,IC50,'=',79,nM,7.1,,,UO_0000065,18.62,0.35,2.11,8.06,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,79
CHEMBL4066096,,None,421.35,1,5.11,38,CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ncn1,IC50,'=',16,nM,7.8,,,UO_0000065,18.5,0.35,2.69,8.84,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,16
CHEMBL4869303,,None,472.25,1,6.28,47; GSK329,CNc1cc(Oc2c(Cl)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2Cl)ncn1,IC50,'=',400,nM,6.4,,,UO_0000065,13.55,0.28,0.12,7.26,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,400
CHEMBL4217207,,None,451.32,0,4.43,8b,CNC(=O)c1cc(Oc2ccc(C3=NNC(c4cccc(Br)c4)C3)cc2)ccn1,IC50,'=',560,nM,6.25,,,UO_0000065,13.85,0.29,1.82,8.27,0,CHEMBL4179085,Inhibition of VEGFR2 (unknown origin) incubated for 10 mins using FAM-labeled peptide and ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177575,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,0.56
CHEMBL4208998,,None,402.45,0,3.68,8h,CNC(=O)c1cc(Oc2ccc(C3=NNC(c4ccc(OC)cc4)C3)cc2)ccn1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4179085,Inhibition of VEGFR2 (unknown origin) incubated for 10 mins using FAM-labeled peptide and ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177575,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,50
CHEMBL4206831,,None,535.61,2,5.49,2; FMF-03-145-1,CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL4186102,Binding affinity to wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4184148,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,76
CHEMBL365133,,None,523.63,1,4.75,46,COc1cc(OC)cc(-c2cc3cnc(N(CCCCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1,IC50,'=',7600,nM,5.12,,,UO_0000065,9.78,0.18,0.37,4.07,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,7.6
CHEMBL4172224,,None,464.33,1,5.03,10d,CCn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(Br)cc3)n4C)ncnc21,Inhibition,'=',81.1,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,81.1
CHEMBL197828,,None,457.48,1,6.17,95,CCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1,IC50,'=',50,nM,7.3,,,UO_0000065,15.96,0.31,1.13,7.86,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,50
CHEMBL271154,,None,622.03,2,5.45,32,CN1CCN(c2ccc(Nc3ncc(NC(=O)c4cc(NC(=O)c5ccc6c(c5)OC(F)(F)O6)ccc4Cl)cn3)cc2)CC1,IC50,'=',13,nM,7.89,,,UO_0000065,12.68,0.24,2.44,6.52,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,13
CHEMBL405401,,None,577.73,2,6.08,21,Cc1ccc(NC(=O)c2ccc(C(C)(C)C)cc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,IC50,'=',32,nM,7.5,,,UO_0000065,12.97,0.24,1.41,7.31,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,32
CHEMBL272888,,None,589.62,2,5.8,13b,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,IC50,'=',24,nM,7.62,,,UO_0000065,12.92,0.24,1.82,7.43,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,24
CHEMBL411632,,None,415.38,0,3.89,13a,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1,IC50,'=',125,nM,6.9,,,UO_0000065,16.62,0.31,3.01,6.28,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,125
CHEMBL401881,,None,508.65,2,5.79,7h,Cc1ccsc1C(=O)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',10,nM,8,,,UO_0000065,15.73,0.3,2.21,11.61,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL269924,,None,529.07,2,6.14,7f,CC(C)Cn1c2ccc(C(=O)c3sccc3Cl)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',7,nM,8.15,,,UO_0000065,15.41,0.3,2.01,11.83,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,7
CHEMBL261174,,None,533.64,2,5.27,28,Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCCN(C)C)cc3)nc2n2c3ccccc3nc12,IC50,'=',4200,nM,5.38,,,UO_0000065,10.08,0.18,0.11,6,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,4.2
CHEMBL249821,,None,539.06,1,4.48,6,Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12,IC50,'=',4.7,nM,8.33,,,UO_0000065,15.45,0.31,3.85,6.92,0,CHEMBL932926,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144020,1,Scientific Literature,J Med Chem,2008,None,,,,4.7
CHEMBL409103,,None,416.48,1,5.34,76,CCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12,IC50,'=',1.3,nM,8.89,,,UO_0000065,21.34,0.39,3.55,12.75,1,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,1.3
CHEMBL5199520,,None,529.04,1,3.67,21,NS(=O)(=O)c1ccc(CCn2c(SCC(=O)Nc3ccc(Cl)cc3)nc3ccccc3c2=O)cc1,IC50,'=',390,nM,6.41,,,UO_0000065,12.11,0.25,2.74,5.16,0,CHEMBL5230848,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5230100,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,0.39
CHEMBL5278037,,None,475,1,5.88,23,Cc1cccc(Cl)c1NC(=O)Nc1ccc(-c2nc(NCCN(C)C)c3ccccc3n2)cc1,IC50,'=',93,nM,7.03,,,UO_0000065,14.8,0.28,1.15,8.56,0,CHEMBL5230863,Inhibition of human VEGFR2 incubated for 10 mins in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5230100,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.1667 hr,INHIBITOR,,93
CHEMBL364000,,None,382.9,0,4.3,40,CN(C)CCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,pIC50(calc),'=',6.71,,,,,,,,,,0,CHEMBL838586,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.71
CHEMBL4159505,,None,297.36,0,1.95,19,CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21,Inhibition,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL4156103,Inhibition of recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152312,1,Scientific Literature,Eur J Med Chem,2018,None,,,,17
CHEMBL271414,,None,497.98,1,7.08,82,COc1cc2nccc(N(C)c3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC,IC50,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,1400
CHEMBL363764,,None,383.84,0,3.91,46,COCCC(=O)Nc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,IC50,'=',593,nM,6.23,,,UO_0000065,16.22,0.31,2.32,6.99,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,0.593
CHEMBL406404,,None,505.55,1,4.88,57,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCN4CCOCC4)c4onc(N)c34)cc2)c1,IC50,'=',45,nM,7.35,,,UO_0000065,14.53,0.27,2.47,6.4,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,45
CHEMBL270489,,None,475.52,1,5,56,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)c4onc(N)c34)cc2)c1,IC50,'=',365,nM,6.44,,,UO_0000065,13.54,0.25,1.44,6.09,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,365
CHEMBL4846334,,None,433.45,0,3.9,16c,CNC(=O)c1ccccc1Nc1nc(Nc2cccc(NC(C)=O)c2)nc2[nH]cc(F)c12,FC,'=',2.63,,,,,,,,,,0,CHEMBL4832092,Upregulation of VEGFR2 phosphorylation at Tyr951 residue in human HCC cells at 30 uM by KEGG analysis relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HCC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4831494,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 30.0 microM,,,2.63
CHEMBL184750,,None,254.29,0,2.8,145c,Cc1cc2c(Nc3ccc(C)c(O)c3)ncnn2c1,IC50,'=',654,nM,6.18,,,UO_0000065,24.32,0.44,3.38,9.9,0,CHEMBL5262915,Inhibition of VEGFR-2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5260813,1,Scientific Literature,Eur J Med Chem,2017,None,,INHIBITOR,,0.654
CHEMBL190443,,None,615.78,2,6.31,50,COc1cc(OC)cc(C2Cc3cnc(N(CCCCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1,IC50,'=',55000,nM,4.26,,,UO_0000065,6.92,0.13,-2.05,3.72,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,55
CHEMBL1242662,,None,319.37,0,3.52,PP17,CC(C)n1nc(-c2ccc3cc(O)ccc3c2)c2c(N)ncnc21,IC50,'=',10,nM,8,,,UO_0000065,25.05,0.46,4.48,8.9,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.01
CHEMBL387591,,None,534.45,2,6.97,38,CN1CCN(Cc2cc(Nc3nc4cc(Oc5ccnc6ccccc56)cc(Cl)c4o3)ccc2Cl)CC1,Ki,'=',2,nM,8.7,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,2
CHEMBL425825,,None,479.97,0,4.6,33,CNc1cc(Oc2ccc3oc(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)ncn1,Ki,'=',20,nM,7.7,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,20
CHEMBL231467,,None,478.99,0,4.33,17,CNc1nccc(Oc2ccc3[nH]c(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)n1,Ki,'=',40,nM,7.4,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,40
CHEMBL397496,,None,499.02,1,6.05,13,CN1CCN(Cc2cc(Nc3nc4cc(Oc5ccnc6ccccc56)ccc4[nH]3)ccc2Cl)CC1,Ki,'=',2,nM,8.7,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,2
CHEMBL230222,,None,489.96,1,6.37,34,CN1CCC[C@@H]1COc1cc(Nc2nc3cc(Oc4ccnc5[nH]ccc45)ccc3o2)ccc1Cl,IC50,'=',5,nM,8.3,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,5
CHEMBL230002,,None,493.95,0,4.98,27,CN1CCC[C@H]1COc1cc(Nc2nc3cc(Oc4ccnc(C(N)=O)c4)ccc3o2)ccc1Cl,IC50,'=',18,nM,7.75,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,18
CHEMBL231568,,None,507.98,2,5.24,22,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1,IC50,'=',15.3,nM,7.82,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,15.3
CHEMBL231469,,None,506.99,1,4.52,20,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)ccn1,IC50,'=',36,nM,7.44,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,36
CHEMBL1095445,,None,452.27,1,6.2,11,Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,IC50,'>',300000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1112816,Inhibition of VEGFR2 phosphorylation in human U251 cells after 10 mins by FLISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157126,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3307756,,,,300
CHEMBL1094808,,None,470.26,1,6.34,13,Nc1nc(Nc2ccc(C(F)(F)F)c(F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,IC50,'=',113100,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1112816,Inhibition of VEGFR2 phosphorylation in human U251 cells after 10 mins by FLISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157126,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3307756,,,,113.1
CHEMBL1254923,,None,373.42,0,4.71,7j,Cc1cccc(NC(=O)Nc2ccc(Oc3ncnc4ccn(C)c34)cc2)c1,IC50,'=',2.7,nM,8.57,,,UO_0000065,22.95,0.42,3.86,10.57,0,CHEMBL1250641,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250545,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,2.7
CHEMBL520803,,None,353.43,0,4.05,13,C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccc4)cc23)c1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,1,CHEMBL1115600,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157122,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,200
CHEMBL1097743,,None,382.39,1,5.51,21,FC(F)(F)c1cccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)c1,IC50,'=',22100,nM,4.66,,,UO_0000065,12.18,0.23,-0.85,8.69,0,CHEMBL1115600,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157122,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,22.1
CHEMBL1242977,,None,479.46,1,5.95,6a,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1,IC50,'=',3270,nM,5.49,,,UO_0000065,11.44,0.21,-0.46,6.16,0,CHEMBL1247961,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240487,1,Scientific Literature,J Med Chem,2010,None,,,,3270
CHEMBL254494,,None,440.42,0,4.37,8d,O=C(Nc1ccc(O)cc1)Nc1cccc2c1C(=O)c1c-2n[nH]c1-c1ccc2c(c1)OCO2,Inhibition,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL928531,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140772,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,70
CHEMBL483313,,None,381.84,0,4.86,17,Nc1nc(Nc2ccc(Cl)cc2F)c2cc(CCc3ccccc3)[nH]c2n1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,1,CHEMBL1115600,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157122,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,200
CHEMBL381973,,None,364.41,0,4.3,4,CCOC(=O)c1cn2ncnc(Oc3ccc4[nH]ccc4c3)c2c1C(C)C,IC50,'=',470,nM,6.33,,,UO_0000065,17.36,0.32,2.03,7.76,0,CHEMBL860941,Inhibitory activity against VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146078,1,Scientific Literature,J Med Chem,2006,None,,,,0.47
CHEMBL381104,,None,308.3,0,2.79,1,COC(=O)c1cc2c(Oc3ccc4[nH]ccc4c3)ncnn2c1,IC50,'=',210,nM,6.68,,,UO_0000065,21.66,0.4,3.89,8.19,0,CHEMBL860941,Inhibitory activity against VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146078,1,Scientific Literature,J Med Chem,2006,None,,,,0.21
CHEMBL205710,,None,400.41,0,3.14,14,COC[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,IC50,'=',42,nM,7.38,,,UO_0000065,18.42,0.35,4.24,7.86,0,CHEMBL860941,Inhibitory activity against VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146078,1,Scientific Literature,J Med Chem,2006,None,,,,0.042
CHEMBL1079946,,None,504.38,2,6.01,7c,Cc1ccc(NC(=O)c2cc(Cl)cc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1,IC50,'=',6365,nM,5.2,,,UO_0000065,10.3,0.2,-0.81,4.69,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,6365
CHEMBL1080299,,None,449.52,1,5.01,7d,Cc1cccc(C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1,IC50,'=',280,nM,6.55,,,UO_0000065,14.58,0.26,1.54,5.92,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,280
CHEMBL1086730,,None,470.92,0,4.75,7f,Cc1ccc(NC(=O)c2ccncc2Cl)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,
CHEMBL1087636,,None,546.56,2,5.51,13b,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN)ncn1,IC50,'=',1748,nM,5.76,,,UO_0000065,10.53,0.2,0.25,4.69,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,1748
CHEMBL1076533,,None,435.49,0,4.7,15i,Cc1ccc(C(=O)Nc2ccccc2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1,IC50,'=',8817,nM,5.05,,,UO_0000065,11.61,0.21,0.35,4.56,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,8817
CHEMBL1076193,,None,583.58,2,6.21,15m,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)cn1,IC50,'=',20,nM,7.7,,,UO_0000065,13.19,0.24,1.49,5.99,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,20
CHEMBL1076194,,None,548.7,2,6.18,22a,Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCCN(C)C)ncn3)c2)c1,IC50,'=',1497,nM,5.83,,,UO_0000065,10.62,0.19,-0.36,5.82,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,1497
CHEMBL1076198,,None,602.67,2,6.89,22e,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1,IC50,'=',249,nM,6.6,,,UO_0000065,10.96,0.2,-0.29,6.6,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,249
CHEMBL1080294,,None,517.52,2,6.03,22j,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(N)c1C,IC50,'=',8181,nM,5.09,,,UO_0000065,9.83,0.18,-0.94,4.59,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,8181
CHEMBL233224,,None,446.99,0,4.81,9i,CN1CCN(CCc2ccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)cc2)CC1,IC50,'=',7,nM,8.15,,,UO_0000065,18.24,0.35,3.34,13.57,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.007
CHEMBL234443,,None,417.74,1,5.5,6a,CC(C)(N)c1ccc(-c2nc(Nc3cccc(Br)c3)ncc2Cl)cc1,IC50,'=',348,nM,6.46,,,UO_0000065,15.46,0.35,0.96,10.12,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.348
CHEMBL5275552,,None,602.62,2,5.05,W28,Cc1ccc(NC(=O)Cn2cc(-c3ccc4c(NC(=O)c5ccc(N6CCNCC6)cc5)n[nH]c4c3)cn2)cc1C(F)(F)F,IC50,'=',0.42,nM,9.38,,,UO_0000065,15.56,0.29,4.33,7.82,0,CHEMBL5249089,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5247592,1,Scientific Literature,Eur J Med Chem,2022,None,,INHIBITOR,,0.42
CHEMBL234626,,None,391.91,1,5.13,9g,CN(C)CCc1ccc(Nc2ncc(Cl)c(-c3cccc4cc[nH]c34)n2)cc1,IC50,'=',455,nM,6.34,,,UO_0000065,16.18,0.31,1.21,11.16,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.455
CHEMBL1097190,,None,358.87,0,3.31,25,Cl.NC1CCc2[nH]c3ccc(OCCc4ccc(O)cc4)cc3c2C1,IC50,'=',27140,nM,4.57,,,UO_0000065,14.16,0.26,1.26,6.41,0,CHEMBL1105617,Inhibition of VEGFR2 after 30 mins by chemiluminescence ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157833,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,27.14
CHEMBL4864736,,None,481.47,0,1.76,23a,O=C(Cn1c(=O)c2nncn2c2ccccc21)Nc1ccc(C(=O)NNC(=O)c2ccccc2)cc1,IC50,'=',8.7,nM,8.06,,,UO_0000065,16.74,0.31,6.3,5.78,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,8.7
CHEMBL194176,,None,435.51,0,4.95,9,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1,IC50,'=',22,nM,7.66,,,UO_0000065,17.58,0.34,2.71,8.12,1,CHEMBL4138365,Inhibition of N-terminal GST-fused human VEGFR2 C-terminal fragment expressed in Sf9 insect cells using poly(Glu:Tyr) 4:1 as substrate,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138043,1,Scientific Literature,Medchemcomm,2017,None,,,,22
CHEMBL249622,,None,323.38,0,2.26,8a,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2ccccc12,IC50,'=',95,nM,7.02,,,UO_0000065,21.72,0.42,4.76,9.73,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,95
CHEMBL429481,,None,402.28,0,3.02,14p,Cc1cc(Br)c2c(/C=C3\C(=O)NN=C3c3cnns3)cn(C)c2c1,IC50,'=',12,nM,7.92,,,UO_0000065,19.69,0.45,4.9,10.98,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,12
CHEMBL399692,,None,343.8,0,2.6,14o,Cn1cc(/C=C2\C(=O)NN=C2c2cnns2)c2ccc(Cl)cc21,IC50,'=',73,nM,7.14,,,UO_0000065,20.76,0.42,4.54,9.89,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,73
CHEMBL250610,,None,369.41,0,1.96,14q,COc1ccc(OC)c2c1c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,Inhibition,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,76
CHEMBL239590,,None,541.74,2,5.98,16,CC(C)N(CCOc1ccc(-c2oc3nccc(NCCN4CCNCC4)c3c2-c2ccccc2)cc1)C(C)C,IC50,'=',67,nM,7.17,,,UO_0000065,13.24,0.24,1.19,10.9,0,CHEMBL903615,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139139,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.067
CHEMBL240432,,None,508.63,1,4.75,15,c1ccc(-c2c(-c3ccc(OCCn4ccnc4)cc3)oc3nccc(NCCN4CCNCC4)c23)cc1,IC50,'=',160,nM,6.8,,,UO_0000065,13.36,0.24,2.05,8.45,0,CHEMBL903615,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139139,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.16
CHEMBL238719,,None,364.45,0,4.54,67,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)(C)C)cc1,IC50,'=',420,nM,6.38,,,UO_0000065,17.5,0.32,1.84,7.97,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.42
CHEMBL221119,,None,548.57,2,6.63,52,CNc1nccc(-c2cccnc2Oc2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)n1,IC50,'>',8000,nM,,,,UO_0000065,,,,,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,8000
CHEMBL220549,,None,480.45,1,5.92,44,COc1ccc(C(F)(F)F)cc1NC(=O)c1ccc(C)c(Oc2ncccc2-c2ccncn2)c1,IC50,'=',100,nM,7,,,UO_0000065,14.57,0.27,1.08,8.12,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,100
CHEMBL5182800,,None,487.63,1,5.43,22,CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCC(c5ccccc5)CC4)c3c2)cc1,Activity,'=',52,%,,,,UO_0000187,,,,,0,CHEMBL5117580,Inhibition of human KDR assessed as residual activity at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113478,1,Scientific Literature,Eur J Med Chem,2022,None,Dose = 10.0 microM,,,52
CHEMBL1241578,,None,348.2,0,3.12,PP487,CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21,IC50,'=',55,nM,7.26,,,UO_0000065,20.85,0.47,4.14,8.08,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.055
CHEMBL4874174,,None,477.52,0,4.74,VIB-MDA-001,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1,Inhibition,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4808057,Inhibition of KDR (unknown origin) at 0.5 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4806968,38,SureChEMBL Patent Bioactivity Data,,2020,None,Dose = 0.5 microM,INHIBITOR,,95
CHEMBL1242751,,None,313.36,0,2.67,PP65,COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1OC,IC50,'=',5290,nM,5.28,,,UO_0000065,16.84,0.31,2.61,5.99,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,5.29
CHEMBL4164333,,None,487.87,1,5.94,10c,CCn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(Cl)c(C(F)(F)F)c3)n4C)ncnc21,Inhibition,'=',44.7,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,44.7
CHEMBL599247,,None,326.36,0,3.56,17b,O=C1Cc2cnc3cc(-c4ccccc4)nn3c2-c2ccccc2N1,IC50,'=',630,nM,6.2,,,UO_0000065,19,0.34,2.64,10.46,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,0.63
CHEMBL603259,,None,356.39,0,3.57,18b,COc1ccc2c(c1)NC(=O)Cc1cnc3cc(-c4ccccc4)nn3c1-2,IC50,'=',1800,nM,5.75,,,UO_0000065,16.12,0.29,2.17,8.38,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,1.8
CHEMBL1242477,,None,293.33,0,2.53,PP110,CC(C)n1nc(-c2ccc3cn[nH]c3c2)c2c(N)ncnc21,IC50,'=',420,nM,6.38,,,UO_0000065,21.74,0.4,3.85,6.49,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.42
CHEMBL1241588,,None,311.35,0,2.43,PP54,CC(C)n1nc(-c2ccc3c(c2)OCCO3)c2c(N)ncnc21,IC50,'=',21000,nM,4.68,,,UO_0000065,15.02,0.28,2.25,5.31,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,21
CHEMBL396265,,None,447.88,1,5.71,5,COc1cc2ncnc(Oc3ccc4[nH]c(Nc5ccc(Cl)cc5)nc4c3)c2cc1OC,Ki,'=',8,nM,8.1,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,8
CHEMBL230109,,None,479.97,0,4.6,32,CNc1nccc(Oc2ccc3oc(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)n1,IC50,'=',303,nM,6.52,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,303
CHEMBL220052,,None,535.53,2,5.75,46,Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCOCC2)cc1Oc1ncccc1-c1ccncn1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,25000
CHEMBL1241949,,None,319.37,0,2.79,PP146,CC(C)n1nc(-c2ccc3nc(N)ccc3c2)c2c(N)ncnc21,IC50,'=',5100,nM,5.29,,,UO_0000065,16.57,0.3,2.5,4.88,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,5.1
CHEMBL1242209,,None,318.38,0,3.51,PP133,Cc1ccc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2n1,IC50,'=',100000,nM,4,,,UO_0000065,12.56,0.23,0.49,4.85,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,100
CHEMBL184311,,None,276.7,0,3.57,144d,Cc1ccc2c(Nc3ccc(F)c(Cl)c3)ncnn12,IC50,'=',3250,nM,5.49,,,UO_0000065,19.83,0.39,1.92,13,0,CHEMBL5262915,Inhibition of VEGFR-2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5260813,1,Scientific Literature,Eur J Med Chem,2017,None,,INHIBITOR,,3.25
CHEMBL1290362,,None,388.45,0,1.44,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1290247,ASN01107570,None,426.27,0,4.11,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1290031,,None,401.49,1,5.61,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1605835,FLOPROPIONE,2,182.18,0,1.4,flopropione,CCC(=O)c1c(O)cc(O)cc1O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1201187,MARAVIROC,4,513.68,2,5.95,maraviroc,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1118,DESVENLAFAXINE,4,263.38,0,2.73,DESVENLAFAXINE SUCCINATE,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2105458,THENALIDINE,4,286.44,0,3.85,thenalidine,CN1CCC(N(Cc2cccs2)c2ccccc2)CC1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2110775,CARPIPRAMINE,-1,446.64,0,4.12,carpipramine,NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL508338,THIMEROSAL,4,404.82,None,None,thiomersal,,AC50,'=',15701.1,nM,4.8,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,15.7011
CHEMBL18442,PLERIXAFOR,4,502.8,2,0.42,plerixafor,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL279898,ENPROFYLLINE,2,194.19,0,-0.18,enprofylline,CCCn1c(=O)[nH]c(=O)c2nc[nH]c21,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL398440,CHLOROXYLENOL,4,156.61,0,2.66,chloroxylenol,Cc1cc(O)cc(C)c1Cl,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1200381,ARGININE HYDROCHLORIDE,4,210.66,None,None,arginine hydrochloride,Cl.N=C(N)NCCC[C@H](N)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3707303,MAGNESIUM PIDOLATE,2,280.52,0,-0.65,magnesium pidolate,O=C([O-])[C@@H]1CCC(O)=N1.O=C([O-])[C@@H]1CCC(O)=N1.[Mg+2],AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1908350,ROKITAMYCIN,2,828.01,2,3.16,rokitamycin,CCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@H]2[C@H](N(C)C)[C@@H](O)[C@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)O[C@@H]2C)C[C@@]1(C)OC(=O)CC,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL404849,SULOCTIDIL,4,337.57,1,5.56,suloctidil,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL567597,ARTEMISININ,4,282.34,0,2.39,artemisinin,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL305906,CETYLPYRIDINIUM,4,304.54,1,6.46,cetylpyridinium,CCCCCCCCCCCCCCCC[n+]1ccccc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL11298,SERINE,3,105.09,0,-1.61,serine,N[C@@H](CO)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL5201102,,None,541.65,1,4.07,Nintedanib,COC(=O)c1ccc2c(C(Nc3ccc(N(C)C(=O)CN4CCN(C)CC4)cc3)c3ccccc3)c(O)[nH]c2c1,IC50,'=',3,nM,8.52,,,UO_0000065,15.74,0.29,4.45,8.43,0,CHEMBL5151973,Inhibition of VEGFR2 (unknown origin) by FISH assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5150004,1,Scientific Literature,J Med Chem,2021,None,,INHIBITOR,,3
CHEMBL5402797,,None,355.47,0,2.47,18,Cc1cc(Nc2ncc(C)c(N3CC4CCC(C3)N4CC#N)n2)sn1,IC50,'=',221,nM,6.66,,,UO_0000065,18.72,0.36,4.19,8.22,0,CHEMBL5334099,Inhibition of KDR (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5331110,1,Scientific Literature,J Med Chem,2023,None,TIME_Lower = 45.0 min | TIME_Upper = 120.0 min,INHIBITOR,,221
CHEMBL389147,,None,998.01,3,-3.08,1,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1118042,Inhibition of VEGFR2 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155516,1,Scientific Literature,J Med Chem,2010,CHEMBL3307501,,,,
CHEMBL2029988,CEP-32496,2,517.46,2,5.91,Agerafenib,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,Kd,'=',7.9,nM,8.1,,,UO_0000065,15.66,0.3,2.19,6.72,0,CHEMBL5152004,Binding affinity to VEGFR2 (unknown origin) assessed as dissociation constant measured by ambit kinomescan assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5150004,1,Scientific Literature,J Med Chem,2021,None,,INHIBITOR,,7.9
CHEMBL462232,,None,528.57,2,6.1,1,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccccc6)C5=O)cc4F)c3s2)c1,IC50,'=',10,nM,8,,,UO_0000065,15.14,0.29,1.9,8.64,0,CHEMBL1103916,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157925,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.01
CHEMBL1088539,,None,499.42,0,4.83,6,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cnn(-c4ccccc4)c3C(F)(F)F)cc2F)ccn1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL1103916,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157925,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,20
CHEMBL390467,,None,322.37,0,4.91,2k,N#Cc1cnc(Nc2ccc3ccccc3c2)nc1-c1ccccc1,IC50,'=',2100,nM,5.68,,,UO_0000065,17.61,0.31,0.77,9.22,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,2.1
CHEMBL4869269,,None,398.85,1,5.08,13h,O=C1Nc2ccccc2/C1=C/c1ccc(-c2cn(-c3ccccc3Cl)nn2)cc1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL4819966,Inhibition of recombinant human His-tagged VEGFR2 expressed in Baculovirus expression system using ADP-Glo as substrate measured after 30 mins in presence of ATP by ADP-Glo kinase assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819005,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 0.5 hr,,,200
CHEMBL3892923,,None,485.47,1,5.82,BDBM235505,Cc1cc(NC(=O)Nc2cc(F)cc(C(C)(F)F)c2)ccc1Oc1cc(NC(=O)C2CC2)ncn1,IC50,'=',9.5,nM,8.02,,410140,UO_0000065,16.52,0.31,2.2,7.62,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3758376,,None,461.59,0,3.8,22c,CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL3761581,Inhibition of KDR (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,,,,10
CHEMBL3902261,,None,586.59,2,5.77,BDBM235557,CN1CCN(Cc2cc(NC(=O)Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)cc(C(F)(F)F)c2)CC1,IC50,'=',16.1,nM,7.79,,410192,UO_0000065,13.29,0.25,2.02,7.89,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898941,,None,488.44,1,6.26,BDBM235573,CC(F)(F)c1cc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)ccc1F,IC50,'=',13.6,nM,7.87,,410208,UO_0000065,16.11,0.31,1.61,8.52,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944186,,None,346.39,0,3.21,BDBM214708,O=C(Nc1cccnc1)N1CCc2nc(Nc3ccccc3)ncc2C1,IC50,'>',10000,nM,,,377138,UO_0000065,,,,,0,CHEMBL3888173,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5082928,,None,342.37,0,2.69,46b,CCc1cc(O)c(F)cc1-c1cc(NCCO)c2nc(N)ncc2c1,IC50,'=',1584.89,nM,5.8,,,UO_0000065,16.94,0.32,3.11,5.56,0,CHEMBL5047431,Inhibition of human GST/6His-tagged VEGFR2 using Biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate incubated for 90 mins in presence of ATP by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5046242,1,Scientific Literature,J Med Chem,2022,None,TIME = 1.5 hr,INHIBITOR,,5.8
CHEMBL3678948,,None,466.59,0,4.63,BDBM173438,C#Cc1cccc(Nc2nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n2C(C)C)c1,IC50,'=',50,nM,7.3,,318782,UO_0000065,15.65,0.28,2.67,9.85,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL365866,,None,494.62,0,4.6,30,CN(c1ccc(NC(=O)NC2CCCC2)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,IC50,'=',31,nM,7.51,,,UO_0000065,15.18,0.29,2.91,6.46,0,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140275,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,31
CHEMBL189408,,None,530.65,1,4.9,26,CN(c1ccc(NC(=O)NCCc2ccccc2)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,IC50,'=',11,nM,7.96,,,UO_0000065,15,0.29,3.06,6.84,0,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140275,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,11
CHEMBL186369,,None,454.56,0,3.67,28,CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1,IC50,'=',26,nM,7.58,,,UO_0000065,16.69,0.32,3.92,6.52,0,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140275,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,26
CHEMBL3656102,,None,517.52,2,5.17,BDBM110613,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCC(=O)O)c[nH]4)c3)cc2)c1,IC50,'=',19,nM,7.72,,231498,UO_0000065,14.92,0.28,2.55,5.31,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3657553,,None,495.97,0,3.19,BDBM138214,Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1C[C@H](O)C[C@H]1C(=O)O,IC50,'=',9458,nM,5.02,,272114,UO_0000065,10.13,0.2,1.83,4.14,0,CHEMBL3707826,Kinase Inhibition Assay: Compounds of the invention were initially diluted to 10 mM in 100% DMSO (CALBIOCHEM) for storage and made into kinase buffer solution to create a compound concentration ranging from 1 uM and 10 uM. Serial dilutions of compounds of the invention were dispensed into a 96-well plate (GREINER BIOSCIENCES) at 6 uL each. Purified full-length human SYK,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3656026,,None,520.49,1,4.61,BDBM110534,COC(=O)CNC(=O)c1c[nH]c(-c2cc(Oc3cc(C(=O)Nc4cc(C)ccc4F)ccc3F)ccn2)c1,IC50,'=',28,nM,7.55,,231420,UO_0000065,14.51,0.27,2.94,6.17,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2386792,,None,557.66,2,5.73,9l,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCCC5)cc4)[nH]n3)cc2)no1,IC50,'=',12,nM,7.92,,,UO_0000065,14.2,0.26,2.19,5.76,0,CHEMBL2390017,Inhibition of recombinant GST tagged VEGFR2 (789 to 1356) (unknown origin) transfected in insect sf9 cells after 120 mins by wallac counting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384934,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3308860,,,,0.012
CHEMBL4800500,,None,424.55,0,2.73,65,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCO)cc32)c1C,Inhibition,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL4769121,Inhibition of wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system at 100 nM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765298,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 100.0 nM,INHIBITOR,,55
CHEMBL4781578,,None,451.57,0,2.61,67,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCC(N)=O)cc32)c1C,Inhibition,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL4769121,Inhibition of wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system at 100 nM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765298,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 100.0 nM,,,19
CHEMBL4878552,,None,522.49,1,4.38,W18,Cc1ccc(NC(=O)Cn2cc(-c3ccc4c(NC(=O)c5cnn(C)c5)n[nH]c4c3)cn2)cc1C(F)(F)F,INH,'=',100.4,uM,,,,UO_0000064,,,,,0,CHEMBL4820637,Inhibition of VEGFR2 (unknown origin) at 1 uM incubated for 10 mins followed by kinase substrate addition and measured after 30 mins by caliper mobility shift assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 1.0 microM | TIME = 0.6667 hr,INHIBITOR,,100.4
CHEMBL13608,TOCERANIB,2,396.47,0,3.09,12f,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1,IC50,'=',60,nM,7.22,,,UO_0000065,18.22,0.34,4.13,9.35,0,CHEMBL819556,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136732,1,Scientific Literature,J Med Chem,2003,None,,,,0.06
CHEMBL4780987,,None,479.01,1,6.4,12f,O=C(Nc1ccc(Cl)cc1)Nc1nc(Sc2c[nH]c3ccccc23)cc(N2CCCCC2)n1,IC50,'=',1820,nM,5.74,,,UO_0000065,11.98,0.24,-0.66,6.68,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,1.82
CHEMBL4064941,,None,386.46,0,4.64,38,Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(N(C)C)c4)cc3)c12,IC50,'=',6920,nM,5.16,,,UO_0000065,13.35,0.24,0.52,6,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,6920
CHEMBL4211614,,None,650.71,1,4.88,12n,Cc1c(C(=O)NCCCN2CCOCC2)sc2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12,IC50,'=',81,nM,7.09,,,UO_0000065,10.9,0.21,2.21,5.26,0,CHEMBL4182024,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2448064,,None,453.35,0,4.55,21,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCNCC1.Cl,IC50,'=',50,nM,7.3,,,UO_0000065,17.51,0.34,2.75,10.69,0,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.05
CHEMBL202244,,None,469.49,0,4.62,10,COC(=O)c1c(OCCN2CCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,Inhibition,'=',86.5,%,,,,UO_0000187,,,,,0,CHEMBL862239,Inhibitory activity against VEGFR2 kinase at 20 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149378,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,86.5
CHEMBL1271641,,None,432.48,0,3.19,11,Oc1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1O,IC50,'=',1,nM,9,,,UO_0000065,20.81,0.38,5.81,9.75,0,CHEMBL1272383,Inhibition of KDR by Hot Spot filtration binding assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1268961,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.001
CHEMBL1271617,,None,278.31,0,3.5,8,Cc1cccc(C(=O)Nc2cccc3cccnc23)c1O,IC50,'=',26.5,nM,7.58,,,UO_0000065,27.22,0.49,4.08,12.18,0,CHEMBL1273328,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1269001,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,26.5
CHEMBL46785,,None,482.64,0,4.55,3,CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Nc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1,IC50,'=',3810,nM,5.42,,,UO_0000065,11.23,0.21,0.87,6.15,0,CHEMBL698970,Inhibition of human VEGF-receptor 2 (kdr) kinase.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135159,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,3.81
CHEMBL3401978,,None,469.45,0,2.66,5,O=c1[nH]c(=O)n(C[C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL4172854,,None,392.85,0,4.41,10b,Cc1ccc(-c2nc3ccccc3n2CC(=O)N/N=C/c2ccccc2Cl)o1,IC50,'=',1260,nM,5.9,,,UO_0000065,15.02,0.29,1.49,8.15,0,CHEMBL4139350,Inhibition of human VEGFR2 using TMB substrate by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138096,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1.26
CHEMBL1084633,,None,442.52,1,5.45,11,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)NC(C)(C)C)c3ccccc23)n1,IC50,'=',2218,nM,5.65,,,UO_0000065,12.78,0.23,0.2,5.59,0,CHEMBL1120723,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,2.218
CHEMBL1084451,,None,570.7,2,7.25,1,CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1,Inhibition,'=',64,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,64
CHEMBL456683,,None,476.57,1,6.88,9,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1,Inhibition,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL1120731,Inhibition of KDR at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155514,1,Scientific Literature,J Med Chem,2010,None,,,,8
CHEMBL4164213,,None,414.51,1,5.81,17d,C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(C(C)(C)C)cc3)cc2)n1,IC50,'=',11.9,nM,7.92,,,UO_0000065,19.12,0.35,2.11,9.53,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,11.9
CHEMBL4172089,,None,392.85,1,5.17,17e,C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)n1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL4174775,,None,574.48,2,6.38,18e,O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCC1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL4161287,,None,486.96,1,5.3,18f,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(-c4ccc5c(=O)nc[nH]c5c4)cc3)CCC2)cc1Cl,IC50,'=',31.4,nM,7.5,,,UO_0000065,15.41,0.29,2.2,7.22,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,31.4
CHEMBL1241859,,None,358.83,0,2.43,PP385,Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNCC1,IC50,'=',3780,nM,5.42,,,UO_0000065,15.11,0.3,2.99,5.32,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,3.78
CHEMBL1241943,,None,372.86,0,2.82,PP391,Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CCC1CCCNC1,IC50,'=',1280,nM,5.89,,,UO_0000065,15.8,0.31,3.07,5.78,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,1.28
CHEMBL1242205,,None,303.32,0,3.39,PP215,Nc1ncnc2[nH]nc(-c3cccc(Oc4ccccc4)c3)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,
CHEMBL1242291,,None,317.35,0,3.18,PP217,Nc1ncnc2[nH]nc(-c3cccc(OCc4ccccc4)c3)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,
CHEMBL1242474,,None,331.42,0,4.27,PP232,CC(C)CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,
CHEMBL4073536,,None,414.51,1,5.42,36,CCN(CC)c1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1,IC50,'=',41966,nM,4.38,,,UO_0000065,10.56,0.19,-1.04,5.09,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,41966
CHEMBL4083222,,None,486.37,0,4.99,6n,C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL1241582,,None,283.34,0,2.15,PP26,CC(C)n1nc(-c2cccc(CO)c2)c2c(N)ncnc21,IC50,'=',100000,nM,4,,,UO_0000065,14.12,0.26,1.85,4.45,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,100
CHEMBL1241772,,None,279.31,0,1.92,PP21,CC(C)n1nc(-c2ccc(C#N)nc2)c2c(N)ncnc21,IC50,'=',100000,nM,4,,,UO_0000065,14.32,0.26,2.08,3.76,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,100
CHEMBL1241773,,None,295.35,0,2.86,PP31,CC(=O)c1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1,IC50,'=',100000,nM,4,,,UO_0000065,13.54,0.25,1.14,4.61,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,100
CHEMBL1242031,,None,332.39,0,1.3,PP41,CC(C)n1nc(-c2cccc(S(N)(=O)=O)c2)c2c(N)ncnc21,IC50,'=',4600,nM,5.34,,,UO_0000065,16.06,0.32,4.04,4.11,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,4.6
CHEMBL1242032,,None,332.39,0,1.3,PP14,CC(C)n1nc(-c2ccc(S(N)(=O)=O)cc2)c2c(N)ncnc21,IC50,'=',98800,nM,4,,,UO_0000065,12.05,0.24,2.71,3.09,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,98.8
CHEMBL148471,,None,310.36,0,4.14,5,O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)Cc1ccccc1-3,IC50,'=',414,nM,6.38,,,UO_0000065,20.57,0.36,2.24,14.22,1,CHEMBL911984,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141396,1,Scientific Literature,J Med Chem,2007,None,,,,414
CHEMBL3671521,,None,516.37,1,4.55,BDBM133732,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(C)C,IC50,'=',698,nM,6.16,,266590,UO_0000065,11.92,0.25,1.61,5.85,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671523,,None,514.36,1,4.47,BDBM133734,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)/C=C/C,IC50,'=',66,nM,7.18,,266592,UO_0000065,13.96,0.3,2.71,6.82,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671524,,None,516.37,1,4.69,BDBM133735,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCC,IC50,'=',954,nM,6.02,,266593,UO_0000065,11.66,0.25,1.33,5.72,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671534,,None,517.36,1,3.24,BDBM133746,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCN,IC50,'=',749,nM,6.13,,266604,UO_0000065,11.84,0.25,2.89,4.67,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671556,,None,516.37,1,4.69,BDBM133768,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(CC)NC(C)=O,IC50,'=',98,nM,7.01,,266626,UO_0000065,13.57,0.29,2.32,6.66,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3800152,,None,543.53,2,5.89,13p,CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1,Inhibition,'=',62.8,%,,,,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,62.8
CHEMBL271864,,None,537.58,1,3.74,32,CC(C)c1c(-c2nnc(N3CCC(N)CC3)o2)cn2ncnc(Nc3cc(C(=O)NC4CC4)c(F)cc3F)c12,IC50,'=',10,nM,8,,,UO_0000065,14.88,0.28,4.26,5.73,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL3323592,,None,336.4,1,5.52,7a,c1ccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)cc1,IC50,'=',2480,nM,5.61,,,UO_0000065,16.66,0.29,0.09,10.46,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,2.48
CHEMBL3323596,,None,366.42,1,5.53,7e,COc1ccccc1-c1nc2ccc(Nc3ccnc4ccccc34)cc2[nH]1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,10
CHEMBL3323610,,None,404.4,1,6.54,7q,FC(F)(F)c1ccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,10
CHEMBL3702602,,None,387.49,0,4,BDBM139542,CC(C)c1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)c1,IC50,'=',21,nM,7.68,,273902,UO_0000065,19.81,0.36,3.68,9.13,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702617,,None,407.56,0,3.96,BDBM139557,CC(C)(C)C1CCC(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)CC1,IC50,'=',307,nM,6.51,,273917,UO_0000065,15.98,0.3,2.55,7.74,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702633,,None,360.42,0,2.58,BDBM139573,Cc1cccc(NC(=O)c2ccnc(N3CCc4nc(N)ncc4C3)c2)c1,IC50,'>',10000,nM,,,273933,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702639,,None,400.36,0,3.25,BDBM139579,Nc1ncc2c(n1)CN(c1ccnc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2,IC50,'>',10000,nM,,,273939,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702669,,None,386.5,0,4.72,BDBM139609,Cc1cc(C(=O)Nc2cccc(C(C)C)c2)cc(N2CCc3ncncc3C2)c1,IC50,'=',159,nM,6.8,,273969,UO_0000065,17.59,0.32,2.08,11.7,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3644553,,None,429.52,0,4.81,BDBM139621,COC(=O)c1cncc2c1CCN(c1cccc(C(=O)Nc3cccc(C(C)C)c3)c1)C2,IC50,'=',12,nM,7.92,,273981,UO_0000065,18.44,0.34,3.11,11.07,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL271760,,None,521.63,1,4.79,16,Cc1ccc(NC(=O)c2ccccc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,IC50,'=',947,nM,6.02,,,UO_0000065,11.55,0.21,1.23,5.88,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,947
CHEMBL272902,,None,415.38,0,3.89,10a,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1,IC50,'=',205,nM,6.69,,,UO_0000065,16.1,0.3,2.8,6.08,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,205
CHEMBL3639549,,None,413.43,1,5.13,BDBM110554,Cc1cccc(NC(=O)c2cccc(Oc3ccnc(-c4cc(C(=O)O)c[nH]4)c3)c2)c1,IC50,'=',29,nM,7.54,,231439,UO_0000065,18.23,0.33,2.41,7.23,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3696084,,None,468.54,1,3.37,BDBM144599,Cc1ccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCO)c3C(N)=O)cc2)cc1,IC50,'=',7,nM,8.15,,280959,UO_0000065,17.4,0.34,4.78,5.15,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4790424,,None,415.37,0,4.5,10; SKLB610,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2)ccn1,IC50,'=',460,nM,6.34,,,UO_0000065,15.26,0.29,1.84,7.89,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,0.46
CHEMBL4776567,,None,414.47,0,4.95,14a,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4C)cc3)c2cc1OC,IC50,'=',115,nM,6.94,,,UO_0000065,16.74,0.31,1.99,8.13,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,0.115
CHEMBL4800071,,None,418.43,0,4.78,14h,COc1cc2ncnc(Nc3ccc(NC(=O)c4cccc(F)c4)cc3)c2cc1OC,IC50,'=',47,nM,7.33,,,UO_0000065,17.51,0.32,2.55,8.58,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,0.047
CHEMBL404497,,None,370.41,0,3.27,6a,CC(=O)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,'=',35,nM,7.46,,,UO_0000065,20.13,0.36,4.19,9.35,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,35
CHEMBL272824,,None,450.49,1,6.45,52,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c2cc1OC,IC50,'=',0.2,nM,9.7,,,UO_0000065,21.53,0.39,3.25,13.92,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.2
CHEMBL25579,,None,453.91,1,5.08,13,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN(C)c1ccncc1,IC50,'=',6,nM,8.22,,,UO_0000065,18.11,0.35,3.14,11.36,1,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.006
CHEMBL271188,,None,432.48,0,4.57,20,COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12,IC50,'=',12,nM,7.92,,,UO_0000065,18.31,0.34,3.35,10.04,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,12
CHEMBL257292,,None,358.41,0,4.16,13b,Cc1ccccc1NC(=O)Nc1ccc(-c2ccnc3[nH]nc(N)c23)cc1,IC50,'=',2.2,nM,8.66,,,UO_0000065,24.16,0.44,4.5,7.96,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,2.2
CHEMBL269885,,None,374.4,0,4.73,35,COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1,IC50,'=',106,nM,6.97,,,UO_0000065,18.63,0.34,2.24,6.81,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,106
CHEMBL269886,,None,412.37,1,5.74,34,Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)c12,IC50,'=',32,nM,7.5,,,UO_0000065,18.18,0.34,1.75,8.04,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,32
CHEMBL4757576,,None,507.95,2,5.23,15a,O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1,Activity,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL4724264,Effect on human recombinant N-terminal GST-tagged KDR (789 to end) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715878,1,Scientific Literature,J Med Chem,2020,None,Dose = 10.0 microM | TIME = 0.5 hr,,,-1
CHEMBL3678960,,None,413.49,1,5.02,BDBM173463,C=CC(=O)Nc1cccc(Nc2ncc3nc(Nc4ccccc4)n(C(C)C)c3n2)c1,IC50,'>',1000,nM,,,318798,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648082,,None,445.34,0,3.17,BDBM100890,COc1cc(Nc2ncc(Br)c(O[C@H](C)[C@H](C)O)n2)ccc1S(C)(=N)=O,IC50,'=',150,nM,6.82,,218167,UO_0000065,15.32,0.36,3.65,5.81,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4796859,,None,505.53,2,6.83,27,Cc1nc(NC(=O)c2cccc(C(F)(F)F)c2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,GI50,'=',5,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.005
CHEMBL4793707,,None,458.59,0,4.89,36,Cc1nc(NC(=O)CC2CCCNC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,GI50,'=',1930,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,1.93
CHEMBL4778971,,None,455.51,1,5.04,19p,Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1,IC50,'=',36900,nM,4.43,,,UO_0000065,9.73,0.18,-0.61,8.17,0,CHEMBL4727762,Inhibition of human KDR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4725327,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,,INHIBITOR,,36900
CHEMBL393636,,None,226.24,0,2.21,3b,O=C1Nc2ccc(O)cc2/C1=C/c1ccc[nH]1,IC50,'=',405.5,nM,6.39,,,UO_0000065,28.25,0.51,4.18,9.82,0,CHEMBL3626703,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3621077,1,Scientific Literature,Medchemcomm,2014,None,,,,405.5
CHEMBL3671572,,None,573.42,1,3.23,BDBM133785,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CCOCC1,IC50,'=',782,nM,6.11,,266643,UO_0000065,10.65,0.23,2.88,5.19,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671585,,None,486.94,0,3.35,BDBM133798,C=CC(=O)Nc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCNC(=O)CN(C)C,IC50,'=',758,nM,6.12,,266656,UO_0000065,12.57,0.25,2.77,5.64,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958054,,None,490.61,1,5.31,18a,COc1ccc(Cn2nc(-c3ccccc3)c3cc(Nc4ccccc4)nc(N4CCNCC4)c32)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3857163,Inhibition of VEGF-165-induced VEGFR2 autophosphorylation in serum-starved HUVEC assessed as decrease in ERK1/2 phosphorylation at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856209,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL4847441,,None,372.81,0,3.81,4,COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1,IC50,'=',131,nM,6.88,,,UO_0000065,,,,,0,CHEMBL4810140,Inhibition of human recombinant N-terminal His6-tagged VEGFR2 expressed in baculovirus infected Sf21insect cells using biotin-labeled EQEDEPEGDYFEWLE peptide as substrate incubated for 20 mins in presence of ATP by plate reader assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808209,1,Scientific Literature,J Med Chem,2021,None,TIME = 0.3333 hr,INHIBITOR,,131
CHEMBL97889,,None,256.13,0,3.04,19,Brc1cnc(Nc2ccccn2)s1,IC50,'=',71,nM,7.15,,,UO_0000065,27.91,0.75,4.11,18.91,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,71
CHEMBL4439227,,None,426.47,0,4.6,g24; XCF-37b,COc1ccc(NC(=O)c2cccc(/C=C3\CC(=O)N(c4ccc(C)cc4)C3=O)c2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4399338,Inhibition of VEGFR2 in VEGF-stimulated HUVEC assessed as downregulation of STAT3 phosphorylation at Tyr705 residue at 1 to 10 uM pre-incubated for 2 hrs followed by VEGF stimulation and measured after 15 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4396917,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307501,,,,
CHEMBL4165836,,None,423.49,0,4.88,8; BM02814,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4cc[nH]c4)c3)o2)c1,IC50,'=',18,nM,7.75,,,UO_0000065,18.29,0.35,2.86,7.97,0,CHEMBL4138365,Inhibition of N-terminal GST-fused human VEGFR2 C-terminal fragment expressed in Sf9 insect cells using poly(Glu:Tyr) 4:1 as substrate,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138043,1,Scientific Literature,Medchemcomm,2017,None,,,,18
CHEMBL4171115,,None,667.71,2,6.63,29b,COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c(F)c3)ccnc2cc1OCCCN1CCCC1,IC50,'=',21,nM,7.68,,,UO_0000065,11.5,0.22,1.05,7.29,0,CHEMBL4147639,Inhibition of KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4445335,,None,595.65,2,7.07,Roxyl-ZV-5J,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1,Inhibition,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4408023,Inhibition of recombinant human KDR (790 to end residues) at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,95
CHEMBL4555782,,None,430.47,0,2.8,24,COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1,Activity,'=',60,%,,,,UO_0000187,,,,,0,CHEMBL4400063,Inhibition of human recombinant KDR (790 to end residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4396947,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,,,,60
CHEMBL4078060,,None,569.64,2,5.49,4d,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)nc2n1C1CCCC1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,0
CHEMBL4080099,,None,565.68,2,5.66,4j,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc5cc(C(=O)N(C)C)n(C6CCCC6)c5n4)cc3)CC2)cc1,Inhibition,'=',9,%,,,,UO_0000187,,,,,1,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,9
CHEMBL4454899,,None,629.49,2,6.47,Roxyl-ZV-14E,CC(C)n1nnc2ccc(-c3nc(Nc4ccc(NC(=O)C5(C(=O)Nc6cccc(Br)c6)CC5)cc4)ncc3F)cc21,Inhibition,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,55
CHEMBL4445335,,None,595.65,2,7.07,Roxyl-ZV-5J,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4407848,Inhibition of VEGFR2 in HUVEC cells assessed as reduction in Src phosphorylation at 20 to 40 nM incubated for 48 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307501,,,,
CHEMBL84332,,None,412.54,0,4.73,8,O=c1ccc(-c2ccc3c(c2)ncn3-c2ccccc2)cn1CCCN1CCCCC1,IC50,'=',37,nM,7.43,,,UO_0000065,18.01,0.33,2.7,17.26,0,CHEMBL818933,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144948,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,37
CHEMBL1966175,,None,322.37,0,2.08,SID103904918,CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL1968868,,None,357.3,0,4.16,SID103904870,N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL4162460,,None,440.29,1,5.09,9o,Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(Cl)c(Cl)c3)n4C)ncnc21,IC50,'=',120.4,nM,6.92,,,UO_0000065,15.72,0.31,1.83,8.37,0,CHEMBL4155774,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,120.4
CHEMBL92623,,None,272.31,0,3.46,2g,c1ccc(-c2cnn3cc(-c4ccncc4)cnc23)cc1,IC50,'=',71,nM,7.15,,,UO_0000065,26.25,0.46,3.69,16.59,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,71
CHEMBL193346,,None,389.84,1,5.48,34,COC(=O)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'=',360,nM,6.44,,,UO_0000065,16.53,0.31,0.96,10.05,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,0.36
CHEMBL4471374,,None,485.9,1,5.34,160,Nc1ncnc2c3c(n(-c4ccc(CC(=O)Nc5ccc(C(F)(F)F)c(Cl)c5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4476415,,None,483.45,0,4.24,166,COc1ccc(NC(=O)Cc2ccc(-n3c4c(c5ncnc(N)c53)COC4)cc2)cc1C(F)(F)F,IC50,'=',10,nM,8,,,UO_0000065,16.55,0.31,3.76,7.67,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,10
CHEMBL4573413,,None,391.48,0,2.33,168,Nc1ncnc2c3c(n(-c4ccc(CC(=O)NC5CCOCC5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL432548,,None,398.51,0,4.34,9,O=c1cc(-c2ccc3c(c2)ncn3-c2ccccc2)ccn1CCN1CCCCC1,IC50,'=',88,nM,7.06,,,UO_0000065,17.7,0.32,2.72,16.39,0,CHEMBL818933,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144948,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,88
CHEMBL4164946,,None,378.82,0,4.1,10a,O=C(Cn1c(-c2ccco2)nc2ccccc21)N/N=C/c1ccccc1Cl,IC50,'=',640,nM,6.19,,,UO_0000065,16.35,0.31,2.09,8.55,0,CHEMBL4139350,Inhibition of human VEGFR2 using TMB substrate by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138096,1,Scientific Literature,Eur J Med Chem,2017,None,,,,0.64
CHEMBL397089,,None,480.45,1,5.35,17,CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2C)n1,IC50,'=',309,nM,6.51,,,UO_0000065,13.55,0.25,1.16,6.39,0,CHEMBL887077,Inhibition of KDR after 90 mins by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139197,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,309
CHEMBL371695,,None,334.79,0,2.94,13e,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3ccccc3Cl)c12,IC50,'=',8000,nM,5.1,,,UO_0000065,15.22,0.32,2.16,5.05,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,8
CHEMBL3808653,,None,419.45,0,3.59,25,CC(C)(C)c1cc(NC(=O)n2ccc3nc(Oc4ncnc5c4CNC5)ccc32)no1,IC50,'=',33,nM,7.48,,,UO_0000065,17.84,0.33,3.89,6.24,0,CHEMBL3812628,Inhibition of Tel fused KDR (unknown origin) expressed in BaF3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808377,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,0.033
CHEMBL221468,,None,371.47,0,1.95,19,CN(C)C(=O)N1CCN(Cc2ccnc(Nc3ncc(C#N)s3)c2)CC1,IC50,'=',10,nM,8,,,UO_0000065,21.54,0.42,6.05,9.05,0,CHEMBL913856,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,None,,,,10
CHEMBL375306,,None,343.42,0,1.35,18,N#Cc1cnc(Nc2cc(CN3CCN(C(N)=O)CC3)ccn2)s1,IC50,'=',8,nM,8.1,,,UO_0000065,23.58,0.46,6.75,7.28,0,CHEMBL913856,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,None,,,,8
CHEMBL221926,,None,393.52,0,3.61,13,CC(=O)N1CCN(Cc2ccnc(Nc3ncc(-c4ccccc4)s3)c2)CC1,IC50,'=',8,nM,8.1,,,UO_0000065,20.58,0.39,4.49,13.2,0,CHEMBL913856,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,None,,,,8
CHEMBL376722,,None,371.47,0,1.92,23,CNC(=O)N1CCN(Cc2ccnc(Nc3ncc(C#N)s3)c2C)CC1,IC50,'=',38,nM,7.42,,,UO_0000065,,,,,0,CHEMBL913857,Inhibition of VEGF-induced DNA synthesis in HEK293 cells expressing human KDR by endothelial cell mitogenesis assay,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,38
CHEMBL4453304,,None,398.41,0,2.54,17,COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4337785,Inhibition of rhVEGF-A-induced of VEGFR2 phosphorylation at Tyr1175 residue in HUVEC at 0.1 uM by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,CHEMBL3307501,,,,
CHEMBL4083528,,None,387.47,1,5.13,14a,Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL4001425,Inhibition of human wild type partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system at 10 uM by KinomeScan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4000195,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1
CHEMBL4085696,,None,371.4,0,4.77,17,Cc1nc2nc(Oc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4001362,Inhibition of recombinant human GST-tagged VEGFR-2 (789-end residues) transphosphorylation activity expressed in baculovirus infected Sf9 cells using poly[Glu:Tyr] (4:1) as substrate after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4000195,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL225318,,None,515.08,2,5.54,62,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5Cl)c4)n[nH]c2-3)CC1,IC50,'=',101,nM,7,,,UO_0000065,13.58,0.27,1.46,15.76,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,101
CHEMBL225090,,None,494.66,1,5.28,61,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',85,nM,7.07,,,UO_0000065,14.29,0.27,1.79,15.93,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,85
CHEMBL434180,,None,474.61,0,4.83,55,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccc(C#CCOc5ccccc5)cc4)n[nH]c2-3)CC1,IC50,'=',962,nM,6.02,,,UO_0000065,12.68,0.23,1.19,13.55,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,962
CHEMBL387972,,None,479.65,1,6.37,73,CC1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',69,nM,7.16,,,UO_0000065,14.93,0.28,0.79,17.4,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,69
CHEMBL225336,,None,522.68,1,4.63,46,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNC(=O)Nc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',11,nM,7.96,,,UO_0000065,15.23,0.29,3.33,10.43,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,11
CHEMBL213507,,None,512.68,2,5.09,1,Cc1cccc(NC(=O)NCc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1,IC50,'=',146,nM,6.84,,,UO_0000065,,,,,1,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,146
CHEMBL225090,,None,494.66,1,5.28,61,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',313,nM,6.5,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,313
CHEMBL374690,,None,469.57,0,4.61,81,CN(C)C(=O)COc1ccc2c(c1)Cc1c(-c3csc(C#CCOc4ccccc4)c3)n[nH]c1-2,IC50,'=',10,nM,8,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,10
CHEMBL263947,,None,470.96,1,5.02,27,CC(C)Oc1cc(OC2CCN(C)CC2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,
CHEMBL401838,,None,550.64,1,4.76,8e,O=C(Cc1ccccc1)NC(=S)Nc1ccc(Oc2ccnc3cc(C(=O)N4CCOCC4)sc23)c(F)c1,IC50,'=',289,nM,6.54,,,UO_0000065,11.88,0.24,1.78,7.05,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,289
CHEMBL4448435,,None,438.47,0,4.28,9d,CCOC(=O)c1ccc(Nc2ccnc(SCC(=O)c3ccc([N+](=O)[O-])cc3)n2)cc1,IC50,'=',410,nM,6.39,,,UO_0000065,14.57,0.28,2.11,5.14,0,CHEMBL4399178,Inhibition of human N-terminal GST tagged VEGFR-2 expressed in baculovirus infected Sf9 cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4469216,,None,469.57,1,6.04,9f,CCOC(=O)c1ccc(Nc2ccnc(SCC(=O)c3ccc(-c4ccccc4)cc3)n2)cc1,IC50,'=',340,nM,6.47,,,UO_0000065,13.78,0.26,0.43,7.97,0,CHEMBL4399178,Inhibition of human N-terminal GST tagged VEGFR-2 expressed in baculovirus infected Sf9 cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4449189,,None,424.5,0,4.17,10a,O=C(CSc1nccc(Nc2ccc(N3CCOCC3)cc2)n1)c1ccc(F)cc1,IC50,'=',260,nM,6.58,,,UO_0000065,15.51,0.3,2.42,9.78,0,CHEMBL4399178,Inhibition of human N-terminal GST tagged VEGFR-2 expressed in baculovirus infected Sf9 cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3686060,,None,488.5,1,5.06,BDBM128422,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(C5CCCO5)s4)ccn23)c1,IC50,'=',45.1,nM,7.35,,259649,UO_0000065,15.04,0.3,2.29,7.86,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690478,,None,414.39,0,4.18,BDBM128537,Cc1nccn1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1,IC50,'=',1340,nM,5.87,,259657,UO_0000065,14.17,0.27,1.69,7.7,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690384,,None,402.38,0,3.42,BDBM128440,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(C#CCCO)ccn23)c1,IC50,'=',349,nM,6.46,,259668,UO_0000065,16.05,0.3,3.04,8.21,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690412,,None,472.43,0,4.16,BDBM128469,COc1cc(OC)nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1,IC50,'>',30000,nM,,,259697,UO_0000065,,,,,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690413,,None,494.52,1,5.74,BDBM128470,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ccc(N5CCCCC5)nc4)ccn23)c1,IC50,'=',94.4,nM,7.03,,259698,UO_0000065,14.21,0.27,1.29,9.42,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690417,,None,572.61,2,6.1,BDBM128475,CC(C)(C)OC(=O)N1CCc2nc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)sc2C1,IC50,'=',18.2,nM,7.74,,259702,UO_0000065,13.52,0.26,1.64,7.67,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL45752,,None,341.42,0,4.69,2d,Cc1cc(C)cc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)c1,IC50,'=',6,nM,8.22,,,UO_0000065,24.08,0.43,3.53,14.78,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,6
CHEMBL246546,,None,311.41,0,2.79,10d,OCCNCc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1,IC50,'=',440,nM,6.36,,,UO_0000065,20.41,0.39,3.57,10.43,0,CHEMBL906389,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139908,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.44
CHEMBL245934,,None,365.5,0,3.91,10a,OCC1CCN(Cc2cccc3c2Cc2c-3n[nH]c2-c2ccsc2)CC1,IC50,'=',27890,nM,4.55,,,UO_0000065,12.46,0.24,0.64,8.73,0,CHEMBL906389,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139908,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,27.89
CHEMBL246166,,None,469.52,0,4.25,20c,COC(=O)C(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1,IC50,'=',36,nM,7.44,,,UO_0000065,15.85,0.3,3.19,7.98,0,CHEMBL906389,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139908,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.036
CHEMBL4534119,,None,501.51,2,7.01,11k,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1,Inhibition,'=',100.2,%,,,,UO_0000187,,,,,0,CHEMBL4412361,Inhibition of VEGFR2 (unknown origin) at 1000 nM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4411287,1,Scientific Literature,Eur J Med Chem,2019,None,,,,100.2
CHEMBL257802,,None,437.52,1,5.28,6a,O=C(Cc1ccccc1)NC(=S)Nc1ccc(Oc2ccnc3ccsc23)c(F)c1,IC50,'=',1134,nM,5.95,,,UO_0000065,13.59,0.27,0.67,9.4,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,1134
CHEMBL148514,,None,402.45,0,4.51,11f,COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)c1,IC50,'=',180,nM,6.75,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,0.18
CHEMBL4247697,,None,360.27,1,5.8,12,Clc1cccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4231140,Inhibition of recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system using Z'-LYTE-Tyr1 as substrate measured after 1 hr by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229346,1,Scientific Literature,Eur J Med Chem,2018,None,,,,
CHEMBL4248316,,None,411.48,0,4.53,19,COc1ccc2c(c1)SCc1cnc(Nc3cc(OC)c(OC)c(OC)c3)nc1-2,Inhibition,'=',46,%,,,,UO_0000187,,,,,0,CHEMBL4231139,Inhibition of recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 7 uM using Z'-LYTE-Tyr1 as substrate measured after 1 hr by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229346,1,Scientific Literature,Eur J Med Chem,2018,None,,,,46
CHEMBL4079829,,None,341.83,0,4.08,7,Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccc(Cl)cc3)c12,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL4007192,Inhibition of VEGF-induced VEGFR2 phosphorylation in human U251 cells preincubated for 60 mins followed by VEGF induction measured after 10 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4004880,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,500
CHEMBL4088389,,None,551.65,2,5.35,4a,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccccc5)CC4)cc3)nc2n1C1CCCC1,Inhibition,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL4056530,Inhibition of human VEGFR2 at 1 uM by enzymatic radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052710,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,8
CHEMBL443296,,None,416.48,0,4.9,9d,CCOc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1,IC50,'=',460,nM,6.34,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,0.46
CHEMBL4074450,,None,501.99,2,6.04,6e,CC[C@H](C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL4091010,,None,528.45,2,6.01,6p,CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL450622,,None,402.45,0,4.51,9c,COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1,IC50,'=',610,nM,6.21,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,0.61
CHEMBL4870465,,None,456.43,0,4.35,W13,CC(=O)Nc1n[nH]c2cc(-c3cnn(CC(=O)Nc4ccc(C)c(C(F)(F)F)c4)c3)ccc12,Inhibition,,,%,,,Dose-Dependent Effect,UO_0000187,,,,,0,CHEMBL4820685,Inhibition of VEGFR2 in human HGC-27 cells assessed as reduction in VEGFR-2 phosphorylation after 24 hrs by westernblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HGC-27,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 24.0 hr,INHIBITOR,,
CHEMBL1079850,,None,521.48,2,6.21,46,O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(C(F)(F)F)ccc1F,IC50,'=',100,nM,7,,,UO_0000065,13.42,0.25,0.79,7.27,0,CHEMBL1115705,Inhibition of VEGFR2 autophosphorylation by cell based assay,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153704,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,100
CHEMBL1095466,,None,393.29,1,5.36,16,Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)ncnc2[nH]1,Ratio IC50,'=',2,,,,,,,,,,0,CHEMBL1112826,Ratio of compound IC50 to semaxanib IC50 for VEGFR2 phosphorylation in human U251 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157126,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3307756,,,,2
CHEMBL3633303,,None,391.86,1,5.42,12n,Cc1ccc(NC(=O)Nc2cccc(-c3cccc4[nH]nc(N)c34)c2)cc1Cl,IC50,'=',41.8,nM,7.38,,,UO_0000065,18.83,0.36,1.96,7.7,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,41.8
CHEMBL3628906,,None,509.43,2,7.08,20,Cc1cc(Oc2ncnc3sc4c(c23)CCCC4)ccc1NC(=O)Nc1cccc(Br)c1,IC50,'=',34,nM,7.47,,,UO_0000065,14.66,0.32,0.39,9.81,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,34
CHEMBL3628809,,None,455.34,1,6.2,13,Cc1cc(Oc2ncnc3sccc23)ccc1NC(=O)Nc1cccc(Br)c1,IC50,'=',16,nM,7.8,,,UO_0000065,17.12,0.38,1.6,10.24,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,16
CHEMBL3628804,,None,323.35,0,4.3,5,CCOC(=O)Nc1ccc(Oc2ncnc3ccccc23)cc1C,IC50,'=',710,nM,6.15,,,UO_0000065,19.02,0.35,1.85,8.38,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,710
CHEMBL3628799,,None,494.42,1,6.72,17,O=C(Nc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1,IC50,'=',310,nM,6.51,,,UO_0000065,13.16,0.29,-0.21,8.25,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,310
CHEMBL2018756,,None,382.42,0,4.27,P2,CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,IC50,'=',500,nM,6.3,,,UO_0000065,16.48,0.31,2.03,6.66,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,500
CHEMBL3676372,,None,547.84,1,3.97,BDBM133834,C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OCCNC(=O)CN(C)C,IC50,'=',10000,nM,5,,266692,UO_0000065,9.13,0.2,1.03,4.61,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676380,,None,561.41,1,2.82,BDBM133842,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(CO)N(C)C,IC50,'=',797,nM,6.1,,266700,UO_0000065,10.86,0.23,3.28,4.74,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676381,,None,538.76,1,4.79,BDBM133845,C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)OC,IC50,'=',79,nM,7.1,,266703,UO_0000065,13.18,0.29,2.31,6.2,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676389,,None,517.36,1,3.24,BDBM133853,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(C)N,IC50,'=',165,nM,6.78,,266711,UO_0000065,13.11,0.28,3.54,5.17,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3633286,,None,544.53,1,4.91,6p,COc1ccc(C(=O)OCCN2CCOCC2)cc1NC(=O)Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL1096416,,None,366.83,1,5.28,24,Fc1cc(Cl)ccc1Nc1ncnc2[nH]c(CCc3ccccc3)cc12,IC50,'=',40500,nM,4.39,,,UO_0000065,11.97,0.23,-0.89,8.2,0,CHEMBL1115600,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157122,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,40.5
CHEMBL1097368,,None,353.43,0,4.97,25,c1ccc(CCc2cc3c(Nc4ccc5[nH]ccc5c4)ncnc3[nH]2)cc1,IC50,'=',31600,nM,4.5,,,UO_0000065,12.73,0.23,-0.47,6.49,0,CHEMBL1115600,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157122,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,31.6
CHEMBL4846532,,None,482.57,0,4.88,19d,Cc1cccc(C)c1NC(=O)c1ccc(NC(=O)CSc2nc3ccccc3n3cnnc23)cc1,IC50,'=',26.7,nM,7.57,,,UO_0000065,15.69,0.3,2.69,7.48,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,26.7
CHEMBL4856747,,None,455.5,0,3.66,19f,O=C(CSc1nc2ccccc2n2cnnc12)Nc1ccc(C(=O)Nc2ccccn2)cc1,IC50,'=',4.6,nM,8.34,,,UO_0000065,18.3,0.35,4.68,7.3,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,4.6
CHEMBL4849165,,None,489.95,0,4.31,19g,O=C(CSc1nc2ccccc2n2cnnc12)Nc1ccc(C(=O)Nc2ccc(Cl)cn2)cc1,IC50,'=',3.9,nM,8.41,,,UO_0000065,17.16,0.34,4.1,7.37,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,3.9
CHEMBL4850662,,None,497.54,0,3.08,21a,O=C(CSc1nc2ccccc2n2cnnc12)Nc1ccc(C(=O)NNC(=O)c2ccccc2)cc1,IC50,'=',29.6,nM,7.53,,,UO_0000065,15.13,0.29,4.45,5.77,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,29.6
CHEMBL4861773,,None,452.47,0,3.24,22b,Cc1cccc(NC(=O)c2ccc(NC(=O)Cn3c(=O)c4nncn4c4ccccc43)cc2)c1,IC50,'=',3.9,nM,8.41,,,UO_0000065,18.58,0.34,5.17,7.62,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,3.9
CHEMBL1097824,,None,525.57,2,5.65,10,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5N)cc4F)c3s2)c1,IC50,'=',800,nM,6.1,,,UO_0000065,11.6,0.22,0.45,5.4,0,CHEMBL1103916,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157925,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.8
CHEMBL599248,,None,280.29,0,1.9,18a,COc1ccc2c(c1)NC(=O)Cc1cnc3ccnn3c1-2,IC50,'=',8600,nM,5.07,,,UO_0000065,18.07,0.33,3.17,7.39,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,8.6
CHEMBL599055,,None,323.31,0,0.19,26b,Cn1c(=O)c2cc3c(nc2n(C)c1=O)-c1cnccc1NC(=O)C3,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,100
CHEMBL5175832,,None,435.48,0,4.02,22,COC(C)(C)C(=O)NC(=O)Nc1ccc(Oc2ccnc(-c3ccnc(C)c3)c2)c(C)n1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106444,Inhibition of VEGFR2 (unknown origin) measured by spectrophotometric analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104171,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL5087770,,None,504.9,2,6.21,17,O=C(Nc1ccc2c(c1)CCCN2c1ccc(C(=O)NO)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',13200,nM,4.88,,,UO_0000065,9.66,0.19,-1.33,5.21,0,CHEMBL5057122,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5055657,1,Scientific Literature,Bioorg Med Chem,2021,None,,INHIBITOR,,1.32
CHEMBL3612225,,None,407.52,1,6.1,3b,COc1ccc(NC(=O)Nc2ccccc2Sc2ccnc3ccsc23)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,100000
CHEMBL3633297,,None,411.39,1,5.47,12h,Nc1n[nH]c2cccc(-c3cccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c3)c12,IC50,'=',331,nM,6.48,,,UO_0000065,15.75,0.3,1.01,6.76,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,331
CHEMBL103055,,None,512.61,1,3.53,5a,CCN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1,IC50,'=',1410,nM,5.85,,,UO_0000065,11.41,0.21,2.32,7.53,0,CHEMBL819550,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136205,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,1.41
CHEMBL5195888,,None,523.64,2,5.25,56b,COc1cc(CCc2cc(-c3nc4ccc(-c5cccc(CN6CCOCC6)c5)cc4[nH]3)n[nH]2)cc(OC)c1,IC50,'=',773.6,nM,6.11,,,UO_0000065,11.67,0.21,0.86,6.92,0,CHEMBL5096260,Inhibition of recombinant N-terminal GST-tagged human KDR (790 to 1356 residues) expressed in baculovirus expression system using IGF-1Rtide peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hrs in the presence of ATP by ADP-Glo reagent based luminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5096142,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 1.167 hr,INHIBITOR,,773.6
CHEMBL5201819,,None,529.69,1,3.63,56o,COc1cc(CCc2cc(-c3nc4ccc(CN5CCC(N6CCNCC6)CC5)cc4[nH]3)n[nH]2)cc(OC)c1,IC50,'=',60.18,nM,7.22,,,UO_0000065,13.63,0.25,3.59,7.65,0,CHEMBL5096260,Inhibition of recombinant N-terminal GST-tagged human KDR (790 to 1356 residues) expressed in baculovirus expression system using IGF-1Rtide peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hrs in the presence of ATP by ADP-Glo reagent based luminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5096142,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 1.167 hr,INHIBITOR,,60.18
CHEMBL5207255,,None,433.51,0,3.59,56p,COc1cc(CCc2cc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)n[nH]2)cc(OC)c1,IC50,'=',53.12,nM,7.28,,,UO_0000065,16.78,0.31,3.68,8.24,0,CHEMBL5096260,Inhibition of recombinant N-terminal GST-tagged human KDR (790 to 1356 residues) expressed in baculovirus expression system using IGF-1Rtide peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hrs in the presence of ATP by ADP-Glo reagent based luminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5096142,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 1.167 hr,INHIBITOR,,53.12
CHEMBL5179660,,None,479.56,0,4.51,56u,COc1cc(CCc2cc(-c3nc4cc(F)c(N5C[C@@H](C)O[C@@H](C)C5)cc4[nH]3)n[nH]2)cc(OC)c1,IC50,'=',301.3,nM,6.52,,,UO_0000065,13.6,0.25,2.01,7.39,0,CHEMBL5096260,Inhibition of recombinant N-terminal GST-tagged human KDR (790 to 1356 residues) expressed in baculovirus expression system using IGF-1Rtide peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hrs in the presence of ATP by ADP-Glo reagent based luminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5096142,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 1.167 hr,INHIBITOR,,301.3
CHEMBL3628807,,None,435.28,1,5.83,6,O=C(Nc1ccc(Oc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1,IC50,'=',8,nM,8.1,,,UO_0000065,18.6,0.39,2.27,10.63,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,8
CHEMBL598434,,None,327.35,0,2.95,19,O=C1Cc2cnc3cc(-c4ccccc4)nn3c2-c2cnccc2N1,IC50,'=',2000,nM,5.7,,,UO_0000065,17.41,0.31,2.75,7.9,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,2
CHEMBL591896,,None,251.25,0,1.29,20a,O=C1Cc2cnc3ccnn3c2-c2ncccc2N1,IC50,'=',87000,nM,4.06,,,UO_0000065,16.16,0.29,2.77,5.63,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,87
CHEMBL608427,,None,252.24,0,0.68,23,O=C1Cc2cnc3ncnn3c2-c2ncccc2N1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,100
CHEMBL604912,,None,348.36,0,3.1,29j,COc1ccc2c(c1)NC(=O)Cc1cnc(Nc3cccc(O)c3)nc1-2,IC50,'=',15,nM,7.82,,,UO_0000065,22.46,0.41,4.72,8.12,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,0.015
CHEMBL597597,,None,319.32,0,2.48,30g,O=C1Cc2cnc(Nc3ccc(O)cc3)nc2-c2cnccc2N1,IC50,'=',130,nM,6.89,,,UO_0000065,21.56,0.39,4.41,6.88,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,0.13
CHEMBL598837,,None,347.38,0,3.18,31i,CCOc1ccc(Nc2ncc3c(n2)-c2ncccc2NC(=O)C3)cc1,IC50,'=',2000,nM,5.7,,,UO_0000065,16.41,0.3,2.52,6.4,0,CHEMBL1067596,Inhibition of VEGFR2 assessed as [33Pi] incorporation by microplate scintillation counting in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,2
CHEMBL604545,,None,318.34,0,3.09,28j,O=C1Cc2cnc(Nc3cccc(O)c3)nc2-c2ccccc2N1,IC50,'=',1600,nM,5.8,,,UO_0000065,18.21,0.33,2.71,6.65,0,CHEMBL1070927,Inhibition of VEGFR2 in HUE cells assessed as inhibition of VEGF-induced autophosphorylation treated for 90 mins before VEGF challenge by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUE,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157616,1,Scientific Literature,J Med Chem,2010,None,,,,1.6
CHEMBL5203405,,None,535.57,2,6.44,5,CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccc5cccnc5c4)cc3)cc2C(F)(F)F)CC1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL5104835,Inhibition of KDR (unknown origin) by Nano-syn mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104101,1,Scientific Literature,RSC Med Chem,2022,None,,INHIBITOR,,
CHEMBL74550,,None,347.81,0,4.41,49,Clc1ccc(Nc2nnc(Cc3ccncc3)c3cnccc23)cc1,IC50,'=',610,nM,6.21,,,UO_0000065,17.87,0.34,1.8,9.77,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.61
CHEMBL4860925,,None,435.6,0,4.29,30m,CNc1nc(C)c(-c2nc(Nc3cccc(N4CCN5CCC4CC5)c3)ncc2C)s1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4820724,Inhibition of recombinant human KDR 790 to end residues ) using myelin basic protein as substrate incubated for 40 mins by scintillation counting method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819032,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 0.6667 hr,INHIBITOR,,
CHEMBL3348846,FEXAGRATINIB,2,463.58,0,3.65,AZD4547,COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1,IC50,'=',67.2,nM,7.17,,,UO_0000065,15.47,0.29,3.52,7.84,0,CHEMBL4426405,Inhibition of recombinant human VEGFR2 using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4474690,,None,518.61,1,3.66,JTE-952; (S)-8b,COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4424889,Inhibition of human N-terminal His-tagged KDR (790 to end residues) expressed in baculovirus infected Sf21 insect cells using myelin basic protein as substrate,A,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4422686,1,Scientific Literature,Bioorg Med Chem Lett,2019,CHEMBL4106362,,,,1000
CHEMBL3633684,,None,387.4,0,4.18,12q,Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccc5c(c4)OCO5)cc3)c12,IC50,'=',1.38,nM,8.86,,,UO_0000065,22.87,0.42,4.68,7.75,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,1.38
CHEMBL3633302,,None,479.38,1,6.49,12m,Nc1n[nH]c2cccc(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)c12,IC50,'=',117,nM,6.93,,,UO_0000065,14.46,0.28,0.44,7.23,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,117
CHEMBL3633301,,None,412.28,1,5.76,12l,Nc1n[nH]c2cccc(-c3cccc(NC(=O)Nc4ccc(Cl)cc4Cl)c3)c12,IC50,'=',205,nM,6.69,,,UO_0000065,16.22,0.33,0.93,6.98,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,205
CHEMBL3633280,,None,558.6,2,6.7,6j,COc1ccc(C(=O)OCCN(C(C)C)C(C)C)cc1NC(=O)Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1,IC50,'=',8400,nM,5.08,,,UO_0000065,9.09,0.17,-1.62,5.47,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,8.4
CHEMBL5085176,,None,372.4,0,2.05,46i,CCc1cc(O)c(F)cc1-c1cc(NC(CO)CO)c2nc(N)ncc2c1,IC50,'=',1258.93,nM,5.9,,,UO_0000065,15.84,0.3,3.85,4.74,0,CHEMBL5047431,Inhibition of human GST/6His-tagged VEGFR2 using Biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate incubated for 90 mins in presence of ATP by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5046242,1,Scientific Literature,J Med Chem,2022,None,TIME = 1.5 hr,INHIBITOR,,5.9
CHEMBL1076465,,None,560.58,2,5.9,13c,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN)ncn1,IC50,'=',1472,nM,5.83,,,UO_0000065,10.4,0.19,-0.07,4.75,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,1472
CHEMBL1076470,,None,630.72,2,7.67,13g,CCN(CC)CCCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1,IC50,'=',885,nM,6.05,,,UO_0000065,9.6,0.18,-1.62,6.05,0,CHEMBL1113981,Inhibition of Tel-fused KDR expressed in mouse BAF3 cells,B,BAO_0000219,cell-based format,None,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154389,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307634,,,,885
CHEMBL4453339,,None,482.47,0,4.1,183,COc1cc(-n2c3c(c4ncnc(N)c42)CCC3)ccc1CC(=O)Nc1ccnc(C(F)(F)F)c1,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL565061,,None,454.41,0,4.84,1,CCOC(=O)c1cnn2c(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)ccnc12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1035539,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151868,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL5186111,,None,499.87,1,6.07,3g,Fc1c(F)c(F)c(Cn2c3ccccc3c3ccn4c[n+](-c5ccccc5)cc4c32)c(F)c1F.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL5199792,,None,402.71,1,5.17,3q,Cn1c2ccccc2c2ccn3c[n+](-c4ccc(Cl)cc4Cl)cc3c21.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL5174876,,None,453.97,1,5.66,3x,Oc1ccc(-[n+]2cc3c4c(ccn3c2)c2ccccc2n4CCCc2ccccc2)cc1.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL2334810,,None,392.44,0,3.89,14a,O=C(Nc1ccccc1)Nc1ccc(NC2=NS(=O)(=O)c3ccccc32)cc1,Inhibition,'=',28,%,,,,UO_0000187,,,,,0,CHEMBL2338949,Inhibition of VEGFR-2 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331514,1,Scientific Literature,Eur J Med Chem,2013,None,,,,28
CHEMBL3884319,,None,386.45,0,4.24,33,CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21,IC50,'=',1445,nM,5.84,,,UO_0000065,15.11,0.28,1.6,7.45,0,CHEMBL3876063,Inhibition of human recombinant His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3875183,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,1445
CHEMBL4544826,,None,488.94,1,5.59,66,COc1cc2ncnc(-n3ncc4cc(NC(=O)Nc5ccc(C)c(Cl)c5)ccc43)c2cc1OC,IC50,'=',12,nM,7.92,,,UO_0000065,16.2,0.31,2.33,7.68,0,CHEMBL5215243,Inhibition of VEGFR-2 (unknown origin) using poly(Glu:Tyr)(4:1) and ATP as substrate by incubated for 1 hr by spectrophotometric based ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5214889,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,12
CHEMBL151948,,None,390.8,0,3.76,31,COCC(=O)Nc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,100
CHEMBL561132,MK-7246,1,416.47,0,3.04,EUB0000297b,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,% Control,'=',82,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507290,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,82
CHEMBL3701243,,None,461.53,0,1.33,14,COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1,IC50,'=',3686,nM,5.43,,,UO_0000065,11.77,0.22,4.1,4.87,0,CHEMBL5256649,Inhibition of N-terminal GST tagged recombinant human VEGFR2 (aa805 to 1356 residues) expressed in baculovirus expression system using Poly- (Glu4:Tyr)-biotin as substrate incubated for 80 mins in presence of ATP by kinase glo method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5252660,1,Scientific Literature,ACS Med Chem Lett,2023,None,TIME = 1.333 hr,INHIBITOR,,3686
CHEMBL399605,,None,348.45,0,4.07,23,CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,Ki,'=',130,nM,6.89,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.13
CHEMBL610181,,None,296.33,0,2.96,1a,COc1ccccc1/C(C)=C/c1coc2nc(N)nc(N)c12,IC50,'=',10300,nM,4.99,,,UO_0000065,16.83,0.31,2.03,4.98,0,CHEMBL1038900,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152608,1,Scientific Literature,Bioorg Med Chem,2009,CHEMBL3307756,,,,10.3
CHEMBL4856623,,None,374.32,0,4.93,4,O=C(Nc1ccc(Oc2ccncn2)cc1)Nc1cccc(C(F)(F)F)c1,IC50,'=',50,nM,7.3,,,UO_0000065,19.5,0.37,2.37,9.59,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,50
CHEMBL4865829,,None,445.45,1,6,22,CC(C)CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1,IC50,'=',320,nM,6.5,,,UO_0000065,14.58,0.28,0.49,7.37,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,320
CHEMBL4859818,,None,367.38,0,4.42,32,CNc1cc(Oc2ccc(NC(=O)Nc3cccc(CF)c3)cc2)ncn1,IC50,'=',400,nM,6.4,,,UO_0000065,17.42,0.32,1.98,7.26,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,400
CHEMBL188149,,None,482.61,0,4.45,29,CCCCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3cccc(CS(C)(=O)=O)c3)n2)cc1,IC50,'=',29,nM,7.54,,,UO_0000065,15.62,0.3,3.09,6.48,0,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140275,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,29
CHEMBL3799292,(R)-9s,None,300.75,0,2.2,EUB0000300,C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,% Control,'=',88,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507301,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,88
CHEMBL189017,,None,451.36,1,6.03,28,Clc1ccc(Nc2cncc(-c3cncc(NCCCc4ccncc4)c3)n2)cc1Cl,IC50,'=',189,nM,6.72,,,UO_0000065,14.9,0.3,0.69,8.89,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,0.189
CHEMBL188284,,None,341.8,0,3.34,38,OCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,IC50,'=',275.42,nM,6.56,,,UO_0000065,19.19,0.37,3.22,7.91,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.56
CHEMBL598911,,None,405.26,1,5.32,3,CC(Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl,IC50,'=',26000,nM,4.58,,,UO_0000065,11.31,0.23,-0.73,7.03,0,CHEMBL1066394,Inhibition of recombinant KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,26000
CHEMBL188387,,None,395.89,0,4.77,54,Clc1cccc(Nc2cncc(-c3cncc(NCC4CCOCC4)c3)n2)c1,IC50,'=',389.05,nM,6.41,,,UO_0000065,16.19,0.31,1.64,8.91,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.41
CHEMBL3929084,,None,481.43,1,5.76,BDBM235529,N#Cc1ccc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)cc2)cc1C(F)(F)F,IC50,'=',10,nM,8,,410164,UO_0000065,16.62,0.31,2.24,6.89,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961228,,None,486.91,1,6.63,BDBM235539,CC(F)(F)c1cc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)cc2)ccc1Cl,IC50,'=',25.4,nM,7.59,,410174,UO_0000065,15.6,0.31,0.97,8.22,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940199,,None,470.45,1,6.19,BDBM235621,Cc1cc(NC(=O)Nc2cccc(C(F)(F)F)c2)ccc1Oc1ccnc(NC(=O)C2CC2)c1,IC50,'=',11.6,nM,7.94,,410256,UO_0000065,16.87,0.32,1.75,8.59,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL382979,,None,395.88,1,5.24,96,Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',3,nM,8.52,,,UO_0000065,21.53,0.43,3.28,9.17,0,CHEMBL871626,Inhibitory concentration against human KDR kinase expressed in NIH3T3 cells with 4 uM Biotin-Ahx-AEEEYFFLFA-amide at ambient temperature for 1 hr,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,CHEMBL3307716,,,,3
CHEMBL191372,,None,511.62,1,3.69,52,COc1cc(OC)cc(C2Cc3cnc(N(CCCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1,IC50,'=',10000,nM,5,,,UO_0000065,9.77,0.18,1.31,3.99,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,10
CHEMBL189851,,None,508.63,1,2.9,102,CCNC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1cc(OC)cc(OC)c1,IC50,'=',62,nM,7.21,,,UO_0000065,14.17,0.27,4.31,6.17,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.062
CHEMBL3978649,,None,436.49,0,3.09,BDBM208443,Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S(C)(C)=O)cnc2N)c1,IC50,'=',1,nM,9,,368398,UO_0000065,20.62,0.4,5.91,7.05,0,CHEMBL3888028,VEGFR2 Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919069,,None,450.5,0,4.13,BDBM208451,CS(C)(=O)=NC(=O)c1cncc(C#Cc2cccc(NC(=O)Nc3ccccc3F)c2)c1,IC50,'=',48,nM,7.32,,368406,UO_0000065,16.25,0.31,3.19,7.28,0,CHEMBL3888028,VEGFR2 Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897137,,None,465.53,0,3.26,BDBM208481,Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=S(C)(=O)CCCO)c2)c1,IC50,'=',1,nM,9,,368423,UO_0000065,19.33,0.37,5.74,7.39,0,CHEMBL3888028,VEGFR2 Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3938078,,None,509.85,2,6.07,BDBM235403,O=C(Nc1ccc(F)c(Oc2cc(NC(=O)C3CC3)ncn2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',14.2,nM,7.85,,410038,UO_0000065,15.39,0.31,1.78,7.46,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3906467,,None,493.39,1,5.56,BDBM235488,O=C(Nc1cc(F)cc(Oc2cc(NC(=O)C3CC3)ncn2)c1)Nc1cc(F)cc(C(F)(F)F)c1,IC50,'=',105,nM,6.98,,410123,UO_0000065,14.14,0.27,1.42,6.63,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3975481,,None,475.4,1,5.42,BDBM235498,O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(Oc2cc(NC(=O)C3CC3)ncn2)cc1F,IC50,'=',8.6,nM,8.07,,410133,UO_0000065,16.97,0.32,2.65,7.66,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3982058,,None,471.44,1,5.59,BDBM235502,Cc1cc(NC(=O)Nc2cccc(C(F)(F)F)c2)ccc1Oc1cc(NC(=O)C2CC2)ncn1,IC50,'=',14.5,nM,7.84,,410137,UO_0000065,16.63,0.31,2.25,7.45,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944876,,None,551.5,2,7.09,BDBM235576,O=C(Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1)Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)c(F)c1,IC50,'=',5,nM,8.3,,410211,UO_0000065,15.05,0.28,1.21,7.89,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL69868,,None,384.48,1,5.9,4,Cc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1,IC50,'=',3350,nM,5.47,,,UO_0000065,14.24,0.26,-0.43,8.3,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,3.35
CHEMBL3928457,,None,367.41,0,4.19,BDBM201229,Nc1n[nH]c2cccc(C#Cc3cccc(NC(=O)Nc4ccccc4)c3)c12,IC50,'=',41,nM,7.39,,357159,UO_0000065,20.11,0.36,3.2,7.71,0,CHEMBL3887844,PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2417932,,None,617.67,1,4.49,6b,O=C(Cc1cccc2ccccc12)NCCNC(=O)C1(NC(=O)c2ccc(C(F)(F)F)nc2)CCN(Cc2ccccc2)CC1,Inhibition,'=',11.05,%,,,,UO_0000187,,,,,0,CHEMBL2422823,Inhibition of VEGFR2 (unknown origin) at 50 uM after 1 hr by luminescence assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2417482,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,11.05
CHEMBL4860596,,None,466.5,0,3.55,22c,Cc1cccc(C)c1NC(=O)c1ccc(NC(=O)Cn2c(=O)c3nncn3c3ccccc32)cc1,IC50,'=',6.8,nM,8.17,,,UO_0000065,17.51,0.32,4.62,7.4,0,CHEMBL4811110,Inhibition of VEGFR-2 (unknown origin) incubated for 60 mins by Kinase-Glo luminescent kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808252,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.0 hr,INHIBITOR,,6.8
CHEMBL3931458,,None,510.56,1,4.4,BDBM202398,NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2C(F)(F)F)CC1,IC50,'=',4083,nM,5.39,,358626,UO_0000065,10.56,0.2,0.99,5.09,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL232542,,None,539.71,2,6.65,18,CCN(CC)C/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)c4cc5ccccc5n4C)c(OC)c3)csc12,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL897114,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148846,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,50
CHEMBL395664,,None,566.73,2,5.65,25,COc1cc(-c2csc3c(/C=C/CNC4CCNCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL897114,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148846,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,50
CHEMBL395666,,None,580.76,2,6.17,27,COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL897114,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148846,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,50
CHEMBL3948670,,None,523.6,2,5.35,BDBM202396,CN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cc2)CC1,IC50,'=',1789,nM,5.75,,358600,UO_0000065,10.98,0.21,0.4,6.83,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931458,,None,510.56,1,4.4,BDBM202398,NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2C(F)(F)F)CC1,IC50,'=',4083,nM,5.39,,358602,UO_0000065,10.56,0.2,0.99,5.09,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963494,,None,437.94,0,2.52,BDBM202407,NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CNC4)c3)ncc2Cl)CC1,IC50,'=',357,nM,6.45,,358609,UO_0000065,14.72,0.28,3.93,5.82,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891581,,None,491.04,0,4.38,BDBM202409,CN1CCC(c2ccc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)CC1,IC50,'=',46,nM,7.34,,358611,UO_0000065,14.94,0.29,2.96,7.56,0,CHEMBL3887862,VEGFR2: Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4851319,,None,556.09,2,5.53,8f,O=C(CN1CCN(c2cc(=O)n(-c3ccccc3)c3ccccc23)CC1)Nc1nc(-c2ccc(Cl)cc2)cs1,IC50,'=',62.7,nM,7.2,,,UO_0000065,12.95,0.25,1.67,10.22,0,CHEMBL4822643,Inhibition of VEGFR-2 (unknown origin) by using poly (Glu:Tyr 4:1) as substrate measured after 45 mins by Kinase-Glo max based microplate reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819122,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 0.75 hr,INHIBITOR,,62.7
CHEMBL45693,,None,495.63,0,4.04,4,CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(C(=O)c5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL698970,Inhibition of human VEGF-receptor 2 (kdr) kinase.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135159,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,50
CHEMBL329350,,None,302.34,0,3.47,2,COc1ccc(-c2cnc3c(-c4ccncc4)cnn3c2)cc1,IC50,'=',37,nM,7.43,,,UO_0000065,24.58,0.44,3.96,14.21,1,CHEMBL818936,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135002,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,37
CHEMBL4536441,,None,511.99,1,4.51,6d,CCCN1C(=O)/C(=N\c2ccc(NC(=O)Nc3ccc(S(N)(=O)=O)cc3)cc2)c2cc(Cl)ccc21,IC50,'=',383.61,nM,6.42,,,UO_0000065,12.53,0.25,1.91,4.79,0,CHEMBL4383827,Inhibition of VEGFR2 (unknown origin) using poly[Glu:Tyr] (4:1) as substrate measured after 5 mins by Alphascreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382220,1,Scientific Literature,Eur J Med Chem,2019,None,,,,383.61
CHEMBL92361,,None,292.29,0,2.56,4,O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12,Inhibition,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL704956,Inhibition of Kinase insert domain receptor (VEGFR2) at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144893,1,Scientific Literature,J Med Chem,2003,None,,,,54
CHEMBL3657546,,None,424.89,0,3.6,BDBM138206,Cc1nn(-c2ccnc(Nc3ccc4oc(C)c(Cl)c4c3)n2)cc1CN1CC(O)C1,IC50,'=',3895,nM,5.41,,272106,UO_0000065,12.73,0.25,1.81,5.86,0,CHEMBL3707826,Kinase Inhibition Assay: Compounds of the invention were initially diluted to 10 mM in 100% DMSO (CALBIOCHEM) for storage and made into kinase buffer solution to create a compound concentration ranging from 1 uM and 10 uM. Serial dilutions of compounds of the invention were dispensed into a 96-well plate (GREINER BIOSCIENCES) at 6 uL each. Purified full-length human SYK,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3109350,,None,418.5,0,3.56,21,COCCOc1ccn2c(-c3ccc4cccc(OCC5CCNC5)c4n3)cnc2c1,IC50,'=',70,nM,7.16,,,UO_0000065,17.1,0.32,3.59,10.23,0,CHEMBL3111862,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108676,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,70
CHEMBL182904,,None,313.74,0,3.89,16,O=C(Nc1ncnc2oc(-c3ccc(Cl)cc3)cc12)C1CC1,IC50,'=',2040,nM,5.69,,,UO_0000065,18.14,0.35,1.8,8.37,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,2.04
CHEMBL3696077,,None,349.42,0,1.65,BDBM144592,COCCCNC(=O)Nc1snc(-c2ccc(N)cc2)c1C(N)=O,IC50,'=',4520,nM,5.34,,280952,UO_0000065,15.3,0.3,3.69,4.04,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL180603,,None,406.45,0,2.21,29,Cc1ccc(Nc2ncnn3cc(C(=O)NCCCn4nccn4)c(C)c23)cc1O,IC50,'=',30,nM,7.52,,,UO_0000065,18.51,0.34,5.31,6.15,0,CHEMBL830878,Inhibitory concentration against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142012,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,30
CHEMBL442388,,None,391.46,0,3.09,59c,CC(O)C(/N=C1\C(O)=CC(=O)C(O)=C1CC1CCCC2CCCCC21)C(=O)O,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL820701,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145828,1,Scientific Literature,J Med Chem,2003,None,,,,50
CHEMBL4441199,,None,376.39,0,4.82,5q,COc1ccc(CC(=O)Nc2ccc3oc(-c4ccccc4F)nc3c2)cc1,IC50,'=',165.9,nM,6.78,,,UO_0000065,18.01,0.33,1.96,10.53,0,CHEMBL4398894,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3608524,,None,502.04,1,4.5,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL352308,,None,501.63,2,6.04,15e,COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCNCCO,IC50,'=',83,nM,7.08,,,UO_0000065,14.12,0.26,1.04,8.34,0,CHEMBL820700,Inhibition of vascular endothelial growth factor receptor 2 autophosphorylation in intact cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146677,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,83
CHEMBL3915272,,None,579.65,1,4.74,BDBM208479,COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)Nc3cc(C)ccc3F)c2)c1,IC50,'=',5,nM,8.3,,368392,UO_0000065,14.32,0.28,3.56,5.43,0,CHEMBL3888027,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3758582,,None,475.62,0,4.83,35b,COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL3761581,Inhibition of KDR (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,,,,10
CHEMBL3758682,,None,407.5,0,4,3c,COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1,Inhibition,'=',12,%,,,,UO_0000187,,,,,0,CHEMBL3761581,Inhibition of KDR (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,,,,12
CHEMBL5196519,,None,522.09,2,5.21,28,C#CCCC1(CCC(=O)N2CCC(NC(=O)NC34CC5CC(Cl)(CC(C3)c3ccccc35)C4)CC2)N=N1,Activity,,,,,,Active,,,,,,0,CHEMBL5112599,Binding affinity to VEGFR2 (unknown origin) in HEK293T cells at 10 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293T,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108068,1,Scientific Literature,J Med Chem,2022,None,Dose = 10.0 microM,INHIBITOR,,
CHEMBL192893,,None,296.33,0,3,8,CC(=O)ON1C(=O)/C(=C\c2[nH]c(C)cc2C)c2ccccc21,IC50,'=',400,nM,6.4,,,UO_0000065,21.59,0.4,3.4,10.25,0,CHEMBL876999,In vitro inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141154,1,Scientific Literature,J Med Chem,2005,None,,,,0.4
CHEMBL5407834,,None,530.63,2,5.38,17a,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(-c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1,IC50,'=',331.1,nM,6.48,,,UO_0000065,12.21,0.23,1.1,5.51,0,CHEMBL5349052,Inhibition of VEGFR2 (unknown origin) by DiscoverX KINOMEscan assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5346912,1,Scientific Literature,Eur J Med Chem,2023,None,,INHIBITOR,,331.1
CHEMBL248557,,None,309.76,0,3.69,2c,O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1,Inhibition,'<=',40,%,,,,UO_0000187,,,,,0,CHEMBL886302,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139946,1,Scientific Literature,Eur J Med Chem,2007,None,,,,40
CHEMBL4764463,,None,655.7,2,7.29,47e,COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,'=',81,nM,7.09,,,UO_0000065,10.82,0.2,-0.2,6.34,0,CHEMBL4682588,Inhibition of human N-terminal GST-fused KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using CSKtide as substrate measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4680122,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 1.0 hr,INHIBITOR,,0.081
CHEMBL5425005,,None,513.58,1,4.03,5i,CN(c1ccc(S(C)(=O)=O)cc1)c1ccnc(Nc2ccc(-c3nc4c(C(N)=O)cccc4[nH]3)cc2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL5324545,Inhibition of VEGFR2 (unknown origin) by Z'-Lyte kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5321287,1,Scientific Literature,J Med Chem,2023,None,,,,10000
CHEMBL462082,,None,409.45,0,4.99,5,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)cc2)n1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1029839,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154530,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,25000
CHEMBL3746370,,None,416.44,0,3.95,11,CC1(c2cc(NC(=O)n3ccc4cc(Oc5ncnc6c5CNC6)ccc43)no2)CC1,IC50,'=',6.2,nM,8.21,,,UO_0000065,19.71,0.36,4.26,7.66,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,6.2
CHEMBL4086998,,None,376.38,0,3.2,8,Cc1cc(NC(=O)n2ccc3cc(Oc4ncnc5c4CNC5)ccc32)no1,IC50,'=',1720,nM,5.76,,,UO_0000065,15.32,0.28,2.56,5.38,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,1720
CHEMBL4086718,,None,417.47,0,3.8,31,CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C)CC4)[nH]n3)c2)ncn1,IC50,'=',2,nM,8.7,,,UO_0000065,20.84,0.38,4.9,7.93,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,2
CHEMBL4077373,,None,472.51,0,4.46,25,CC(=O)N1Cc2ncnc(Oc3ccc4c(ccn4C(=O)Nc4cc(C5CC5)on4)c3)c2C[C@@H]1C,IC50,'=',5.5,nM,8.26,,,UO_0000065,17.48,0.32,3.8,7.16,0,CHEMBL4059315,Inhibition of human KDR cytoplasmic domain (807 to 1356 residues) after 60 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,5.5
CHEMBL4176748,,None,474.53,1,5.91,30d,O=c1oc2cc(O)ccc2c(Nc2ccc(OCCN3CCCCC3)cc2)c1-c1ccc(F)cc1,Inhibition,'=',88.42,%,,,,UO_0000187,,,,,0,CHEMBL4134006,Inhibition of His-tagged human VEGFR2 at 40 uM incubated for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130448,1,Scientific Literature,Eur J Med Chem,2017,None,,,,88.42
CHEMBL4162192,,None,501.58,2,6.13,39d,COc1ccc(-c2c(Oc3ccc(OCCN4CCCCC4)cc3)c3ccc(OC)cc3oc2=O)cc1,Inhibition,'=',67.63,%,,,,UO_0000187,,,,,0,CHEMBL4134006,Inhibition of His-tagged human VEGFR2 at 40 uM incubated for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130448,1,Scientific Literature,Eur J Med Chem,2017,None,,,,67.63
CHEMBL4165320,,None,460.84,1,6.19,17a,C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)n1,IC50,'=',6.17,nM,8.21,,,UO_0000065,17.81,0.35,2.02,9.88,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,6.17
CHEMBL4160936,,None,357.38,0,3.78,8a,Cn1ncc2c(Oc3ccc4[nH]c(Nc5ccccc5)nc4c3)ncnc21,Inhibition,'=',15.6,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,15.6
CHEMBL4164339,,None,371.4,0,4.08,8c,Cc1cccc(Nc2nc3cc(Oc4ncnc5c4cnn5C)ccc3[nH]2)c1,Inhibition,'=',10.4,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,10.4
CHEMBL4172230,,None,391.82,0,4.43,8d,Cn1ncc2c(Oc3ccc4[nH]c(Nc5cccc(Cl)c5)nc4c3)ncnc21,Inhibition,'=',7.2,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,7.2
CHEMBL4173458,,None,427.51,1,5.08,9j,Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(C(C)(C)C)cc3)n4C)ncnc21,Inhibition,'=',84.2,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,84.2
CHEMBL4795648,,None,641.63,2,6.4,10b,COCCOc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OCCOC,IC50,'=',79.2,nM,7.1,,,UO_0000065,11.07,0.21,0.7,5.47,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,79.2
CHEMBL4786987,,None,639.62,2,6.15,10d,O=c1c(-c2ccc(F)cc2)c[nH]c2ccnc(Nc3ccc(Oc4ncnc5cc6c(cc45)OCCOCCOCCO6)c(F)c3)c12,IC50,'=',47.6,nM,7.32,,,UO_0000065,11.45,0.21,1.17,5.65,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,47.6
CHEMBL4076112,,None,445.41,0,3.78,35,CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1,Activity,'<=',10,%,,,,UO_0000187,,,,,0,CHEMBL4059357,Inhibition of human VEGFR2 assessed as remaining activity at 1 uM after 30 mins by qPCR method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,10
CHEMBL1290072,,None,304.35,0,4.6,15,COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1,INH,'>',100,uM,,,,UO_0000064,,,,,0,CHEMBL4190476,Inhibition of recombinant human GST-tagged VEGFR2 expressed in baculovirus infected Sf9 insect cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4797072,,None,472.62,1,6.36,12e,Cc1ccc(C)c(NC(=O)Nc2nc(Sc3c[nH]c4ccccc34)cc(N3CCCCC3)n2)c1,IC50,'=',310,nM,6.51,,,UO_0000065,13.77,0.26,0.15,7.57,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,0.31
CHEMBL4798001,,None,552.66,2,5.48,12o,COc1ccc(NC(=O)Nc2nc(Sc3c[nH]c4ccccc34)cc(N3CCN(c4ccccn4)CC3)n2)cc1,IC50,'=',4150,nM,5.38,,,UO_0000065,9.74,0.18,-0.1,4.84,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,4.15
CHEMBL3403518,,None,311.39,0,4.39,11,Cc1nc(N(C)c2ccc(OC(C)C)cc2)c2cc(C)oc2n1,IC50,'=',38.5,nM,7.42,,,UO_0000065,23.81,0.44,3.02,14.43,0,CHEMBL3404062,Inhibition of VEGFR2 in human U251 cells compound pretreated for 60 min before VEGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3400114,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307756,,,,38.5
CHEMBL4792190,,None,472.62,1,5.05,6e,Cc1ccc(C(=O)Nc2cc(Nc3ncnc4sc5c(c34)CCN(C)C5)ccc2N(C)C)cc1,Activity,'=',83,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,83
CHEMBL4793743,,None,568.63,2,6.07,7a,CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccc(C(F)(F)F)cc2)C4)ccc1N(C)C,Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,95
CHEMBL1721885,SU-014813,2,442.49,0,1.69,SU-14813,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,Kd,'=',2.3,nM,8.64,,,UO_0000065,19.52,0.37,6.95,8.1,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,2.3
CHEMBL4788980,,None,412.51,0,3.73,23,CCN(CC)CCCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',480,nM,6.32,,,UO_0000065,15.32,0.29,2.59,8.18,0,CHEMBL4769107,Inhibition of tracer 236 binding to recombinant human N-terminal GST-tagged full length KDR (790 to 1356 residues) expressed in baculovirus expression system incubated for 1 hr by Lanthascreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765298,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 1.0 hr,INHIBITOR,,480
CHEMBL4800500,,None,424.55,0,2.73,65,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCO)cc32)c1C,IC50,'=',848,nM,6.07,,,UO_0000065,14.3,0.27,3.34,6.23,0,CHEMBL4769107,Inhibition of tracer 236 binding to recombinant human N-terminal GST-tagged full length KDR (790 to 1356 residues) expressed in baculovirus expression system incubated for 1 hr by Lanthascreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765298,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 1.0 hr,INHIBITOR,,848
CHEMBL4788376,,None,433.56,0,3.65,66,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCC#N)cc32)c1C,IC50,'=',1328,nM,5.88,,,UO_0000065,13.55,0.25,2.23,5.82,0,CHEMBL4769107,Inhibition of tracer 236 binding to recombinant human N-terminal GST-tagged full length KDR (790 to 1356 residues) expressed in baculovirus expression system incubated for 1 hr by Lanthascreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765298,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 1.0 hr,INHIBITOR,,1328
CHEMBL4795330,,None,465.6,0,2.87,69,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCNC(C)=O)cc32)c1C,IC50,'=',2164,nM,5.67,,,UO_0000065,12.17,0.23,2.79,5.33,0,CHEMBL4769107,Inhibition of tracer 236 binding to recombinant human N-terminal GST-tagged full length KDR (790 to 1356 residues) expressed in baculovirus expression system incubated for 1 hr by Lanthascreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765298,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 1.0 hr,INHIBITOR,,2164
CHEMBL4786010,,None,345.4,0,4.51,15b,O=C(Cc1ccccc1)Nc1ccc(NC(=O)Nc2ccccc2)cc1,Inhibition,,,%,,,Dose-dependent effect,UO_0000187,,,,,0,CHEMBL4772153,Inhibition of VEGFR2 in human HT-29 cells assessed as reduction in MEK expression incubated for 48 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HT-29,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765379,1,Scientific Literature,Eur J Med Chem,2020,None,Dose_Lower = 1.0 microM | Dose_Upper = 10.0 microM | TIME = 48.0 hr,INHIBITOR,,
CHEMBL1762523,,None,460.58,0,3.97,5,Cc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1,IC50,'=',115,nM,6.94,,,UO_0000065,15.07,0.28,2.97,10.52,0,CHEMBL1764818,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759854,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.115
CHEMBL4758900,,None,468.44,1,5.66,14q,COc1cc2ncnc(Nc3ccc(NC(=O)c4cccc(C(F)(F)F)c4)cc3)c2cc1OC,IC50,'=',1400,nM,5.85,,,UO_0000065,12.5,0.24,0.19,6.86,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,1.4
CHEMBL4750711,,None,526.33,2,5.25,14n,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4I)cc3)c2cc1OC,IC50,'=',420,nM,6.38,,,UO_0000065,12.12,0.28,1.13,7.47,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,0.42
CHEMBL272645,,None,358.4,1,5.03,33,Cc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1,IC50,'=',16,nM,7.8,,,UO_0000065,21.75,0.39,2.77,8.37,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,16
CHEMBL412278,,None,433.46,0,3.97,24,COCCNC(=O)c1cccc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12,IC50,'=',314,nM,6.5,,,UO_0000065,15,0.28,2.53,7.08,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,314
CHEMBL269915,,None,451.48,1,5.84,64,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccccn5)cccc4c3)c2cc1OC,IC50,'=',0.8,nM,9.1,,,UO_0000065,20.15,0.37,3.26,11.02,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.8
CHEMBL272670,,None,404.86,1,5.37,44,CNc1cc(Oc2ccc3c(C(=O)Nc4ccc(Cl)cc4)cccc3c2)ncn1,IC50,'=',20,nM,7.7,,,UO_0000065,19.02,0.36,2.33,10.11,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,20
CHEMBL1683649,,None,368.44,1,6.28,6,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(CCCCC(F)(F)F)cc1OC2(C)C,Ki,'=',25,nM,7.6,,,UO_0000065,20.63,0.4,1.32,25.8,0,CHEMBL1686402,Inhibition of human recombinant His-tagged VEGFR2 assessed as infrared absorption,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681679,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.025
CHEMBL1684662,,None,352.4,0,4.53,4g,O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1,Inhibition,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL1685689,Inhibition of KDR at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,25
CHEMBL231568,,None,507.98,2,5.24,22,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1,Ki,'=',2.8,nM,8.55,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,2.8
CHEMBL1162958,,None,394.82,0,4.77,21,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)cc4)nc3c2)ccn1,Ki,'=',12,nM,7.92,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,12
CHEMBL231468,,None,496.04,1,5.01,18,CSc1nccc(Oc2ccc3[nH]c(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)n1,Ki,'=',128,nM,6.89,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,128
CHEMBL427837,,None,559.07,2,6.07,14,COc1cc2nccc(Oc3ccc4[nH]c(Nc5ccc(Cl)c(CN6CCN(C)CC6)c5)nc4c3)c2cc1OC,Ki,'=',0.2,nM,9.7,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,0.2
CHEMBL413621,,None,506.01,1,4.25,7,CNC(=O)c1cc(Oc2ccc3[nH]c(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)ccn1,IC50,'=',146,nM,6.84,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,146
CHEMBL375819,,None,382.35,0,3.73,6b,Nc1ncc(C#Cc2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)cn1,IC50,'<',1,nM,,,,UO_0000065,,,,,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,1
CHEMBL4218252,,None,448.48,0,3.79,41,COc1cc(OC)c2c(Oc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1,GI50,'=',1222,nM,,,,UO_0000065,,,,,0,CHEMBL4201681,Inhibition of KDR (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4196201,1,Scientific Literature,J Med Chem,2018,None,,,,1.222
CHEMBL3893914,,None,363.43,0,3.23,3g,Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1,Km,'=',90000,nM,,,,UO_0000065,,,,,0,CHEMBL3871911,Activity at KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3871290,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,90
CHEMBL3920219,,None,433.94,0,4.22,17a,COc1ccc(Cn2nc(-c3ccccc3)c3cc(Cl)nc(N4CCNCC4)c32)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3857162,Inhibition of VEGF-165-induced VEGFR2 autophosphorylation in serum-starved HUVEC assessed as decrease in AKT phosphorylation at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856209,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL3891846,,None,441.58,1,5.96,6n,C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1,Inhibition,'=',44,%,,,,UO_0000187,,,,,0,CHEMBL3857057,Inhibition of His tagged recombinant human KDR (789 to 1356 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856204,1,Scientific Literature,Eur J Med Chem,2016,None,,,,44
CHEMBL1761939,,None,468.87,1,5.88,17,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(F)c(Cl)c4)cc3)c2cc1OC,IC50,'=',40,nM,7.4,,,UO_0000065,15.78,0.31,1.52,7.82,0,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.04
CHEMBL1761942,,None,466.5,1,6.24,20,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c2cc1OC,IC50,'=',30,nM,7.52,,,UO_0000065,16.13,0.29,1.28,7.95,0,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.03
CHEMBL4098293,,None,487.64,0,3.91,24,Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccsc12,EC50,'=',24,nM,7.62,,,UO_0000065,15.63,0.3,3.71,7.54,0,CHEMBL4057777,Inhibition of VEGF stimulated VEGFR2 phosphorylation at Y165 residues in HUVEC preincubated for 1 hr followed by VEGF addition measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052763,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.024
CHEMBL3394112,,None,558.63,1,4.03,6s,COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL3395940,Inhibition of KDR (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393036,1,Scientific Literature,J Med Chem,2015,None,,,,50
CHEMBL218110,,None,526.54,1,4.4,6k,CN(C)[C@@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1,IC50,'=',810,nM,6.09,,,UO_0000065,11.57,0.22,1.69,6.97,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,810
CHEMBL237679,,None,366.81,0,4.17,16,O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1noc2ccccc12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL408565,,None,343.22,0,3.76,K00006,O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2,IC50,'=',70,nM,7.16,,,UO_0000065,20.85,0.47,3.39,15.94,0,CHEMBL939341,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,,,,70
CHEMBL1681951,,None,430.83,0,4.27,4u,CO/N=C/c1c(N)ncnc1Oc1ccc(NC(=O)Nc2cccc(F)c2)c(Cl)c1,IC50,'=',1.7,nM,8.77,,,UO_0000065,20.36,0.4,4.5,7.09,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,1.7
CHEMBL1681954,,None,462.84,0,4.08,4x,CO/N=C/c1c(N)ncnc1Oc1ccc(NC(=O)NCc2ccc(F)cc2F)c(Cl)c1,IC50,'=',10.3,nM,7.99,,,UO_0000065,17.26,0.34,3.91,6.45,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,10.3
CHEMBL1681962,,None,344.38,0,2.28,5g,CCNC(=O)Nc1ccc(Oc2ncnc(N)c2/C=N/OC)c(C)c1,IC50,'=',180,nM,6.75,,,UO_0000065,19.59,0.37,4.46,5.45,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.18
CHEMBL1681964,,None,330.35,0,1.97,5j,CCNC(=O)Nc1ccc(Oc2ncnc(N)c2/C=N/OC)cc1,IC50,'=',142,nM,6.85,,,UO_0000065,20.73,0.39,4.88,5.53,0,CHEMBL1686633,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681715,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.142
CHEMBL4748292,,None,429.34,0,3.56,46,CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(O[C@H](C)[C@@H](C)O)n2)cc1,IC50,'=',32,nM,7.5,,,UO_0000065,17.46,0.41,3.93,6.93,0,CHEMBL4709747,Inhibition of GST-tagged recombinant human VEGFR2 expressed in Sf-9 cells incubated for 10 mins by scintillation counting method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4706546,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr,INHIBITOR,,32
CHEMBL3644033,,None,405.4,0,2.79,48,C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F,IC50,'=',477,nM,6.32,,,UO_0000065,15.59,0.32,3.53,6.23,0,CHEMBL4709747,Inhibition of GST-tagged recombinant human VEGFR2 expressed in Sf-9 cells incubated for 10 mins by scintillation counting method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4706546,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr,INHIBITOR,,477
CHEMBL4212117,,None,530.63,1,4.37,13f,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCCC(=O)NO)cc4)n3)cc2nn1C,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4195400,Inhibition of VEGF-stimulated VEGFR2 phosphorylation in human HUVEC cells at 100 nM preincubated for 2 hrs followed by VEGF stimulation by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,
CHEMBL271101,,None,473.46,0,4.67,4,CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3C)ccc2C)c(OC)n1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL948989,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142332,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,25000
CHEMBL4208280,,None,460.5,0,2.42,13a,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCC(=O)NO)cc4)n3)cc2nn1C,Inhibition,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,95
CHEMBL4216745,,None,605.75,2,6.08,14f,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCCC(=O)Nc5ccccc5N)cc4)n3)cc2nn1C,Inhibition,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,93
CHEMBL4204082,,None,403.45,0,3.3,6a,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NO)cc4)n3)cc2nn1C,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,99
CHEMBL4213341,,None,478.56,1,5.02,6d,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)Nc5ccccc5N)cc4)n3)cc2nn1C,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,100
CHEMBL1688246,,None,396.38,0,4.56,1,FC(F)(F)c1cccc(-c2nnc(-c3cccnc3NCc3ccncc3)[nH]2)c1,IC50,'=',1100,nM,5.96,,,UO_0000065,15.03,0.28,1.4,7.51,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,1.1
CHEMBL204754,,None,402.41,0,3.65,14,c1cnc(NCc2ccncc2)c(-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c1,IC50,'=',170,nM,6.77,,,UO_0000065,16.82,0.31,3.12,6.31,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,0.17
CHEMBL257788,,None,399.45,0,3.43,22,CCO/N=C/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL3792850,,None,411.51,0,4.14,26,O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12,Inhibition,'=',15.8,%,,,,UO_0000187,,,,,0,CHEMBL3794771,Inhibition of human N-terminal GST-tagged KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using fluorescence labelled CSKtide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792292,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,15.8
CHEMBL4171077,,None,469.43,1,5.17,10a,CCn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21,Inhibition,'=',59.6,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,59.6
CHEMBL3656121,,None,607.66,2,5.27,BDBM110632,COC(=O)CCC=S(C)(=O)NC(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)ccn2)c1,IC50,'=',13,nM,7.89,,231517,UO_0000065,12.98,0.25,2.62,5.2,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3759127,,None,526.64,1,4.65,15a,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',560,nM,6.25,,,UO_0000065,11.87,0.22,1.6,6.81,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.56
CHEMBL1823222,,None,468.6,0,4.38,13e,CCCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL1828298,Inhibition of KDR activity by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1821705,1,Scientific Literature,J Med Chem,2011,None,,,,5000
CHEMBL241918,,None,557.61,1,3.64,23,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(OC)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,IC50,'=',371.5,nM,6.43,,,UO_0000065,11.53,0.21,2.79,4.87,0,CHEMBL892958,Inhibition of human VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,371.5
CHEMBL243837,,None,562.03,1,4.29,21,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(Cl)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,IC50,'=',80.2,nM,7.1,,,UO_0000065,12.63,0.24,2.81,5.78,0,CHEMBL892958,Inhibition of human VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,80.2
CHEMBL396472,,None,479.46,0,3.35,34,COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=CC3=O)c2cc1OC,IC50,'=',188,nM,6.73,,,UO_0000065,14.03,0.26,3.38,6.18,0,CHEMBL892960,Inhibition of human VEGFR2 in presence of 1 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,188
CHEMBL243629,,None,527.58,1,3.63,19,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4ccccc4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,IC50,'=',783.1,nM,6.11,,,UO_0000065,11.57,0.21,2.48,4.97,0,CHEMBL892960,Inhibition of human VEGFR2 in presence of 1 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,783.1
CHEMBL242349,,None,491.5,0,3.22,32,COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(OC)c4)=CC3=O)c2cc1OC,Ratio,'=',5,,,,,,,,,,0,CHEMBL892962,Ratio of IC50 for VEGFR2 in presence of 1 mM ATP to IC50 for VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,5
CHEMBL241919,,None,541.61,1,3.94,24,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(C)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,Ratio,'=',3.2,,,,,,,,,,0,CHEMBL892962,Ratio of IC50 for VEGFR2 in presence of 1 mM ATP to IC50 for VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,3.2
CHEMBL243839,,None,533.61,1,3.69,22,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccs4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,Ratio,'=',3.9,,,,,,,,,,0,CHEMBL892962,Ratio of IC50 for VEGFR2 in presence of 1 mM ATP to IC50 for VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,3.9
CHEMBL4088455,,None,322.37,0,3.75,13,Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL4057521,Inhibition of KDR (unknown origin) at 0.49 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052759,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,5
CHEMBL233828,,None,350.43,0,2.86,52,CC(C)(C)c1ccc(NC(=O)c2nnnn2CCc2ccncc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL233828,,None,350.43,0,2.86,52,CC(C)(C)c1ccc(NC(=O)c2nnnn2CCc2ccncc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL234013,,None,444.84,1,5.6,48,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nc2ccccc2n1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL236205,,None,376.34,0,3.67,20,O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1,IC50,'=',28,nM,7.55,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.028
CHEMBL234203,,None,360.34,0,3.79,42,O=C(Nc1ccc(C(F)(F)F)cc1)c1nccn1CCc1ccncc1,IC50,'=',1660,nM,5.78,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,1.66
CHEMBL3604205,,None,291.35,0,3.72,6,COc1ccc2c(c1)CCCN2c1ncnc2ccccc12,IC50,'=',111.1,nM,6.95,,,UO_0000065,23.87,0.43,3.23,18.18,0,CHEMBL4714414,Inhibition of VEGFR2 in human U251 cells preincubated for 60 mins followed by VEGF stimulation and measured after 10 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4706704,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 1.167 hr,INHIBITOR,,111.1
CHEMBL4098587,,None,445.88,0,4.63,6a,CC(C)(C)OC(=O)NCC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL4080555,,None,459.91,1,5.02,6b,C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4011797,Inhibition of VEGFR2 (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011588,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL3920219,,None,433.94,0,4.22,17a,COc1ccc(Cn2nc(-c3ccccc3)c3cc(Cl)nc(N4CCNCC4)c32)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3857157,Inhibition of VEGF-165-induced VEGFR2 autophosphorylation at Tyr1175 in serum-starved HUVEC at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856209,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL142425,,None,362.41,0,4.22,42b,C[C@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL819560,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145138,1,Scientific Literature,J Med Chem,2003,None,,,,10
CHEMBL1969102,,None,440.53,1,5.89,BDBM50381698,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1,IC50,'=',2.18,nM,8.66,,249753,UO_0000065,19.66,0.37,2.77,7.97,0,CHEMBL3705427,Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4076032,,None,393.42,0,4.93,8,Cc1ccc(F)c(NC(=O)Nc2ccc(C3CC(O)=Nc4[nH]nc(C)c43)cc2)c1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,50000
CHEMBL430812,,None,413.53,0,4.13,11,O=c1nc(-c2ccc3c(c2)ncn3-c2ccccc2)ccn1CCCN1CCCCC1,IC50,'=',96,nM,7.02,,,UO_0000065,16.97,0.31,2.89,12.54,0,CHEMBL818933,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144948,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,96
CHEMBL4079775,,None,368.4,0,4.45,27,Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(C#N)c4)cc3)c12,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,50000
CHEMBL499866,,None,438.54,0,4.98,CER-0264196,Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1,Inhibition,'=',81,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,81
CHEMBL520451,,None,478.55,0,3.07,CER-0264356,O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,1
CHEMBL4091741,,None,391.41,0,4.73,10,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1,IC50,'=',1856,nM,5.73,,,UO_0000065,14.64,0.27,1,5.57,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,1856
CHEMBL4100645,,None,373.42,0,4.59,11,Cc1cccc(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1,IC50,'=',1224,nM,5.91,,,UO_0000065,15.83,0.29,1.32,5.74,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,1224
CHEMBL4101778,,None,427.46,1,5.76,17,Cc1n[nH]c2nccc(-c3ccc(NC(=S)Nc4cccc(C(F)(F)F)c4)cc3)c12,IC50,'=',8008,nM,5.1,,,UO_0000065,11.92,0.23,-0.66,7.77,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,8008
CHEMBL3774953,,None,349.75,0,3.89,40,COc1cc2ncnc(Nc3c(F)ccc(O)c3Cl)c2cc1OC,IC50,'=',5400,nM,5.27,,,UO_0000065,15.06,0.3,1.38,6.89,0,CHEMBL3778241,Inhibition of KDR (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by Cell titre glo-based luminescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307634,,,,5400
CHEMBL3774430,,None,323.35,0,3.05,44,COc1cc2ncnc(N3CCc4c(O)cccc43)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3778241,Inhibition of KDR (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by Cell titre glo-based luminescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307634,,,,10000
CHEMBL357803,,None,389.25,0,3.9,16b,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c(C)c1CCC(=O)O,IC50,'=',1730,nM,5.76,,,UO_0000065,14.8,0.33,1.86,7.01,0,CHEMBL816967,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,1.73
CHEMBL150291,,None,454.57,1,5.48,36,CC(C)OC(C)c1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',411,nM,6.39,,,UO_0000065,14.05,0.26,0.91,10.06,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,411
CHEMBL3660285,,None,571.61,2,6.29,BDBM110657,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CCC(CC(=O)O)CC5)c[nH]4)c3)cc2)c1,IC50,'=',31,nM,7.51,,231542,UO_0000065,13.14,0.24,1.22,5.49,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648077,,None,646.75,None,None,BDBM100883,C[C@@H](Nc1nc(Nc2ccc(S(=O)(=NS(=O)(=O)CC[Si](C)(C)C)C3CCCC3)cc2)ncc1Br)C(C)(C)O,IC50,'=',910,nM,6.04,,218171,UO_0000065,9.34,None,None,None,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648093,,None,487.38,0,3.74,BDBM100902,CCOC(=O)N=S(C)(=O)c1ccc(Nc2ncc(Br)c(O[C@H](C)[C@H](C)O)n2)cc1,IC50,'=',110,nM,6.96,,218176,UO_0000065,14.28,0.33,3.22,5.66,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL430090,,None,442.4,1,5.75,50,COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12,IC50,'=',31,nM,7.51,,,UO_0000065,16.97,0.32,1.76,7.33,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,31
CHEMBL271796,,None,412.37,1,5.74,14,Nc1noc2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,IC50,'=',65,nM,7.19,,,UO_0000065,17.43,0.33,1.45,7.71,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,65
CHEMBL404223,,None,344.38,0,3.85,13a,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,IC50,'=',4.5,nM,8.35,,,UO_0000065,24.24,0.44,4.5,7.68,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,4.5
CHEMBL407485,,None,225.25,0,2.66,8,Nc1ccc(-c2cccc3onc(N)c23)cc1,IC50,'=',18840,nM,4.72,,,UO_0000065,20.98,0.38,2.06,6.05,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,18840
CHEMBL260307,,None,390.42,1,5.48,53,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(C)c4onc(N)c34)cc2)c1,IC50,'=',71,nM,7.15,,,UO_0000065,18.31,0.34,1.67,7.67,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,71
CHEMBL400061,,None,432.3,0,3.03,8m,COc1ccc2c(c(/C=C3\C(=O)NN=C3c3snnc3C)cn2C)c1Br,IC50,'=',23,nM,7.64,,,UO_0000065,17.67,0.4,4.61,9.38,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,23
CHEMBL3656122,,None,521.57,1,4.95,BDBM110633,C=S(C)(=O)NC(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)ccn2)c1,IC50,'=',8,nM,8.1,,231518,UO_0000065,15.52,0.3,3.15,6.47,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3590221,,None,447.51,1,0.78,3,CN(C)CC(=O)N1CCC(n2ncc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n2)CC1,IC50,'=',210,nM,6.68,,,UO_0000065,14.92,0.28,5.9,4.88,0,CHEMBL3591470,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588784,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,0.21
CHEMBL205166,,None,402.41,0,3.65,16,c1ccc(CNc2ncccc2-c2nnc(Nc3ccc4c(c3)OCCO4)o2)nc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,10
CHEMBL381122,,None,388.39,0,3.61,10,c1ccc(CNc2ncccc2-c2nnc(Nc3ccc4c(c3)OCO4)o2)nc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL205166,,None,402.41,0,3.65,16,c1ccc(CNc2ncccc2-c2nnc(Nc3ccc4c(c3)OCCO4)o2)nc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL1688351,,None,441.45,0,4.13,22,c1cnc(NCc2ccc3[nH]ncc3c2)c(-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL3628801,,None,280.71,0,4.28,10,Fc1ccc(Oc2ncnc3sccc23)cc1Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,10000
CHEMBL387929,,None,515.08,2,5.54,64,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccc(Cl)cc5)c4)n[nH]c2-3)CC1,IC50,'=',419,nM,6.38,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,419
CHEMBL3633290,,None,361.38,0,4.6,12a,Nc1n[nH]c2cccc(-c3cccc(NC(=O)Nc4ccccc4F)c3)c12,IC50,'=',53.6,nM,7.27,,,UO_0000065,20.12,0.37,2.67,7.59,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,53.6
CHEMBL3586068,,None,535.66,2,6.63,W11,CCN(CC)CCCOc1ccc(NC(=O)Nc2ccc(-c3ccc(NC(=O)C(C)(C)C)nc3)cc2)cc1F,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,
CHEMBL537435,,None,425.95,1,5.2,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL196020,,None,403.51,1,5.23,table5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3752135,,None,553.86,2,6.94,7e,O=c1sc2cc(Nc3ncnc4c3cnn4-c3ccc(Cl)cc3)ccc2n1Cc1ccc(Cl)cc1Cl,Activity,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL3757171,Inhibition of human VEGFR2 at 10 uM after 20 to 40 mins by liquid scintillation counting analysis in presence of [28P]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751764,1,Scientific Literature,Medchemcomm,2015,None,,,,1
CHEMBL3818867,,None,348.39,0,4.3,11,Cc1c2ccc(Nc3ccnc(Nc4ccc(F)cc4)n3)cc2nn1C,Inhibition,'=',63.82,%,,,,UO_0000187,,,,,0,CHEMBL3820577,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 1 hr by Z'LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,63.82
CHEMBL3604469,,None,428.36,0,3.59,6d,CC[S@@](=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@@H](C)O)n2)cc1,IC50,'=',32,nM,7.5,,,UO_0000065,17.5,0.41,3.9,6.75,0,CHEMBL3607091,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3603804,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,32
CHEMBL3586055,,None,325.32,0,4.67,L7,O=C(Nc1ccc(-c2cccnc2)cc1)Nc1ccc(F)c(F)c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,
CHEMBL366241,,None,403.51,1,5.46,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL198297,,None,433.54,0,4.82,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL246150,,None,438.53,1,6.35,15,CNc1cc(-c2cccnc2Oc2cccc(NC(=O)c3cccc(C(C)C)c3)c2)ccn1,IC50,'=',18,nM,7.75,,,UO_0000065,17.66,0.32,1.39,10.17,0,CHEMBL887077,Inhibition of KDR after 90 mins by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139197,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,18
CHEMBL3593293,,None,535.7,1,4.59,8,CCN1CCN(c2cc(Nc3ncc(-c4ccc(NS(=O)(=O)c5ccccc5)cc4)s3)nc(C)n2)CC1,IC50,'=',170,nM,6.77,,,UO_0000065,12.64,0.25,2.18,6.55,0,CHEMBL3595190,Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3593229,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,0.17
CHEMBL231410,,None,410.5,1,6.34,7m,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc5ccccc45)cc3)c12,IC50,'=',75,nM,7.12,,,UO_0000065,17.36,0.32,0.78,8.9,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,75
CHEMBL396494,,None,385.45,1,5.06,7h,N#Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1,IC50,'=',45,nM,7.35,,,UO_0000065,19.06,0.36,2.29,7.08,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,45
CHEMBL231128,,None,501.62,2,7.71,12f,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cncc6ccccc56)cnc(N)c34)cc2)c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,
CHEMBL394789,,None,374.47,1,5.5,7d,Cc1ccccc1NC(=O)Nc1ccc(-c2csc3ccnc(N)c23)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,
CHEMBL3593290,,None,533.66,1,4.99,7h,CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1,IC50,'=',25,nM,7.6,,,UO_0000065,14.25,0.27,2.61,6.11,0,CHEMBL3595190,Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3593229,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,0.025
CHEMBL3593287,,None,505.61,1,4.34,7e,Cc1nc(Nc2ncc(-c3ccc(NC(=O)Nc4cc(C)on4)cc3)s2)cc(N2CCN(C)CC2)n1,IC50,'=',15,nM,7.82,,,UO_0000065,15.47,0.3,3.48,6.29,0,CHEMBL3595190,Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3593229,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,0.015
CHEMBL4174586,,None,442.36,0,4.94,16a,Cn1ncc2c(Oc3ccc4oc(Nc5ccc(OC(F)(F)F)cc5)nc4c3)ncnc21,Inhibition,'=',22.3,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,22.3
CHEMBL4175295,,None,439.4,0,4.8,9s,Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(C(F)(F)F)cc3)n4C)ncnc21,IC50,'=',63.2,nM,7.2,,,UO_0000065,16.38,0.31,2.4,8.71,0,CHEMBL4155774,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,63.2
CHEMBL1683339,,None,427.45,1,6.13,6b,O=C(Nc1cccc(C(F)(F)F)c1)c1c[nH]c2cccc(SCc3ccncc3)c12,Inhibition,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL1687576,Inhibition of KDR assessed as phosphorylation level of substrate at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681739,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,92
CHEMBL375306,,None,343.42,0,1.35,18,N#Cc1cnc(Nc2cc(CN3CCN(C(N)=O)CC3)ccn2)s1,IC50,'=',24,nM,7.62,,,UO_0000065,,,,,0,CHEMBL912804,Inhibition of VEGF-induced KDR autophosphorylation expressed in HEK293 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,24
CHEMBL395080,,None,549.63,2,5.27,46c,COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL894171,Inhibition of recombinant KDR by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148724,1,Scientific Literature,J Med Chem,2007,None,,,,50
CHEMBL3612326,,None,479.94,1,7.76,5e,O=C(Nc1ccc(Sc2ccnc3ccsc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',1947,nM,5.71,,,UO_0000065,11.9,0.25,-2.05,10.57,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,1947
CHEMBL3612230,,None,395.48,1,6.23,4d,O=C(Nc1ccc(F)cc1)Nc1cccc(Sc2ccnc3ccsc23)c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3615904,Inhibition of VEGFR2 phosphorylation in HUVEC at 1 uM by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307501,,,,
CHEMBL3612233,,None,445.49,1,7.11,4g,O=C(Nc1cccc(Sc2ccnc3ccsc23)c1)Nc1cccc(C(F)(F)F)c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3614226,Inhibition of VEGFR2 phosphorylation in HUVEC at 2.5 to 5 uM by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307501,,,,
CHEMBL374690,,None,469.57,0,4.61,81,CN(C)C(=O)COc1ccc2c(c1)Cc1c(-c3csc(C#CCOc4ccccc4)c3)n[nH]c1-2,IC50,'=',42,nM,7.38,,,UO_0000065,15.71,0.3,2.77,10.94,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,42
CHEMBL2023483,,None,432.48,0,4.57,17,COc1ccc2c(Oc3ccc(CC(=O)Nc4n[nH]c(C)c4C)c(OC)c3)ccnc2c1,IC50,'=',515,nM,6.29,,,UO_0000065,14.54,0.27,1.72,6.39,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.515
CHEMBL2023475,,None,420.44,0,4.57,9,CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4ccc(F)cc34)cc2OC)cn1,IC50,'=',4066,nM,5.39,,,UO_0000065,12.82,0.24,0.82,6.89,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,4.066
CHEMBL2023495,,None,433.47,0,3.84,29,CCn1cc(NC(=O)Cc2ncc(Oc3ccnc4cc(OC)ccc34)cc2OC)cn1,IC50,'=',4718,nM,5.33,,,UO_0000065,12.29,0.23,1.49,5.31,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,4.718
CHEMBL199528,,None,313.43,0,4.16,9a,CCCCN(C)C(=O)c1cc2c(-c3ccccc3)[nH]nc2s1,IC50,'=',350,nM,6.46,,,UO_0000065,20.6,0.4,2.3,13.18,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.35
CHEMBL69964,,None,495.95,0,3.53,26m,Cc1cc(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]c1C(=O)N1CCN(C)CC1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL2348350,,None,438.56,0,2.4,15u,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL4806820,Inhibition of human VEGFR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4804286,38,SureChEMBL Patent Bioactivity Data,,2020,None,Dose = 2000.0 nM,,,67
CHEMBL462315,,None,368.42,0,2.81,25,O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1,IC50,'=',790,nM,6.1,,,UO_0000065,16.56,0.32,3.29,7.15,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,0.79
CHEMBL518204,,None,413.37,1,5.3,26,O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,10
CHEMBL223572,,None,456.55,0,4.6,43a,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)c4[nH]nc(N)c34)cc2)c1,IC50,'=',390,nM,6.41,,,UO_0000065,14.04,0.26,1.81,5.92,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,390
CHEMBL499883,,None,279.37,0,3.96,23,Nc1nccc(/C=C/c2ccsc2-c2ccccc2)n1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,100
CHEMBL524322,,None,321.41,0,3.2,22,Nc1nccc(/C=C/c2c(-c3ccccc3)nc3n2CCS3)n1,IC50,'=',3200,nM,5.5,,,UO_0000065,17.1,0.33,2.29,7.89,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,3.2
CHEMBL3747699,,None,465.48,0,2.23,12,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21,Inhibition,'=',24,%,,,,UO_0000187,,,,,0,CHEMBL3750778,Inhibition of VEGFR2 (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745672,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,24
CHEMBL3758875,,None,527.63,2,5.04,15j,COc1cc2c(Nc3ccc(NC(=O)c4ccc(C)cc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,'=',2000,nM,5.7,,,UO_0000065,10.8,0.2,0.66,5.82,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,2
CHEMBL3633275,,None,548.52,2,5.03,6e,COc1ccc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3cc(C(=O)OCCN(C)C)ccc3OC)c2)cn1,IC50,'=',5400,nM,5.27,,,UO_0000065,9.6,0.18,0.24,4.73,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,5.4
CHEMBL3633690,,None,439.5,0,3.51,T1,CCS(=O)(=O)c1ccc(OC)c(Nc2cn(-c3ccc(O)c(-c4cc[nH]c4)c3)nn2)c1,IC50,'=',40100,nM,4.4,,,UO_0000065,10,0.19,0.89,3.6,0,CHEMBL3636166,Inhibition of GST-tagged human recombinant VEGFR2 kinase expressed in Sf9 insect cells by radiometric protein kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632540,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,40100
CHEMBL3753208,,None,374.32,0,4.69,5c,O=C(Nc1ccccn1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F,IC50,'=',86.74,nM,7.06,,,UO_0000065,18.87,0.36,2.37,9.27,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,86.74
CHEMBL3633760,,None,416.87,0,4.09,6c,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OCCCCC(=O)NO,IC50,'=',613,nM,6.21,,,UO_0000065,14.9,0.29,2.12,5.88,0,CHEMBL3636774,Inhibition VEGFR2 (unknown origin) for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632579,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,613
CHEMBL3633765,,None,475.34,0,4.59,6h,COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCCCCC(=O)NO,IC50,'=',462,nM,6.33,,,UO_0000065,13.33,0.29,1.75,6,0,CHEMBL3636774,Inhibition VEGFR2 (unknown origin) for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632579,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,462
CHEMBL1909350,GSK-949675A,None,421.89,0,0.8,GSK949675A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl,Inhibition,'=',64.83,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,64.83
CHEMBL3633299,,None,371.44,1,5.07,12j,Cc1cccc(C)c1NC(=O)Nc1cccc(-c2cccc3[nH]nc(N)c23)c1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL3633294,,None,377.83,1,5.11,12e,Nc1n[nH]c2cccc(-c3cccc(NC(=O)Nc4cccc(Cl)c4)c3)c12,IC50,'=',0.5,nM,9.3,,,UO_0000065,24.62,0.47,4.19,9.71,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,0.5
CHEMBL3633289,,None,549.51,1,4.12,6s,COc1ccc(C(=O)OCCN2CCOCC2)cc1NC(=O)Nc1cc(-c2cn[nH]c2)ccc1OC(F)(F)F,IC50,'=',14900,nM,4.83,,,UO_0000065,8.78,0.17,0.71,3.8,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,14.9
CHEMBL3633287,,None,582.58,2,6,6q,COc1ccc(C(=O)OCCN2CCOCC2)cc1NC(=O)Nc1cc(-c2ccc3[nH]ccc3c2)cc(C(F)(F)F)c1,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL3633272,,None,503.48,1,4.53,6b,COc1ccc(C(=O)OCCN(C)C)cc1NC(=O)Nc1cc(-c2cncnc2)cc(C(F)(F)F)c1,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL2425652,,None,309.38,0,1.89,4,N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL2428345,Competitive binding affinity to VEGFR2 (unknown origin) at 10 uM in presence of ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424622,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,50
CHEMBL3586056,,None,358.23,1,5.7,L8,O=C(Nc1ccc(-c2cccnc2)cc1)Nc1ccc(Cl)c(Cl)c1,IC50,'=',2.19,nM,8.66,,,UO_0000065,24.17,0.49,2.96,16.03,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,2.19
CHEMBL3586057,,None,425.33,1,6.43,L9,O=C(Nc1ccc(-c2cccnc2)cc1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,'=',0.22,nM,9.66,,,UO_0000065,22.71,0.44,3.23,17.88,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,0.22
CHEMBL3586074,,None,382.37,0,4.03,W17,CNC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(F)c3)cc2)cn1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,
CHEMBL3586075,,None,482.38,1,5.79,W18,CNC(=O)c1cc(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2)ccn1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,
CHEMBL3594105,,None,675.16,2,5.88,58,COc1cc2c(Oc3ccc(NC(=O)c4[nH]c(=O)n(-c5ccccc5Cl)c4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,'=',92.6,nM,7.03,,,UO_0000065,10.42,0.2,1.15,6.17,0,CHEMBL3594717,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4210100,,None,588.57,2,5.59,17f,COc1cc2c(cc1OC)Nc1ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c1NC2,IC50,'=',62.5,nM,7.2,,,UO_0000065,12.24,0.23,1.61,5.31,0,CHEMBL4194204,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190351,1,Scientific Literature,Eur J Med Chem,2017,None,,,,62.5
CHEMBL230413,,None,425.49,0,3.68,table5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL425749,,None,393.45,1,5.03,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL231139,,None,380.4,0,3.49,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL398154,,None,528.57,1,3.03,20,CCOc1cc2ncnc(NC3=CC(=O)C(OCc4ccccn4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,Ratio,'=',7.5,,,,,,,,,,0,CHEMBL892962,Ratio of IC50 for VEGFR2 in presence of 1 mM ATP to IC50 for VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,7.5
CHEMBL3124950,,None,540.6,2,6.19,3e,CC(C)(C#N)c1cccc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3C(=O)O)c2)c1,IC50,'=',15,nM,7.82,,,UO_0000065,14.47,0.27,1.63,5.53,0,CHEMBL3129557,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate pretreated for 5 mins before substrate addition measured after overnight incubation,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124815,1,Scientific Literature,J Med Chem,2013,None,,,,15
CHEMBL3941664,,None,453.45,1,5.37,BDBM235455,CC(F)(F)c1cncc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)cc2)c1,IC50,'=',6.5,nM,8.19,,410090,UO_0000065,18.06,0.34,2.82,7.78,0,CHEMBL3888586,Inhibition Assay: [Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [Instrument]: PerKinElmer's ENVISION plate reader. [Materials]: Optiplate-384 well plate (PerKinElmer),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL238737,,None,389.38,0,4.01,34,Cc1cc(NC(=O)c2c(NCc3ccncc3)ncn2C)ccc1C(F)(F)F,Ki,'=',0.16,nM,9.8,,,UO_0000065,25.16,0.48,5.79,13.64,0,CHEMBL885903,Inhibition of VEGFR2 by [32P]ATP-competitive radioassay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.16
CHEMBL3955038,,None,473.43,1,5.41,BDBM223054,COc1cccc(/C(=C/C(N)=O)c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)c1,IC50,'=',945,nM,6.03,,389857,UO_0000065,12.73,0.24,0.61,6.45,0,CHEMBL3888326,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927422,,None,473.43,1,5.41,BDBM223055,COc1ccc(/C(=C/C(N)=O)c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1,IC50,'=',457,nM,6.34,,389858,UO_0000065,13.39,0.25,0.93,6.78,0,CHEMBL3888326,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5277445,,None,635.78,2,3.22,12b,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccncc5)cc4)nc(N4CCOCC4)n3)s2)CC1,Inhibition,'=',1.74,%,,,,UO_0000187,,,,,0,CHEMBL5240749,Inhibition of KDR (unknown origin) at 1 uM by kinase-glo luminescent assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5236659,1,Scientific Literature,Bioorg Med Chem,2023,None,DOSE = 1.0 microM,,,1.74
CHEMBL3894814,,None,424.46,0,4.04,BDBM201211,CC(=O)Nc1cn2nc(C#Cc3ccc(NC(=O)Nc4cccc(C)c4)cc3)ccc2n1,IC50,'>',10000,nM,,,357192,UO_0000065,,,,,0,CHEMBL3887846,PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952283,,None,378.39,0,4.13,BDBM201222,O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1cc2ccccc2o1,IC50,'>',10000,nM,,,357203,UO_0000065,,,,,0,CHEMBL3887846,PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3309474,,None,482.87,0,4.47,3f,Nc1nccc(Oc2ccc(-n3cc(C(=O)NCc4ccc(F)cc4)ccc3=O)cc2F)c1Cl,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL3372650,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351718,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,25
CHEMBL191160,,None,422.96,1,5.22,53,Clc1cccc(Nc2cncc(-c3cncc(NCCCN4CCCCC4)c3)n2)c1,IC50,'=',398.11,nM,6.4,,,UO_0000065,15.13,0.29,1.18,9.7,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.4
CHEMBL4165455,,None,536.59,1,3.92,9c,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCCC1=O)CC2)c1ccccc1,IC50,'=',230,nM,6.64,,,UO_0000065,12.37,0.23,2.72,6.14,0,CHEMBL4136262,Inhibition of recombinant VEGFR2 (unknown origin) by off-chip mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130560,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,230
CHEMBL4166319,,None,496.57,0,3.86,9a,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN(C)C)CC2)c1ccccc1,IC50,'=',65,nM,7.19,,,UO_0000065,14.47,0.27,3.33,7.9,0,CHEMBL4136262,Inhibition of recombinant VEGFR2 (unknown origin) by off-chip mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130560,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,65
CHEMBL234624,,None,391.91,1,5.13,9e,CN(C)CCc1ccc(Nc2ncc(Cl)c(-c3ccc4[nH]ccc4c3)n2)cc1,IC50,'=',103,nM,6.99,,,UO_0000065,17.83,0.34,1.86,12.29,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.103
CHEMBL234452,,None,391.91,1,5.13,9c,CN(C)CCc1ccc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)cc1,IC50,'=',7,nM,8.15,,,UO_0000065,20.81,0.4,3.02,14.35,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.007
CHEMBL240406,,None,359.39,0,3.79,72,Cc1noc(NCc2ccncc2)c1C(=O)Nc1cnc2ccccc2c1,IC50,'=',1220,nM,5.91,,,UO_0000065,16.45,0.3,2.12,6.36,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.22
CHEMBL241667,,None,375.35,0,3.7,13,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'=',790,nM,6.1,,,UO_0000065,16.26,0.31,2.4,8.49,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.79
CHEMBL238719,,None,364.45,0,4.54,67,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)(C)C)cc1,IC50,'=',210,nM,6.68,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.21
CHEMBL429643,,None,409.8,0,4.35,53,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',110,nM,6.96,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.11
CHEMBL238735,,None,409.8,0,4.35,27,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',170,nM,6.77,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.17
CHEMBL241667,,None,375.35,0,3.7,13,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'=',550,nM,6.26,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.55
CHEMBL392985,,None,375.35,0,3.7,9,Cn1cnc(NCc2cccnc2)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL238939,,None,432.4,0,4.07,38,Cn1ncc(NCCc2ccc3c(c2)OCO3)c1C(=O)Nc1cccc(C(F)(F)F)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL240644,,None,383.46,0,4.35,49,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(-c2ccccc2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL392964,,None,432.4,0,4.07,39,Cn1ncc(NCCc2ccc3c(c2)OCO3)c1C(=O)Nc1ccc(C(F)(F)F)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885901,Inhibition of VEGFR2 by cell-based assay,F,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL240606,,None,410.78,0,4.91,73,Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL393779,,None,363.47,0,3.98,19,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)(C)C)cc1,Ki,'=',0.2,nM,9.7,,,UO_0000065,26.68,0.49,5.72,13.5,0,CHEMBL885903,Inhibition of VEGFR2 by [32P]ATP-competitive radioassay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.2
CHEMBL3093583,,None,524.51,1,4.41,3e,O=C(Nc1ccc(Oc2ccc3nc(NC(=O)C4CC4)cn3n2)c(F)c1)c1cccn(-c2ccccc2)c1=O,IC50,'=',2.5,nM,8.6,,,UO_0000065,16.4,0.3,4.19,7.19,0,CHEMBL3094552,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 5 mins followed by 10 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,2.5
CHEMBL3099481,,None,562.67,2,6,D5,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCN4CCCC4)cc3C)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,'=',40.9,nM,7.39,,,UO_0000065,13.13,0.25,1.39,6.49,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,40.9
CHEMBL3114024,,None,390.52,0,4.91,7g,CSc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1,IC50,'=',51,nM,7.29,,,UO_0000065,18.67,0.36,2.38,12.39,0,CHEMBL3116994,Inhibition of VEGFR-2 tyrosine kinase (unknown origin) after 30 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3112549,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,51
CHEMBL3656113,,None,501.54,2,3.9,BDBM110624,Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCC(O)CO)c[nH]4)c3)cc2)c1,IC50,'=',9,nM,8.05,,231509,UO_0000065,16.04,0.3,4.15,5.41,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3696075,,None,609.61,1,4.55,BDBM144590,NC(=O)c1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)nsc1NC(=O)NCCCN1CCOCC1,IC50,'=',6,nM,8.22,,280950,UO_0000065,13.49,0.27,3.67,5.46,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2031893,,None,528.54,2,5.23,3,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,INH,'=',7.8,nM,,,,UO_0000065,,,,,0,CHEMBL3594728,Inhibition of VEGFR-2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3593176,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,7.8
CHEMBL3086536,,None,417.54,0,4.49,(S,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL243916,,None,487.41,1,6.12,46,CC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1,IC50,'=',2.6,nM,8.59,,,UO_0000065,17.61,0.33,2.47,7.94,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,2.6
CHEMBL243914,,None,504.4,2,6.6,41,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2o1,IC50,'=',4.8,nM,8.32,,,UO_0000065,16.49,0.32,1.72,7.25,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,4.8
CHEMBL3975634,,None,452.51,0,4.75,BDBM139540,CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4,IC50,'=',39.49,nM,7.4,,273893,UO_0000065,16.36,0.3,2.65,10.15,0,CHEMBL3707510,Kinase Inhibition Assay: The compound of Example 39,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4160854,,None,522.35,2,6.28,16a,Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12,IC50,'=',3.45,nM,8.46,,,UO_0000065,16.2,0.36,2.18,9.62,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,3.45
CHEMBL4167663,,None,400.48,1,5.64,17f,C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(C(C)C)c3)cc2)n1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL151358,,None,382.46,1,5.06,38,CC(C)OCc1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1ccccc1C4,IC50,'=',55,nM,7.26,,,UO_0000065,18.98,0.34,2.2,13.41,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,55
CHEMBL598523,,None,336.19,1,5.82,(S)-2,C[C@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL1066394,Inhibition of recombinant KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,50000
CHEMBL3911339,,None,451.48,1,5.97,BDBM228521,COC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1,IC50,'=',2,nM,8.7,,399267,UO_0000065,19.27,0.37,2.73,9.71,0,CHEMBL3888410,FLIPR (Fluorometric Imaging Plate Reader) Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 96-well fibronectin coated black-walled plates overnight at 37 °C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 °C. Cells were washed 4 times (Original Cell Wash,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897945,,None,522.56,2,5.77,BDBM228568,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCC(=O)O)sc34)cc2)c1,IC50,'=',2,nM,8.7,,399301,UO_0000065,16.65,0.32,2.93,6.71,0,CHEMBL3888410,FLIPR (Fluorometric Imaging Plate Reader) Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 96-well fibronectin coated black-walled plates overnight at 37 °C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 °C. Cells were washed 4 times (Original Cell Wash,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961927,,None,535.65,2,6.25,BDBM228572,CCN(CC)CCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1,IC50,'=',11,nM,7.96,,399305,UO_0000065,14.86,0.29,1.71,8.33,0,CHEMBL3888410,FLIPR (Fluorometric Imaging Plate Reader) Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 96-well fibronectin coated black-walled plates overnight at 37 °C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 °C. Cells were washed 4 times (Original Cell Wash,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891953,,None,394.41,0,4.94,BDBM228575,Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)O)sc23)c1,IC50,'=',162,nM,6.79,,399307,UO_0000065,17.22,0.33,1.85,6.68,0,CHEMBL3888410,FLIPR (Fluorometric Imaging Plate Reader) Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 96-well fibronectin coated black-walled plates overnight at 37 °C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 °C. Cells were washed 4 times (Original Cell Wash,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3978824,,None,623.68,2,6.08,BDBM228553,COC(=O)C1CCCN1CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1,IC50,'=',6,nM,8.22,,399337,UO_0000065,13.18,0.26,2.14,6.75,0,CHEMBL3888411,Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927233,,None,540.55,2,5.91,BDBM228567,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCC(=O)O)sc34)cc2F)c1,IC50,'=',13,nM,7.89,,399351,UO_0000065,14.59,0.28,1.98,6.08,0,CHEMBL3888411,Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891953,,None,394.41,0,4.94,BDBM228575,Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)O)sc23)c1,IC50,'=',39,nM,7.41,,399359,UO_0000065,18.78,0.36,2.47,7.29,0,CHEMBL3888411,Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920518,,None,477.56,1,6.27,BDBM228588,CCN(CC)C(=O)c1cc2nccc(Oc3cccc(C(=O)Nc4cc(C)ccc4F)c3)c2s1,IC50,'=',7,nM,8.15,,399372,UO_0000065,17.08,0.33,1.88,11.4,0,CHEMBL3888411,Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3098320,,None,342.79,0,3.82,8j,CN(C)c1ccc(Nc2nc(Cl)nc3cc4c(cc23)OCO4)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3101601,Inhibition of VEGFR2 (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098085,1,Scientific Literature,Eur J Med Chem,2014,None,,,,100
CHEMBL3099477,,None,536.63,2,5.47,D1,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCN(C)C)cc3C)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,
CHEMBL3946490,,None,537.61,1,3.55,BDBM208462,Cc1ccc(F)c(C(=O)Nc2cccc(C#Cc3cncc(C(=O)N=S(=O)(CCCO)CCCO)c3)c2)c1,IC50,'=',9,nM,8.05,,368375,UO_0000065,14.97,0.29,4.5,6.24,0,CHEMBL3888027,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985051,,None,579.68,1,4.18,BDBM208478,COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(C(=O)Nc3cc(C(C)(C)C)on3)c2)c1,IC50,'=',10,nM,8,,368391,UO_0000065,13.8,0.27,3.82,4.8,0,CHEMBL3888027,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3401979,,None,438.44,0,4.38,6,Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)no1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL3401982,,None,439.43,0,3.36,9,O=c1nc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]o1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL3401985,,None,437.45,0,4.11,12,Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]n1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL3401986,,None,412.44,0,3.26,13,CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL3774450,,None,297.31,0,3.1,5,COc1cc2ncnc(Nc3ccccc3O)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,10000
CHEMBL404393,,None,354.86,1,5.1,9,S=C(Nc1ccc(Cl)cc1)c1ccccc1OCc1ccncc1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL929241,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145619,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0
CHEMBL220057,,None,357.42,0,4.76,17b,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,IC50,'=',13,nM,7.89,,,UO_0000065,,,,,0,CHEMBL920442,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,13
CHEMBL221574,,None,490.58,1,5.15,37,CCN(CC)CCOn1nc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)cccc21,IC50,'=',15,nM,7.82,,,UO_0000065,,,,,0,CHEMBL920442,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,15
CHEMBL223129,,None,451.91,0,4.66,35,COCCOn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cccc21,IC50,'=',13,nM,7.89,,,UO_0000065,17.45,0.34,3.23,7.62,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,13
CHEMBL373435,,None,413.48,1,5.15,44,CC(=O)Nc1nn(C)c2cccc(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)c12,IC50,'=',12000,nM,4.92,,,UO_0000065,11.9,0.22,-0.23,5.59,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,12000
CHEMBL222817,,None,449.49,0,4.45,36,COCCOn1nc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)cccc21,IC50,'=',21,nM,7.68,,,UO_0000065,17.08,0.32,3.23,7.42,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,21
CHEMBL390696,,None,571.58,2,5.82,53,CN1CCN(CCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1,IC50,'=',33,nM,7.48,,,UO_0000065,13.09,0.25,1.66,7.67,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,33
CHEMBL243912,,None,519.48,2,6.69,34,COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1,IC50,'=',10,nM,8,,,UO_0000065,15.4,0.3,1.31,7.4,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,10
CHEMBL243911,,None,488.4,1,5.51,33,CC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)nc3)cc2[nH]1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,
CHEMBL397757,,None,520.4,1,4.97,32,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c[n+]3[O-])cc2[nH]1,IC50,'=',230,nM,6.64,,,UO_0000065,12.76,0.25,1.67,4.6,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,230
CHEMBL169797,,None,424.5,0,3.49,2,COc1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)c1,IC50,'=',1110,nM,5.96,,,UO_0000065,14.03,0.26,2.46,7.64,0,CHEMBL820673,In vitro inhibitory concentration against VEGF receptor 2.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148412,1,Scientific Literature,J Med Chem,2004,None,,,,1.11
CHEMBL356626,,None,440.54,0,4.92,20,CCCOCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',13,nM,7.89,,,UO_0000065,17.9,0.33,2.97,12.42,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,13
CHEMBL4446068,,None,414.47,1,5.54,8,O=C(Nc1nc2ccc(F)cc2s1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,'=',980,nM,6.01,,,UO_0000065,14.5,0.27,0.47,10.05,0,CHEMBL4363095,Inhibition of recombinant human N-terminal GST-tagged VEGFR2 (805 to 1356 residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947822,,None,471.56,1,7.54,22(c),C=C(c1cccc(NC(=O)OCc2ccccc2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1,Ki,'=',0.64,nM,9.19,,,UO_0000065,19.5,0.35,1.65,13.72,0,CHEMBL3881022,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,0.64
CHEMBL3951147,,None,422.49,1,5.26,41(dd),CC(C)=CC(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1,Inhibition,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,98
CHEMBL3918836,,None,404.47,0,4.78,37(d),CNC(=O)c1cccc(F)c1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,Inhibition,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL3881023,Inhibition of unphosphorylated human 50 residues truncated cytoplasmic domain of VEGFR2 E990V mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 50 nM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,P35968,E990V,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3880421,38,SureChEMBL Patent Bioactivity Data,,2003,None,,,,26
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,IC50,'=',124.7,nM,,Potential transcription error,,UO_0000065,,,,,1,CHEMBL3404062,Inhibition of VEGFR2 in human U251 cells compound pretreated for 60 min before VEGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3400114,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307756,,,,124.7
CHEMBL3422069,,None,514.7,2,6.43,40,CN1CCC(Oc2ccc(-c3n[nH]c4ccc(C(=O)NC(c5ccsc5)C5CCCC5)cc34)cc2)CC1,IC50,'=',2900,nM,5.54,,,UO_0000065,10.76,0.2,-0.89,7.88,0,CHEMBL3423901,Inhibition of recombinant KDR (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3421533,1,Scientific Literature,J Med Chem,2015,None,,,,2.9
CHEMBL4086319,,None,354.37,0,1.17,17,CC1(C)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL4048647,Inhibition of KDR (unknown origin) at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043290,1,Scientific Literature,J Med Chem,2018,None,,,,4
CHEMBL71985,,None,369.43,0,4.93,24,CC(C)n1cc(-c2ccc(Oc3ccc(C#N)cc3)cc2)c2c(N)ncnc21,IC50,'=',129,nM,6.89,,,UO_0000065,18.65,0.34,1.96,7.68,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.129
CHEMBL3426917,,None,460.91,1,5.64,HC-1144,[2H]C([2H])([2H])Oc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC([2H])([2H])[2H],IC50,'=',2.38,nM,8.62,,,UO_0000065,18.96,0.37,2.98,8,0,CHEMBL3429404,Inhibition of recombinant VEGFR2 (unknown origin) by cell-free assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425418,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,2.38
CHEMBL4788820,,None,444.56,1,5.74,12h,O=C(Nc1ccccc1)Nc1nc(Sc2c[nH]c3ccccc23)cc(N2CCCCC2)n1,IC50,'=',4550,nM,5.34,,,UO_0000065,12.02,0.23,-0.4,6.22,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,4.55
CHEMBL4789042,,None,522.64,2,5.47,12n,O=C(Nc1ccccc1)Nc1nc(Sc2c[nH]c3ccccc23)cc(N2CCN(c3ccccn3)CC2)n1,IC50,'=',1710,nM,5.77,,,UO_0000065,11.03,0.21,0.3,5.65,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,1.71
CHEMBL4796483,,None,501.02,2,7.46,12x,Cc1cc(Cl)ccc1NC(=O)Nc1nc(Nc2ccccc2)cc(Sc2c[nH]c3ccccc23)n1,IC50,'=',2820,nM,5.55,,,UO_0000065,11.08,0.22,-1.91,5.86,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,2.82
CHEMBL3309995,,None,334.34,0,1.76,10b,Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3375007,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352169,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,10
CHEMBL67241,GW794607X,None,372.44,0,3.48,GW794607X,CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',17.33,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,17.33
CHEMBL3353362,,None,474.61,1,6.1,41,O=C1Nc2ccccc2[C@]12C[C@H]2c1ccc2c(/C=C/c3ccc(CN4CCCCC4)cc3)n[nH]c2c1,IC50,'=',12,nM,7.92,,,UO_0000065,16.69,0.3,1.82,12.98,0,CHEMBL3364612,Inhibition of KDR (unknown origin) by FRET-based homogeneous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351767,1,Scientific Literature,J Med Chem,2015,None,,,,12
CHEMBL1812493,,None,333.33,0,3.41,4703197,O=C(Nc1ccc2[nH]c(-c3ccc(F)cc3)nc2c1)c1cnccn1,Inhibition,'=',0.58,%,,,,UO_0000187,,,,,0,CHEMBL1817444,Inhibition of VEGFR-2 at 20 uM after 1 hrs by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1811776,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,0.58
CHEMBL4177014,,None,548.65,1,3.41,21h,CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-n5nccn5)ccc43)c3ccccc3)cc2)CC1,IC50,'=',1.9,nM,8.72,,,UO_0000065,15.9,0.29,5.31,8.84,0,CHEMBL4136262,Inhibition of recombinant VEGFR2 (unknown origin) by off-chip mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130560,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,1.9
CHEMBL4169611,,None,565.6,1,4.73,21b,CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(OC(F)(F)F)ccc43)c3ccccc3)cc2)CC1,IC50,'=',34,nM,7.47,,,UO_0000065,13.2,0.25,2.74,9.68,0,CHEMBL4136262,Inhibition of recombinant VEGFR2 (unknown origin) by off-chip mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130560,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,34
CHEMBL3732423,,None,450.37,0,3.55,P-0065,O=C(c1c(F)ccc(NS(=O)(=O)c2c(F)cccc2F)c1F)c1c[nH]c2ncncc12,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
CHEMBL3728954,,None,470.5,0,4.57,P-0033,CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(F)c(C(=O)c3c[nH]c4ncncc34)c2F)cc1,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
CHEMBL3731088,,None,407.4,0,2.22,P-0020,O=C(c1c(F)ccc(NS(=O)(=O)N2CCCC2)c1F)c1c[nH]c2ncncc12,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
CHEMBL3732892,,None,406.41,0,3.15,P-0013,O=C(c1c(F)ccc(NS(=O)(=O)C2CCCC2)c1F)c1c[nH]c2ncncc12,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
CHEMBL3728149,,None,482.39,0,4.29,P-0004,O=C(c1c(F)ccc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1F)c1c[nH]c2ncncc12,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
CHEMBL3596862,,None,459.51,1,5.87,9,COc1ccc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cc1,IC50,'>',2000,nM,,,,UO_0000065,,,,,0,CHEMBL3598606,Inhibition of KDR (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3596123,1,Scientific Literature,Medchemcomm,2014,None,,,,2
CHEMBL3596879,,None,433.47,0,4.6,26,Cn1cc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cn1,IC50,'=',1400,nM,5.85,,,UO_0000065,13.5,0.25,1.25,4.88,0,CHEMBL3598606,Inhibition of KDR (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3596123,1,Scientific Literature,Medchemcomm,2014,None,,,,1.4
CHEMBL3809563,,None,493.36,1,5.28,6b,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(Br)c4)ccc3C)cnc2[nH]1,Inhibition,'=',59,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,59
CHEMBL3809960,,None,458.47,0,4.25,6s,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3C)cnc2[nH]1,Inhibition,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,58
CHEMBL3809817,,None,403.44,0,3.85,6w,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc[nH]c4)ccc3C)cnc2[nH]1,Inhibition,'=',37,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,37
CHEMBL3808782,,None,510.64,1,4.69,7x,CC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1,Inhibition,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,88
CHEMBL3809233,,None,609.65,2,5.64,26y,COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1,Inhibition,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,86
CHEMBL125898,,None,564.69,1,3.88,76,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCOCC1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL819558,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135998,1,Scientific Literature,J Med Chem,2002,None,,,,30
CHEMBL3589742,,None,390.83,1,5.06,9f,O=C(Nc1ccc(Cl)cc1)Nc1ccc(/N=C2\C(=O)Nc3ccccc32)cc1,IC50,'=',2510,nM,5.6,,,UO_0000065,14.33,0.27,0.54,6.78,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,2.51
CHEMBL1079428,,None,307.38,0,3.34,7,Cn1cnc(-c2ccccc2)c1-c1cc2c(N)ncnc2s1,IC50,'=',10000,nM,5,,,UO_0000065,16.27,0.31,1.66,7.18,0,CHEMBL1115834,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154391,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',72,nM,7.14,,,UO_0000065,15.31,0.28,2.79,10.28,1,CHEMBL4179085,Inhibition of VEGFR2 (unknown origin) incubated for 10 mins using FAM-labeled peptide and ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177575,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,0.072
CHEMBL576985,,None,474.57,1,6.17,20,CNc1ncc2cc(-c3c(C)ccc4c(Nc5ccc6c(c5)NC(=O)C6(C)C)nccc34)ccc2n1,IC50,'=',240,nM,6.62,,,UO_0000065,13.95,0.25,0.45,7.21,0,CHEMBL1047420,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155237,1,Scientific Literature,J Med Chem,2009,None,,,,240
CHEMBL3759830,,None,556.67,1,4.66,15f,COc1ccc(C(=O)Nc2ccc(Nc3ncnc4cc(OCCCN5CCN(C)CC5)c(OC)cc34)cc2)cc1,IC50,'=',2020,nM,5.7,,,UO_0000065,10.23,0.19,1.03,5.63,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,2.02
CHEMBL3754324,,None,430.33,1,5.26,3,CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1,Inhibition,'=',64.9,%,,,,UO_0000187,,,,,0,CHEMBL3756760,Inhibition of human KDR using srctide as substrate at 10 uM after 1 hr in presence of 30 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751797,1,Scientific Literature,Medchemcomm,2015,None,,,,64.9
CHEMBL44915,,None,395.39,1,5.4,3a,Cc1cc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)cc(C(F)(F)F)c1,IC50,'=',5,nM,8.3,,,UO_0000065,20.99,0.39,2.9,14.92,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,5
CHEMBL297156,,None,341.42,0,4.69,6,Cc1cc(C)cc(Nc2cc(-n3ccnc3-c3ccccc3)ncn2)c1,IC50,'=',1808,nM,5.74,,,UO_0000065,16.82,0.3,1.05,10.32,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,1808
CHEMBL3298678,,None,449.91,0,2.66,38,O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1,Inhibition,'=',14.6,%,,,,UO_0000187,,,,,0,CHEMBL3366848,Inhibition of KDR (unknown origin) at 100 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297705,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,14.6
CHEMBL3806189,,None,584.62,2,5.05,54,CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1,Inhibition,'>',99,%,,,,UO_0000187,,,,,0,CHEMBL3806844,Inhibition of human recombinant VEGFR2 expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3804768,1,Scientific Literature,J Med Chem,2016,CHEMBL4106362,,,,99
CHEMBL3808720,,None,362.31,0,4.59,10,Nc1cc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)on1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3812631,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,None,,,,10
CHEMBL395824,,None,340.81,0,3.45,54,CN(C(=O)c1ccnn1CCc1ccncc1)c1ccc(Cl)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL4089898,,None,529.57,2,5.05,2g,CN1CCN(Cc2ccc(NC(=O)c3cc(C#Cc4cncc5ccccc45)ccn3)cc2C(F)(F)F)CC1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4061838,,None,570.66,2,6.78,2f,CC(C)c1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2ccccc12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3747481,,None,439.4,0,4.93,33g,O=C(Nc1cccc(C(F)(F)F)c1)n1ccc2cc(Oc3ncnc4c3CNC4)ccc21,IC50,'=',0.4,nM,9.4,,,UO_0000065,21.39,0.4,4.47,11.59,0,CHEMBL3749262,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse BaF3 cells using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL608533,MIDOSTAURIN,4,570.65,2,5.91,PKC-412,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'=',3200,nM,5.5,,,UO_0000065,9.63,0.17,-0.42,7.07,1,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,3200
CHEMBL3758739,,None,431.83,0,4.84,28,CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3C(F)F)nc21,Inhibition,'=',96.4,%,,,,UO_0000187,,,,,0,CHEMBL3761299,Inhibition of KDR (unknown origin) at 1000 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758169,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,96.4
CHEMBL3814311,,None,468.42,0,3.29,13,Nc1ncnc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)c1/C=N/O,IC50,'=',140,nM,6.85,,,UO_0000065,14.63,0.28,3.56,4.51,0,CHEMBL3816037,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3813791,,None,526.5,1,3.22,14i,Nc1ncnc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)c1/C=N/OCCCO,IC50,'=',560,nM,6.25,,,UO_0000065,11.87,0.22,3.03,3.88,0,CHEMBL3816037,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3814828,,None,579.61,1,4.32,18b,Nc1ncnc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)c1/C=N/OCCCN1CCCC1,IC50,'=',340,nM,6.47,,,UO_0000065,11.16,0.21,2.15,4.49,0,CHEMBL3816037,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4094561,,None,567.65,2,5.05,4p,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(O)cc5)CC4)cc3)nc2n1C1CCCC1,Inhibition,'=',36,%,,,,UO_0000187,,,,,0,CHEMBL4056530,Inhibition of human VEGFR2 at 1 uM by enzymatic radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052710,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,36
CHEMBL3828117,,None,524.62,2,5.47,20d,COc1ccc2c(c1)C(=O)c1c-2n(-c2ccc(OCCCN3CCCCC3)cc2)c(=O)c2cc(OC)ccc12,IC50,,,,,,Not Active,,,,,,0,CHEMBL3829138,Inhibition of recombinant human His-tagged cytoplasmic VEGFR2 (789 to 1356 residues) expressed in baculovirus expression system incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3826943,1,Scientific Literature,Eur J Med Chem,2016,None,,,,
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4055550,Inhibition of VEGFR2 in human BT474 cells assessed as reduction in Akt phosphorylation at 20 to 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,
CHEMBL234625,,None,391.91,1,5.13,9f,CN(C)CCc1ccc(Nc2ncc(Cl)c(-c3ccc4cc[nH]c4c3)n2)cc1,IC50,'=',15,nM,7.82,,,UO_0000065,19.96,0.38,2.69,13.76,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.015
CHEMBL3827784,,None,482.54,0,4.48,21d,O=C1c2cc(O)ccc2-c2c1c1ccc(O)cc1c(=O)n2-c1ccc(OCCN2CCCCC2)cc1,IC50,'=',250,nM,6.6,,,UO_0000065,13.68,0.25,2.12,7.18,0,CHEMBL3829138,Inhibition of recombinant human His-tagged cytoplasmic VEGFR2 (789 to 1356 residues) expressed in baculovirus expression system incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3826943,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.25
CHEMBL3827045,,None,468.51,0,4.09,21c,O=C1c2cc(O)ccc2-c2c1c1ccc(O)cc1c(=O)n2-c1ccc(OCCN2CCCC2)cc1,Inhibition,,,%,,,Dose-dependent effect,UO_0000187,,,,,0,CHEMBL3829140,Inhibition of VEGFR2 in HUVEC assessed as reduction in expression of phosphorylated VEGFR2 incubated for 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3826943,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307501,,,,
CHEMBL3323598,,None,364.45,1,6.08,7g,CCc1ccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)cc1,IC50,'=',5490,nM,5.26,,,UO_0000065,14.43,0.26,-0.82,9.81,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,5.49
CHEMBL3818835,,None,545.99,2,5.88,10a,COc1ccc(Nc2nccc(-n3ncc4cc(NC(=O)Nc5cc(Cl)c(OC)cc5OC)ccc43)n2)cc1,Inhibition,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL3820578,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,27
CHEMBL401860,,None,537.47,2,6.95,2,COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3c(F)cccc3C(F)(F)F)cc2)cc1,IC50,'=',3,nM,8.52,,,UO_0000065,15.86,0.3,1.57,7.39,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,3
CHEMBL258436,,None,483.62,1,5.51,42,C/C(=N\OCC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',51,nM,7.29,,,UO_0000065,15.08,0.28,1.78,9.93,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,51
CHEMBL401876,,None,441.54,0,4.49,34,CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',4,nM,8.4,,,UO_0000065,19.02,0.35,3.91,11.44,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,4
CHEMBL404322,,None,385.43,0,3.26,27,C/C(=N\O)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,'=',1,nM,9,,,UO_0000065,23.35,0.42,5.74,9.44,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,1
CHEMBL257789,,None,399.45,0,3.43,23,CO/N=C(\C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,'=',1,nM,9,,,UO_0000065,22.53,0.41,5.57,10.68,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,1
CHEMBL257787,,None,385.43,0,3.04,21,CO/N=C/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL258015,,None,455.56,0,4.56,35,CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',4,nM,8.4,,,UO_0000065,18.43,0.34,3.84,11.44,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,4
CHEMBL178174,,None,450.5,0,3.84,30,Cc1ccc(Nc2ncnn3cc(NC(=O)OCCCn4nccn4)c(C(C)C)c23)cc1O,IC50,'=',7,nM,8.15,,,UO_0000065,18.1,0.34,4.31,6.2,0,CHEMBL830878,Inhibitory concentration against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142012,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,7
CHEMBL404401,,None,468.47,0,3.86,21,CNc1nnc(-c2cn3ncnc(Nc4cc(C(=O)NC5CC5)c(F)cc4F)c3c2C(C)C)o1,IC50,'=',20,nM,7.7,,,UO_0000065,16.43,0.31,3.84,6.3,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL183025,,None,476.54,1,5.8,14b,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(NC(=O)c4ccccc4)c4c3CNC4=O)cc2)c1,IC50,'=',470,nM,6.33,,,UO_0000065,13.28,0.24,0.53,6.37,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,470
CHEMBL271372,,None,512.54,1,4.81,13d,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NC2CCN(C)CC2)nc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,25000
CHEMBL272673,,None,528.54,1,4.05,13e,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NCCN2CCOCC2)nc1,IC50,'>',8300,nM,,,,UO_0000065,,,,,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,8300
CHEMBL438016,,None,603.65,2,6.11,29,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)c(C)c1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,IC50,'=',2540,nM,5.59,,,UO_0000065,9.27,0.17,-0.51,5.46,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,2540
CHEMBL272850,,None,581.68,1,4.8,22,COc1cc(OC)cc(C(=O)Nc2ccc(C)c(C(=O)Nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3)c2)c1,IC50,'=',120,nM,6.92,,,UO_0000065,11.9,0.22,2.12,5.72,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,120
CHEMBL1688356,,None,439.48,0,4.47,27,c1ccc(-c2nnc(Nc3ccc4c(c3)OCCO4)[nH]2)c(NCc2ccc3[nH]ncc3c2)c1,IC50,'=',3100,nM,5.51,,,UO_0000065,12.53,0.23,1.04,4.88,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,3.1
CHEMBL203642,,None,445.44,0,3.99,18,c1cnc(NCc2ccc3c(c2)OCO3)c(-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL4795532,,None,464.62,0,4.58,22,CSCCC(N)C(=O)Nc1nc(C)c(-c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)s1,GI50,'=',101,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.101
CHEMBL4787523,,None,519.55,2,6.76,29,Cc1nc(NC(=O)Cc2cccc(C(F)(F)F)c2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,GI50,'=',13,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.013
CHEMBL4785817,,None,501.62,2,6.89,32,Cc1nc(NC(=O)Cc2cccc3ccccc23)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,GI50,'=',15,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.015
CHEMBL4792446,,None,449.54,0,4.16,38,COCCOCC(=O)Nc1nc(C)c(-c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)s1,GI50,'=',1780,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,1.78
CHEMBL429585,,None,502.93,2,7.24,78,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3F)c2cc1OC,IC50,'=',0.3,nM,9.52,,,UO_0000065,18.93,0.36,2.28,13.67,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.3
CHEMBL4095789,,None,499.6,0,3.99,18,Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccc(F)cc12,EC50,'=',146,nM,6.84,,,UO_0000065,13.68,0.25,2.85,6.77,0,CHEMBL4057777,Inhibition of VEGF stimulated VEGFR2 phosphorylation at Y165 residues in HUVEC preincubated for 1 hr followed by VEGF addition measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052763,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.146
CHEMBL272252,,None,344.37,0,4.29,28,COc1ccc2c(Oc3ccc4c(C(N)=O)cccc4c3)ccnc2c1,IC50,'=',1.2,nM,8.92,,,UO_0000065,25.9,0.47,4.63,11.98,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,1.2
CHEMBL270086,,None,362.36,0,4.86,30,Nc1noc2cccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,IC50,'=',44,nM,7.36,,,UO_0000065,20.3,0.37,2.5,7.89,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,44
CHEMBL411725,,None,344.37,0,4.72,23,Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,IC50,'=',23,nM,7.64,,,UO_0000065,22.18,0.4,2.92,8.2,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,23
CHEMBL213507,,None,512.68,2,5.09,10,Cc1cccc(NC(=O)NCc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1,IC50,'=',146,nM,6.84,,,UO_0000065,13.33,0.25,1.75,8.96,0,CHEMBL869850,Inhibition of KDR phosphorylation in NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146863,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307716,,,,146
CHEMBL4093021,,None,578.19,2,5.86,27,CC(C)(C)c1cc2ncnc(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)c(Cl)c4)nc3N)c2s1,EC50,'=',80,nM,7.1,,,UO_0000065,12.27,0.24,1.24,7.03,0,CHEMBL4057777,Inhibition of VEGF stimulated VEGFR2 phosphorylation at Y165 residues in HUVEC preincubated for 1 hr followed by VEGF addition measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052763,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,0.08
CHEMBL386365,,None,364.4,0,4.26,2a,COc1cc2c(cc1OC)Oc1ncnc(Nc3cccc(C)c3)c1NC2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL215191,,None,363.42,0,3.78,4d,COc1cc2c(cc1OC)Nc1ncnc(NCc3ccccc3)c1NC2,IC50,'=',2000,nM,5.7,,,UO_0000065,,,,,0,CHEMBL906927,Inhibition of KDR measured as pGAT-biotin peptide phosphorylation by HTRF assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149491,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,2
CHEMBL234863,,None,385.85,0,4.36,12,CC1C=C2OCOC2=C(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)C1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL234203,,None,360.34,0,3.79,42,O=C(Nc1ccc(C(F)(F)F)cc1)c1nccn1CCc1ccncc1,IC50,'=',470,nM,6.33,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.47
CHEMBL392329,,None,332.37,0,2.65,30,O=C(Nc1ccc2cn[nH]c2c1)c1ccnn1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL236420,,None,334.42,0,3.9,24,CC(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,IC50,'=',74,nM,7.13,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.074
CHEMBL236419,,None,392.79,0,3.94,22,O=C(Nc1cccc(OC(F)(F)Cl)c1)c1ccnn1CCc1ccncc1,Ki,'=',70,nM,7.16,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.07
CHEMBL393001,,None,328.76,0,2.22,49,O=C(Nc1ccc(Cl)cc1)c1nnnn1CCc1ccncc1,IC50,'=',2030,nM,5.69,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,2.03
CHEMBL236419,,None,392.79,0,3.94,22,O=C(Nc1cccc(OC(F)(F)Cl)c1)c1ccnn1CCc1ccncc1,IC50,'=',21,nM,7.68,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.021
CHEMBL220640,,None,524.63,2,6.38,24,CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C4CCCCC4)ccc3OC)ccc2C)n1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,25000
CHEMBL219158,,None,564.57,2,5.79,47,CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCOCC3)ccc2C)n1,IC50,'=',310,nM,6.51,,,UO_0000065,11.53,0.22,0.72,6.41,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,310
CHEMBL193643,,None,404.4,0,2.56,2r,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)ccc1C(=O)c1c(F)cccc1F,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL833474,In vitro inhibitory concentration against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144370,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,100
CHEMBL98475,,None,336.46,0,4.54,2,c1ccc(-c2cnc(Nc3ccc(CN4CCCC4)cn3)s2)cc1,IC50,'=',28,nM,7.55,,,UO_0000065,,,,,0,CHEMBL913857,Inhibition of VEGF-induced DNA synthesis in HEK293 cells expressing human KDR by endothelial cell mitogenesis assay,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,28
CHEMBL224842,,None,377.5,0,2.16,22,CS(=O)(=O)C1CCN(Cc2ccnc(Nc3ncc(C#N)s3)c2)CC1,IC50,'=',48,nM,7.32,,,UO_0000065,,,,,0,CHEMBL913857,Inhibition of VEGF-induced DNA synthesis in HEK293 cells expressing human KDR by endothelial cell mitogenesis assay,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,48
CHEMBL222225,,None,300.39,0,1.56,16,N#Cc1cnc(Nc2cc(CN3CCNCC3)ccn2)s1,IC50,'=',13,nM,7.89,,,UO_0000065,,,,,0,CHEMBL912804,Inhibition of VEGF-induced KDR autophosphorylation expressed in HEK293 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,13
CHEMBL221875,,None,336.46,0,4.54,12,c1ccc(-c2cnc(Nc3cc(CN4CCCC4)ccn3)s2)cc1,IC50,'=',15,nM,7.82,,,UO_0000065,,,,,0,CHEMBL912804,Inhibition of VEGF-induced KDR autophosphorylation expressed in HEK293 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,15
CHEMBL197828,,None,457.48,1,6.17,95,CCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1,IC50,'=',23,nM,7.64,,,UO_0000065,,,,,0,CHEMBL884695,Cellular inhibition of VEGF induced human KDR phosphorylation in 3T3 murine fibroblasts,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141091,1,Scientific Literature,J Med Chem,2005,None,,,,23
CHEMBL4796999,,None,474.59,1,5.75,12g,COc1ccc(NC(=O)Nc2nc(Sc3c[nH]c4ccccc34)cc(N3CCCCC3)n2)cc1,IC50,'=',1130,nM,5.95,,,UO_0000065,12.53,0.24,0.2,6.25,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,1.13
CHEMBL4782982,,None,460.56,1,5.36,12j,COc1ccc(NC(=O)Nc2nc(Sc3c[nH]c4ccccc34)cc(N3CCCC3)n2)cc1,IC50,'=',2610,nM,5.58,,,UO_0000065,12.12,0.23,0.22,5.87,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,2.61
CHEMBL4076909,,None,540.5,2,5.18,26,CC(=O)N1Cc2ncnc(Oc3ccc4c(ccn4C(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c3)c2C[C@@H]1C,IC50,'=',0.7,nM,9.15,,,UO_0000065,16.94,0.32,3.97,7.93,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,0.7
CHEMBL4092692,,None,458.48,0,4.07,24,CC(=O)N1CCc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4CC4)on3)c2)C1,IC50,'=',2.1,nM,8.68,,,UO_0000065,18.93,0.35,4.61,7.52,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,2.1
CHEMBL230109,,None,479.97,0,4.6,32,CNc1nccc(Oc2ccc3oc(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)n1,Ki,'=',25,nM,7.6,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,25
CHEMBL230223,,None,525.97,2,5.38,36,CNC(=O)c1cc(Oc2cc(F)c3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1,IC50,'=',31,nM,7.51,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,31
CHEMBL230107,,None,560.05,2,6.33,30,COc1cc2nccc(Oc3ccc4oc(Nc5ccc(Cl)c(CN6CCN(C)CC6)c5)nc4c3)c2cc1OC,IC50,'=',10,nM,8,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,10
CHEMBL425672,,None,507.98,2,5.15,26,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OCC5CCNCC5)c4)nc3c2)ccn1,IC50,'=',94,nM,7.03,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,94
CHEMBL1162958,,None,394.82,0,4.77,21,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)cc4)nc3c2)ccn1,IC50,'=',766,nM,6.12,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,766
CHEMBL427837,,None,559.07,2,6.07,14,COc1cc2nccc(Oc3ccc4[nH]c(Nc5ccc(Cl)c(CN6CCN(C)CC6)c5)nc4c3)c2cc1OC,IC50,'=',16.6,nM,7.78,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,16.6
CHEMBL231254,,None,345.43,0,4.8,14,Nc1nccc2scc(-c3ccc(NC(=O)c4ccccc4)cc3)c12,IC50,'=',12000,nM,4.92,,,UO_0000065,14.25,0.27,0.12,7.24,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,12000
CHEMBL231415,,None,366.49,0,5,7l,Nc1nccc2scc(-c3ccc(NC(=O)NC4CCCCC4)cc3)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,
CHEMBL394619,,None,374.47,1,5.5,7b,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1,IC50,'=',32,nM,7.5,,,UO_0000065,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,32
CHEMBL4079937,,None,406.45,0,4.13,27,CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(C)C)on3)c2)ncn1,IC50,'=',25.2,nM,7.6,,,UO_0000065,18.7,0.35,3.47,7.09,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,25.2
CHEMBL4077291,,None,444.5,0,4.55,16,CCN1CCc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4CC4)on3)c2)C1,IC50,'=',7.9,nM,8.1,,,UO_0000065,18.23,0.34,3.55,8.24,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,7.9
CHEMBL4079136,,None,434.46,0,3.16,10,CC(C)(CO)c1cc(NC(=O)n2ccc3cc(Oc4ncnc5c4CNC5)ccc32)no1,IC50,'=',2.5,nM,8.6,,,UO_0000065,19.8,0.37,5.44,6.76,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,2.5
CHEMBL3746562,,None,429.48,0,3.72,4,CC1(c2cc(NC(=O)n3ccc4cc(Oc5ncnc6c5CCNC6)ccc43)n[nH]2)CC1,IC50,'=',2.3,nM,8.64,,,UO_0000065,20.11,0.37,4.92,7.87,0,CHEMBL4059305,Inhibition of KDR (unknown origin) expressed in mouse Ba/F3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052831,1,Scientific Literature,J Med Chem,2018,None,,,,2.3
CHEMBL231209,,None,378.43,1,5.33,7f,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,IC50,'=',15,nM,7.82,,,UO_0000065,20.67,0.4,2.49,9.77,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,15
CHEMBL231255,,None,360.44,1,5.19,7a,Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,IC50,'=',72,nM,7.14,,,UO_0000065,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,72
CHEMBL400102,,None,402.5,0,3.09,28,CN1CCN(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CC1,Ki,'>',6660,nM,,,,UO_0000065,,,,,0,CHEMBL925259,Inhibition of phosphorylated-Kdr after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140496,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,6.66
CHEMBL249179,,None,372.35,0,4.36,15,O=C(Nc1ccc(C(F)(F)F)cc1)c1cccnc1NCc1ccncc1,Ki,'=',9,nM,8.05,,,UO_0000065,21.61,0.41,3.69,12.02,0,CHEMBL925259,Inhibition of phosphorylated-Kdr after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140496,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.009
CHEMBL541726,,None,457.37,0,4.53,27,CN1CCN(c2ccc(Nc3ncc(NC(=O)c4c(Cl)cccc4Cl)cn3)cc2)CC1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,25000
CHEMBL4126750,,None,397.49,0,3.72,43,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4124650,Inhibition of recombinant human N-terminal His6-tagged KDR (790 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,,,,100
CHEMBL258014,,None,441.54,0,4.32,33,CCCn1c2ccc(/C(C)=N/OC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',1,nM,9,,,UO_0000065,20.38,0.37,4.68,12.25,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,1
CHEMBL249599,,None,348.41,0,3.39,27,CC(O)c1cccc(NC(=O)c2cccnc2NCc2ccncc2)c1,Ki,'>',6660,nM,,,,UO_0000065,,,,,0,CHEMBL925259,Inhibition of phosphorylated-Kdr after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140496,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,6.66
CHEMBL4209540,,None,318.41,0,4.31,4b,Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1,Activity,'=',41,%,,,,UO_0000187,,,,,0,CHEMBL4178171,Inhibition of VEGFR2 (unknown origin) assessed as residual activity at 500 nM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177526,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,41
CHEMBL374997,,None,583.01,2,7.29,54,CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2Cl)n1,IC50,'=',675,nM,6.17,,,UO_0000065,10.58,0.21,-1.12,6.69,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,675
CHEMBL3893914,,None,363.43,0,3.23,3g,Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1,Ratio,'=',65,10'-4No_unit,,,,,,,,,0,CHEMBL3871927,Ratio of Km to Ki for KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3871290,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,65
CHEMBL398989,,None,461.01,1,5.2,9k,CCN1CCN(CCc2ccc(Nc3ncc(Cl)c(-c4ccc5cc[nH]c5c4)n3)cc2)CC1,IC50,'=',37,nM,7.43,,,UO_0000065,16.12,0.31,2.23,12.37,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.037
CHEMBL375284,,None,342.4,1,5.18,47,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1,IC50,'=',18,nM,7.75,,,UO_0000065,22.62,0.41,2.56,11.09,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,18
CHEMBL221574,,None,490.58,1,5.15,37,CCN(CC)CCOn1nc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)cccc21,IC50,'=',74,nM,7.13,,,UO_0000065,14.54,0.27,1.98,7.32,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,74
CHEMBL392313,,None,384.44,0,4.57,26,O=C(Nc1ccc(Oc2ccccc2)cc1)c1ccnn1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL233823,,None,394.78,0,4.45,32,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1,IC50,'=',95,nM,7.02,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.095
CHEMBL3628793,,None,322.37,0,4.25,2,CCOC(=O)Nc1ccc(Nc2ncnc3ccccc23)cc1C,IC50,'=',3820,nM,5.42,,,UO_0000065,16.81,0.31,1.17,7.12,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,3820
CHEMBL233829,,None,396.76,0,3.24,53,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nnnn1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL3958173,,None,512.65,1,4.14,8,CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3864903,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937949,,None,265.27,0,3.07,6c,O=C(O)c1ccc(Nc2nncc3ccccc23)cc1,IC50,'=',0.68,nM,9.17,,,UO_0000065,34.56,0.63,6.1,12.21,0,CHEMBL3870505,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3633296,,None,385.47,1,5.58,12g,CC(C)c1cccc(NC(=O)Nc2cccc(-c3cccc4[nH]nc(N)c34)c2)c1,IC50,'=',2.28,nM,8.64,,,UO_0000065,22.42,0.41,3.06,9.02,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,2.28
CHEMBL272691,,None,457.51,1,5.91,67,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5nccs5)cccc4c3)c2cc1OC,IC50,'=',0.3,nM,9.52,,,UO_0000065,20.81,0.39,3.61,11.53,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.3
CHEMBL3696088,,None,385.42,0,3.58,BDBM144603,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc(N)c3C(N)=O)cc2)c1,IC50,'=',24,nM,7.62,,280963,UO_0000065,19.77,0.39,4.04,6.19,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL520975,,None,278.31,0,3.09,12g,COc1ccc2[nH]c(-c3cccc4c3C(=O)NC4)cc2c1,IC50,'=',1100,nM,5.96,,,UO_0000065,21.41,0.39,2.87,11.01,0,CHEMBL981687,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144154,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,1.1
CHEMBL3752074,,None,350.38,0,3.8,5a,COc1cc(NC(=O)Nc2ccccn2)cc(-c2cccnc2)c1OC,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,500
CHEMBL491429,,None,433.78,1,5.29,19,O=C(Nc1cncnc1)c1c(Cl)ccc2c(Nc3cccc(C(F)(F)F)c3)noc12,IC50,'=',353,nM,6.45,,,UO_0000065,14.87,0.29,1.16,6.94,0,CHEMBL990802,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144163,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.353
CHEMBL3931691,,None,453.5,0,4.51,17f,CCc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncn2)cc1,IC50,'=',3600,nM,5.44,,,UO_0000065,12,0.22,0.93,5.13,0,CHEMBL3865779,Inhibition of VEGFR2 (unknown origin) by mobility shift/LanthaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864193,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,3.6
CHEMBL3890887,,None,471.49,0,4.64,17n,CCc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc(C(=O)NC)c4)c(F)c3)ncn2)cc1,IC50,'=',1200,nM,5.92,,,UO_0000065,12.56,0.23,1.28,5.58,0,CHEMBL3865779,Inhibition of VEGFR2 (unknown origin) by mobility shift/LanthaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864193,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,1.2
CHEMBL4870465,,None,456.43,0,4.35,W13,CC(=O)Nc1n[nH]c2cc(-c3cnn(CC(=O)Nc4ccc(C)c(C(F)(F)F)c4)c3)ccc12,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4820693,Inhibition of VEGFR2 in human HGC-27 cells assessed as downregulation of Akt phosphorylation at Tyr308 at 0.1 to 1 uM after 24 hrs by Westernblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HGC-27,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,Dose_Lower = 0.1 microM | Dose_Upper = 1.0 microM | TIME = 24.0 hr,INHIBITOR,,
CHEMBL461777,,None,417.49,0,3.87,4m,CN1C(=O)/C(=C/c2ccc(/C=C/C(=O)NCc3ccncc3)s2)Oc2ccccc21,Inhibition,'=',77.1,%,,,,UO_0000187,,,,,0,CHEMBL1001089,Inhibition of KDR expressed in baculovirus system at 4 ug/ml by ELISA,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140887,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,77.1
CHEMBL2333445,,None,339.42,0,3.44,1,CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1,Activity,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL2350066,Inhibition of KDR (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2346629,1,Scientific Literature,Eur J Med Chem,2013,None,,,,86
CHEMBL3740910,,None,506.53,2,6.63,2j,O=C(Nc1ccc(CN2CCCC2)cc1)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,IC50,'=',565,nM,6.25,,,UO_0000065,12.33,0.23,-0.38,7.6,0,CHEMBL3745462,Inhibition of VEGFR-2 (unknown origin) assessed as ATP level by luminescence analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3739356,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,565
CHEMBL3754722,,None,351.37,0,3.2,6c,COc1cc(NC(=O)Nc2ccncc2)cc(-c2cncnc2)c1OC,IC50,'=',491.9,nM,6.31,,,UO_0000065,17.95,0.33,3.11,6.42,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,491.9
CHEMBL3753854,,None,457.97,0,4.71,16e,O=C(CN1CCN(c2nnc(-c3ccccc3)c3ccccc23)CC1)Nc1ccccc1Cl,IC50,'=',3950,nM,5.4,,,UO_0000065,11.8,0.22,0.69,8.81,0,CHEMBL3756334,Inhibition of VGFR-2 (unknown origin) using poly-GluTyr (4:1) as substrate after 5 mins by Alpha Screen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,3.95
CHEMBL3753534,,None,457.97,0,4.71,16g,O=C(CN1CCN(c2nnc(-c3ccccc3)c3ccccc23)CC1)Nc1ccc(Cl)cc1,IC50,'=',3840,nM,5.42,,,UO_0000065,11.83,0.22,0.71,8.83,0,CHEMBL3756334,Inhibition of VGFR-2 (unknown origin) using poly-GluTyr (4:1) as substrate after 5 mins by Alpha Screen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,3.84
CHEMBL495729,,None,453.55,1,5.58,6c,Cc1nnc(-c2ccc(-c3cc(NC(=O)c4ccnc(N5CCCC5)c4)ccc3C)c(C)c2)o1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL497353,,None,455.56,0,4.39,18d,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2c(N)noc2c1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL998572,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141712,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,20
CHEMBL2036727,,None,335.8,0,4.43,2c,Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2038040,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2036867,,None,345.41,0,4.17,2e,CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2038040,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3753162,,None,506.64,2,5.18,21e,O=C(CN1CCN(c2nnc(-c3ccccc3)c3ccccc23)CC1)Nc1nc(-c2ccccc2)cs1,IC50,'=',2380,nM,5.62,,,UO_0000065,11.1,0.21,0.44,7.57,0,CHEMBL3756334,Inhibition of VGFR-2 (unknown origin) using poly-GluTyr (4:1) as substrate after 5 mins by Alpha Screen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,2.38
CHEMBL398302,,None,343.8,0,2.9,8d,Cc1nnsc1C1=NNC(=O)/C1=C\c1c[nH]c2ccc(Cl)cc12,IC50,'>',300,nM,,,,UO_0000065,,,,,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,300
CHEMBL427709,,None,323.38,0,2.26,14g,Cc1ccc2c(c1)c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,IC50,'=',35,nM,7.46,,,UO_0000065,23.06,0.44,5.2,10.33,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,35
CHEMBL250395,,None,353.41,0,2.26,8n,COc1cccc2c(/C=C3\C(=O)NN=C3c3snnc3C)cn(C)c12,IC50,'=',109,nM,6.96,,,UO_0000065,19.7,0.38,4.7,8.55,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,109
CHEMBL398301,,None,341.37,0,2.39,8b,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2ccc(F)cc12,IC50,'=',99,nM,7,,,UO_0000065,20.52,0.4,4.61,9.71,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,99
CHEMBL3959997,,None,355.4,0,3.96,11,Cc1cc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1,IC50,'=',6.5,nM,8.19,,,UO_0000065,23.04,0.41,4.23,8.85,0,CHEMBL3861874,Inhibition of human KDR by time-resolved fluorescence or time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3860107,1,Scientific Literature,J Med Chem,2016,None,,,,6.5
CHEMBL98896,,None,254.32,0,3.34,4,c1ccc(-c2cnc(Nc3cnccn3)s2)cc1,IC50,'=',23,nM,7.64,,,UO_0000065,30.03,0.58,4.3,15.07,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,23
CHEMBL402279,,None,524.53,1,3.56,35,CC(C)c1c(-c2nnc(O[C@H]3CCNC3)o2)cn2ncnc(Nc3cc(C(=O)NC4CC4)c(F)cc3F)c12,IC50,'=',36,nM,7.44,,,UO_0000065,14.19,0.27,3.88,5.66,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,36
CHEMBL271087,,None,525.56,1,3.97,26,CC(C)c1c(-c2nnc(NCC(C)(C)N)o2)cn2ncnc(Nc3cc(C(=O)NC4CC4)c(F)cc3F)c12,IC50,'=',220,nM,6.66,,,UO_0000065,12.67,0.24,2.69,4.49,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,220
CHEMBL410664,,None,376.39,1,5.17,40,Cc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1F,IC50,'=',15,nM,7.82,,,UO_0000065,20.79,0.38,2.65,8.4,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,15
CHEMBL377959,,None,350.49,0,3.46,18,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccsc4)n[nH]c2-3)CC1,IC50,'=',400,nM,6.4,,,UO_0000065,18.25,0.35,2.94,18.2,0,CHEMBL866098,Inhibition of KDR-mediated biotin-Ahx-AEEEYFFLFA-amide substrate phosphorylation in presence of 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145317,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.4
CHEMBL209806,,None,351.48,0,2.85,21,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4cscn4)n[nH]c2-3)CC1,IC50,'=',7480,nM,5.13,,,UO_0000065,14.58,0.28,2.28,10.67,0,CHEMBL866098,Inhibition of KDR-mediated biotin-Ahx-AEEEYFFLFA-amide substrate phosphorylation in presence of 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145317,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,7.48
CHEMBL378058,,None,364.52,0,3.77,24,Cc1csc(-c2n[nH]c3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)c1,IC50,'=',12540,nM,4.9,,,UO_0000065,13.45,0.26,1.13,13.94,0,CHEMBL866098,Inhibition of KDR-mediated biotin-Ahx-AEEEYFFLFA-amide substrate phosphorylation in presence of 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145317,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,12.54
CHEMBL379103,,None,336.46,0,3.46,27,CN1CCN(c2ccc3c(c2)Cc2c(-c4cccs4)n[nH]c2-3)CC1,IC50,'=',1005000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL866098,Inhibition of KDR-mediated biotin-Ahx-AEEEYFFLFA-amide substrate phosphorylation in presence of 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145317,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,1005
CHEMBL212084,,None,318.41,0,3.95,35,c1cn(Cc2ccc3c(c2)-c2[nH]nc(-c4ccsc4)c2C3)cn1,IC50,'=',147000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL866098,Inhibition of KDR-mediated biotin-Ahx-AEEEYFFLFA-amide substrate phosphorylation in presence of 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145317,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,147
CHEMBL215971,,None,232.29,0,3.65,2,c1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1,IC50,'=',1200,nM,5.92,,,UO_0000065,25.49,0.45,2.27,20.64,0,CHEMBL866098,Inhibition of KDR-mediated biotin-Ahx-AEEEYFFLFA-amide substrate phosphorylation in presence of 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145317,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,1.2
CHEMBL426009,,None,479.65,0,4.92,68,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',36,nM,7.44,,,UO_0000065,15.52,0.29,2.52,15.77,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,36
CHEMBL223551,,None,359.48,0,3.47,51,CN1CCN(Cc2ccc3c(c2)Cc2c(Nc4ccccc4)n[nH]c2-3)CC1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,50
CHEMBL224834,,None,448.55,1,5.38,82,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4ccnc4)ccc2-3)cs1)COc1ccccc1,IC50,'=',195,nM,6.71,,,UO_0000065,14.96,0.28,1.33,12.04,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,195
CHEMBL446143,ORNITHINE,3,132.16,0,-0.86,ornithine,NCCC[C@H](N)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL395110,MEPAZINE,4,310.47,0,4.63,pecazine,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1111,AMBRISENTAN,4,378.43,0,3.52,ambrisentan,COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL788,IDOXURIDINE,4,354.1,0,-1.22,idoxuridine,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2023225,,None,454.56,1,5.9,17,Cc1ccccc1NC(=O)Nc1ccc(-c2csc3c(-c4cnn(C)c4)cnc(N)c23)cc1,IC50,'=',2,nM,8.7,,,UO_0000065,19.14,0.36,2.8,8.89,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,2
CHEMBL2022852,,None,514.63,2,7.24,30,CC(C)CCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,IC50,'=',25,nM,7.6,,,UO_0000065,14.77,0.28,0.36,7.77,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,25
CHEMBL589583,DELAPRIL,3,452.55,0,2.61,delapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL224496,,None,480.64,0,4.89,56,CN1CCN(Cc2ccc3c(c2)-c2[nH]nc(-c4csc(C#CCOc5ccccc5)c4)c2C3)CC1,IC50,'=',197,nM,6.71,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,197
CHEMBL1738797,ALECTINIB,4,482.63,0,4.77,alectinib,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,AC50,'=',663.9,nM,6.18,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,0.6639
CHEMBL235668,TIPIRACIL,4,242.67,0,0.29,tipiracil,N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1276342,CEFMINOX,2,519.59,2,-1.84,cefminox,CO[C@@]1(NC(=O)CSC[C@@H](N)C(=O)O)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL50444,MEGLUTOL,2,162.14,0,-0.31,meglutol,CC(O)(CC(=O)O)CC(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2335379,,None,354.42,0,3.45,10,C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccn4)cc23)c1,IC50,'=',43600,nM,4.36,,,UO_0000065,12.3,0.22,0.91,4.71,0,CHEMBL2343567,Inhibition of VEGF-induced VEGFR2 phosphorylation in human U251 cells overexpressing Flk-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331499,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,43.6
CHEMBL2335018,,None,482.51,1,5.89,17,CC(C)(C)C(=O)Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1,IC50,'=',16700,nM,4.78,,,UO_0000065,9.9,0.19,-1.11,5,0,CHEMBL2343567,Inhibition of VEGF-induced VEGFR2 phosphorylation in human U251 cells overexpressing Flk-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331499,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,16.7
CHEMBL247468,,None,512.66,1,4.35,27,c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3ncnc(NCCN4CCNCC4)c23)cc1,IC50,'=',3096,nM,5.51,,,UO_0000065,10.75,0.2,1.16,7,0,CHEMBL902561,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139142,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,3.096
CHEMBL3951620,,None,473.58,1,5.63,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3984573,,None,487.56,1,3.01,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917670,,None,373.42,0,3.92,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3984055,,None,391.41,0,4.06,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929290,,None,504.59,2,5.93,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932057,,None,478.56,1,5.53,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3928197,,None,458.57,1,5.28,Table 4-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894623,,None,526,2,7.26,9c,COc1cc2c(Nc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ncnc2cc1OCc1ccccc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3877876,Inhibition of N-terminal GST-tagged human VEGFR-2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3877259,1,Scientific Literature,Eur J Med Chem,2017,None,,,,10000
CHEMBL3923551,,None,541.66,2,5.04,19a,COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',576,nM,6.24,,,UO_0000065,11.52,0.21,1.2,6.01,0,CHEMBL3877876,Inhibition of N-terminal GST-tagged human VEGFR-2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3877259,1,Scientific Literature,Eur J Med Chem,2017,None,,,,576
CHEMBL3961005,,None,540.77,1,4.84,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL541643,,None,349.84,0,2.9,1,Cl.Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1,IC50,'=',91000,nM,4.04,,,UO_0000065,12.89,0.25,1.14,6.91,0,CHEMBL887591,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144634,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,91
CHEMBL3656077,,None,576.59,2,3.16,BDBM110588,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCC(=O)NCC(O)CO)c[nH]4)c3)cc2)c1,IC50,'=',20,nM,7.7,,231473,UO_0000065,13.35,0.25,4.54,4.33,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3798019,,None,331.32,0,4.33,10,COc1cc2ncnc(Nc3cccc(C(F)F)c3)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3797215,,None,321.34,0,3.27,15,COc1cc2ncnc(Nc3cccc4cn[nH]c34)c2cc1OC,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,
CHEMBL2032018,,None,548.56,2,5.14,43h,COc1ccc2c(Oc3ccc(NC(=O)c4c(-c5cc(C)on5)n(C)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',501,nM,6.3,,,UO_0000065,11.48,0.21,1.16,4.99,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,501
CHEMBL2032016,,None,544.57,2,5.23,43f,COc1ccc2c(Oc3ccc(NC(=O)c4c(-c5cccnc5)n(C)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',2830,nM,5.55,,,UO_0000065,10.19,0.18,0.32,4.9,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,2830
CHEMBL2032015,,None,544.57,2,5.23,43e,COc1ccc2c(Oc3ccc(NC(=O)c4c(-c5ccccn5)n(C)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',1380,nM,5.86,,,UO_0000065,10.76,0.2,0.63,5.18,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,1380
CHEMBL2032014,,None,544.57,2,5.23,43d,COc1ccc2c(Oc3ccc(NC(=O)c4c(-c5ccncc5)n(C)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'>',6600,nM,,,,UO_0000065,,,,,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,6600
CHEMBL2031913,,None,568.61,2,5.81,42c,COc1ccc2c(Oc3ccc(NC(=O)c4c(C5CCOCC5)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',945,nM,6.03,,,UO_0000065,10.6,0.2,0.21,6.24,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,945
CHEMBL196747,,None,393.45,1,5.03,table5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL321359,,None,224.26,0,2.52,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL370006,,None,256.33,0,2.83,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3800021,,None,321.34,0,3.27,16,COc1cc2ncnc(Nc3ccc4cn[nH]c4c3)c2cc1OC,IC50,'=',5200,nM,5.28,,,UO_0000065,16.44,0.3,2.01,6.22,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,5.2
CHEMBL3800327,,None,321.34,0,3.27,18,COc1cc2ncnc(Nc3cccc4[nH]ncc34)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3797688,,None,428.46,0,3.25,37,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCOCC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3798584,,None,490.56,0,3.03,40,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCS(=O)(=O)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL190210,,None,601.75,2,5.92,49,COc1cc(OC)cc(C2Cc3cnc(N(CCCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1,IC50,'=',1400,nM,5.85,,,UO_0000065,9.73,0.18,-0.07,5.12,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,1.4
CHEMBL188901,,None,373.82,0,3.87,70,OCCCNc1cnc(F)c(-c2cncc(Nc3cccc(Cl)c3)n2)c1,IC50,'=',251,nM,6.6,,,UO_0000065,17.66,0.35,2.73,7.96,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,0.251
CHEMBL3759111,,None,414.44,0,3.97,6ac,COc1cc2ncnc(Nc3ccccc3F)c2cc1OCCCCCC(=O)NO,IC50,'=',918,nM,6.04,,,UO_0000065,14.57,0.27,2.07,5.72,0,CHEMBL3762407,Inhibition of VEGFR2 (unknown origin) preincubated for 5 mins followed by addition of ATP/gastrin precursor(Tyr87) biotinylated peptide cocktail incubated for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758114,1,Scientific Literature,Eur J Med Chem,2016,None,,,,918
CHEMBL3936025,,None,503.35,1,4.49,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913860,,None,545.5,2,5.47,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959857,,None,516.39,1,4.4,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1683329,,None,376.85,1,5.08,5a,O=C(Nc1ccc(Cl)cc1)c1c[nH]c2cccc(NCc3ccncc3)c12,Inhibition,'=',23,%,,,,UO_0000187,,,,,0,CHEMBL1687576,Inhibition of KDR assessed as phosphorylation level of substrate at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681739,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,23
CHEMBL3984039,,None,525.05,0,3.64,291,COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',8.913,nM,8.05,,,UO_0000065,16.48,0.31,4.41,9.07,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,8.05
CHEMBL3900296,,None,462.28,1,6.55,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903022,,None,573.42,3,5.02,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985254,,None,477.35,0,4.31,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935265,,None,512.4,2,5.37,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966040,,None,477.33,0,3.99,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951755,,None,432.88,0,3.88,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933897,,None,487.39,0,4.79,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925322,,None,475.47,0,3.68,912,COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1,IC50,'=',549.54,nM,6.26,,,UO_0000065,13.17,0.25,2.58,7.32,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.26
CHEMBL3912646,,None,545.51,2,6.74,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925803,,None,527.43,1,4.12,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951258,,None,532.47,1,4.86,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981956,,None,353.77,0,3.79,2,Nc1c(C(=O)c2cc3ccccc3o2)cnn1-c1cc(O)ccc1Cl,IC50,'=',170,nM,6.77,,,UO_0000065,19.14,0.37,2.98,7.18,0,CHEMBL3861874,Inhibition of human KDR by time-resolved fluorescence or time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3860107,1,Scientific Literature,J Med Chem,2016,None,,,,170
CHEMBL382070,,None,306.37,0,2.35,13d,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cccs3)c12,IC50,'=',6000,nM,5.22,,,UO_0000065,17.04,0.36,2.87,5.18,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,6
CHEMBL1668414,,None,411.29,0,4.26,3,COc1cc(O)c2c(c1)/C=C/CCCC(=O)C[C@H](Br)C[C@H](C)OC2=O,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,100
CHEMBL1668419,,None,332.4,0,3.58,9,COc1cc(O)c2c(c1)CCCCCC(=O)/C=C/C[C@H](C)OC2=O,IC50,'=',310,nM,6.51,,,UO_0000065,19.58,0.37,2.93,8.94,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,0.31
CHEMBL3899216,,None,381.42,0,3.47,5c,Cc1cc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)no1,IC50,'=',9.7,nM,8.01,,,UO_0000065,21.01,0.41,4.54,7.28,0,CHEMBL3870505,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL401064,,None,433.52,1,5.21,9c,CC(C)NCc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12,IC50,'=',1000,nM,6,,,UO_0000065,13.84,0.25,0.79,6.3,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1
CHEMBL3976548,,None,352.78,0,3.53,4,Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1cc(O)ccc1Cl,IC50,'=',28,nM,7.55,,,UO_0000065,21.41,0.41,4.02,7.79,0,CHEMBL3861874,Inhibition of human KDR by time-resolved fluorescence or time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3860107,1,Scientific Literature,J Med Chem,2016,None,,,,28
CHEMBL360401,,None,351.41,0,3.09,15,COc1cccc(Nc2cncc(-c3cncc(NCCCO)c3)n2)c1,pIC50(calc),'=',6.36,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.36
CHEMBL223534,,None,297.32,0,2.62,10,CO/N=C/c1c(N)ncnc1Oc1ccc2[nH]cc(C)c2c1,IC50,'=',1038,nM,5.98,,,UO_0000065,20.13,0.37,3.36,6.08,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,1.038
CHEMBL2032030,,None,570.62,2,5.7,58d,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(O)C(C)C)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',389,nM,6.41,,,UO_0000065,11.23,0.21,0.71,5.96,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,389
CHEMBL231649,,None,415.29,0,4.55,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL375491,,None,480.64,0,4.89,53,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4cc(C#CCOc5ccccc5)cs4)n[nH]c2-3)CC1,IC50,'=',50,nM,7.3,,,UO_0000065,15.19,0.28,2.41,16.45,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,50
CHEMBL223220,,None,526.71,2,5.43,4,Cc1cccc(NC(=O)N(C)Cc2ccc(-c3n[nH]c4c3Cc3ccc(CN5CCN(C)CC5)cc3-4)s2)c1,IC50,'=',64,nM,7.19,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,64
CHEMBL225278,,None,494.62,0,4.41,76,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1=O,IC50,'=',18,nM,7.75,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,18
CHEMBL2377456,,None,467.98,1,6.98,3d,O=c1[nH]c(-c2ccc(Cl)cc2)nc2cc(-c3cn(Cc4ccccc4)c4ccccc34)sc12,Inhibition,'=',73.4,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,73.4
CHEMBL2377475,,None,359.29,None,None,35,Cc1ccc(-c2cc3nnnc(N4CCOCC4)c3[se]2)cc1,Inhibition,'=',72.5,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,72.5
CHEMBL2377489,,None,292.37,0,0.92,21,C1CCN(c2nnnc3nc(N4CCOCC4)sc23)C1,Inhibition,'=',16.2,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,16.2
CHEMBL193290,,None,311.34,0,1.54,15,Cc1cc(C(=O)NCCO)[nH]c1/C=C1\C(=O)Nc2ccccc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL876999,In vitro inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141154,1,Scientific Literature,J Med Chem,2005,None,,,,10
CHEMBL365585,,None,455.51,0,4.09,(3'-S)-2a,CC1(C)O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@]1(O)CO,IC50,'=',65,nM,7.19,,,UO_0000065,15.78,0.29,3.1,7.22,0,CHEMBL828722,Inhibition of baculovirus expressed human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139527,1,Scientific Literature,J Med Chem,2005,None,,,,65
CHEMBL3752752,,None,491.52,1,5.08,16c,O=C(CN1CCN(c2nnc(-c3ccccc3)c3ccccc23)CC1)Nc1cccc(C(F)(F)F)c1,IC50,'=',3660,nM,5.44,,,UO_0000065,11.06,0.21,0.36,8.86,0,CHEMBL3756334,Inhibition of VGFR-2 (unknown origin) using poly-GluTyr (4:1) as substrate after 5 mins by Alpha Screen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,3.66
CHEMBL4077674,,None,581.68,2,5.36,4m,COc1cccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc5cc(C(=O)N(C)C)n(C6CCCC6)c5n4)cc3)CC2)c1,Inhibition,'=',-2,%,,,,UO_0000187,,,,,0,CHEMBL4056530,Inhibition of human VEGFR2 at 1 uM by enzymatic radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052710,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,-2
CHEMBL3759203,,None,510.98,2,6.87,9c,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4Cl)cc3)ncnc2cc1OCc1ccccc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,10
CHEMBL3793678,,None,375.22,0,3.22,4,COc1cc2ncn(Cc3ccc(Br)cc3)c(=O)c2cc1OC,Inhibition,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3794304,,None,356.38,0,3.84,15,O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCO3,Inhibition,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3633694,,None,451.51,0,3.58,T5,CCS(=O)(=O)c1ccc(OC)c(Nc2cn(-c3ccc(O)c(-c4cccnc4)c3)nn2)c1,IC50,,,,,,Not Active,,,,,,0,CHEMBL3636166,Inhibition of GST-tagged human recombinant VEGFR2 kinase expressed in Sf9 insect cells by radiometric protein kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632540,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,
CHEMBL3633691,,None,542.62,2,5.12,T2,CCS(=O)(=O)c1ccc(OC)c(Nc2cn(-c3ccc(NC(N)=O)c(-c4cccc5ccccc45)c3)nn2)c1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3636166,Inhibition of GST-tagged human recombinant VEGFR2 kinase expressed in Sf9 insect cells by radiometric protein kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632540,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,1
CHEMBL3616990,,None,216.24,0,2.54,Page 600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2396883,,None,382.41,0,3.78,11,COc1ccc2c(c1)C=C(C(=O)/C=C/c1c(OC)cc(OC)cc1OC)CO2,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2400316,Inhibition of human KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396526,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,
CHEMBL4173756,,None,521.62,1,4.63,A6,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(CN3CCN(C)CC3)cc2c1)c1ccccc1,IC50,'=',106.1,nM,6.97,,,UO_0000065,13.37,0.24,2.34,7.78,0,CHEMBL4132764,Inhibition of N-terminal biotinylated DYKDDDDK tagged human VEGFR2 (790 to 1356 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130391,1,Scientific Literature,Eur J Med Chem,2017,None,,,,106.1
CHEMBL4162191,,None,473.53,1,5.53,41d,O=c1oc2cc(O)ccc2c(Oc2ccc(OCCN3CCCCC3)cc2)c1-c1ccc(O)cc1,Inhibition,'=',66.08,%,,,,UO_0000187,,,,,0,CHEMBL4134006,Inhibition of His-tagged human VEGFR2 at 40 uM incubated for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130448,1,Scientific Literature,Eur J Med Chem,2017,None,,,,66.08
CHEMBL4164062,,None,584.65,1,4.48,CPMA10,Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(OCCCN6CCOCC6)c(F)c5)CC4)cc3)cc2n1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4135859,Inhibition of VEGFR-2 (unknown origin) after 60 mins by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130538,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL4175773,,None,400.48,1,5.64,VDAU2,C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(C(C)C)c3)cc2)cn1,IC50,'=',2.1,nM,8.68,,,UO_0000065,21.67,0.4,3.04,10.44,0,CHEMBL4135859,Inhibition of VEGFR-2 (unknown origin) after 60 mins by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130538,1,Scientific Literature,Eur J Med Chem,2017,None,,,,2.1
CHEMBL4171943,,None,376.39,0,4.66,VDAU6,C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cc2)cn1,IC50,'=',7.97,nM,8.1,,,UO_0000065,21.52,0.4,3.44,9.74,0,CHEMBL4135859,Inhibition of VEGFR-2 (unknown origin) after 60 mins by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130538,1,Scientific Literature,Eur J Med Chem,2017,None,,,,7.97
CHEMBL4777894,,None,671.66,2,7.72,22f,COc1cc2ncnc(Oc3ccc(Nc4nccc5c4c(=O)c(-c4ccc(F)cc4)cn5CC(=O)c4ccccc4)cc3F)c2cc1OC,IC50,'>',3000,nM,,,,UO_0000065,,,,,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,,,3000
CHEMBL306295,,None,328.38,0,4.06,60,Oc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1,ED50,'=',250,nM,6.6,,,UO_0000065,,,,,0,CHEMBL818396,Inhibition of VEGF-stimulated autophosphorylation of VEGF-receptor 2 (KDR) expressed in CHO cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,CHEMBL3308072,,,,250
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4134023,Inhibition of VEGFR2 phosphorylation in human MCF7 cells at 4 uM incubated for 24 hrs by Western blot method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,MCF7,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130448,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL421961,,None,341.37,0,3.11,12,COCCOc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC,IC50,'<',5,nM,,,,UO_0000065,,,,,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.005
CHEMBL4091341,,None,518.62,2,5.79,8c,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCCC2)cc1)c1ccccc1,Inhibition,'=',91.9,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,91.9
CHEMBL4059568,,None,532.64,2,6.18,8d,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCCCC2)cc1)c1ccccc1,Inhibition,'=',84.1,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,84.1
CHEMBL4065508,,None,560.7,2,6.49,8k,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(Cn2cccc2CN2CCC(C)CC2)cc1)c1ccccc1,Inhibition,'=',69.8,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,69.8
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Activity,'=',66,%,,,,UO_0000187,,,,,0,CHEMBL4384892,Inhibition of VEGFR2 internalization in HMEC1 cells assessed as membrane VEGFR2 level at 14 uM after 24 hrs by flow cytometry (Rvb = 100%),B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,None,,,,66
CHEMBL4470783,,None,462.55,1,6.15,21,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1cc(C)cc(C)c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4384920,Inhibition of VEGFR2 internalization in human A549 cells at 48 uM after 24 hrs by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,A549,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307651,,,,
CHEMBL4475243,,None,433.54,0,4.17,9g,C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1,IC50,'=',113.4,nM,6.95,,,UO_0000065,,,,,0,CHEMBL4382848,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4227572,,None,514.45,2,6.27,a2,CNC(=O)c1ccc(Sc2ccc(NC(=O)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2)nc1,IC50,'=',508,nM,6.29,,,UO_0000065,12.23,0.25,0.02,7.57,0,CHEMBL4223401,Inhibition of VEGFR2 (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 30 mins by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219211,1,Scientific Literature,Bioorg Med Chem,2018,None,,,,508
CHEMBL4229181,,None,464.44,1,5.39,a3,CNC(=O)c1ccc(Sc2ccc(NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc2)nc1,IC50,'=',102,nM,6.99,,,UO_0000065,15.05,0.3,1.6,8.41,0,CHEMBL4223401,Inhibition of VEGFR2 (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 30 mins by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219211,1,Scientific Literature,Bioorg Med Chem,2018,None,,,,102
CHEMBL4226090,,None,480.51,1,5.56,b6,CNC(=O)c1ccc(Sc2ccc(NC(=S)Nc3ccc(F)c(C(F)(F)F)c3)cc2)nc1,IC50,'=',74,nM,7.13,,,UO_0000065,14.84,0.3,1.57,10.8,0,CHEMBL4223401,Inhibition of VEGFR2 (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 30 mins by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219211,1,Scientific Literature,Bioorg Med Chem,2018,None,,,,74
CHEMBL4225828,,None,496.97,1,6.07,c4,CNC(=O)c1ccc(Sc2cccc(NC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)nc1,IC50,'=',63,nM,7.2,,,UO_0000065,14.49,0.31,1.13,10.9,0,CHEMBL4223401,Inhibition of VEGFR2 (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 30 mins by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219211,1,Scientific Literature,Bioorg Med Chem,2018,None,,,,63
CHEMBL4072383,,None,385.47,0,4.22,10,COc1ccc2c(c1)CCCN2c1nc(N)nc2c(Cc3ccccc3)c[nH]c12,IC50,'=',84.3,nM,7.07,,,UO_0000065,18.35,0.33,2.85,8.84,0,CHEMBL3998243,Inhibition of VEGFR-2 in human U251 cells assessed as reduction in VEGF induced phosphorylation preincubated for 60 mins followed by VEGF addition measured after 10 mins by ELISA method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3997769,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,84.3
CHEMBL96149,,None,302.34,0,3.47,51,COc1ccc(-c2cnn3cc(-c4ccncc4)cnc23)cc1,IC50,'=',37,nM,7.43,,,UO_0000065,24.58,0.44,3.96,14.21,0,CHEMBL3995183,Inhibition of recombinant human GST-fused KDR kinase expressed in insect Sf21 cells using poly-Glu/Tyr (4:1) peptide as substrate,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994587,1,Scientific Literature,Eur J Med Chem,2017,None,,,,37
CHEMBL324335,,None,406.51,0,3.84,54,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cs1,IC50,'=',4,nM,8.4,,,UO_0000065,20.66,0.4,4.56,16.18,1,CHEMBL3995183,Inhibition of recombinant human GST-fused KDR kinase expressed in insect Sf21 cells using poly-Glu/Tyr (4:1) peptide as substrate,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994587,1,Scientific Literature,Eur J Med Chem,2017,None,,,,4
CHEMBL4104466,,None,440.36,1,5.99,18f,Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Cl)cc4Cl)cc3)cc2n1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3993539,Inhibition of VEGFR2 (unknown origin) after 60 mins by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992524,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1000
CHEMBL3909619,,None,456.52,0,3.84,Table 2-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4790511,,None,428.49,1,5.21,14e,CCc1ccc(C(=O)Nc2ccc(Nc3ncnc4cc(OC)c(OC)cc34)cc2)cc1,IC50,'=',380,nM,6.42,,,UO_0000065,14.98,0.27,1.21,7.52,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,0.38
CHEMBL399605,,None,348.45,0,4.07,23,CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,Ki,'=',140,nM,6.85,,,UO_0000065,19.67,0.36,2.78,11.46,0,CHEMBL897508,Displacement of [32P]ATP from human VEGFR2 after 45 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.14
CHEMBL3800408,,None,372.4,0,3.13,23,CNCCOc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3799867,,None,426.49,0,4.4,29,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCCCC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3797561,,None,476.53,0,2.64,39,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCS(=O)(=O)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3798349,,None,480.46,0,4.94,42,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCCC1C(F)(F)F,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3797991,,None,409.42,0,3.85,45,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCc1nccn1C,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3800155,,None,399.42,0,4.09,48,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCC1CCCO1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3261905,,None,415.92,1,5.92,19,CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3269391,Inhibition of human KDR kinase at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259681,1,Scientific Literature,J Med Chem,2014,None,,,,
CHEMBL4868909,,None,385.38,0,3.69,4a,COc1cccc(-c2cc(-c3c(O)c4ccccc4oc3=O)nc(N)c2C#N)c1,IC50,'=',42,nM,7.38,,,UO_0000065,19.14,0.35,3.69,6.03,0,CHEMBL4810014,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4808203,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,0.042
CHEMBL3775585,,None,366.2,0,4.4,39,COc1cc2ncnc(Nc3c(Cl)ccc(O)c3Cl)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3778241,Inhibition of KDR (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by Cell titre glo-based luminescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307634,,,,10000
CHEMBL3605102,,None,398.49,1,5.74,14b,Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1,IC50,'=',343,nM,6.46,,,UO_0000065,16.22,0.3,0.72,9.8,0,CHEMBL3607491,Inhibition of KDR (unknown origin) using poly (Glu-Tyr,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL187609,,None,586.6,2,6.08,22,CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,IC50,'=',6,nM,8.22,,,UO_0000065,14.02,0.27,2.14,6.55,0,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140275,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,6
CHEMBL4165199,,None,525.87,2,5.83,22g,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1nn(-c2ccc(Cl)c(C(F)(F)F)c2)ccc1=O,IC50,'=',2400,nM,5.62,,,UO_0000065,10.69,0.21,-0.21,5.52,0,CHEMBL4141527,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138148,1,Scientific Literature,Eur J Med Chem,2017,None,,,,2.4
CHEMBL185477,,None,343.39,0,4.24,4a,O=C(Nc1ccccc1)Nc1ccc(-c2cccc3c2CNC3=O)cc1,IC50,'=',1800,nM,5.75,,,UO_0000065,16.73,0.3,1.5,8.18,0,CHEMBL829417,Inhibition of Vascular endothelial growth factor receptor 2 (KDR),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137187,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,1.8
CHEMBL191336,,None,356.82,0,3.12,20,OCCCNc1cc(-c2ncnc(Nc3cccc(Cl)c3)n2)ccn1,IC50,'=',3500,nM,5.46,,,UO_0000065,15.29,0.3,2.34,5.69,0,CHEMBL828555,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145155,1,Scientific Literature,J Med Chem,2005,None,,,,3.5
CHEMBL189825,,None,339.37,0,3.22,11,OCCCNc1cncc(-c2cncc(Nc3cccc(F)c3)n2)c1,pIC50(calc),'=',6.7,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.7
CHEMBL187571,,None,355.83,0,3.73,19,OCCCNc1cncc(-c2cncc(Nc3ccccc3Cl)n2)c1,IC50,'=',1010,nM,6,,,UO_0000065,16.85,0.33,2.27,7.23,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,1.01
CHEMBL189947,,None,416.92,1,5.38,24,Clc1ccc(Nc2cncc(-c3cncc(NCCCc4ccncc4)c3)n2)cc1,pIC50(calc),'=',5.87,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,5.87
CHEMBL188087,,None,507.64,1,3.5,16,CCNC(=O)Nc1nc2cc(NCCCN3CCN(C)CC3)ncc2cc1-c1cc(OC)cc(OC)c1,IC50,'=',51,nM,7.29,,,UO_0000065,14.37,0.27,3.79,7.02,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.051
CHEMBL190162,,None,503.48,2,6.28,36,CCNC(=O)Nc1nc2cc(NCCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl,IC50,'=',130,nM,6.89,,,UO_0000065,13.68,0.28,0.61,8.38,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.13
CHEMBL3809754,,None,419.45,0,3.59,26,CC(C)(C)c1cc(NC(=O)n2ccc3ncc(Oc4ncnc5c4CNC5)cc32)no1,IC50,'=',55,nM,7.26,,,UO_0000065,17.31,0.32,3.67,6.05,0,CHEMBL3812628,Inhibition of Tel fused KDR (unknown origin) expressed in BaF3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808377,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,0.055
CHEMBL392306,,None,465.05,0,4.52,7e,CN1CCN(CCc2ccc(Nc3ncc(Cl)c(-c4ccc(C(C)(C)N)cc4)n3)cc2)CC1,IC50,'=',76,nM,7.12,,,UO_0000065,15.31,0.29,2.6,10.13,0,CHEMBL892704,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147841,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.076
CHEMBL249381,,None,367.39,0,1.73,14d,COC(=O)c1ccc2c(c1)c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,IC50,'=',73,nM,7.14,,,UO_0000065,19.43,0.37,5.41,7.25,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,73
CHEMBL249176,,None,334.36,0,1.82,14c,Cn1cc(/C=C2\C(=O)NN=C2c2cnns2)c2cc(C#N)ccc21,IC50,'=',174,nM,6.76,,,UO_0000065,20.22,0.38,4.94,7.04,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,174
CHEMBL400253,,None,383.43,0,2.27,8p,COc1ccc(OC)c2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C,IC50,'=',20,nM,7.7,,,UO_0000065,20.08,0.39,5.43,8.49,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,20
CHEMBL4174041,,None,491.66,1,5.13,12,CCc1ccc2nc(C(c3ccc(OC)c(OC)c3)n3cc(CCN4CCCCC4)nn3)sc2c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4135682,Inhibition of VEGF-induced VEGFR2 phosphorylation at Tyr1175 residues in HUVEC pretreated for 30 mins followed by VEGF stimulation for 20 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130527,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,
CHEMBL240456,,None,391.35,0,3.58,44,Cn1ncc(NCc2ccncc2)c1C(=O)Nc1cccc(OC(F)(F)F)c1,IC50,'=',2440,nM,5.61,,,UO_0000065,14.34,0.27,2.03,6.92,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,2.44
CHEMBL238737,,None,389.38,0,4.01,34,Cc1cc(NC(=O)c2c(NCc3ccncc3)ncn2C)ccc1C(F)(F)F,IC50,'=',510,nM,6.29,,,UO_0000065,16.16,0.31,2.28,8.76,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.51
CHEMBL238735,,None,409.8,0,4.35,27,Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',1260,nM,5.9,,,UO_0000065,14.4,0.29,1.55,8.21,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.26
CHEMBL392964,,None,432.4,0,4.07,39,Cn1ncc(NCCc2ccc3c(c2)OCO3)c1C(=O)Nc1ccc(C(F)(F)F)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL885900,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139078,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL429481,,None,402.28,0,3.02,14p,Cc1cc(Br)c2c(/C=C3\C(=O)NN=C3c3cnns3)cn(C)c2c1,Activity,,,,,,Not Active,,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,
CHEMBL375447,,None,450.42,1,5.91,43,Cc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)cc1Oc1ncccc1-c1ccncn1,IC50,'=',705,nM,6.15,,,UO_0000065,13.66,0.25,0.24,7.99,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,705
CHEMBL3593294,,None,529.67,2,5.54,9,CCN1CCN(c2cc(Nc3ncc(-c4ccc(NC(=O)OCc5ccccc5)cc4)s3)nc(C)n2)CC1,IC50,'=',120,nM,6.92,,,UO_0000065,13.07,0.25,1.38,7.25,0,CHEMBL3595190,Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3593229,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,0.12
CHEMBL4096031,,None,288.31,0,1.7,23c,CC(O)c1cc(-c2nn(C(C)C)c3ncnc(N)c23)no1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4029926,Inhibition of VEGFR2 (unknown origin) at 1 uM,A,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028821,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,,,,
CHEMBL176702,,None,359.43,0,2.75,1p,Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CNCCO)c1,IC50,'=',3600,nM,5.44,,,UO_0000065,15.15,0.28,2.69,6.12,0,CHEMBL700241,Tested in vitro for inhibition of KDR-receptor tyrosine kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,3.6
CHEMBL173550,,None,410.52,0,4.33,12a,CC(=O)N1CCN(Cc2ccc(-c3ccn4c(-c5ccccc5)cnc4c3)cc2)CC1,IC50,'=',300,nM,6.52,,,UO_0000065,,,,,0,CHEMBL845293,Intrinsic potency against VEGF stimulated KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146681,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,300
CHEMBL4101852,,None,522.57,1,4.82,3h,COc1cncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c1,IC50,'=',110.2,nM,6.96,,,UO_0000065,,,,,0,CHEMBL4002764,Inhibition of recombinant KDR (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4066819,,None,430.51,0,2.63,52h,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4029533,Inhibition of VEGFR2 (unknown origin) at <1 uM using biotinylated poly[Glu:Tyr] (4:1) as substrate pretreated for 5 mins followed by substrate addition measured after 10 mins by Alphascreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028808,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,
CHEMBL3809924,,None,527.63,1,4.24,26x,COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1,Inhibition,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,67
CHEMBL4162153,,None,468.29,0,4.69,9p,Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3cc(F)ccc3Br)n4C)ncnc21,Inhibition,'=',48.6,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,48.6
CHEMBL4177120,,None,437.26,0,4.8,16d,Cn1ncc2c(Oc3ccc4oc(Nc5ccc(Br)cc5)nc4c3)ncnc21,Inhibition,'=',18.9,%,,,,UO_0000187,,,,,0,CHEMBL4155773,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152295,1,Scientific Literature,Eur J Med Chem,2018,None,,,,18.9
CHEMBL3735648,,None,467.61,1,5.52,6,CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21,IC50,'=',104,nM,6.98,,,UO_0000065,14.93,0.27,1.46,10.1,0,CHEMBL3830416,Inhibition of N-terminal His6-tagged recombinant human KDR (790 residues) expressed in insect Sf21 cells using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4096971,,None,295.35,0,3.07,41,CCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,50000
CHEMBL4284823,,None,338.34,0,3.62,Yfq33,COc1cccc(Nc2cc(NC(=O)c3ccc(F)cc3)ncn2)c1,Inhibition,'=',20.8,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,20.8
CHEMBL4294871,,None,407.24,0,2.87,Yfq59,O=C(/C=C/c1ccc(F)cc1Br)Nc1cc(N2CCOCC2)ncn1,Inhibition,'=',5.7,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,5.7
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',43.1,%,,,,UO_0000187,,,,,0,CHEMBL4055527,Inhibition of VEGFR2 phosphorylation in human BT474 cells at 20 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,43.1
CHEMBL404253,,None,306.49,0,4.78,1,C/C1=C\[C@H](O)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1,Inhibition,'=',65.3,%,,,,UO_0000187,,,,,0,CHEMBL4055524,Inhibition of VEGFR2 phosphorylation in human MDA-MB-231 cells at 50 uM by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052660,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,65.3
CHEMBL101221,,None,344.37,0,4.83,1,CC(=O)Nc1oc(-c2cc3ccccc3cc2O)nc1-c1ccccc1,IC50,'=',16,nM,7.8,,,UO_0000065,22.64,0.41,2.97,10.34,0,CHEMBL819548,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136194,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,16
CHEMBL4471009,,None,399.44,0,2.29,34,COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)[C@@H](N)/C=C\C[C@H](C)OC2=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4337764,Inhibition of human VEGFR2 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,None,,,,10000
CHEMBL4533447,,None,398.41,0,2.54,15,COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,IC50,'=',54,nM,7.27,,,UO_0000065,18.24,0.34,4.73,6.42,0,CHEMBL4337764,Inhibition of human VEGFR2 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,None,,,,54
CHEMBL2012519,,None,364.39,0,1.52,L-783277,COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,IC50,'=',2.9,nM,8.54,,,UO_0000065,23.43,0.45,7.02,7.54,0,CHEMBL4337764,Inhibition of human VEGFR2 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,None,,,,2.9
CHEMBL206463,,None,342.81,0,3.21,18b,Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2cc(Cl)ccc21,IC50,'=',59,nM,7.23,,,UO_0000065,21.09,0.43,4.02,12.19,0,CHEMBL866859,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146951,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,59
CHEMBL372617,,None,485.93,1,6.45,7l,COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)cc1,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL828385,Inhibitory concentration against human vascular endothelial growth factor receptor 2; Not determined,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143549,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,
CHEMBL219557,,None,552.46,2,6.18,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL221193,,None,526.54,1,4.4,6j,CN(C)C1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)CC1,IC50,'=',170,nM,6.77,,,UO_0000065,12.86,0.24,2.37,7.75,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,170
CHEMBL374985,,None,483.47,0,4.86,6f,Nc1ncc(C#Cc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)cn1,IC50,'=',480,nM,6.32,,,UO_0000065,13.07,0.25,1.46,7.51,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,480
CHEMBL220482,,None,465.48,0,4.72,6e,Nc1ncc(C#Cc2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)cn1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,1000
CHEMBL473332,,None,389.19,0,4.99,1,O=c1cc2oc3cc(O)c(O)cc3c(-c3cccc(Cl)c3Cl)c-2cc1O,Inhibition,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL944263,Inhibition of KDR at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140897,1,Scientific Literature,J Med Chem,2009,None,,,,73
CHEMBL77933,,None,459.27,1,6.14,65,FC(F)(F)c1cc(Br)cc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1,ED50,'=',39,nM,7.41,,,UO_0000065,,,,,0,CHEMBL818396,Inhibition of VEGF-stimulated autophosphorylation of VEGF-receptor 2 (KDR) expressed in CHO cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,CHEMBL3308072,,,,39
CHEMBL270093,,None,485.54,1,5.46,23,COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)NCc3ccc(C)cc3)c2cc1OC,IC50,'=',26,nM,7.58,,,UO_0000065,15.62,0.29,2.13,9.23,0,CHEMBL950174,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144028,1,Scientific Literature,J Med Chem,2008,None,,,,26
CHEMBL3793594,,None,372.42,0,4.13,2,COc1cc2ncn(Cc3cccc(-c4ccccc4)c3)c(=O)c2cc1OC,Inhibition,'=',33,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4085010,,None,333.36,0,3.3,60,Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccn[nH]4)cc3)c12,IC50,'=',2391,nM,5.62,,,UO_0000065,16.86,0.31,2.32,5.05,0,CHEMBL4012620,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011618,1,Scientific Literature,J Med Chem,2017,None,,,,2391
CHEMBL4066412,,None,1788.97,None,None,3,CCN(CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C)CCOCCOCCNC(=O)c1cc(OCc2cn(CCCCN3C[C@@H]4C[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N4)nn2)cc(OCc2cn(CCCCN3C[C@@H]4C[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N4)nn2)c1,IC50,'=',420,nM,6.38,,,UO_0000065,3.56,None,None,None,0,CHEMBL4001115,Inhibition of recombinant human VEGFR2 expressed in Sf9 cells using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4000184,1,Scientific Literature,J Med Chem,2017,None,,,,420
CHEMBL4089159,,None,395.8,0,3.65,13,COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O,Inhibition,'=',2.5,%,,,,UO_0000187,,,,,0,CHEMBL4011872,Inhibition of KDR (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4011589,1,Scientific Literature,Eur J Med Chem,2017,None,,,,2.5
CHEMBL4061297,,None,339.79,0,3.66,6j,Nc1nc(NCc2ccc(Cl)cc2)c2c(n1)[nH]c1ccc(O)cc12,Ki,'=',3240,nM,5.49,,,UO_0000065,16.16,0.31,1.83,5.5,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4102074,,None,335.37,0,3.02,6m,COc1ccccc1CNc1nc(N)nc2[nH]c3ccc(O)cc3c12,Ki,'=',850,nM,6.07,,,UO_0000065,18.1,0.33,3.05,5.57,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4061797,,None,365.39,0,3.03,6q,COc1ccc(CNc2nc(N)nc3[nH]c4ccc(O)cc4c23)cc1OC,Ki,'=',11070,nM,4.96,,,UO_0000065,13.56,0.25,1.93,4.19,0,CHEMBL4021781,Inhibition of VEGFR2 (unknown origin) using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL255405,,None,412.49,0,4.15,6d,CCCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',3,nM,8.52,,,UO_0000065,20.66,0.38,4.37,12.37,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,3
CHEMBL260531,,None,445.48,0,3.66,30,COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(C(N)=O)cc34)ccc12,IC50,'=',22,nM,7.66,,,UO_0000065,17.19,0.32,4,6.79,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,22
CHEMBL409103,,None,416.48,1,5.34,16,CCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12,IC50,'=',1.3,nM,8.89,,,UO_0000065,21.34,0.39,3.55,12.75,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,1.3
CHEMBL270277,,None,483.96,1,7.05,81,COc1cc2nccc(Nc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC,IC50,'=',8,nM,8.1,,,UO_0000065,16.73,0.32,1.05,11.17,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,8
CHEMBL202714,,None,368.25,0,4.48,24,O=C(Nc1ccc(Cl)c(Cl)c1)c1scnc1CCc1cnoc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL861911,Inhibitory activity against VEGFR2 transiently transfected in 293 adenovirus transfected kidney cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148628,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL270755,,None,428.49,1,5.34,13,COc1cc2nccc(Oc3ccc4c(C(=O)NCC5CC5)cccc4c3)c2cc1OC,IC50,'=',11,nM,7.96,,,UO_0000065,18.57,0.34,2.62,11.42,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,11
CHEMBL406404,,None,505.55,1,4.88,57,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCN4CCOCC4)c4onc(N)c34)cc2)c1,IC50,'=',22,nM,7.66,,,UO_0000065,15.15,0.28,2.78,6.67,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,22
CHEMBL410663,,None,430.36,1,5.88,41,Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12,IC50,'=',94,nM,7.03,,,UO_0000065,16.33,0.31,1.15,7.54,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,94
CHEMBL410664,,None,376.39,1,5.17,40,Cc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1F,IC50,'=',40,nM,7.4,,,UO_0000065,19.65,0.36,2.23,7.94,0,CHEMBL949293,Inhibition of human KDR phosphorylation in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,40
CHEMBL3912757,,None,511.59,1,4.62,662,COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',5370.32,nM,5.27,,,UO_0000065,10.3,0.19,0.65,5.25,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.27
CHEMBL3895645,,None,505.4,1,4.75,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3945028,,None,508.76,1,3.7,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916828,,None,419.43,0,0.37,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957914,,None,443.55,1,5.38,208,COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3955563,,None,539.08,1,4.13,302,COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3928646,,None,499.62,1,5.49,305,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3902581,,None,476.54,0,2.37,312,CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL258014,,None,441.54,0,4.32,33,CCCn1c2ccc(/C(C)=N/OC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',1,nM,9,,,UO_0000065,20.38,0.37,4.68,12.25,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,1
CHEMBL255282,,None,413.48,0,3.44,31,CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL257793,,None,427.51,0,4.07,25,CO/N=C(/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4)C(C)C,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL401897,,None,469.59,0,4.95,43,CCn1c2ccc(/C(C)=N/OCC(C)C)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',3,nM,8.52,,,UO_0000065,18.15,0.33,3.57,11.61,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,3
CHEMBL3897714,,None,439.37,0,4.93,BDBM201209,O=C(Nc1ccc(C#Cc2ccc3nccn3n2)cc1)Nc1cc(C(F)(F)F)ccc1F,IC50,'=',448,nM,6.35,,357139,UO_0000065,14.45,0.27,1.42,8.9,0,CHEMBL3887844,PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1255011,,None,344.37,0,4.01,13a,Cn1ccc2ncnc(Oc3cccc(C(=O)Nc4ccccc4)c3)c21,IC50,'=',870,nM,6.06,,,UO_0000065,17.6,0.32,2.05,8.78,0,CHEMBL1250641,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250545,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,870
CHEMBL1254276,,None,457.41,1,5.43,20c,COc1cc(Oc2ncnc3ccn(C)c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1,IC50,'=',14,nM,7.85,,,UO_0000065,17.17,0.33,2.42,8.7,0,CHEMBL1250641,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250545,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,14
CHEMBL4204561,,None,577.69,2,5.3,14d,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCC(=O)Nc5ccccc5N)cc4)n3)cc2nn1C,Inhibition,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,94
CHEMBL380598,,None,288.31,0,2.74,12,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccccc1,Inhibition,'=',21,%,,,,UO_0000187,,,,,0,CHEMBL865272,Inhibition of human VEGFR2 expressed in Sf9 cells at 10 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,21
CHEMBL3265344,,None,339.87,0,4.46,29,CN(C)CCN(Cc1ccc(Cl)cc1)c1ccc2ccccc2n1,Inhibition,'=',14,%,,,,UO_0000187,,,,,0,CHEMBL3266379,Inhibition of KDR (unknown origin) at 1 uM by Z'-LYTE assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259731,1,Scientific Literature,Eur J Med Chem,2014,None,,,,14
CHEMBL3984316,,None,421.54,1,6.17,BDBM205989,CC(C)c1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccccc45)C3)c2)c1,IC50,'=',30,nM,7.52,,364624,UO_0000065,17.85,0.32,1.35,16.63,0,CHEMBL3887950,VEGRR2: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890120,,None,481.6,1,5.16,BDBM205993,CC(C)c1ccc(NC(=O)c2cccc(N3CCc4c(cnc5cc(CO)c(CO)cc45)C3)c2)cc1,IC50,'=',20,nM,7.7,,364627,UO_0000065,15.99,0.29,2.54,8.98,0,CHEMBL3887950,VEGRR2: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966912,,None,413.55,1,5.67,BDBM205994,CCc1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccsc45)C3)c2)c1,IC50,'=',12,nM,7.92,,364628,UO_0000065,19.15,0.36,2.25,17.51,0,CHEMBL3887950,VEGRR2: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985924,,None,421.46,0,2.84,BDBM214707,COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)cc(OC)c1OC,IC50,'>',100000,nM,,,377137,UO_0000065,,,,,0,CHEMBL3888173,VEGFR2 Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL149073,,None,354.36,0,2.84,16c,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)c(C)c1CCC(=O)O,IC50,'=',70,nM,7.16,,,UO_0000065,20.19,0.38,4.31,5.99,0,CHEMBL816967,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,0.07
CHEMBL60541,,None,373.39,0,1.13,15b,CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2,IC50,'=',6600,nM,5.18,,,UO_0000065,13.87,0.27,4.05,4.41,0,CHEMBL676766,Inhibitory activity was tested against FLK kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136528,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,6.6
CHEMBL53753,,None,330.19,0,3.57,PD-158780,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,Residual Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218932,,None,340.59,0,4.85,PKR_Inhibitor_Negative_Control,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,Residual Activity,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL478980,,None,283.33,0,2.46,DNA_PK_Inhibitor_V,O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,Residual Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218939,,None,361.47,0,3.93,MEK_Inhibitor_I,N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,Residual Activity,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218941,,None,398.22,0,3.51,Indirubin_6bromo_aceto,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,Residual Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL387187,,None,413.4,1,5.33,EGFR_Inhibitor,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,Residual Activity,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL53753,,None,330.19,0,3.57,PD-158780,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,Residual Activity,'=',40,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL174426,,None,354.21,0,4.02,BPIQ_I,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,Residual Activity,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648097,,None,385.29,0,3.81,BDBM100908,CCOc1nc(Nc2ccc(S(=N)(=O)CC)cc2)ncc1Br,IC50,'=',89,nM,7.05,,218177,UO_0000065,18.3,0.44,3.24,8.02,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4785657,,None,416.51,1,5.33,12v,O=C(Nc1ccccc1)Nc1nc(NC2CC2)cc(Sc2c[nH]c3ccccc23)n1,IC50,'=',5220,nM,5.28,,,UO_0000065,12.68,0.24,-0.05,5.58,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,5.22
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',1210,nM,5.92,,,UO_0000065,12.73,0.25,0.37,6.41,0,CHEMBL4770312,Inhibition of human N-terminal GST tagged VEGFR2 expressed in Sf9 insect cells using Poly- (Glu4:Tyr)-biotin substrate incubated for 45 mins by Kinase Glo Plus Luminescence kinase assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765329,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 0.75 hr,INHIBITOR,,1.21
CHEMBL293068,,None,324.29,0,1.92,15f,O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1[nH]cc2c1CCOC2=O,IC50,'=',6200,nM,5.21,,,UO_0000065,16.06,0.3,3.29,4.8,0,CHEMBL676766,Inhibitory activity was tested against FLK kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136528,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,6.2
CHEMBL4786010,,None,345.4,0,4.51,15b,O=C(Cc1ccccc1)Nc1ccc(NC(=O)Nc2ccccc2)cc1,Inhibition,,,%,,,Dose-dependent effect,UO_0000187,,,,,0,CHEMBL4772150,Inhibition of VEGFR2 in human HT-29 cells assessed as reduction in VEGFR2 phosphorylation incubated for 48 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HT-29,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765379,1,Scientific Literature,Eur J Med Chem,2020,None,Dose_Lower = 1.0 microM | Dose_Upper = 10.0 microM | TIME = 48.0 hr,INHIBITOR,,
CHEMBL149201,,None,386.45,0,4.81,16f,Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O,IC50,'=',10000,nM,5,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,10
CHEMBL190473,,None,415.93,1,5.98,59,Clc1cccc(Nc2cncc(-c3cncc(NCCCc4ccccc4)c3)n2)c1,IC50,'=',2290.87,nM,5.64,,,UO_0000065,13.56,0.26,-0.34,8.99,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,5.64
CHEMBL190473,,None,415.93,1,5.98,59,Clc1cccc(Nc2cncc(-c3cncc(NCCCc4ccccc4)c3)n2)c1,pIC50(calc),'=',5.76,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,5.76
CHEMBL191251,,None,297.75,0,3.52,37,Nc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,pIC50(calc),'=',6.02,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.02
CHEMBL365140,,None,454.53,0,3.42,105,COc1cc(OC)cc(-c2cc3cnc(NCCCO)nc3nc2NC(=O)NC(C)(C)C)c1,IC50,'=',71,nM,7.15,,,UO_0000065,15.73,0.3,3.73,5.48,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.071
CHEMBL190473,,None,415.93,1,5.98,59,Clc1cccc(Nc2cncc(-c3cncc(NCCCc4ccccc4)c3)n2)c1,IC50,'=',2277,nM,5.64,,,UO_0000065,13.57,0.26,-0.34,9,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,2.277
CHEMBL365727,,None,481.6,0,4.81,77,COc1cc(OC)cc(-c2cc3cnc(NCCCCCO)cc3nc2NC(=O)NC(C)(C)C)c1,IC50,'=',6,nM,8.22,,,UO_0000065,17.07,0.32,3.41,6.99,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,0.006
CHEMBL1271480,,None,417.47,0,2.46,5,O=c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)c[nH]1,IC50,'=',100,nM,7,,,UO_0000065,16.77,0.31,4.54,8.26,0,CHEMBL1272383,Inhibition of KDR by Hot Spot filtration binding assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1268961,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.1
CHEMBL189825,,None,339.37,0,3.22,11,OCCCNc1cncc(-c2cncc(Nc3cccc(F)c3)n2)c1,IC50,'=',169.82,nM,6.77,,,UO_0000065,19.95,0.37,3.55,8.16,0,CHEMBL831656,Inhibitory concentration (experimental) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.77
CHEMBL189998,,None,423.95,0,3.64,50,Clc1cccc(Nc2cncc(-c3cncc(NCCCN4CCNCC4)c3)n2)c1,pIC50(calc),'=',6.9,,,,,,,,,,0,CHEMBL831655,Inhibitory concentration (calculated) against vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,6.9
CHEMBL3577123,,None,410.5,0,4.74,12,CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)cnc2n1,IC50,'=',1900,nM,5.72,,,UO_0000065,13.94,0.26,0.98,6.23,0,CHEMBL3578340,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576847,1,Scientific Literature,J Med Chem,2015,None,,,,1.9
CHEMBL185716,,None,575.55,2,5.44,20,CN(c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1)c1ccnc(Nc2ccc(S(N)(=O)=O)cc2)n1,IC50,'=',1,nM,9,,,UO_0000065,15.64,0.31,3.56,6.32,0,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140275,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,1
CHEMBL3908272,,None,378.42,0,2.96,5e,O=S(=O)(Nc1ncccn1)c1ccc(Nc2nncc3ccccc23)cc1,IC50,'=',8.5,nM,8.07,,,UO_0000065,21.33,0.41,5.11,7.35,0,CHEMBL3870505,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3612226,,None,402.5,1,5.96,3c,N#Cc1ccc(NC(=O)Nc2ccccc2Sc2ccnc3ccsc23)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,100000
CHEMBL3612228,,None,407.52,1,6.1,4b,COc1ccc(NC(=O)Nc2cccc(Sc3ccnc4ccsc34)c2)cc1,IC50,'=',107,nM,6.97,,,UO_0000065,17.1,0.34,0.87,11.02,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,107
CHEMBL3934260,,None,497.04,0,4.57,570,COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3919884,,None,460.54,0,3.17,697,COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3896249,,None,615.78,2,6.22,650,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1,IC50,'=',3801.89,nM,5.42,,,UO_0000065,8.8,0.16,-0.8,5.07,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.42
CHEMBL3941227,,None,484.56,0,2.91,758,COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3981418,,None,472.01,0,4.17,432,Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3891892,,None,514.51,1,4.25,92,COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3979314,,None,465.51,0,2,387,COc1cc(OCCO)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3926245,,None,585.71,1,4.88,620,COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3966071,,None,460.58,0,4.49,727,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3942506,,None,529.04,0,3,803,COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl,IC50,'=',6918.31,nM,5.16,,,UO_0000065,10.48,0.2,2.16,4.27,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.16
CHEMBL3950169,,None,550.35,0,3.36,902,Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3952885,,None,512.62,1,4.9,903,COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3896720,,None,454.53,0,4.69,923,COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3908978,,None,421.45,1,5.18,209,Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3965364,,None,413.53,1,5.37,22,CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3972564,,None,419.92,1,5.24,237,COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3906284,,None,431.56,0,3.57,775,[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3931421,,None,458.57,0,4.66,284,COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3979328,,None,515.45,2,5.49,729,COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl,IC50,'=',31.62,nM,7.5,,,UO_0000065,14.55,0.29,2.01,9.7,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.5
CHEMBL3975193,,None,477.53,0,4.03,731,COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',141.25,nM,6.85,,,UO_0000065,14.34,0.26,2.82,7.52,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.85
CHEMBL3900551,,None,542.94,1,5,734,COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl,IC50,'=',616.6,nM,6.21,,,UO_0000065,12.26,0.24,1.21,9.12,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.21
CHEMBL3941337,,None,505.58,2,5.25,741,COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3917908,,None,566.15,1,4.91,744,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl,IC50,'=',64.57,nM,7.19,,,UO_0000065,13.57,0.25,2.28,8.92,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.19
CHEMBL3906284,,None,431.56,0,3.57,775,[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1,IC50,'=',36.31,nM,7.44,,,UO_0000065,17.74,0.33,3.87,8.7,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.44
CHEMBL3939332,,None,494.6,1,5.52,635,COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',177.83,nM,6.75,,,UO_0000065,13.65,0.25,1.23,8.63,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.75
CHEMBL3962549,,None,407.45,0,3.7,401,CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4677.35,nM,5.33,,,UO_0000065,13.08,0.24,1.63,6.99,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.33
CHEMBL3961923,,None,567.69,1,4.92,463,COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3955745,,None,395.46,0,3.27,556,[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL4248525,,None,490.63,0,3.88,37,CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL4235377,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229506,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,,,,4000
CHEMBL4247298,,None,586.7,2,5.44,15i,Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL4231002,Binding affinity to wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229344,1,Scientific Literature,Eur J Med Chem,2018,None,,,,92
CHEMBL3752370,,None,375.31,0,4.08,6i,O=C(Nc1ccncc1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F,IC50,'=',22.16,nM,7.65,,,UO_0000065,20.39,0.39,3.57,8.6,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,22.16
CHEMBL4278922,,None,517.96,2,7.63,9c,O=C(Nc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,Ratio IC50,'=',2.1,,,,,,,,,,0,CHEMBL4252290,Potency index,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3752671,,None,448.53,0,3.93,16d,N#Cc1ccc(NC(=O)CN2CCN(c3nnc(-c4ccccc4)c4ccccc34)CC2)cc1,IC50,'=',4350,nM,5.36,,,UO_0000065,11.95,0.22,1.43,6.3,0,CHEMBL3756334,Inhibition of VGFR-2 (unknown origin) using poly-GluTyr (4:1) as substrate after 5 mins by Alpha Screen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,4.35
CHEMBL3942716,,None,467.55,0,3.23,828,COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',85.11,nM,7.07,,,UO_0000065,15.12,0.29,3.84,7.11,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.07
CHEMBL3923808,,None,472.55,0,3.81,307,COc1cc(OC)cc(N(CC(=O)N2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1905.46,nM,5.72,,,UO_0000065,12.1,0.22,1.91,6.68,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,5.72
CHEMBL3981706,,None,543.72,2,5.08,386,COc1cc(OC)cc(N(CCNC2CC(C)(C)NC(C)(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',676.08,nM,6.17,,,UO_0000065,11.35,0.21,1.09,6.9,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,6.17
CHEMBL3927947,,None,592.19,2,5.14,372,COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',36.31,nM,7.44,,,UO_0000065,13.39,0.25,2.3,10.36,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,7.44
CHEMBL3955685,,None,483.02,0,4.18,427,COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1698.24,nM,5.77,,,UO_0000065,12.92,0.24,1.59,7.46,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,5.77
CHEMBL3775903,,None,315.3,0,3.24,14,COc1cc2ncnc(Nc3cccc(O)c3F)c2cc1OC,IC50,'=',280,nM,6.55,,,UO_0000065,20.78,0.39,3.31,8.57,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,280
CHEMBL169473,,None,311.34,0,3.4,9,COc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1,IC50,'=',4800,nM,5.32,,,UO_0000065,17.08,0.32,1.92,8.12,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,4800
CHEMBL3774643,,None,322.32,0,2.97,18,COc1cc2ncnc(Nc3cccc(O)c3C#N)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,10000
CHEMBL3775879,,None,315.3,0,3.24,19,COc1cc2ncnc(Nc3ccc(F)c(O)c3)c2cc1OC,IC50,'=',72,nM,7.14,,,UO_0000065,22.65,0.42,3.9,9.34,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,72
CHEMBL3775190,,None,366.2,0,4.4,29,COc1cc2ncnc(Nc3cc(O)c(Cl)cc3Cl)c2cc1OC,IC50,'=',15,nM,7.82,,,UO_0000065,21.37,0.45,3.42,10.23,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,15
CHEMBL440727,,None,329.33,0,3.54,30,COc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC,IC50,'=',2.3,nM,8.64,,,UO_0000065,26.23,0.49,5.1,11.29,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,2.3
CHEMBL3775415,,None,345.79,0,4.06,31,COc1cc2ncnc(Nc3cc(O)c(C)cc3Cl)c2cc1OC,IC50,'=',17,nM,7.77,,,UO_0000065,22.47,0.44,3.71,10.16,0,CHEMBL3778238,Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL4106362,,,,17
CHEMBL3775981,,None,416.87,0,4.25,8c,O=C(Cn1c(=O)c(/C=C\c2ccncc2)nc2ccccc21)Nc1ccc(Cl)cc1,Inhibition,'=',44,%,,,,UO_0000187,,,,,0,CHEMBL3778335,Inhibition of human recombinant VEGFR-2 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774355,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,44
CHEMBL3977320,,None,530.42,1,4.79,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3977030,,None,516.45,2,6.54,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3893575,,None,516.45,2,6.19,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914599,,None,491.42,1,5.57,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909596,,None,487.35,1,5.08,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937598,,None,535.43,1,4.72,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932578,,None,473.36,0,4.4,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919493,,None,501.41,2,5.18,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896927,,None,428.92,0,4.05,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL396737,,None,366.47,1,5.25,7o,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccs4)cc3)c12,IC50,'=',30,nM,7.52,,,UO_0000065,20.53,0.41,2.27,9.4,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,30
CHEMBL3897256,,None,489.4,1,5.18,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949155,,None,432.88,0,3.88,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL196025,,None,354.41,0,4.45,9,Cc1cccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)c1,IC50,'=',1600,nM,5.8,,,UO_0000065,16.35,0.29,1.35,7.16,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,1.6
CHEMBL370193,,None,419.28,0,4.9,10,NC(=O)c1ccc(-c2nnc(Nc3cccc(Br)c3)c3ccccc23)cc1,IC50,'=',1200,nM,5.92,,,UO_0000065,14.12,0.3,1.02,7.32,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,1.2
CHEMBL194746,,None,374.83,0,4.79,11,NC(=O)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'=',1300,nM,5.89,,,UO_0000065,15.7,0.3,1.1,7.28,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,1.3
CHEMBL372910,,None,345.83,1,6,39,Cc1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL471901,,None,340.31,0,1.71,Syk_Inhibitor_II,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,Residual Activity,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL104264,,None,446.37,0,3.58,H89,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,Residual Activity,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL258721,,None,473.36,0,4.5,RGB-286147,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,Residual Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4516982,BI 1935,None,498.47,0,3.8,EUB0000542,CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O,% Control,'=',81,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507283,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,81
CHEMBL379896,,None,345.43,0,1.32,3l,COCCN1CCN(c2cc(Nc3ncc(C#N)s3)ncn2)CC1,IC50,'=',9,nM,8.05,,,UO_0000065,23.29,0.46,6.73,8.92,0,CHEMBL860566,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138163,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,9
CHEMBL381817,,None,287.35,0,1.09,3i,N#Cc1cnc(Nc2cc(N3CCC(N)C3)ncn2)s1,IC50,'=',16,nM,7.8,,,UO_0000065,27.13,0.53,6.71,7.51,0,CHEMBL860566,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138163,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,16
CHEMBL42,CLOZAPINE,4,326.83,0,3.72,clozapine,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1651913,OXYFEDRINE,2,313.4,0,2.98,oxyfedrine,COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2106889,PIROXICAM CINNAMATE,-1,461.5,0,3.28,cinnoxicam,CN1C(C(=O)Nc2ccccn2)=C(OC(=O)/C=C/c2ccccc2)c2ccccc2S1(=O)=O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL399042,,None,420.43,0,4.5,10a,COC(=O)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12,IC50,'=',100000,nM,4,,,UO_0000065,9.51,0.17,-0.5,3.65,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,100
CHEMBL1290246,,None,421.48,0,3.91,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1290136,,None,399.86,0,4.44,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2430252,,None,476.6,0,4.75,43,Cc1[nH]c2c(c1C(=O)N1CCC(N3CCCCC3)CC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21,IC50,'=',8,nM,8.1,,,UO_0000065,16.99,0.32,3.35,11.83,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,8
CHEMBL2430260,,None,422.5,0,3.49,34,Cc1[nH]c2c(c1C(=O)NCCN1CCCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21,IC50,'=',9.7,nM,8.01,,,UO_0000065,18.97,0.35,4.52,10.38,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,9.7
CHEMBL2430264,,None,440.98,0,4.25,23,CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(Cl)cc21,IC50,'=',2.6,nM,8.59,,,UO_0000065,19.47,0.38,4.34,11.12,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,2.6
CHEMBL2430263,,None,406.53,0,3.59,21,CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccccc21,IC50,'=',9.4,nM,8.03,,,UO_0000065,19.74,0.37,4.44,10.39,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,9.4
CHEMBL222225,,None,300.39,0,1.56,16,N#Cc1cnc(Nc2cc(CN3CCNCC3)ccn2)s1,IC50,'=',15,nM,7.82,,,UO_0000065,26.05,0.51,6.26,10.18,0,CHEMBL913856,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,None,,,,15
CHEMBL221468,,None,371.47,0,1.95,19,CN(C)C(=O)N1CCN(Cc2ccnc(Nc3ncc(C#N)s3)c2)CC1,IC50,'=',40,nM,7.4,,,UO_0000065,,,,,0,CHEMBL912804,Inhibition of VEGF-induced KDR autophosphorylation expressed in HEK293 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,40
CHEMBL374240,,None,301.28,0,2.45,11,CO/N=C/c1c(N)ncnc1Oc1ccc2[nH]ccc2c1F,IC50,'=',117,nM,6.93,,,UO_0000065,23.01,0.43,4.48,7.04,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.117
CHEMBL219998,,None,387.44,0,4.77,29b,COc1ccc(-c2ccc(NC(=O)Nc3cccc(C)c3)cc2)c2c(N)n[nH]c12,IC50,'=',26,nM,7.58,,,UO_0000065,19.58,0.36,2.82,7.22,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,26
CHEMBL202378,,None,390.4,0,3.39,17a,COc1cc2c3c(c4c5ccccc5n(C)c4c2c(OC)c1OC)C(=O)NC3=O,IC50,'=',640,nM,6.19,,,UO_0000065,15.87,0.29,2.8,7.86,0,CHEMBL865274,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,None,,,,640
CHEMBL201512,,None,328.32,0,1.61,11,COc1cc(C2=C(c3cc[nH]c3)C(=O)NC2=O)cc(OC)c1OC,Inhibition,'=',16,%,,,,UO_0000187,,,,,0,CHEMBL865273,Inhibition of human VEGFR2 expressed in Sf9 cells at 100 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,16
CHEMBL381099,,None,309.32,0,2.27,9,COc1ccc(C2=C(c3ccc(OC)cc3)C(=O)NC2=O)cc1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL865272,Inhibition of human VEGFR2 expressed in Sf9 cells at 10 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,100
CHEMBL202378,,None,390.4,0,3.39,17a,COc1cc2c3c(c4c5ccccc5n(C)c4c2c(OC)c1OC)C(=O)NC3=O,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL865273,Inhibition of human VEGFR2 expressed in Sf9 cells at 100 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,0
CHEMBL372076,,None,279.3,0,2.26,7,COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1,Inhibition,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL865273,Inhibition of human VEGFR2 expressed in Sf9 cells at 100 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,101
CHEMBL3671516,,None,504.39,1,4.63,BDBM133727,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1SCCNC(C)=O,IC50,'=',785,nM,6.11,,266585,UO_0000065,12.1,0.27,1.48,6.36,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671519,,None,534.41,1,4.26,BDBM133730,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CSC,IC50,'=',635,nM,6.2,,266588,UO_0000065,11.6,0.26,1.94,5.89,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,Pazopanib,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL2438103,Inhibition of VEGFR2 (unknown origin) phosphorylation at 1 ug/mL by cell-based Western blotting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2434840,1,Scientific Literature,Eur J Med Chem,2013,None,,,,
CHEMBL3810135,,None,419.45,0,3.59,27,CC(C)(C)c1cc(NC(=O)n2ncc3cc(Oc4ncnc5c4CNC5)ccc32)no1,IC50,'=',4400,nM,5.36,,,UO_0000065,12.77,0.24,1.77,4.46,0,CHEMBL3812628,Inhibition of Tel fused KDR (unknown origin) expressed in BaF3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808377,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,4.4
CHEMBL3809754,,None,419.45,0,3.59,26,CC(C)(C)c1cc(NC(=O)n2ccc3ncc(Oc4ncnc5c4CNC5)cc32)no1,IC50,'=',450,nM,6.35,,,UO_0000065,15.13,0.28,2.76,5.29,0,CHEMBL3812627,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808377,1,Scientific Literature,ACS Med Chem Lett,2016,None,,,,0.45
CHEMBL3809254,,None,362.31,0,4.59,12,Nc1cc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)no1,IC50,'=',7100,nM,5.15,,,UO_0000065,14.21,0.27,0.56,5.53,0,CHEMBL3812631,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,None,,,,7.1
CHEMBL3808728,,None,409.45,0,4.62,20,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)C4CC4)on3)cc2)no1,IC50,'=',10000,nM,5,,,UO_0000065,12.21,0.23,0.38,4.09,0,CHEMBL3812632,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse Baf3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3671577,,None,555.41,1,3.77,BDBM133790,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CC=CC1,IC50,'=',486,nM,6.31,,266648,UO_0000065,11.37,0.24,2.54,5.82,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671578,,None,486.3,0,4.21,BDBM133791,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1=NCCO1,IC50,'=',478,nM,6.32,,266649,UO_0000065,13,0.28,2.11,6.47,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671581,,None,443.87,0,3.81,BDBM133794,C=CC(=O)Nc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCNC(C)=O,IC50,'=',114,nM,6.94,,266652,UO_0000065,15.64,0.31,3.13,6.6,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL256920,,None,483.62,1,6.01,6c,CSc1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1,IC50,'=',346,nM,6.46,,,UO_0000065,13.36,0.28,0.45,10.21,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,346
CHEMBL3797930,,None,541.99,2,6.05,13m,CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2F)ccn1,Inhibition,'=',2.7,%,,,,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,2.7
CHEMBL3797752,,None,586.46,2,5.94,13x,O=C(Nc1ccc(Oc2ccnc(-c3nncn3CCCN3CCOCC3)c2)c(F)c1)Nc1ccc(Cl)cc1Cl,Inhibition,,,%,,,Not Determined,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,
CHEMBL400569,,None,467.58,0,3.42,15c,CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)c3c2)c1,IC50,'=',25,nM,7.6,,,UO_0000065,16.26,0.3,4.18,7.48,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.025
CHEMBL245968,,None,499.59,0,4.74,20b,COCCOCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1,IC50,'=',270,nM,6.57,,,UO_0000065,13.15,0.25,1.83,7.69,0,CHEMBL906389,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139908,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.27
CHEMBL245769,,None,455.54,0,4.72,20a,COCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1,IC50,'=',53,nM,7.28,,,UO_0000065,15.97,0.3,2.56,9.54,0,CHEMBL906389,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139908,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.053
CHEMBL2018885,,None,482.9,1,6.18,101,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(F)c(Cl)c4)c(C)c3)c2cc1OC,IC50,'=',6,nM,8.22,,,UO_0000065,17.03,0.33,2.04,8.69,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.006
CHEMBL3961267,,None,484.99,0,2.77,288,CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3963728,,None,377.88,0,4.57,54,Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3954298,,None,476.54,0,2.78,313,CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3958756,,None,485.98,1,6.04,355,COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3932577,,None,448.53,0,2.77,79a,CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',1584.89,nM,5.8,,,UO_0000065,12.93,0.24,3.03,5.95,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.8
CHEMBL3955817,,None,432.48,0,4.04,80,COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4897.79,nM,5.31,,,UO_0000065,12.28,0.23,1.27,5.42,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.31
CHEMBL3945369,,None,458.57,0,4.19,29,CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3984039,,None,525.05,0,3.64,291,COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',223.87,nM,6.65,,,UO_0000065,13.61,0.25,3.01,7.49,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.65
CHEMBL3928627,,None,389.43,0,4.72,293,COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3931381,,None,458.57,0,4.28,61,CNCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'=',7079.46,nM,5.15,,,UO_0000065,11.23,0.21,0.87,6.66,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.15
CHEMBL3902581,,None,476.54,0,2.37,312,CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3897858,,None,423.45,0,2.76,315,COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'=',4570.88,nM,5.34,,,UO_0000065,12.61,0.24,2.58,5.53,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.34
CHEMBL3912569,,None,496.59,0,3.12,335,CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',812.83,nM,6.09,,,UO_0000065,12.26,0.24,2.97,5.46,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.09
CHEMBL3962554,,None,515.66,1,4.21,351,COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4168.69,nM,5.38,,,UO_0000065,10.43,0.19,1.17,7.5,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.38
CHEMBL3975447,,None,527.04,0,4.62,87,COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',407.38,nM,6.39,,,UO_0000065,13.03,0.24,1.77,9.32,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.39
CHEMBL3921243,,None,455.52,0,4.08,353,COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3928956,,None,485.98,1,6.04,358,COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3892155,,None,580.06,1,4.54,709,COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl,IC50,'=',38.02,nM,7.42,,,UO_0000065,13.65,0.26,2.88,7.18,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.42
CHEMBL3987162,,None,460.54,0,3.71,710,COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',407.38,nM,6.39,,,UO_0000065,13.88,0.26,2.68,6.77,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.39
CHEMBL3935838,,None,449.51,0,2.71,736,COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1,IC50,'=',165.96,nM,6.78,,,UO_0000065,15.08,0.28,4.07,6.41,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.78
CHEMBL3946938,,None,415.52,0,3.18,617,[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1,IC50,'=',77.62,nM,7.11,,,UO_0000065,17.54,0.32,3.93,8.31,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.11
CHEMBL3978349,,None,463.54,0,3.1,746,COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1,IC50,'=',181.97,nM,6.74,,,UO_0000065,14.54,0.27,3.64,6.37,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.74
CHEMBL3948306,,None,490.57,0,4.94,753,COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3984035,,None,498.59,0,3.3,754,COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',97.72,nM,7.01,,,UO_0000065,14.06,0.26,3.71,7.19,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.01
CHEMBL3932817,,None,511.07,0,4.8,623,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl,IC50,'=',245.47,nM,6.61,,,UO_0000065,13.93,0.26,1.81,8.55,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.61
CHEMBL3969747,,None,462.55,0,3.24,763,COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3965482,,None,514.03,0,4.24,657,COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl,IC50,'>=',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3969414,,None,501.51,2,5.15,781,COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1,IC50,'=',138.04,nM,6.86,,,UO_0000065,13.68,0.26,1.71,8.02,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.86
CHEMBL3927140,,None,506.57,1,4.64,795,COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1949.84,nM,5.71,,,UO_0000065,11.27,0.21,1.07,6.53,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,5.71
CHEMBL3939018,,None,483.57,0,4.71,659,C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1,IC50,'=',177.83,nM,6.75,,,UO_0000065,13.96,0.26,2.04,9.06,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.75
CHEMBL3915450,,None,509.57,1,4.7,799,COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',112.2,nM,6.95,,,UO_0000065,13.64,0.25,2.25,6.93,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.95
CHEMBL3950510,,None,516.52,1,3.92,661,COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1,IC50,'=',89.13,nM,7.05,,,UO_0000065,13.65,0.26,3.13,6.32,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.05
CHEMBL3912250,,None,510.6,2,5.22,811,COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',165.96,nM,6.78,,,UO_0000065,13.28,0.24,1.56,7.76,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.78
CHEMBL3957928,,None,494.53,0,4.77,814,COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3982570,,None,509.05,0,4.67,361,COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',6760.83,nM,5.17,,,UO_0000065,10.94,0.2,0.5,7.54,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.17
CHEMBL3922698,,None,510.62,1,3.04,363,COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1,IC50,'=',8511.38,nM,5.07,,,UO_0000065,9.93,0.19,2.03,4.04,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.07
CHEMBL3905485,,None,537.11,2,5.45,366,COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1122.02,nM,5.95,,,UO_0000065,11.88,0.22,0.5,8.68,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.95
CHEMBL3893718,,None,487.61,0,3.61,379,COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',7244.36,nM,5.14,,,UO_0000065,10.54,0.19,1.53,5.44,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.14
CHEMBL3898601,,None,487.68,None,None,385,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C[Si](C)(C)C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3956571,,None,409.88,0,3.82,392,COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4570.88,nM,5.34,,,UO_0000065,13.03,0.25,1.52,7,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.34
CHEMBL3969824,,None,487.44,0,4.83,414,COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1288.25,nM,5.89,,,UO_0000065,13.06,0.25,1.06,8.65,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.89
CHEMBL3893344,,None,432.53,0,3.89,449,CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'=',2344.23,nM,5.63,,,UO_0000065,13.02,0.24,1.74,7.28,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.63
CHEMBL3947361,,None,497.04,0,4.49,452,COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',398.11,nM,6.4,,,UO_0000065,13.9,0.26,1.91,8.28,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.4
CHEMBL3909551,,None,540.07,1,3.39,134,CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl,IC50,'=',4073.8,nM,5.39,,,UO_0000065,10.7,0.2,2,5.06,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.39
CHEMBL3899692,,None,544.53,1,3.62,454,COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1479.11,nM,5.83,,,UO_0000065,10.71,0.2,2.21,5.09,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.83
CHEMBL3921197,,None,570.72,2,4.52,457,COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1,IC50,'=',3467.37,nM,5.46,,,UO_0000065,9.57,0.18,0.94,5.84,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.46
CHEMBL3954671,,None,488.59,0,3.64,470,COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4168.69,nM,5.38,,,UO_0000065,11.01,0.2,1.74,6.06,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.38
CHEMBL3904441,,None,626.61,2,5.47,474,COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl,IC50,'=',2398.83,nM,5.62,,,UO_0000065,9.52,0.19,0.15,6.98,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.62
CHEMBL3959573,,None,468.99,0,4.02,483,CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl,IC50,'=',2089.3,nM,5.68,,,UO_0000065,13.13,0.24,1.66,6.22,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.68
CHEMBL3975714,,None,392.44,0,3.27,488,COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',7413.1,nM,5.13,,,UO_0000065,13.07,0.24,1.86,6.25,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.13
CHEMBL3933707,,None,550.69,1,3.69,489,COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',457.09,nM,6.34,,,UO_0000065,11.51,0.22,2.65,6.17,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.34
CHEMBL3944438,,None,420.45,0,2.66,500,CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',512.86,nM,6.29,,,UO_0000065,14.96,0.28,3.63,6.54,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.29
CHEMBL3930298,,None,445.52,0,4.22,508,COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4897.79,nM,5.31,,,UO_0000065,11.92,0.22,1.09,7.12,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.31
CHEMBL3903198,,None,488.55,0,4.03,514,COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1148.15,nM,5.94,,,UO_0000065,12.16,0.23,1.91,6.26,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.94
CHEMBL3979908,,None,389.43,0,4.5,538,C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',6606.93,nM,5.18,,,UO_0000065,13.3,0.24,0.68,9.24,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.18
CHEMBL3890187,,None,535.61,1,4.81,806,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3924891,,None,508.58,2,5.3,807,COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3906945,,None,479.54,0,4.69,819,COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',3388.44,nM,5.47,,,UO_0000065,11.41,0.21,0.78,6.01,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.47
CHEMBL3893344,,None,432.53,0,3.89,449,CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'=',63.1,nM,7.2,,,UO_0000065,16.65,0.31,3.31,9.31,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.2
CHEMBL3961400,,None,622.21,1,4.76,455,COc1cc(OC)cc(N(CCCN2CCC(N3C[C@@H](C)O[C@@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',61.66,nM,7.21,,,UO_0000065,12.31,0.23,2.45,8.9,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.21
CHEMBL3911621,,None,500.65,2,5.49,33,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1,IC50,'=',33.88,nM,7.47,,,UO_0000065,14.92,0.28,1.98,9.66,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.47
CHEMBL3901119,,None,488.59,0,3.95,604,COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',22.39,nM,7.65,,,UO_0000065,15.66,0.29,3.7,8.84,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.65
CHEMBL3898346,,None,418.5,0,3.53,608,COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',102.33,nM,6.99,,,UO_0000065,16.7,0.31,3.46,7.65,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.99
CHEMBL3922607,,None,418.5,0,3.53,611,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1,IC50,'=',269.15,nM,6.57,,,UO_0000065,15.7,0.29,3.04,7.19,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.57
CHEMBL3974693,,None,502.62,1,4.03,281,COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3923296,,None,472.59,0,4.72,286,COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3909318,,None,488.59,0,4.02,298,COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3966626,,None,441.92,0,3.18,405,COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3975986,,None,480.01,0,4.78,408,COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1000,nM,6,,,UO_0000065,13.53,0.25,1.22,9.19,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL396056,,None,503.41,2,6.34,17,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2[nH]1,IC50,'=',3.5,nM,8.46,,,UO_0000065,16.8,0.32,2.12,7.2,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,3.5
CHEMBL169757,,None,286.34,0,3.67,1a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3298400,,None,345.47,0,3.05,1,CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3300853,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,10
CHEMBL3909626,,None,509.35,2,5.36,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937857,,None,513.34,2,5.92,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3895848,,None,506.39,2,6.51,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983938,,None,477.39,1,5.18,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910064,,None,530.48,2,6.88,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952315,,None,477.39,1,5.18,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3953937,,None,432.88,0,3.88,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2325901,,None,244.3,0,1.97,3a,CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12,Inhibition,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL2329537,Inhibition of KDR (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,,,,84
CHEMBL4581517,,None,595.65,2,7.07,Roxyl-ZV-5I,Cc1cccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)c1,Inhibition,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,95
CHEMBL4452858,,None,568.59,2,5.85,Roxyl-ZV-14B,CC(C)n1nnc2ccc(-c3nc(Nc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4)ncc3F)cc21,Inhibition,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,84
CHEMBL183171,,None,341.8,0,4.67,21,O=C(Nc1ncnc2oc(-c3ccc(Cl)cc3)cc12)C1CCCC1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,20
CHEMBL182007,,None,321.38,0,4.33,22,Cc1ccc(-c2cc3c(NC(=O)C4CCCC4)ncnc3o2)cc1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL833502,Inhibition of Vascular endothelial growth factor receptor 2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137112,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,20
CHEMBL4441751,,None,487.28,0,4.45,127,O=C(N/N=C/c1c(Cl)cccc1Cl)Nc1ccc(Oc2ccnc(-n3cnnn3)c2)c(F)c1,Inhibition,'=',14,%,,,,UO_0000187,,,,,0,CHEMBL4310822,Inhibition of recombinant GST-tagged human KDR (789 to end residues) expressed in baculovirus infected Sf9 cells at 10 uM using peptide as substrate preincubated for 1 hr followed by substrate addition measured after 20 mins by HTRF assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4308877,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3308860,,,,14
CHEMBL364052,,None,356.81,0,3.78,36,OCCCNc1cncc(-c2cncc(Oc3cccc(Cl)c3)n2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,10
CHEMBL4449692,,None,361.41,0,3.79,4,COc1cc(Nc2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1,IC50,'=',560,nM,6.25,,,UO_0000065,17.3,0.32,2.46,8.44,0,CHEMBL4374885,Inhibition of human VEGFR2 (805 to 1171 residues) by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4373688,1,Scientific Literature,Medchemcomm,2019,None,,,,0.56
CHEMBL4448754,,None,533.57,1,4.18,25b,COc1cc(C(=O)NC2CCNCC2)ccc1Nc1nc(Nc2ccccc2P(C)(C)=O)c2cc[nH]c2n1,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL4314026,Inhibition of recombinant His-tagged human KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 0.5 uM using tyr 01 as substrate in presence of ATP at Km concentration after 1 hr by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4311976,1,Scientific Literature,Eur J Med Chem,2019,None,,,,1
CHEMBL2408731,,None,361.43,0,4.4,6n,Cc1nn(C)cc1-c1cnc(N)c2oc(-c3csc4cnccc34)cc12,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL2410657,Inhibition of KDR autophosphorylation overexpressed in VEGF-stimulated human HEK293 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407065,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3307715,,,,20
CHEMBL2408615,,None,464.53,0,4.89,13e,Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(CF)c(-c3cccc4nnsc34)oc12,IC50,'=',18300,nM,4.74,,,UO_0000065,10.2,0.2,-0.15,4.09,0,CHEMBL2410657,Inhibition of KDR autophosphorylation overexpressed in VEGF-stimulated human HEK293 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407065,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3307715,,,,18.3
CHEMBL2408613,,None,509.6,2,5.48,13c,Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(-c3cccnc3)c(-c3cccc4nnsc34)oc12,IC50,'=',8200,nM,5.09,,,UO_0000065,9.98,0.19,-0.39,3.95,0,CHEMBL2410657,Inhibition of KDR autophosphorylation overexpressed in VEGF-stimulated human HEK293 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407065,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3307715,,,,8.2
CHEMBL4216286,,None,429.48,0,3.7,10b,Cc1c2ccc(N(C)c3ccnc(Nc4cccc(/C=C/C(=O)NO)c4)n3)cc2nn1C,Inhibition,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,97
CHEMBL4217092,,None,516.61,1,3.98,13e,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCC(=O)NO)cc4)n3)cc2nn1C,Inhibition,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,98
CHEMBL4212674,,None,544.66,1,4.76,13g,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCCCC(=O)NO)cc4)n3)cc2nn1C,Inhibition,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,92
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,Pazopanib,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4195400,Inhibition of VEGF-stimulated VEGFR2 phosphorylation in human HUVEC cells at 100 nM preincubated for 2 hrs followed by VEGF stimulation by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,
CHEMBL4522385,,None,449.46,0,3.96,40,COc1cc(F)c(CC(=O)Nc2ccc(-n3c4c(c5ncnc(N)c53)CCC4)cc2)c(F)c1,IC50,'=',10,nM,8,,,UO_0000065,17.8,0.33,4.04,8.42,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,10
CHEMBL4439124,,None,452.44,0,4.09,35,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccnc(C(F)(F)F)c5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4438291,,None,435.89,0,4.47,42,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccc(Cl)cc5F)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4211837,,None,478.56,1,5.02,6e,Cc1c2ccc(N(C)c3ccnc(Nc4cccc(C(=O)Nc5ccccc5N)c4)n3)cc2nn1C,Inhibition,'=',63,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,63
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,T1/2,'<',0.08333,hr,,,,UO_0000032,,,,,0,CHEMBL1821213,Inhibition of human N-terminal His-tagged non-phosphorylated VEGFR2 assessed as dissociation half life after 60 mins by activity based 100 fold dilution assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,5
CHEMBL4463074,,None,616.07,2,7.42,Roxyl-ZV-5D,Cc1nc2c(F)cc(-c3nc(Nc4ccc(NC(=O)C5(C(=O)Nc6ccc(Cl)cc6)CC5)cc4)ncc3F)cc2n1C(C)C,Inhibition,'=',74,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,74
CHEMBL4445335,,None,595.65,2,7.07,Roxyl-ZV-5J,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1,Inhibition,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,95
CHEMBL254832,FENDILINE,2,315.46,1,5.56,fendiline,CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL4465698,,None,448.91,1,6.19,14,O=C(Nc1nc2ccc(Cl)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,'=',97,nM,7.01,,,UO_0000065,15.62,0.31,0.82,11.73,0,CHEMBL4363095,Inhibition of recombinant human N-terminal GST-tagged VEGFR2 (805 to 1356 residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1382,TOLTERODINE,4,325.5,1,5.34,tolterodine,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1988300,,None,383.48,1,5.17,SID103905092,Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1,Ki,'=',50.12,nM,7.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.3
CHEMBL1983963,,None,359.39,0,4.42,SID103904275,Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1,Ki,'=',5.012,nM,8.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.3
CHEMBL1985092,,None,377.83,1,5.55,SID103905577,Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL196363,,None,375.46,0,4.89,SID103904276,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1,Ki,'>',2.512,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.6
CHEMBL2000029,,None,380.46,0,4.43,SID103904485,Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1977346,,None,338.11,0,2.39,SID103905414,O=C1Nc2ccccc2Nc2nnc(I)cc21,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL2001998,,None,457.54,0,2.64,SID103904816,CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL1982753,,None,359.86,0,3.26,SID103904807,NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1975418,,None,315.38,0,3.75,SID103904512,c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1,Ki,'=',7943.28,nM,5.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1992073,,None,373.48,0,2.56,SID103904917,CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6
CHEMBL1968590,,None,380.5,0,4.22,SID103905091,CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12,Ki,'=',6.31,nM,8.2,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.2
CHEMBL3297892,,None,263.3,0,3.56,5,C#Cc1cccc(Nc2nc(C)nc3oc(C)cc23)c1,IC50,'=',76.3,nM,7.12,,,UO_0000065,27.03,0.49,3.56,13.97,0,CHEMBL3299341,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297731,1,Scientific Literature,Bioorg Med Chem,2014,CHEMBL3307756,,,,76.3
CHEMBL3093582,,None,538.54,1,4.72,3g,Cc1ccc(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c(F)c2)c(=O)n1-c1ccccc1,IC50,'=',1.4,nM,8.85,,,UO_0000065,16.44,0.3,4.13,7.4,0,CHEMBL3094546,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 60 mins followed by 1000 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.4
CHEMBL3298000,,None,319.79,0,3.62,21,COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1.Cl,IC50,'=',20.2,nM,7.7,,,UO_0000065,27.16,0.5,4.07,14.97,0,CHEMBL3299341,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297731,1,Scientific Literature,Bioorg Med Chem,2014,CHEMBL3307756,,,,20.2
CHEMBL4439053,,None,452.92,0,4.58,8g,O=C(Nc1cnn(-c2ccccc2)c1)c1cccc(NS(=O)(=O)c2ccc(Cl)cc2)c1,IC50,'=',2390,nM,5.62,,,UO_0000065,12.41,0.25,1.04,6.04,0,CHEMBL4387503,Inhibition of VEGFR2 (unknown origin) incubated for 30 mins by enzyme immunoassay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4385653,1,Scientific Literature,Bioorg Med Chem,2019,None,,,,2.39
CHEMBL4552065,,None,356.41,0,2.47,8a,Cn1cc(NC(=O)c2cccc(NS(=O)(=O)c3ccccc3)c2)cn1,IC50,'=',20410,nM,4.69,,,UO_0000065,13.16,0.26,2.22,5.04,0,CHEMBL4387503,Inhibition of VEGFR2 (unknown origin) incubated for 30 mins by enzyme immunoassay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4385653,1,Scientific Literature,Bioorg Med Chem,2019,None,,,,20.41
CHEMBL4443086,,None,581.67,1,4.81,22,CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1,Inhibition,'=',35.5,%,,,,UO_0000187,,,,,0,CHEMBL4370594,Inhibition of VEGFR2 (unknown origin) using Kemptide as substrate at 1 uM after 60 mins by ADP-Glo luminescence assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368924,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,,,,35.5
CHEMBL3288512,,None,396.43,1,5.36,4k,Nc1n[nH]c2cccc(-c3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)c12,IC50,'=',7.1,nM,8.15,,,UO_0000065,20.56,0.37,2.79,9.72,0,CHEMBL3295610,Inhibition of VEGFR-2 (unknown origin) expressed in baculovirus expression system using poly (4 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3261954,,None,444.53,0,4.62,6a,COc1ccc(-c2cc3ccc(OC)cc3c(=O)n2-c2ccc(OCCN(C)C)cc2)cc1,Inhibition,'=',66.07,%,,,,UO_0000187,,,,,0,CHEMBL3268857,Inhibition of VEGFR-2 (unknown origin) at 0.1 mg/ml after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259730,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,66.07
CHEMBL2324873,,None,345.47,0,4.54,C13,Cc1ccc(C2=NN(C(N)=S)C(c3ccc4ccccc4c3)C2)cc1,IC50,'=',2100,nM,5.68,,,UO_0000065,16.43,0.31,1.14,13.64,0,CHEMBL2327211,Inhibition of VEGFR-2 (unknown origin) using gastrin as substrate after 1 hr by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321654,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,2.1
CHEMBL2005824,,None,523.02,2,7.17,SID103904435,O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccccc3Cl)n2)c1)c1ccccc1,Ki,'=',794.33,nM,6.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.1
CHEMBL2004716,,None,542.71,2,5.97,SID103904320,CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12,Ki,'=',5.012,nM,8.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.3
CHEMBL3914525,,None,505.58,2,6.91,9e,COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4C)cc3)ncnc2cc1OCc1ccccc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3877876,Inhibition of N-terminal GST-tagged human VEGFR-2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3877259,1,Scientific Literature,Eur J Med Chem,2017,None,,,,10000
CHEMBL3969446,,None,484.6,0,4.98,60,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1,IC50,'=',5370.32,nM,5.27,,,UO_0000065,10.87,0.2,0.29,6.81,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.27
CHEMBL3948321,,None,512.66,2,5.4,72,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1,IC50,'=',5248.07,nM,5.28,,,UO_0000065,10.3,0.19,-0.12,7.7,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.28
CHEMBL3926311,,None,432.48,0,2.93,74,CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3898355,,None,405.46,0,3.56,26,COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'=',2290.87,nM,5.64,,,UO_0000065,13.91,0.26,2.08,5.85,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.64
CHEMBL3969815,,None,481,0,4.27,25,COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl,IC50,'=',1862.09,nM,5.73,,,UO_0000065,12.89,0.24,1.46,7.22,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.73
CHEMBL3912505,,None,539.68,1,4.9,273,COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',5128.61,nM,5.29,,,UO_0000065,9.8,0.18,0.39,6.64,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.29
CHEMBL3939278,,None,432.53,0,3.8,280,CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',4570.88,nM,5.34,,,UO_0000065,12.35,0.23,1.54,6.91,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.34
CHEMBL3945277,,None,497.04,0,4.57,699,COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',2691.53,nM,5.57,,,UO_0000065,12.09,0.22,1,7.2,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.57
CHEMBL3954368,,None,479.56,0,3.87,214,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1,IC50,'=',1819.7,nM,5.74,,,UO_0000065,11.97,0.23,1.87,5.77,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,5.74
CHEMBL4451586,,None,698.1,2,8.11,Roxyl-ZV-6K,Cc1nc2c(F)cc(-c3nc(Nc4ccc(CNC(=O)C5(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)cc4)ncc3F)cc2n1C(C)C,Inhibition,'=',57,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,57
CHEMBL4593249,,None,585.04,2,6.36,Roxyl-ZV-14C,CC(C)n1nnc2ccc(-c3nc(Nc4ccc(NC(=O)C5(C(=O)Nc6cccc(Cl)c6)CC5)cc4)ncc3F)cc21,Inhibition,'=',60,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,60
CHEMBL4445335,,None,595.65,2,7.07,Roxyl-ZV-5J,Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4407847,Inhibition of VEGFR2 in HUVEC cells assessed as reduction in Akt phosphorylation at 20 to 40 nM incubated for 48 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307501,,,,
CHEMBL4470783,,None,462.55,1,6.15,21,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1cc(C)cc(C)c1,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4384925,Inhibition of VEGFR2 phosphorylation in human A549 cells assessed as phosphorylated VEGFR2 level at 10 uM after 30 mins by Western blot assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,A549,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307651,,,,100
CHEMBL4548509,,None,448.52,1,5.84,15,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1cccc(C)c1,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4384926,Inhibition of VEGFR2 in human A549 cells assessed as reduction in ERK1/2 phosphorylation by measuring phosphorylated VEGFR2 level at 10 uM after 30 mins by Western blot assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,A549,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307651,,,,100
CHEMBL305194,,None,413.8,0,3.84,26f,Cc1cc(C(=O)O)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,IC50,'=',8920,nM,5.05,,,UO_0000065,12.2,0.24,1.21,4.21,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,8.92
CHEMBL69709,,None,397.84,0,4.47,26i,Cc1cc(C)c(/C=C2\C(=O)N(C)c3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1,IC50,'=',5820,nM,5.24,,,UO_0000065,13.16,0.26,0.77,7.08,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,5.82
CHEMBL305246,,None,495.95,0,3.53,26l,Cc1cc(C(=O)N2CCN(C)CC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL4203415,,None,474.53,0,2.81,13b,Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCC(=O)NO)cc4)n3)cc2nn1C,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL4195371,Inhibition of VEGFR-2 (unknown origin) at 0.2 uM after 40 mins by kinase-Glo assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190394,1,Scientific Literature,J Med Chem,2018,None,,,,99
CHEMBL1516,OLMESARTAN,3,446.51,0,3.66,olmesartan,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL61593,CYCLOTHIAZIDE,4,389.89,0,1.23,cyclothiazide,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1200908,HALOBETASOL PROPIONATE,4,484.97,0,4.05,ulobetasol propionate,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2107831,LUSUTROMBOPAG,4,591.56,2,8.52,lusutrombopag,CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3774580,,None,313.31,0,2.8,10,COc1cc2ncnc(Nc3cccc(O)c3O)c2cc1OC,IC50,'=',5700,nM,5.24,,,UO_0000065,16.74,0.31,2.44,5.42,0,CHEMBL3778241,Inhibition of KDR (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by Cell titre glo-based luminescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307634,,,,5700
CHEMBL3905501,,None,570.27,1,4.93,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3955359,,None,461.88,0,3.73,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3808758,,None,456.5,0,4.46,6r,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCC5)ccc3C)cnc2[nH]1,Inhibition,'=',33,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,33
CHEMBL3808466,,None,526.64,1,4.27,6x,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1,Inhibition,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,73
CHEMBL3808943,,None,594.64,2,5.59,8y,Cc1ccc(NC(=O)c2ccc(CN3CCC(N(C)C)C3)c(C(F)(F)F)c2)cc1CNc1cnc2[nH]c(C(=O)O)cc2c1,Inhibition,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,80
CHEMBL4290280,,None,488.27,0,4.69,Yfq51,COc1ccc(Nc2cc(NC(=O)/C=C/c3ccc(F)cc3Br)ncn2)c([N+](=O)[O-])c1,Inhibition,'=',11.3,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,11.3
CHEMBL4283201,,None,320.74,0,2.68,Yfq63,O=C(O)CCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1,Inhibition,'=',0.6,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,0.6
CHEMBL3809608,,None,424.51,0,4.99,22,CC(C)(C)C(=O)Nc1cc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)cc2)[nH]n1,IC50,'=',310,nM,6.51,,,UO_0000065,15.33,0.29,1.52,5.21,0,CHEMBL3812631,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,None,,,,0.31
CHEMBL4278031,,None,326.79,0,4.63,Yfq01,COc1cccc(Nc2cc(Nc3cccc(Cl)c3)ncn2)c1,Inhibition,'=',19.2,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,19.2
CHEMBL4284551,,None,435.32,0,4.43,Yfq90,CCCC(C)OC(=O)CCC(=O)Nc1cc(Nc2cccc(Br)c2)ncn1,Inhibition,'=',14.8,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,14.8
CHEMBL3942328,,None,475.55,0,2.74,504,CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3905048,,None,487.61,0,3.43,530,COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3911621,,None,500.65,2,5.49,33,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3953117,,None,469.55,0,4.43,557,COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3956579,,None,502.62,1,4.2,701,COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3933000,,None,633.7,1,4.48,509,COc1cc(OC)cc(N(CCCN2CCC[C@H]2CNS(=O)(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3943933,,None,515.66,1,4.26,515,COc1cc(OC)cc(N(CCCN2C[C@@H](C)N[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',6456.54,nM,5.19,,,UO_0000065,10.06,0.19,0.93,6.44,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.19
CHEMBL3931790,,None,515.62,1,3.38,519,COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3934487,,None,486.58,0,3.52,102,COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3969373,,None,432.53,0,3.92,365,COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3935825,,None,595.02,1,4.01,95,COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3898568,,None,469.55,0,4.02,458,COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3951847,,None,457.54,0,3.69,140,COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3895443,,None,500.53,1,4.73,718,COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3896142,,None,460.54,0,3.9,756,COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3978754,,None,543.53,1,4.31,827,COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1,IC50,'=',5011.87,nM,5.3,,,UO_0000065,9.75,0.18,0.99,5.28,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.3
CHEMBL4225781,,None,572.67,1,4.3,28,C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1,Inhibition,'=',7.5,%,,,,UO_0000187,,,,,0,CHEMBL4222217,Inhibition of recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219138,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,,,,7.5
CHEMBL2047246,,None,292.32,0,3.51,4,Nc1nc2c(c(Nc3cccc(F)c3)n1)-c1ccccc1C2,IC50,'=',55700,nM,4.25,,,UO_0000065,14.55,0.26,0.74,6.66,0,CHEMBL2050144,Inhibition of VEGFR2 in human U251 cells pretreated for 60 mins measured after 1 hr by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046359,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,55.7
CHEMBL4523063,,None,584.64,1,4.67,2e,COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1,Inhibition,'=',-3,%,,,,UO_0000187,,,,,0,CHEMBL4354259,Inhibition of KDR (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4351011,1,Scientific Literature,Eur J Med Chem,2019,None,,,,-3
CHEMBL3793896,,None,359.18,0,2.94,13,O=c1c2cc3c(cc2ncn1Cc1ccc(Br)cc1)OCO3,Inhibition,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3582439,,None,359.41,0,4.27,14,Fc1cccc([C@H]2CCCN2c2ccc3ncc(-c4ccccn4)n3n2)c1,IC50,'=',6500,nM,5.19,,,UO_0000065,14.43,0.26,0.92,11.2,0,CHEMBL3583132,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3580662,1,Scientific Literature,ACS Med Chem Lett,2015,CHEMBL3307634,,,,6.5
CHEMBL3781610,,None,411.51,1,5.43,20p,COc1cccc(Nc2cncc3ncc(-c4ccc(N5CCCCC5)cc4)nc23)c1,IC50,'=',8840,nM,5.05,,,UO_0000065,12.28,0.22,-0.38,8,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,8.84
CHEMBL3401908,,None,483.69,1,6.74,14,C[C@H]1[C@H](C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC/C(=N\O)[C@](C)(C(=O)O)[C@@H]5CC[C@]43C)[C@H]12,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL3405094,Inhibition of VEGFR-2 (unknown origin) at 50 uM after 1 hr by luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399926,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,4
CHEMBL147112,,None,402.45,0,4.51,11g,COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C,IC50,'=',1470,nM,5.83,,,UO_0000065,14.49,0.27,1.32,6.38,0,CHEMBL816967,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,1.47
CHEMBL3288854,,None,425.51,0,2.84,3b,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1,Ki,'=',3.8,nM,8.42,,,UO_0000065,19.79,0.37,5.58,10.46,0,CHEMBL3296758,Binding affinity to VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286339,1,Scientific Literature,Eur J Med Chem,2014,None,,,,0.0038
CHEMBL300767,,None,310.31,0,2.23,15a,COc1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL676766,Inhibitory activity was tested against FLK kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136528,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,20
CHEMBL3353344,,None,406.49,1,5.12,25,Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccccc45)ccc23)c(C)n1,IC50,'=',2100,nM,5.68,,,UO_0000065,13.97,0.25,0.56,8.03,0,CHEMBL3364612,Inhibition of KDR (unknown origin) by FRET-based homogeneous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351767,1,Scientific Literature,J Med Chem,2015,None,,,,2100
CHEMBL3353359,,None,489.62,0,4.86,38,CN1CCN(Cc2ccc(/C=C/c3n[nH]c4cc([C@@H]5C[C@@]56C(=O)Nc5ccccc56)ccc34)cc2)CC1,IC50,'=',120,nM,6.92,,,UO_0000065,14.14,0.26,2.06,10.77,0,CHEMBL3364612,Inhibition of KDR (unknown origin) by FRET-based homogeneous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351767,1,Scientific Literature,J Med Chem,2015,None,,,,120
CHEMBL3125888,,None,536.54,2,6.51,8A,N#Cc1c(Oc2cccc(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12,IC50,'=',150,nM,6.82,,,UO_0000065,12.72,0.25,0.31,6.55,0,CHEMBL3129557,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate pretreated for 5 mins before substrate addition measured after overnight incubation,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124815,1,Scientific Literature,J Med Chem,2013,None,,,,150
CHEMBL3125892,,None,541.59,2,6.4,3b,CC(C)(C#N)c1cccc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3[N+](=O)[O-])c2)c1,IC50,'=',70,nM,7.16,,,UO_0000065,13.21,0.25,0.75,4.86,0,CHEMBL3129557,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate pretreated for 5 mins before substrate addition measured after overnight incubation,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124815,1,Scientific Literature,J Med Chem,2013,None,,,,70
CHEMBL55496,,None,498.65,0,2.68,3n,CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2,IC50,'=',7100,nM,5.15,,,UO_0000065,10.33,0.2,2.47,4.5,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,7.1
CHEMBL55594,,None,455.58,0,3.01,4c,CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2,IC50,'=',100,nM,7,,,UO_0000065,15.37,0.3,3.99,7.65,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.1
CHEMBL44608,,None,381.36,1,5.09,2k,FC(F)(F)c1cccc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)c1,IC50,'=',10,nM,8,,,UO_0000065,20.98,0.39,2.91,14.38,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,10
CHEMBL25610,,None,432.88,0,3.89,21,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCOCC1,IC50,'=',40,nM,7.4,,,UO_0000065,17.09,0.34,3.51,10.76,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.04
CHEMBL460466,,None,526.57,2,6.1,48b,CCCn1c(C)c(C(=O)Nc2ccc(Oc3ccnc4cc(OC)ccc34)c(F)c2)c(=O)n1-c1ccccc1,Ki,'=',161,nM,6.79,,,UO_0000065,12.9,0.24,0.69,7.77,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,161
CHEMBL4577116,,None,536.3,2,5.74,6s,O=C(Nc1ccc(C(=O)N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',2730,nM,5.56,,,UO_0000065,10.37,0.21,-0.18,4.98,0,CHEMBL4330587,Inhibition of VEGFR-2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate after 5 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330065,1,Scientific Literature,Eur J Med Chem,2019,None,,,,2.73
CHEMBL4559188,,None,512.75,1,4.83,6i,O=C(Nc1ccc(Cl)cc1)Nc1ccc(C(=O)N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1,IC50,'=',3740,nM,5.43,,,UO_0000065,10.58,0.23,0.6,4.86,0,CHEMBL4330587,Inhibition of VEGFR-2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate after 5 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330065,1,Scientific Literature,Eur J Med Chem,2019,None,,,,3.74
CHEMBL2207940,,None,390.46,1,5.37,4j,O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-],Inhibition,'=',9.9,%,,,,UO_0000187,,,,,0,CHEMBL2215278,Inhibition of KDR at 100 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2203138,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,9.9
CHEMBL258844,,None,551.65,2,6.32,Akti_1_2,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,Residual Activity,'=',107,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL596674,,None,331.46,1,5.32,ZM-39923,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,Residual Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259551,,None,327.35,0,2.92,FR-180204,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,Residual Activity,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL50894,ALSTERPAULLONE,None,293.28,0,3.24,Alsterpaullone,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,Residual Activity,'=',52,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL296586,KENPAULLONE,None,327.18,0,4.09,Kenpaullone,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,Residual Activity,'=',74,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL311228,,None,346.82,0,2.63,52,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,Residual Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1802728,,None,422.53,0,4.54,NU6140,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,Residual Activity,'=',33,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL366266,,None,411.47,0,3.41,PKC_beta_inhibitor,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,Residual Activity,'=',22,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL47940,,None,370.46,1,5.59,Lck_Inhibitor,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,Residual Activity,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL59110,,None,298.27,0,2.36,15g,O=C1Nc2ccc(F)cc2/C1=C/c1[nH]cc2c1CCOC2=O,IC50,'=',10000,nM,5,,,UO_0000065,16.76,0.31,2.64,7.02,0,CHEMBL676766,Inhibitory activity was tested against FLK kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136528,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,10
CHEMBL512605,,None,371.4,0,4.13,11,O=C(c1ccccc1NCc1ccc2c(c1)OCO2)c1n[nH]c2ccccc12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL976314,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL278724,SB-202474,None,279.34,0,3.71,SB-202474,CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,Residual Activity,'=',118,%,,,,UO_0000187,,,,,0,CHEMBL2219237,Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL21156,,None,309.34,0,3.99,JAK_Inhibitor_I,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,Residual Activity,'=',24,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL266325,,None,346.39,0,4.59,D65476,CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,Residual Activity,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1398474,,None,344.89,1,5.71,Akt_Inhibitor_X,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,Residual Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL150151,,None,416.48,0,4.82,16i,COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1,IC50,'=',520,nM,6.28,,,UO_0000065,15.09,0.28,1.46,6.87,0,CHEMBL816967,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,0.52
CHEMBL1644616,,None,304.38,0,4.15,1,S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1,Inhibition,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL1646178,Inhibition of human KDR at 10 uM after 60 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1641539,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,105
CHEMBL237679,,None,366.81,0,4.17,16,O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1noc2ccccc12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL392935,,None,320.4,0,3.34,19,CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,IC50,'=',120,nM,6.92,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.12
CHEMBL234009,,None,352.39,0,2.79,34,COc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1OC,IC50,'=',90,nM,7.05,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.09
CHEMBL236205,,None,376.34,0,3.67,20,O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1,Ki,'=',90,nM,7.05,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.09
CHEMBL400253,,None,383.43,0,2.27,8p,COc1ccc(OC)c2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C,Inhibition,'=',51,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,51
CHEMBL45214,,None,314.35,0,3.47,4c,c1ccc(-c2nccn2-c2ccnc(Nc3ccncc3)n2)cc1,IC50,'=',273,nM,6.56,,,UO_0000065,20.88,0.37,3.09,9.58,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,273
CHEMBL467980,,None,384.44,0,4.36,10,CC(=O)Nc1ccc(CNc2ccccc2C(=O)c2n[nH]c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL976314,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL513169,,None,380.45,1,5.2,36,Cc1cccc2c(C(=O)c3ccccc3NCc3ccc4cn[nH]c4c3)c[nH]c12,IC50,'=',950,nM,6.02,,,UO_0000065,15.83,0.28,0.82,8.19,0,CHEMBL976314,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.95
CHEMBL2111784,,None,472.63,1,6.99,37,C[C@H](Nc1cc(-c2sc(C3CCN(C)CC3)nc2-c2ccc(F)cc2)ccn1)c1ccccc1,IC50,'=',1700,nM,5.77,,,UO_0000065,12.21,0.23,-1.22,14.05,0,CHEMBL818932,Inhibition of human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147483,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,1.7
CHEMBL2152940,,None,395.41,0,4.41,16a,O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2155702,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2150974,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL1683339,,None,427.45,1,6.13,6b,O=C(Nc1cccc(C(F)(F)F)c1)c1c[nH]c2cccc(SCc3ccncc3)c12,IC50,'=',309,nM,6.51,,,UO_0000065,15.23,0.3,0.38,11.27,0,CHEMBL1687577,Inhibition of KDR assessed as phosphorylation level of substrate by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681739,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,309
CHEMBL3644547,,None,358.45,0,4.6,BDBM139615,Cc1cccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)cc2)c1,IC50,'=',2200,nM,5.66,,273975,UO_0000065,15.78,0.29,1.06,9.88,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL117052,,None,372.43,0,3.26,12,NC1CCN(C(=O)c2ccc3[nH]c(-c4cc5ccccc5nc4O)cc3c2)C1,IC50,'=',5,nM,8.3,,,UO_0000065,22.29,0.4,5.04,8.72,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,5
CHEMBL47965,,None,279.35,0,3.33,5h,Cc1cc(C)cc(Nc2nccc(-n3ccnc3C)n2)c1,IC50,'=',765,nM,6.12,,,UO_0000065,21.89,0.4,2.79,10.99,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,765
CHEMBL316384,,None,398.51,0,4.95,4,c1ccc(-n2cnc3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc32)cc1,IC50,'=',37,nM,7.43,,,UO_0000065,18.65,0.34,2.48,17.21,0,CHEMBL818933,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144948,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,37
CHEMBL5276696,,None,597.66,2,3.53,68d,Cc1c(C(=O)Nc2ccc(Oc3ccnc(-c4nncn4CN4CCN(C)CC4)c3)c(F)c2)c(=O)n(-c2ccccc2)n1C,IC50,'=',190,nM,6.72,,,UO_0000065,11.25,0.21,3.19,5.83,0,CHEMBL5246168,Inhibition of human VEGFR2 (unknown origin) incubated for 1 hrs in presence of ATP by ELISA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5244255,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 1.0 hr,INHIBITOR,,0.19
CHEMBL276711,SEMAXANIB,3,238.29,0,3.12,3 (SU-5416),Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,ED50,'=',930,nM,6.03,,,UO_0000065,,,,,0,CHEMBL818396,Inhibition of VEGF-stimulated autophosphorylation of VEGF-receptor 2 (KDR) expressed in CHO cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,CHEMBL3308072,,,,930
CHEMBL431930,,None,359.41,0,4.83,5e,Cc1cc(C)cc(Nc2nccc(-n3ccnc3-c3cccc(F)c3)n2)c1,IC50,'=',45,nM,7.35,,,UO_0000065,20.44,0.37,2.52,13.21,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,45
CHEMBL233827,,None,378.31,0,2.46,51,O=C(Nc1ccc(OC(F)(F)F)cc1)c1nnnn1CCc1ccncc1,IC50,'=',2650,nM,5.58,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,2.65
CHEMBL233631,,None,398.47,0,4.35,27,O=C(Nc1ccc(OCc2ccccc2)cc1)c1ccnn1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL232802,,None,316.75,0,3.02,15,O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cnoc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL397323,,None,326.79,0,3.43,11,O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccncc1,IC50,'=',77,nM,7.11,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.077
CHEMBL233823,,None,394.78,0,4.45,32,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1,IC50,'=',180,nM,6.75,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.18
CHEMBL233821,,None,332.37,0,2.65,29,O=C(Nc1ccc2[nH]ncc2c1)c1ccnn1CCc1ccncc1,IC50,'=',5150,nM,5.29,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,5.15
CHEMBL201949,,None,249.27,0,2.25,8,O=C1NC(=O)C(c2ccccc2)=C1c1ccccc1,Inhibition,'=',81,%,,,,UO_0000187,,,,,0,CHEMBL865272,Inhibition of human VEGFR2 expressed in Sf9 cells at 10 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,81
CHEMBL5191854,,None,396.41,0,2.27,20,COCC(=O)NC(=O)Nc1ccc(Oc2ccnc(-c3cnn(C)c3)c2)c(C)n1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106444,Inhibition of VEGFR2 (unknown origin) measured by spectrophotometric analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104171,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL234201,,None,375.86,1,5.18,39,O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2n1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL236205,,None,376.34,0,3.67,20,O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1,IC50,'=',18,nM,7.75,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,0.018
CHEMBL250196,,None,343.8,0,2.6,14i,Cn1cc(/C=C2\C(=O)NN=C2c2cnns2)c2c(Cl)cccc21,Inhibition,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,26
CHEMBL250853,,None,402.28,0,3.02,8i,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(Br)c12,Inhibition,'=',51,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,51
CHEMBL88606,,None,343.22,0,4.15,4b,O=C1Nc2ccc(Br)cc2/C1=C/c1cc2c([nH]1)CCCC2,IC50,'=',70,nM,7.16,,,UO_0000065,20.85,0.47,3,15.94,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,0.07
CHEMBL331465,,None,400.48,0,3.77,4b,c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1,IC50,'=',9,nM,8.05,,,UO_0000065,20.09,0.37,4.28,15.51,0,CHEMBL818936,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135002,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,9
CHEMBL2448066,,None,483.37,0,4.6,17,COc1cc2c(Nc3cc(O)c(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl,IC50,'=',8,nM,8.1,,,UO_0000065,18.12,0.36,3.5,10.15,0,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.008
CHEMBL3690421,,None,426.4,0,4.45,BDBM128479,Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1,IC50,'=',420,nM,6.38,,259706,UO_0000065,14.95,0.28,1.93,7.57,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3642840,,None,490.57,0,4.91,BDBM106565,C=CC(=O)N1CCc2cc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)ccc2C1,IC50,'=',10000,nM,5,,225334,UO_0000065,10.19,0.18,0.09,4.99,0,CHEMBL3705145,Inhibition Assay (KDR): Compounds may be screened for their ability to inhibit KDR using a standard coupled enzyme assay (Fox et al.,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL203585,,None,329.39,0,1.22,3e,CC(=O)N1CCN(c2cc(Nc3ncc(C#N)s3)ncn2)CC1,IC50,'=',44,nM,7.36,,,UO_0000065,,,,,0,CHEMBL860567,Inhibition of human KDR expressed in HEK293 cells by KDR autophosphorylation assay,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138163,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,44
CHEMBL3262852,,None,557.42,2,5.3,11f,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cccc(Cl)c3Cl)cc2F)ccn1,Inhibition,'=',12.8,%,,,,UO_0000187,,,,,0,CHEMBL3271574,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 20 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259649,1,Scientific Literature,Eur J Med Chem,2014,None,,,,12.8
CHEMBL428534,,None,396.47,0,4.21,23,COc1cc2c(Nc3ccc(C)cc3F)ncnc2cc1OCC1CCNCC1,IC50,'=',30,nM,7.52,,,UO_0000065,18.97,0.35,3.31,11.01,0,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.03
CHEMBL352977,,None,468.94,0,4.88,9,COc1cc2c(Nc3c(Cl)ccc4occc34)ncnc2cc1OCCCN1CCOCC1,IC50,'=',1230,nM,5.91,,,UO_0000065,12.6,0.24,1.03,7.22,0,CHEMBL820673,In vitro inhibitory concentration against VEGF receptor 2.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148412,1,Scientific Literature,J Med Chem,2004,None,,,,1.23
CHEMBL3925081,,None,408.48,0,3.18,399,[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',83.18,nM,7.08,,,UO_0000065,17.46,0.32,3.9,8.28,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.08
CHEMBL3904777,,None,528.57,2,3.54,91,CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL151015,,None,386.38,0,3.12,33,COCC(=O)Nc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC,IC50,'=',300,nM,6.52,,,UO_0000065,16.88,0.32,3.4,6.18,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.3
CHEMBL5208297,,None,412.45,0,3.2,01-08-2007,NC(=O)/C=C/c1ccc(COc2ccc(-n3cc4cccc(C(N)=O)c4n3)cc2)cc1,IC50,'=',3.4,nM,8.47,,,UO_0000065,20.53,0.37,5.27,7.48,0,CHEMBL5116337,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113426,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,INHIBITOR,,3.4
CHEMBL151863,,None,468.6,1,5.87,37,CCCCOC(C)c1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',130,nM,6.89,,,UO_0000065,14.69,0.27,1.02,10.85,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,130
CHEMBL234011,,None,404.39,0,4.29,38,Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(OC(F)(F)F)cc2)c1C,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL234201,,None,375.86,1,5.18,39,O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2n1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL233824,,None,348.45,0,4.07,44,CC(C)(C)c1ccc(NC(=O)c2nccn2CCc2ccncc2)cc1,IC50,'=',940,nM,6.03,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.94
CHEMBL391104,,None,376.34,0,3.67,43,O=C(Nc1ccc(OC(F)(F)F)cc1)c1nccn1CCc1ccncc1,IC50,'=',790,nM,6.1,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.79
CHEMBL240429,,None,370.45,1,5.75,6,c1ccc(-c2oc3nccc(NC[C@@H]4CCCO4)c3c2-c2ccccc2)cc1,IC50,'=',4200,nM,5.38,,,UO_0000065,14.51,0.26,-0.37,11.37,0,CHEMBL903615,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139139,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,4.2
CHEMBL250838,,None,348.39,0,2.13,8f,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2ccc(C#N)cc12,IC50,'>',300,nM,,,,UO_0000065,,,,,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,300
CHEMBL398459,,None,367.39,0,1.73,14m,COC(=O)c1cccc2c1c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,IC50,'=',22,nM,7.66,,,UO_0000065,20.84,0.4,5.93,7.78,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,22
CHEMBL250196,,None,343.8,0,2.6,14i,Cn1cc(/C=C2\C(=O)NN=C2c2cnns2)c2c(Cl)cccc21,IC50,'=',16,nM,7.8,,,UO_0000065,22.68,0.46,5.2,10.8,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,16
CHEMBL249994,,None,327.34,0,2.09,14h,Cn1cc(/C=C2\C(=O)NN=C2c2cnns2)c2c(F)cccc21,IC50,'=',16,nM,7.8,,,UO_0000065,23.82,0.46,5.71,10.8,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,16
CHEMBL399119,,None,339.38,0,1.96,14e,COc1ccc2c(c1)c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,IC50,'=',28,nM,7.55,,,UO_0000065,22.25,0.43,5.59,9.28,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,28
CHEMBL250853,,None,402.28,0,3.02,8i,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(Br)c12,IC50,'=',34,nM,7.47,,,UO_0000065,18.57,0.42,4.45,10.35,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,34
CHEMBL250837,,None,353.41,0,2.26,8e,COc1ccc2c(c1)c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C,IC50,'=',90,nM,7.05,,,UO_0000065,19.94,0.38,4.79,8.66,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,90
CHEMBL399119,,None,339.38,0,1.96,14e,COc1ccc2c(c1)c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,Inhibition,'=',51,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,51
CHEMBL4471491,,None,595.38,2,3.54,10g,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,IC50,'=',67.84,nM,7.17,,,UO_0000065,12.04,0.24,3.63,4.26,0,CHEMBL4362207,Inhibition of N-terminal GST-tagged human VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4359867,1,Scientific Literature,Eur J Med Chem,2019,None,,,,67.84
CHEMBL250198,,None,339.38,0,1.96,14k,COc1cccc2c1c(/C=C1\C(=O)NN=C1c1cnns1)cn2C,Inhibition,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,76
CHEMBL297675,,None,343.39,0,4.08,2f,COc1cccc(Nc2nccc(-n3ccnc3-c3ccccc3)n2)c1,IC50,'=',20,nM,7.7,,,UO_0000065,22.42,0.4,3.62,11.87,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,20
CHEMBL74850,,None,347.81,1,5.06,38,Clc1ccc(Oc2nnc(Cc3ccncc3)c3ccccc23)cc1,IC50,'=',1600,nM,5.8,,,UO_0000065,16.66,0.32,0.74,12.1,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,1.6
CHEMBL75076,,None,350.85,0,4.74,53,Clc1ccc(Nc2nnc(Cc3ccncc3)c3c2CCCC3)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,10
CHEMBL2062289,,None,550.52,0,3.36,SB-698596-AC,CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,Inhibition,'=',4.46,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.46
CHEMBL1909408,GSK-200398A,None,616.15,1,4.38,GSK200398A,Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1,Inhibition,'=',8.91,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.91
CHEMBL4440813,,None,360.39,0,4.2,BD2,COc1ccc(-c2ccc(Cn3cc(-c4ccccc4F)nn3)cc2)cn1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4330408,Inhibition of VEGFR2 (unknown origin) after 1 hr by ADP-Glo reagent based luminescent assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330058,1,Scientific Literature,Eur J Med Chem,2019,None,,,,1000
CHEMBL405021,,None,277.33,0,3.58,SB-732941,O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1,Inhibition,'=',12.58,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,12.58
CHEMBL1993877,,None,226.28,0,2.11,SID103904990,C#Cc1cn(C2CCCC2)c2ncnc(N)c12,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.7
CHEMBL477979,GW785974X,None,350.46,0,3.94,GW785974X,Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',0.78,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,0.78
CHEMBL477069,GSK-1173862A,None,517.61,2,5.28,GSK1173862A,CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1,Inhibition,'=',16.55,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,16.55
CHEMBL1993374,,None,297.82,0,3.79,SID103904936,CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1970142,,None,525.64,2,5.67,SID103904293,CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1,Ki,'=',6.31,nM,8.2,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.2
CHEMBL1967302,,None,398.47,0,3.67,SID103904477,NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL260135,,None,287.33,0,3.27,SID103905492,Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12,Ki,'=',7943.28,nM,5.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1965507,,None,418.48,0,4.48,SID103904355,Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1,Ki,'>',3981.07,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.4
CHEMBL2002202,,None,243.69,0,3.25,SID103904568,O=C1NCc2ccc(-c3ccc(Cl)cc3)cc21,Ki,'=',79432.82,nM,4.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.1
CHEMBL1970290,,None,526.69,2,6.04,SID103904826,CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1,Ki,'=',1584.89,nM,5.8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.8
CHEMBL3927914,,None,325.4,0,2.95,7f,COc1ccc(NC(=S)NNc2nncc3ccccc23)cc1,IC50,'=',5.7,nM,8.24,,,UO_0000065,25.34,0.49,5.29,11.6,0,CHEMBL3870505,Inhibition of VEGFR-2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4467643,,None,498.45,1,5.18,13e,O=c1c2c(Nc3ccc(Oc4ccnc5[nH]c(O)nc45)c(F)c3)nccc2ccn1-c1ccc(F)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4366682,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain expressed in baculovirus expression system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4364278,1,Scientific Literature,Eur J Med Chem,2019,None,,,,
CHEMBL4553056,,None,583.34,2,5.78,13g,Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1I,IC50,'=',63.2,nM,7.2,,,UO_0000065,12.34,0.28,1.42,7.57,0,CHEMBL4366682,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain expressed in baculovirus expression system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4364278,1,Scientific Literature,Eur J Med Chem,2019,None,,,,63.2
CHEMBL221736,,None,260.3,0,3.68,3,O=c1[nH]c2ccccc2cc1-c1cc2ccccc2[nH]1,IC50,'=',8,nM,8.1,,,UO_0000065,31.11,0.55,4.42,16.64,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,8
CHEMBL4584893,,None,422.87,1,5.35,5i,COc1ccc(CC(=O)Nc2ccc3oc(-c4ccc(Cl)cc4)nc3c2)cc1OC,IC50,'=',386.4,nM,6.41,,,UO_0000065,15.17,0.29,1.06,8.71,0,CHEMBL4398894,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4581003,,None,385.86,0,3.35,T.3,COc1ccc(Cc2cn(CCNC(=O)Nc3ccc(Cl)cc3)nn2)cc1,Activity,'=',47,%,,,,UO_0000187,,,,,0,CHEMBL4347538,Binding affinity to human VEGFR2 at 100 uM incubated for 30 mins by ELISA relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4346668,1,Scientific Literature,Eur J Med Chem,2019,None,,,,47
CHEMBL3221547,,None,467.35,1,5.39,79,CCCOc1cc2ncnc(Nc3ccc(NC(=O)OCC)c(Cl)c3)c2cc1OC.Cl,IC50,'=',500,nM,6.3,,,UO_0000065,14.62,0.29,0.91,6.66,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,0.5
CHEMBL369014,,None,358.4,0,3.85,1i,CCOC(=O)c1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1,IC50,'=',1100,nM,5.96,,,UO_0000065,16.63,0.3,2.11,7.18,0,CHEMBL700241,Tested in vitro for inhibition of KDR-receptor tyrosine kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133080,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,1.1
CHEMBL1289601,LENVATINIB,4,426.86,0,4.07,Lenvatinib,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,IC50,'=',4,nM,8.4,,,UO_0000065,19.67,0.38,4.33,7.27,1,CHEMBL4307050,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4304778,1,Scientific Literature,Eur J Med Chem,2019,None,,,,4
CHEMBL4582226,,None,429.48,0,3.53,117,COc1ccc(CC(=O)Nc2ccc(-n3c4c(c5ncnc(N)c53)COC4)cc2)cc1C,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4591501,,None,469.42,0,4.11,165,Nc1ncnc2c3c(n(-c4ccc(CC(=O)Nc5ccc(OC(F)(F)F)cc5)cc4)c12)COC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4544668,,None,454.41,0,3.63,174,Nc1ncnc2c3c(n(-c4ccc(CC(=O)Nc5ccc(C(F)(F)F)cn5)cc4)c12)COC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL374453,GSK-299115A,None,415.28,0,4.39,GSK299115A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1,Inhibition,'=',3.14,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,3.14
CHEMBL65884,GW817396X,None,362.37,0,3.41,GW817396X,COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1,Inhibition,'=',8.15,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.15
CHEMBL188247,GW832467X,None,504.47,2,5.7,GW832467X,Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1,Inhibition,'=',2.81,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2.81
CHEMBL410072,GW301784X,None,445.5,0,0.85,GW301784X,CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',9.03,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9.03
CHEMBL317566,,None,302.34,0,3.47,3d,COc1cccc(-c2cnn3cc(-c4ccncc4)cnc23)c1,IC50,'=',510,nM,6.29,,,UO_0000065,20.81,0.37,2.82,12.03,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,510
CHEMBL206544,GW682841X,None,340.43,1,5.32,GW682841X,CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',9.43,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9.43
CHEMBL215993,GW284372X,None,393.45,1,6.21,GW284372X,c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,0.23
CHEMBL1909351,GW824645A,None,368.82,0,2.61,GW824645A,Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1,Inhibition,'=',15.35,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,15.35
CHEMBL1271533,,None,416.49,0,2.75,8,Nc1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1,IC50,'=',58,nM,7.24,,,UO_0000065,17.38,0.32,4.49,7.97,0,CHEMBL1272383,Inhibition of KDR by Hot Spot filtration binding assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1268961,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,0.058
CHEMBL477583,GW743024X,None,374.44,0,4.65,GW743024X,Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',62.01,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,62.01
CHEMBL352308,,None,501.63,2,6.04,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL486124,GW874091X,None,352.44,0,2.23,GW874091X,Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12,Inhibition,'=',5.25,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.25
CHEMBL3287319,,None,678.06,2,6.73,3q,CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(C(F)(F)F)c5)CC4)cc3F)n2)c1,IC50,'=',83.6,nM,7.08,,,UO_0000065,10.44,0.21,0.35,5.08,0,CHEMBL3291812,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL593245,,None,624.69,2,6.57,9,COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3OC(F)(F)F)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL593306,,None,570.72,2,5.68,16,COc1ccc2nc(-c3ccc(Nc4ncnc5cc(OCCCN6CCN(C)CC6)c(OC)cc45)cc3)sc2c1,IC50,'=',690,nM,6.16,,,UO_0000065,10.8,0.21,0.48,7.26,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.69
CHEMBL593293,,None,430.49,1,5.37,3,COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OC,IC50,'=',6900,nM,5.16,,,UO_0000065,11.99,0.23,-0.21,5.77,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,6.9
CHEMBL231623,GSK-620503A,None,307.33,0,3.24,GSK620503A,NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N,Inhibition,'=',6.66,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.66
CHEMBL941,IMATINIB,4,493.62,0,4.59,Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Activity,'=',57,%,,,,UO_0000187,,,,,0,CHEMBL1769232,Binding affinity to human Vegfr2 assessed as residual binding at 10 uM by site dependent competitive binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1764978,1,Scientific Literature,J Med Chem,2011,None,,,,57
CHEMBL1909392,GW580496A,None,643.99,2,6.11,GW580496A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl,Inhibition,'=',10.12,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,10.12
CHEMBL1794065,GSK-554170A,None,539.52,0,1.58,GSK554170A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,Inhibition,'=',71.24,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,71.24
CHEMBL4517719,,None,421.29,1,6.27,22m,O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4304962,Inhibition of wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system at 1 uM by Kinomescan method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4304739,1,Scientific Literature,J Med Chem,2019,None,,,,
CHEMBL607196,,None,380.45,0,4.53,6,O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1066110,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152632,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0
CHEMBL495771,GW708336X,None,337.39,0,1.6,GW708336X,c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1,Inhibition,'=',47.98,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,47.98
CHEMBL1794057,GW284408X,None,292.3,0,2.26,GW284408X,O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1,Inhibition,'=',13.74,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,13.74
CHEMBL3747669,,None,446.51,0,4.62,33r,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C(C)(C)C)on3)c2)CN1,IC50,'=',4,nM,8.4,,,UO_0000065,18.81,0.35,3.78,7.84,0,CHEMBL3749262,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse BaF3 cells using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL150581,,None,299.31,0,3.53,2,COc1cc2ncnc(Nc3ccccc3F)c2cc1OC,IC50,'=',2700,nM,5.57,,,UO_0000065,18.6,0.35,2.04,9.9,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,2.7
CHEMBL3781003,,None,375.86,1,5.63,4f,COc1ccc(Cc2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'=',3870,nM,5.41,,,UO_0000065,14.4,0.27,-0.22,11.51,0,CHEMBL3784202,Inhibition of recombinant human VEGFR-2 expressed in Spodoptera frugiperda cells after 5 mins by using biotinylated poly-GluTyr (4:1) as substrate by Alpha Screen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779892,1,Scientific Literature,Eur J Med Chem,2016,None,,,,3.87
CHEMBL4584949,,None,539.54,2,6.16,23a,Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21,IC50,'=',22910,nM,4.64,,,UO_0000065,8.6,0.16,-1.52,4.73,0,CHEMBL4376512,Inhibition of purified recombinant VEGFR2 kinase domain (unknown origin) using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4373740,1,Scientific Literature,Eur J Med Chem,2020,None,,,,22910
CHEMBL3740163,,None,531.59,1,4.99,24,CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)n2)c1,IC50,'=',3.8,nM,8.42,,,UO_0000065,15.84,0.3,3.43,6.86,0,CHEMBL3745584,Inhibition of human recombinant VEGFR-2 expressed in baculovirus using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3741592,,None,510.58,2,5.82,3g,CS(=O)(=O)c1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1,IC50,'=',1.6,nM,8.8,,,UO_0000065,17.23,0.32,2.98,7.98,0,CHEMBL3745584,Inhibition of human recombinant VEGFR-2 expressed in baculovirus using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4467107,,None,393.47,0,4.41,7c,COc1ccc(C(=O)CSc2nccc(Nc3ccc(C(C)=O)cc3)n2)cc1,IC50,'=',490,nM,6.31,,,UO_0000065,16.04,0.31,1.9,7.77,0,CHEMBL4399178,Inhibition of human N-terminal GST tagged VEGFR-2 expressed in baculovirus infected Sf9 cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4438418,,None,441.51,1,5.56,8g,O=C(O)c1ccc(Nc2ccnc(SCC(=O)c3ccc(-c4ccccc4)cc3)n2)cc1,IC50,'=',570,nM,6.24,,,UO_0000065,14.14,0.27,0.68,6.77,0,CHEMBL4399178,Inhibition of human N-terminal GST tagged VEGFR-2 expressed in baculovirus infected Sf9 cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',10,nM,8,,,UO_0000065,17.21,0.34,2.45,8.66,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.01
CHEMBL3759155,,None,497.6,1,5.5,15g,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCN1CCCCC1,IC50,'=',4720,nM,5.33,,,UO_0000065,10.7,0.2,-0.17,6.01,0,CHEMBL3760416,Inhibition of human VEGFR-2 preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758083,1,Scientific Literature,Eur J Med Chem,2016,None,,,,4.72
CHEMBL1668415,,None,413.31,0,4.18,4,COc1cc(O)c2c(c1)CCCCCC(=O)C[C@H](Br)C[C@H](C)OC2=O,IC50,'=',4300,nM,5.37,,,UO_0000065,12.98,0.29,1.19,7.37,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,4.3
CHEMBL1668418,,None,330.38,0,3.66,8,COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O,IC50,'=',1000,nM,6,,,UO_0000065,18.16,0.34,2.34,8.24,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,1
CHEMBL1668420,,None,330.38,0,3.66,10,COc1cc(O)c2c(c1)/C=C\CCCC(=O)/C=C/C[C@H](C)OC2=O,IC50,'=',2300,nM,5.64,,,UO_0000065,17.07,0.32,1.98,7.74,0,CHEMBL1670833,Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1667852,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3308860,,,,2.3
CHEMBL3678947,,None,521.47,2,5.41,BDBM173437,CC(C)n1c(Nc2cccc(Br)c2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,IC50,'=',140,nM,6.85,,318781,UO_0000065,13.14,0.28,1.44,9.24,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3759327,,None,447.29,0,3.81,6ea,COc1cc2ncnc(Nc3ccccc3Br)c2cc1OCCCC(=O)NO,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3762407,Inhibition of VEGFR2 (unknown origin) preincubated for 5 mins followed by addition of ATP/gastrin precursor(Tyr87) biotinylated peptide cocktail incubated for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758114,1,Scientific Literature,Eur J Med Chem,2016,None,,,,10000
CHEMBL574738,AST-487,1,529.57,2,5.11,AST-487,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,Kd,'=',200,nM,6.7,,,UO_0000065,12.65,0.24,1.59,7.08,1,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,200
CHEMBL4473213,,None,528.63,2,5.56,NPA101.3,CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4359486,Inhibition of recombinant human VEGFR2 expressed in HEK293 cells assessed as reduction in VEGFA-induced VEGFR2 autophosphorylation at 1 to 10 nM preincubated for 2 hrs followed by VEGFA-stimulation and measured after 15 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4354879,1,Scientific Literature,J Med Chem,2020,CHEMBL3307715,,,,
CHEMBL4554182,,None,468.94,1,6.19,5,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1ccccc1Cl,Activity,'=',36,%,,,,UO_0000187,,,,,0,CHEMBL4384924,Inhibition of VEGF165-induced VEGFR2 activation in HMEC1 cells assessed as reduction in ERK1/2 phosphorylation by measuring phosphorylated ERK1/2 level at 10 uM preincubated for 24 hrs followed by VEGF stimulation for 30 mins by Western blot assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,None,,,,36
CHEMBL43773,,None,580.69,1,4.81,5,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2o1,IC50,'>',50000,nM,,,,UO_0000065,,,,,1,CHEMBL816965,Inhibition of vascular endothelial growth factor receptor 2 activity with 1 mM ATP and biotinylated lck peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146742,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,50
CHEMBL357815,,None,414.83,0,3.85,30,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCn1ccnn1,IC50,'=',10,nM,8,,,UO_0000065,19.29,0.38,4.15,9.2,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.01
CHEMBL3798257,,None,426.31,1,5.13,9d,Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3802295,Inhibition of KDR (unknown origin) by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797088,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,1000
CHEMBL3787112,,None,349.44,0,3.04,2,Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,IC50,'=',440,nM,6.36,,,UO_0000065,18.19,0.33,3.32,7.93,0,CHEMBL3789996,Inhibition of KDR (unknown origin) in presence of [gamma33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3785066,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,0.44
CHEMBL3787112,,None,349.44,0,3.04,2,Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,IC50,'=',440,nM,6.36,,,UO_0000065,18.19,0.33,3.32,7.93,1,CHEMBL3789405,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3784924,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,0.44
CHEMBL71722,,None,369.43,0,4.93,23,CC(C)n1cc(-c2ccc(Oc3ccccc3C#N)cc2)c2c(N)ncnc21,IC50,'=',161,nM,6.79,,,UO_0000065,18.39,0.33,1.86,7.57,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.161
CHEMBL3758502,,None,347.38,0,3.25,1,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,Inhibition,'=',97.2,%,,,,UO_0000187,,,,,0,CHEMBL3762902,Inhibition of KDR (unknown origin) at 100 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758169,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,97.2
CHEMBL2377455,,None,523.61,2,6.35,3c,COc1cc(-c2nc3cc(-c4cn(Cc5ccccc5)c5ccccc45)sc3c(=O)[nH]2)cc(OC)c1OC,Inhibition,'=',52,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,52
CHEMBL2377488,,None,325.27,None,None,23,CC(C)(C)c1cc2nnnc(N3CCOCC3)c2[se]1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,
CHEMBL2377498,,None,270.31,0,3.69,11,CC(=O)c1cccc(Oc2ncnc3sccc23)c1,Inhibition,'=',21.9,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,21.9
CHEMBL3221265,,None,416.91,0,4.44,49,CCCC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C.Cl,IC50,'=',4300,nM,5.37,,,UO_0000065,14.11,0.26,0.93,6.29,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,4.3
CHEMBL1289925,,None,422.54,0,4.35,AG-028262,CNC(=O)c1csc2cc(Oc3ccnc4cc(C5=NCCN5C)sc34)ccc12,IC50,'=',0.34,nM,9.47,,,UO_0000065,22.41,0.45,5.12,14.17,0,CHEMBL1292980,Inhibition of recombinant VEGFR2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1287660,1,Scientific Literature,Eur J Med Chem,2010,None,,,,0.34
CHEMBL3219502,,None,411.7,None,None,6c,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,
CHEMBL3219512,,None,413.24,None,None,12b,COCCOc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OCCOC,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,99
CHEMBL3220329,,None,578.67,2,5.24,T13,COc1cc(-c2cc(NC(=O)Nc3cc(OCCN4CCOCC4)ccc3C)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3222612,Inhibition of VEGFR-2 (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,
CHEMBL3220328,,None,562.67,2,6,T12,COc1cc(-c2cc(NC(=O)Nc3cc(OCCN4CCCC4)ccc3C)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,'=',8.9,nM,8.05,,,UO_0000065,14.31,0.27,2.05,7.07,0,CHEMBL3222612,Inhibition of VEGFR-2 (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,8.9
CHEMBL4853870,,None,493.56,0,3.56,8d,COc1ccc(-c2csc(NC(=O)CN3CCN(c4cc(=O)[nH]c5ccc(F)cc45)CC3)n2)cc1,IC50,'=',51.09,nM,7.29,,,UO_0000065,14.77,0.28,3.73,8.05,0,CHEMBL4822643,Inhibition of VEGFR-2 (unknown origin) by using poly (Glu:Tyr 4:1) as substrate measured after 45 mins by Kinase-Glo max based microplate reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819122,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 0.75 hr,INHIBITOR,,51.09
CHEMBL1987813,,None,292.24,0,-0.74,4,O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL3813076,Inhibition of human VEGFR2 (787 to 1253 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808372,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,100
CHEMBL3633285,,None,577.6,2,5.91,6o,COc1ccc(C(=O)OCCN(C(C)C)C(C)C)cc1NC(=O)Nc1cc(-c2cnn(C)c2)ccc1OC(F)(F)F,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL3633284,,None,563.58,2,5.9,6n,COc1ccc(C(=O)OCCN(C(C)C)C(C)C)cc1NC(=O)Nc1cc(-c2cn[nH]c2)ccc1OC(F)(F)F,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL3633281,,None,596.65,2,7.78,6k,COc1ccc(C(=O)OCCN(C(C)C)C(C)C)cc1NC(=O)Nc1cc(-c2ccc3[nH]ccc3c2)cc(C(F)(F)F)c1,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL3616960,,None,501.51,1,4.57,6a,Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C,Inhibition,'=',8.27,%,,,,UO_0000187,,,,,0,CHEMBL3620005,Inhibition of VEGFR2 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3616395,1,Scientific Literature,Eur J Med Chem,2015,None,,,,8.27
CHEMBL3774951,,None,311.34,0,3.4,27,COc1cc2ncnc(Nc3cc(O)ccc3C)c2cc1OC,IC50,'=',1400,nM,5.85,,,UO_0000065,18.8,0.35,2.45,7.65,0,CHEMBL3778241,Inhibition of KDR (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by Cell titre glo-based luminescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774350,1,Scientific Literature,Eur J Med Chem,2016,CHEMBL3307634,,,,1400
CHEMBL3596868,,None,435.51,1,5.93,15,CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cncc(-c4ccsc4)n3)c2)no1,IC50,'>',2000,nM,,,,UO_0000065,,,,,0,CHEMBL3598606,Inhibition of KDR (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3596123,1,Scientific Literature,Medchemcomm,2014,None,,,,2
CHEMBL3629013,,None,392.51,0,3.59,11,N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1,Inhibition,'=',5.2,%,,,,UO_0000187,,,,,0,CHEMBL3631835,Inhibition of KDR (unknown origin) at 1 uM by FRET method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627690,1,Scientific Literature,J Med Chem,2015,None,,,,5.2
CHEMBL3628810,,None,475.76,1,6.54,14,O=C(Nc1cccc(Br)c1)Nc1ccc(Oc2ncnc3sccc23)cc1Cl,IC50,'=',9,nM,8.05,,,UO_0000065,16.91,0.39,1.51,10.57,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,9
CHEMBL3628792,,None,333.82,1,5.11,15,Fc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,10000
CHEMBL1688539,,None,273.7,0,4.17,1,Fc1ccc(Nc2ncnc3ccccc23)cc1Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3631056,Inhibition of human recombinant VEGFR-2 after 1 hr using [gamma-32P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627661,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,10000
CHEMBL3819033,,None,366.77,0,4.12,8b,O=[N+]([O-])c1ccc2c(cnn2-c2ccnc(Nc3ccc(Cl)cc3)n2)c1,Inhibition,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL3820578,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,8
CHEMBL3817989,,None,347.38,0,3.81,6g,CONc1ccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)cc1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL3820578,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,100
CHEMBL139877,SULFACARBAMIDE,4,215.23,0,-0.37,sulfacarbamide,NC(=O)NS(=O)(=O)c1ccc(N)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1201392,FLUMETHASONE,2,410.46,0,1.84,flumetasone,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL1262,OXICONAZOLE,4,429.13,1,6.12,oxiconazole,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3799035,,None,320.35,0,3.87,11,COc1cc2ncnc(Nc3ccc4cc[nH]c4c3)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL1201139,MEGESTROL ACETATE,4,384.52,0,4.58,megestrol acetate,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL94081,ALCLOFENAC,4,226.66,0,2.53,alclofenac,C=CCOc1ccc(CC(=O)O)cc1Cl,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL420762,MOZAVAPTAN,4,427.55,1,5.29,mozavaptan,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL444814,L-CITRULLINE,3,175.19,0,-1.15,citrulline,NC(=O)NCCC[C@H](N)C(=O)O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL3394469,,None,447.45,0,4.45,28a,Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12,Inhibition,'=',89.9,%,,,,UO_0000187,,,,,0,CHEMBL3396223,Inhibition of purified VEGFR2 (unknown origin) at 0.1 uM after 60 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392979,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,89.9
CHEMBL2325894,,None,338.37,0,0.94,3p,C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-6,%,,,,UO_0000187,,,,,0,CHEMBL2329185,Inhibition of KDR (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,,,,-6
CHEMBL3798442,,None,441.51,0,3.16,35,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN1CCN(C)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3819389,,None,606.04,3,5.9,10c,COc1cc(OC)c(NC(=O)Nc2ccc3c(cnn3-c3ccnc(Nc4cc(OC)c(OC)c(OC)c4)n3)c2)cc1Cl,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL3820578,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,100
CHEMBL3322566,,None,584.68,1,3.93,13,COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)cc1,IC50,'=',20.7,nM,7.68,,,UO_0000065,13.14,0.24,3.75,5.31,0,CHEMBL3362101,Inhibition of VEGFR2 (unknown origin) using poly[Glu:Tyr] substrate by radioisotope-based P81 filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351387,1,Scientific Literature,Eur J Med Chem,2014,None,,,,20.7
CHEMBL3792855,,None,376.21,0,2.62,1,COc1cc2ncn(Cc3cccnc3Br)c(=O)c2cc1OC,Inhibition,'=',24,%,,,,UO_0000187,,,,,0,CHEMBL3796153,Inhibition of human KDR using phosphatidylinositol 4,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3813717,,None,496.47,0,3.93,10,CNc1ncnc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)c1/C=N/OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3816037,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1429,DESMOPRESSIN,4,1069.24,None,None,desmopressin,N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2105300,REPIRINAST,2,355.39,0,3.45,repirinast,Cc1ccc2c([nH]c(=O)c3c(=O)cc(C(=O)OCCC(C)C)oc32)c1C,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL463,AMINOHIPPURIC ACID,4,194.19,0,0.08,aminohippuric acid,Nc1ccc(C(=O)NCC(=O)O)cc1,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL2403370,,None,408.46,0,2.33,6,COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCOCC1)C3)C(=O)N2,IC50,'=',5,nM,8.3,,,UO_0000065,20.32,0.38,5.97,9.55,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.005
CHEMBL3809643,,None,498.47,0,4.92,30,C[C@H]1Cc2c(ncnc2Oc2ccc3ccn(C(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c3c2)CN1,IC50,'=',160,nM,6.8,,,UO_0000065,13.63,0.26,1.88,6.35,0,CHEMBL3812627,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808377,1,Scientific Literature,ACS Med Chem Lett,2016,None,,,,0.16
CHEMBL3808854,,None,340.39,0,3.59,15,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(N)n[nH]3)cc2)no1,IC50,'=',610,nM,6.21,,,UO_0000065,18.26,0.34,2.62,5.1,0,CHEMBL3812631,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,None,,,,0.61
CHEMBL3809608,,None,424.51,0,4.99,22,CC(C)(C)C(=O)Nc1cc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)cc2)[nH]n1,IC50,'=',390,nM,6.41,,,UO_0000065,15.1,0.28,1.42,5.13,0,CHEMBL3812632,Inhibition of Tel-fused KDR (unknown origin) expressed in mouse Baf3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,CHEMBL3307634,,,,0.39
CHEMBL1823220,,None,450.54,0,3.41,13c,C#Cc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,IC50,'=',455,nM,6.34,,,UO_0000065,14.08,0.25,2.93,8.76,0,CHEMBL1828298,Inhibition of KDR activity by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1821705,1,Scientific Literature,J Med Chem,2011,None,,,,455
CHEMBL360190,BASTADIN 7,None,938.22,3,7.94,4,O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O,IC50,'=',1300,nM,5.89,,,UO_0000065,6.27,0.16,-2.05,3.23,0,CHEMBL2345552,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331160,1,Scientific Literature,J Nat Prod,2013,None,,,,1.3
CHEMBL565603,,None,533.56,2,6.22,14,CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)CC(=O)Nc5cccc(F)c5)cc4F)c3s2)c1,IC50,'=',10,nM,8,,,UO_0000065,14.99,0.29,1.78,8.15,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,10
CHEMBL3577117,,None,439.54,0,4.62,6,CNc1cc2nc(C)c(-c3cc(NC(=O)NC[C@@H](O)C(C)(C)C)c(F)cc3C)cc2cn1,IC50,'=',750,nM,6.12,,,UO_0000065,13.93,0.26,1.5,6.18,0,CHEMBL3578340,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576847,1,Scientific Literature,J Med Chem,2015,None,,,,0.75
CHEMBL3577116,,None,453.56,1,5.13,5,CCn1c(=O)c(-c2cc(NC(=O)NCCC(C)(C)C)c(F)cc2C)cc2cnc(NC)cc21,IC50,'=',25,nM,7.6,,,UO_0000065,16.76,0.31,2.47,8.63,0,CHEMBL3578340,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576847,1,Scientific Literature,J Med Chem,2015,None,,,,0.025
CHEMBL483321,CP-724714,2,469.55,0,4.95,CP-724714,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,,,,10
CHEMBL3288520,,None,383.41,0,4.51,4s,Cc1cc(NC(=O)c2cccc3cc(-c4cccc5[nH]nc(N)c45)ccc23)no1,IC50,'=',9.7,nM,8.01,,,UO_0000065,20.9,0.38,3.5,7.3,0,CHEMBL3295610,Inhibition of VEGFR-2 (unknown origin) expressed in baculovirus expression system using poly (4 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL232800,,None,326.79,0,3.43,9,O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccccn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL237680,,None,315.76,0,2.75,17,O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1c[nH]cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL399606,,None,368.44,0,4.44,25,O=C(Nc1ccc(-c2ccccc2)cc1)c1ccnn1CCc1ccncc1,IC50,'=',950,nM,6.02,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.95
CHEMBL399605,,None,348.45,0,4.07,23,CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,IC50,'=',42,nM,7.38,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.042
CHEMBL375577,,None,543.67,2,8.71,50,COc1ccc(C2CCCCC2)cc1NC(=O)c1ccc(C)c(Oc2ncccc2-c2ccnc3ccccc23)c1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,25000
CHEMBL4209280,,None,447.5,0,4.4,26,COc1cc2nccc(Oc3ccc(NC(=O)Cc4cnn(C(C)C)c4)nc3)c2cc1OC,GI50,'=',761,nM,,,,UO_0000065,,,,,0,CHEMBL4201681,Inhibition of KDR (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4196201,1,Scientific Literature,J Med Chem,2018,None,,,,0.761
CHEMBL2348093,,None,489.38,1,5.21,BRN-250,CC(c1ncnc(Cl)c1F)N1CCC(Nc2ncccc2C(=O)Nc2cccc(Cl)c2)CC1,Inhibition,,,%,,,Dose-dependent effect,UO_0000187,,,,,0,CHEMBL2352588,Inhibition of VEGF-induced VEGFR2 in human HUVEC cell assessed as AKT phosphorylation at Ser473 incubated 1 hr prior to VEGF-challenge measured after 30 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2346518,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3307501,,,,
CHEMBL380243,,None,547.13,2,5.77,56,CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5ccc(Cl)cc5)s4)c2C3)CC1,IC50,'=',21,nM,7.68,,,UO_0000065,14.03,0.28,1.91,11.37,0,CHEMBL869847,Inhibition of KDR at 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146863,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,21
CHEMBL3401904,,None,580.85,2,6.19,7,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4[C@@H](C)[C@H](C)CC[C@]4(C)CC[C@]23C)[C@@]1(C)C(=O)N1CCNCC1,Inhibition,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL3405094,Inhibition of VEGFR-2 (unknown origin) at 50 uM after 1 hr by luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399926,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,96
CHEMBL219332,,None,550.69,2,6.31,17,CCCn1c2ccc(NC(=O)Nc3ccc(SC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',14,nM,7.85,,,UO_0000065,14.26,0.27,1.54,8.45,0,CHEMBL814076,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,14
CHEMBL219581,,None,539.04,2,6.24,30,CCCn1c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,Activity,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL856506,Activity at VEGFR2 by autophosphorylation assay relative to control,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,26
CHEMBL387385,,None,459.31,0,4.98,6p,O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1,Ki,'=',3900,nM,5.41,,,UO_0000065,11.78,0.24,0.43,5.77,0,CHEMBL917087,Inhibition of KDR kinase,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142871,1,Scientific Literature,J Med Chem,2007,None,,,,3.9
CHEMBL383434,,None,427.39,0,4.95,29,FC(F)(F)Oc1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1,IC50,'=',350,nM,6.46,,,UO_0000065,15.11,0.28,1.51,7.51,0,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.35
CHEMBL381704,,None,373.42,0,4.06,39,COc1ccccc1Nc1nnc(-c2cccnc2CCc2ccncc2)o1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,
CHEMBL204621,,None,412.28,1,5.36,41,Clc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1Cl,IC50,'=',94,nM,7.03,,,UO_0000065,17.04,0.34,1.67,9.16,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.094
CHEMBL204681,,None,310.38,0,2.33,19,Cn1cc(CC2C(=O)NN=C2c2nccs2)c2ccccc21,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL866861,Inhibition of VEGFR2 at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146951,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,5
CHEMBL554497,,None,449.5,0,2.6,39,O=S(=O)(c1cccc2nonc12)n1ccc2ncc(-c3cnn(C4CCNCC4)c3)cc21,Activity,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL1053887,Inhibition of KDR assessed as residual activity at 20 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152913,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,3
CHEMBL3287603,,None,592.62,2,5.8,18a,CS(=O)(=O)Cc1cccc(Nc2cc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccn2)c1,IC50,'=',16,nM,7.8,,,UO_0000065,13.15,0.25,2,6.16,0,CHEMBL3291812,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3287314,,None,589.65,2,5.36,3l,Cc1cccc(NC(=O)C2(C(=O)Nc3ccc(Oc4ccnc(Nc5cccc(CS(C)(=O)=O)c5)n4)c(F)c3)CC2)c1,Inhibition,'=',42.7,%,,,,UO_0000187,,,,,0,CHEMBL3291813,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4633337,,None,378.34,0,1.81,3a,Cc1cc(=O)oc2cc(OCC(=O)NN3C(=O)c4ccccc4C3=O)ccc12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4627705,Inhibition of VEGFR2 in human MCF7 cells by horseradish peroxidase-coupled TMB substrate based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,MCF7,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4627262,1,Scientific Literature,Bioorg Med Chem,2020,CHEMBL3308403,,,,
CHEMBL223237,,None,470.58,0,4.57,22c,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3c(N)nn4CCN3CCOCC3)cc2)c1,IC50,'=',1300,nM,5.89,,,UO_0000065,12.51,0.23,1.32,6.04,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,1300
CHEMBL387312,,None,371.44,0,4.77,22a,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3c(N)nn4C)cc2)c1,IC50,'=',11,nM,7.96,,,UO_0000065,21.43,0.39,3.19,9.37,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,11
CHEMBL243017,,None,373.46,0,3.49,9a,CC(C)(N)c1ccc(-c2nc(Nc3ccc(CCO)cc3)ncc2C#N)cc1,IC50,'=',52,nM,7.28,,,UO_0000065,19.5,0.36,3.79,6.75,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.052
CHEMBL233876,,None,274.29,0,2.55,2m,N#Cc1cnc(Nc2ncccn2)nc1-c1ccccc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL233668,,None,302.34,0,3.77,2g,COc1cccc(Nc2ncc(C#N)c(-c3ccccc3)n2)c1,IC50,'=',380,nM,6.42,,,UO_0000065,21.24,0.38,2.65,9.06,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.38
CHEMBL1650545,,None,452.92,0,3.47,18,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl,IC50,'=',550,nM,6.26,,,UO_0000065,15.03,0.29,2.79,7.19,0,CHEMBL1656202,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1649074,1,Scientific Literature,J Med Chem,2011,None,,,,550
CHEMBL493986,,None,397.48,0,4.04,1,Cc1ccn(-c2ccc3c(c2)NCC3(C)C)c(=O)c1-c1ccc2nc(N)ncc2c1,IC50,'=',48,nM,7.32,,,UO_0000065,18.41,0.33,3.28,8.53,0,CHEMBL955808,Inhibition of KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150317,1,Scientific Literature,J Med Chem,2008,None,,,,0.048
CHEMBL426004,,None,375.41,0,4.9,17r,Cc1ccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)cc1F,IC50,'=',36,nM,7.44,,,UO_0000065,19.83,0.36,2.54,7.77,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,36
CHEMBL2334808,,None,427.87,0,4.51,12c,O=C(Nc1ccc(Cl)cc1)Nc1ccc(OC2=NS(=O)(=O)c3ccccc32)cc1,Inhibition,'=',15,%,,,,UO_0000187,,,,,0,CHEMBL2338949,Inhibition of VEGFR-2 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331514,1,Scientific Literature,Eur J Med Chem,2013,None,,,,15
CHEMBL2334805,,None,495.78,1,5.85,9b,O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)C(Nc1ccc(Cl)cc1Cl)=NS2(=O)=O,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2338949,Inhibition of VEGFR-2 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331514,1,Scientific Literature,Eur J Med Chem,2013,None,,,,
CHEMBL558708,,None,439.56,1,5.06,3,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCCC2)C1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1058962,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152979,1,Scientific Literature,J Med Chem,2009,None,,,,10
CHEMBL2420900,,None,362.48,0,2.93,42,c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL2422074,Inhibition of KDR (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2417369,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,11
CHEMBL211060,,None,456.55,0,3.09,12,O=C(NCCN1CCOCC1)c1ccc(F)c(NCc2cnc(Nc3ccccn3)s2)c1,IC50,'=',85,nM,7.07,,,UO_0000065,15.49,0.3,3.98,7.74,0,CHEMBL866816,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138058,1,Scientific Literature,J Med Chem,2006,None,,,,85
CHEMBL207445,,None,461.93,0,3.5,30,COCC[C@@H](C(N)=O)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL208286,,None,433.87,0,2.45,28,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CO)C(N)=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL206955,,None,429.88,0,3.62,4,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CCC[C@@H]1C(N)=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL191993,,None,468.96,1,6.21,45,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1,IC50,'=',39,nM,7.41,,,UO_0000065,15.8,0.32,1.2,9.1,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.039
CHEMBL372662,,None,486.48,0,3.28,48,CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(CN(C)C)o4)c(C(C)C)c23)c(F)cc1F,IC50,'=',66,nM,7.18,,,UO_0000065,14.76,0.28,3.9,5.85,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,66
CHEMBL247619,,None,509.42,1,3.39,40,CNC(=O)Nc1ccc(CNc2c(C(=O)Nc3ccc4c(c3)OC(F)(F)C(F)(F)O4)cnn2C)cn1,IC50,'=',43,nM,7.37,,,UO_0000065,14.46,0.28,3.98,5.6,0,CHEMBL922924,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140657,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,43
CHEMBL496505,,None,370.41,0,3.54,21,CC(=O)c1ccc(-n2ccc(C)c(-c3ccc4nc(N)ncc4c3)c2=O)cc1,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL955808,Inhibition of KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150317,1,Scientific Literature,J Med Chem,2008,None,,,,5
CHEMBL498557,,None,396.37,0,4.36,13,Cc1ccn(-c2ccc(C(F)(F)F)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1,IC50,'=',1800,nM,5.75,,,UO_0000065,14.49,0.27,1.38,7.78,0,CHEMBL955808,Inhibition of KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150317,1,Scientific Literature,J Med Chem,2008,None,,,,1.8
CHEMBL2436727,,None,393.41,0,2.37,5i,O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3ncn[nH]3)c2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL2438102,Inhibition of VEGFR2 (unknown origin) phosphorylation at 5 ug/mL by cell-based Western blotting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2434840,1,Scientific Literature,Eur J Med Chem,2013,None,,,,
CHEMBL2436724,,None,382.85,0,3.12,5e,O=S(=O)(Nc1ccc(O)c(Sc2ncn[nH]2)c1)c1ccc(Cl)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2438102,Inhibition of VEGFR2 (unknown origin) phosphorylation at 5 ug/mL by cell-based Western blotting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2434840,1,Scientific Literature,Eur J Med Chem,2013,None,,,,
CHEMBL2436727,,None,393.41,0,2.37,5i,O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3ncn[nH]3)c2)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL2438103,Inhibition of VEGFR2 (unknown origin) phosphorylation at 1 ug/mL by cell-based Western blotting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2434840,1,Scientific Literature,Eur J Med Chem,2013,None,,,,
CHEMBL452679,,None,1221.6,None,None,GU40E,CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(CCCCN)C(=O)CN(Cc1ccco1)C(=O)CN(CCCCN)C(=O)CNCCc1c[nH]c2ccccc12,Activity,,,,,,Active,,,,,,0,CHEMBL956465,Displacement of GU40C-FITC form human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL467132,,None,1236.62,None,None,GU40C,CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)Cc1ccc2c(c1)OCO2)C(C)c1ccccc1)C(=O)CNCCCCN,Activity,,,,,,Active,,,,,,0,CHEMBL956465,Displacement of GU40C-FITC form human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL501200,,None,634.99,2,6.54,CER-0262584,O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,0
CHEMBL1807472,,None,468.58,0,2.84,8m,CCS(=O)(=O)Nc1cccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1810161,Inhibition of recombinant GST-tagged VEGFR2 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1806486,1,Scientific Literature,Bioorg Med Chem,2011,CHEMBL3308860,,,,1
CHEMBL1807480,,None,517.61,1,3.96,8u,O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(CN2CCOCC2)cc1,IC50,'=',560,nM,6.25,,,UO_0000065,12.08,0.23,2.29,5.37,0,CHEMBL1810161,Inhibition of recombinant GST-tagged VEGFR2 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1806486,1,Scientific Literature,Bioorg Med Chem,2011,CHEMBL3308860,,,,0.56
CHEMBL1807485,,None,484.63,0,3.21,12c,CCCCS(=O)(=O)Nc1cccc(-c2cc(Nc3cc(N4CCN(C)CC4)nc(C)n3)[nH]n2)c1,IC50,'>',1000000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1810161,Inhibition of recombinant GST-tagged VEGFR2 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1806486,1,Scientific Literature,Bioorg Med Chem,2011,CHEMBL3308860,,,,1000
CHEMBL1807789,,None,548.67,1,3.85,12h,Cc1nc(NCCCN2CCOCC2)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1,Inhibition,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL1810356,Inhibition of recombinant GST-tagged VEGFR2 expressed in Sf9 insect cells at 1 uM after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1806486,1,Scientific Literature,Bioorg Med Chem,2011,CHEMBL3308860,,,,55
CHEMBL516554,MYROCIN A,None,358.39,0,2.09,6,C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1816877,Inhibition of recombinant VEGF-R2 assessed as 33Pi incorporation after 60 mins by scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1811781,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,
CHEMBL2011305,,None,383.35,1,5.76,13h,Fc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nc2-c2ccncc2)cc1,IC50,'=',27000,nM,4.57,,,UO_0000065,11.92,0.22,-1.19,14.88,0,CHEMBL2015056,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2011304,,None,418.69,1,6.7,13a,Fc1ccc(-c2cn(-c3c(Cl)cc(Cl)cc3Cl)nc2-c2ccncc2)cc1,IC50,'=',210,nM,6.68,,,UO_0000065,15.95,0.34,-0.02,21.74,0,CHEMBL2015056,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2032013,,None,551.6,2,5.07,43c,COc1ccc2c(Oc3ccc(NC(=O)c4c(C5CCOCC5)n(C)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',2720,nM,5.57,,,UO_0000065,10.09,0.19,0.5,5.08,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,2720
CHEMBL429138,,None,469.59,1,5.27,41,C/C(=N\OC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',4,nM,8.4,,,UO_0000065,17.88,0.33,3.13,11.44,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,4
CHEMBL2408735,,None,372.41,0,3.96,6r,Cn1cc(-c2cnc(N)c3oc(-c4csc5cnccc45)cc23)c(C#N)n1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2410657,Inhibition of KDR autophosphorylation overexpressed in VEGF-stimulated human HEK293 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407065,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3307715,,,,
CHEMBL271170,,None,376.39,1,5.17,13,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)c1,IC50,'=',21,nM,7.68,,,UO_0000065,20.4,0.37,2.51,8.24,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,21
CHEMBL407708,,None,496.52,0,4.64,24,CC(C)Nc1nnc(-c2cn3ncnc(Nc4cc(C(=O)NC5CC5)c(F)cc4F)c3c2C(C)C)o1,IC50,'=',21,nM,7.68,,,UO_0000065,15.46,0.29,3.04,6.28,0,CHEMBL949197,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143868,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,21
CHEMBL404571,,None,412.38,0,4.87,14b,Nc1n[nH]c2ccnc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,IC50,'=',7.1,nM,8.15,,,UO_0000065,19.76,0.37,3.28,7.5,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,7.1
CHEMBL272767,,None,372.43,0,4.47,14d,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3nccc4[nH]nc(N)c34)cc2)c1,IC50,'=',65,nM,7.19,,,UO_0000065,19.3,0.35,2.72,6.61,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,65
CHEMBL2386810,,None,518.03,1,4.3,14f,Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cccc(Cl)c4)cc3)n[nH]2)cc(N2CCNCC2)n1,IC50,'=',38,nM,7.42,,,UO_0000065,14.32,0.27,3.12,6.04,0,CHEMBL2390017,Inhibition of recombinant GST tagged VEGFR2 (789 to 1356) (unknown origin) transfected in insect sf9 cells after 120 mins by wallac counting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384934,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3308860,,,,0.038
CHEMBL2386805,,None,502.58,1,3.29,14a,Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cc(C)on4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1,IC50,'=',100,nM,7,,,UO_0000065,13.93,0.26,3.71,5,0,CHEMBL2390017,Inhibition of recombinant GST tagged VEGFR2 (789 to 1356) (unknown origin) transfected in insect sf9 cells after 120 mins by wallac counting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384934,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3308860,,,,0.1
CHEMBL4863263,,None,396.43,0,4.87,14b,Cc1ccccc1-n1cc(-c2ccc(C=C3C(=O)Nc4ccc(F)cc43)cc2)nn1,IC50,'=',71550,nM,4.14,,,UO_0000065,10.46,0.19,-0.72,6.93,0,CHEMBL4819966,Inhibition of recombinant human His-tagged VEGFR2 expressed in Baculovirus expression system using ADP-Glo as substrate measured after 30 mins in presence of ATP by ADP-Glo kinase assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819005,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 0.5 hr,INHIBITOR,,71.55
CHEMBL407063,,None,607.61,2,5.94,18,Cc1ccc(NC(=O)c2cc(F)cc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,IC50,'=',17,nM,7.77,,,UO_0000065,12.79,0.24,1.83,7.58,0,CHEMBL951933,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144680,1,Scientific Literature,J Med Chem,2008,None,,,,17
CHEMBL2337366,,None,339.79,0,4.1,8,COc1cccc(Nc2nc(N)nc3[nH]c4cccc(Cl)c4c23)c1,IC50,'=',70100,nM,4.15,,,UO_0000065,12.23,0.24,0.05,4.68,0,CHEMBL2344597,Inhibition of VEGFR2 in human U251 cells assessed as inhibition of VEGF-induced tyrosine phosphorylation incubated for 60 mins prior to VEGF-activation measured 10 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331095,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,70.1
CHEMBL2016897,,None,349.44,0,2.03,13,O=c1[nH]c2ccccc2cc1-c1nc2c([nH]1)CN(C1CCNCC1)CC2,IC50,'=',5000,nM,5.3,,,UO_0000065,15.17,0.28,3.27,6.9,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,5
CHEMBL2016911,,None,423.47,0,1.14,27,COc1ccc2[nH]c(=O)c(-c3nc4c([nH]3)CN(C(=O)CN3CCOCC3)CC4)cc2c1,IC50,'=',760,nM,6.12,,,UO_0000065,14.45,0.27,4.98,5.91,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.76
CHEMBL2016926,,None,403.42,0,2.58,42,O=C(Cc1ccncc1)N1CCc2nc(-c3cc4cc(F)ccc4[nH]c3=O)[nH]c2C1,IC50,'=',8.6,nM,8.07,,,UO_0000065,19.99,0.37,5.49,8.51,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.0086
CHEMBL3671526,,None,557.42,1,4.01,BDBM133737,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)/C=C/CN(C)C,IC50,'=',875,nM,6.06,,266595,UO_0000065,10.87,0.23,2.05,5.58,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2018757,,None,396.45,0,4.66,53,CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,IC50,'=',850,nM,6.07,,,UO_0000065,15.31,0.29,1.41,6.42,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.85
CHEMBL2018765,,None,418.9,0,4.9,64,CCN(CC)CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC,IC50,'=',6900,nM,5.16,,,UO_0000065,12.32,0.24,0.26,8.67,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,6.9
CHEMBL1761936,,None,396.45,0,4.36,84,CCCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',400,nM,6.4,,,UO_0000065,16.14,0.3,2.04,6.76,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.4
CHEMBL225335,,None,462.62,0,3.47,88,COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(CN4CCN(C)CC4)cc2-3)cs1,IC50,'=',30,nM,7.52,,,UO_0000065,16.26,0.31,4.05,14.03,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,30
CHEMBL225334,,None,494.62,0,4.41,77,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)C(=O)C1,IC50,'=',2,nM,8.7,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,2
CHEMBL3702621,,None,325.42,0,2.1,BDBM139561,CCN(CC)C(=O)c1cccc(N2CCc3nc(N)ncc3C2)c1,IC50,'=',1250,nM,5.9,,273921,UO_0000065,18.14,0.34,3.8,7.83,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702624,,None,414.39,0,3.29,BDBM139564,Nc1ncc2c(n1)CCN(c1ccnc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2,IC50,'>',10000,nM,,,273924,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2047252,,None,326.76,0,4.17,12,Nc1nc2c(c(Nc3ccc(F)c(Cl)c3)n1)-c1ccccc1C2,IC50,'=',72900,nM,4.14,,,UO_0000065,12.66,0.25,-0.03,6.48,0,CHEMBL2050144,Inhibition of VEGFR2 in human U251 cells pretreated for 60 mins measured after 1 hr by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046359,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,72.9
CHEMBL240431,,None,511.67,1,4.95,14,c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3nccc(NCCN4CCNCC4)c23)cc1,IC50,'=',210,nM,6.68,,,UO_0000065,13.05,0.24,1.73,10.15,0,CHEMBL903615,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139139,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.21
CHEMBL3690589,,None,515.57,1,4.84,BDBM128652,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4nnc(CCN5CCCC5)s4)ccn23)c1,IC50,'=',220,nM,6.66,,259906,UO_0000065,12.91,0.25,1.82,7.61,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694654,,None,484.49,0,3.79,BDBM128667,CN(C)Cc1cnc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)nc1N,IC50,'=',140,nM,6.85,,259912,UO_0000065,14.15,0.27,3.06,6.04,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL231270,,None,540.55,2,5.35,11,CNC(=O)c1cc(Oc2ccc3[nH]c(Nc4cc(OCCN5CCCC5)cc(C(F)(F)F)c4)nc3c2)ccn1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,
CHEMBL2032031,,None,557.58,1,4.01,67,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(O)CN)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',382,nM,6.42,,,UO_0000065,11.51,0.21,2.41,4.8,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,382
CHEMBL525767,SCOPARASIN B,None,543.61,1,2.05,Scoparasin B,COc1ccc(C[C@@H]2NC(=O)[C@@]34OC(=O)O/C=C/[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]3[C@H](O)[C@](C)(O)[C@@H](C)[C@@H]24)cc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL5229896,Inhibition of VEGF-A-mediated VEGFR2 signaling pathway in human HMEC-1 cells assessed as reduction in VEGFR2 phosphorylation at Tyr1175 residue at 5 to 15 nM incubated for 36 hrs by western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HMEC-1,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5226385,1,Scientific Literature,J Nat Prod,2023,None,DOSE_Lower = 5.0 nM | DOSE_Upper = 15.0 nM | TIME = 36.0 hr,INHIBITOR,,
CHEMBL473826,,None,501.55,2,5.37,12a,Nc1ccccc1NC(=O)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)cn3)c2)cc1,IC50,'=',1500,nM,5.82,,,UO_0000065,11.61,0.21,0.45,4.32,0,CHEMBL1022425,Inhibition of VEGFR2 by liquid scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153406,1,Scientific Literature,J Med Chem,2009,None,,,,1.5
CHEMBL5411585,,None,616.04,2,7.61,I10,COc1cc2c(Oc3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)c(Cl)c3)ncnc2cc1OCCCN1CCCC1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL5328046,Inhibition of VEGF-driven VEGFR2 phosphorylation in HUVEC at 1 nM preincubated with compound for 1 hrs followed by VEGF stimulation and measured after 5 mins by Western blot analysis relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5325476,1,Scientific Literature,Bioorg Med Chem,2023,CHEMBL3307501,DOSE = 1.0 nM | TIME = 1.083 hr,INHIBITOR,,100
CHEMBL1171837,PONATINIB,4,532.57,1,4.46,Ponatinib,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,AC50,'=',1,nM,9,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291913,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,0.001
CHEMBL223604,,None,442.54,1,5.17,80,COCCOc1ccc2c(c1)Cc1c(-c3csc(C#CCOc4ccccc4)c3)n[nH]c1-2,IC50,'=',40,nM,7.4,,,UO_0000065,16.72,0.32,2.23,13.12,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,40
CHEMBL225261,,None,509.64,1,4.34,75,NC(=O)N1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',9,nM,8.05,,,UO_0000065,15.79,0.3,3.71,9.2,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,9
CHEMBL629,AMITRIPTYLINE,4,277.41,0,4.17,amitriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291913,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL230414,,None,306.18,0,4,table5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL477563,,None,423.5,0,2.83,12g,Cc1nc2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc2n1C,IC50,'=',17,nM,7.77,,,UO_0000065,18.35,0.35,4.94,6.53,0,CHEMBL983779,Inhibition of human VEGFR2-mediated proliferation of HUVEC,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155848,1,Scientific Literature,J Med Chem,2008,None,,,,17
CHEMBL476572,,None,499.6,0,4.34,12d,Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1Cc1ccccc1,IC50,'=',2.6,nM,8.59,,,UO_0000065,17.18,0.33,4.25,7.21,0,CHEMBL983779,Inhibition of human VEGFR2-mediated proliferation of HUVEC,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155848,1,Scientific Literature,J Med Chem,2008,None,,,,2.6
CHEMBL2021941,,None,439.54,1,6.49,13,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cc[nH]c5)cnc(N)c34)cc2)c1,IC50,'=',1,nM,9,,,UO_0000065,20.48,0.38,2.51,9.39,0,CHEMBL2024778,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,CHEMBL3307716,,,,1
CHEMBL3959201,,None,539.04,1,3.73,333,COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3966748,,None,404.47,0,3.52,338,COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3900268,,None,608.58,2,8.33,346,COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3962554,,None,515.66,1,4.21,351,COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL518174,,None,542.57,2,5.07,4,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(C[C@@H](C)O)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,IC50,'=',236,nM,6.63,,,UO_0000065,12.21,0.23,1.56,6.16,0,CHEMBL989220,Inhibition VEGFR2-mediated survival of HUVEC,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157538,1,Scientific Literature,J Med Chem,2008,CHEMBL3307501,,,,236
CHEMBL473288,,None,389.28,0,4.17,15,O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1,Ki,'=',90,nM,7.05,,,UO_0000065,18.1,0.42,2.88,10.53,0,CHEMBL1036678,Inhibition of VEGFR2 at IC50 concentration by ATP based competition assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.09
CHEMBL3934355,,None,487.56,0,2.62,144,COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4570.88,nM,5.34,,,UO_0000065,10.95,0.2,2.72,5.47,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.34
CHEMBL3919750,,None,472.59,0,4.16,539,COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',4466.84,nM,5.35,,,UO_0000065,11.32,0.21,1.19,6.73,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.35
CHEMBL3951360,,None,448.55,0,4.7,558,COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',2818.38,nM,5.55,,,UO_0000065,12.37,0.23,0.85,8.15,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.55
CHEMBL3948744,,None,548.09,1,4.95,103,COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1122.02,nM,5.95,,,UO_0000065,11.63,0.21,1,6.44,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.95
CHEMBL3911746,,None,534.06,1,5.09,563,COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',1905.46,nM,5.72,,,UO_0000065,11.5,0.21,0.63,6.88,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.72
CHEMBL3966316,,None,488.49,0,4.86,582,COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3943610,,None,598.75,1,3.81,583,COc1cc(OC)cc(N(CCN2CCN(C3CCN(C(C)=O)CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1513.56,nM,5.82,,,UO_0000065,9.72,0.18,2.01,6.32,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.82
CHEMBL3922607,,None,418.5,0,3.53,611,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3956579,,None,502.62,1,4.2,701,COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3921441,,None,425.52,0,3.57,711,[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1621.81,nM,5.79,,,UO_0000065,13.8,0.26,2.22,6.77,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.79
CHEMBL3914473,,None,527.72,2,5.5,721,CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3898926,,None,455.39,1,5.47,722,CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',6456.54,nM,5.19,,,UO_0000065,11.4,0.23,-0.28,8.82,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.19
CHEMBL3898881,,None,419.49,0,3.57,3,COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',40.74,nM,7.39,,,UO_0000065,17.62,0.33,3.82,8.64,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.39
CHEMBL3925306,,None,549.12,2,5.45,62,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl,IC50,'=',28.18,nM,7.55,,,UO_0000065,14.73,0.27,2.1,9.76,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.55
CHEMBL3951245,,None,486.53,0,4.14,23,COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'=',123.03,nM,6.91,,,UO_0000065,14.2,0.26,2.77,6.19,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.91
CHEMBL3948623,,None,500.6,1,4.54,226,CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'=',346.74,nM,6.46,,,UO_0000065,12.9,0.24,1.92,6.84,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.46
CHEMBL3915235,,None,473.58,0,4.83,52,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1,IC50,'=',123.03,nM,6.91,,,UO_0000065,14.59,0.27,2.08,8.08,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.91
CHEMBL3918092,,None,509.05,0,4.67,241,COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',24.55,nM,7.61,,,UO_0000065,16.1,0.3,2.94,11.1,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.61
CHEMBL3964675,,None,542.68,1,4.91,55,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1,IC50,'=',75.86,nM,7.12,,,UO_0000065,13.12,0.24,2.21,8.02,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.12
CHEMBL3957473,,None,639.25,2,3.65,644,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl,IC50,'=',2398.83,nM,5.62,,,UO_0000065,9.32,0.17,1.97,5.4,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.62
CHEMBL3965482,,None,514.03,0,4.24,657,COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl,IC50,'=',3235.94,nM,5.49,,,UO_0000065,11.5,0.21,1.25,5.79,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.49
CHEMBL2023494,,None,485.58,1,5.6,28,COc1ccc2c(Oc3ccc(CC(=O)Nc4cc(C)cc(CN(C)C)c4)c(OC)c3)ccnc2c1,IC50,'=',23,nM,7.64,,,UO_0000065,15.73,0.29,2.04,10.47,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.023
CHEMBL3983694,,None,490.57,0,4.94,634,COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL261508,,None,390.53,1,5.29,K00236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986861,,None,519.05,0,4.19,631,COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',4677.35,nM,5.33,,,UO_0000065,11.04,0.2,1.14,6.89,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.33
CHEMBL3978313,,None,505.58,1,4.67,809,CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',8128.31,nM,5.09,,,UO_0000065,10.07,0.18,0.42,5.64,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.09
CHEMBL458440,,None,325.8,0,1.15,A,Cl.N[C@@H](CCCCN/C=C1\C(=O)Nc2ccccc21)C(=O)O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1016024,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154450,1,Scientific Literature,Eur J Med Chem,2008,None,,,,10
CHEMBL3969192,,None,447.97,1,5.23,407,C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',776.25,nM,6.11,,,UO_0000065,14.85,0.27,0.88,10.9,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.11
CHEMBL3966305,,None,525.05,0,4.03,436,COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl,IC50,'=',27.54,nM,7.56,,,UO_0000065,15.47,0.29,3.53,7.52,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.56
CHEMBL3945373,,None,446.51,0,3.32,447,COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',131.83,nM,6.88,,,UO_0000065,15.41,0.28,3.56,7.29,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.88
CHEMBL254964,,None,534.64,2,5.52,8f,O=C(Cc1ccccc1)NC(=S)Nc1ccc(Oc2ccnc3cc(C(=O)N4CCCC4)sc23)c(F)c1,IC50,'=',9,nM,8.05,,,UO_0000065,15.05,0.3,2.53,9.63,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,9
CHEMBL475509,,None,394.38,0,4.3,9,O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1,IC50,'=',41,nM,7.39,,,UO_0000065,18.73,0.37,3.09,9.7,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,0.041
CHEMBL473268,,None,412.82,1,5.07,19,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1,IC50,'=',530,nM,6.28,,,UO_0000065,15.2,0.32,1.21,9.38,0,CHEMBL1034026,Inhibition of VEGFR2 expressed in HEK293 cells assessed as inhibition of receptor phosphorylation by ELISA,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3307715,,,,0.53
CHEMBL3979687,,None,446.38,1,7.04,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957171,,None,502.36,1,4.06,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948661,,None,579.79,2,8.49,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL483525,,None,338.29,0,1.85,2,Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12,IC50,'=',0.7,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL962872,Inhibition of recombinant VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157406,1,Scientific Literature,J Nat Prod,2008,None,,,,7
CHEMBL3979195,,None,549.46,2,5.11,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956056,,None,501.37,2,5.42,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944791,,None,483.78,1,5.05,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3893176,,None,479.36,0,3.76,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947769,,None,519.47,2,6.2,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913496,,None,499.93,0,3.44,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958778,,None,593.46,2,5.3,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923692,,None,575.9,1,4.73,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947700,,None,558.42,2,5.21,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3969472,,None,529.38,2,5.2,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976226,,None,491.38,0,4.71,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986102,,None,560.44,1,3.84,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3973632,,None,585.5,1,3.85,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3962203,,None,477.39,1,5.22,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924098,,None,507.82,1,4.82,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3972712,,None,539.83,2,5.43,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3921482,,None,495.38,1,5.32,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947643,,None,538.85,2,5.07,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923645,,None,561.86,1,4.81,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927849,,None,575.89,2,5.2,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937048,,None,449.84,0,4.06,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2063324,,None,539.64,2,5.23,8d,O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)OCc1ccccc1,IC50,'=',120,nM,6.92,,,UO_0000065,12.82,0.24,1.69,6.37,0,CHEMBL2066305,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2062390,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,120
CHEMBL2063331,,None,529.6,1,3.8,8k,Cc1cc(COC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2)no1,IC50,'=',370,nM,6.43,,,UO_0000065,12.14,0.23,2.63,5,0,CHEMBL2066305,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2062390,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,370
CHEMBL502803,,None,423.55,1,6.2,10,CC(Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1)c1ccccc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,100
CHEMBL469469,,None,500.61,1,4,40,CCN(CC)CCNC(=O)c1cnn2c(N)c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)cnc12,IC50,'=',500,nM,6.3,,,UO_0000065,12.59,0.23,2.3,4.86,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,500
CHEMBL472302,,None,358.41,0,3.93,14,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4ccnn4c3N)cc2)c1,IC50,'=',70,nM,7.16,,,UO_0000065,19.96,0.36,3.22,7.35,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,70
CHEMBL4576115,,None,441.92,0,4.68,29,Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N,Inhibition,'=',95.5,%,,,,UO_0000187,,,,,0,CHEMBL4325589,Inhibition of recombinant human VEGFR2 (D1-7) expressed in Spodoptera frugiperda insect cells at 1000 nM using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3133758,,None,553.04,2,5.89,20,CCN(CCO)CCCOc1ccc2c(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncnc2c1,IC50,'=',95,nM,7.02,,,UO_0000065,12.7,0.25,1.13,6.29,0,CHEMBL3136337,Inhibition of VEGFR2 (unknown origin) after 1 hr by Caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3132845,1,Scientific Literature,Medchemcomm,2013,None,,,,95
CHEMBL3133757,,None,603.04,2,6.77,19,CCN(CCO)CCCOc1ccc2c(Nc3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)ncnc2c1,IC50,'=',91,nM,7.04,,,UO_0000065,11.68,0.23,0.27,6.31,0,CHEMBL3136337,Inhibition of VEGFR2 (unknown origin) after 1 hr by Caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3132845,1,Scientific Literature,Medchemcomm,2013,None,,,,91
CHEMBL425831,,None,541.44,2,5.17,37,CNC(=O)c1cc(Oc2cc(Cl)c3oc(Nc4ccc(Cl)c(CN5CCN(C)CC5)c4)nc3c2)ccn1,Ki,'=',10,nM,8,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,10
CHEMBL230107,,None,560.05,2,6.33,30,COc1cc2nccc(Oc3ccc4oc(Nc5ccc(Cl)c(CN6CCN(C)CC6)c5)nc4c3)c2cc1OC,Ki,'=',0.5,nM,9.3,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,0.5
CHEMBL389963,,None,561.04,2,7.06,29,COc1cc2nccc(Oc3ccc4oc(Nc5ccc(Cl)c(OC[C@@H]6CCCN6C)c5)nc4c3)c2cc1OC,Ki,'=',0.5,nM,9.3,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,0.5
CHEMBL231168,,None,514.51,1,4.81,8,CNC(=O)c1cc(Oc2ccc3[nH]c(Nc4ccc(C(F)(F)F)c(OCCN(C)C)c4)nc3c2)ccn1,Ki,'=',3,nM,8.52,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,3
CHEMBL427264,,None,443.82,1,6.65,6,FC(F)(F)c1cc(Nc2nc3cc(Oc4ccnc5[nH]ccc45)ccc3[nH]2)ccc1Cl,Ki,'=',48,nM,7.32,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,48
CHEMBL230003,,None,562.03,2,6.45,28,COc1cc2ncnc(Oc3ccc4oc(Nc5ccc(Cl)c(OC[C@@H]6CCCN6C)c5)nc4c3)c2cc1OC,IC50,'=',55,nM,7.26,,,UO_0000065,,,,,0,CHEMBL895906,Inhibition of FGF-induced HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,55
CHEMBL362558,LY-2090314,2,512.55,1,3.42,12,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL828051,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J Med Chem,2004,None,,,,20
CHEMBL361898,,None,450.97,1,5.14,62,O=C(CCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1)N1CCCCC1,IC50,'=',610,nM,6.21,,,UO_0000065,13.78,0.27,1.07,7.48,0,CHEMBL829518,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140334,1,Scientific Literature,J Med Chem,2005,None,,,,0.61
CHEMBL1923983,,None,379.42,0,1.82,4m,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3128233,,None,508.58,1,4.95,8f,COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c3cnn4CCc3ccccc3)c2)cc1OC,IC50,'=',2030,nM,5.69,,,UO_0000065,11.19,0.2,0.74,5.52,0,CHEMBL3130576,Inhibition of recombinant human VEGFR2 incubated for 5 mins with substrate prior to protein addition by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124801,1,Scientific Literature,J Med Chem,2014,None,,,,2.03
CHEMBL4452810,,None,406.41,0,4.83,5o,COc1ccc(CC(=O)Nc2ccc3oc(-c4ccccc4F)nc3c2)cc1OC,Inhibition,'=',84.2,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4584219,,None,421.29,1,5.75,5ad,Cc1ccc(CC(=O)Nc2ccc3oc(-c4ccccc4Br)nc3c2)cc1,Inhibition,'=',89.1,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3764045,TAS-115,1,518.57,1,4.59,TAS-115,CNC(=O)c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2cc1OC,IC50,'=',30,nM,7.52,,,UO_0000065,14.51,0.28,2.93,7.41,0,CHEMBL3766503,Inhibition of recombinant N-terminal 6His-tagged VEGFR-2 (unknown origin) using FL-Peptide 22 as substrate after 90 mins by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3763130,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.03
CHEMBL4520126,,None,498.51,1,6.81,13c,O=c1c2c(Nc3ccc(Oc4ccnc5ccsc45)c(F)c3)nccc2ccn1-c1ccc(F)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4366682,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain expressed in baculovirus expression system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4364278,1,Scientific Literature,Eur J Med Chem,2019,None,,,,
CHEMBL231128,,None,501.62,2,7.71,12f,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cncc6ccccc56)cnc(N)c34)cc2)c1,IC50,'=',388,nM,6.41,,,UO_0000065,12.78,0.24,-1.3,6.9,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,388
CHEMBL231255,,None,360.44,1,5.19,7a,Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,IC50,'=',56,nM,7.25,,,UO_0000065,20.12,0.38,2.06,9.06,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,56
CHEMBL394790,,None,394.89,1,5.84,7g,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',56,nM,7.25,,,UO_0000065,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,56
CHEMBL242131,,None,444.31,0,4.33,27,CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3F)c2c1,IC50,'=',4389,nM,5.36,,,UO_0000065,12.06,0.26,1.03,7.64,0,CHEMBL892958,Inhibition of human VEGFR2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147965,1,Scientific Literature,Bioorg Med Chem,2007,None,,,,4389
CHEMBL98475,,None,336.46,0,4.54,2,c1ccc(-c2cnc(Nc3ccc(CN4CCCC4)cn3)s2)cc1,IC50,'=',6,nM,8.22,,,UO_0000065,24.44,0.47,3.68,20.03,1,CHEMBL913856,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,None,,,,6
CHEMBL224036,,None,342.43,0,1.82,15,CC(=O)N1CCN(Cc2ccnc(Nc3ncc(C#N)s3)c2)CC1,IC50,'=',36,nM,7.44,,,UO_0000065,,,,,0,CHEMBL913857,Inhibition of VEGF-induced DNA synthesis in HEK293 cells expressing human KDR by endothelial cell mitogenesis assay,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,36
CHEMBL376722,,None,371.47,0,1.92,23,CNC(=O)N1CCN(Cc2ccnc(Nc3ncc(C#N)s3)c2C)CC1,IC50,'=',16,nM,7.8,,,UO_0000065,,,,,0,CHEMBL912804,Inhibition of VEGF-induced KDR autophosphorylation expressed in HEK293 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,16
CHEMBL234084,,None,302.34,0,3.77,2p,COc1ccccc1Nc1ncc(C#N)c(-c2ccccc2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,10
CHEMBL233454,,None,355.45,0,4.35,2a,N#Cc1cnc(Nc2ccc(CN3CCCC3)cc2)nc1-c1ccccc1,IC50,'=',61,nM,7.21,,,UO_0000065,20.3,0.36,2.86,11.13,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.061
CHEMBL234944,,None,458.57,0,3.66,14e,CC(C)(N)c1ccc(-c2nc(Nc3ccc(OCCN4CCOCC4)cc3)ncc2C#N)cc1,IC50,'=',450,nM,6.35,,,UO_0000065,13.84,0.25,2.69,5.81,0,CHEMBL894745,Inhibition of VEGFR2 activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.45
CHEMBL4548580,,None,547.73,2,6.37,21e,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1,Inhibition,'=',56,%,,,,UO_0000187,,,,,0,CHEMBL4377952,Inhibition of recombinant human KDR (790 to end residues) at 1 uM using MBP as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4376814,1,Scientific Literature,Eur J Med Chem,2019,None,,,,56
CHEMBL4468161,,None,453.43,0,3.48,138,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccc(C(F)(F)F)nn5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4436435,,None,505.63,2,5.16,173,CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3c4c(c5ncnc(N)c53)CCC4)cc2)n(-c2ccccc2)n1,IC50,'<',10,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,10
CHEMBL599993,,None,391.27,1,5.79,7,CC(Oc1ccc2ncc(/C=C/CN)cc2c1)c1c(Cl)ccc(F)c1Cl,IC50,'=',33000,nM,4.48,,,UO_0000065,11.45,0.24,-1.31,9.31,0,CHEMBL1066394,Inhibition of recombinant KDR by TR-FRET assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,33000
CHEMBL3264107,,None,411.44,1,5.73,52a,CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL3267962,Inhibition of VEGFR2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259517,1,Scientific Literature,J Med Chem,2014,None,,,,11
CHEMBL595373,,None,512.64,2,6.57,25,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,Residual activity,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL1073160,Residual activity of VEGFR2 at 0.1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,73
CHEMBL604879,,None,338.41,0,3.96,5,CCCCC(=Cc1coc2nc(=N)[nH]c(N)c12)c1ccccc1OC,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL1038900,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152608,1,Scientific Literature,Bioorg Med Chem,2009,CHEMBL3307756,,,,500
CHEMBL4514617,,None,546.89,2,6.52,13d,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2c2c1OCCO2,IC50,'=',2.4,nM,8.62,,,UO_0000065,15.76,0.31,2.1,8.3,0,CHEMBL4396022,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using Ulight-JAK-1(Tyr1023) peptide as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by spectrometric method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4393710,1,Scientific Literature,Eur J Med Chem,2019,None,,,,2.4
CHEMBL4282387,,None,635.67,1,3.45,27a,Cc1c(OCC(O)CN2CCN(C)CC2)cn2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4268571,Inhibition of VEGFR2 in HUVEC assessed as decrease in PI3K phosphorylation at 6 to 54 nM after 2 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265953,1,Scientific Literature,Eur J Med Chem,2018,None,,,,
CHEMBL241681,,None,506.46,2,7.55,15a,Nc1ncc(-c2ccccc2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,IC50,'=',30,nM,7.52,,,UO_0000065,14.85,0.28,-0.03,8.07,0,CHEMBL902104,Inhibition of human recombinant GST-6XHis-VEGFR2 by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138370,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,30
CHEMBL150817,,None,376.82,0,4.8,17,COCCOc1cc2nccc(Nc3ccc(Cl)cc3F)c2cc1OC,IC50,'=',10,nM,8,,,UO_0000065,21.23,0.42,3.2,15.21,0,CHEMBL812620,Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132549,1,Scientific Literature,J Med Chem,1999,None,,,,0.01
CHEMBL250394,,None,337.41,0,2.56,8l,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(C)c12,IC50,'=',58,nM,7.24,,,UO_0000065,21.45,0.41,4.68,10.03,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,58
CHEMBL250836,,None,357.83,0,2.91,8c,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2ccc(Cl)cc12,IC50,'=',152,nM,6.82,,,UO_0000065,19.05,0.39,3.91,9.45,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,152
CHEMBL151959,,None,454.57,1,5.31,22 (+/-),CCC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',12,nM,7.92,,,UO_0000065,17.42,0.32,2.61,12.48,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,12
CHEMBL593770,,None,584.75,2,5.71,22,COc1cc2c(N(C)c3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1073379,Inhibition of VEGFR2 by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL4167759,,None,395.44,0,4.9,16d,Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(F)c(F)c4)cc3)c12,IC50,'=',19.97,nM,7.7,,,UO_0000065,19.47,0.38,2.8,9.78,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,19.97
CHEMBL4171035,,None,442.4,1,5.42,17h,C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)n1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL4169220,,None,531.41,2,5.41,18g,Cc1cc(Br)ccc1NC(=O)C1(C(=O)Nc2ccc(-c3ccc4c(=O)nc[nH]c4c3)cc2)CCC1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,500
CHEMBL194746,,None,374.83,0,4.79,26,NC(=O)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'=',1300,nM,5.89,,,UO_0000065,15.7,0.3,1.1,7.28,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,1.3
CHEMBL196511,,None,340.39,0,4.14,39,NC(=O)c1ccc(-c2nnc(Nc3ccccc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL195727,,None,397.81,1,6.21,42,FC(F)(Cl)Oc1ccc(Nc2nnc(-c3ccccc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL196939,,None,388.86,1,5.05,43,CNC(=O)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'=',3100,nM,5.51,,,UO_0000065,14.17,0.27,0.46,8.23,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,3.1
CHEMBL4169054,,None,489.54,1,6.26,40d,COc1ccc2c(Oc3ccc(OCCN4CCCCC4)cc3)c(-c3ccc(F)cc3)c(=O)oc2c1,Inhibition,'=',55.13,%,,,,UO_0000187,,,,,0,CHEMBL4134006,Inhibition of His-tagged human VEGFR2 at 40 uM incubated for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130448,1,Scientific Literature,Eur J Med Chem,2017,None,,,,55.13
CHEMBL4169053,,None,475.52,1,5.96,42d,O=c1oc2cc(O)ccc2c(Oc2ccc(OCCN3CCCCC3)cc2)c1-c1ccc(F)cc1,Inhibition,'=',82.91,%,,,,UO_0000187,,,,,0,CHEMBL4134006,Inhibition of His-tagged human VEGFR2 at 40 uM incubated for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130448,1,Scientific Literature,Eur J Med Chem,2017,None,,,,82.91
CHEMBL4160821,,None,549.64,1,3.88,21c,CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5nnco5)ccc43)c3ccccc3)cc2)CC1,IC50,'=',4,nM,8.4,,,UO_0000065,15.28,0.28,4.52,7.86,0,CHEMBL4136262,Inhibition of recombinant VEGFR2 (unknown origin) by off-chip mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130560,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,4
CHEMBL4168811,,None,538.6,1,3.63,3; KBP-7018,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCOCC1)CC2)c1ccccc1,IC50,'=',110,nM,6.96,,,UO_0000065,12.92,0.24,3.33,6.94,0,CHEMBL4136262,Inhibition of recombinant VEGFR2 (unknown origin) by off-chip mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130560,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,110
CHEMBL4161351,,None,508.58,1,4.72,A17,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]cc(CN3CCOCC3)c2c1)c1ccccc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4132764,Inhibition of N-terminal biotinylated DYKDDDDK tagged human VEGFR2 (790 to 1356 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130391,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL526901,,None,277.33,0,3.65,15,CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL1035889,Binding affinity to human KDR at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,,,,
CHEMBL4443752,,None,541.56,2,6.93,9d,CCCCC(=O)Nc1cc(Oc2ccc(Nc3nccc4[nH]cc(-c5ccc(F)cc5)c(=O)c34)cc2F)ccn1,IC50,'=',26.9,nM,7.57,,,UO_0000065,13.98,0.26,0.64,6.95,0,CHEMBL4376512,Inhibition of purified recombinant VEGFR2 kinase domain (unknown origin) using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4373740,1,Scientific Literature,Eur J Med Chem,2020,None,,,,26.9
CHEMBL4174041,,None,491.66,1,5.13,12,CCc1ccc2nc(C(c3ccc(OC)c(OC)c3)n3cc(CCN4CCCCC4)nn3)sc2c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4135685,Inhibition of VEGFR2 in HUVEC assessed as decrease in VEGF-induced FAK phosphorylation at Tyr397 residues pretreated for 30 mins followed by VEGF stimulation for 20 mins by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130527,1,Scientific Literature,ACS Med Chem Lett,2017,None,,,,
CHEMBL4165827,,None,466.54,0,4.95,A5,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(CN(C)C)cc2c1)c1ccccc1,IC50,'=',138.3,nM,6.86,,,UO_0000065,14.7,0.27,1.91,7.93,0,CHEMBL4132764,Inhibition of N-terminal biotinylated DYKDDDDK tagged human VEGFR2 (790 to 1356 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4130391,1,Scientific Literature,Eur J Med Chem,2017,None,,,,138.3
CHEMBL3917220,,None,475.38,0,4.93,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3968522,,None,537.82,2,5.18,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL437322,,None,218.25,0,1.13,3c,N#Cc1cnc(Nc2cc(N)ncn2)s1,IC50,'=',41,nM,7.39,,,UO_0000065,33.85,0.67,6.26,7.35,0,CHEMBL860566,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138163,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,41
CHEMBL148880,,None,398.46,0,3.48,8,O=C1NCc2c1c1c(c3c2c2cc(CO)ccc2n3CCCO)Cc2ccccc2-1,IC50,'=',208,nM,6.68,,,UO_0000065,16.77,0.3,3.2,8.97,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,208
CHEMBL3962233,,None,610.55,2,6.35,19g,COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',279,nM,6.55,,,UO_0000065,10.74,0.21,0.2,6.31,0,CHEMBL3877876,Inhibition of N-terminal GST-tagged human VEGFR-2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3877259,1,Scientific Literature,Eur J Med Chem,2017,None,,,,279
CHEMBL3938494,,None,590.13,2,6,19h,COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4C)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',178,nM,6.75,,,UO_0000065,11.44,0.22,0.75,6.5,0,CHEMBL3877876,Inhibition of N-terminal GST-tagged human VEGFR-2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3877259,1,Scientific Literature,Eur J Med Chem,2017,None,,,,178
CHEMBL3968499,,None,432.53,0,3.8,272,CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',575.44,nM,6.24,,,UO_0000065,14.43,0.27,2.44,8.07,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.24
CHEMBL3898120,,None,458.57,0,4.41,207,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3937972,,None,514.51,1,4.25,648,COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',2290.87,nM,5.64,,,UO_0000065,10.96,0.21,1.39,5.97,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.64
CHEMBL3904736,,None,509.36,2,6.02,719,Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL4593593,,None,663.65,2,7.46,Roxyl-ZV-6H,Cc1nc2c(F)cc(-c3nc(Nc4ccc(CNC(=O)C5(C(=O)Nc6ccc(C(F)(F)F)cc6)CC5)cc4)ncc3F)cc2n1C(C)C,Inhibition,'=',74,%,,,,UO_0000187,,,,,0,CHEMBL4407837,Inhibition of recombinant human VEGFR2 (790 to end residues) using myelin ba as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4406821,1,Scientific Literature,Eur J Med Chem,2019,None,,,,74
CHEMBL563845,,None,387.44,0,4.97,EGFR_ErbB_2_Inhibitor,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,Residual Activity,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218936,,None,567.11,1,4.31,Met_Kinase_Inhibitor,CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,Residual Activity,'=',20,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1221601,,None,555.85,2,5.66,CGK733,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,Residual Activity,'=',102,%,,,,UO_0000187,,,,,0,CHEMBL2219238,Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4534119,,None,501.51,2,7.01,11k,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1,Inhibition,'=',99.2,%,,,,UO_0000187,,,,,0,CHEMBL4412391,Inhibition of VEGFR2 (unknown origin) at 100 nM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4411287,1,Scientific Literature,Eur J Med Chem,2019,None,,,,99.2
CHEMBL4474945,,None,393.47,0,4.41,6c,COc1ccc(C(=O)CSc2nccc(Nc3cccc(C(C)=O)c3)n2)cc1,IC50,'=',420,nM,6.38,,,UO_0000065,16.21,0.31,1.97,7.86,0,CHEMBL4399178,Inhibition of human N-terminal GST tagged VEGFR-2 expressed in baculovirus infected Sf9 cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4453308,,None,427.91,1,5.03,9a,CCOC(=O)c1ccc(Nc2ccnc(SCC(=O)c3ccc(Cl)cc3)n2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4399178,Inhibition of human N-terminal GST tagged VEGFR-2 expressed in baculovirus infected Sf9 cells using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1974310,,None,272.3,0,3.2,SID103904987,NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL272938,,None,358.41,0,4.16,SID103904299,Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1,Ki,'=',1.259,nM,8.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.9
CHEMBL1991008,,None,209.25,0,2.81,SID103905031,Nc1n[nH]c2c(-c3ccccc3)cccc12,Ki,'=',50118.72,nM,4.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.3
CHEMBL394619,,None,374.47,1,5.5,SID103904295,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1,Ki,'=',10,nM,8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8
CHEMBL2006836,,None,451.44,0,3.88,SID103905299,CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1980704,,None,345.43,0,4.13,SID103905204,Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL223367,,None,431.88,0,3.51,SID103905150,N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2001641,,None,243.27,0,1.37,SID103905295,CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1,Ki,'=',39810.72,nM,4.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.4
CHEMBL2004365,,None,459.57,0,0.99,SID103905320,CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL66570,,None,509.97,1,3.92,26o,CCN1CCN(C(=O)c2cc(C)c(/C=C3\C(=O)Nc4ncnc(Nc5ccc(F)c(Cl)c5)c43)[nH]2)CC1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL4470783,,None,462.55,1,6.15,21,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1cc(C)cc(C)c1,Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL4384926,Inhibition of VEGFR2 in human A549 cells assessed as reduction in ERK1/2 phosphorylation by measuring phosphorylated VEGFR2 level at 10 uM after 30 mins by Western blot assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,A549,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307651,,,,85
CHEMBL4457390,,None,482.96,1,6.5,25,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1ccc(Cl)c(C)c1,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4384899,Inhibition of VEGFR2 internalization in HMEC1 cells assessed as membrane VEGFR2 level at 15 uM after 24 hrs by flow cytometry (Rvb = 100%),B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,None,,,,80
CHEMBL4548509,,None,448.52,1,5.84,15,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1cccc(C)c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4384911,Inhibition of VEGFR2 internalization in HMEC1 cells at 8 uM after 24 hrs by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,None,,,,
CHEMBL4437831,,None,462.55,1,6.15,23,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)Nc1ccc(C)c(C)c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4384913,Inhibition of VEGFR2 internalization in HMEC1 cells at 12 uM after 24 hrs by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382260,1,Scientific Literature,Eur J Med Chem,2019,None,,,,
CHEMBL1081312,,None,319.37,0,3.07,PP121,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,IC50,'=',41,nM,7.39,,,UO_0000065,23.13,0.42,4.32,7.51,0,CHEMBL1243938,Inhibition of VEGFR2-mediated proliferation of HUVEC in VEGF-supplemented medium at 0.04 to 10 uM after 24 hrs by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,41
CHEMBL1230790,,None,269.31,0,2.36,S1,CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21,IC50,'=',213,nM,6.67,,,UO_0000065,24.77,0.46,4.31,7.43,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,0.213
CHEMBL1234815,,None,275.31,0,2.77,S2,Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,IC50,'=',1100,nM,5.96,,,UO_0000065,21.64,0.39,3.19,8.56,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,1.1
CHEMBL200217,,None,529.04,1,4.69,4,COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c1,IC50,'=',400,nM,6.4,,,UO_0000065,12.09,0.24,1.71,7.34,0,CHEMBL863346,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141956,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,0.4
CHEMBL405021,,None,277.33,0,3.58,SB-732941,O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1,Inhibition,'=',4.79,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.79
CHEMBL92564,,None,302.34,0,3.47,2e,COc1ccc(-c2cnc3c(-c4ccccn4)cnn3c2)cc1,IC50,'=',1000,nM,6,,,UO_0000065,19.85,0.36,2.53,11.47,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,1000
CHEMBL480371,GW853609X,None,496.31,1,5.55,GW853609X,NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br,Inhibition,'=',4.43,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.43
CHEMBL506153,GW876790X,None,330.35,0,0.03,GW876790X,CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21,Inhibition,'=',4.45,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.45
CHEMBL201090,,None,406.39,0,3.39,16a,COc1ccc2[nH]c3c4c(OC)c(OC)c(OC)cc4c4c(c3c2c1)C(=O)NC4=O,Inhibition,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL865273,Inhibition of human VEGFR2 expressed in Sf9 cells at 100 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,17
CHEMBL313500,,None,370.45,1,5.06,4i,COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2cc3c([nH]2)CCCC3)cc1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,20
CHEMBL371449,,None,454.48,0,4.43,19,COc1cc(C2=C(c3c(-c4ccccc4)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC,Inhibition,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL865272,Inhibition of human VEGFR2 expressed in Sf9 cells at 10 uM,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,CHEMBL3308860,,,,97
CHEMBL272414,GW416469X,None,358.42,0,1.81,GW416469X,CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',14.56,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,14.56
CHEMBL69757,GW817394X,None,362.37,0,3.41,GW817394X,COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1,Inhibition,'=',10.07,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,10.07
CHEMBL270054,GW280670X,None,350.79,0,1.76,GW280670X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1,Inhibition,'=',16.91,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,16.91
CHEMBL48362,,None,430.48,0,2.17,7,CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc(S(N)(=O)=O)cc2)C3=O)CC1,Inhibition,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL819554,Inhibition of Vascular endothelial growth factor receptor 2 (VEGF-KDR) at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135924,1,Scientific Literature,J Med Chem,2002,None,,,,25
CHEMBL3781261,,None,510,2,7.27,7f,COc1ccc(Cc2nnc(Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)c3ccccc23)cc1,IC50,'=',114,nM,6.94,,,UO_0000065,13.61,0.26,-0.33,7.87,0,CHEMBL3784202,Inhibition of recombinant human VEGFR-2 expressed in Spodoptera frugiperda cells after 5 mins by using biotinylated poly-GluTyr (4:1) as substrate by Alpha Screen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779892,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0.114
CHEMBL3780121,,None,443.86,1,6.65,4g,COc1ccc(Cc2nnc(Nc3ccc(Cl)c(C(F)(F)F)c3)c3ccccc23)cc1,IC50,'=',1340,nM,5.87,,,UO_0000065,13.23,0.26,-0.78,12.48,0,CHEMBL3784202,Inhibition of recombinant human VEGFR-2 expressed in Spodoptera frugiperda cells after 5 mins by using biotinylated poly-GluTyr (4:1) as substrate by Alpha Screen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779892,1,Scientific Literature,Eur J Med Chem,2016,None,,,,1.34
CHEMBL3780536,,None,341.41,0,4.97,4a,COc1ccc(Cc2nnc(Nc3ccccc3)c3ccccc23)cc1,IC50,'=',5760,nM,5.24,,,UO_0000065,15.35,0.28,0.27,11.14,0,CHEMBL3784202,Inhibition of recombinant human VEGFR-2 expressed in Spodoptera frugiperda cells after 5 mins by using biotinylated poly-GluTyr (4:1) as substrate by Alpha Screen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779892,1,Scientific Literature,Eur J Med Chem,2016,None,,,,5.76
CHEMBL243907,GW673715X,None,445.48,1,5.74,GW673715X,CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,Inhibition,'=',55.82,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,55.82
CHEMBL221736,,None,260.3,0,3.68,3,O=c1[nH]c2ccccc2cc1-c1cc2ccccc2[nH]1,IC50,'=',8,nM,8.1,,,UO_0000065,31.11,0.55,4.42,16.64,1,CHEMBL2020689,Inhibition of VEGFR-2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,8
CHEMBL2016894,,None,280.33,0,1.91,1,CN1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',1000,nM,6,,,UO_0000065,21.4,0.39,4.09,9.26,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,1
CHEMBL1909389,GW574782A,None,633.09,2,6.37,GW574782A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl,Inhibition,'=',4.72,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.72
CHEMBL3397945,,None,466.97,1,5.07,19g,O=C(Nc1ccc(OCCCN2CCOCC2)c(Cl)c1)c1cccc(-c2cccc(O)c2)c1,IC50,'=',125.82,nM,6.9,,,UO_0000065,14.78,0.29,1.83,9.71,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,125.82
CHEMBL3397919,,None,440.47,0,4.11,20g,COc1ccc(C(=O)Nc2ccc(OCCN(C)C)c(F)c2)c(-c2cccc(O)c2)c1O,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,
CHEMBL2016928,,None,399.45,0,3.82,44,Cc1cccc(NC(=O)N2CCc3nc(-c4cc5ccccc5[nH]c4=O)[nH]c3C2)c1,IC50,'=',2.1,nM,8.68,,,UO_0000065,21.72,0.4,4.86,9.24,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.0021
CHEMBL3633758,,None,388.81,0,3.31,6a,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OCCC(=O)NO,IC50,'=',476,nM,6.32,,,UO_0000065,16.26,0.32,3.01,5.99,0,CHEMBL3636774,Inhibition VEGFR2 (unknown origin) for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632579,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,476
CHEMBL3808619,,None,382.42,0,3.96,23,CC(=O)Nc1cc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)cc2)[nH]n1,IC50,'=',21,nM,7.68,,,UO_0000065,20.08,0.37,3.72,6.15,0,CHEMBL3812631,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808391,1,Scientific Literature,ACS Med Chem Lett,2016,None,,,,0.021
CHEMBL3593289,,None,547.69,2,5.38,7g,CCCCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(C)CC5)nc(C)n4)s3)cc2)no1,IC50,'=',55,nM,7.26,,,UO_0000065,13.26,0.25,1.88,5.84,0,CHEMBL3595190,Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3593229,1,Scientific Literature,Eur J Med Chem,2015,CHEMBL3308860,,,,0.055
CHEMBL3589749,,None,408.82,1,5.2,9n,O=C(Nc1ccc(Cl)cc1)Nc1ccc(/N=C2\C(=O)Nc3ccc(F)cc32)cc1,IC50,'=',1930,nM,5.71,,,UO_0000065,13.98,0.27,0.51,6.92,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,1.93
CHEMBL95502,,None,394.5,0,4.21,SB-221466,CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1,Inhibition,'=',-0.9,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,-0.9
CHEMBL1909342,,None,395.44,0,1.77,SB-657836-AAA,N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O,Inhibition,'=',6.56,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.56
CHEMBL4111809,,None,559.63,1,3.67,BDBM173429,CC(=O)Nc1cccc(Nc2nc3cnc(Nc4ccc(C(=O)N[N+]5=CCN(C)CC5)cc4F)nc3n2C(C)C)c1,IC50,'>',1000,nM,,,318774,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3696076,,None,537.65,1,3.71,BDBM144591,Cc1ccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCOCC4)c3C(N)=O)cc2)cc1,IC50,'=',8,nM,8.1,,280951,UO_0000065,15.06,0.29,4.39,5.37,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL588025,GW770249A,None,467.81,1,5.27,GW770249A,Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,Inhibition,'=',63.76,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,63.76
CHEMBL493326,GSK-317314A,None,427.91,0,4.99,GSK317314A,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1,Inhibition,'=',13.37,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,13.37
CHEMBL1909369,GW693917A,None,556.93,2,7.07,GW693917A,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl,Inhibition,'=',69.84,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,69.84
CHEMBL4290281,,None,356.81,0,4.63,Yfq09,COc1ccc(OC)c(Nc2cc(Nc3ccc(Cl)cc3)ncn2)c1,Inhibition,'=',6.5,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,6.5
CHEMBL4283517,,None,386.84,0,4.64,Yfq13,COc1cc(Nc2cc(Nc3ccc(Cl)cc3)ncn2)cc(OC)c1OC,Inhibition,'=',37.1,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,37.1
CHEMBL4289280,,None,342.76,0,4.27,Yfq36,O=C(Nc1cc(Nc2cccc(Cl)c2)ncn1)c1ccc(F)cc1,Inhibition,'=',-0.6,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,-0.6
CHEMBL4283515,,None,415.28,1,5.19,Yfq55,COc1ccc(/C=C/C(=O)Nc2cc(Nc3ccc(Cl)cc3Cl)ncn2)cc1,Inhibition,'=',6.1,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,6.1
CHEMBL2016894,,None,280.33,0,1.91,1,CN1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',1000,nM,6,,,UO_0000065,21.4,0.39,4.09,9.26,0,CHEMBL2020689,Inhibition of VEGFR-2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,1
CHEMBL1794068,GSK-326090A,None,558.63,2,6.07,GSK326090A,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,Inhibition,'=',34.43,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,34.43
CHEMBL4289040,,None,429.5,0,2.89,21,COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,Inhibition,'=',7,%,,,,UO_0000187,,,,,0,CHEMBL4255116,Inhibition of recombinant human His-tagged KDR cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251655,1,Scientific Literature,Eur J Med Chem,2018,None,,,,7
CHEMBL218088,GW435821X,None,268.32,0,2.67,GW435821X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1,Inhibition,'=',4.56,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.56
CHEMBL271594,GW300653X,None,358.42,0,2.23,GW300653X,CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1,Inhibition,'=',4.21,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,4.21
CHEMBL4278518,,None,393.43,0,1.15,Yfq85,CCOC(=O)CCC(=O)Nc1cc(Nc2ccc(S(N)(=O)=O)cc2)ncn1,Inhibition,'=',7.7,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,7.7
CHEMBL560733,,None,441.5,0,3.4,1,Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1,Inhibition,'=',-5.84,%,,,,UO_0000187,,,,,0,CHEMBL1054876,Inhibition of VEGFR2 at 10 uM by HotSpot assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153464,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,-5.84
CHEMBL4533447,,None,398.41,0,2.54,15,COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,GI50,'=',540,nM,,,,UO_0000065,,,,,0,CHEMBL4337762,Inhibition of TEL-fused VEGFR2 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,None,,,,0.54
CHEMBL4572320,,None,400.43,0,2.76,16,COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O,GI50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL4337762,Inhibition of TEL-fused VEGFR2 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,None,,,,25
CHEMBL4453304,,None,398.41,0,2.54,17,COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4337784,Inhibition of rhVEGF-A-induced of VEGFR2 phosphorylation at Tyr1175 residue in HUVEC at 0.1 uM incubated for 2 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,CHEMBL3307501,,,,
CHEMBL2377470,,None,464.55,1,6.56,1c,COc1ccc(Oc2nnnc3cc(-c4cn(Cc5ccccc5)c5ccccc45)sc23)cc1,Inhibition,'=',1.7,%,,,,UO_0000187,,,,,0,CHEMBL2379186,Inhibition of human recombinant VEGFR2 at 200 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375356,1,Scientific Literature,Eur J Med Chem,2013,None,,,,1.7
CHEMBL2385579,,None,346.39,0,2.62,13a,c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1,IC50,'=',1.68,nM,8.78,,,UO_0000065,25.33,0.46,6.15,12.3,0,CHEMBL2390517,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384981,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,1.68
CHEMBL4530473,,None,398.41,0,2.54,18,COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)C/C=C/[C@H](C)OC2=O,IC50,'=',14,nM,7.85,,,UO_0000065,19.71,0.37,5.31,6.93,0,CHEMBL4337764,Inhibition of human VEGFR2 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334496,1,Scientific Literature,J Med Chem,2019,None,,,,14
CHEMBL4286178,,None,332.36,0,3.58,Yfq45,O=C(/C=C/c1ccccc1)Nc1cc(Nc2ccc(O)cc2)ncn1,Inhibition,'=',1.3,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,1.3
CHEMBL4289137,,None,384.44,0,1.78,Yfq68,CN1CCN(c2ccc(Nc3cc(NC(=O)CCC(=O)O)ncn3)cc2)CC1,Inhibition,'=',18.8,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,18.8
CHEMBL4289032,,None,470.57,1,5.02,Yfq91,CCCC(C)OC(=O)CCC(=O)Nc1cc(Nc2cccc(C(=O)OC(C)CCC)c2)ncn1,Inhibition,'=',4.9,%,,,,UO_0000187,,,,,0,CHEMBL4267375,Inhibition of N-terminal GST-tagged human KDR cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265907,1,Scientific Literature,Eur J Med Chem,2018,None,,,,4.9
CHEMBL47962,,None,343.39,0,3.48,5d,Cc1cc(C)cc(Nc2nccc(-n3ccnc3-c3cncnc3)n2)c1,IC50,'=',149,nM,6.83,,,UO_0000065,19.88,0.36,3.35,8.39,0,CHEMBL811942,Biochemical inhibition of phosphorylation of a poly-Glu/Tyr (4:1) peptide substrate by isolated vascular endothelial growth factor receptor 2 (cloned and expressed as a GST-fusion protein).,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136377,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,149
CHEMBL3800022,,None,557.55,2,6.28,13k,CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2F)ccn1,Inhibition,,,%,,,Not Determined,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,
CHEMBL3798456,,None,544.42,2,6.17,13t,CN(C)CCCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)cc3Cl)cc2F)ccn1,Inhibition,'=',11.3,%,,,,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,11.3
CHEMBL4871367,,None,463.54,0,3.55,8a,O=C(CN1CCN(c2cc(=O)[nH]c3ccc(F)cc23)CC1)Nc1nc(-c2ccccc2)cs1,IC50,'=',46.83,nM,7.33,,,UO_0000065,15.81,0.3,3.78,9.01,0,CHEMBL4822643,Inhibition of VEGFR-2 (unknown origin) by using poly (Glu:Tyr 4:1) as substrate measured after 45 mins by Kinase-Glo max based microplate reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819122,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 0.75 hr,INHIBITOR,,46.83
CHEMBL2180603,,None,320.4,0,2.96,SKLB1002,COc1cc2ncnc(Sc3nnc(C)s3)c2cc1OC,IC50,'=',32,nM,7.5,,,UO_0000065,23.39,0.49,4.53,10.7,1,CHEMBL3757179,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751764,1,Scientific Literature,Medchemcomm,2015,None,,,,32
CHEMBL4858980,,None,442.45,0,4.82,W19,CCNc1n[nH]c2cc(-c3cnn(CC(=O)Nc4ccc(C)c(C(F)(F)F)c4)c3)ccc12,IC50,'=',38,nM,7.42,,,UO_0000065,16.77,0.32,2.6,8.47,0,CHEMBL4820638,Inhibition of VEGFR2 (unknown origin) incubated for 10 mins followed by kinase substrate addition and measured after 30 mins by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 0.6667 hr,INHIBITOR,,38
CHEMBL4877128,,None,492.5,1,6.09,W25,Cc1ccc(NC(=O)Cc2ccc(-c3ccc4c(NC(=O)C5CC5)n[nH]c4c3)cc2)cc1C(F)(F)F,INH,'=',92.4,uM,,,,UO_0000064,,,,,0,CHEMBL4820637,Inhibition of VEGFR2 (unknown origin) at 1 uM incubated for 10 mins followed by kinase substrate addition and measured after 30 mins by caliper mobility shift assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 1.0 microM | TIME = 0.6667 hr,INHIBITOR,,92.4
CHEMBL4861302,,None,400.36,0,3.67,W7,Nc1n[nH]c2cc(-c3cnn(CC(=O)Nc4cccc(C(F)(F)F)c4)c3)ccc12,IC50,'=',7.4,nM,8.13,,,UO_0000065,20.31,0.38,4.46,8,0,CHEMBL4820638,Inhibition of VEGFR2 (unknown origin) incubated for 10 mins followed by kinase substrate addition and measured after 30 mins by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4819027,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 0.6667 hr,INHIBITOR,,7.4
CHEMBL566515,,None,417.43,0,2.35,66,COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12,Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL1045671,Binding affinity to VEGFR2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154183,1,Scientific Literature,J Med Chem,2009,None,,,,96
CHEMBL510320,,None,1266.6,None,None,GU40B,CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CNCCCCN,Activity,,,,,,Active,,,,,,0,CHEMBL956465,Displacement of GU40C-FITC form human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL69827,,None,402.45,0,3.53,9,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CC(O)C(O)C1,IC50,'=',270,nM,6.57,,,UO_0000065,16.32,0.3,3.04,6.17,0,CHEMBL817617,Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132739,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.27
CHEMBL1996923,,None,188.02,0,2.26,SID103905681,Clc1cc2nn[nH]c2cc1Cl,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL305782,,None,455.88,0,4.47,26b,Cc1[nH]c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)c(C)c1CCC(=O)O,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL406660,,None,362.36,0,4.86,36,Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c12,IC50,'=',134,nM,6.87,,,UO_0000065,18.97,0.35,2.01,7.38,0,CHEMBL949290,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142358,1,Scientific Literature,J Med Chem,2008,None,,,,134
CHEMBL410840,,None,456.42,1,5.49,19,COc1cc2nccc(Oc3ccc4c(C(=O)NCC(F)(F)F)cccc4c3)c2cc1OC,IC50,'=',3.8,nM,8.42,,,UO_0000065,18.45,0.35,2.93,12.08,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,3.8
CHEMBL406914,,None,430.5,1,5.73,18,COc1cc2nccc(Oc3ccc4c(C(=O)NC(C)(C)C)cccc4c3)c2cc1OC,IC50,'=',1500,nM,5.82,,,UO_0000065,13.53,0.25,0.09,8.36,0,CHEMBL951280,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144684,1,Scientific Literature,J Med Chem,2008,None,,,,1500
CHEMBL1784637,,None,582.63,1,2.87,8h,CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C,IC50,'=',2.3,nM,8.64,,,UO_0000065,14.83,0.28,5.77,8.41,0,CHEMBL1785585,Inhibition of human VEGFR2 using poly[Glu:Tyr] by Hotspot assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781971,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,2.3
CHEMBL330042,,None,283.4,0,4.51,4,c1cc(-c2cnn3cc(C4CCCCC4)cnc23)cs1,IC50,'=',280,nM,6.55,,,UO_0000065,23.12,0.45,2.04,21.71,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,280
CHEMBL392329,,None,332.37,0,2.65,30,O=C(Nc1ccc2cn[nH]c2c1)c1ccnn1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL233821,,None,332.37,0,2.65,29,O=C(Nc1ccc2[nH]ncc2c1)c1ccnn1CCc1ccncc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,10
CHEMBL2088110,,None,301.31,0,1.34,23,Cc1cc(CNc2nccc(Nc3cc(CO)[nH]n3)n2)on1,IC50,'=',19952.62,nM,4.7,,,UO_0000065,15.6,0.29,3.36,3.77,0,CHEMBL2090013,Inhibition of recombinant N terminal GST-tagged human KDR (805 to 1356) expressed in baculovirus infected Sf9 cells after 90 mins by caliper mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086247,1,Scientific Literature,J Med Chem,2012,CHEMBL3308860,,,,4.7
CHEMBL233824,,None,348.45,0,4.07,44,CC(C)(C)c1ccc(NC(=O)c2nccn2CCc2ccncc2)cc1,IC50,'=',2250,nM,5.65,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,2.25
CHEMBL391069,,None,343.39,0,3.32,28,O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1,IC50,'=',1220,nM,5.91,,,UO_0000065,,,,,0,CHEMBL897503,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA,F,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307715,,,,1.22
CHEMBL374259,,None,566.56,2,6.77,53,CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2F)n1,IC50,'=',2000,nM,5.7,,,UO_0000065,10.06,0.19,-1.07,6.18,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,2000
CHEMBL233823,,None,394.78,0,4.45,32,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1,Ki,'=',170,nM,6.77,,,UO_0000065,,,,,0,CHEMBL897502,Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148870,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.17
CHEMBL218057,,None,430.47,0,4.45,34,COc1cc(Nc2ncnc(-c3cccnc3Nc3ccccc3)n2)cc(OC)c1OC,IC50,'>=',5000,nM,,,,UO_0000065,,,,,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,5000
CHEMBL223528,,None,431.5,0,4.79,34f,COCCOc1ccc(-c2ccc(NC(=O)Nc3cccc(C)c3)cc2)c2c(N)n[nH]c12,IC50,'=',15,nM,7.82,,,UO_0000065,,,,,0,CHEMBL920442,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,15
CHEMBL2152768,,None,504.61,1,4.13,3,CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1,Inhibition,'=',-16.4,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2157155,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2151019,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,-16.4
CHEMBL2180567,,None,488.82,0,4.66,III-8,N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(Cl)cc3)nc(Br)c3cccnc23)CC1,Inhibition,'=',34,%,,,,UO_0000187,,,,,0,CHEMBL2185480,Inhibition of KDR at 10 uM incubated for 60 mins using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2180881,,None,379.37,0,2.16,17,COc1cc(C2=C(c3c[nH]c4cccnc34)C(=O)NC2=O)cc(OC)c1OC,IC50,'=',373,nM,6.43,,,UO_0000065,16.94,0.31,4.27,6.27,0,CHEMBL2183649,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2177085,1,Scientific Literature,J Med Chem,2012,None,,,,373
CHEMBL2204531,,None,553.02,2,6.14,4,CC(=O)Nc1nc2ccc(N(C)c3ccc(F)c(NC(=O)c4cccc(OC(C)(C)C#N)c4Cl)c3)nc2s1,IC50,'=',14,nM,7.85,,,UO_0000065,14.2,0.28,1.71,6.53,0,CHEMBL2210733,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2203033,1,Scientific Literature,Bioorg Med Chem,2012,None,,,,14
CHEMBL2348093,,None,489.38,1,5.21,BRN-250,CC(c1ncnc(Cl)c1F)N1CCC(Nc2ncccc2C(=O)Nc2cccc(Cl)c2)CC1,Inhibition,,,%,,,Dose-dependent effect,UO_0000187,,,,,0,CHEMBL2352587,Inhibition of VEGF-induced VEGFR2 phosphorylation at Tyr1175 in human HUVEC cell incubated 1 hr prior to VEGF-challenge measured after 5 mins by PathScan ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2346518,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3307501,,,,
CHEMBL3702634,,None,388.48,0,3.39,BDBM139574,CC(C)c1cccc(NC(=O)c2ccnc(N3CCc4nc(N)ncc4C3)c2)c1,IC50,'>',10000,nM,,,273934,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702652,,None,419.55,0,4.24,BDBM139592,CC(C)c1ccc(NC(=O)c2ccnc(N3CCc4nc(CS)ncc4C3)c2)cc1,IC50,'>',10000,nM,,,273952,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702657,,None,458.51,1,5.05,BDBM139597,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1N1CCc2nc(CS)ncc2C1,IC50,'=',71,nM,7.15,,273957,UO_0000065,15.59,0.31,2.1,12.3,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702661,,None,427.43,0,4.2,BDBM139601,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1N1CCc2nc(N)ncc2C1,IC50,'=',8,nM,8.1,,273961,UO_0000065,18.94,0.36,3.9,9.62,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL224547,,None,466.61,0,4.89,71,CN1CCN(c2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',11,nM,7.96,,,UO_0000065,17.06,0.32,3.07,17.93,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,11
CHEMBL376779,,None,543.72,1,3.79,44,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNS(=O)(=O)c5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',45,nM,7.35,,,UO_0000065,13.51,0.26,3.56,9.03,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,45
CHEMBL271271,,None,413.48,0,4.96,10,COc1cccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1,IC50,'<',16000,nM,,,,UO_0000065,,,,,0,CHEMBL946935,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143258,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,16
CHEMBL3780151,,None,350.78,1,5.23,9d,Fc1ccc(Nc2cncc3nc(-c4ccccc4)cnc23)cc1Cl,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,100
CHEMBL3781696,,None,413.48,0,4.28,20n,COc1ccc(-c2cnc3cncc(Nc4ccc(N5CCOCC5)cc4)c3n2)cc1,IC50,'=',3310,nM,5.48,,,UO_0000065,13.25,0.24,1.2,7.57,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,3.31
CHEMBL3690432,,None,501.51,1,4.01,BDBM128490,CNC(=O)C(C)(C)/N=C/C(C=N)c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1,IC50,'=',50.8,nM,7.29,,259717,UO_0000065,14.54,0.28,3.28,5.89,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690434,,None,525.54,1,4.56,BDBM128492,CC(C)(C(=O)NC1CC1)n1cc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)cn1,IC50,'=',55,nM,7.26,,259719,UO_0000065,13.81,0.26,2.7,6.89,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690442,,None,510.52,1,3.89,BDBM128500,CN1CCN(c2ncc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CC1,IC50,'=',73.4,nM,7.13,,259728,UO_0000065,13.97,0.26,3.24,7.87,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690464,,None,441.41,0,4.76,BDBM128522,COc1cccc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1,IC50,'=',79,nM,7.1,,259750,UO_0000065,16.09,0.3,2.34,8.82,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690468,,None,428.37,0,3.44,BDBM128526,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4c[nH]c(=O)cn4)ccn23)c1,IC50,'=',180,nM,6.75,,259755,UO_0000065,15.75,0.3,3.3,6.47,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3644022,,None,459.49,0,4.1,BDBM129349,C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(=O)C3CCCC3)cc2)ncc1C(F)(F)F,IC50,'=',230,nM,6.64,,260766,UO_0000065,14.45,0.29,2.54,6.55,0,CHEMBL3705462,Kinase Assay: VEGF receptor tyrosine kinase (90 ng/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3644024,,None,433.45,0,3.57,BDBM129351,CC(C)S(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(O[C@H](C)[C@@H](C)O)n2)cc1,IC50,'=',170,nM,6.77,,260768,UO_0000065,15.62,0.32,3.2,6.68,0,CHEMBL3705462,Kinase Assay: VEGF receptor tyrosine kinase (90 ng/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690580,,None,480.37,1,5.16,BDBM128643,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4cnc(C(F)(F)F)nc4)ccn23)c1,IC50,'=',63,nM,7.2,,259894,UO_0000065,14.99,0.29,2.04,8.55,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694668,,None,442.4,0,3.63,BDBM128682,O=C(NCC(F)(F)F)Nc1cccc(-c2cnc3cc(-c4ncc(CO)cn4)ccn23)c1,IC50,'=',240,nM,6.62,,259916,UO_0000065,14.96,0.28,2.99,6.34,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694653,,None,496.5,0,3.93,BDBM128666,Nc1nc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1CN1CCC1,IC50,'=',140,nM,6.85,,259922,UO_0000065,13.8,0.26,2.92,6.04,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL254913,,None,427.42,1,3.93,9b,Nc1ccc(NC(=O)Nc2cccc3c2C(=O)c2c-3n[nH]c2-c2ccc(O)c(O)c2)cc1,Inhibition,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL928531,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140772,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,58
CHEMBL3809587,,None,428.49,0,4.83,6a,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C)c4)ccc3C)cnc2[nH]1,Inhibition,'=',72,%,,,,UO_0000187,,,,,0,CHEMBL3812147,Inhibition of full length His-tagged human recombinant VEGFR2 expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808348,1,Scientific Literature,J Med Chem,2016,None,,,,72
CHEMBL398296,,None,343.8,0,2.6,14b,Cn1cc(/C=C2\C(=O)NN=C2c2cnns2)c2cc(Cl)ccc21,Inhibition,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL903322,Inhibition of human VEGFR2 in HUVEC at 50 nM by phosphorylation assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307501,,,,26
CHEMBL247866,,None,442.56,1,5.85,32,CC(C)Nc1ncnc2oc(-c3ccc(OCCN4CCCC4)cc3)c(-c3ccccc3)c12,IC50,'=',537,nM,6.27,,,UO_0000065,14.17,0.26,0.42,9.89,0,CHEMBL902561,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139142,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,0.537
CHEMBL257787,,None,385.43,0,3.04,21,CO/N=C/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,'=',18,nM,7.75,,,UO_0000065,20.09,0.36,4.7,9.19,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,18
CHEMBL258015,,None,455.56,0,4.56,35,CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',7,nM,8.15,,,UO_0000065,17.9,0.33,3.59,11.1,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,7
CHEMBL258433,,None,441.54,0,4.46,29,C/C(=N\OCC(C)C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4,IC50,'=',10,nM,8,,,UO_0000065,18.12,0.33,3.54,9.49,0,CHEMBL929873,Inhibition of human recombinant VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,10
CHEMBL257794,,None,441.54,0,4.46,26,CCO/N=C(/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4)C(C)C,IC50,,,,,,Not Determined,,,,,,0,CHEMBL929874,Inhibition of VEGF-stimulated VEGFR2 autophosphorylation in HUVEC cells at 50 nM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141537,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307501,,,,
CHEMBL400568,,None,427.51,0,4.21,15b,CCCNCc1cncc(-c2cnc3[nH]nc(-c4nc5c(COC)cccc5[nH]4)c3c2)c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,
CHEMBL4286011,,None,361.45,0,4.25,17d,Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(NC(C)(C)C)ncc32)cc1,IC50,'=',84.5,nM,7.07,,,UO_0000065,19.57,0.36,2.82,7.78,0,CHEMBL4268024,Inhibition of recombinant human N-terminal His6-tagged KDR (790 to end residues) expressed in baculovirus infected Sf21 insect cells after 60 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265936,1,Scientific Literature,Eur J Med Chem,2018,None,,,,84.5
CHEMBL249303,,None,447.55,1,5.56,9d,CCN(CC)Cc1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12,IC50,'=',1550,nM,5.81,,,UO_0000065,12.98,0.23,0.25,6.73,0,CHEMBL888276,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140014,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,1.55
CHEMBL240158,,None,490.01,0,4.29,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4277848,,None,636.66,1,3.66,27b,Cc1c(OCC(O)CN2CCC(O)CC2)cn2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12,IC50,'=',6.6,nM,8.18,,,UO_0000065,12.85,0.24,4.52,5.43,0,CHEMBL4268564,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4527240,,None,435.83,0,4.89,7v,O=C(Nc1ccc(Nc2ccc([N+](=O)[O-])c3ncnc(O)c23)cc1)c1cccc(Cl)c1,Inhibition,'=',63.2,%,,,,UO_0000187,,,,,0,CHEMBL4410421,Inhibition of VEGFR2 (unknown origin) at 1 uM using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3401903,,None,511.75,2,6.24,6,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4[C@@H](C)[C@H](C)CC[C@]4(C)CC[C@]23C)[C@@]1(C)C(N)=O,Inhibition,'=',44,%,,,,UO_0000187,,,,,0,CHEMBL3405094,Inhibition of VEGFR-2 (unknown origin) at 50 uM after 1 hr by luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399926,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,44
CHEMBL306284,,None,347.81,0,4.41,table5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL396219,,None,437.86,0,3.92,table5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL433321,,None,347.81,0,4.41,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1984274,,None,424.42,0,2.44,SID103905483,O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2002105,,None,213.04,0,1.3,SID103905528,Nc1n[nH]c2ncc(Br)cc12,Ki,'=',19952.62,nM,4.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.7
CHEMBL2004934,,None,350.39,0,4.39,SID103904558,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL3093581,,None,523.52,2,5.02,25a,O=C(Nc1ccc(Oc2ccc3nc(NC(=O)C4CC4)cn3c2)c(F)c1)c1cccn(-c2ccccc2)c1=O,IC50,'=',0.14,nM,9.85,,,UO_0000065,18.82,0.35,4.83,9.23,0,CHEMBL3094546,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 60 mins followed by 1000 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,0.14
CHEMBL3093587,,None,509.53,1,3.61,3c,Cn1cc(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)cc2)c(=O)n1-c1ccccc1,IC50,'=',20,nM,7.7,,,UO_0000065,15.11,0.28,4.09,6.18,0,CHEMBL3094546,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 60 mins followed by 1000 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,20
CHEMBL1977134,,None,532.48,2,6.04,SID103904270,Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12,Ki,'=',12.59,nM,7.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.9
CHEMBL2000408,,None,438.48,0,4.18,SID103904770,Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2004515,,None,239.23,0,2.35,SID103905089,c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.6
CHEMBL1967531,,None,361.43,0,4.58,SID103904284,Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,Ki,'=',158.49,nM,6.8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.8
CHEMBL512380,,None,379.24,0,3.76,31,O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1034022,Inhibition of VEGFR2 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL458532,,None,439.34,1,5.32,32,O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1034022,Inhibition of VEGFR2 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136839,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,10
CHEMBL1965387,,None,500.99,2,6.38,SID103904860,Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,Ki,'=',15.85,nM,7.8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.8
CHEMBL1990288,,None,399.43,1,5.36,SID103904410,CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL3287592,,None,543.53,2,5.85,10f,CC(=O)c1cccc(Nc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)n2)c1,IC50,'=',181,nM,6.74,,,UO_0000065,12.4,0.23,0.89,5.51,0,CHEMBL3291812,Inhibition of VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL463054,MACROSPORIN,None,284.27,0,2.19,2,COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O,IC50,'=',2.4,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL1026232,Inhibition of recombinant VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151842,1,Scientific Literature,J Nat Prod,2009,None,,,,2.4
CHEMBL256718,,None,338.79,0,4.57,8,O=C(Nc1ccc(Cl)cc1)c1ccccc1OCc1ccncc1,Inhibition,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL929241,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145619,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,54
CHEMBL402504,,None,536.65,2,5.77,8d,CCN(CC)C(=O)c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1,IC50,'=',386,nM,6.41,,,UO_0000065,11.95,0.24,0.64,7.68,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,386
CHEMBL518646,,None,482.97,0,3.1,8d,Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NCCN1CCOCC1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL972550,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156722,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,100
CHEMBL601719,CRIZOTINIB,4,450.35,1,5.04,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL258396,,None,518.6,2,5.08,10f,Cn1ncnc1-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1,IC50,'=',28,nM,7.55,,,UO_0000065,14.56,0.29,2.47,8.04,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,28
CHEMBL516639,,None,494.47,1,6.69,5d,COc1cc2nccc(Oc3ccc4c(Nc5ccc(C(F)(F)F)cc5)nn(C)c4c3)c2cc1OC,IC50,'=',70,nM,7.16,,,UO_0000065,14.47,0.27,0.46,10.16,0,CHEMBL973628,Inhibition of recombinant KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157345,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.07
CHEMBL527110,,None,319.39,0,3.61,16,Nc1ccnc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL995227,Inhibition of recombinant KDR expressed in baculovirus-Sf21 system,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156614,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,100
CHEMBL4175949,,None,428.35,1,5.93,16c,Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(Cl)cc4Cl)cc3)c12,IC50,'=',24.33,nM,7.61,,,UO_0000065,17.77,0.37,1.68,9.67,0,CHEMBL4140580,Inhibition of VEGFR2 (unknown origin) using Poly E4Y1 substrate after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4138129,1,Scientific Literature,Eur J Med Chem,2017,None,,,,24.33
CHEMBL270828,,None,356.43,0,3.56,5b,CCn1c2ccccc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',15,nM,7.82,,,UO_0000065,21.95,0.4,4.26,15.09,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,15
CHEMBL403402,,None,430.37,1,5.01,13k,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,IC50,'=',2.4,nM,8.62,,,UO_0000065,20.03,0.38,3.61,7.93,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,2.4
CHEMBL255956,,None,358.41,0,4.16,13d,Cc1ccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)cc1,IC50,'=',2.9,nM,8.54,,,UO_0000065,23.82,0.43,4.38,7.85,0,CHEMBL930117,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,2.9
CHEMBL223360,LINIFANIB,3,375.41,0,4.9,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL272938,,None,358.41,0,4.16,11a,Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1,IC50,'=',0.6,nM,9.22,,,UO_0000065,25.73,0.47,5.06,8.48,0,CHEMBL930118,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142252,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3307716,,,,0.6
CHEMBL3093586,,None,493.53,0,4.62,3b,Cc1cc(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)cc2)nn1-c1ccccc1,IC50,'=',89,nM,7.05,,,UO_0000065,14.29,0.26,2.43,6.11,0,CHEMBL3094552,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 5 mins followed by 10 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,89
CHEMBL3985692,,None,500.56,1,4.79,223,COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1,IC50,'=',112.2,nM,6.95,,,UO_0000065,13.88,0.26,2.16,6.91,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.95
CHEMBL3893642,,None,432.53,0,3.88,645,COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',38.9,nM,7.41,,,UO_0000065,17.13,0.32,3.53,8.39,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.41
CHEMBL3985182,,None,476.54,0,4.63,690,COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',630.96,nM,6.2,,,UO_0000065,13.01,0.24,1.57,7.93,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.2
CHEMBL3926245,,None,585.71,1,4.88,620,COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',95.5,nM,7.02,,,UO_0000065,11.99,0.22,2.14,7.16,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.02
CHEMBL3966200,,None,496.56,0,4.82,728,COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',60.26,nM,7.22,,,UO_0000065,14.54,0.27,2.4,9.34,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.22
CHEMBL3983918,,None,614.5,1,4.24,730,COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F,IC50,'=',33.88,nM,7.47,,,UO_0000065,14.93,0.28,3.23,7.1,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.47
CHEMBL3974273,,None,491.56,0,4.21,689,COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',602.56,nM,6.22,,,UO_0000065,12.65,0.23,2.01,5.97,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.22
CHEMBL3896142,,None,460.54,0,3.9,756,COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2,IC50,'=',33.88,nM,7.47,,,UO_0000065,16.22,0.3,3.57,8.63,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.47
CHEMBL3908707,,None,460.58,0,4.53,757,COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',42.66,nM,7.37,,,UO_0000065,16,0.3,2.84,10.75,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.37
CHEMBL3953771,,None,576.44,2,5.34,791,COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1,IC50,'=',138.04,nM,6.86,,,UO_0000065,11.9,0.23,1.52,6.84,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.86
CHEMBL3959787,,None,507.55,1,4.04,793,COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6
CHEMBL3986861,,None,519.05,0,4.19,631,COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',338.84,nM,6.47,,,UO_0000065,13.41,0.25,2.28,8.37,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.47
CHEMBL2032023,,None,538.58,2,6.26,48c,C=C(C)Cn1c(C)c(C(=O)Nc2ccc(Oc3ccnc4cc(OC)ccc34)c(F)c2)c(=O)n1-c1ccccc1,Ki,'=',74.1,nM,7.13,,,UO_0000065,13.24,0.24,0.87,8.16,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,74.1
CHEMBL3644029,,None,429.34,0,3.97,BDBM129356,CS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(OCCC(F)(F)F)n2)cc1,IC50,'>',1000,nM,,,260773,UO_0000065,,,,,0,CHEMBL3705462,Kinase Assay: VEGF receptor tyrosine kinase (90 ng/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2023501,,None,486.5,0,3.56,22,CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(Nc4cccnc4)nc3n(C)c2=O)c1F,Inhibition,'>',90,%,,,,UO_0000187,,,,,0,CHEMBL2026968,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021811,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,90
CHEMBL3578239,,None,335.36,0,3.52,6m,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4226907,,None,503.76,1,4.88,8a,O=C(N/N=C/c1ccc(F)cc1Cl)N1CCc2ncnc(Nc3cccc(Br)c3)c2C1,IC50,'=',133.2,nM,6.88,,,UO_0000065,13.65,0.3,2,8.33,0,CHEMBL4221533,Inhibition of VEGFR2 (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219106,1,Scientific Literature,Bioorg Med Chem,2018,None,,,,133.2
CHEMBL3099460,,None,533.63,2,5.7,A5,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCN4CCCC4)cc3)cc(OC)c2OC)ccc1C(C)=O,IC50,'=',179,nM,6.75,,,UO_0000065,12.64,0.24,1.05,6.86,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,179
CHEMBL1683653,,None,248.28,0,2.43,17,COc1cc2ncnc(OC(C)C)c2cc1OC,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL1686404,Inhibition of human recombinant His-tagged VEGFR2 assessed as infrared absorption at 10 uM by ELISA assay in presence of 20 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681679,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,2
CHEMBL1683646,,None,379.34,1,5.72,2,CC1=C[C@H]2c3c(O)cc(CCCCBr)cc3OC(C)(C)[C@@H]2CC1,pKi,'=',1.62,uM,,Manually validated,,UO_0000064,,,,,0,CHEMBL1686402,Inhibition of human recombinant His-tagged VEGFR2 assessed as infrared absorption,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681679,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,1.62
CHEMBL4209229,,None,509.48,1,4.98,8,CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(F)(F)F)cc(CN(C)C)c2F)c(F)c1,IC50,'=',1830.3,nM,5.74,,,UO_0000065,11.26,0.22,0.76,7.71,0,CHEMBL4199571,Inhibition of human KDR using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4196113,1,Scientific Literature,ACS Med Chem Lett,2018,None,,,,1830.3
CHEMBL1684525,,None,420.5,0,3.86,9k,Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1,Inhibition,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL1685689,Inhibition of KDR at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,75
CHEMBL3309969,,None,604.35,1,4.43,3s,COc1cc(=O)n(-c2ccc(Oc3ccnc(N)c3I)c(F)c2)cc1C(=O)NCc1ccc(F)cc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL3372650,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351718,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,25
CHEMBL370099,,None,303.45,0,4.33,8g,CCCCCCCCCCCCn1cc2c(N)ncnc2n1,Ki,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1686402,Inhibition of human recombinant His-tagged VEGFR2 assessed as infrared absorption,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681679,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,1000
CHEMBL2010877,,None,463.55,0,4.65,11i,CC(C)n1c2ccc(Nc3cccnn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',10,nM,8,,,UO_0000065,17.26,0.31,3.35,8.92,0,CHEMBL2015672,Inhibition of human recombinant VEGF-R2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,10
CHEMBL2032025,,None,528.54,1,4.68,58b,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CCO)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',191,nM,6.72,,,UO_0000065,12.71,0.24,2.04,6.24,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,191
CHEMBL2036726,,None,315.38,0,4.08,2b,Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2038040,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702646,,None,445.47,0,4.14,BDBM139586,O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(N2CCc3nc(CS)ncc3C2)n1,IC50,'>',10000,nM,,,273946,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3644555,,None,455.44,0,4.7,BDBM139623,COC(=O)c1cncc2c1CCN(c1cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2,IC50,'=',8,nM,8.1,,273983,UO_0000065,17.78,0.34,3.4,11.32,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2334811,,None,422.47,0,3.9,14b,COc1ccc(NC(=O)Nc2ccc(NC3=NS(=O)(=O)c4ccccc43)cc2)cc1,Inhibition,'=',30,%,,,,UO_0000187,,,,,0,CHEMBL2338949,Inhibition of VEGFR-2 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331514,1,Scientific Literature,Eur J Med Chem,2013,None,,,,30
CHEMBL2018745,,None,352.39,0,3.74,39,CCC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',7300,nM,5.14,,,UO_0000065,14.58,0.27,1.4,6.02,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,7.3
CHEMBL2018776,,None,516.04,2,6.1,75,CCCCOc1cc2c(Nc3ccc(NC(=O)OC)c(Cl)c3)ncnc2cc1OCCN(CC)CC,IC50,'=',7400,nM,5.13,,,UO_0000065,9.94,0.19,-0.97,5.24,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,7.4
CHEMBL2322701,,None,323.79,0,4.18,1,Cc1[nH]nc2c1N=C(c1ccccc1Cl)c1cc(N)ccc1N2,IC50,'=',34,nM,7.47,,,UO_0000065,23.07,0.44,3.29,9.44,0,CHEMBL2327153,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321712,1,Scientific Literature,ACS Med Chem Lett,2013,None,,,,0.034
CHEMBL2152791,,None,314.38,0,4.69,12,COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2155702,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2150974,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL446182,,None,408.41,0,2.77,16,COc1ccc2[nH]cc(C3=C(c4cc(OC)c(OC)c(OC)c4)C(=O)NC3=O)c2c1,IC50,'=',930,nM,6.03,,,UO_0000065,14.77,0.27,3.26,6.1,0,CHEMBL865274,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149451,1,Scientific Literature,J Med Chem,2006,None,,,,930
CHEMBL2337371,,None,411.87,1,5.63,13,CC(C)(C)C(=O)Nc1nc(Nc2cccc(F)c2)c2c(n1)[nH]c1cccc(Cl)c12,IC50,'=',31200,nM,4.51,,,UO_0000065,10.94,0.21,-1.12,5.45,0,CHEMBL2344597,Inhibition of VEGFR2 in human U251 cells assessed as inhibition of VEGF-induced tyrosine phosphorylation incubated for 60 mins prior to VEGF-activation measured 10 mins by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331095,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3307756,,,,31.2
CHEMBL81026,,None,300.36,0,4.7,2,COc1ccc(-c2ccc3c(c2)ncn3-c2ccccc2)cc1,IC50,'=',113,nM,6.95,,,UO_0000065,23.13,0.41,2.25,25.68,0,CHEMBL818933,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144948,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,113
CHEMBL2023222,,None,440.53,1,6.76,11,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccoc5)cnc(N)c34)cc2)c1,IC50,'=',8,nM,8.1,,,UO_0000065,18.38,0.35,1.34,8.69,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,8
CHEMBL2021941,,None,439.54,1,6.49,13,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cc[nH]c5)cnc(N)c34)cc2)c1,IC50,'=',4,nM,8.4,,,UO_0000065,19.11,0.36,1.91,8.76,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,4
CHEMBL2022853,,None,550.64,2,5.24,31,CS(=O)(=O)CCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,IC50,'=',1,nM,9,,,UO_0000065,16.34,0.32,3.76,6.82,0,CHEMBL2024776,Inhibition of KDR using 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021801,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,1
CHEMBL3671512,,None,515.34,1,4.22,BDBM133723,C=CNC(=O)NCCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1NC(=O)C=C,IC50,'=',264,nM,6.58,,266581,UO_0000065,12.77,0.27,2.36,5.61,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702658,,None,458.51,1,5.05,BDBM139598,Cc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc(N2CCc3nc(CS)ncc3C2)c1,IC50,'>',1000,nM,,,273958,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3702671,,None,419.55,0,4.24,BDBM139611,CC(C)c1cccc(NC(=O)c2cncc(N3CCc4nc(CS)ncc4C3)c2)c1,IC50,'>',10000,nM,,,273971,UO_0000065,,,,,0,CHEMBL3706174,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microliter plates that were coated overnight with 75 .mu.g/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1688347,,None,402.41,0,3.65,13,c1cnc(NCCc2ccncc2)c(-c2nnc(Nc3ccc4c(c3)OCO4)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,10
CHEMBL1688250,,None,415.48,0,1.76,5,CS(=O)(=O)c1ccc(-c2nnc(-c3cccnc3NCC3COCCO3)[nH]2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1695273,Inhibition of VEGFR2 expressed HEK293 cells,B,BAO_0000219,cell-based format,None,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,CHEMBL3307715,,,,10
CHEMBL3690447,,None,427.39,0,3.72,BDBM128505,Nc1nccnc1-c1ccn2c(-c3cccc(NC(=O)NCC(F)(F)F)c3)cnc2c1,IC50,'=',1640,nM,5.79,,259733,UO_0000065,13.54,0.25,2.07,5.25,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690457,,None,510.48,1,3.08,BDBM128515,O=C1CN(c2ncc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CCN1,IC50,'=',83.4,nM,7.08,,259743,UO_0000065,13.87,0.26,4,6.07,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690458,,None,510.48,1,3.08,BDBM128516,O=C1CN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)nn2)CCN1,IC50,'=',12,nM,7.92,,259744,UO_0000065,15.52,0.29,4.84,6.8,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3690463,,None,426.4,0,4.45,BDBM128521,Cc1cncc(-c2ccn3c(-c4cccc(NC(=O)NCC(F)(F)F)c4)cnc3c2)n1,IC50,'=',329,nM,6.48,,259749,UO_0000065,15.2,0.29,2.03,7.7,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694719,,None,509.54,1,4.67,BDBM128736,NC1CCN(c2ccc(-c3ccn4c(-c5cccc(NC(=O)NCC(F)(F)F)c5)cnc4c3)cn2)CC1,IC50,'=',5,nM,8.3,,259896,UO_0000065,16.29,0.31,3.63,8.25,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4802045,BAY-091,None,440.48,1,5.56,EUB0001564,CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O,Inhibition,'=',50.07,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4887916,KDR(h) Millipore kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4800729,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1.0 uM,,,50.07
CHEMBL2046840,,None,412.37,1,5.19,5,O=C(Nc1ccc(-c2cccc3[nH][nH]c(=O)c23)cc1)Nc1cccc(C(F)(F)F)c1,IC50,'=',10,nM,8,,,UO_0000065,19.4,0.36,2.81,8.91,0,CHEMBL2049999,Inhibition of KDR in presence of 1 mM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046389,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.01
CHEMBL4436592,,None,506.58,2,6.93,5ab,O=C(Nc1ccc2oc(-c3ccccc3Br)nc2c1)c1ccc(Cl)c(Br)c1,Inhibition,'=',71.4,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4589602,,None,531.79,2,6.12,5ai,COc1cc(CC(=O)Nc2ccc3oc(-c4ccc(Cl)c(Br)c4)nc3c2)cc(OC)c1OC,Inhibition,'=',47.5,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4537095,,None,471.74,1,6.1,5aj,COc1ccc(CC(=O)Nc2ccc3oc(-c4ccc(Cl)c(Br)c4)nc3c2)cc1,Inhibition,'=',79.9,%,,,,UO_0000187,,,,,0,CHEMBL4398893,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4443305,,None,615.35,2,6.23,19h,Cc1cc2ccnc(Nc3ccc(Oc4ccnc(N)c4I)c(F)c3)c2c(=O)n1-c1ccc(F)cc1F,IC50,'=',17.3,nM,7.76,,,UO_0000065,12.61,0.29,1.53,8.17,0,CHEMBL4366682,Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain expressed in baculovirus expression system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4364278,1,Scientific Literature,Eur J Med Chem,2019,None,,,,17.3
CHEMBL4541917,,None,388.42,0,4.69,5d,COc1ccc(CC(=O)Nc2ccc3oc(-c4ccccc4)nc3c2)cc1OC,IC50,'=',578.8,nM,6.24,,,UO_0000065,16.06,0.29,1.55,8.48,0,CHEMBL4398894,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4516406,,None,418.45,0,4.7,5e,COc1cc(CC(=O)Nc2ccc3oc(-c4ccccc4)nc3c2)cc(OC)c1OC,IC50,'=',357.2,nM,6.45,,,UO_0000065,15.41,0.28,1.75,7.78,0,CHEMBL4398894,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4441017,,None,462.13,1,6.82,5h,O=C(Nc1ccc2oc(-c3ccc(Cl)cc3)nc2c1)c1ccc(Cl)c(Br)c1,IC50,'=',338.3,nM,6.47,,,UO_0000065,14,0.33,-0.35,11.74,0,CHEMBL4398894,Inhibition of VEGFR2 (unknown origin) using Poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4792576,,None,611.61,2,6.51,10o,COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OCC(C)(C)O,IC50,'=',52.9,nM,7.28,,,UO_0000065,11.9,0.22,0.77,5.53,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,52.9
CHEMBL4790015,,None,650.69,2,7.22,10q,COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OCCCN1CCCC1,IC50,'=',145.4,nM,6.84,,,UO_0000065,10.51,0.19,-0.38,5.97,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,145.4
CHEMBL4779200,,None,664.71,2,7.61,10r,COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OCCCN1CCCCC1,IC50,'=',207.6,nM,6.68,,,UO_0000065,10.05,0.19,-0.93,5.84,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,207.6
CHEMBL4784431,,None,535.54,2,6.23,22a,COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3)c2cc1OC,IC50,'=',111.3,nM,6.95,,,UO_0000065,12.98,0.24,0.72,6.25,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,111.3
CHEMBL4765039,,None,414.47,0,4.95,14b,COc1cc2ncnc(Nc3ccc(NC(=O)c4cccc(C)c4)cc3)c2cc1OC,IC50,'=',16,nM,7.8,,,UO_0000065,18.81,0.34,2.85,9.13,0,CHEMBL4736486,Inhibition of VEGFR2 (unknown origin) by caliper mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732151,1,Scientific Literature,Bioorg Med Chem Lett,2021,None,,INHIBITOR,,0.016
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',80,nM,7.1,,,UO_0000065,17.81,0.33,3.77,9.19,1,CHEMBL4307050,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4304778,1,Scientific Literature,Eur J Med Chem,2019,None,,,,80
CHEMBL4778057,,None,403.51,1,5.15,21,Cc1nc(NC(=O)C(C)C)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,GI50,'=',181,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.181
CHEMBL4788338,,None,511.61,2,5.76,31,COc1ccc(CC(=O)Nc2nc(C)c(-c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)s2)cc1OC,GI50,'=',19,nM,,,,UO_0000065,,,,,0,CHEMBL4774718,Inhibition of wild type TEL fused VEGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay,A,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765452,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 72.0 hr,INHIBITOR,,0.019
CHEMBL4461293,,None,469.44,0,4.83,48,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5ccc(F)cc5C(F)(F)F)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4464095,,None,481.48,0,4.7,132,COc1ccc(CC(=O)Nc2ccc(-n3c4c(c5ncnc(N)c53)CCC4)cc2)cc1C(F)(F)F,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4459240,,None,452.44,0,4.09,155,Nc1ncnc2c3c(n(-c4ccc(CC(=O)Nc5ccc(C(F)(F)F)nc5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL56109,,None,527.69,1,1.84,3o,CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2,IC50,'=',400,nM,6.4,,,UO_0000065,12.12,0.24,4.56,5.43,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.4
CHEMBL4533369,,None,539.62,1,4.95,9c,Cc1ccc(CN2C(=O)/C(=N\c3ccc(NC(=O)Nc4ccc(S(N)(=O)=O)cc4)cc3)c3ccccc32)cc1,IC50,'=',462.38,nM,6.33,,,UO_0000065,11.74,0.22,1.39,4.73,0,CHEMBL4383827,Inhibition of VEGFR2 (unknown origin) using poly[Glu:Tyr] (4:1) as substrate measured after 5 mins by Alphascreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382220,1,Scientific Literature,Eur J Med Chem,2019,None,,,,462.38
CHEMBL267293,,None,394.41,0,2.28,12j,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCn1cncn1,IC50,'=',85,nM,7.07,,,UO_0000065,17.93,0.33,4.79,6.75,0,CHEMBL819556,Inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136732,1,Scientific Literature,J Med Chem,2003,None,,,,0.085
CHEMBL3940489,,None,520.39,1,4.56,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3945072,,None,506.37,1,4.17,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983466,,None,520.39,1,4.51,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924380,,None,496.32,0,4.74,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3895458,,None,502.37,1,4.01,Table 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958507,,None,601.49,2,6.77,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4792676,,None,539.62,1,4.94,7b,CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccccn2)C4)cc1NC(=O)c1ccco1,Activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL4769250,Inhibition of recombinant human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765301,1,Scientific Literature,Eur J Med Chem,2020,None,Dose = 1.0 microM | TIME = 0.6667 hr,,,77
CHEMBL2153823,,None,410.52,0,3.2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4790527,,None,597.58,2,6.38,10e,COCCOc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OC,IC50,'=',139.9,nM,6.85,,,UO_0000065,11.47,0.21,0.47,5.69,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,INHIBITOR,,139.9
CHEMBL4778632,,None,581.58,2,6.86,22d,CCn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ncnc5cc(OC)c(OC)cc45)c(F)c3)nccc21,IC50,'>',3000,nM,,,,UO_0000065,,,,,0,CHEMBL4774500,Inhibition of recombinant VEGFR2 kinase domain (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765445,1,Scientific Literature,Eur J Med Chem,2020,None,,,,3000
CHEMBL460465,,None,498.51,1,5.22,1,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',24,nM,7.62,,,UO_0000065,15.29,0.28,2.4,8.72,0,CHEMBL989219,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157538,1,Scientific Literature,J Med Chem,2008,None,,,,24
CHEMBL461293,,None,540.55,2,5.28,6,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)=O)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',2,nM,8.7,,,UO_0000065,16.09,0.3,3.42,8.33,0,CHEMBL989219,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157538,1,Scientific Literature,J Med Chem,2008,None,,,,2
CHEMBL3818283,,None,320.33,0,3.98,6b,Fc1ccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)cc1,IC50,'=',201,nM,6.7,,,UO_0000065,20.91,0.38,2.72,8.53,0,CHEMBL3820579,Inhibition of VEGFR-2 (unknown origin) after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,201
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,T1/2,'=',4.333,hr,,,,UO_0000032,,,,,0,CHEMBL1821213,Inhibition of human N-terminal His-tagged non-phosphorylated VEGFR2 assessed as dissociation half life after 60 mins by activity based 100 fold dilution assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,260
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,Ki,'=',0.024,nM,10.62,,,UO_0000065,23.84,0.45,5.06,13.1,0,CHEMBL1821211,Inhibition of human N-terminal His-tagged non-phosphorylated VEGFR2 after 60 mins by activity based 100 fold dilution assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,0.024
CHEMBL1254007,,None,445.38,1,5.56,20d,Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21,T1/2,'<',0.08333,hr,,,,UO_0000032,,,,,0,CHEMBL1821216,Inhibition of human N-terminal His-tagged phosphorylated VEGFR2 assessed as dissociation half life after 60 mins by ligand displacement based enzyme-inhibitor dilution assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1817643,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,5
CHEMBL529217,,None,422.48,0,3.7,22,CCOCn1cc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2)c2ccccc21,IC50,'=',5300,nM,5.28,,,UO_0000065,12.49,0.23,1.58,7.44,0,CHEMBL957977,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157465,1,Scientific Literature,J Med Chem,2008,None,,,,5.3
CHEMBL358843,,None,472.61,0,4.65,31,CC(C)[S+]([O-])Cc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',309,nM,6.51,,,UO_0000065,13.77,0.26,1.86,8.42,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,309
CHEMBL263902,,None,253.31,0,2.3,1b,Cc1cccc(C2=Nc3c(N)ncnc3NCC2)c1,IC50,'=',3000,nM,5.52,,,UO_0000065,21.8,0.4,3.22,7.25,0,CHEMBL927115,Inhibition of KDR in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,3
CHEMBL464510,,None,501.54,2,5.6,7,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)CC(=O)Nc5ccccc5)cc4F)c3s2)c1,IC50,'=',15,nM,7.82,,,UO_0000065,15.6,0.3,2.22,7.97,0,CHEMBL960946,Inhibition of GST-fused recombinant VGFR2 catalytic domain expressed in baculovirus-infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153284,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,0.015
CHEMBL1834595,,None,715.64,3,5.02,7r,C#CCCCn1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1837487,Inhibition of VEGFR2 glycosylation in human HUVEC cells at 2 uM after 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1833959,1,Scientific Literature,J Med Chem,2011,CHEMBL3307501,,,,
CHEMBL475351,,None,403.47,0,5,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL461776,,None,417.49,0,3.87,4l,CN1C(=O)/C(=C/c2ccc(/C=C/C(=O)NCc3cccnc3)s2)Oc2ccccc21,IC50,'=',1480,nM,5.83,,,UO_0000065,13.96,0.27,1.96,8.15,0,CHEMBL1001090,Inhibition of KDR expressed in baculovirus system by ELISA,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140887,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,1.48
CHEMBL4075561,,None,633.63,2,7.09,23,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC,Inhibition,'<',20,%,,,,UO_0000187,,,,,0,CHEMBL4033342,Inhibition of VEGFR2 in human prostate cancer cells assessed as decrease in Akt activation at 10 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028913,1,Scientific Literature,J Med Chem,2018,None,,,,20
CHEMBL1834657,INFIGRATINIB PHOSPHATE,4,658.48,2,5.35,1h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3694692,,None,479.83,0,4.52,BDBM128706,Nc1nc(-c2ccn3c(-c4cc(Cl)cc(NC(=O)NCC(F)(F)F)c4)cnc3c2)ncc1F,IC50,'=',280,nM,6.55,,259929,UO_0000065,13.66,0.27,2.03,5.94,0,CHEMBL3705513,In Vitro Kinase Inhibition Assay: VEGFR2 (from Upstate),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL196838,,None,441.43,1,5.45,41,NC(=O)c1ccc(-c2nnc(Sc3ccc(OC(F)(F)F)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL194737,,None,482.92,1,6.35,46,CC(C)NC(=O)c1ccc(-c2nnc(Nc3ccc(OC(F)(F)Cl)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,10
CHEMBL3671541,,None,546.35,1,3.46,BDBM133753,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(=O)OCC,IC50,'=',251,nM,6.6,,266611,UO_0000065,12.08,0.26,3.14,5.02,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671557,,None,516.37,1,4.35,BDBM133769,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNCCC=O,IC50,'=',698,nM,6.16,,266627,UO_0000065,11.92,0.25,1.81,5.85,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703196,,None,501.52,1,4.41,BDBM149703,Cc1c(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccccc2)n1C,Kd,'=',6.3,nM,8.2,,288364,UO_0000065,16.35,0.3,3.79,7.65,0,CHEMBL3705591,Kinase Assay: KDR (h) is incubated with 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3671510,,None,531.39,1,4.49,BDBM133721,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)NC(C)C,IC50,'=',895,nM,6.05,,266579,UO_0000065,11.38,0.24,1.56,5.16,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1835956,,None,649.54,2,4.13,17a,O=c1[nH]ncn1-c1ccc(N2CCN(c3ccc(OC[C@@H]4CO[C@@](Cn5cncn5)(c5ccc(Cl)cc5Cl)O4)cc3)CC2)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1837487,Inhibition of VEGFR2 glycosylation in human HUVEC cells at 2 uM after 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1833959,1,Scientific Literature,J Med Chem,2011,CHEMBL3307501,,,,
CHEMBL1834583,,None,705.65,3,5.26,7f,CC(C)Cn1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1837487,Inhibition of VEGFR2 glycosylation in human HUVEC cells at 2 uM after 24 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1833959,1,Scientific Literature,J Med Chem,2011,CHEMBL3307501,,,,
CHEMBL3909551,,None,540.07,1,3.39,134,CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3970423,,None,514.67,2,5.7,480,COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',7943.28,nM,5.1,,,UO_0000065,9.91,0.18,-0.6,7.44,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.1
CHEMBL3933707,,None,550.69,1,3.69,489,COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3896623,,None,525.05,0,3.95,553,COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3955385,,None,501.55,1,4.5,739,COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL1834657,INFIGRATINIB PHOSPHATE,4,658.48,2,5.35,1h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3984039,,None,525.05,0,3.64,291,COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'=',10.72,nM,7.97,,,UO_0000065,16.31,0.3,4.33,8.98,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.97
CHEMBL3922100,,None,470.53,0,2.52,627,COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',6760.83,nM,5.17,,,UO_0000065,10.99,0.2,2.65,5.3,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.17
CHEMBL3979908,,None,389.43,0,4.5,538,C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1,IC50,'=',416.87,nM,6.38,,,UO_0000065,16.38,0.3,1.88,11.38,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,6.38
CHEMBL3910444,,None,529.65,1,3.77,541,COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',27.54,nM,7.56,,,UO_0000065,14.27,0.26,3.79,6.77,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.56
CHEMBL3984571,,None,492.58,1,5.38,921,COc1cc(OC)cc(N(C[C@@H]2C[C@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3987037,,None,404.47,0,3.14,84,COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3982668,,None,511.03,0,3.52,299,COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3968009,,None,458.48,1,3.35,31,COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3981955,,None,514.03,0,4.24,14a,COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl,IC50,'=',69.18,nM,7.16,,,UO_0000065,14.99,0.28,2.92,7.56,0,CHEMBL3880341,Inhibition of human VEGFR2 using Btn-Flt3 as substrate after 120 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,None,,,,7.16
CHEMBL500952,,None,434.54,1,5.48,37,N#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1,IC50,'=',248,nM,6.61,,,UO_0000065,15.2,0.27,1.13,9.69,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,248
CHEMBL2036726,,None,315.38,0,4.08,2b,Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1,IC50,'=',25000,nM,4.6,,,UO_0000065,14.59,0.26,0.52,8.27,0,CHEMBL2038025,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL523571,,None,291.31,0,2.79,8b,Cn1c(=O)c(-c2nc3ccccc3[nH]2)c(O)c2ccccc21,IC50,'=',5800,nM,5.24,,,UO_0000065,17.98,0.33,2.45,7.38,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,5.8
CHEMBL1682543,,None,216.27,0,2.27,9b,Nc1nc(-c2ccc3[nH]ncc3c2)cs1,Ki,'>',8880,nM,,,,UO_0000065,,,,,0,CHEMBL1685433,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681650,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,8.88
CHEMBL521155,,None,292.3,0,1.77,1,Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12,IC50,'=',81000,nM,4.09,,,UO_0000065,14,0.25,2.32,3.99,0,CHEMBL949886,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137681,1,Scientific Literature,Eur J Med Chem,2009,None,,,,81
CHEMBL204710,,None,388.39,0,3.61,6,c1cnc(NCc2ccncc2)c(-c2nnc(Nc3ccc4c(c3)OCO4)o2)c1,IC50,'=',1890,nM,5.72,,,UO_0000065,14.74,0.27,2.11,5.34,0,CHEMBL1695274,Inhibition of VEGFR-2 kinase assessed as phosphorylated level of pGAT-biotin peptide preincubated for 5 to 10 mins before addition of substrate measured after 2 hrs by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1687699,1,Scientific Literature,ACS Med Chem Lett,2010,None,,,,1.89
CHEMBL1766529,,None,473.46,0,4.44,21b,CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1768688,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1765011,1,Scientific Literature,J Med Chem,2011,None,,,,10000
CHEMBL1965988,,None,427.53,0,4.81,SID103904300,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1,Ki,'=',7.943,nM,8.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.1
CHEMBL1966808,,None,323.38,0,2.57,SID103904979,O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2003420,,None,384.48,0,2.34,SID103904793,O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2007266,,None,498.56,1,6.17,SID103905330,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1,Ki,'=',12.59,nM,7.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.9
CHEMBL2005475,,None,339.46,0,4.6,SID103904997,O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.2
CHEMBL2006785,,None,361.25,1,5.64,SID103904745,Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1979690,,None,434.94,0,4.25,SID103904406,CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1,Ki,'=',12.59,nM,7.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.9
CHEMBL1965303,,None,343.35,0,2.11,SID103905216,COc1cc(Nc2ncnc(Nc3cc[nH]n3)n2)cc(OC)c1OC,Ki,'=',3981.07,nM,5.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.4
CHEMBL1976196,,None,405.24,0,4.97,SID103905631,O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL336961,AZAKENPAULLONE,None,328.17,0,3.49,SID103905441,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1995592,,None,367.8,0,2.77,SID103905641,Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.2
CHEMBL1163565,,None,530.98,1,4.92,5o,CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1168306,Inhibition of VEGFR2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,50
CHEMBL1682552,,None,332.41,0,4.02,11c,c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1,Ki,,,,,,Not Determined,,,,,,0,CHEMBL1685433,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681650,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,
CHEMBL304271,,None,542.02,1,3.57,26r,CCN(CC)CC(O)CNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1,IC50,'=',360,nM,6.44,,,UO_0000065,11.89,0.23,2.87,4.76,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,0.36
CHEMBL1682354,,None,344.2,0,4.18,4l,Clc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1Cl,Ki,,,,,,Not Determined,,,,,,0,CHEMBL1685405,Inhibition of KDR after 1 hr,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681644,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,
CHEMBL452288,,None,440.53,1,5.66,29,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cccs5)cnn4c3N)cc2)c1,IC50,'=',15,nM,7.82,,,UO_0000065,17.76,0.33,2.16,8.04,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,15
CHEMBL469467,,None,434.5,1,5.6,25,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5ccccc5)cnn4c3N)cc2)c1,IC50,'=',17,nM,7.77,,,UO_0000065,17.88,0.32,2.17,7.98,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,17
CHEMBL452284,,None,430.37,0,4.78,14d,Nc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cnc2ccnn12,IC50,'=',14,nM,7.85,,,UO_0000065,18.25,0.35,3.07,8.07,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,14
CHEMBL180331,,None,433.44,1,5.83,6b,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,IC50,'=',0.4,nM,9.4,,,UO_0000065,21.68,0.4,3.57,11.5,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,0.4
CHEMBL512839,,None,509.47,2,5.79,34c,Cn1cc(-c2ccn3c(N)c(-c4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cnc23)cn1,IC50,'=',28,nM,7.55,,,UO_0000065,14.82,0.28,1.76,7.39,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,28
CHEMBL520144,,None,288.25,0,2.38,5,COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1,IC50,'=',0.64,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL962872,Inhibition of recombinant VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157406,1,Scientific Literature,J Nat Prod,2008,None,,,,6.4
CHEMBL483526,,None,272.26,0,2.67,3,COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1,IC50,'=',1.1,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL962872,Inhibition of recombinant VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157406,1,Scientific Literature,J Nat Prod,2008,None,,,,1.1
CHEMBL382596,,None,361.83,0,4.99,40,O=C(c1ccccc1CNc1ccc(Cl)cc1)n1ccc2cnccc21,Activity,,,,,,Not Determined,,,,,,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL472504,,None,484.56,0,3.32,39,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(C(=O)N5CCN(C)CC5)cnn4c3N)cc2)c1,IC50,'=',790,nM,6.1,,,UO_0000065,12.59,0.23,2.78,5.05,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,790
CHEMBL507533,,None,430.47,0,4.11,36,CCOC(=O)c1cnn2c(N)c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)cnc12,IC50,'=',25,nM,7.6,,,UO_0000065,17.66,0.32,3.49,6.15,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,25
CHEMBL470074,,None,434.5,1,5.6,27,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4cc(-c5ccccc5)nn4c3N)cc2)c1,IC50,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,12500
CHEMBL507533,,None,430.47,0,4.11,36,CCOC(=O)c1cnn2c(N)c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)cnc12,IC50,'=',220,nM,6.66,,,UO_0000065,15.47,0.28,2.55,5.38,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,220
CHEMBL453578,,None,435.49,0,4.99,33,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cccnc5)cnn4c3N)cc2)c1,IC50,'=',7,nM,8.15,,,UO_0000065,18.73,0.34,3.16,7.4,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,7
CHEMBL510814,,None,478.51,1,5.33,32,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5ccc6c(c5)OCO6)cnn4c3N)cc2)c1,IC50,'=',21,nM,7.68,,,UO_0000065,16.05,0.29,2.35,6.63,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,21
CHEMBL510788,,None,412.38,0,4.64,14a,Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2ccnn12,IC50,'=',35,nM,7.46,,,UO_0000065,18.08,0.34,2.82,7.66,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,35
CHEMBL1684800,,None,572.98,2,6.4,7c,COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1687341,inhibition of KDR at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681781,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,0
CHEMBL173799,,None,517.38,1,3.97,20,COc1cc2c(Nc3c(Br)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1,IC50,'=',42640,nM,4.37,,,UO_0000065,8.45,0.18,0.4,5.01,0,CHEMBL820673,In vitro inhibitory concentration against VEGF receptor 2.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148412,1,Scientific Literature,J Med Chem,2004,None,,,,42.64
CHEMBL2180560,,None,454.37,0,4,III-1,N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccccc3)nc(Br)c3cccnc23)CC1,Inhibition,,,%,,,Not Determined,UO_0000187,,,,,0,CHEMBL2185480,Inhibition of KDR at 10 uM incubated for 60 mins using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL359316,,None,440.54,1,5.09,34,CCOC(C)c1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3,IC50,'=',240,nM,6.62,,,UO_0000065,15.03,0.27,1.53,10.43,0,CHEMBL817492,In vitro inhibitory concentration against human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145920,1,Scientific Literature,J Med Chem,2003,None,,,,240
CHEMBL2180878,,None,379.37,0,2.16,13,COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC,IC50,'=',37,nM,7.43,,,UO_0000065,19.59,0.36,5.27,7.25,0,CHEMBL2183649,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2177085,1,Scientific Literature,J Med Chem,2012,None,,,,37
CHEMBL1965495,,None,234.26,0,2.81,SID103905398,Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.3
CHEMBL1994830,,None,344.78,0,4.37,SID103905372,Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1973711,,None,287.66,0,1.98,SID103905594,N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL17370,,None,361.45,1,5.67,SID103905410,CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1278149,,None,379.19,0,4.34,5c,COc1cc2ncnc(Oc3ccc(Br)c(F)c3)c2cc1OC,IC50,'=',600,nM,6.22,,,UO_0000065,16.41,0.37,1.88,11.64,0,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.6
CHEMBL1984711,,None,425.49,1,5.03,SID103905215,COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC,Ki,'=',63.1,nM,7.2,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.2
CHEMBL1761938,,None,452.42,1,5.36,16,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)cc3)c2cc1OC,IC50,'=',90,nM,7.05,,,UO_0000065,15.57,0.29,1.69,7.45,0,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.09
CHEMBL1990254,,None,317.39,0,3.18,SID103904554,NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1,Ki,'>',5011.87,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.3
CHEMBL1761945,,None,481.92,1,5.85,24,COc1cc2ncnc(N(C)c3ccc(NC(=O)Nc4ccc(F)c(Cl)c4)cc3)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1763555,Inhibition of recombinant human VEGFR-2-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759979,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,10
CHEMBL176019,,None,392.49,0,4.35,14d,CC(C)N(Cc1ccccc1)c1nc(O)nc(Nc2ccc3ncsc3c2)n1,IC50,'=',18,nM,7.75,,,UO_0000065,19.73,0.38,3.39,8.9,0,CHEMBL831136,In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,None,,,,0.018
CHEMBL1684654,,None,331.42,0,3.79,11o,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL1686046,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,5
CHEMBL447602,,None,612.66,3,5.18,62,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1,Ki,'=',83,nM,7.08,,,UO_0000065,11.56,0.21,1.9,6.27,0,CHEMBL971817,Inhibition of phosphorylated KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,,,,83
CHEMBL69106,,None,355.76,0,3.83,26a,O=C1Nc2ncnc(Nc3ccc(F)c(Cl)c3)c2/C1=C/c1ccc[nH]1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL3288526,,None,396.48,1,5.35,14c,Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12,IC50,'=',0.9,nM,9.05,,,UO_0000065,22.82,0.43,3.7,11.18,0,CHEMBL3295611,Inhibition of VEGFR-2 in HUVEC assessed as inhibition of VEGF (1 to 165)-induced cell proliferation preincubated for 2 hrs followed by VEGF (1 to 165) induction measured after 48 hrs by CCK8 assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286125,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,0.9
CHEMBL329142,,None,306.76,0,4.11,3b,Clc1cccc(-c2cnn3cc(-c4ccncc4)cnc23)c1,IC50,'=',350,nM,6.46,,,UO_0000065,21.05,0.4,2.35,14.99,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,350
CHEMBL1909377,,None,341.8,0,3.29,SB-400868-A,Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1,Inhibition,'=',11.73,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,11.73
CHEMBL1933148,,None,323.36,0,1.76,3,Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1,Inhibition,'<',80,%,,,,UO_0000187,,,,,0,CHEMBL1936346,Inhibition of human VEGFR2 at 3 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933005,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,80
CHEMBL1940174,,None,409.53,1,5.25,8a,CC1(C)c2ccc(C3CCN(C4CC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21,IC50,'=',882,nM,6.05,,,UO_0000065,14.78,0.27,0.8,10.11,0,CHEMBL1942686,Inhibition of KDR using Bio-Gastrintide as substrate by TR-FRET assay in presence of 50 uM of ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938232,1,Scientific Literature,Bioorg Med Chem,2012,None,,,,882
CHEMBL1096626,GSK-938890A,None,447.5,0,2.28,GSK938890A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21,Inhibition,'=',71.18,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,71.18
CHEMBL495902,GW820759X,None,291.35,0,3.43,GW820759X,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1,Inhibition,'=',3.28,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,3.28
CHEMBL1922224,,None,398.63,1,6.68,6,Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@]2(C)[C@@H]([C@H](C)/C=C/CC(C)C)CC[C@@H]12,IC50,'=',4950,nM,5.3,,,UO_0000065,13.31,0.25,-1.37,13.11,0,CHEMBL1926234,Inhibition of recombinant human VEGF-R2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL456294,CALICOFEROL I,None,414.63,1,6.08,18,Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)[C@@H](O)C[C@@H]12,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL1926234,Inhibition of recombinant human VEGF-R2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL191705,GW621431X,None,400.46,0,4.09,GW621431X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1,Inhibition,'=',58.9,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,58.9
CHEMBL1946262,,None,348.41,0,3.24,56,O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1,Activity,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL1948943,Inhibition of KDR assessed as activity remaining at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944561,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,62
CHEMBL1794072,,None,490,1,5.74,SB-682330-A,CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,0.23
CHEMBL1950984,,None,426.52,1,5.82,15,CNC(=O)c1cc(Oc2ccc3nc(Nc4cccc(C(C)(C)C)c4)ccc3c2)ccn1,IC50,'<',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1953554,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949510,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,1
CHEMBL3099482,,None,578.67,2,5.24,D6,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCN4CCOCC4)cc3C)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,'=',129,nM,6.89,,,UO_0000065,11.91,0.22,1.65,5.6,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,129
CHEMBL3578214,,None,384.27,0,4.71,4c,Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1,Activity,'=',31,%,,,,UO_0000187,,,,,0,CHEMBL3580039,Inhibition of human KDR assessed as residual activity at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576773,1,Scientific Literature,J Med Chem,2015,None,,,,31
CHEMBL3093579,,None,574.01,2,5.33,26,Cc1ccc(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c(F)c2)c(=O)n1-c1ccccc1.Cl,IC50,'=',2.2,nM,8.66,,,UO_0000065,16.11,0.3,3.33,8.11,0,CHEMBL3094552,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 5 mins followed by 10 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,2.2
CHEMBL3093584,,None,538.54,1,4.72,3f,Cc1ccn(-c2ccccc2)c(=O)c1C(=O)Nc1ccc(Oc2ccc3nc(NC(=O)C4CC4)cn3n2)c(F)c1,IC50,'=',2.8,nM,8.55,,,UO_0000065,15.88,0.29,3.83,7.15,0,CHEMBL3094552,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 5 mins followed by 10 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,2.8
CHEMBL3093585,,None,527.52,1,3.75,3d,Cn1cc(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c(F)c2)c(=O)n1-c1ccccc1,IC50,'=',5.6,nM,8.25,,,UO_0000065,15.64,0.29,4.5,6.63,0,CHEMBL3094552,Inhibition of N-terminal FLAG-tagged VEGFR2 cytoplasmic domain (790 to 1356) (unknown origin) expressed in baculovirus expression system using biotinylated poly-GluTyr (4:1) as substrate preincubated for 5 mins followed by 10 uM of ATP addition measured after 10 mins by AlphaScreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3091368,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,5.6
CHEMBL3763360,,None,534.98,2,5.99,10e,COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@H]2CCOC2)cc1,IC50,'=',886,nM,6.05,,,UO_0000065,11.31,0.22,0.06,6.4,0,CHEMBL3766408,Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3763091,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,886
CHEMBL237571,,None,483.59,1,5.69,SB-633825,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1,Inhibition,'=',47.78,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,47.78
CHEMBL522709,GSK-317315A,None,461.47,1,5.35,GSK317315A,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1,Inhibition,'=',2.92,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2.92
CHEMBL2325101,,None,417.34,1,7.5,D14,Clc1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1Cl,IC50,'=',1830,nM,5.74,,,UO_0000065,13.75,0.27,-1.76,36.78,0,CHEMBL2327211,Inhibition of VEGFR-2 (unknown origin) using gastrin as substrate after 1 hr by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321654,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.83
CHEMBL2325087,,None,400.33,1,5.54,C14,NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc2ccccc2c1,IC50,'=',3200,nM,5.5,,,UO_0000065,13.73,0.29,-0.05,13.2,0,CHEMBL2327211,Inhibition of VEGFR-2 (unknown origin) using gastrin as substrate after 1 hr by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321654,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,3.2
CHEMBL370006,,None,256.33,0,2.83,1,Cc1sc2ncnc(N)c2c1-c1ccc(N)cc1,IC50,'=',4570.88,nM,5.34,,,UO_0000065,20.83,0.41,2.51,6.86,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,5.34
CHEMBL1242469,,None,312.31,0,2.22,PP469,N#CCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,IC50,'=',2130,nM,5.67,,,UO_0000065,18.16,0.34,3.45,4.99,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,2.13
CHEMBL3221548,,None,566.53,2,6.49,80,CCCCOc1cc2c(Nc3ccc(NC(=O)OCC)c(Cl)c3)ncnc2cc1OCCN(CC)CC.Cl,IC50,'=',4800,nM,5.32,,,UO_0000065,10.03,0.2,-1.17,5.44,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,4.8
CHEMBL3221550,,None,418.88,0,4.35,30,CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1.Cl,IC50,'=',5000,nM,5.3,,,UO_0000065,13.86,0.26,0.95,5.6,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,5
CHEMBL1254199,,None,408.3,0,4.66,4,CN(c1cccc(Br)c1)c1nc(N)nc2[nH]c(Cc3ccccc3)cc12,IC50,'=',89200,nM,4.05,,,UO_0000065,9.92,0.21,-0.61,5.72,0,CHEMBL1252157,Inhibition of VEGFR2 expressed in human A431 cells,B,BAO_0000219,cell-based format,None,None,None,A-431,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250424,1,Scientific Literature,Bioorg Med Chem,2010,CHEMBL3307523,,,,89.2
CHEMBL3678958,RUSERONTINIB,3,443.56,0,4.04,BDBM173454,CC(C)n1c(Nc2cccnc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,IC50,'>',1000,nM,,,318796,UO_0000065,,,,,0,CHEMBL3707647,Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1277072,HENATINIB,1,468.53,0,2.04,25,Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(C[C@H](O)CN1CCOCC1)CCC2,IC50,'=',26,nM,7.58,,,UO_0000065,16.19,0.3,5.55,7.75,0,CHEMBL1285790,Inhibition of VEGFR2-induced cell proliferation in HUVEC after 72 hrs by sulforhodamine B method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275399,1,Scientific Literature,J Med Chem,2010,None,,,,0.026
CHEMBL3656105,,None,503.49,1,4.77,BDBM110616,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCC(=O)O)c[nH]4)c3)cc2)c1,IC50,'=',13,nM,7.89,,231501,UO_0000065,15.66,0.29,3.12,5.42,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3656090,,None,535.51,2,5.3,BDBM110601,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCC(=O)O)c[nH]4)c3)cc2F)c1,IC50,'=',24,nM,7.62,,231486,UO_0000065,14.23,0.27,2.32,5.24,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1940252,,None,502.55,1,3.53,25,CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1,Inhibition,'=',51,%,,,,UO_0000187,,,,,0,CHEMBL1942181,Inhibition of KDR at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938337,1,Scientific Literature,J Med Chem,2011,None,,,,51
CHEMBL1258603,,None,446.52,0,4.57,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1940846,,None,382.7,1,6.46,8,Cc1ccc2nc(Cl)c(/C=C/C(=O)c3cc(Cl)sc3Cl)cc2c1,IC50,'=',81.43,nM,7.09,,,UO_0000065,18.52,0.42,0.63,23.66,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,81.43
CHEMBL1940847,,None,392.7,1,5.92,9,Cc1ccc2nc(Cl)c(/C=C/C(=O)c3sccc3Br)cc2c1,IC50,'=',129.26,nM,6.89,,,UO_0000065,17.54,0.43,0.97,22.99,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,129.26
CHEMBL1940858,,None,392.7,1,5.92,20,Cc1ccc2cc(/C=C/C(=O)c3sccc3Br)c(Cl)nc2c1,IC50,'=',112.26,nM,6.95,,,UO_0000065,17.7,0.43,1.03,23.2,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,112.26
CHEMBL1940862,,None,327.84,1,5.46,24,Cc1ccsc1C(=O)/C=C/c1cc2cccc(C)c2nc1Cl,IC50,'=',267.27,nM,6.57,,,UO_0000065,20.05,0.41,1.11,21.94,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,267.27
CHEMBL3754319,,None,438.53,0,4.31,18e,COc1ccc(C(=O)CN2CCN(c3nnc(-c4ccccc4)c4ccccc34)CC2)cc1,IC50,'=',2250,nM,5.65,,,UO_0000065,12.88,0.23,1.34,9.64,0,CHEMBL3756334,Inhibition of VGFR-2 (unknown origin) using poly-GluTyr (4:1) as substrate after 5 mins by Alpha Screen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751694,1,Scientific Literature,Eur J Med Chem,2016,None,,,,2.25
CHEMBL3586066,,None,524.47,2,7.41,W9,CC(C)(C)C(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2)cn1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,1000
CHEMBL3586071,,None,448.83,1,5.42,W14,CNC(=O)c1cc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',0.15,nM,9.82,,,UO_0000065,21.89,0.43,4.4,11.82,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,0.15
CHEMBL3589745,,None,374.38,0,4.54,9i,O=C(Nc1ccccc1)Nc1ccc(/N=C2\C(=O)Nc3ccc(F)cc32)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,
CHEMBL3589746,,None,442.37,1,5.56,9j,O=C(Nc1ccc(/N=C2\C(=O)Nc3ccc(F)cc32)cc1)Nc1cccc(C(F)(F)F)c1,IC50,'=',2120,nM,5.67,,,UO_0000065,12.83,0.24,0.11,6.87,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,2.12
CHEMBL3588869,,None,392.37,0,4.68,9l,O=C(Nc1ccc(F)cc1)Nc1ccc(/N=C2\C(=O)Nc3ccc(F)cc32)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,
CHEMBL3589809,,None,390.83,1,5.06,9q,O=C(Nc1ccccc1)Nc1ccc(/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3590864,Inhibition of VEGFR2 (unknown origin) using biotinylated poly-GluTyr by ELISA reader,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3588799,1,Scientific Literature,Eur J Med Chem,2015,None,,,,
CHEMBL3633685,,None,358.41,0,4.16,12r,Cc1ccnc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL3633305,,None,350.41,0,3.91,12p,Nc1n[nH]c2cccc(-c3cccc(NC(=O)Nc4nccs4)c3)c12,IC50,'>',500,nM,,,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL3633283,,None,575.59,2,5.97,6m,COc1ccc(C(=O)OCCN(C(C)C)C(C)C)cc1NC(=O)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F,IC50,'>',500000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,500
CHEMBL249697,BMS-345541,None,255.32,0,1.87,BMS-345541,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,10000
CHEMBL4070403,,None,520.63,2,6.04,8b,CCN(CC)Cc1cccn1-c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)OC)ccc32)c2ccccc2)cc1,IC50,'=',164.62,nM,6.78,,,UO_0000065,13.03,0.24,0.74,8.97,0,CHEMBL3993992,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,164.62
CHEMBL4081227,,None,278.34,0,3.52,52,c1cc(-c2cnn3cc(-c4ccsc4)cnc23)ccn1,IC50,'=',24,nM,7.62,,,UO_0000065,27.38,0.52,4.1,17.69,0,CHEMBL3995183,Inhibition of recombinant human GST-fused KDR kinase expressed in insect Sf21 cells using poly-Glu/Tyr (4:1) peptide as substrate,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994587,1,Scientific Literature,Eur J Med Chem,2017,None,,,,24
CHEMBL4069394,,None,492.58,1,5.26,8a,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1,Inhibition,'=',93.8,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,93.8
CHEMBL3759798,,None,386.38,0,3.19,6ba,COc1cc2ncnc(Nc3ccc(F)cc3)c2cc1OCCCC(=O)NO,IC50,'=',376,nM,6.42,,,UO_0000065,16.63,0.31,3.23,6.08,0,CHEMBL3762407,Inhibition of VEGFR2 (unknown origin) preincubated for 5 mins followed by addition of ATP/gastrin precursor(Tyr87) biotinylated peptide cocktail incubated for 30 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758114,1,Scientific Literature,Eur J Med Chem,2016,None,,,,376
CHEMBL4093247,,None,574.36,2,5.83,10e,Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(OC(F)(F)F)ccc5Br)CC4)cc3)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3993539,Inhibition of VEGFR2 (unknown origin) after 60 mins by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992524,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL3668019,,None,423.52,0,4.94,BDBM36356,CN(C)CCCOc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1,IC50,'=',2062,nM,5.69,,303526,UO_0000065,13.42,0.24,0.75,10.24,0,CHEMBL3707799,Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3753811,,None,380.35,0,4.75,7e,O=C(Nc1nccs1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F,IC50,'=',106.52,nM,6.97,,,UO_0000065,18.33,0.37,2.22,9.16,0,CHEMBL3756969,Inhibition of KDR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3751776,1,Scientific Literature,Bioorg Med Chem,2016,None,,,,106.52
CHEMBL3628823,,None,365.46,0,4.38,3e,COc1ccc(CNc2ncc3c(n2)-c2ccc(OC)cc2SC3)cc1,Inhibition,'<',20,%,,,,UO_0000187,,,,,0,CHEMBL3630447,Inhibition of human KDR at 7 uM incubated for 50 mins by omnia tyr peptide 8 substrate based fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627617,1,Scientific Literature,Eur J Med Chem,2015,None,,,,20
CHEMBL231570,,None,493.95,0,4.6,25,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(CN5CCOCC5)c4)nc3c2)ccn1,Ki,'=',4,nM,8.4,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,4
CHEMBL231569,,None,481.94,0,4.71,23,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OCCN(C)C)c4)nc3c2)ccn1,Ki,'=',4,nM,8.4,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,4
CHEMBL3577121,,None,423.54,1,5.65,10,CNc1cc2nc(C)c(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)cc2cn1,IC50,'=',170,nM,6.77,,,UO_0000065,15.98,0.3,1.12,8.58,0,CHEMBL3578340,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576847,1,Scientific Literature,J Med Chem,2015,None,,,,0.17
CHEMBL3577114,,None,520.57,2,5.14,3,CNc1cc2c(cn1)cc(-c1ccc(F)c(NC(=O)Nc3cc(C(C)(C)C)no3)c1)c(=O)n2[C@H]1CCOC1,IC50,'=',0.46,nM,9.34,,,UO_0000065,17.94,0.34,4.2,7.57,0,CHEMBL3578340,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3576847,1,Scientific Literature,J Med Chem,2015,None,,,,0.00046
CHEMBL426211,,None,480.45,1,5.35,59,CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1,IC50,'=',97,nM,7.01,,,UO_0000065,14.6,0.27,1.66,6.88,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,97
CHEMBL218576,,None,562.6,2,6.94,55,CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2C)n1,IC50,'=',461,nM,6.34,,,UO_0000065,11.26,0.21,-0.6,6.87,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,461
CHEMBL373682,,None,532.57,2,6.85,41,Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCCCC2)cc1Nc1ncccc1-c1ccncn1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,25000
CHEMBL385178,,None,396.45,1,5.13,35,O=C(Nc1ccc(Oc2ccccc2)cc1)c1cccnc1NCc1ccncc1,IC50,'=',38,nM,7.42,,,UO_0000065,18.72,0.34,2.29,9.75,0,CHEMBL908504,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J Med Chem,2007,None,,,,38
CHEMBL3114023,,None,372.48,0,4.8,7f,Cc1cc(C)cc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)c1,IC50,'=',21,nM,7.68,,,UO_0000065,20.61,0.37,2.88,13.04,0,CHEMBL3116994,Inhibition of VEGFR-2 tyrosine kinase (unknown origin) after 30 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3112549,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,21
CHEMBL3109337,,None,436.49,0,3.65,trans-27,COCCOc1ccn2c(-c3ccc4cccc(O[C@@H]5CCNC[C@H]5F)c4n3)cnc2c1,IC50,'=',20,nM,7.7,,,UO_0000065,17.64,0.33,4.05,11.01,0,CHEMBL3111862,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108676,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,20
CHEMBL3109356,,None,436.49,0,3.65,cis-27,COCCOc1ccn2c(-c3ccc4cccc(O[C@@H]5CCNC[C@@H]5F)c4n3)cnc2c1,IC50,'=',28,nM,7.55,,,UO_0000065,17.3,0.32,3.9,10.8,0,CHEMBL3111862,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108676,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,28
CHEMBL3109338,,None,436.49,0,3.65,29,COCCOc1ccn2c(-c3ccc4cccc(O[C@H]5CCNC[C@@H]5F)c4n3)cnc2c1,IC50,'=',16,nM,7.8,,,UO_0000065,17.86,0.33,4.15,11.15,0,CHEMBL3111862,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108676,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,16
CHEMBL3109344,,None,418.5,0,3.71,15,COCCOc1ccn2c(-c3ccc4cccc(O[C@H]5CCCNC5)c4n3)cnc2c1,IC50,'=',102,nM,6.99,,,UO_0000065,16.71,0.31,3.28,10,0,CHEMBL3111862,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108676,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,102
CHEMBL3109342,,None,432.52,0,3.95,13,COCCOc1ccn2c(-c3ccc4cccc(OCC5CCNCC5)c4n3)cnc2c1,IC50,'=',389,nM,6.41,,,UO_0000065,14.82,0.27,2.46,9.17,0,CHEMBL3111862,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3108676,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,389
CHEMBL2152968,,None,465.5,1,5.57,29d,CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2155702,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2150974,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL3648119,,None,444.36,0,2.83,BDBM2556,COC[C@H](Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)[C@H](C)O,IC50,'=',300,nM,6.52,,7550,UO_0000065,14.68,0.34,3.69,5.43,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648116,,None,428.36,0,3.59,BDBM2546,C[C@H](Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)C(C)(C)O,IC50,'=',64,nM,7.19,,6397,UO_0000065,16.79,0.39,3.6,6.48,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5202029,,None,351.41,0,2.64,20,CCc1cccc(C(=O)Nc2cc(C)nn2-c2nc(CC)cc(=O)[nH]2)c1,Inhibition,'=',28,%,,,,UO_0000187,,,,,0,CHEMBL5161389,Inhibition of human recombinant VEGFR2 assessed as inhibition of phosphorylation activity at 10 uM using 33P-labeleled peptide substrate by radiometric scintillation counting assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5154791,1,Scientific Literature,J Med Chem,2022,None,Dose = 10.0 microM,,,28
CHEMBL216693,,None,556.06,1,4.33,25,CN1CCN(CCCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,IC50,'=',1000,nM,6,,,UO_0000065,10.79,0.21,1.67,6.63,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,1
CHEMBL266188,,None,492.58,0,4.18,17,c1cc(Nc2ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c23)c2c(c1)OCCO2,IC50,'=',50,nM,7.3,,,UO_0000065,14.82,0.28,3.12,8.37,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,0.05
CHEMBL216703,,None,515.01,1,4.3,9,COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOC4)c23)c1,IC50,'=',50,nM,7.3,,,UO_0000065,14.18,0.28,3,8.37,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,0.05
CHEMBL217493,,None,527.07,2,5.85,8,COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCCCC4)c23)c1,IC50,'=',5500,nM,5.26,,,UO_0000065,9.98,0.19,-0.59,6.75,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,5.5
CHEMBL5278505,,None,475.55,0,1.72,15,COc1cc(C#Cc2nn([C@H]3CCN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1,IC50,'=',1206,nM,5.92,,,UO_0000065,12.45,0.23,4.2,5.3,0,CHEMBL5256649,Inhibition of N-terminal GST tagged recombinant human VEGFR2 (aa805 to 1356 residues) expressed in baculovirus expression system using Poly- (Glu4:Tyr)-biotin as substrate incubated for 80 mins in presence of ATP by kinase glo method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5252660,1,Scientific Literature,ACS Med Chem Lett,2023,None,TIME = 1.333 hr,INHIBITOR,,1206
CHEMBL5435452,,None,310.37,0,3.13,32,O=C(/C=C/c1cccc(F)c1)c1ccc(N2CCNCC2)cc1,IC50,'=',800,nM,6.1,,,UO_0000065,19.64,0.36,2.97,18.85,0,CHEMBL5380330,Inhibition of human recombinant VEGFR-2 kinase activity using poly(Glu-Tyr) at 4:1 ratio as substrate incubated for 2.5 hrs by ELISA method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5376014,1,Scientific Literature,RSC Med Chem,2024,None,TIME = 2.5 hr,INHIBITOR,,0.8
CHEMBL5434432,,None,234.24,0,1.45,34,N#CCc1nnc(NC(=O)c2ccco2)s1,IC50,'=',7.4,nM,8.13,,,UO_0000065,34.71,0.69,6.68,8.86,0,CHEMBL5380331,Inhibition of human recombinant VEGFR-2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5376014,1,Scientific Literature,RSC Med Chem,2024,None,,INHIBITOR,,7.4
CHEMBL4205052,,None,372.43,0,3.67,8i,CNC(=O)c1cc(Oc2ccc(C3=NNC(c4ccccc4)C3)cc2)ccn1,IC50,'=',2300,nM,5.64,,,UO_0000065,15.14,0.28,1.97,7.46,0,CHEMBL4179085,Inhibition of VEGFR2 (unknown origin) incubated for 10 mins using FAM-labeled peptide and ATP by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177575,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,2.3
CHEMBL4785602,,None,358.51,0,3.97,46,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1,Activity,'=',94.46,%,,,,UO_0000187,,,,,0,CHEMBL4674338,Inhibition of human KDR using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673210,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,Dose = 1.0 microM,,,94.46
CHEMBL4749141,,None,367.48,0,3.23,44,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1,Activity,'=',13.59,%,,,,UO_0000187,,,,,0,CHEMBL4674338,Inhibition of human KDR using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673210,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,Dose = 1.0 microM,INHIBITOR,,13.59
CHEMBL1794068,GSK-326090A,None,558.63,2,6.07,GSK326090A,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,Inhibition,'=',2.65,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2.65
CHEMBL318892,,None,428.52,1,5.16,SB-236687,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1,Inhibition,'=',12.39,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,12.39
CHEMBL224496,,None,480.64,0,4.89,56,CN1CCN(Cc2ccc3c(c2)-c2[nH]nc(-c4csc(C#CCOc5ccccc5)c4)c2C3)CC1,IC50,'=',42,nM,7.38,,,UO_0000065,15.35,0.29,2.49,16.62,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,42
CHEMBL224917,,None,449.54,0,4.78,84,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4ccnn4)ccc2-3)cs1)COc1ccccc1,IC50,'=',124,nM,6.91,,,UO_0000065,15.36,0.29,2.13,10.06,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,124
CHEMBL395334,,None,520.04,1,4.26,19,CNC(=O)c1cc(Oc2ccc3c(c2)nc(Nc2ccc(Cl)c(CN4CCN(C)CC4)c2)n3C)ccn1,Ki,'=',10,nM,8,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,10
CHEMBL231067,,None,590.55,2,5.98,10,CNC(=O)c1cc(Oc2ccc3[nH]c(Nc4ccc(C(F)(F)C(F)(F)F)c(OC[C@H]5CCCN5C)c4)nc3c2)ccn1,Ki,'=',9,nM,8.05,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,9
CHEMBL213478,,None,448.45,1,6.29,15,CNc1ncc2cc(-c3cc(Nc4nc5cc(C(F)(F)F)ccc5[nH]4)ccc3C)ccc2n1,IC50,'=',1438,nM,5.84,,,UO_0000065,13.03,0.24,-0.45,7.44,0,CHEMBL853495,Inhibition of KDR by HTRF kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149344,1,Scientific Literature,J Med Chem,2006,None,,,,1438
CHEMBL212953,,None,564.61,2,6.2,36,CCN(CC)CC(=O)Nc1ccc(C(F)(F)F)cc1NC(=O)c1ccc(C)c(-c2ccc3nc(NC)ncc3c2)c1,IC50,'=',306,nM,6.51,,,UO_0000065,11.54,0.22,0.31,6.56,0,CHEMBL853495,Inhibition of KDR by HTRF kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149344,1,Scientific Literature,J Med Chem,2006,None,,,,306
CHEMBL3660284,,None,490.49,1,5.11,BDBM110656,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4c[nH]c(C(=O)OCCO)c4)c3)cc2)c1,IC50,'=',36,nM,7.44,,231541,UO_0000065,15.18,0.28,2.33,5.93,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3657551,,None,498.51,0,4.12,BDBM138212,Cc1nn(-c2cccc(Nc3ccc4c(c3)c(C(=O)C(F)(F)F)cn4C)n2)cc1CN1CC[C@@H](O)C1,IC50,'=',502,nM,6.3,,272112,UO_0000065,12.64,0.24,2.18,7.14,0,CHEMBL3707826,Kinase Inhibition Assay: Compounds of the invention were initially diluted to 10 mM in 100% DMSO (CALBIOCHEM) for storage and made into kinase buffer solution to create a compound concentration ranging from 1 uM and 10 uM. Serial dilutions of compounds of the invention were dispensed into a 96-well plate (GREINER BIOSCIENCES) at 6 uL each. Purified full-length human SYK,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2397141,,None,470.88,0,4.63,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5283863,,None,384.44,0,4.82,11,CCc1cccc(NC(=O)c2cccc3cc(Oc4cc(N)ncn4)ccc23)c1,IC50,'=',1,nM,9,,,UO_0000065,23.41,0.42,4.18,9.99,0,CHEMBL5252747,Inhibition of VEGF-induced human VEGFR2 autophosphorylation transfected in CHO cells measured after 2 hrs by chemiluminescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5252510,1,Scientific Literature,J Med Chem,2016,None,TIME = 2.0 hr,INHIBITOR,,0.001
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,'=',10.2,nM,7.99,,,UO_0000065,20.05,0.38,4.66,10.35,0,CHEMBL5252748,Inhibition of human recombinant GST-fused VEGFR2 kinase domain transphosphorylation expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate measured after 10 mins in presence of gamma-[33P]-ATP by scintillation counting analysis,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5252510,1,Scientific Literature,J Med Chem,2016,None,TIME = 0.1667 hr,INHIBITOR,,0.0102
CHEMBL3353349,,None,500.55,2,5.77,28,CN(C)Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccc(OC(F)F)cc45)ccc23)cc1,IC50,'=',4900,nM,5.31,,,UO_0000065,10.61,0.2,-0.46,7.56,0,CHEMBL3364612,Inhibition of KDR (unknown origin) by FRET-based homogeneous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351767,1,Scientific Literature,J Med Chem,2015,None,,,,4900
CHEMBL3797288,,None,358.37,0,2.87,21,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCN,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3797413,,None,373.38,0,3.56,49,COCCOc1cc2ncnc(Nc3c(F)ccc(O)c3C)c2cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3797416,,None,515.66,1,4.6,15,CCc1nc(Nc2cc(CCc3cc(OC)cc(OC)c3)[nH]n2)c2ccc(N3CCN(CC)CC3)cc2n1,IC50,'=',35.8,nM,7.45,,,UO_0000065,14.44,0.27,2.85,8.14,0,CHEMBL3804518,Inhibition of recombinant VEGFR2 (unknown origin) using (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1956891,,None,428.72,1,5.22,12a,Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)cc3)c2n1,IC50,'=',65300,nM,4.18,,,UO_0000065,9.76,0.22,-1.03,6.09,0,CHEMBL1959284,Inhibition of VEGF-induced VEGFR2 autophosphorylation in human U251 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955729,1,Scientific Literature,Bioorg Med Chem,2012,CHEMBL3307756,,,,65.3
CHEMBL3907764,,None,447.37,1,5.55,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3818193,,None,381.42,0,2.49,6i,NS(=O)(=O)c1ccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)cc1,IC50,'=',24.5,nM,7.61,,,UO_0000065,19.95,0.38,5.12,5.49,0,CHEMBL3820579,Inhibition of VEGFR-2 (unknown origin) after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,24.5
CHEMBL3819410,,None,422.4,0,3.49,8c,COc1cc(Nc2nccc(-n3ncc4cc([N+](=O)[O-])ccc43)n2)cc(OC)c1OC,IC50,'=',690,nM,6.16,,,UO_0000065,14.59,0.27,2.67,4.87,0,CHEMBL3820579,Inhibition of VEGFR-2 (unknown origin) after 40 mins by Kinase-GloPlus luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817755,1,Scientific Literature,Medchemcomm,2016,None,,,,690
CHEMBL230911,GSK-625137A,None,289.34,0,3.1,GSK625137A,NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N,Inhibition,'=',10.73,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,10.73
CHEMBL2409789,,None,405.46,0,3.92,29f,Cc1ccc(Oc2ccc3nc(NC(=O)C4CC4)nn3c2)cc1NC(=O)C1CCC1,IC50,'=',3.9,nM,8.41,,,UO_0000065,20.74,0.38,4.49,8.61,0,CHEMBL2410830,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition measured after overnight incubation under dark condition by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,3.9
CHEMBL2409789,,None,405.46,0,3.92,29f,Cc1ccc(Oc2ccc3nc(NC(=O)C4CC4)nn3c2)cc1NC(=O)C1CCC1,IC50,'=',3,nM,8.52,,,UO_0000065,21.02,0.39,4.6,8.73,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,3
CHEMBL2409786,,None,445.48,0,3.47,29c,Cc1ccc(Oc2ccc3nc(NC(=O)C4CC4)nn3c2)cc1NC(=O)c1cn(C)nc1C,IC50,'=',1.9,nM,8.72,,,UO_0000065,19.58,0.36,5.25,7.55,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.9
CHEMBL2409781,,None,448.51,0,4.13,22a,Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4n3)c2)n(C)n1,IC50,'=',1.3,nM,8.89,,,UO_0000065,19.81,0.38,4.76,8,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.3
CHEMBL2409777,,None,445.48,0,3.47,13c,Cc1cc(NC(=O)c2cc(C)nn2C)cc(Oc2ccc3nc(NC(=O)C4CC4)nn3c2)c1,IC50,'=',2.1,nM,8.68,,,UO_0000065,19.48,0.36,5.21,7.52,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,2.1
CHEMBL2409776,,None,445.48,0,3.47,13b,Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2C)n(C)n1,IC50,'=',1.9,nM,8.72,,,UO_0000065,19.58,0.36,5.25,7.55,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.9
CHEMBL2409775,,None,431.46,0,3.16,13a,Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)c2)n(C)n1,IC50,'=',1.1,nM,8.96,,,UO_0000065,20.76,0.38,5.8,7.76,0,CHEMBL2410842,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,1.1
CHEMBL189353,GW809897X,None,571.49,2,6.48,GW809897X,CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,Inhibition,'=',24.58,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,24.58
CHEMBL3815128,,None,553.57,1,3.79,18a,CN(C)CCCO/N=C/c1c(N)ncnc1Oc1ccc(NC(=O)C2(C(=O)Nc3ccc(F)cc3)CC2)cc1F,IC50,'=',170,nM,6.77,,,UO_0000065,12.23,0.23,2.98,4.7,0,CHEMBL3816037,Inhibition of recombinant VEGFR2 (unknown origin) using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928291,,None,422.87,1,5.94,44,O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,Inhibition,'=',15,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909349,GSK-1007102B,None,561.52,0,2.28,GSK1007102B,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F,Inhibition,'=',75.36,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,75.36
CHEMBL3323605,,None,415.29,1,6.28,7n,Brc1ccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)cc1,IC50,'=',180,nM,6.75,,,UO_0000065,16.24,0.34,0.46,12.58,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,0.18
CHEMBL2409778,,None,449.45,0,3.3,13d,Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1,IC50,'=',2.2,nM,8.66,,,UO_0000065,19.26,0.36,5.36,7.5,0,CHEMBL2410830,Inhibition of human VEGFR2 using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition measured after overnight incubation under dark condition by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2407020,1,Scientific Literature,Bioorg Med Chem,2013,None,,,,2.2
CHEMBL3798631,,None,376.85,0,4.77,6i,CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3802295,Inhibition of KDR (unknown origin) by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797088,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,1000
CHEMBL1794064,GSK-561866B,None,470.41,0,0.12,GSK561866B,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,Inhibition,'=',-3.31,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,-3.31
CHEMBL2401832,,None,465.31,1,5.16,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2401832,,None,465.31,1,5.16,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3797607,,None,525.54,2,5.54,13l,CCN(CC)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccc(F)c(F)c3)cc2F)ccn1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3801450,Inhibition of VGFR2 (unknown origin) at 10 uM after 1 hr by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797160,1,Scientific Literature,Eur J Med Chem,2016,None,,,,0
CHEMBL2397146,,None,470.88,0,4.63,9,CNC(=O)c1ccc(O[C@H]2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)CC2)cn1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL2399719,Inhibition of VEGFR-2 (unknown origin) at 10 uM after 1 hr by luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396585,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,
CHEMBL213138,,None,511.7,1,4.62,14,Cc1cccc(CC(=O)NCc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1,IC50,'=',2777,nM,5.56,,,UO_0000065,10.86,0.21,0.94,8.65,0,CHEMBL869847,Inhibition of KDR at 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146863,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,2777
CHEMBL4475515,,None,301.38,0,2.32,5,CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1NC,IC50,'=',2510,nM,5.6,,,UO_0000065,18.58,0.36,3.28,6.52,0,CHEMBL4316523,Inhibition of GST-6His-tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide as substrate after 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4312039,1,Scientific Literature,ACS Med Chem Lett,2019,None,,,,2.51
CHEMBL387590,,None,488.98,1,5.64,35,CN1CCN(Cc2cc(Nc3nc4cc(Oc5ccnc6[nH]ccc56)ccc4o3)ccc2Cl)CC1,IC50,'=',52,nM,7.28,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,52
CHEMBL2403378,,None,352.35,0,2.32,14,CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc([N+](=O)[O-])cc43)cc2C1,IC50,'=',60,nM,7.22,,,UO_0000065,20.5,0.38,4.9,6.67,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.06
CHEMBL2403376,,None,375.35,0,3.43,12,CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(C(F)(F)F)cc43)cc2C1,IC50,'=',320,nM,6.5,,,UO_0000065,17.3,0.33,3.06,9.96,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.32
CHEMBL1928304,,None,384.46,1,5.02,38,O=C(c1cc2ccccc2[nH]1)c1cc2c(NCc3ccccc3)ncnc2s1,Inhibition,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL220523,,None,295.3,0,2.38,5,CO/N=C/c1c(N)ncnc1Oc1ccc2ncccc2c1,IC50,'=',700,nM,6.16,,,UO_0000065,20.84,0.38,3.77,6.44,0,CHEMBL907874,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139745,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.7
CHEMBL1928315,,None,439.92,1,6.67,58,O=C(c1cc2ccccc2s1)c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,Inhibition,'=',22,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945499,,None,480.08,1,6.45,11g,CC(C)c1ccc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2,IC50,'=',1400,nM,5.85,,,UO_0000065,12.19,0.24,-0.6,11.03,0,CHEMBL1948345,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944579,1,Scientific Literature,J Med Chem,2012,None,,,,1400
CHEMBL2408611,,None,466.95,1,5.07,13a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2436724,,None,382.85,0,3.12,5e,O=S(=O)(Nc1ccc(O)c(Sc2ncn[nH]2)c1)c1ccc(Cl)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2438103,Inhibition of VEGFR2 (unknown origin) phosphorylation at 1 ug/mL by cell-based Western blotting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2434840,1,Scientific Literature,Eur J Med Chem,2013,None,,,,
CHEMBL395335,,None,509.99,2,5.49,24,CCN(CC)CCOc1cc(Nc2nc3cc(Oc4ccnc(C(=O)NC)c4)ccc3o2)ccc1Cl,Ki,'=',5,nM,8.3,,,UO_0000065,,,,,0,CHEMBL895899,Inhibition of KDR phosphorylation,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,None,,,,5
CHEMBL230003,,None,562.03,2,6.45,28,COc1cc2ncnc(Oc3ccc4oc(Nc5ccc(Cl)c(OC[C@@H]6CCCN6C)c5)nc4c3)c2cc1OC,IC50,'=',6,nM,8.22,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,6
CHEMBL231569,,None,481.94,0,4.71,23,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OCCN(C)C)c4)nc3c2)ccn1,IC50,'=',88,nM,7.06,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,88
CHEMBL397496,,None,499.02,1,6.05,13,CN1CCN(Cc2cc(Nc3nc4cc(Oc5ccnc6ccccc56)ccc4[nH]3)ccc2Cl)CC1,IC50,'=',40,nM,7.4,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,40
CHEMBL231370,,None,533.55,2,7.14,12,CN1CCC[C@@H]1COc1cc(Nc2nc3cc(Oc4ccnc5ccccc45)ccc3[nH]2)ccc1C(F)(F)F,IC50,'=',32.4,nM,7.49,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,32.4
CHEMBL231269,,None,540.55,2,5.35,9,CNC(=O)c1cc(Oc2ccc3[nH]c(Nc4ccc(C(F)(F)F)c(OC[C@H]5CCCN5C)c4)nc3c2)ccn1,IC50,'=',84,nM,7.08,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,84
CHEMBL213290,,None,549.6,2,5.93,48,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1,IC50,'=',15,nM,7.82,,,UO_0000065,14.24,0.27,1.89,9.86,0,CHEMBL853495,Inhibition of KDR by HTRF kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149344,1,Scientific Literature,J Med Chem,2006,None,,,,15
CHEMBL4436907,,None,468.3,0,4.72,6h,O=C(Nc1ccc(Cl)cc1)Nc1ccc(C(=O)N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1,IC50,'=',3980,nM,5.4,,,UO_0000065,11.53,0.23,0.68,4.83,0,CHEMBL4330587,Inhibition of VEGFR-2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate after 5 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330065,1,Scientific Literature,Eur J Med Chem,2019,None,,,,3.98
CHEMBL4550584,,None,277.35,0,3.81,2a,c1ccc(-c2ncc3c(n2)-c2cccnc2SC3)cc1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL4340078,Inhibition of recombinant human KDR at 7 uM incubated for 1 hr using Tyr1 substrate by fluorimetry based Z'-LYTE-Tyr1 Peptide assay relative to untreated control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4339217,1,Scientific Literature,ACS Med Chem Lett,2019,None,,,,10
CHEMBL2430254,,None,451.53,0,3.5,27,CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc([N+](=O)[O-])cc21,IC50,'=',25.7,nM,7.59,,,UO_0000065,16.81,0.31,4.09,6.31,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,25.7
CHEMBL2430266,,None,420.56,0,3.9,25,CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(C)cc21,IC50,'=',2.3,nM,8.64,,,UO_0000065,20.54,0.38,4.74,11.19,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,2.3
CHEMBL2430265,,None,485.43,0,4.36,24,CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(Br)cc21,IC50,'=',3.9,nM,8.41,,,UO_0000065,17.32,0.37,4.05,10.89,0,CHEMBL2434542,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429742,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,3.9
CHEMBL204846,,None,449.56,1,6.51,24,CC(C)(C)c1ccc(Nc2nnc(-c3cc4ccccc4nc3CCc3ccncc3)o2)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,
CHEMBL382654,,None,417.89,0,4.78,5c,O=C1c2ccccc2NC(=O)[C@H]2[C@H]1[C@@H](c1cccc(Cl)c1)C[C@]2(O)c1ccccc1,Inhibition,'>',50,%,,,,UO_0000187,,,,,0,CHEMBL866853,Inhibition of VEGFR2 at 10 uM in presence of 0.1 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146950,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,50
CHEMBL3099457,,None,535.64,2,5.95,A2,CCN(CC)CCOc1ccc(NC(=O)Nc2cc(OC)c(OC)c(-c3ccc(C(C)=O)c(OC)c3)c2)cc1,IC50,'>',300,nM,,,,UO_0000065,,,,,0,CHEMBL3102332,Inhibition of VEGFR2 (unknown origin) after 30 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098016,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,300
CHEMBL1928307,,None,438.43,1,6.17,40,O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(C(F)(F)F)cc3)ncnc2s1,Inhibition,'=',24,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1969151,,None,370.89,0,3.96,SID103904199,CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL1969190,,None,410.38,1,5.01,SID103904443,COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12,Ki,'=',125.89,nM,6.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.9
CHEMBL1995211,,None,266.35,0,3.84,SID103904207,CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1976732,,None,410.38,0,3.29,SID103905067,CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1993510,,None,396.37,1,5.69,SID103904748,O=C(Nc1ccc(-n2cnc3ccccc32)cc1)Nc1cccc(C(F)(F)F)c1,Ki,'=',3.162,nM,8.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.5
CHEMBL1984402,,None,243.27,0,1.23,SID103905439,CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N,Ki,'=',19952.62,nM,4.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.7
CHEMBL1988622,,None,221.26,0,2.9,SID103905671,C(=Cc1ccc2nccn2n1)c1ccccc1,Ki,'>',100000,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4
CHEMBL362558,LY-2090314,2,512.55,1,3.42,SID103905564,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL485556,,None,472.55,0,3.58,SID103905075,CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6
CHEMBL1998545,,None,332.4,0,3.08,SID103904581,O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1970104,,None,290.37,0,4.4,SID103904904,CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.6
CHEMBL1986970,,None,390.45,0,2.59,SID103904516,COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2001228,,None,626.12,2,7.14,SID103904407,O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.7
CHEMBL2006581,,None,384.85,0,1.29,SID103905388,CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1994555,,None,265.32,0,3.39,SID103905323,CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL1997023,,None,265.29,0,1.39,SID103905667,CN(C)c1cc2sncc2cc1NC(=O)C(=O)O,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1993166,,None,775.93,3,0.17,SID103905218,CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1998110,,None,356.47,0,4.01,SID103904920,[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL1975233,,None,317.74,0,2.96,SID103904892,COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1976090,,None,218.25,0,0.8,SID103905284,Nc1ncnc2c1sc1ncnc(N)c12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.9
CHEMBL1975256,,None,386.42,1,1.79,SID103905141,Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL308645,,None,441.85,0,4.16,26e,Cc1cc(CCC(=O)O)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL68774,,None,370.46,1,5.59,11,Nc1ncnc2c1c(-c1ccccc1Oc1ccccc1)cn2C1CCCC1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL817617,Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132739,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,50
CHEMBL67057,,None,559.63,1,4.82,28b,Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(ccn4Cc4ccccc4)c3)c21,IC50,'=',2050,nM,5.69,,,UO_0000065,10.16,0.18,0.87,4.85,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,2.05
CHEMBL2403375,,None,365.43,0,3.2,11,CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(OC(C)C)cc43)cc2C1,IC50,'=',900,nM,6.05,,,UO_0000065,16.54,0.31,2.85,8.12,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.9
CHEMBL2403365,,None,368.44,0,2.21,1,COc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCCN)c1C)C(=O)N2,IC50,'<',1000,nM,,,,UO_0000065,,,,,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,1
CHEMBL220317,,None,364.43,0,3.61,14,Nc1n[nH]c2cccc(-c3ccc(NS(=O)(=O)c4ccccc4)cc3)c12,IC50,'=',4620,nM,5.33,,,UO_0000065,14.64,0.28,1.73,5.29,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,4620
CHEMBL223304,,None,359.39,0,4.16,17o,Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(O)c4)cc3)c12,IC50,'=',55,nM,7.26,,,UO_0000065,20.2,0.37,3.1,6.26,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,55
CHEMBL223236,,None,433.49,1,5.02,22d,COCCn1nc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)cccc21,IC50,'=',3090,nM,5.51,,,UO_0000065,12.71,0.24,0.49,5.85,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,3090
CHEMBL373845,,None,469.59,0,4.51,43b,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(CN4CCN(C)CC4)c4[nH]nc(N)c34)cc2)c1,IC50,'=',1200,nM,5.92,,,UO_0000065,12.61,0.23,1.41,5.79,0,CHEMBL920439,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,None,,,,1200
CHEMBL316671,,None,401.58,1,6.31,3e,c1ccc2c(c1)c(-c1cncc(-c3ccsc3)c1)cn2CCCN1CCCCC1,IC50,'=',38,nM,7.42,,,UO_0000065,18.48,0.35,1.11,35.23,0,CHEMBL819548,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136194,1,Scientific Literature,Bioorg Med Chem Lett,2003,None,,,,38
CHEMBL390156,,None,480.64,0,4.89,8,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',6,nM,8.22,,,UO_0000065,17.11,0.32,3.33,18.52,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,6
CHEMBL416444,,None,345.41,0,3.43,6,NCCn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,IC50,,,nM,,,Not Determined,UO_0000065,,,,,0,CHEMBL811945,Inhibition of Vascular endothelial growth factor receptor 2(Not tested),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135158,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,
CHEMBL5201057,,None,567.87,2,7.09,3o,Fc1c(F)c(F)c(Cn2c3ccccc3c3ccn4c[n+](-c5ccc(C(F)(F)F)cc5)cc4c32)c(F)c1F.[Cl-],IC50,'=',900,nM,6.05,,,UO_0000065,11.36,0.22,-1.04,45.73,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,INHIBITOR,,0.9
CHEMBL5196328,,None,481.04,1,6.02,3w,CN(C)c1ccc(-[n+]2cc3c4c(ccn3c2)c2ccccc2n4CCCc2ccccc2)cc1.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL3656068,,None,663.66,2,3.91,BDBM110579,Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N[C@@H](CCC(=O)OCCO)C(=O)OCCO)c[nH]4)c3)cc2F)c1,IC50,'=',17,nM,7.77,,231464,UO_0000065,11.71,0.22,3.86,3.86,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3656034,,None,500.53,1,4.78,BDBM110542,Cc1ccc(F)c(NC(=O)c2cccc(Oc3ccnc(-c4cc(C(=O)N5CC[C@H](O)C5)c[nH]4)c3)c2)c1,IC50,'=',41,nM,7.39,,231428,UO_0000065,14.76,0.27,2.61,6.87,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660282,,None,530.89,2,6.97,BDBM110654,COC(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)ccn2)c1,IC50,'=',130,nM,6.89,,231539,UO_0000065,12.97,0.25,-0.08,6.54,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1762114,,None,403.49,0,3.32,4c,CN(C)C(=O)N1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn23)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1762898,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759853,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,10
CHEMBL506414,GW684626B,None,467.98,1,7.53,GW684626B,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1,Inhibition,'=',7.67,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.67
CHEMBL1721885,SU-014813,2,442.49,0,1.69,SU-14813,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,Kd,'=',2.3,nM,8.64,,,UO_0000065,19.52,0.37,6.95,8.1,1,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,,,,2.3
CHEMBL1794062,GW577921A,None,302.76,0,4.09,GW577921A,COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl,Inhibition,'=',10.62,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,10.62
CHEMBL5202910,,None,566.65,1,4.83,3f,COCCOc1ccnc(C#Cc2ccc3c4c(oc3c2)C(C)(C)c2cc(OCCN3CCOCC3)ccc2C4=O)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,,,1000
CHEMBL5198427,,None,518.61,2,5.72,5a,CC1(C)c2cc(N3CCOCC3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCC4CC4)ccn3)ccc21,IC50,'=',690,nM,6.16,,,UO_0000065,11.88,0.22,0.44,9.51,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,INHIBITOR,,690
CHEMBL188247,GW832467X,None,504.47,2,5.7,GW832467X,Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1,Inhibition,'=',-0.67,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,-0.67
CHEMBL1794060,GW575533A,None,332.79,0,4.1,GW575533A,COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl,Inhibition,'=',10.6,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,10.6
CHEMBL1794067,GSK-978744A,None,487.97,0,3.71,GSK978744A,C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',22.16,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,22.16
CHEMBL5180197,,None,375.9,1,5.12,3b,CCCCn1c2ccccc2c2ccn3c[n+](-c4ccccc4)cc3c21.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL1983006,,None,347.72,0,2.35,SID103904900,COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1,Ki,'=',5011.87,nM,5.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.3
CHEMBL360847,,None,468.56,0,3.51,SID103905239,CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL2002450,,None,240.26,0,3.09,SID103905456,COc1ccc(-c2ccc(N)cc2)c2cnoc12,Ki,'>',79432.82,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.1
CHEMBL3732044,,None,318.87,0,2.88,Example 4,Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O,Inhibition,'=',-28,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL3734481,Inhibition of recombinant human KDR using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727354,38,SureChEMBL Patent Bioactivity Data,,2011,None,,,,-28
CHEMBL3321897,,None,353.39,0,4.62,7f,Oc1ccccc1-c1nc2ccc(Nc3ncnc4ccccc34)cc2[nH]1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3368964,Inhibition of human recombinant VEGFR2 pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352651,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,10
CHEMBL2348862,,None,383.45,0,1.95,10b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3220319,,None,536.63,2,5.55,T3,COc1cc(-c2cc(NC(=O)Nc3ccc(OCCCN(C)C)cc3)cc(OC)c2OC)ccc1/C(C)=N/O,IC50,'=',203,nM,6.69,,,UO_0000065,12.47,0.23,1.14,5.88,0,CHEMBL3222612,Inhibition of VEGFR-2 (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217755,1,Scientific Literature,Medchemcomm,2013,None,,,,203
CHEMBL3221558,,None,425.27,0,4.22,38,COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl.Cl,IC50,'=',5050,nM,5.3,,,UO_0000065,13.62,0.27,1.08,5.6,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,5.05
CHEMBL3219622,,None,873.22,3,9.68,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL521000,,None,396.54,0,2.89,CER-0263745,CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,5
CHEMBL453336,,None,484.55,0,4.88,26,COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC,IC50,'=',1600,nM,5.8,,,UO_0000065,11.96,0.22,0.92,8.17,0,CHEMBL957977,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157465,1,Scientific Literature,J Med Chem,2008,None,,,,1.6
CHEMBL3221559,,None,425.27,0,4.22,39,COC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1Cl.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,10
CHEMBL3322564,,None,416.44,0,3.48,11b,COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1,Inhibition,'=',48,%,,,,UO_0000187,,,,,0,CHEMBL3362109,Inhibition of VEGFR2 (unknown origin) using poly[Glu:Tyr] substrate at 1 uM by radioisotope-based P81 filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351387,1,Scientific Literature,Eur J Med Chem,2014,None,,,,48
CHEMBL3321892,,None,337.39,0,4.92,7a,c1ccc(-c2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1,IC50,'=',830,nM,6.08,,,UO_0000065,18.02,0.32,1.16,9.15,0,CHEMBL3368964,Inhibition of human recombinant VEGFR2 pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352651,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,0.83
CHEMBL406381,KRN-633,1,416.87,0,4.62,K00589a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL461109,,None,399.48,1,5.27,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL473556,,None,414.49,1,5.67,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL523122,,None,485.93,0,3.47,43,COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1,Activity,,,,,,Not Active,,,,,,0,CHEMBL1022372,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153429,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,
CHEMBL4075266,,None,547.46,2,6.21,10i,Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)c12,IC50,'=',1.35,nM,8.87,,,UO_0000065,16.2,0.31,2.66,7.86,0,CHEMBL3993539,Inhibition of VEGFR2 (unknown origin) after 60 mins by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992524,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1.35
CHEMBL4060113,,None,480.36,1,5.48,10n,Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(Cl)c5)CC4)c3)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3993539,Inhibition of VEGFR2 (unknown origin) after 60 mins by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992524,1,Scientific Literature,Eur J Med Chem,2017,None,,,,
CHEMBL4082005,,None,480.36,1,5.48,10m,Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5ccc(Cl)cc5Cl)CC4)c3)c12,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3993539,Inhibition of VEGFR2 (unknown origin) after 60 mins by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992524,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1000
CHEMBL3656053,,None,472.5,0,4.23,BDBM110563,Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc(-c3cc(C(=O)N4CC[C@H](O)C4)c[nH]3)c2)c1,IC50,'=',29,nM,7.54,,231448,UO_0000065,15.95,0.29,3.31,6.25,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660301,,None,417.44,1,5.54,BDBM110673,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3cc(N)nc(-c4ccc[nH]4)c3)cc2)c1,IC50,'=',2704,nM,5.57,,231558,UO_0000065,13.34,0.25,0.03,5.3,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL67,COMBRETASTATIN A4,-1,316.35,0,3.6,CA-4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3998243,Inhibition of VEGFR-2 in human U251 cells assessed as reduction in VEGF induced phosphorylation preincubated for 60 mins followed by VEGF addition measured after 10 mins by ELISA method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3997769,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,
CHEMBL226838,,None,335.41,0,4.47,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3104852,,None,226.18,0,0.93,3,COC1OC(=O)c2c(O)c(O)c(O)c(C)c21,IC50,'=',26400,nM,4.58,,,UO_0000065,20.24,0.39,3.65,4.76,0,CHEMBL3108315,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J Nat Prod,2014,None,,,,26.4
CHEMBL3656055,,None,417.42,0,4.81,BDBM110565,COC(=O)c1c[nH]c(-c2cc(Oc3cccc(NC(=O)c4occc4C)c3)ccn2)c1,IC50,'=',29,nM,7.54,,231452,UO_0000065,18.06,0.33,2.73,7.08,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660297,,None,521.57,1,4.95,BDBM110669,C=S(C)(=O)NC(=O)c1cc(-c2cc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)ccn2)c[nH]1,IC50,'=',33,nM,7.48,,231554,UO_0000065,14.34,0.28,2.53,5.98,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3696079,,None,576.6,1,4.02,BDBM144594,NC(=O)c1c(-c2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2)nsc1NC(=O)NCCCN1CCOCC1,IC50,'=',4520,nM,5.34,,280954,UO_0000065,9.27,0.18,1.32,3.85,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3633298,,None,373.42,0,4.46,12i,COc1cccc(NC(=O)Nc2cccc(-c3cccc4[nH]nc(N)c34)c2)c1,IC50,'=',21,nM,7.68,,,UO_0000065,20.56,0.37,3.22,7.31,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,21
CHEMBL3633293,,None,377.83,1,5.11,12d,Nc1n[nH]c2cccc(-c3cccc(NC(=O)Nc4ccccc4Cl)c3)c12,IC50,'=',116,nM,6.94,,,UO_0000065,18.36,0.35,1.83,7.24,0,CHEMBL3636058,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632507,1,Scientific Literature,Eur J Med Chem,2015,None,,,,116
CHEMBL474863,,None,507.58,2,5.43,16a,Nc1ccccc1NC(=O)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)cn1,IC50,'=',4400,nM,5.36,,,UO_0000065,10.55,0.2,-0.07,3.97,0,CHEMBL1022425,Inhibition of VEGFR2 by liquid scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153406,1,Scientific Literature,J Med Chem,2009,None,,,,4.4
CHEMBL473825,,None,521.61,2,5.74,14b,Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)s2)cc1Nc1ncc(-c2cccnc2)cn1,IC50,'=',11000,nM,4.96,,,UO_0000065,9.51,0.18,-0.78,3.68,0,CHEMBL1022425,Inhibition of VEGFR2 by liquid scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153406,1,Scientific Literature,J Med Chem,2009,None,,,,11
CHEMBL3648114,,None,458.38,0,3.26,BDBM2537,CN=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)cc1OC,IC50,'=',29,nM,7.54,,6389,UO_0000065,16.44,0.38,4.28,6.93,0,CHEMBL3707963,Kinase Assay: Kinase assay using either CDK1,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL491680,,None,361.84,0,4.59,10,Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1,IC50,'=',390,nM,6.41,,,UO_0000065,17.71,0.34,1.82,11.52,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.39
CHEMBL522133,,None,429.83,1,5.61,18,FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl,IC50,'=',440,nM,6.36,,,UO_0000065,14.79,0.29,0.75,11.43,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.44
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',10.7,nM,7.97,,,UO_0000065,17.08,0.31,3.62,11.48,0,CHEMBL3620034,Inhibition of VEGFR2 (unknown origin) after 40 mins by scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3616395,1,Scientific Literature,Eur J Med Chem,2015,None,,,,10.7
CHEMBL328029,,None,264.33,0,3.39,4a,O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCCC2,IC50,'=',480,nM,6.32,,,UO_0000065,23.9,0.43,2.93,14.08,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,0.48
CHEMBL2419762,,None,405.89,1,5.2,9,Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1,Inhibition,'=',30,%,,,,UO_0000187,,,,,0,CHEMBL2422319,Inhibition of VEGFR2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2417485,1,Scientific Literature,Eur J Med Chem,2013,None,,,,30
CHEMBL491502,,None,411.39,0,4.84,9,FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1,IC50,'=',66,nM,7.18,,,UO_0000065,17.45,0.33,2.34,11.07,0,CHEMBL960809,Inhibition of VEGFR2 by HTRF assay in presence of 2 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.066
CHEMBL118832,,None,408.48,0,2.68,15,O=S(=O)(c1ccc2[nH]c(-c3cc4ccccc4nc3O)cc2c1)N1CCNCC1,IC50,'=',11,nM,7.96,,,UO_0000065,19.48,0.37,5.28,8.09,0,CHEMBL820698,Inhibition of VEGF receptor 2 mediated phosphorylation of poly-Glu/Tyr (4:1),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137936,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,11
CHEMBL498551,,None,374.45,0,2.41,19aa,CN1CCN(c2cccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c23)CC1,IC50,'=',17,nM,7.77,,,UO_0000065,20.75,0.38,5.36,8.26,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,0.017
CHEMBL496764,,None,389.46,0,1.99,19p,CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(N)ccc5[nH]c4=O)nc3c2)CC1,IC50,'=',19,nM,7.72,,,UO_0000065,19.83,0.36,5.73,6.43,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,0.019
CHEMBL3422071,,None,509.65,2,5.76,41,CN1CCC(Oc2ccc(-c3n[nH]c4ccc(C(=O)NC(c5ccccn5)C5CCCC5)cc34)cc2)CC1,IC50,'=',6100,nM,5.21,,,UO_0000065,10.23,0.19,-0.55,6.27,0,CHEMBL3423901,Inhibition of recombinant KDR (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3421533,1,Scientific Literature,J Med Chem,2015,None,,,,6.1
CHEMBL518867,,None,477.54,0,3.8,58,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1,IC50,'=',150,nM,6.82,,,UO_0000065,14.29,0.27,3.02,6.51,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,150
CHEMBL3288502,,None,378.44,1,5.22,4a,Nc1n[nH]c2cccc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12,IC50,'=',3.8,nM,8.42,,,UO_0000065,22.25,0.4,3.2,10.05,0,CHEMBL3295611,Inhibition of VEGFR-2 in HUVEC assessed as inhibition of VEGF (1 to 165)-induced cell proliferation preincubated for 2 hrs followed by VEGF (1 to 165) induction measured after 48 hrs by CCK8 assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286125,1,Scientific Literature,ACS Med Chem Lett,2014,None,,,,3.8
CHEMBL3657549,,None,441.9,0,3.18,BDBM138209,Cc1cn(-c2nc(Nc3ccc4c(c3)c(Cl)nn4C)ncc2F)cc1CN1CC(O)C1,IC50,'=',150,nM,6.82,,272109,UO_0000065,15.44,0.3,3.64,8.12,0,CHEMBL3707826,Kinase Inhibition Assay: Compounds of the invention were initially diluted to 10 mM in 100% DMSO (CALBIOCHEM) for storage and made into kinase buffer solution to create a compound concentration ranging from 1 uM and 10 uM. Serial dilutions of compounds of the invention were dispensed into a 96-well plate (GREINER BIOSCIENCES) at 6 uL each. Purified full-length human SYK,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',3.5,nM,8.46,,,UO_0000065,18.12,0.33,4.11,12.18,1,CHEMBL3615424,Inhibition of human KDR using and Ulight-CAGAGAIETDKEYYTVKD as substrate after 1 hr by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3611997,1,Scientific Literature,Eur J Med Chem,2015,None,,,,3.5
CHEMBL1682549,,None,382.49,1,5.97,9h,c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)c(-c3ccccc3)s2)cc1,Ki,'>',8880,nM,,,,UO_0000065,,,,,0,CHEMBL1685433,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681650,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,8.88
CHEMBL244297,,None,539.45,2,7,49,O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,IC50,'=',5.1,nM,8.29,,,UO_0000065,15.37,0.29,1.29,6.84,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,5.1
CHEMBL505698,,None,358.41,0,3.93,23,Cc1cccc(NC(=O)Nc2cccc(-c3cnc4ccnn4c3N)c2)c1,IC50,'=',6600,nM,5.18,,,UO_0000065,14.45,0.26,1.25,5.32,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,6600
CHEMBL511843,,None,415.46,0,3.29,38,CNC(=O)c1cnn2c(N)c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)cnc12,IC50,'=',100,nM,7,,,UO_0000065,16.85,0.31,3.71,5.54,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,100
CHEMBL489058,,None,558.15,2,6.43,5m,CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1,IC50,'=',1000,nM,6,,,UO_0000065,10.75,0.21,-0.43,8.22,0,CHEMBL991656,Inhibition of KDR in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142456,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,1
CHEMBL513031,,None,423.27,0,4.39,6c,Nc1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)cnc2c(Br)cnn12,IC50,'=',1600,nM,5.8,,,UO_0000065,13.69,0.29,1.41,5.95,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,1600
CHEMBL394790,,None,394.89,1,5.84,7g,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',22,nM,7.66,,,UO_0000065,19.39,0.39,1.82,9.57,0,CHEMBL907546,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,22
CHEMBL268826,,None,451.56,1,6.56,12d,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccncc5)cnc(N)c34)cc2)c1,IC50,'=',4,nM,8.4,,,UO_0000065,,,,,0,CHEMBL907547,Inhibition of human KDR phosphorylation in NIH3T3 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144590,1,Scientific Literature,Bioorg Med Chem Lett,2007,CHEMBL3307716,,,,4
CHEMBL3660292,,None,515.55,2,5.17,BDBM110664,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CC[C@@H](O)C5)c[nH]4)c3)cc2)c1,IC50,'=',15,nM,7.82,,231549,UO_0000065,15.18,0.28,2.65,6.54,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3401981,,None,438.44,0,4.38,8,Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)on1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL3397917,,None,462.55,0,4.89,20e,COc1ccc(C(=O)Nc2ccc(OCCN3CCCCC3)cc2)c(-c2cccc(O)c2)c1O,IC50,'=',4.38,nM,8.36,,,UO_0000065,18.07,0.34,3.47,9.16,0,CHEMBL3399480,Inhibition of VEGFR2 (unknown origin) using ATP measured luminescence by ADP-Glo Kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3396971,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,4.38
CHEMBL5419219,,None,388.43,0,3.12,40,O=C(CN1C(=O)S/C(=C/c2cccs2)C1=O)Nc1ccc(C(=O)O)cc1,IC50,'=',83,nM,7.08,,,UO_0000065,18.23,0.37,3.96,6.82,0,CHEMBL5380333,Inhibition of human recombinant VEGFR-2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5376014,1,Scientific Literature,RSC Med Chem,2024,None,,INHIBITOR,,83
CHEMBL3353339,,None,275.31,0,2.94,9,O=C1Nc2ccccc2[C@]12C[C@@H]2c1ccc2cn[nH]c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3364612,Inhibition of KDR (unknown origin) by FRET-based homogeneous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351767,1,Scientific Literature,J Med Chem,2015,None,,,,
CHEMBL2180576,,None,460.35,0,3.83,II-4,CN(C)CCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL2185480,Inhibition of KDR at 10 uM incubated for 60 mins using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL443268,,None,540,1,3.23,26j,Cc1cc(C(=O)NCCN2CCOCC2)[nH]c1/C=C1\C(=O)N(C)c2ncnc(Nc3ccc(F)c(Cl)c3)c21,IC50,'=',10100,nM,5,,,UO_0000065,9.25,0.18,1.77,4.33,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,10.1
CHEMBL4476834,,None,452.44,0,4.09,154,Nc1ncnc2c3c(n(-c4ccc(CC(=O)Nc5ccc(C(F)(F)F)cn5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL4447901,,None,423.52,0,4.16,162,Nc1ncnc2c3c(n(-c4ccc(CC(=O)Nc5ccc6c(c5)CCC6)cc4)c12)CCC3,IC50,'=',10,nM,8,,,UO_0000065,18.89,0.34,3.84,9.32,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,10
CHEMBL4462298,,None,440.53,0,4.28,124,Nc1ncnc2c3c(n(-c4ccc(NC(=O)Cc5nc6ccccc6s5)cc4)c12)CCC3,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL4418434,Displacement of kinase tracer 236 from recombinant human His-tagged KDR cytoplasmic domain (789 to 1356 residues) expressed in baculovirus-infected insect cells measured after 5 hrs by TR-FRET based LanthaScreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4418299,38,SureChEMBL Patent Bioactivity Data,,2016,None,,,,200
CHEMBL3764798,,None,604.59,1,4.54,10d,Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3767837,Inhibition of human KDR at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3763132,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,0
CHEMBL3322568,,None,442.48,0,3.87,14b,COc1ccc(NC(=O)C2(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)CC2)cc1,Inhibition,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL3362109,Inhibition of VEGFR2 (unknown origin) using poly[Glu:Tyr] substrate at 1 uM by radioisotope-based P81 filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351387,1,Scientific Literature,Eur J Med Chem,2014,None,,,,27
CHEMBL3323602,,None,370.84,1,6.18,7k,Clc1ccccc1-c1nc2ccc(Nc3ccnc4ccccc34)cc2[nH]1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,10
CHEMBL3323614,,None,433.28,1,6.42,7u,Fc1ccc(Br)c(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)c1,IC50,'=',7820,nM,5.11,,,UO_0000065,11.79,0.25,-1.31,9.53,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,7.82
CHEMBL4570733,,None,347.81,0,4.1,6a,Clc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4423708,Inhibition of VEGFR-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4422634,1,Scientific Literature,Eur J Med Chem,2019,None,,,,
CHEMBL3933130,,None,480.33,0,3.64,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942671,,None,532.45,2,5.56,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983201,,None,577.42,2,8.41,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898627,,None,515.4,2,5.81,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916485,,None,510.41,2,6.79,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923153,,None,530.46,2,5.85,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976896,,None,533.5,2,6.74,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914394,,None,559.54,2,7.13,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL98385,,None,267.36,0,4.26,13,Cc1cccc(Nc2ncc(-c3ccccc3)s2)n1,IC50,'=',10,nM,8,,,UO_0000065,29.92,0.58,3.74,21.16,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,10
CHEMBL150177,,None,389.43,0,1.79,16d,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c(C)c1CCC(=O)O,IC50,'=',42800,nM,4.37,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,42.8
CHEMBL4527824,,None,355.42,0,1.82,11,NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@H](C[C@@H]1O)C2,IC50,'=',7940,nM,5.1,,,UO_0000065,14.35,0.28,3.28,4.81,0,CHEMBL4316523,Inhibition of GST-6His-tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide as substrate after 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4312039,1,Scientific Literature,ACS Med Chem Lett,2019,None,,,,7.94
CHEMBL3822573,,None,250.3,0,3.99,15,Cc1ccc(O)cc1Nc1ccnc2ccccc12,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL3825642,Inhibition of VEGFR2(unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3822396,1,Scientific Literature,J Med Chem,2016,None,,,,5000
CHEMBL4535949,,None,516.88,2,2.87,9b,COc1cc2c(Nc3ccc(F)cc3Cl)ncnc2cc1OCCNC(=O)Cn1cnc([N+](=O)[O-])n1,IC50,'=',517.33,nM,6.29,,,UO_0000065,12.16,0.24,3.42,3.95,0,CHEMBL4362207,Inhibition of N-terminal GST-tagged human VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4359867,1,Scientific Literature,Eur J Med Chem,2019,None,,,,517.33
CHEMBL4540303,,None,601.42,2,3.16,10c,COc1cc2c(Nc3ccc(C)c(Br)c3)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,IC50,'=',407.47,nM,6.39,,,UO_0000065,10.62,0.22,3.23,3.79,0,CHEMBL4362207,Inhibition of N-terminal GST-tagged human VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4359867,1,Scientific Literature,Eur J Med Chem,2019,None,,,,407.47
CHEMBL4583526,,None,508.33,1,4.19,6n,COc1ccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)cc1,IC50,'=',1240,nM,5.91,,,UO_0000065,11.62,0.24,1.72,4.88,0,CHEMBL4330587,Inhibition of VEGFR-2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate after 5 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330065,1,Scientific Literature,Eur J Med Chem,2019,None,,,,1.24
CHEMBL319789,,None,287.78,0,4.6,14,Clc1ccc(Nc2ncc(-c3ccccc3)s2)nc1,IC50,'=',35,nM,7.46,,,UO_0000065,25.91,0.54,2.86,19.72,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,35
CHEMBL4448354,,None,328.38,0,3.03,6g,Nc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1,IC50,'=',55.95,nM,7.25,,,UO_0000065,22.08,0.4,4.22,8.79,0,CHEMBL4423708,Inhibition of VEGFR-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4422634,1,Scientific Literature,Eur J Med Chem,2019,None,,,,55.95
CHEMBL4449321,,None,380.37,1,5.07,BD14,FC(F)(F)c1ccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4330408,Inhibition of VEGFR2 (unknown origin) after 1 hr by ADP-Glo reagent based luminescent assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330058,1,Scientific Literature,Eur J Med Chem,2019,None,,,,
CHEMBL3780758,,None,381.48,1,5.43,14g,c1ccc(-c2cnc3c(Nc4ccc(N5CCCCC5)cc4)nccc3n2)cc1,IC50,'=',1100,nM,5.96,,,UO_0000065,15.62,0.28,0.53,11.05,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,1.1
CHEMBL5184711,,None,383.88,1,5.01,3aa,Cn1c2ccccc2c2ccn3c[n+](-c4ccc5ccccc5c4)cc3c21.[Cl-],IC50,,,,,,ND,,,,,,0,CHEMBL5113200,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5108086,1,Scientific Literature,RSC Med Chem,2022,None,,,,
CHEMBL3401904,,None,580.85,2,6.19,7,CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4[C@@H](C)[C@H](C)CC[C@]4(C)CC[C@]23C)[C@@]1(C)C(=O)N1CCNCC1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3405095,Inhibition of phosphorylation of VEGFR-2 in HUVEC cells at 50 uM after 8 hrs by Western blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399926,1,Scientific Literature,Bioorg Med Chem,2015,CHEMBL3307501,,,,
CHEMBL3353340,,None,378.44,0,4.51,12,O=C1Nc2ccccc2[C@]12C[C@H]2c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1,IC50,'=',1300,nM,5.89,,,UO_0000065,15.55,0.28,1.38,8.33,0,CHEMBL3364612,Inhibition of KDR (unknown origin) by FRET-based homogeneous assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351767,1,Scientific Literature,J Med Chem,2015,None,,,,1.3
CHEMBL5174778,,None,420.47,0,3.82,7,Cc1nc(NC(=O)NC(=O)C2CCCC2)ccc1Oc1ccnc(-c2cnn(C)c2)c1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106444,Inhibition of VEGFR2 (unknown origin) measured by spectrophotometric analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104171,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL3676391,,None,605.42,1,4.29,BDBM18747,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCOCCOC(=O)CC(=O)OCC,IC50,'=',985,nM,6.01,,176885,UO_0000065,9.92,0.21,1.72,4.35,0,CHEMBL3705420,Tyrosine Kinase Assay: VEGFR2 (KDR,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5179072,,None,450.5,0,3.44,14,Cc1nc(NC(=O)NC(=O)CC2CCOCC2)ccc1Oc1ccnc(-c2cnn(C)c2)c1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106444,Inhibition of VEGFR2 (unknown origin) measured by spectrophotometric analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104171,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL2113192,,None,479.44,0,2.29,50,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=C(OC)C3=O)c2cc1OC,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL2113166,,None,389.8,0,2.23,9a,COCCOc1cc2ncnc(NC3=CC(=O)C(Cl)=CC3=O)c2cc1OC,IC50,'=',4.4,nM,8.36,,,UO_0000065,21.44,0.42,6.13,8.39,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,4.4
CHEMBL2113172,,None,419.82,0,2.21,9c,COCCOc1cc2ncnc(NC3=CC(=O)C(OC)=C(Cl)C3=O)c2cc1OC,IC50,'=',5.1,nM,8.29,,,UO_0000065,19.75,0.39,6.08,7.62,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,5.1
CHEMBL3706822,,None,419.82,0,2.21,9e,COCCOc1cc2ncnc(NC3=CC(=O)C(Cl)=C(OC)C3=O)c2cc1OC,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,1000
CHEMBL2113183,,None,385.38,0,1.64,9h,COCCOc1cc2ncnc(NC3=CC(=O)C=C(OC)C3=O)c2cc1OC,IC50,'=',3.8,nM,8.42,,,UO_0000065,21.85,0.41,6.78,7.73,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,3.8
CHEMBL371551,,None,429.43,0,1.66,14,COCCOC1=CC(=O)C(Nc2ncnc3cc(OCCOC)c(OC)cc23)=CC1=O,IC50,'=',474.4,nM,6.32,,,UO_0000065,14.73,0.28,4.66,5.35,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,474.4
CHEMBL3706825,,None,385.38,0,1.64,16,COCCOc1cc2ncnc(NC3=CC(=O)C(OC)=CC3=O)c2cc1OC,IC50,'=',436.3,nM,6.36,,,UO_0000065,16.5,0.31,4.72,5.84,0,CHEMBL862696,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 1 mm ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,436.3
CHEMBL196511,,None,340.39,0,4.14,15,NC(=O)c1ccc(-c2nnc(Nc3ccccc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL196657,,None,371.44,1,5.45,43,CCOc1ccc(-c2nnc(Nc3ccc(OC)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL370206,,None,355.44,1,5.75,45,CCOc1ccc(-c2nnc(Nc3ccc(C)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL204053,,None,321.77,0,4.42,19,Clc1ccc(Nc2nnc(-c3cn[nH]c3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL866514,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146055,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL5396135,,None,398.54,0,2.01,31,Cc1cc(Nc2ncc(C)c(N3CC(CC#N)(N4CCN(C)CC4)C3)n2)sn1,IC50,'=',1501,nM,5.82,,,UO_0000065,14.61,0.28,3.81,6.92,0,CHEMBL5334099,Inhibition of KDR (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5331110,1,Scientific Literature,J Med Chem,2023,None,TIME_Lower = 45.0 min | TIME_Upper = 120.0 min,INHIBITOR,,1501
CHEMBL5429675,,None,343.46,0,2.33,16,Cc1cc(Nc2ncc(C)c(N3CCN(CC#N)C(C)C3)n2)sn1,IC50,'=',55,nM,7.26,,,UO_0000065,21.14,0.41,4.93,8.97,0,CHEMBL5334099,Inhibition of KDR (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5331110,1,Scientific Literature,J Med Chem,2023,None,TIME_Lower = 45.0 min | TIME_Upper = 120.0 min,INHIBITOR,,55
CHEMBL205325,,None,399.5,1,5.35,19,CC(C)(C)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1,Ki,'=',130,nM,6.89,,,UO_0000065,17.24,0.31,1.54,8.97,0,CHEMBL864980,Binding affinity to VEGFR2 at 0.043 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.13
CHEMBL566621,,None,421.45,1,5.2,2,O=C(CC(=O)Nc1ccc(Oc2ccnc3ccsc23)c(F)c1)Nc1ccccc1,IC50,'=',200,nM,6.7,,,UO_0000065,15.9,0.3,1.5,8.34,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,200
CHEMBL566623,,None,529.55,2,5.16,7,Cn1ccnc1C(=O)c1cc2nccc(Oc3ccc(NC(=O)CC(=O)Nc4ccccc4)cc3F)c2s1,IC50,'=',50,nM,7.3,,,UO_0000065,13.79,0.26,2.14,6.34,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,50
CHEMBL565990,,None,543.58,2,5.64,9,CCn1cnc(C(=O)c2cc3nccc(Oc4ccc(NC(=O)CC(=O)Nc5ccccc5)cc4F)c3s2)c1,IC50,'=',5,nM,8.3,,,UO_0000065,15.27,0.29,2.66,7.21,0,CHEMBL1050654,Inhibition of GST-fused recombinant VEGFR2 expressed in baculovirus infected Sf9 cells after 10 mins by DELFIA assay,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156747,1,Scientific Literature,Bioorg Med Chem Lett,2009,CHEMBL3308860,,,,5
CHEMBL3401988,,None,437.45,0,4.37,15,Cc1noc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)n1,Ki,'>',4000,nM,,,,UO_0000065,,,,,0,CHEMBL3405454,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3399966,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,,,,4
CHEMBL204718,,None,431.89,1,5.03,11,Cn1cnc(NCc2ccc3ccccc3n2)c1-c1nnc(Nc2ccc(Cl)cc2)o1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL862191,Inhibition of VEGFR2 in 293 adenovirus transfected kidney cells by cell-based ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,kidney,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL175506,,None,392.49,0,4.58,8,COc1nc(Nc2ccc3ncsc3c2)nc(NC(C)(C)c2ccccc2)n1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL835238,Inhibition of KDR-induced MAP kinase autophosphorylation assay in HUVEC cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,CHEMBL3307501,,,,30
CHEMBL175830,,None,361.41,0,3.54,14f,CC(C)(Nc1nc(O)nc(Nc2ccc3[nH]cnc3c2)n1)c1ccccc1,IC50,'=',240,nM,6.62,,,UO_0000065,18.32,0.33,3.08,5.93,0,CHEMBL831136,In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142716,1,Scientific Literature,J Med Chem,2005,None,,,,0.24
CHEMBL187431,,None,254.29,0,2.8,16,Cc1ccc(Nc2ncnn3c(C)ccc23)cc1O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL827963,In vitro inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138664,1,Scientific Literature,J Med Chem,2004,None,,,,10
CHEMBL188522,,None,254.29,0,2.8,14,Cc1ccc(Nc2ncnn3ccc(C)c23)cc1O,IC50,'=',60,nM,7.22,,,UO_0000065,28.4,0.52,4.42,11.56,0,CHEMBL827963,In vitro inhibition of Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138664,1,Scientific Literature,J Med Chem,2004,None,,,,0.06
CHEMBL2338334,,None,293.37,0,2.23,6R,CN1C/C(=C\c2ccccn2)C(=O)[C@H](Cc2ccccn2)C1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL2344113,Inhibition of recombinant KDR (unknown origin) by FRET-based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331439,1,Scientific Literature,J Med Chem,2013,None,,,,100
CHEMBL5170239,,None,441.8,0,3.28,28b,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1nnc2ccc(N3CCOCC3)nn12,Activity,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL5104355,Binding affinity to VEGFR2 (unknown origin) at 10 uM using ULight-4E-BP1 peptide as substrate incubated for 1 hr in presence of ATP by fluorescence based analysis relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104091,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 10.0 microM | TIME = 1.0 hr,,,3
CHEMBL309331,,None,388.47,1,6.03,58,c1ccc(-c2ccc(Nc3nnc(Cc4ccncc4)c4ccccc34)cc2)cc1,ED50,'=',85,nM,7.07,,,UO_0000065,,,,,0,CHEMBL818396,Inhibition of VEGF-stimulated autophosphorylation of VEGF-receptor 2 (KDR) expressed in CHO cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,CHO,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,CHEMBL3308072,,,,85
CHEMBL5182544,,None,460.58,0,3.94,56r,COc1cc(CCc2cc(-c3nc4ccc(N5C[C@@H](C)N[C@@H](C)C5)cc4[nH]3)n[nH]2)cc(OC)c1,IC50,'=',158,nM,6.8,,,UO_0000065,14.77,0.27,2.86,7.47,0,CHEMBL5096260,Inhibition of recombinant N-terminal GST-tagged human KDR (790 to 1356 residues) expressed in baculovirus expression system using IGF-1Rtide peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hrs in the presence of ATP by ADP-Glo reagent based luminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5096142,1,Scientific Literature,Eur J Med Chem,2021,None,TIME = 1.167 hr,INHIBITOR,,158
CHEMBL71541,,None,374.44,0,4.55,25,CC(C)n1cc(-c2ccc(Oc3ccccc3CO)cc2)c2c(N)ncnc21,IC50,'=',144,nM,6.84,,,UO_0000065,18.27,0.33,2.29,7.94,0,CHEMBL817790,Inhibitory activity against vascular endothelial growth factor receptor 2 (VEGFR2) at a concentration of 5 uM ATP.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132740,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.144
CHEMBL445799,,None,556.59,2,5.46,58e,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,Ki,'=',1160,nM,5.94,,,UO_0000065,10.66,0.2,0.48,5.52,1,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,1160
CHEMBL2023490,,None,432.48,0,4.27,24,COc1cc2nccc(Oc3ccc(CC(=O)Nc4cn(C)nc4C)cc3)c2cc1OC,IC50,'=',183,nM,6.74,,,UO_0000065,15.58,0.29,2.47,7.7,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.183
CHEMBL3959345,,None,511.03,0,3.25,332,COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3986661,,None,522.03,2,5.56,340,COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3911516,,None,457.56,1,5.45,354,COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',3019.95,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.52
CHEMBL3941705,,None,451.53,1,5.39,360,COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880347,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3941174,,None,460.54,0,4.67,536,COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5
CHEMBL3911621,,None,500.65,2,5.49,33,COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1,IC50,'=',954.99,nM,6.02,,,UO_0000065,12.02,0.22,0.53,7.78,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,6.02
CHEMBL3968039,,None,604.16,2,6.31,19i,COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(C)c(C)c4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,IC50,'=',79,nM,7.1,,,UO_0000065,11.76,0.23,0.79,6.84,0,CHEMBL3877876,Inhibition of N-terminal GST-tagged human VEGFR-2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3877259,1,Scientific Literature,Eur J Med Chem,2017,None,,,,79
CHEMBL3913322,,None,473.46,0,4.11,148,COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',3235.94,nM,5.49,,,UO_0000065,11.6,0.22,1.38,6.42,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.49
CHEMBL2036869,,None,317.35,0,3.48,2g,Cn1c(-c2ccnc(Nc3ccc(O)cc3)n2)nc2ccccc21,IC50,'=',9200,nM,5.04,,,UO_0000065,15.87,0.29,1.56,6.64,0,CHEMBL2038025,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2036870,,None,317.35,0,3.48,2h,Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21,IC50,'=',3200,nM,5.5,,,UO_0000065,17.31,0.31,2.01,7.24,0,CHEMBL2038025,Inhibition of recombinant VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL233001,GW620972X,None,332.43,0,4.9,GW620972X,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,Inhibition,'=',9.83,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,9.83
CHEMBL3984461,,None,477.57,0,4.24,14,COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1,IC50,'=',4265.8,nM,5.37,,,UO_0000065,11.24,0.21,1.13,5.67,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.37
CHEMBL3919884,,None,460.54,0,3.17,697,COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1513.56,nM,5.82,,,UO_0000065,12.64,0.23,2.65,6.72,0,CHEMBL3880346,Inhibition of VEGFR2 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL3307634,,,,5.82
CHEMBL2018747,,None,394.48,0,4.83,41,CCCCC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,IC50,'=',6800,nM,5.17,,,UO_0000065,13.1,0.24,0.34,6.05,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,6.8
CHEMBL2018753,,None,416.87,1,5,49,CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl,IC50,'=',3300,nM,5.48,,,UO_0000065,13.15,0.26,0.48,5.79,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,3.3
CHEMBL2018767,,None,459.39,1,5.17,66,CCN(CC)CCOc1cc2ncnc(Nc3ccc(C)c(Br)c3)c2cc1OC,IC50,'=',6450,nM,5.19,,,UO_0000065,11.3,0.24,0.02,8.72,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,6.45
CHEMBL1076330,,None,308.37,0,2.74,12,Cn1cnc(-c2ccccc2)c1-c1nc2c(N)ncnc2s1,IC50,'=',84000,nM,4.08,,,UO_0000065,13.22,0.25,1.34,4.94,0,CHEMBL1115834,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154391,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,84
CHEMBL499624,,None,490.61,0,4.44,CER-0262696,O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1,Inhibition,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,6
CHEMBL499606,,None,455.61,1,6.09,CER-0263948,Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,0
CHEMBL499865,,None,469.55,0,4.26,CER-0264160,COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1,Inhibition,'=',7,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,7
CHEMBL2047981,,None,541.84,2,7.6,11c,O=C(Nc1ccc(Oc2ccnc(-c3ncc(C(F)(F)F)[nH]3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,Inhibition,'=',3.5,%,,,,UO_0000187,,,,,0,CHEMBL2051525,Inhibition of KDR at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046400,1,Scientific Literature,Bioorg Med Chem,2012,None,,,,3.5
CHEMBL5190410,,None,459.51,0,3.32,14,Cc1nc(-c2cnc(NC3CCOCC3)[nH]c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106379,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104170,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL5199002,,None,526.61,2,5.26,5d,CC1(C)c2cc(NS(C)(=O)=O)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCC4CC4)ccn3)ccc21,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,,,1000
CHEMBL3956164,,None,444.54,0,4.02,19,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1,IC50,'=',190.55,nM,6.72,,,UO_0000065,15.12,0.28,2.7,7.36,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,6.72
CHEMBL3893398,,None,525.64,1,2.97,316,COc1cc(OC)cc(N(CCCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',15.85,nM,7.8,,,UO_0000065,14.84,0.29,4.83,6.8,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,7.8
CHEMBL3967011,,None,494.55,0,4.53,377,COc1cc(OC)cc(N(CCCN2CC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',120.23,nM,6.92,,,UO_0000065,13.99,0.26,2.39,10.1,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,6.92
CHEMBL3910393,,None,403.46,0,4.73,222,COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',1412.54,nM,5.85,,,UO_0000065,14.5,0.27,1.12,10.43,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,5.85
CHEMBL3925008,,None,511.63,1,4.81,381,COc1cc(OC)cc(N(CCCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',67.61,nM,7.17,,,UO_0000065,14.01,0.26,2.36,7.77,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,7.17
CHEMBL3933000,,None,633.7,1,4.48,509,COc1cc(OC)cc(N(CCCN2CCC[C@H]2CNS(=O)(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,IC50,'=',5.248,nM,8.28,,,UO_0000065,13.07,0.26,3.8,7.22,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,8.28
CHEMBL460772,,None,467.5,1,6.23,6,COc1cc2nccc(Oc3ccc(-c4ccc(Cc5ccccc5)nn4)cc3F)c2cc1OC,Ki,'=',56,nM,7.25,,,UO_0000065,15.51,0.28,1.02,10.93,0,CHEMBL971817,Inhibition of phosphorylated KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,,,,56
CHEMBL461648,,None,497.53,1,5.53,7,COc1cc2nccc(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)c2cc1OC,Ki,'>',1300,nM,,,,UO_0000065,,,,,0,CHEMBL971817,Inhibition of phosphorylated KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,,,,1300
CHEMBL3586064,,None,424.45,1,5.66,W7,CC(C)(C)C(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(F)c3)cc2)cn1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,
CHEMBL2023115,,None,463.49,0,3.85,3,CCn1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2OC)cn1,IC50,'>',690,nM,,,,UO_0000065,,,,,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.69
CHEMBL2023493,,None,432.48,0,4.27,27,COc1ccc2c(Oc3ccc(CC(=O)Nc4cc(C)nn4C)c(OC)c3)ccnc2c1,IC50,'>',9740,nM,,,,UO_0000065,,,,,0,CHEMBL2027406,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2021798,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,9.74
CHEMBL1173230,,None,431.45,0,4.55,24,COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc(O)c(OC)c2)cc1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL1176712,Inhibition of KDR at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177651,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,5
CHEMBL517021,,None,445.45,1,6.11,27,FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1,IC50,'=',310,nM,6.51,,,UO_0000065,14.61,0.27,0.4,11.7,0,CHEMBL960813,Inhibition of VEGF-induced phosphorylation of VEGFR2 by cell-based ELISA,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153264,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,,,,0.31
CHEMBL4086939,,None,506.61,2,5.32,8j,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(Cn2cccc2CN(C)C)cc1)c1ccccc1,Inhibition,'=',90.3,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,90.3
CHEMBL4069394,,None,492.58,1,5.26,8a,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1,IC50,'=',51.7,nM,7.29,,,UO_0000065,14.79,0.27,2.03,9.64,0,CHEMBL3993992,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,51.7
CHEMBL196668,,None,396.49,1,5.44,34,CC(C)(C)c1cccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)c1,IC50,'=',470,nM,6.33,,,UO_0000065,15.96,0.29,0.89,7.82,1,CHEMBL1006966,Inhibition of VEGFR2 by HTRF method,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140880,1,Scientific Literature,Bioorg Med Chem,2009,None,,,,0.47
CHEMBL4099682,,None,394.91,0,4.62,6.HCl,COc1ccc(Nc2nc(C)nc3c(Cc4ccccc4)cn(C)c23)cc1.Cl,IC50,'=',26.7,nM,7.57,,,UO_0000065,21.13,0.38,2.95,14.57,0,CHEMBL3998243,Inhibition of VEGFR-2 in human U251 cells assessed as reduction in VEGF induced phosphorylation preincubated for 60 mins followed by VEGF addition measured after 10 mins by ELISA method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3997769,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,26.7
CHEMBL3586050,,None,452.23,1,6.05,L2,O=C(Nc1ccc(-c2cccnc2)cc1)Nc1ccc(Br)cc1OC(F)(F)F,IC50,'>',200,nM,,,,UO_0000065,,,,,0,CHEMBL3587278,Inhibition of VEGFR-2 (unknown origin) after 1 hr by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3585346,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,200
CHEMBL4087886,,None,546.67,2,6.43,8e,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCC(C)CC2)cc1)c1ccccc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3993992,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,
CHEMBL4065508,,None,560.7,2,6.49,8k,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(Cn2cccc2CN2CCC(C)CC2)cc1)c1ccccc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3993992,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,
CHEMBL446122,,None,1168.54,None,None,GU40A,C=CCN(CC(=O)N(CCc1c[nH]c2ccccc12)CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)C(=O)CN(CC(C)C)C(=O)CN(CCOC)C(=O)CNCCCCN,Activity,,,,,,Active,,,,,,0,CHEMBL956461,Binding affinity to human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL525198,,None,2768.61,None,None,GU40C4,CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)NCCCCCC(=O)NCCC(=O)NC(CCCCNC(=O)CN(CCCCN)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(CCCCN)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CNCCCCN)C(C)c1ccccc1)C(N)=O)CC(C)C)Cc1ccc2c(c1)OCO2)C(C)c1ccccc1)C(=O)CNCCCCN,Activity,,,,,,Active,,,,,,0,CHEMBL956463,Displacement of fluorescein-labeled GU40C4 from human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL525198,,None,2768.61,None,None,GU40C4,CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)NCCCCCC(=O)NCCC(=O)NC(CCCCNC(=O)CN(CCCCN)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(CCCCN)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CNCCCCN)C(C)c1ccccc1)C(N)=O)CC(C)C)Cc1ccc2c(c1)OCO2)C(C)c1ccccc1)C(=O)CNCCCCN,Activity,,,,,,Active,,,,,,0,CHEMBL956461,Binding affinity to human recombinant VEGFR2 extracellular domain by ELISA like binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150420,1,Scientific Literature,Bioorg Med Chem,2008,None,,,,
CHEMBL409892,GW305178X,None,367.39,0,1.65,GW305178X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1,Inhibition,'=',61.59,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,61.59
CHEMBL2152947,,None,479.52,1,5.96,16g,CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2155702,Inhibition of VEGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2150974,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL2386803,,None,570.7,1,4.68,10g,CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)Nc5cc(C(C)(C)C)on5)cc4)n[nH]3)cc2)CC1,IC50,'=',18,nM,7.75,,,UO_0000065,13.57,0.25,3.06,5.89,0,CHEMBL2390017,Inhibition of recombinant GST tagged VEGFR2 (789 to 1356) (unknown origin) transfected in insect sf9 cells after 120 mins by wallac counting analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2384934,1,Scientific Literature,Bioorg Med Chem,2013,CHEMBL3308860,,,,0.018
CHEMBL1097171,,None,313.4,0,4.63,26,O=C1Cc2ccccc2Cc2cc(NCc3ccccc3)ccc21,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1108247,Inhibition of VGFR2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157789,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,
CHEMBL2032029,,None,525.57,1,4.32,59a,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',932,nM,6.03,,,UO_0000065,11.47,0.21,1.71,5,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,932
CHEMBL2032026,,None,511.54,1,3.94,59b,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CCO)n(-c5ccccc5)c4=O)nc3)ccnc2c1,Ki,'=',234,nM,6.63,,,UO_0000065,12.96,0.24,2.69,5.5,0,CHEMBL2032454,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,,,,234
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,'=',90,nM,7.05,,,UO_0000065,15.16,0.3,1.5,7.63,1,CHEMBL2382764,Inhibition of human VEGFR2 kinase domain expressed in SF9 cells by TR-FRET assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2380250,1,Scientific Literature,Bioorg Med Chem Lett,2013,CHEMBL3308860,,,,90
CHEMBL2381858,,None,381.83,0,3.2,VH02,O=C(NCc1cn(-c2ccc3cn[nH]c3c2)nn1)Nc1cccc(CCl)c1,IC50,'=',560,nM,6.25,,,UO_0000065,16.37,0.32,3.05,6.22,0,CHEMBL2382765,Inhibition of human recombinant VEGFR2 expressed in insect cells using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 to 60 mins by fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2380250,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.56
CHEMBL1928302,,None,369.38,0,4.12,30,O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(O)cc3)ncnc2[nH]1,Inhibition,'=',31,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928306,,None,398.49,1,5.58,39,C[C@@H](Nc1ncnc2sc(C(=O)c3cc4ccccc4[nH]3)cc12)c1ccccc1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4085653,,None,440.36,1,5.99,18h,Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Cl)c(Cl)c4)cc3)cc2n1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3993539,Inhibition of VEGFR2 (unknown origin) after 60 mins by ADP-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992524,1,Scientific Literature,Eur J Med Chem,2017,None,,,,1000
CHEMBL1971289,,None,264.31,0,1.93,SID103905207,CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL2403372,,None,446.43,0,3.34,8,O=C1Nc2ccc(C(F)(F)F)cc2/C1=C/c1cc2c([nH]1)CCN(C(=O)N1CCOCC1)C2,IC50,'=',83,nM,7.08,,,UO_0000065,15.86,0.3,3.74,9.12,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.083
CHEMBL2403368,,None,404.43,0,3.01,4,COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)c1cnoc1C)C3)C(=O)N2,IC50,'=',16,nM,7.8,,,UO_0000065,19.28,0.35,4.79,7.76,0,CHEMBL2406185,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401634,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,,,,0.016
CHEMBL196747,,None,393.45,1,5.03,15,Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(F)c2)cc1,IC50,'=',54.95,nM,7.26,,,UO_0000065,18.45,0.35,2.23,7.81,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,7.26
CHEMBL382979,,None,395.88,1,5.24,53,Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',3.02,nM,8.52,,,UO_0000065,21.52,0.43,3.28,9.17,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,8.52
CHEMBL1242378,,None,302.31,0,1.44,PP450,C[C@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,IC50,'=',1900,nM,5.72,,,UO_0000065,18.93,0.36,4.28,4.94,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,1.9
CHEMBL4083218,,None,575.67,1,4.86,10a,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(C(C)=O)CC2)cc1)c1ccccc1,Inhibition,'=',66.4,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,66.4
CHEMBL4099641,,None,611.72,1,4.27,10b,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(S(C)(=O)=O)CC2)cc1)c1ccccc1,Inhibition,'=',46.7,%,,,,UO_0000187,,,,,0,CHEMBL3993991,Inhibition of human N-terminal GST-tagged VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system at 1 uM preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3992544,1,Scientific Literature,Bioorg Med Chem,2017,None,,,,46.7
CHEMBL371889,,None,405.48,0,4.9,12,COc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1,IC50,'=',34.67,nM,7.46,,,UO_0000065,18.4,0.35,2.56,7.3,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,7.46
CHEMBL369908,,None,466.57,1,5.88,41,Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4ccncc4)sc4ncnc(N)c34)cc2)c1,IC50,'=',52.48,nM,7.28,,,UO_0000065,15.6,0.29,1.4,6.88,0,CHEMBL1243603,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240323,1,Scientific Literature,J Mol Graph Model,2007,None,,,,7.28
CHEMBL1999749,,None,544.66,2,6.51,SID103905566,COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2004355,,None,375.41,0,0.51,SID103905187,CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1999112,,None,409.42,0,1.09,SID103905318,CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1,Ki,'=',7943.28,nM,5.1,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2006765,,None,392.39,0,3.82,SID103904636,CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.6
CHEMBL1975503,,None,226.24,0,1.27,SID103905134,Nc1ccc(-c2cccn3c(=O)[nH]nc23)cc1,Ki,'=',39810.72,nM,4.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.4
CHEMBL2006567,,None,258.31,0,2.22,SID103905192,CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1965423,,None,405.5,1,5.46,SID103905062,CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21,Ki,'>',5011.87,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.3
CHEMBL392642,,None,416.55,0,3.9,SID103905471,CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1983348,,None,386.46,0,4.26,SID103904905,CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1,Ki,'=',125.89,nM,6.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.9
CHEMBL1983449,,None,307.35,0,2.65,SID103904951,Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2000894,,None,386.41,0,2.67,SID103905355,Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1993243,,None,353.4,0,3.03,SID103905095,CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12,Ki,'=',31.62,nM,7.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.5
CHEMBL1968926,,None,268.35,0,3.16,SID103905039,c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL4781567,,None,522.61,1,3.25,34a,CC(=O)NS(=O)(=O)c1ccc(NC(=O)CSc2nc3ccccc3c(=O)n2-c2ccc(C)cc2)cc1,IC50,'=',0.377,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL4677737,Inhibition of human VEGFR2 incubated for 2.5 hrs by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673301,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 2.5 hr,INHIBITOR,,0.377
CHEMBL88462,,None,370.45,1,5.06,4h,COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1cc2c([nH]1)CCCC2,IC50,'=',20000,nM,4.7,,,UO_0000065,12.68,0.23,-0.36,8.68,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,20
CHEMBL317438,,None,387.55,1,5.92,CC20,c1ccc2c(c1)c(-c1cncc(-c3ccsc3)c1)cn2CCN1CCCCC1,IC50,'=',111,nM,6.96,,,UO_0000065,17.95,0.34,1.03,33.02,1,CHEMBL5138021,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5136983,1,Scientific Literature,Bioorg Med Chem,2022,None,,INHIBITOR,,111
CHEMBL4760160,,None,520.61,2,5.68,28a,Cc1ccc(-n2c(SCC(=O)Nc3ccc(C(=O)Nc4ccccc4)cc3)nc3ccccc3c2=O)cc1,IC50,'=',0.713,ug.mL-1,,,,UO_0000274,,,,,0,CHEMBL4677737,Inhibition of human VEGFR2 incubated for 2.5 hrs by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673301,1,Scientific Literature,Bioorg Med Chem,2021,None,TIME = 2.5 hr,INHIBITOR,,0.713
CHEMBL1202478,,None,523.83,1,5.31,11,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC/C=C/CN1CCCC1.Cl,IC50,'=',8,nM,8.1,,,UO_0000065,16.61,0.36,2.79,13.61,0,CHEMBL817494,Inhibition of vascular endothelial growth factor receptor 2 kinase activity at a concentration of 2 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135889,1,Scientific Literature,J Med Chem,2002,None,,,,0.008
CHEMBL1762534,,None,477.57,0,3.06,16,COc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)n1,IC50,'=',989,nM,6,,,UO_0000065,12.57,0.23,2.94,6.82,0,CHEMBL1764818,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759854,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.989
CHEMBL1762529,,None,506.61,1,3.16,11,COc1cc(CO)cc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1,IC50,'=',190,nM,6.72,,,UO_0000065,13.27,0.25,3.56,7.04,0,CHEMBL1764818,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1759854,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,0.19
CHEMBL3799933,,None,442.49,0,3.64,38,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCOCC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL3785951,,None,508.6,1,3.25,33,CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3789996,Inhibition of KDR (unknown origin) in presence of [gamma33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3785066,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,,,,10
CHEMBL3321895,,None,351.41,1,5.23,7d,Cc1ccc(-c2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1,IC50,'=',4760,nM,5.32,,,UO_0000065,15.15,0.27,0.09,8,0,CHEMBL3368964,Inhibition of human recombinant VEGFR2 pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352651,1,Scientific Literature,Bioorg Med Chem,2014,None,,,,4.76
CHEMBL3781479,,None,381.48,1,5.43,9e,c1ccc(-c2cnc3c(Nc4ccc(N5CCCCC5)cc4)cncc3n2)cc1,IC50,'=',2060,nM,5.69,,,UO_0000065,14.91,0.27,0.26,10.54,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,2.06
CHEMBL3781538,,None,381.48,1,5.43,9f,c1ccc(Nc2cncc3nc(-c4ccc(N5CCCCC5)cc4)cnc23)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,100
CHEMBL3781795,,None,381.48,1,5.43,18b,c1ccc(-c2cnc3cnc(Nc4ccc(N5CCCCC5)cc4)cc3n2)cc1,IC50,'=',17060,nM,4.77,,,UO_0000065,12.5,0.22,-0.66,8.84,0,CHEMBL3784515,Inhibition of N-terminal His6-tagged human recombinant KDR (790 to end residues) expressed in baculovirus infected insect Sf21 cells after 1 hr by Alphascreen assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779774,1,Scientific Literature,Medchemcomm,2016,CHEMBL4106362,,,,17.06
CHEMBL181361,GW693481X,None,305.37,0,3.4,GW693481X,Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',8.02,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,8.02
CHEMBL1909396,GW768505A,None,573.93,2,6.95,GW768505A,COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl,Inhibition,'=',75.42,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,75.42
CHEMBL1241775,,None,306.33,0,1.99,PP139,CC(C)n1nc(-c2cnc3nccnc3c2)c2c(N)ncnc21,IC50,'=',12000,nM,4.92,,,UO_0000065,16.06,0.29,2.93,4.54,0,CHEMBL1243976,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,,,,12
CHEMBL1164181,,None,469.42,0,4.63,5g,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1168306,Inhibition of VEGFR2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,,,,50
CHEMBL2011061,,None,477.57,0,4.73,15,CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1c-4cnn1C)C(=O)NC3,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2015674,Inhibition of human VEGFR2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010689,1,Scientific Literature,J Med Chem,2012,None,,,,
CHEMBL5418423,,None,411.37,0,2.49,1,NC(=O)CCn1cc(-c2ccc3ncnc(Nc4cc(O)c(F)cc4F)c3c2)nn1,IC50,'=',7,nM,8.15,,,UO_0000065,19.82,0.37,5.66,6.19,0,CHEMBL5380313,Inhibition of human recombinant VEGFR-2 in the presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5376014,1,Scientific Literature,RSC Med Chem,2024,None,,INHIBITOR,,0.007
CHEMBL5404662,,None,471.47,0,2.12,17,Cc1nc2ccccc2n(CC(=O)Nc2ccc(C(=O)NNC(=O)c3ccccc3O)cc2)c1=O,IC50,'=',1190,nM,5.92,,,UO_0000065,12.57,0.23,3.8,4.16,0,CHEMBL5380325,Inhibition of VEGFR-2 (unknown origin) kinase activity using poly(Glu-Tyr) at 4:1 ratio as substrate in presence of ATP incubated for 5 mins by ELISA method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5376014,1,Scientific Literature,RSC Med Chem,2024,None,TIME = 0.08333 hr,INHIBITOR,,1.19
CHEMBL2113166,,None,389.8,0,2.23,9a,COCCOc1cc2ncnc(NC3=CC(=O)C(Cl)=CC3=O)c2cc1OC,IC50,'=',569.1,nM,6.25,,,UO_0000065,16.02,0.32,4.01,6.27,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,569.1
CHEMBL2113174,,None,447.45,0,3.07,13,COCCOc1cc2ncnc(NC3=CC(=O)C(Oc4ccccc4)=CC3=O)c2cc1OC,IC50,'=',560.1,nM,6.25,,,UO_0000065,13.97,0.26,3.18,5.74,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,560.1
CHEMBL2113165,,None,528.61,1,3.95,22,COCCOc1cc2ncnc(NC3=CC(=O)C(N4CCC(Cc5ccccc5)CC4)=CC3=O)c2cc1OC,IC50,'=',298.6,nM,6.53,,,UO_0000065,12.34,0.23,2.57,6.34,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,298.6
CHEMBL196705,,None,368.44,0,4.76,16,Cc1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)c(C)c1,IC50,'=',6900,nM,5.16,,,UO_0000065,14.01,0.25,0.4,6.38,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,6.9
CHEMBL1683335,,None,370.46,1,5.04,5g,Cc1cc(C)cc(NC(=O)c2c[nH]c3cccc(NCc4ccncc4)c23)c1,Inhibition,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL1687576,Inhibition of KDR assessed as phosphorylation level of substrate at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681739,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,19
CHEMBL329201,,None,290.3,0,3.6,3a,Fc1ccc(-c2cnn3cc(-c4ccncc4)cnc23)cc1,IC50,'=',63,nM,7.2,,,UO_0000065,24.8,0.45,3.6,16.71,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,63
CHEMBL1811988,,None,378.86,1,5.67,7r,COc1ccc2nc3cc(Cl)ccc3c(NCc3ccccc3OC)c2c1,Inhibition,'=',44.03,%,,,,UO_0000187,,,,,0,CHEMBL1816341,Inhibition of VEGFR2 at 50 uM after 1 hr,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1811850,1,Scientific Literature,Bioorg Med Chem,2011,None,,,,44.03
CHEMBL1910894,,None,369.47,0,4.62,4,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)c[nH]c3c2)cc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912531,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,25
CHEMBL91815,,None,442.52,1,5.08,9i,COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)cc1,IC50,'=',30,nM,7.52,,,UO_0000065,17,0.31,2.44,8.23,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,0.03
CHEMBL295528,,None,596.78,2,5.12,13,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)CC(C)(C)c1ccccc1,IC50,'=',34600,nM,4.46,,,UO_0000065,7.47,0.14,-0.66,3.9,0,CHEMBL698970,Inhibition of human VEGF-receptor 2 (kdr) kinase.,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135159,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,34.6
CHEMBL379088,,None,596.68,2,6.02,37,CN1CCN(Cc2ccc3c(c2)Cc2c-3n[nH]c2-c2ccc(CN(C)C(=O)Nc3cccc(OC(F)(F)F)c3)s2)CC1,IC50,'=',27,nM,7.57,,,UO_0000065,12.68,0.25,1.55,9.86,0,CHEMBL869847,Inhibition of KDR at 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146863,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,27
CHEMBL2011301,,None,279.3,0,1.62,9,NC(=O)c1c(-c2ccncc2)nn(-c2ccccc2)c1N,IC50,'=',48000,nM,4.32,,,UO_0000065,15.46,0.28,2.7,4.33,0,CHEMBL2015056,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL231570,,None,493.95,0,4.6,25,CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(CN5CCOCC5)c4)nc3c2)ccn1,IC50,'=',117,nM,6.93,,,UO_0000065,,,,,0,CHEMBL895900,Inhibition of VEGF-stimulated HUVEC cell proliferation after 72 hrs,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148766,1,Scientific Literature,J Med Chem,2007,CHEMBL3307501,,,,117
CHEMBL1928292,,None,377.41,0,4.4,24,C#Cc1cccc(Nc2ncnc3[nH]c(C(=O)c4cc5ccccc5[nH]4)cc23)c1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928293,,None,394.46,1,5.13,34,C#Cc1cccc(Nc2ncnc3sc(C(=O)c4cc5ccccc5[nH]4)cc23)c1,Inhibition,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928298,,None,450.27,1,5.32,28,O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(Br)cc3F)ncnc2[nH]1,Inhibition,'=',22,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928300,,None,511.94,2,6.79,29,O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(OCc4cccc(F)c4)cc3Cl)ncnc2[nH]1,Inhibition,'=',53,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928303,,None,367.41,0,4.28,31,O=C(c1cc2ccccc2[nH]1)c1cc2c(NCc3ccccc3)ncnc2[nH]1,Inhibition,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1928308,,None,438.43,1,6.17,41,O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3cccc(C(F)(F)F)c3)ncnc2s1,Inhibition,'=',29,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1922961,,None,429.51,0,3.83,5a,Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccccc3)c12,IC50,'>',300,nM,,,,UO_0000065,,,,,0,CHEMBL1925062,Inhibition of human cytoplasmic domain of VEGFR-2 by time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1921676,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,300
CHEMBL225248,,None,526.71,2,5.43,2,Cc1cccc(NC(=O)N(C)Cc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1,IC50,'=',146,nM,6.84,,,UO_0000065,,,,,1,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,146
CHEMBL224918,,None,449.54,0,4.78,85,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4cncn4)ccc2-3)cs1)COc1ccccc1,IC50,'=',15,nM,7.82,,,UO_0000065,,,,,0,CHEMBL914746,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by Western blot,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,15
CHEMBL219253,,None,539.04,2,6.24,31,CCCn1c2ccc(NC(=O)Nc3ccccc3Cl)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',9,nM,8.05,,,UO_0000065,14.93,0.28,1.81,8.65,0,CHEMBL814076,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,9
CHEMBL219493,,None,457.53,0,4.52,40,CCCn1c2ccc(NC(=O)OCC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL856506,Activity at VEGFR2 by autophosphorylation assay relative to control,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,76
CHEMBL218557,,None,535.6,2,5.57,37,CCCn1c2ccc(NC(=O)Oc3ccc(OC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL856506,Activity at VEGFR2 by autophosphorylation assay relative to control,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137253,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,76
CHEMBL2029988,CEP-32496,2,517.46,2,5.91,Agerafenib,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,IC50,'=',17,nM,7.77,,,UO_0000065,15.01,0.29,1.86,6.44,0,CHEMBL5152021,Inhibition of recombinant VEGFR2 (unknown origin) incubated for 120 mins by Perkin Elmer electrophoretic mobility shift platform method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5150004,1,Scientific Literature,J Med Chem,2021,None,TIME = 2.0 hr,INHIBITOR,,17
CHEMBL207975,,None,385.47,1,5.18,22,CC(C)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1,IC50,'=',250,nM,6.6,,,UO_0000065,17.13,0.31,1.42,8.6,0,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.25
CHEMBL205544,,None,443.84,1,5.22,28,FC(F)(Cl)Oc1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1,IC50,'=',530,nM,6.28,,,UO_0000065,14.14,0.28,1.06,7.3,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.53
CHEMBL381182,,None,411.39,1,5.07,27,FC(F)(F)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1,Ki,'=',120,nM,6.92,,,UO_0000065,16.82,0.32,1.85,9.02,0,CHEMBL864982,Binding affinity to VEGFR2 at 0.058 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.12
CHEMBL69966,,None,497.56,0,2.39,26s,C#Cc1cccc(Nc2ncnc3c2/C(=C/c2[nH]c(C(=O)NCCN4CCOCC4)cc2C)C(=O)N3)c1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL363639,,None,415.43,0,3.2,13,CCOC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3F)c2c1C(C)C,IC50,'=',34,nM,7.47,,,UO_0000065,17.98,0.34,4.27,6.99,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,34
CHEMBL192318,,None,545.59,1,4.59,23,CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCCCN4CCCCC4)c(C(C)C)c23)c(F)cc1F,IC50,'=',79,nM,7.1,,,UO_0000065,13.02,0.25,2.51,5.82,0,CHEMBL829589,Inhibition of human vascular endothelial growth factor receptor 2 kinase activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144449,1,Scientific Literature,J Med Chem,2005,None,,,,79
CHEMBL191779,,None,388.45,0,3.9,29,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccc(OC)cc3)o2)c1,IC50,'=',87,nM,7.06,,,UO_0000065,18.18,0.36,3.16,7.79,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,0.087
CHEMBL210003,,None,374.4,0,4.07,25,CCc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1,IC50,'=',250,nM,6.6,,,UO_0000065,,,,,0,CHEMBL864249,Inhibition of KDR by cellular assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.25
CHEMBL313746,,None,340.43,1,5.05,4f,O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1cc2c([nH]1)CCCC2,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL812787,Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133768,1,Scientific Literature,J Med Chem,2000,None,,,,20
CHEMBL1928312,,None,452.9,1,5.95,46,COc1ccc2[nH]c(C(=O)c3cc4c(Nc5ccc(F)c(Cl)c5)ncnc4s3)cc2c1,Inhibition,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL1930724,Inhibition of VEGFR2 using poly(Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL192668,,None,525.65,1,4.08,53,COc1cc(OC)cc(C2Cc3cnc(N(CCCCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1,IC50,'=',20000,nM,4.7,,,UO_0000065,8.94,0.17,0.62,3.75,0,CHEMBL829083,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145157,1,Scientific Literature,J Med Chem,2005,None,,,,20
CHEMBL1271692,,None,332.34,0,1.42,22,NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(=O)[nH]c3)o2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1272383,Inhibition of KDR by Hot Spot filtration binding assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1268961,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,10
CHEMBL1271780,,None,357.21,0,4.26,18,Cc1cc(Br)cc(C(=O)Nc2cnc3ccccc3c2)c1O,IC50,'=',12.4,nM,7.91,,,UO_0000065,22.13,0.49,3.65,12.71,0,CHEMBL1273328,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1269001,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,,,,12.4
CHEMBL69129,,None,386.45,0,4.56,8,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCC(O)C1,IC50,'=',85,nM,7.07,,,UO_0000065,18.3,0.33,2.51,8.2,0,CHEMBL817617,Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132739,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,0.085
CHEMBL92238,,None,272.31,0,3.46,2h,c1ccc(-c2cnn3cc(-c4ccccn4)cnc23)cc1,IC50,'=',88,nM,7.06,,,UO_0000065,25.91,0.46,3.6,16.38,0,CHEMBL819551,Inhibitory activity at VEGF-2 receptor.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1135353,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,88
CHEMBL244300,,None,540.52,2,6.26,54,CS(=O)(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1,IC50,'=',4000,nM,5.4,,,UO_0000065,9.99,0.2,-0.86,4.93,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,4000
CHEMBL244079,,None,485.42,1,6.2,16,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1,IC50,'=',5,nM,8.3,,,UO_0000065,17.1,0.32,2.1,7.07,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,5
CHEMBL328644,,None,252.34,0,4.55,9,c1ccc(Nc2ncc(-c3ccccc3)s2)cc1,IC50,'=',124,nM,6.91,,,UO_0000065,27.37,0.52,2.36,27.72,0,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146769,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,124
CHEMBL244106,,None,561.49,2,5.76,51,COCCOCC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1,IC50,'=',5.4,nM,8.27,,,UO_0000065,14.72,0.28,2.51,6.53,0,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148750,1,Scientific Literature,J Med Chem,2007,None,,,,5.4
CHEMBL1979718,,None,345.41,0,3.68,SID103905662,Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2003286,,None,251.26,0,1.72,SID103905210,COc1cc(C=C2SC(=O)NC2=O)ccc1O,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL2002165,,None,502.58,2,5.57,SID103904322,CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,Ki,'=',5.012,nM,8.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.3
CHEMBL1979318,,None,378.17,0,2.54,SID103905101,Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2,Ki,'=',3162.28,nM,5.5,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.5
CHEMBL1977619,,None,245.26,0,2.16,SID103905074,O=C(O)c1cc(-c2cccs2)n2nccc2n1,Ki,'>',79432.82,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,4.1
CHEMBL1965033,,None,406.34,0,4.55,SID103904457,Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL408478,,None,497.55,1,6.74,71,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5cc(C(C)(C)C)on5)cccc4c3)c2cc1OC,IC50,'=',0.8,nM,9.1,,,UO_0000065,18.28,0.34,2.36,9.5,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.8
CHEMBL406388,,None,451.48,1,5.84,65,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)c2cc1OC,IC50,'=',0.8,nM,9.1,,,UO_0000065,20.15,0.37,3.26,11.02,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.8
CHEMBL407715,,None,506.6,2,7.75,60,COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(C(C)(C)C)cc5)cccc4c3)c2cc1OC,IC50,'=',0.7,nM,9.15,,,UO_0000065,18.07,0.33,1.4,13.14,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,0.7
CHEMBL272827,,None,403.87,1,5.97,41,CNc1cc(Oc2ccc3c(C(=O)Nc4ccc(Cl)cc4)cccc3c2)ccn1,IC50,'=',7,nM,8.15,,,UO_0000065,20.19,0.38,2.18,12.89,0,CHEMBL932834,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144685,1,Scientific Literature,J Med Chem,2008,None,,,,7
CHEMBL270306,,None,485.54,1,5.71,24,COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)N[C@@H](C)c3ccccc3)c2cc1OC,IC50,'=',1,nM,9,,,UO_0000065,18.54,0.34,3.29,10.96,0,CHEMBL950174,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144028,1,Scientific Literature,J Med Chem,2008,None,,,,1
CHEMBL270057,,None,471.51,1,5.78,12,COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3cccc(C)c3)c2cc1OC,IC50,'=',1,nM,9,,,UO_0000065,19.09,0.35,3.22,10.96,0,CHEMBL950174,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144028,1,Scientific Literature,J Med Chem,2008,None,,,,1
CHEMBL444105,,None,494.62,1,5.49,7e,CC(C)Cn1c2ccc(C(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,'=',6,nM,8.22,,,UO_0000065,16.62,0.31,2.73,11.93,0,CHEMBL950347,Inhibition of VEGFR2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143906,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,6
CHEMBL68258,,None,422.49,0,2.07,29,Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(N3CCCCC3)c21,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL816964,Inhibition of tyrosine phosphorylation in cells expressing human VEGFR2 (Flk-1/KDR) kinase,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1134862,1,Scientific Literature,Bioorg Med Chem Lett,2002,None,,,,20
CHEMBL404639,,None,514.61,2,6.35,10h,O=C(Cc1ccccc1)NC(=S)Nc1ccc(Oc2ccnc3cc(-c4ccccn4)sc23)c(F)c1,IC50,'=',17,nM,7.77,,,UO_0000065,15.1,0.29,1.42,10.2,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,17
CHEMBL254760,,None,517.61,2,5.68,10a,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1,IC50,'=',6,nM,8.22,,,UO_0000065,15.88,0.31,2.54,10.14,0,CHEMBL924779,Inhibition of human VEGFR2-dependent HUVEC proliferation,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.006
CHEMBL256974,,None,480.55,0,4.38,8a,NC(=O)c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1,IC50,'=',129,nM,6.89,,,UO_0000065,14.34,0.29,2.51,6.48,0,CHEMBL924759,Inhibition of GST tagged VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,None,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145636,1,Scientific Literature,Bioorg Med Chem Lett,2008,CHEMBL3308860,,,,129
CHEMBL469171,,None,367.41,0,4.28,6,O=C(c1ccccc1NCc1ccc2[nH]ncc2c1)c1n[nH]c2ccccc12,IC50,'=',800,nM,6.1,,,UO_0000065,16.59,0.3,1.82,7.05,0,CHEMBL976314,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.8
CHEMBL513680,,None,381.44,0,4.29,15,Cn1nc(C(=O)c2ccccc2NCc2ccc3cn[nH]c3c2)c2ccccc21,IC50,'=',300,nM,6.52,,,UO_0000065,17.1,0.31,2.23,8.63,0,CHEMBL976315,Inhibition of KDR autophosphorylation by cell based assay,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.3
CHEMBL469171,,None,367.41,0,4.28,6,O=C(c1ccccc1NCc1ccc2[nH]ncc2c1)c1n[nH]c2ccccc12,IC50,'=',120,nM,6.92,,,UO_0000065,18.84,0.34,2.64,8,0,CHEMBL976315,Inhibition of KDR autophosphorylation by cell based assay,B,BAO_0000219,cell-based format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155904,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.12
CHEMBL5433629,,None,468.93,0,3.88,11c,NS(=O)(=O)c1ccccc1NC(=O)Nc1nc(-c2ccccc2)n(-c2ccc(Cl)cc2)n1,IC50,'=',271,nM,6.57,,,UO_0000065,14,0.28,2.69,4.98,0,CHEMBL5352293,Inhibition of VEGFR-2 (unknown origin) incubated for 45 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5346980,1,Scientific Literature,J Med Chem,2023,None,TIME = 0.75 hr,INHIBITOR,,271
CHEMBL211378,,None,360.38,0,3.82,SID103904365,Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1,Ki,'=',100,nM,7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7
CHEMBL1991800,,None,446.53,0,4.38,SID103904760,CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1986756,,None,360.34,0,4.86,SID103904878,CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.6
CHEMBL2000345,,None,384.23,0,4.41,SID103905618,COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.7
CHEMBL1994938,,None,482.41,0,4.72,SID103904796,Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12,Ki,'=',12.59,nM,7.9,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.9
CHEMBL5189828,,None,443.51,0,3.72,6,Cc1nc(-c2cnc(N3CCCCC3)[nH]c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1,IC50,'>',3300,nM,,,,UO_0000065,,,,,0,CHEMBL5106379,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5104170,1,Scientific Literature,Bioorg Med Chem Lett,2022,None,,,,3300
CHEMBL5169941,,None,530.62,2,5.72,5b,CC1(C)c2cc(N3CC4(COC4)C3)ccc2C(=O)c2c1oc1cc(C#Cc3cc(OCC4CC4)ccn3)ccc21,IC50,'=',430,nM,6.37,,,UO_0000065,12,0.22,0.65,9.82,0,CHEMBL5119505,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5113522,1,Scientific Literature,J Med Chem,2022,None,,INHIBITOR,,430
CHEMBL447427,PROTOSAPPANIN A,None,272.26,0,1.97,24,O=C1COc2cc(O)ccc2-c2cc(O)c(O)cc2C1,Inhibition,'=',3.6,%,,,,UO_0000187,,,,,0,CHEMBL986515,Inhibition of KDR at 10 uM by ELISA,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155833,1,Scientific Literature,J Med Chem,2008,None,,,,3.6
CHEMBL272902,,None,415.38,0,3.89,8,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1,IC50,'=',205,nM,6.69,,,UO_0000065,16.1,0.3,2.8,6.08,1,CHEMBL946389,Inhibition of KDR,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1158158,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.205
CHEMBL207821,,None,411.39,1,5.07,10,FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccccn3)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL4647153,,None,507.59,1,4.96,7e,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cnc(-n2cccc2CN(C)C)c(C)c1)c1ccccc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4623159,Inhibition of N-terminal GST fused human VEGFR2 cytoplasmic domain (790 to 1356 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4622841,1,Scientific Literature,Bioorg Med Chem,2020,None,,,,1000
CHEMBL4638817,,None,507.59,1,4.96,7k,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN(C)C)nc1)c1ccccc1,IC50,'=',700,nM,6.16,,,UO_0000065,12.13,0.22,1.19,6.96,0,CHEMBL4623159,Inhibition of N-terminal GST fused human VEGFR2 cytoplasmic domain (790 to 1356 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4622841,1,Scientific Literature,Bioorg Med Chem,2020,None,,,,700
CHEMBL510814,,None,478.51,1,5.33,32,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5ccc6c(c5)OCO6)cnn4c3N)cc2)c1,IC50,'=',17,nM,7.77,,,UO_0000065,16.24,0.29,2.44,6.71,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,17
CHEMBL452522,,None,440.53,1,5.66,30,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5ccsc5)cnn4c3N)cc2)c1,IC50,'=',11,nM,7.96,,,UO_0000065,18.07,0.34,2.3,8.18,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,11
CHEMBL452287,,None,437.3,0,4.69,6,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(Br)cnn4c3N)cc2)c1,IC50,'=',86,nM,7.07,,,UO_0000065,16.16,0.34,2.38,7.26,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,86
CHEMBL508928,,None,438.5,0,4.33,34,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1,IC50,'=',1,nM,9,,,UO_0000065,20.52,0.37,4.67,7.82,0,CHEMBL948355,Inhibition of human KDR phosphorylation expressed in mouse NIH3T3 cells by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,CHEMBL3307716,,,,1
CHEMBL92461,,None,307.38,0,4.13,43,COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,IC50,'=',185,nM,6.73,,,UO_0000065,21.9,0.42,2.6,17.08,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,185
CHEMBL453057,,None,437.51,0,4.94,34a,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)ccn4c3N)cc2)c1,IC50,'=',3,nM,8.52,,,UO_0000065,19.48,0.35,3.58,8.33,0,CHEMBL948354,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155009,1,Scientific Literature,J Med Chem,2008,None,,,,3
CHEMBL118258,,None,486.54,0,4.62,45,CN1CCC(O)(c2cn(-c3ccnc(NC4CCCC4)n3)c(-c3cccc(C(F)(F)F)c3)n2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL818932,Inhibition of human vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147483,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,10
CHEMBL74646,,None,398.36,1,5.52,66,Fc1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc(C(F)(F)F)c1,IC50,'=',200,nM,6.7,,,UO_0000065,16.82,0.32,1.18,13.21,0,CHEMBL702231,Inhibitory activity against kinase domain containing receptor (KDR/VEGFR2),B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1133741,1,Scientific Literature,J Med Chem,2000,None,,,,0.2
CHEMBL4578164,MRL-CB1-NC,None,550.85,2,5.8,EUB0002784a,CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O,% Control,'=',82,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880006,KinomeScan assay: inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: R787/P1253 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507287,54,SGC Frankfurt - Donated Chemical Probes,,2021,None,Compound concentration None 1000.0 nM,,,82
CHEMBL200723,,None,438.48,0,2.34,60,COC1=CC(=O)C(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)=CC1=O,IC50,'=',239.7,nM,6.62,,,UO_0000065,15.1,0.28,4.28,6.44,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,239.7
CHEMBL3706843,,None,514.58,1,3.91,63,COc1cc2c(NC3=CC(=O)C(OCc4ccccc4)=CC3=O)ncnc2cc1OCC1CCN(C)CC1,IC50,'=',26.1,nM,7.58,,,UO_0000065,14.74,0.27,3.67,7.37,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,26.1
CHEMBL199455,,None,438.48,0,2.48,64,COC1=CC(=O)C(Nc2ncnc3cc(OCCCN4CCCC4)c(OC)cc23)=CC1=O,IC50,'=',158.6,nM,6.8,,,UO_0000065,15.51,0.29,4.32,6.61,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,158.6
CHEMBL2113163,,None,504.54,1,3.64,74,COc1cc2c(NC3=CC(=O)C(OCc4ccco4)=CC3=O)ncnc2cc1OCCCN1CCCC1,IC50,'=',5.1,nM,8.29,,,UO_0000065,16.44,0.31,4.65,7.15,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,5.1
CHEMBL194597,,None,327.39,1,5.05,48,COc1ccc(Nc2nnc(-c3ccccc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL2113167,,None,398.42,0,1.56,10,COCCOc1cc2ncnc(NC3=CC(=O)C(N(C)C)=CC3=O)c2cc1OC,IC50,'=',5000.3,nM,5.3,,,UO_0000065,13.31,0.25,3.74,5.15,0,CHEMBL864515,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 100 uM glutathione,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,5000.3
CHEMBL2113168,,None,440.46,0,1.33,11,COCCOc1cc2ncnc(NC3=CC(=O)C(N4CCOCC4)=CC3=O)c2cc1OC,IC50,'=',101.2,nM,7,,,UO_0000065,15.88,0.3,5.66,6.24,0,CHEMBL864514,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,101.2
CHEMBL407008,,None,374.83,0,4.79,8,NC(=O)c1ccc(-c2nnc(Nc3cccc(Cl)c3)c3ccccc23)cc1,IC50,'=',1700,nM,5.77,,,UO_0000065,15.39,0.29,0.98,7.13,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,1.7
CHEMBL3706819,,None,491.5,0,3.09,28,COCCOc1cc2ncnc(NC3=CC(=O)C(OCCOc4ccccc4)=CC3=O)c2cc1OC,IC50,'=',117.8,nM,6.93,,,UO_0000065,14.1,0.26,3.84,5.87,0,CHEMBL862695,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 10 uM ATP and in presence of 5% mouse plasma,B,BAO_0000366,cell-free format,Homo sapiens,CHEMBL3559721,Plasma,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,117.8
CHEMBL2113169,,None,413.43,0,2.42,29,COCCOc1cc2ncnc(NC3=CC(=O)C(OC(C)C)=CC3=O)c2cc1OC,IC50,'=',542.9,nM,6.26,,,UO_0000065,15.15,0.29,3.85,5.75,0,CHEMBL862696,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 1 mm ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141211,1,Scientific Literature,J Med Chem,2005,None,,,,542.9
CHEMBL196399,,None,375.86,1,6.09,44,CCOc1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL871636,Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143454,1,Scientific Literature,Bioorg Med Chem Lett,2005,None,,,,10
CHEMBL233877,,None,306.76,0,4.41,2o,N#Cc1cnc(Nc2ccc(Cl)cc2)nc1-c1ccccc1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL894746,Inhibition of VEGFR2 activity at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148688,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,50
CHEMBL206658,,None,401.47,1,6.38,16,Cc1cc2cc(Nc3nnc(-c4cccc5cnccc45)c4ccccc34)ccc2[nH]1,IC50,'=',230,nM,6.64,,,UO_0000065,16.53,0.29,0.26,9.98,0,CHEMBL866514,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146055,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.23
CHEMBL380508,,None,380.43,1,6.04,15,Cc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)c(F)c1,IC50,'=',430,nM,6.37,,,UO_0000065,16.74,0.3,0.33,12.56,0,CHEMBL866514,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146055,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.43
CHEMBL203346,,None,390.49,1,6.71,8,CC(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1,IC50,'=',17,nM,7.77,,,UO_0000065,19.9,0.35,1.06,15.32,0,CHEMBL866514,Inhibition of VEGFR2 by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146055,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.017
CHEMBL204220,,None,362.44,1,5.9,11,Cc1ccccc1Nc1nnc(-c2cccc3cnccc23)c2ccccc12,Inhibition,'=',59,%,,,,UO_0000187,,,,,0,CHEMBL866516,Inhibition of VEGFR2 at 10 uM by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146055,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,59
CHEMBL206348,,None,359.4,0,4.78,30,Cc1ccc(NC(=O)c2ccccc2Cn2ccc3cnccc32)c(F)c1,IC50,'=',290,nM,6.54,,,UO_0000065,18.19,0.33,1.76,13.93,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.29
CHEMBL437889,,None,429.83,1,6.01,28,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccccc1Cn1ccc2cnccc21,IC50,'=',310,nM,6.51,,,UO_0000065,15.14,0.3,0.5,13.87,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.31
CHEMBL205610,,None,427.84,1,5.5,18,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1ccccc1Cn1ccc2cnccc21,IC50,'=',73,nM,7.14,,,UO_0000065,16.68,0.32,1.64,12.71,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.073
CHEMBL203965,,None,383.5,1,5.63,14,CC(C)(C)c1ccc(NC(=O)c2ccccc2Cn2ccc3cnccc32)cc1,IC50,'=',52,nM,7.28,,,UO_0000065,18.99,0.34,1.65,15.52,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.052
CHEMBL202011,,None,354.41,0,4.49,D,O=C(Nc1cnc2ccccc2c1)c1ccccc1NCc1ccncc1,IC50,'=',15,nM,7.82,,,UO_0000065,22.08,0.4,3.33,11.69,1,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.015
CHEMBL410686,,None,406.43,0,4.28,14,Cc1cc2c(F)c(Nc3ncnn4cc(-c5nnc(C)o5)c(C(C)C)c34)cnc2[nH]1,IC50,'=',13,nM,7.89,,,UO_0000065,19.4,0.36,3.61,7.18,0,CHEMBL929417,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145598,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.013
CHEMBL412081,,None,392.4,0,3.97,9,Cc1noc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4F)c3c2C(C)C)n1,IC50,'=',30,nM,7.52,,,UO_0000065,19.17,0.35,3.55,6.85,0,CHEMBL929417,Inhibition of human VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145598,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,,,,0.03
CHEMBL48834,,None,342.41,0,4.08,Figure 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL206742,,None,381.83,0,3.87,6,Cn1cnc(NCc2cccnc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL204718,,None,431.89,1,5.03,11,Cn1cnc(NCc2ccc3ccccc3n2)c1-c1nnc(Nc2ccc(Cl)cc2)o1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL862189,Inhibition of VEGFR2 by enzymatic assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139649,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL382797,,None,450.42,1,5.56,14,FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccc4[nH]ncc4c3)o2)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,10
CHEMBL524453,,None,507.55,1,4.27,49,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)Cn2ccnc2)cc1)c1ccccc1,IC50,'=',6,nM,8.22,,,UO_0000065,16.2,0.3,3.95,7.79,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,6
CHEMBL179061,,None,429.48,1,6,6f,COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccccc4C)cc3)c2cc1OC,IC50,'=',2.3,nM,8.64,,,UO_0000065,20.11,0.37,2.64,10.57,0,CHEMBL876146,Inhibition of vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142694,1,Scientific Literature,J Med Chem,2005,None,,,,2.3
CHEMBL526836,,None,392.44,0,2.54,19w,CN1CCN(c2ccc3[nH]c(-c4c(N)c5cccc(F)c5[nH]c4=O)nc3c2)CC1,IC50,'=',560,nM,6.25,,,UO_0000065,15.93,0.29,3.71,6.65,0,CHEMBL1010124,Inhibition of human recombinant VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139379,1,Scientific Literature,J Med Chem,2009,None,,,,0.56
CHEMBL501752,,None,443.98,1,6.26,36,O=C1Nc2cc(Cl)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1,IC50,'=',129,nM,6.89,,,UO_0000065,15.52,0.29,0.63,15.53,0,CHEMBL1017182,Inhibition of human VEGFR2 expressed in Sf9 cells,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137777,1,Scientific Literature,J Med Chem,2009,CHEMBL3308860,,,,129
CHEMBL373598,,None,447.88,0,3.35,16a,N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2,Ki,'>',8210,nM,,,,UO_0000065,,,,,0,CHEMBL914402,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142994,1,Scientific Literature,J Med Chem,2007,None,,,,8.21
CHEMBL391692,,None,540.9,2,8.2,15b,Nc1ncc(-c2cccc(Cl)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,IC50,'=',933,nM,6.03,,,UO_0000065,11.15,0.22,-2.17,6.47,0,CHEMBL902104,Inhibition of human recombinant GST-6XHis-VEGFR2 by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138370,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,933
CHEMBL400398,,None,464.35,0,4.38,15,Cn1cc(/C=C2\C(=O)NN=C2c2snnc2-c2ccccc2)c2c(Br)cccc21,IC50,'=',89,nM,7.05,,,UO_0000065,15.18,0.33,2.67,9.77,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,89
CHEMBL400400,,None,287.35,0,1.71,16,Cc1cc(C)c(/C=C2\C(=O)NN=C2c2snnc2C)[nH]1,IC50,'=',197,nM,6.71,,,UO_0000065,23.34,0.46,5,8.08,0,CHEMBL903321,Inhibition of human cytoplasmic VEGFR2 expressed in baculovirus after 15 mins by time resolved fluorescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139105,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,,,,197
CHEMBL382218,,None,425.41,1,5.38,43,Cc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1C(F)(F)F,IC50,'=',92,nM,7.04,,,UO_0000065,16.54,0.31,1.66,9.17,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.092
CHEMBL207975,,None,385.47,1,5.18,22,CC(C)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1,IC50,'=',390,nM,6.41,,,UO_0000065,16.63,0.3,1.23,8.35,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,0.39
CHEMBL207099,,None,446.38,1,5.96,12,Fc1ccc(CCc2ncccc2-c2nnc(Nc3cccc(C(F)(F)F)c3)o2)cc1F,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL205244,,None,411.39,1,5.07,33,FC(F)(F)c1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1,IC50,'=',440,nM,6.36,,,UO_0000065,15.45,0.29,1.29,8.28,0,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.44
CHEMBL205097,,None,321.31,0,2.02,16a,Cn1cc(/C=C2\C(=O)NN=C2c2cnccn2)c2cc(F)ccc21,IC50,'=',23,nM,7.64,,,UO_0000065,23.77,0.43,5.62,10.58,0,CHEMBL866859,Inhibition of VEGFR2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146951,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,23
CHEMBL526914,,None,454.53,0,4.88,CER-0263680,COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1,Inhibition,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,8
CHEMBL4568120,,None,388.83,0,3.29,G28_14,C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl,Activity,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL4335134,Inhibition of human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334438,1,Scientific Literature,Eur J Med Chem,2019,None,,,,98
CHEMBL404571,,None,412.38,0,4.87,25,Nc1n[nH]c2ccnc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,IC50,'=',99,nM,7,,,UO_0000065,16.99,0.32,2.13,6.44,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,99
CHEMBL256246,,None,430.37,1,5.01,18,Nc1n[nH]c2cncc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,IC50,'=',1.3,nM,8.89,,,UO_0000065,20.65,0.39,3.88,8.17,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,1.3
CHEMBL257479,,None,358.41,0,4.16,3,Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)c1,IC50,'=',1,nM,9,,,UO_0000065,25.11,0.46,4.84,8.28,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,1
CHEMBL272767,,None,372.43,0,4.47,27,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3nccc4[nH]nc(N)c34)cc2)c1,IC50,'=',12,nM,7.92,,,UO_0000065,21.27,0.39,3.45,7.29,1,CHEMBL3053620,Inhibition of KDR kinase activity (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,7.9208
CHEMBL404367,,None,372.43,0,4.17,20,Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1,IC50,'=',4.6,nM,8.34,,,UO_0000065,22.39,0.41,4.17,8.52,1,CHEMBL3053620,Inhibition of KDR kinase activity (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,8.3372
CHEMBL273187,,None,376.4,0,4.3,12,Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F,IC50,'=',1.1,nM,8.96,,,UO_0000065,23.8,0.44,4.66,8.24,1,CHEMBL3053620,Inhibition of KDR kinase activity (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,8.9586
CHEMBL255746,,None,378.82,0,4.5,5,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',1,nM,9,,,UO_0000065,23.76,0.46,4.5,8.28,1,CHEMBL3053620,Inhibition of KDR kinase activity (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,9
CHEMBL256825,,None,378.82,0,4.5,24,Nc1n[nH]c2ccnc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',46,nM,7.34,,,UO_0000065,19.37,0.37,2.84,6.75,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,7.3372
CHEMBL404367,,None,372.43,0,4.17,20,Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1,IC50,'=',1.8,nM,8.74,,,UO_0000065,23.48,0.43,4.57,8.94,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,8.7447
CHEMBL273187,,None,376.4,0,4.3,12,Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F,IC50,'=',1.2,nM,8.92,,,UO_0000065,23.7,0.44,4.62,8.21,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,8.9208
CHEMBL255743,,None,376.4,0,4.3,10,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)c1,IC50,'=',1,nM,9,,,UO_0000065,23.91,0.44,4.7,8.28,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,9
CHEMBL258141,,None,380.36,0,4.13,8,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cc(F)cc(F)c4)cc3)c12,IC50,'=',8.1,nM,8.09,,,UO_0000065,21.27,0.39,3.96,7.44,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,8.0915
CHEMBL255956,,None,358.41,0,4.16,4,Cc1ccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)cc1,IC50,'=',16,nM,7.8,,,UO_0000065,21.75,0.39,3.64,7.17,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,7.7959
CHEMBL257292,,None,358.41,0,4.16,2,Cc1ccccc1NC(=O)Nc1ccc(-c2ccnc3[nH]nc(N)c23)cc1,IC50,'=',2.2,nM,8.66,,,UO_0000065,24.16,0.44,4.5,7.96,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,8.6576
CHEMBL404223,,None,344.38,0,3.85,1,Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,IC50,'=',4,nM,8.4,,,UO_0000065,24.39,0.44,4.55,7.72,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,8.3979
CHEMBL404257,,None,376.4,0,4.3,26,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nccc4[nH]nc(N)c34)cc2)c1,IC50,'=',61,nM,7.21,,,UO_0000065,19.17,0.35,2.91,6.64,1,CHEMBL3053621,Inhibition of KDR (unknown origin) in cell-based assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3045402,1,Scientific Literature,Med Chem Res,2012,None,,,,61
CHEMBL3657545,,None,452.95,0,3.47,BDBM138205,Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)nn4C(C)C)n2)cc1CN1CC(O)C1,IC50,'=',1913,nM,5.72,,272105,UO_0000065,12.62,0.24,2.25,5.9,0,CHEMBL3707826,Kinase Inhibition Assay: Compounds of the invention were initially diluted to 10 mM in 100% DMSO (CALBIOCHEM) for storage and made into kinase buffer solution to create a compound concentration ranging from 1 uM and 10 uM. Serial dilutions of compounds of the invention were dispensed into a 96-well plate (GREINER BIOSCIENCES) at 6 uL each. Purified full-length human SYK,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL171125,,None,438.48,0,3.21,18,COc1cc2c(Nc3cccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1,IC50,'=',4960,nM,5.3,,,UO_0000065,12.1,0.23,2.09,6.08,0,CHEMBL820673,In vitro inhibitory concentration against VEGF receptor 2.,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148412,1,Scientific Literature,J Med Chem,2004,None,,,,4.96
CHEMBL2004871,,None,297.33,0,3.13,SID103905252,OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL101311,,None,448.35,0,4.57,SID103905214,CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1,Ki,'=',1584.89,nM,5.8,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.8
CHEMBL1978200,,None,424.46,0,4.01,SID103904764,Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1984432,,None,303.37,0,3.49,SID103904530,Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL1994693,,None,387.47,0,4.68,SID103904349,Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,6.3
CHEMBL371206,,None,403.51,1,5.51,SID103904294,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1,Ki,'=',19.95,nM,7.7,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.7
CHEMBL1982980,,None,432.35,1,7,SID103905172,CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,5.1
CHEMBL3628812,,None,325.82,1,5.15,2c,Clc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1,IC50,'>',50000,nM,,,,UO_0000065,,,,,0,CHEMBL3630448,Inhibition of human KDR incubated for 50 mins by omnia tyr peptide 8 substrate based fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627617,1,Scientific Literature,Eur J Med Chem,2015,None,,,,50
CHEMBL3696082,,None,375.37,0,1.97,BDBM144597,NC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)nsc1NC(=O)N1CCCC1=O,IC50,'>',10000,nM,,,280957,UO_0000065,,,,,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3800542,,None,426.49,0,4.4,28,COc1cc2c(Nc3c(F)ccc(O)c3C)ncnc2cc1OCCCN1CCCC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3804160,Inhibition of recombinant KDR (unknown origin) expressed in IL3 deficient BAF3 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,BaF3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797122,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3307634,,,,10
CHEMBL1922981,,None,432.48,0,4.27,8b,Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3cccc(F)c3)cccc21,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1925070,Inhibition of human cytoplasmic domain of VEGFR-2 at 1 uM by time-resolved fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1921676,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,,,,50
CHEMBL3326761,,None,365.42,0,2.94,35,CS(=O)(=O)c1ccc(-c2cc3c(Nc4ccncc4)ncnn3c2)cc1,Inhibition,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL3376327,Inhibition of KDR (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351500,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,94
CHEMBL1973145,,None,390.47,0,4.48,SID103904363,Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1,Ki,'=',25.12,nM,7.6,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,7.6
CHEMBL1934320,,None,584.04,2,6.95,1a,CN1CCC(COc2ccc3c(Nc4ccc(CC(=O)Nc5ccc(Cl)c(C(F)(F)F)c5)cc4)ncnc3c2)CC1,IC50,'=',87,nM,7.06,,,UO_0000065,12.09,0.24,0.11,8.89,0,CHEMBL1937306,Inhibition of human GST-tagged VEGFR2 intracellular domain using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate after 30 mins by HTRF assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933000,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,87
CHEMBL2031893,,None,528.54,2,5.23,3,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,IC50,'=',7.8,nM,8.11,,,UO_0000065,15.34,0.28,2.88,8.39,1,CHEMBL3293757,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3286137,1,Scientific Literature,Eur J Med Chem,2014,None,,,,7.8
CHEMBL3656028,,None,474.47,0,3.93,BDBM110536,COC(=O)CNC(=O)c1c[nH]c(-c2cc(Oc3cccc(NC(=O)c4occc4C)c3)ccn2)c1,IC50,'=',29,nM,7.54,,231422,UO_0000065,15.89,0.29,3.61,5.56,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1978166,,None,525.72,2,7.54,SID103904271,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1,Ki,'=',3.981,nM,8.4,,active,UO_0000065,,,,,0,CHEMBL1963788,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,,,,8.4
CHEMBL3612224,,None,377.49,1,6.09,3a,O=C(Nc1ccccc1)Nc1ccccc1Sc1ccnc2ccsc12,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,100000
CHEMBL300853,,None,540.69,1,2.81,4m,CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2,IC50,'=',800,nM,6.1,,,UO_0000065,11.28,0.22,3.29,4.96,0,CHEMBL820703,Inhibitory activity against Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146690,1,Scientific Literature,Bioorg Med Chem Lett,2004,None,,,,0.8
CHEMBL3612234,,None,479.94,1,7.76,4h,O=C(Nc1cccc(Sc2ccnc3ccsc23)c1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,'=',16,nM,7.8,,,UO_0000065,16.24,0.34,0.04,14.43,0,CHEMBL3615783,Inhibition of VEGFR2 (unknown origin) using Tyr1 peptide as substrate after 1 hr by FRET-based assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3612032,1,Scientific Literature,Bioorg Med Chem,2015,None,,,,16
CHEMBL3656046,,None,463.52,0,4.64,BDBM110556,Cc1ccsc1C(=O)Nc1cccc(Oc2ccnc(-c3cc(C(=O)OCCO)c[nH]3)c2)c1,IC50,'=',24,nM,7.62,,231441,UO_0000065,16.44,0.32,2.98,6.71,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660288,,None,489.51,0,4.68,BDBM110660,Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCO)c[nH]4)c3)cc2)c1,IC50,'=',53,nM,7.28,,231545,UO_0000065,14.86,0.28,2.6,5.67,0,CHEMBL3705785,Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL417804,,None,445.5,0,4.87,SB-251527,COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',6.68,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.68
CHEMBL473420,GSK-1030058A,None,492.48,1,5.49,GSK1030058A,COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,Inhibition,'=',49.56,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,49.56
CHEMBL4864978,,None,437.42,1,7,9,Cc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2ccccc2n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,,,10000
CHEMBL4855081,,None,349.39,0,4.26,31,CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C)c3)cc2)ncn1,IC50,'=',800,nM,6.1,,,UO_0000065,17.45,0.32,1.84,6.91,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,800
CHEMBL4856606,,None,451.84,1,5.94,49,CNc1cc(Oc2c(C)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2Cl)ncn1,IC50,'=',400,nM,6.4,,,UO_0000065,14.16,0.28,0.46,7.26,0,CHEMBL4841802,Inhibition of GST-6His tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide substrate incubated for 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4840354,1,Scientific Literature,J Med Chem,2021,None,TIME = 1.5 hr,INHIBITOR,,400
CHEMBL1909370,GW694234A,None,532.78,1,5.94,GW694234A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl,Inhibition,'=',68.05,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,68.05
CHEMBL3701241,,None,404.43,0,1.39,11,C=CC(=O)N1CC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1,IC50,'=',3029,nM,5.52,,,UO_0000065,13.65,0.25,4.13,5.09,0,CHEMBL5256649,Inhibition of N-terminal GST tagged recombinant human VEGFR2 (aa805 to 1356 residues) expressed in baculovirus expression system using Poly- (Glu4:Tyr)-biotin as substrate incubated for 80 mins in presence of ATP by kinase glo method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5252660,1,Scientific Literature,ACS Med Chem Lett,2023,None,TIME = 1.333 hr,INHIBITOR,,3029
CHEMBL5399711,,None,382.42,0,4.44,26,COc1cc(-c2cc(-c3ccc4ccccc4c3)nc(NN)c2C#N)ccc1O,IC50,'=',0.19,nM,9.72,,,UO_0000065,25.42,0.46,5.28,9.33,0,CHEMBL5380326,Inhibition of VEGFR-2 (unknown origin) kinase activity using poly(Glu-Tyr) at 4:1 ratio as substrate in presence of ATP incubated for 1 hr by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5376014,1,Scientific Literature,RSC Med Chem,2024,None,TIME = 1.0 hr,INHIBITOR,,0.19
CHEMBL3696087,,None,367.43,0,3.44,BDBM144602,Cc1ccc(NC(=O)Nc2ccc(-c3nsc(N)c3C(N)=O)cc2)cc1,IC50,'=',176,nM,6.75,,280962,UO_0000065,18.38,0.35,3.31,5.49,0,CHEMBL3705991,Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS),,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1761931,,None,368.39,0,3.96,43,CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',5600,nM,5.25,,,UO_0000065,14.26,0.27,1.29,5.55,1,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,5.6
CHEMBL2018748,,None,382.42,0,4.35,44,CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,IC50,'=',5000,nM,5.3,,,UO_0000065,13.86,0.26,0.95,5.6,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,5
CHEMBL2018752,,None,402.84,0,4.61,48,CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl,IC50,'=',500,nM,6.3,,,UO_0000065,15.64,0.31,1.69,6.66,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,0.5
CHEMBL2018766,,None,463.35,1,5,65,CCN(CC)CCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1OC,IC50,'=',1000,nM,6,,,UO_0000065,12.95,0.28,1,10.08,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,1
CHEMBL2018770,,None,453.54,0,4.59,69,CCN(CC)CCOc1cc2ncnc(Nc3ccc(NC(=O)OC)c(C)c3)c2cc1OC,IC50,'=',6950,nM,5.16,,,UO_0000065,11.37,0.21,0.57,5.27,0,CHEMBL2020643,Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016491,1,Scientific Literature,J Med Chem,2012,None,,,,6.95
CHEMBL427998,,None,396.37,0,4.04,6a,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc(N)nc1,IC50,'=',2,nM,8.7,,,UO_0000065,21.95,0.41,4.66,10.75,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,2
CHEMBL373621,,None,514.53,1,4.26,6h,CN(C)CCCN(C)c1ccc(C(F)(F)F)cc1NC(=O)c1cc(C#Cc2cnc(N)nc2)ccc1F,IC50,'=',11,nM,7.96,,,UO_0000065,15.47,0.29,3.7,9.11,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,11
CHEMBL219103,,None,479.51,1,5.03,6d,Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCCCC2)cc1C#Cc1cnc(N)nc1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,1000
CHEMBL221019,,None,431.42,1,5.61,13e,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc2ccccc2n1,IC50,'=',4,nM,8.4,,,UO_0000065,19.47,0.36,2.79,15.3,0,CHEMBL910167,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141381,1,Scientific Literature,J Med Chem,2007,None,,,,4
CHEMBL3968233,,None,467.33,0,4.54,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958898,,None,511.78,1,4.65,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1940869,,None,392.7,1,5.92,31,Cc1cccc2cc(/C=C/C(=O)c3sccc3Br)c(Cl)nc12,IC50,'=',312.98,nM,6.5,,,UO_0000065,16.56,0.4,0.58,21.71,0,CHEMBL1944151,Inhibition of VEGFR-2 after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938258,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,312.98
CHEMBL225311,,None,507.66,1,4.24,69,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNC(=O)c5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',3,nM,8.52,,,UO_0000065,16.79,0.31,4.28,13.26,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,3
CHEMBL390735,,None,494.62,0,4.53,78,CN1CCN(C(=O)c2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,'=',44,nM,7.36,,,UO_0000065,14.87,0.28,2.83,11.97,0,CHEMBL914744,Inhibition of human KDR kinase by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,None,,,,44
CHEMBL225639,,None,418.57,0,3.19,58,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCCO)c4)n[nH]c2-3)CC1,IC50,'=',40,nM,7.4,,,UO_0000065,,,,,0,CHEMBL914745,Inhibition of VEGF-induced phosphorylation of human KDR expressed in mouse NIH3T3 cell line by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147155,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,40
CHEMBL596761,,None,424.5,0,4.09,Table 1-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3928646,,None,499.62,1,5.49,305,COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1,IC50,'=',501.19,nM,6.3,,,UO_0000065,12.61,0.23,0.81,8.45,0,CHEMBL3880351,Inhibition of recombinant human N-terminal His6-tagged VEGFR2 (790 end residues) expressed in baculovirus infected insect Sf21 cells using Btn-Flt3 as substrate after 1 hr by time resolved fluorescence assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf21,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3879910,38,SureChEMBL Patent Bioactivity Data,,2014,CHEMBL4106362,,,,6.3
CHEMBL3930429,,None,516.45,2,6.49,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983179,,None,462.38,0,4.31,Table 6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL306865,GW784752X,None,345.37,0,2.67,GW784752X,COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',28.81,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,28.81
CHEMBL189148,GW829055X,None,398.86,1,5.25,GW829055X,Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1,Inhibition,'=',42.15,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,42.15
CHEMBL475761,GW784684X,None,564.09,2,6.81,GW784684X,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,Inhibition,'=',7.83,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.83
CHEMBL2016904,,None,467.57,0,4.1,20,O=C(c1ccc(CN2CCCCC2)cc1)N1CCc2nc(-c3cc4ccccc4[nH]c3=O)[nH]c2C1,IC50,'=',1.3,nM,8.89,,,UO_0000065,19,0.35,4.79,10.44,0,CHEMBL2020676,Inhibition of recombinant VEGFR-2 kinase domain by homogeneous time-resolved fluorescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016553,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,,,,0.0013
CHEMBL233002,,None,350.42,1,5.04,SB-814597,N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2,Inhibition,'=',6.61,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,6.61
CHEMBL220244,GW427984X,None,296.37,0,3.28,GW427984X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1,Inhibition,'=',7.06,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,7.06
CHEMBL365248,GW810372X,None,402.34,0,3.84,GW810372X,COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',14.8,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,14.8
CHEMBL375248,,None,357.44,0,1.61,20,CNC(=O)N1CCN(Cc2ccnc(Nc3ncc(C#N)s3)c2)CC1,IC50,'=',27,nM,7.57,,,UO_0000065,,,,,0,CHEMBL912804,Inhibition of VEGF-induced KDR autophosphorylation expressed in HEK293 cells,F,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149259,1,Scientific Literature,J Med Chem,2004,CHEMBL3307715,,,,27
CHEMBL4561931,,None,287.35,0,1.86,4,CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1N,IC50,'=',40000,nM,4.4,,,UO_0000065,15.31,0.3,2.54,4.41,0,CHEMBL4316523,Inhibition of GST-6His-tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide as substrate after 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4312039,1,Scientific Literature,ACS Med Chem Lett,2019,None,,,,40
CHEMBL3221544,,None,524.45,1,5.32,76,CCOC(=O)Nc1ccc(Nc2ncnc3cc(OCCN(CC)CC)c(OC)cc23)cc1Cl.Cl,IC50,'=',3300,nM,5.48,,,UO_0000065,11.23,0.22,0.16,5.6,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,3.3
CHEMBL3221561,,None,439.3,0,4.61,41,CCOC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1Cl.Cl,IC50,'=',5550,nM,5.26,,,UO_0000065,13.05,0.26,0.65,5.56,0,CHEMBL3226104,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217416,1,Scientific Literature,Medchemcomm,2011,None,,,,5.55
CHEMBL223478,,None,486.58,0,4.48,34d,Cc1cccc(NC(=O)Nc2ccc(-c3ccc(OCCN4CCOCC4)c4[nH]nc(N)c34)cc2)c1,IC50,'=',56,nM,7.25,,,UO_0000065,,,,,0,CHEMBL920442,Inhibition of VEGF-induced human KDR phosphorylation in mouse 3T3 cells by ELISA,F,BAO_0000219,cell-based format,Homo sapiens,None,None,NIH3T3,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J Med Chem,2007,CHEMBL3307716,,,,56
CHEMBL3220823,,None,350.81,0,4.54,4g,COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1,Activity,'=',98.6,%,,,,UO_0000187,,,,,0,CHEMBL3225766,Inhibition of VEGFR2 (unknown origin) at 10 uM assessed as residual enzyme activity,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217737,1,Scientific Literature,Medchemcomm,2013,None,,,,98.6
CHEMBL185962,,None,242.24,0,1.4,SB-736302,Nc1nonc1-c1nc2cnccc2n1C1CC1,Inhibition,'=',14.28,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,14.28
CHEMBL188794,GW829115X,None,496.88,1,6.28,GW829115X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1,Inhibition,'=',1.69,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,1.69
CHEMBL524057,GW683768X,None,280.34,0,2.32,GW683768X,CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1,Inhibition,'=',5.8,%,,,,UO_0000187,,,,,0,CHEMBL1962123,GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,5.8
CHEMBL4463359,,None,493.32,0,3.8,10i,COc1ccc(C(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)cc1,IC50,'=',710,nM,6.15,,,UO_0000065,12.46,0.26,2.35,5.65,0,CHEMBL4330587,Inhibition of VEGFR-2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate after 5 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330065,1,Scientific Literature,Eur J Med Chem,2019,None,,,,0.71
CHEMBL220465,GSK-248233A,None,484.52,0,4.19,GSK248233A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21,Inhibition,'=',2.18,%,,,,UO_0000187,,,,,0,CHEMBL1962122,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,,,,2.18
CHEMBL4781578,,None,451.57,0,2.61,67,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCC(N)=O)cc32)c1C,IC50,'=',3820,nM,5.42,,,UO_0000065,12,0.22,2.81,4.5,0,CHEMBL4769107,Inhibition of tracer 236 binding to recombinant human N-terminal GST-tagged full length KDR (790 to 1356 residues) expressed in baculovirus expression system incubated for 1 hr by Lanthascreen assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765298,1,Scientific Literature,Eur J Med Chem,2020,None,TIME = 1.0 hr,INHIBITOR,,3820
CHEMBL491473,CEDIRANIB,3,450.51,1,5.22,Cediranib,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,IC50,'=',0.5,nM,9.3,,,UO_0000065,20.65,0.38,4.08,12.83,0,CHEMBL4332288,Inhibition of VEGFR2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330108,1,Scientific Literature,Bioorg Med Chem,2019,None,,,,0.5
CHEMBL4590038,,None,429.44,0,3.43,6e,COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)Nc3ccccc3)cc1)C(=O)N2,IC50,'=',490,nM,6.31,,,UO_0000065,14.69,0.27,2.88,5.22,0,CHEMBL4330587,Inhibition of VEGFR-2 (unknown origin) using biotinylated poly-GluTyr (4:1) as substrate after 5 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330065,1,Scientific Literature,Eur J Med Chem,2019,None,,,,0.49
CHEMBL4459023,,None,365.44,0,3.01,T.6,COc1ccc(Cc2cn(CCNC(=O)Nc3ccccc3C)nn2)cc1,Activity,'=',121,%,,,,UO_0000187,,,,,0,CHEMBL4347515,Inhibition of VEGFR2 in human A549 cells assessed as phosphorylated VEGFR2 level at 100 uM incubated for 24 hrs by sandwich ELISA relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,A549,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4346668,1,Scientific Literature,Eur J Med Chem,2019,CHEMBL3307651,,,,121
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4323757,Inhibition of VEGFR2 in HUVEC assessed as inhibition of VEGF-induced tube formation at 1 uM incubated for 8 hrs by inverted microscopic method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4321834,1,Scientific Literature,J Nat Prod,2019,CHEMBL3307501,,,,
CHEMBL474579,CEFOTETAN,4,575.63,2,-1.4,cefotetan,CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,AC50,'>',30000,nM,,,Summarised AC50 (mean value for measurements with a relation sign '='; largest value for measurements with relation sign '>'),UO_0000065,,,,,0,CHEMBL5291913,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5291721,1,Scientific Literature,Nat Commun,2023,None,,,,30
CHEMBL4558980,,None,299.36,0,2.07,6,NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCC2,IC50,'=',7940,nM,5.1,,,UO_0000065,17.04,0.33,3.03,5.94,0,CHEMBL4316523,Inhibition of GST-6His-tagged VEGFR2 (unknown origin) using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 peptide as substrate after 90 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL4312039,1,Scientific Literature,ACS Med Chem Lett,2019,None,,,,7.94
CHEMBL3219512,,None,413.24,None,None,12b,COCCOc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OCCOC,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL3223748,Inhibition of VEGF-induced KDR phosphorylation in human HUVEC cells at 1 uM by immunoblot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,CHEMBL3307501,,,,
CHEMBL3220397,,None,325.32,0,3.09,15,COc1cc2ncnc(Nc3cccc(C(=O)O)c3)c2cc1OC,Inhibition,'=',7,%,,,,UO_0000187,,,,,0,CHEMBL3223752,Inhibition of KDR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3217494,1,Scientific Literature,Medchemcomm,2010,None,,,,7
CHEMBL5093894,,None,526.59,1,4.47,3a-P1,Cc1ccc(C(=O)Nc2ccc3c(c2)C(F)(F)C[C@@H]3N2CCN(C)CC2)cc1C#Cc1cnc2cccnn12,IC50,'<',10,nM,,,,UO_0000065,,,,,0,CHEMBL5039707,Inhibition of human KDR/VEGFR2 using poly [Glu:Tyr] as substrate incubated for 30 mins followed by 33P-ATP addition and measured after 2 hrs by liquid scintillation counter method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL5038588,1,Scientific Literature,J Med Chem,2021,None,TIME = 2.5 hr,INHIBITOR,,10
CHEMBL1914676,,None,353.43,0,1.81,13,Cc1[nH]c(/C=C2\C(=O)Nc3ccncc32)c(C)c1C(=O)NCCN(C)C,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1920169,Inhibition of VEGF-induced VEGFR2 phosphorylation in human HCT116 cells at 0.2 to 20 uM treated 30 mins before VEGF challenge measured after 2 hrs by immuno blot analysis,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HCT-116,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914337,1,Scientific Literature,Eur J Med Chem,2011,CHEMBL3308372,,,,
CHEMBL259141,,None,217.28,0,0.89,6,NC1CCN(c2ncnc3[nH]ccc23)CC1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3137150,Inhibition of human KDR cytoplasmic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3132769,1,Scientific Literature,Medchemcomm,2014,None,,,,0
CHEMBL1911513,,None,420.94,1,5.06,BRN-103,O=C(Nc1cccc(Cl)c1)c1cccnc1NC1CCN(Cc2ccccc2)CC1,Inhibition,,,%,,,Dose-dependent effect,UO_0000187,,,,,0,CHEMBL1913172,Inhibition of VEGFR2 phosphorylation at tyr-1175 in VEGF-stimulated HUVEC preincubated for 1 hr before VEGF induction measured after 5 mins by Western blot analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,HUVEC,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909624,1,Scientific Literature,Bioorg Med Chem Lett,2011,CHEMBL3307501,,,,
CHEMBL306012,,None,300.79,0,4.09,3,CC(C)(C)n1cc(-c2ccc(Cl)cc2)c2c(N)ncnc21,IC50,'=',2680,nM,5.57,,,UO_0000065,18.52,0.36,1.48,9.82,0,CHEMBL817617,Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132739,1,Scientific Literature,Bioorg Med Chem Lett,2000,None,,,,2.68
CHEMBL380068,,None,554.76,2,6.21,39,CCCN(Cc1ccc(-c2[nH]nc3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)s1)C(=O)Nc1cccc(C)c1,IC50,'=',35,nM,7.46,,,UO_0000065,13.44,0.25,1.25,11.05,0,CHEMBL869847,Inhibition of KDR at 1 mM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146863,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,35
CHEMBL3322567,,None,430.44,0,4,14a,O=C1Nc2cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)ccc2/C1=C/c1ccc[nH]1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3362101,Inhibition of VEGFR2 (unknown origin) using poly[Glu:Tyr] substrate by radioisotope-based P81 filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351387,1,Scientific Literature,Eur J Med Chem,2014,None,,,,
CHEMBL3339360,,None,624.64,2,6.75,40,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,'=',560,nM,6.25,,,UO_0000065,10.01,0.19,-0.5,7.33,0,CHEMBL3385131,Inhibition of KDR (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352497,1,Scientific Literature,Eur J Med Chem,2014,None,,,,560
CHEMBL3344216,,None,595.1,2,6.65,2i,CN(C)[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3385742,Inhibition of KDR (unknown origin) by ELISA method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352165,1,Scientific Literature,Eur J Med Chem,2014,None,,,,200000
CHEMBL3344212,,None,649.19,2,8.01,2e,CS(=O)(=O)CC(NC1CCCCC1)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3385742,Inhibition of KDR (unknown origin) by ELISA method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352165,1,Scientific Literature,Eur J Med Chem,2014,None,,,,200000
CHEMBL3344209,,None,567.04,2,6.05,2a,CS(=O)(=O)CC(N)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,'>',200000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3385742,Inhibition of KDR (unknown origin) by ELISA method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352165,1,Scientific Literature,Eur J Med Chem,2014,None,,,,200000
CHEMBL540203,,None,404.31,0,4.12,29,Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)o3)c12,IC50,'=',16000,nM,4.8,,,UO_0000065,11.86,0.23,0.68,3.63,0,CHEMBL864248,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,16
CHEMBL371239,,None,326.43,0,2.68,9f,CN1CCN(C(=O)c2cc3c(-c4ccccc4)[nH]nc3s2)CC1,IC50,'=',4000,nM,5.4,,,UO_0000065,16.54,0.32,2.72,10.33,0,CHEMBL864551,Inhibitory activity against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,4
CHEMBL383172,,None,403.45,0,4,3b,Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc(NC2CCCC2)c1C#N,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL872207,Inhibitory concentration against KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1141103,1,Scientific Literature,J Med Chem,2005,None,,,,30
CHEMBL436968,,None,486.96,0,4.25,31,CC(C)Oc1cc(OCCN2CCOCC2)cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c12,IC50,'=',10000,nM,5,,,UO_0000065,10.27,0.2,0.75,5.73,0,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,10
CHEMBL381206,,None,487,0,4.92,10,COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c1,IC50,'=',30,nM,7.52,,,UO_0000065,15.45,0.3,2.6,9.65,1,CHEMBL855514,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137334,1,Scientific Literature,J Med Chem,2006,None,,,,0.03
CHEMBL381293,,None,427.39,0,4.95,36,FC(F)(F)Oc1cccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)c1,IC50,'=',550,nM,6.26,,,UO_0000065,14.65,0.28,1.31,7.28,0,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.55
CHEMBL381182,,None,411.39,1,5.07,27,FC(F)(F)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1,IC50,'=',58,nM,7.24,,,UO_0000065,17.59,0.33,2.17,9.43,0,CHEMBL864971,Inhibition of VEGFR2 phosphorylation in presence of 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.058
CHEMBL204425,,None,357.42,0,4.36,37,Cc1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1,IC50,'=',2140,nM,5.67,,,UO_0000065,15.86,0.29,1.31,7.39,0,CHEMBL863825,Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,HEK293,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1146931,1,Scientific Literature,Bioorg Med Chem Lett,2006,CHEMBL3307715,,,,2.14
CHEMBL205138,,None,433.56,1,6.79,41,CC(C)(C)c1ccc(NC(=O)c2c(Cn3ccc4cnccc43)ccc3ccccc23)cc1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL866567,Inhibitory activity against VEGFR-2 using 2 uM ATP by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139022,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,
CHEMBL378370,,None,429.88,0,3.49,24,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1CCNC1=O,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL870115,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147701,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,10
CHEMBL3330859,,None,591.16,1,4.61,5i,CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl,Inhibition,'=',53.5,%,,,,UO_0000187,,,,,0,CHEMBL3383515,Inhibition of purified KDR (unknown origin) at 1 uM after 60 mins by ELISA kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352334,1,Scientific Literature,Eur J Med Chem,2014,None,,,,53.5
CHEMBL379372,,None,396.86,0,4.63,11,Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,IC50,'=',50,nM,7.3,,,UO_0000065,,,,,0,CHEMBL864249,Inhibition of KDR by cellular assay,F,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,0.05
CHEMBL211327,,None,388.46,0,4.84,16,Cc1cc(C)c2oc(Nc3ccc(-c4nsc5ncnc(N)c45)cc3)nc2c1,IC50,'=',43000,nM,4.37,,,UO_0000065,11.24,0.21,-0.47,4.25,0,CHEMBL864248,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,43
CHEMBL213510,,None,390.47,0,4.21,14,Cc1cccc(NC(=O)Nc2ccc(Cc3nsc4ncnc(N)c34)cc2)c1,IC50,'=',8600,nM,5.07,,,UO_0000065,12.97,0.25,0.86,4.79,0,CHEMBL864248,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145310,1,Scientific Literature,Bioorg Med Chem Lett,2006,None,,,,8.6
CHEMBL318728,GW549390X,None,236.27,0,4.09,5,c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,IC50,'=',1200,nM,5.92,,,UO_0000065,25.06,0.45,1.83,15.56,0,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142709,1,Scientific Literature,J Med Chem,2005,None,,,,1.2
CHEMBL263769,,None,584.7,2,6.85,27,Cc1cccc(C)c1OC(=O)N(c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1)c1ccc(F)cc1OC(C)C,IC50,'=',4800,nM,5.32,,,UO_0000065,9.1,0.17,-1.53,6.4,0,CHEMBL870980,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145338,1,Scientific Literature,J Med Chem,2006,None,,,,4.8
CHEMBL214775,,None,571.68,2,6.52,37,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN(C)C)cc3)n2)c(OC)c1,IC50,'=',230,nM,6.64,,,UO_0000065,11.61,0.22,0.12,6.75,0,CHEMBL870980,Inhibition of KDR,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145338,1,Scientific Literature,J Med Chem,2006,None,,,,0.23
CHEMBL3309402,,None,677.71,2,7.13,33,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)cc5)c(=O)c5ccccc45)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,'=',70.41,nM,7.15,,,UO_0000065,10.55,0.2,0.02,6.63,0,CHEMBL3367410,Inhibition of VEGFR2 (unknown origin) after 30 mins using poly (Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL210963,,None,434.47,0,1.54,6s,CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N,Ki,'>',8900,nM,,,,UO_0000065,,,,,0,CHEMBL863156,Inhibition of Kdr,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148638,1,Scientific Literature,J Med Chem,2006,None,,,,8900
CHEMBL3288513,,None,396.43,1,5.36,4l,Nc1n[nH]c2cccc(-c3ccc4c(C(=O)Nc5ccc(F)cc5)cccc4c3)c12,IC50,'=',9.2,nM,8.04,,,UO_0000065,20.27,0.37,2.68,9.59,0,CHEMBL3295610,Inhibition of VEGFR-2 (unknown origin) expressed in baculovirus expression system using poly (4 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3288511,,None,396.43,1,5.36,4j,Nc1n[nH]c2cccc(-c3ccc4c(C(=O)Nc5ccccc5F)cccc4c3)c12,IC50,'=',18.7,nM,7.73,,,UO_0000065,19.49,0.35,2.37,9.22,0,CHEMBL3295610,Inhibition of VEGFR-2 (unknown origin) expressed in baculovirus expression system using poly (4 Glu,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264257,,None,374.45,0,2.64,7f,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL3269297,Inhibition of KDR (unknown origin) assessed as residual activity at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,,,,82
CHEMBL3657552,,None,417.47,0,2.57,BDBM138213,CC(=O)c1c[nH]c2ccc(Nc3nccc(-n4cc(CN5CC(O)C5)c(C)n4)n3)cc12,IC50,'=',581,nM,6.24,,272113,UO_0000065,14.94,0.27,3.67,5.57,0,CHEMBL3707826,Kinase Inhibition Assay: Compounds of the invention were initially diluted to 10 mM in 100% DMSO (CALBIOCHEM) for storage and made into kinase buffer solution to create a compound concentration ranging from 1 uM and 10 uM. Serial dilutions of compounds of the invention were dispensed into a 96-well plate (GREINER BIOSCIENCES) at 6 uL each. Purified full-length human SYK,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3297895,,None,273.72,0,4.24,8,Cc1nc(Nc2ccc(Cl)cc2)c2cc(C)oc2n1,IC50,'=',70.2,nM,7.15,,,UO_0000065,26.13,0.51,2.91,14.04,0,CHEMBL3299341,Inhibition of VEGFR2 in human U251 cells by phosphotyrosine ELISA assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U-251,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297731,1,Scientific Literature,Bioorg Med Chem,2014,CHEMBL3307756,,,,70.2
CHEMBL446637,,None,610.19,2,5.59,CER-0262586,O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL965681,Inhibition of KDR at 10 uM by HTRF assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150387,1,Scientific Literature,J Med Chem,2008,None,,,,10
CHEMBL3323594,,None,350.43,1,5.83,7c,Cc1cccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)c1,IC50,'=',6800,nM,5.17,,,UO_0000065,14.75,0.26,-0.66,9.64,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,6.8
CHEMBL3323600,,None,354.39,1,5.66,7i,Fc1cccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)c1,IC50,'=',3520,nM,5.45,,,UO_0000065,15.39,0.28,-0.21,10.17,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,3.52
CHEMBL3323603,,None,370.84,1,6.18,7l,Clc1cccc(-c2nc3ccc(Nc4ccnc5ccccc45)cc3[nH]2)c1,IC50,'=',2400,nM,5.62,,,UO_0000065,15.15,0.28,-0.56,10.48,0,CHEMBL3373860,Inhibition of VEGFR2 (unknown origin) using ATP/substrate peptide after 1 hr by colorimetric ELISA,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352150,1,Scientific Literature,Eur J Med Chem,2014,None,,,,2.4
CHEMBL147761,,None,310.35,0,3.14,9a,Cc1c[nH]c(/C=C2\C(=O)Nc3cccc(C)c32)c1CCC(=O)O,IC50,'=',100,nM,7,,,UO_0000065,,,,,0,CHEMBL696131,Inhibitory activity of compound against VEGF induced cell proliferation,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1132535,1,Scientific Literature,J Med Chem,1999,None,,,,0.1
CHEMBL406804,,None,621.7,2,4.67,32,COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OCCN1CCOCC1,IC50,'=',1700,nM,5.77,,,UO_0000065,9.28,0.17,1.1,4.92,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,1.7
CHEMBL271131,,None,469.51,0,4.72,1,COc1cc(Nc2ncnc(-n3c(Nc4ccccc4)nc4ccccc43)n2)cc(OC)c1OC,IC50,'=',7,nM,8.15,,,UO_0000065,17.37,0.32,3.43,7.53,0,CHEMBL934190,Inhibition of KDR by HTRF assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL1143254,1,Scientific Literature,J Med Chem,2008,None,,,,0.007
CHEMBL3727705,,None,374.4,0,2.62,P-0049,O=C(c1cccc(NS(=O)(=O)C2CCC2)c1F)c1c[nH]c2ncncc12,IC50,'<=',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3734114,Inhibition of KDR (unknown origin) by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727342,38,SureChEMBL Patent Bioactivity Data,,2012,None,,,,10
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
